cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
BRCA	cis	1	rs1000083	chr5:96533469	ERAP2	chr5:96211644-96255398:+	-0.28	-4.05	5.6E-5	Cisplatin-induced ototoxicity	
BRCA	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.33	7.52	1.15E-13	Crohn's disease	
BRCA	cis	1	rs10003641	chr4:71340427	AMTN	chr4:71384298-71398459:+	0.26	7.54	1.01E-13	Alcoholism (heaviness of drinking)	
BRCA	cis	1	rs10005932	chr4:122664782	EXOSC9	chr4:122722472-122738175:+	0.13	4.27	2.1E-5	Type 2 diabetes	
BRCA	cis	1	rs10007119	chr4:3473066	LRPAP1	chr4:3514290-3534224:-	0.11	3.85	0.000127	Triglycerides;Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs10007789	chr4:165890377	TRIM61	chr4:165875600-165898818:-	0.25	7.81	1.35E-14	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.21	-5.34	1.13E-7	Longevity	
BRCA	cis	1	rs10011835	chr4:71340722	AMTN	chr4:71384298-71398459:+	0.26	7.59	7.07E-14	Alcoholism (heaviness of drinking)	
BRCA	cis	1	rs10012335	chr4:17628630	MED28	chr4:17616273-17629791:+	0.14	3.63	0.000301	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs1001373	chr1:171684506	VAMP4	chr1:171669298-171711214:-	0.19	5.4	8.1E-8	Hippocampal atrophy	
BRCA	cis	1	rs10016433	chr4:122664771	EXOSC9	chr4:122722472-122738175:+	0.13	4.27	2.1E-5	Type 2 diabetes	
BRCA	cis	1	rs10017445	chr4:68423787	STAP1	chr4:68424446-68473053:+	-0.17	-6.16	1.02E-9	Parkinson's disease	
BRCA	cis	1	rs10018049	chr4:39117401	KLHL5	chr4:39046659-39123828:+	-0.16	-5.03	5.75E-7	Uric acid levels	
BRCA	cis	1	rs10023907	chr4:88772535	SPP1	chr4:88896802-88904562:+	-0.18	-5.76	1.07E-8	Bone mineral density;Bone mineral density (paediatric, total body less head)	
BRCA	cis	1	rs10026676	chr4:56478752	SRD5A3	chr4:56212409-56237866:+	-0.17	-4.33	1.65E-5	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs1002675	chr3:38445226	XYLB	chr3:38388251-38456467:+	0.19	5.68	1.7E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs1002676	chr3:38444932	LOC100128640	chr3:38492524-38496311:-	-0.14	-3.78	0.000165	Electrocardiographic conduction measures	
BRCA	cis	1	rs1002676	chr3:38444932	XYLB	chr3:38388251-38456467:+	-0.21	-6.3	4.29E-10	Electrocardiographic conduction measures	
BRCA	cis	1	rs10026775	chr4:39116775	KLHL5	chr4:39046659-39123828:+	-0.16	-4.99	7.02E-7	Uric acid levels	
BRCA	cis	1	rs10027325	chr4:282608	ZNF718	chr4:53272-156488:+	0.29	6.77	2.08E-11	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs10027437	chr4:103557251	MANBA	chr4:103552644-103682151:-	0.19	4.97	7.68E-7	Primary biliary cirrhosis	
BRCA	cis	1	rs10027813	chr4:39121438	KLHL5	chr4:39046659-39123828:+	-0.15	-4.71	2.77E-6	Uric acid levels	
BRCA	cis	1	rs10029851	chr4:109628025	LOC285456	chr4:109459346-109541613:-	0.25	5.25	1.82E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs10030019	chr4:106998448	TBCK	chr4:106967233-107237861:-	0.23	7.28	6.31E-13	Airflow obstruction	
BRCA	cis	1	rs10030904	chr4:39115223	KLHL5	chr4:39046659-39123828:+	-0.16	-5.01	6.29E-7	Uric acid levels	
BRCA	cis	1	rs10031525	chr4:54519579	LNX1	chr4:54326439-54518682:-	0.13	3.45	0.000582	Beard thickness	
BRCA	cis	1	rs10032326	chr4:17630717	MED28	chr4:17616273-17629791:+	0.14	3.61	0.000325	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs10036292	chr5:115595871	COMMD10	chr5:115420727-115628978:+	0.22	4.57	5.42E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs10037055	chr5:176691279	MXD3	chr5:176732501-176739292:-	0.11	4.77	2.08E-6	Migraine without aura	
BRCA	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.25	-7.74	2.36E-14	Eye color traits	
BRCA	cis	1	rs10037872	chr5:82439920	XRCC4	chr5:82373317-82649577:+	-0.12	-3.57	0.000372	Hypertension	
BRCA	cis	1	rs10041281	chr5:172886305	ATP6V0E1	chr5:172410763-172461900:+	-0.1	-3.4	0.000702	Stroke	
BRCA	cis	1	rs10042854	chr5:82439695	TMEM167A	chr5:82348667-82373272:-	0.12	4.23	2.54E-5	Hypertension	
BRCA	cis	1	rs10042854	chr5:82439695	XRCC4	chr5:82373317-82649577:+	0.15	4.22	2.63E-5	Hypertension	
BRCA	cis	1	rs10043018	chr5:82434317	XRCC4	chr5:82373317-82649577:+	-0.12	-3.54	0.000411	Hypertension	
BRCA	cis	1	rs10043228	chr5:115597048	COMMD10	chr5:115420727-115628978:+	0.22	4.57	5.36E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs1004467	chr10:104594507	SFXN2	chr10:104474298-104498946:+	-0.22	-4.49	7.77E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs10046678	chr8:23816123	CHMP7	chr8:23101150-23119512:+	-0.16	-3.42	0.000658	Subcutaneous adipose tissue	
BRCA	cis	1	rs10046678	chr8:23816123	ENTPD4	chr8:23243442-23315244:-	-0.13	-3.44	0.000599	Subcutaneous adipose tissue	
BRCA	cis	1	rs10046678	chr8:23816123	RHOBTB2	chr8:22844930-22877710:+	-0.15	-4.01	6.55E-5	Subcutaneous adipose tissue	
BRCA	cis	1	rs1004868	chr2:231038910	SP110	chr2:231033645-231084827:-	0.21	4.08	4.79E-5	Obesity-related traits	
BRCA	cis	1	rs1004869	chr2:231039271	SP110	chr2:231033645-231084827:-	0.21	4.05	5.42E-5	Obesity-related traits	
BRCA	cis	1	rs10051240	chr5:115569931	COMMD10	chr5:115420727-115628978:+	0.21	4.49	7.77E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.75	18.4	7.24E-66	Type 2 diabetes	
BRCA	cis	1	rs10055844	chr5:82437095	XRCC4	chr5:82373317-82649577:+	-0.12	-3.45	0.000584	Hypertension	
BRCA	cis	1	rs10055868	chr5:115471612	COMMD10	chr5:115420727-115628978:+	0.24	5.08	4.56E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs10055948	chr5:82439256	XRCC4	chr5:82373317-82649577:+	-0.12	-3.54	0.000421	Hypertension	
BRCA	cis	1	rs10062350	chr5:115453497	COMMD10	chr5:115420727-115628978:+	0.23	4.57	5.52E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs10066259	chr5:115451892	COMMD10	chr5:115420727-115628978:+	0.21	4.16	3.51E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs10068	chr17:33901965	SLFN12L	chr17:33801926-33864880:-	0.09	4.83	1.57E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs10073364	chr5:115592582	COMMD10	chr5:115420727-115628978:+	0.22	4.57	5.42E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs10076701	chr5:131596419	PDLIM4	chr5:131593351-131609145:+	-0.16	-5.57	3.31E-8	Blood metabolite levels	
BRCA	cis	1	rs10076701	chr5:131596419	SLC22A5	chr5:131705401-131731302:+	-0.13	-4.84	1.5E-6	Blood metabolite levels	
BRCA	cis	1	rs10077862	chr5:82437141	XRCC4	chr5:82373317-82649577:+	-0.12	-3.45	0.000584	Hypertension	
BRCA	cis	1	rs10079394	chr5:115600919	COMMD10	chr5:115420727-115628978:+	0.23	4.82	1.66E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs10082611	chr11:27320108	LGR4	chr11:27387510-27494334:-	0.15	4.4	1.22E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10082678	chr11:27320448	LGR4	chr11:27387510-27494334:-	-0.16	-4.47	8.81E-6	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10082679	chr11:27320658	LGR4	chr11:27387510-27494334:-	0.15	4.27	2.16E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10083488	chr14:65853346	LOC645431	chr14:65877313-65879335:-	-0.23	-4.82	1.64E-6	Ischemic stroke	
BRCA	cis	1	rs1009051	chr3:49521549	AMT	chr3:49454212-49460012:-	0.14	4.76	2.18E-6	Menarche (age at onset)	
BRCA	cis	1	rs1009051	chr3:49521549	CCDC36	chr3:49235861-49295537:+	0.1	3.94	8.84E-5	Menarche (age at onset)	
BRCA	cis	1	rs1009051	chr3:49521549	GMPPB	chr3:49758932-49761384:-	-0.12	-3.58	0.000353	Menarche (age at onset)	
BRCA	cis	1	rs1009051	chr3:49521549	NCKIPSD	chr3:48711280-48723334:-	0.16	4.01	6.48E-5	Menarche (age at onset)	
BRCA	cis	1	rs1009051	chr3:49521549	P4HTM	chr3:49027341-49044579:+	0.09	3.78	0.000168	Menarche (age at onset)	
BRCA	cis	1	rs1009051	chr3:49521549	WDR6	chr3:49044637-49053386:+	-0.15	-4.61	4.6E-6	Menarche (age at onset)	
BRCA	cis	1	rs1009170	chr14:92636713	NDUFB1	chr14:92582470-92588153:-	0.12	4.06	5.32E-5	Dialysis-related mortality	
BRCA	cis	1	rs10093594	chr8:96033236	C8orf38	chr8:95908040-96088396:+	0.15	3.56	0.000394	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs10096455	chr8:96041250	C8orf38	chr8:95908040-96088396:+	-0.18	-4.46	9.09E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs10097215	chr8:2506899	CLN8	chr8:1711870-1734735:+	0.24	4.18	3.14E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
BRCA	cis	1	rs10098197	chr8:96042890	C8orf38	chr8:95908040-96088396:+	-0.18	-4.47	8.83E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs10098453	chr8:96029756	C8orf38	chr8:95908040-96088396:+	0.14	3.38	0.000741	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs1010117	chr20:23608421	CST1	chr20:23728191-23731574:-	0.21	4.55	6.04E-6	Chronic kidney disease	
BRCA	cis	1	rs10106491	chr8:96038959	C8orf38	chr8:95908040-96088396:+	-0.18	-4.39	1.26E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs10110267	chr8:92073814	LRRC69	chr8:92114847-92231464:+	-0.17	-4.29	1.98E-5	Migraine - clinic-based	
BRCA	cis	1	rs1011054	chr4:120202387	MAD2L1	chr4:120980579-120988013:-	0.08	3.51	0.000475	Corneal astigmatism	
BRCA	cis	1	rs10110591	chr8:8576608	CLDN23	chr8:8559666-8561616:+	0.16	4.09	4.72E-5	Obesity-related traits	
BRCA	cis	1	rs10110591	chr8:8576608	ERI1	chr8:8860314-8890849:+	0.17	4.38	1.3E-5	Obesity-related traits	
BRCA	cis	1	rs10110591	chr8:8576608	PPP1R3B	chr8:8993774-9009084:-	0.16	4.23	2.49E-5	Obesity-related traits	
BRCA	cis	1	rs10110591	chr8:8576608	TNKS	chr8:9413445-9639855:+	0.13	3.89	0.000105	Obesity-related traits	
BRCA	cis	1	rs10112230	chr8:96038072	C8orf38	chr8:95908040-96088396:+	-0.18	-4.39	1.26E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.36	-10.03	1.12E-22	Rheumatoid arthritis	
BRCA	cis	1	rs10117059	chr9:123653477	TRAF1	chr9:123664672-123691479:-	0.1	4.75	2.36E-6	Rheumatoid arthritis	
BRCA	cis	1	rs1012376	chr14:65294790	CHURC1	chr14:65381140-65411309:+	0.27	4.48	8.09E-6	Daytime sleep phenotypes	
BRCA	cis	1	rs1012603	chr2:55274531	CCDC88A	chr2:55514978-55647057:-	-0.16	-3.46	0.000563	Refractive astigmatism	
BRCA	cis	1	rs10127539	chr1:110620117	ALX3	chr1:110602998-110613322:-	-0.14	-4.17	3.36E-5	Blood metabolite levels	
BRCA	cis	1	rs10136948	chr14:75511075	EIF2B2	chr14:75469612-75476292:+	0.19	5.35	1.07E-7	Height	
BRCA	cis	1	rs10136948	chr14:75511075	MLH3	chr14:75480467-75518235:-	0.21	6.44	1.76E-10	Height	
BRCA	cis	1	rs10139204	chr14:24382905	AP1G2	chr14:24028777-24037279:-	-0.19	-3.82	0.000139	Bipolar disorder	
BRCA	cis	1	rs10139204	chr14:24382905	CMA1	chr14:24974712-24977471:-	-0.16	-3.41	0.000673	Bipolar disorder	
BRCA	cis	1	rs10139204	chr14:24382905	NGDN	chr14:23938898-23947401:+	-0.21	-3.47	0.000534	Bipolar disorder	
BRCA	cis	1	rs10139204	chr14:24382905	RABGGTA	chr14:24734746-24740803:-	-0.19	-3.64	0.000286	Bipolar disorder	
BRCA	cis	1	rs10139288	chr14:52506486	NID2	chr14:52471521-52535946:-	0.08	3.56	0.000384	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs1014244	chr10:118466150	C10orf82	chr10:118423208-118429775:-	-0.13	-3.76	0.000181	Age at smoking initiation in chronic obstructive pulmonary disease	
BRCA	cis	1	rs1014246	chr10:118466042	C10orf82	chr10:118423208-118429775:-	-0.13	-3.76	0.000181	Age at smoking initiation in chronic obstructive pulmonary disease	
BRCA	cis	1	rs1014897	chr20:895457	PSMF1	chr20:1093906-1148424:+	-0.14	-3.46	0.000567	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs10149651	chr14:104394440	TDRD9	chr14:104394817-104519002:+	-0.41	-10.56	7.07E-25	Bipolar disorder	
BRCA	cis	1	rs10149880	chr14:75633008	EIF2B2	chr14:75469612-75476292:+	-0.2	-5.56	3.45E-8	Height	
BRCA	cis	1	rs10149880	chr14:75633008	MLH3	chr14:75480467-75518235:-	-0.22	-6.95	6.54E-12	Height	
BRCA	cis	1	rs10153800	chr2:242179134	FARP2	chr2:242295711-242434255:+	0.14	3.59	0.000342	Chronic lymphocytic leukemia	
BRCA	cis	1	rs10155014	chr3:49432321	AMT	chr3:49454212-49460012:-	0.14	4.97	7.82E-7	Menarche (age at onset)	
BRCA	cis	1	rs10155014	chr3:49432321	CCDC36	chr3:49235861-49295537:+	0.1	3.86	0.000122	Menarche (age at onset)	
BRCA	cis	1	rs10155014	chr3:49432321	NCKIPSD	chr3:48711280-48723334:-	0.17	4.28	2.02E-5	Menarche (age at onset)	
BRCA	cis	1	rs10155014	chr3:49432321	P4HTM	chr3:49027341-49044579:+	0.1	4.12	4.11E-5	Menarche (age at onset)	
BRCA	cis	1	rs10155014	chr3:49432321	WDR6	chr3:49044637-49053386:+	-0.14	-4.34	1.56E-5	Menarche (age at onset)	
BRCA	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.82	-27.84	1.19E-128	Homocysteine levels	
BRCA	cis	1	rs10157597	chr1:45990278	MMACHC	chr1:45965856-45976737:+	-0.15	-4.33	1.66E-5	Homocysteine levels	
BRCA	cis	1	rs10160456	chr11:27336704	LGR4	chr11:27387510-27494334:-	0.15	4.22	2.66E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10160687	chr11:27337183	LGR4	chr11:27387510-27494334:-	0.15	4.22	2.66E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10160868	chr12:62795433	FAM19A2	chr12:62102043-62653925:-	0.17	3.75	0.000185	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10160955	chr12:62793195	FAM19A2	chr12:62102043-62653925:-	0.17	3.66	0.000266	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10163148	chr15:31212684	MTMR15	chr15:31196055-31235307:+	0.14	3.53	0.000438	Hypertriglyceridemia	
BRCA	cis	1	rs10164319	chr19:18569833	LRRC25	chr19:18501955-18508421:-	-0.15	-7.18	1.27E-12	Breast cancer	
BRCA	cis	1	rs10164323	chr19:18569492	LRRC25	chr19:18501955-18508421:-	-0.14	-6.91	8.06E-12	Breast cancer	
BRCA	cis	1	rs10165098	chr2:27796526	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.03	6.02E-5	Oral cavity cancer	
BRCA	cis	1	rs10165485	chr2:54481636	C2orf73	chr2:54558071-54588714:+	0.18	4.59	5.05E-6	Telomere length	
BRCA	cis	1	rs10165527	chr2:43782868	LOC100129726	chr2:43454350-43455994:+	0.12	3.55	0.0004	Glomerular filtration rate (creatinine)	
BRCA	cis	1	rs10165561	chr2:234172915	SAG	chr2:234216309-234255701:+	0.13	4.04	5.75E-5	Crohn's disease	
BRCA	cis	1	rs10166544	chr2:160140799	WDSUB1	chr2:160092305-160143236:-	0.31	3.7	0.000226	Sudden cardiac arrest	
BRCA	cis	1	rs10170846	chr2:223517705	FARSB	chr2:223436162-223520827:-	-0.16	-4.67	3.4E-6	Schizophrenia (inflammation and infection response interaction)	
BRCA	cis	1	rs1017280	chr4:55011123	FIP1L1	chr4:54243820-54326102:+	-0.19	-4.25	2.29E-5	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs1017302	chr12:9367402	LOC642846	chr12:9436253-9466684:+	0.14	4.78	2.0E-6	Non-alcoholic fatty liver disease histology (AST)	
BRCA	cis	1	rs10173181	chr2:17780733	GEN1	chr2:17935162-17966632:+	0.14	3.39	0.000735	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs1017697	chr2:219170462	GPBAR1	chr2:219125738-219128582:+	-0.27	-4.97	7.88E-7	Smooth-surface caries	
BRCA	cis	1	rs1017698	chr2:219170525	TMBIM1	chr2:219138917-219157280:-	-0.15	-4.56	5.73E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs10177970	chr2:37512968	CEBPZ	chr2:37428778-37458740:-	0.17	5.43	6.87E-8	Chronic lymphocytic leukemia	
BRCA	cis	1	rs10178975	chr2:37514564	CEBPZ	chr2:37428778-37458740:-	-0.17	-5.31	1.33E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs10178982	chr2:202227640	ALS2CR12	chr2:202153148-202222101:-	-0.2	-5.3	1.39E-7	Basal cell carcinoma	
BRCA	cis	1	rs10178982	chr2:202227640	PPIL3	chr2:201735680-201753999:-	-0.15	-4.08	4.87E-5	Basal cell carcinoma	
BRCA	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.55	17.78	3.7E-62	Response to antipsychotic treatment	
BRCA	cis	1	rs10183486	chr2:171990971	MAP1D	chr2:172864804-172945586:+	-0.15	-3.87	0.000114	Menopause (age at onset)	
BRCA	cis	1	rs10183486	chr2:171990971	TLK1	chr2:171847333-172087824:-	-0.15	-4.73	2.53E-6	Menopause (age at onset)	
BRCA	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.22	5.37	9.75E-8	Metabolite levels	
BRCA	cis	1	rs1018741	chr21:34686345	IFNAR1	chr21:34696734-34732126:+	0.13	3.4	0.000692	Narcolepsy	
BRCA	cis	1	rs1018742	chr21:34686381	IFNAR1	chr21:34696734-34732126:+	0.13	3.4	0.000692	Narcolepsy	
BRCA	cis	1	rs10187501	chr2:165532454	SLC38A11	chr2:165754812-165812035:-	0.17	5.02	6.14E-7	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
BRCA	cis	1	rs10189996	chr2:240908800	NDUFA10	chr2:240900158-240964798:-	0.27	6.86	1.13E-11	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.28	7.04	3.32E-12	Metabolite levels	
BRCA	cis	1	rs1019217	chr11:22842622	GAS2	chr11:22688160-22834546:+	0.11	3.4	0.000708	Dialysis-related mortality	
BRCA	cis	1	rs1019217	chr11:22842622	SVIP	chr11:22843600-22851382:-	0.24	6.72	3.04E-11	Dialysis-related mortality	
BRCA	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.69	-20.4	2.44E-78	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs10193383	chr2:219157692	GPBAR1	chr2:219125738-219128582:+	-0.11	-3.72	0.000208	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs10193383	chr2:219157692	TMBIM1	chr2:219138917-219157280:-	0.13	3.93	9.11E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs10193610	chr2:240940618	NDUFA10	chr2:240900158-240964798:-	0.28	7.35	3.85E-13	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs10194090	chr2:160110579	WDSUB1	chr2:160092305-160143236:-	0.33	4.08	4.81E-5	Sudden cardiac arrest	
BRCA	cis	1	rs10196279	chr2:160116291	WDSUB1	chr2:160092305-160143236:-	0.3	3.71	0.000215	Sudden cardiac arrest	
BRCA	cis	1	rs10199101	chr2:160081949	WDSUB1	chr2:160092305-160143236:-	0.27	3.4	0.00069	Sudden cardiac arrest	
BRCA	cis	1	rs10205364	chr2:27794233	KRTCAP3	chr2:27665263-27667163:+	-0.13	-3.96	8.05E-5	Oral cavity cancer	
BRCA	cis	1	rs10205487	chr2:70151471	ANXA4	chr2:69969127-70053594:+	0.13	3.9	0.000102	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs10206064	chr2:219157959	GPBAR1	chr2:219125738-219128582:+	-0.11	-3.72	0.000208	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs10206064	chr2:219157959	TMBIM1	chr2:219138917-219157280:-	0.13	3.93	9.11E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs10206231	chr2:202229225	ALS2CR12	chr2:202153148-202222101:-	-0.2	-5.17	2.76E-7	Basal cell carcinoma	
BRCA	cis	1	rs10206231	chr2:202229225	PPIL3	chr2:201735680-201753999:-	-0.15	-4.09	4.59E-5	Basal cell carcinoma	
BRCA	cis	1	rs10206993	chr2:240900919	NDUFA10	chr2:240900158-240964798:-	0.25	6.75	2.48E-11	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs10208155	chr2:61115039	AHSA2	chr2:61404553-61414058:+	-0.12	-4.93	9.69E-7	Inflammatory skin disease	
BRCA	cis	1	rs10208155	chr2:61115039	C2orf74	chr2:61372243-61391964:+	0.28	6.05	1.95E-9	Inflammatory skin disease	
BRCA	cis	1	rs10208728	chr2:219917303	GLB1L	chr2:220101505-220110131:-	-0.2	-3.66	0.000269	Height	
BRCA	cis	1	rs10209620	chr2:61173941	AHSA2	chr2:61404553-61414058:+	-0.11	-4.58	5.18E-6	Inflammatory skin disease	
BRCA	cis	1	rs10209620	chr2:61173941	C2orf74	chr2:61372243-61391964:+	0.27	5.89	5.23E-9	Inflammatory skin disease	
BRCA	cis	1	rs10212259	chr3:123811210	CCDC14	chr3:123632276-123680255:-	0.18	3.46	0.000555	PR interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs10212259	chr3:123811210	SEC22A	chr3:122920774-122992980:+	0.29	3.74	0.000192	PR interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs10212259	chr3:123811210	UMPS	chr3:124449213-124464038:+	0.27	4	6.73E-5	PR interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs10214634	chr6:26564582	BTN2A3	chr6:26422317-26431927:+	0.16	5.37	9.72E-8	Educational attainment	
BRCA	cis	1	rs10214634	chr6:26564582	C6orf41	chr6:26924772-26991752:+	-0.13	-4.01	6.6E-5	Educational attainment	
BRCA	cis	1	rs10214634	chr6:26564582	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.58	0.000364	Educational attainment	
BRCA	cis	1	rs10215453	chr7:77488678	PHTF2	chr7:77428109-77586818:+	-0.15	-4.46	9.16E-6	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs10218458	chr1:107571327	NTNG1	chr1:107682629-108024471:+	0.16	3.45	0.000573	AIDS	
BRCA	cis	1	rs10218458	chr1:107571327	PRMT6	chr1:107599267-107601907:+	0.23	4.72	2.72E-6	AIDS	
BRCA	cis	1	rs10220371	chr14:88501852	ZC3H14	chr14:89029253-89079852:+	0.19	4.24	2.4E-5	Multiple sclerosis	
BRCA	cis	1	rs10223664	chr6:98677699	C6orf167	chr6:97590038-97731061:-	0.14	3.4	0.000705	Quantitative traits	
BRCA	cis	1	rs10228845	chr7:21583617	DNAH11	chr7:21582833-21941455:+	-0.23	-6.57	7.9E-11	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
BRCA	cis	1	rs10229224	chr7:21583921	DNAH11	chr7:21582833-21941455:+	-0.23	-6.44	1.82E-10	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
BRCA	cis	1	rs10234018	chr7:66146284	CRCP	chr7:65579805-65619551:+	0.15	3.96	8.05E-5	Aortic root size	
BRCA	cis	1	rs10234018	chr7:66146284	LOC493754	chr7:65993446-66057363:-	0.15	3.94	8.62E-5	Aortic root size	
BRCA	cis	1	rs10235395	chr7:12286050	VWDE	chr7:12370509-12443852:-	-0.15	-4.04	5.8E-5	Response to amphetamines	
BRCA	cis	1	rs1023586	chr14:81462283	TSHR	chr14:81421869-81612646:+	-0.13	-3.86	0.00012	Graves' disease	
BRCA	cis	1	rs10236369	chr7:12280838	VWDE	chr7:12370509-12443852:-	-0.13	-3.67	0.000259	Response to amphetamines	
BRCA	cis	1	rs10239908	chr7:87497323	DBF4	chr7:87505544-87538856:+	0.13	3.47	0.000532	Bone mineral density (spine) and age at menarche	
BRCA	cis	1	rs10242018	chr7:110929652	IMMP2L	chr7:110303110-111202538:-	0.15	4.17	3.29E-5	Schizophrenia	
BRCA	cis	1	rs10242542	chr7:117522914	CTTNBP2	chr7:117350708-117513561:-	-0.13	-3.93	9.0E-5	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs10243198	chr7:142822210	TMEM139	chr7:142982044-142985140:+	-0.2	-3.43	0.000631	Dermatomyositis	
BRCA	cis	1	rs10245031	chr7:117498461	CTTNBP2	chr7:117350708-117513561:-	-0.14	-4.09	4.62E-5	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs10247443	chr7:50620586	FIGNL1	chr7:50511834-50518088:-	-0.13	-4.58	5.28E-6	Malaria	
BRCA	cis	1	rs10247526	chr7:65780696	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.49	1.3E-10	Diabetic kidney disease	
BRCA	cis	1	rs10247526	chr7:65780696	CRCP	chr7:65579805-65619551:+	0.22	3.69	0.000238	Diabetic kidney disease	
BRCA	cis	1	rs10247526	chr7:65780696	LOC493754	chr7:65993446-66057363:-	-0.22	-3.68	0.00025	Diabetic kidney disease	
BRCA	cis	1	rs10250513	chr7:50621488	FIGNL1	chr7:50511834-50518088:-	-0.12	-4.28	2.04E-5	Malaria	
BRCA	cis	1	rs10252765	chr7:66228732	TYW1	chr7:66461817-66704496:+	0.15	4.13	3.99E-5	Aortic root size	
BRCA	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.36	10.21	2.02E-23	Longevity;Endometriosis	
BRCA	cis	1	rs10270805	chr7:16500142	ISPD	chr7:16127152-16460947:-	-0.23	-3.44	0.000614	Response to statin therapy	
BRCA	cis	1	rs1027087	chr12:26470850	BHLHE41	chr12:26272961-26278003:-	0.13	3.64	0.000288	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs1027087	chr12:26470850	SSPN	chr12:26348269-26405853:+	0.11	3.6	0.000333	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs10270960	chr7:117525639	CTTNBP2	chr7:117350708-117513561:-	-0.14	-4.26	2.18E-5	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs10274773	chr7:66133578	CRCP	chr7:65579805-65619551:+	0.13	3.38	0.000758	Aortic root size	
BRCA	cis	1	rs10274773	chr7:66133578	TYW1	chr7:66461817-66704496:+	-0.15	-4.02	6.33E-5	Aortic root size	
BRCA	cis	1	rs10279537	chr7:77474961	PHTF2	chr7:77428109-77586818:+	-0.15	-4.43	1.06E-5	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs1028390	chr6:55935791	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs1029740	chr7:22873586	TOMM7	chr7:22852254-22862421:-	-0.15	-4.88	1.22E-6	Fibrinogen	
BRCA	cis	1	rs1030136	chr2:190735660	ORMDL1	chr2:190634994-190649097:-	0.22	3.69	0.000238	Subcutaneous adipose tissue	
BRCA	cis	1	rs1030420	chr8:67360725	C8orf46	chr8:67405491-67430757:+	0.16	3.96	7.94E-5	Blood metabolite levels	
BRCA	cis	1	rs1031902	chr5:82448127	XRCC4	chr5:82373317-82649577:+	-0.12	-3.56	0.00038	Hypertension	
BRCA	cis	1	rs1033667	chr22:29130300	HSCB	chr22:29138043-29153488:+	0.12	3.48	0.000522	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs1033667	chr22:29130300	LOC284900	chr22:28315364-28404267:+	0.13	3.4	0.000697	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs1034219	chr1:93022678	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	9.0E-7	Cholesterol, total	
BRCA	cis	1	rs1035142	chr2:202153078	ALS2CR12	chr2:202153148-202222101:-	-0.28	-7.4	2.73E-13	Melanoma;Esophageal squamous cell carcinoma	
BRCA	cis	1	rs1036036	chr4:39112724	KLHL5	chr4:39046659-39123828:+	-0.15	-4.72	2.65E-6	Uric acid levels	
BRCA	cis	1	rs1036037	chr4:39112892	KLHL5	chr4:39046659-39123828:+	-0.16	-4.99	7.04E-7	Uric acid levels	
BRCA	cis	1	rs1036038	chr4:39113003	KLHL5	chr4:39046659-39123828:+	-0.16	-4.91	1.06E-6	Uric acid levels	
BRCA	cis	1	rs1037036	chr17:18764077	FAM18B	chr17:18684582-18710026:+	-0.17	-4.66	3.62E-6	Educational attainment (years of education)	
BRCA	cis	1	rs1037036	chr17:18764077	LOC220594	chr17:18414577-18445234:-	-0.17	-4.02	6.23E-5	Educational attainment (years of education)	
BRCA	cis	1	rs1039302	chr12:121236258	SPPL3	chr12:121201036-121342151:-	0.18	4.07	4.95E-5	Quantitative traits	
BRCA	cis	1	rs1039438	chr5:156476770	TIMD4	chr5:156346293-156390266:-	-0.13	-3.45	0.000587	Hypertriglyceridemia	
BRCA	cis	1	rs1039664	chr7:65449716	CCT6P1	chr7:65216092-65228661:+	0.33	7.19	1.21E-12	Diabetic kidney disease	
BRCA	cis	1	rs1039664	chr7:65449716	LOC493754	chr7:65993446-66057363:-	0.2	3.49	0.000504	Diabetic kidney disease	
BRCA	cis	1	rs1039664	chr7:65449716	ZNF117	chr7:64434830-64467121:-	-0.26	-4.73	2.55E-6	Diabetic kidney disease	
BRCA	cis	1	rs10402468	chr19:17384003	ANKLE1	chr19:17392454-17398454:+	0.21	5.85	6.44E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10402468	chr19:17384003	ANO8	chr19:17434032-17445638:-	0.15	3.68	0.000242	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10402468	chr19:17384003	OCEL1	chr19:17337055-17340027:+	0.17	5.08	4.54E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10402468	chr19:17384003	PLVAP	chr19:17462264-17488137:-	-0.09	-3.44	0.000613	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10403249	chr19:18604942	LRRC25	chr19:18501955-18508421:-	-0.14	-6.98	5.1E-12	Breast cancer	
BRCA	cis	1	rs10403540	chr19:39204846	LGALS7	chr19:39261608-39264157:-	-0.2	-6.16	1.03E-9	Heart rate	
BRCA	cis	1	rs10405457	chr19:44296582	LYPD5	chr19:44300080-44324808:-	-0.14	-4.02	6.26E-5	Breast cancer	
BRCA	cis	1	rs10405457	chr19:44296582	ZNF155	chr19:44488355-44502477:+	-0.13	-3.57	0.000377	Breast cancer	
BRCA	cis	1	rs10405457	chr19:44296582	ZNF404	chr19:44376516-44384288:-	-0.2	-5.51	4.42E-8	Breast cancer	
BRCA	cis	1	rs10405636	chr19:18538742	LRRC25	chr19:18501955-18508421:-	-0.14	-6.97	5.61E-12	Breast cancer	
BRCA	cis	1	rs10406778	chr19:39170473	LGALS7	chr19:39261608-39264157:-	-0.18	-5.67	1.87E-8	Heart rate	
BRCA	cis	1	rs10406920	chr19:17389648	ANKLE1	chr19:17392454-17398454:+	0.21	5.96	3.37E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10406920	chr19:17389648	OCEL1	chr19:17337055-17340027:+	0.15	4.55	5.88E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10406920	chr19:17389648	PLVAP	chr19:17462264-17488137:-	-0.09	-3.51	0.00047	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs1040726	chr20:3264267	ITPA	chr20:3190056-3204504:+	-0.14	-4.03	6.02E-5	IFN-related cytopenia	
BRCA	cis	1	rs1040727	chr20:3264292	ITPA	chr20:3190056-3204504:+	-0.15	-4.24	2.42E-5	IFN-related cytopenia	
BRCA	cis	1	rs10408585	chr19:22613247	ZNF257	chr19:22235266-22273901:+	-0.21	-3.47	0.000549	Dental caries;Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs10409483	chr19:18590223	LRRC25	chr19:18501955-18508421:-	-0.14	-6.82	1.55E-11	Breast cancer	
BRCA	cis	1	rs10409485	chr19:41920765	B3GNT8	chr19:41931265-41934635:-	0.25	7.69	3.33E-14	Height	
BRCA	cis	1	rs10409505	chr19:18590251	LRRC25	chr19:18501955-18508421:-	-0.14	-6.82	1.55E-11	Breast cancer	
BRCA	cis	1	rs10411009	chr19:18606266	LRRC25	chr19:18501955-18508421:-	-0.13	-6.62	5.57E-11	Breast cancer	
BRCA	cis	1	rs10412219	chr19:33413246	SLC7A9	chr19:33321421-33360683:-	-0.19	-5.46	5.93E-8	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
BRCA	cis	1	rs10412972	chr19:52154905	KLK14	chr19:51581154-51587502:-	-0.17	-3.49	0.000501	Plasma plasminogen levels	
BRCA	cis	1	rs10412972	chr19:52154905	SIGLEC14	chr19:52145808-52150132:-	-0.18	-4.36	1.45E-5	Plasma plasminogen levels	
BRCA	cis	1	rs10412972	chr19:52154905	ZNF577	chr19:52359056-52394145:-	-0.16	-3.44	0.000614	Plasma plasminogen levels	
BRCA	cis	1	rs10413462	chr19:12054636	ZNF763	chr19:12035900-12091196:+	-0.35	-5.92	4.27E-9	Multiple sclerosis	
BRCA	cis	1	rs10413735	chr19:41921071	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.34	4.36E-13	Height	
BRCA	cis	1	rs10415219	chr19:39150235	LGALS7	chr19:39261608-39264157:-	-0.17	-5.28	1.53E-7	Heart rate	
BRCA	cis	1	rs10416654	chr19:17385176	ANKLE1	chr19:17392454-17398454:+	0.21	5.95	3.59E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10416654	chr19:17385176	ANO8	chr19:17434032-17445638:-	0.14	3.47	0.000547	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10416654	chr19:17385176	OCEL1	chr19:17337055-17340027:+	0.15	4.63	4.02E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10417311	chr19:41902038	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.37	3.52E-13	Height	
BRCA	cis	1	rs10417997	chr19:41902361	B3GNT8	chr19:41931265-41934635:-	-0.21	-6.62	5.61E-11	Height	
BRCA	cis	1	rs10418154	chr19:17386006	ANKLE1	chr19:17392454-17398454:+	0.21	5.88	5.55E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10418154	chr19:17386006	ANO8	chr19:17434032-17445638:-	0.14	3.46	0.000572	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10418154	chr19:17386006	OCEL1	chr19:17337055-17340027:+	0.15	4.6	4.75E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10418362	chr19:17386107	ANKLE1	chr19:17392454-17398454:+	0.2	5.8	8.96E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10418362	chr19:17386107	ANO8	chr19:17434032-17445638:-	0.14	3.44	0.000595	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10418362	chr19:17386107	OCEL1	chr19:17337055-17340027:+	0.15	4.66	3.55E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs10421887	chr19:44294849	LYPD5	chr19:44300080-44324808:-	0.13	3.82	0.000142	Breast cancer	
BRCA	cis	1	rs10421887	chr19:44294849	ZNF155	chr19:44488355-44502477:+	0.14	3.83	0.000135	Breast cancer	
BRCA	cis	1	rs10421887	chr19:44294849	ZNF404	chr19:44376516-44384288:-	0.22	6.12	1.27E-9	Breast cancer	
BRCA	cis	1	rs1042194	chr10:96495484	HELLS	chr10:96305543-96361855:+	0.12	3.42	0.000641	Migraine	
BRCA	cis	1	rs10422783	chr19:41906436	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.27	6.87E-13	Height	
BRCA	cis	1	rs10422956	chr19:41901261	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.25	7.86E-13	Height	
BRCA	cis	1	rs10425982	chr19:18586519	LRRC25	chr19:18501955-18508421:-	-0.14	-6.83	1.4E-11	Breast cancer	
BRCA	cis	1	rs10431058	chr11:107481518	ALKBH8	chr11:107373454-107436461:-	-0.11	-3.56	0.000394	Common traits (Other)	
BRCA	cis	1	rs10431505	chr12:58178589	B4GALNT1	chr12:58019551-58026985:-	0.12	3.6	0.00033	Multiple sclerosis	
BRCA	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.43	11.02	8.37E-27	Multiple sclerosis	
BRCA	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.34	-10.38	4.1E-24	Multiple sclerosis	
BRCA	cis	1	rs10431505	chr12:58178589	XRCC6BP1	chr12:58335445-58351051:+	-0.18	-5.03	5.7E-7	Multiple sclerosis	
BRCA	cis	1	rs1043413	chr19:41939297	B3GNT8	chr19:41931265-41934635:-	0.21	6.3	4.26E-10	Height	
BRCA	cis	1	rs1043441	chr22:39130964	APOBEC3C	chr22:39410265-39414823:+	-0.11	-4.08	4.81E-5	Resting heart rate	
BRCA	cis	1	rs1043441	chr22:39130964	JOSD1	chr22:39081549-39096459:-	-0.14	-4.2	2.9E-5	Resting heart rate	
BRCA	cis	1	rs1043441	chr22:39130964	LOC646851	chr22:38974125-39052634:-	0.13	3.65	0.000279	Resting heart rate	
BRCA	cis	1	rs1043441	chr22:39130964	TOMM22	chr22:39077954-39080763:+	-0.11	-3.41	0.000665	Resting heart rate	
BRCA	cis	1	rs1043550	chr7:128409225	OPN1SW	chr7:128412545-128415844:-	0.16	3.91	9.69E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
BRCA	cis	1	rs10439608	chr20:30258814	COX4I2	chr20:30225691-30232800:+	0.18	6.81	1.59E-11	Subcortical brain region volumes	
BRCA	cis	1	rs10439608	chr20:30258814	MYLK2	chr20:30407178-30422500:+	0.31	7.98	3.88E-15	Subcortical brain region volumes	
BRCA	cis	1	rs10443172	chr1:85485768	MCOLN2	chr1:85391267-85462796:-	0.16	4.64	3.94E-6	Serum sulfate level	
BRCA	cis	1	rs10444533	chr12:107229705	C12orf23	chr12:107349544-107367811:+	0.17	4.1	4.4E-5	Social autistic-like traits	
BRCA	cis	1	rs10444533	chr12:107229705	MTERFD3	chr12:107371069-107380929:-	0.17	4.89	1.18E-6	Social autistic-like traits	
BRCA	cis	1	rs10446630	chr4:17958690	NCAPG	chr4:17812525-17846485:+	0.09	4.2	2.91E-5	Height	
BRCA	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.82	-27.58	7.41E-127	Homocysteine levels	
BRCA	cis	1	rs1044717	chr1:45976587	MMACHC	chr1:45965856-45976737:+	-0.14	-3.94	8.83E-5	Homocysteine levels	
BRCA	cis	1	rs10448080	chr8:28604791	CCDC25	chr8:27590835-27630170:-	0.14	3.63	0.000294	Height	
BRCA	cis	1	rs10448080	chr8:28604791	ELP3	chr8:27947749-28048667:+	0.18	4.6	4.67E-6	Height	
BRCA	cis	1	rs10448080	chr8:28604791	EXTL3	chr8:28559153-28611202:+	0.13	3.68	0.000249	Height	
BRCA	cis	1	rs10448080	chr8:28604791	FBXO16	chr8:28285930-28347784:-	0.13	3.58	0.000353	Height	
BRCA	cis	1	rs10448080	chr8:28604791	INTS9	chr8:28625180-28747698:-	0.16	4.2	2.93E-5	Height	
BRCA	cis	1	rs10448080	chr8:28604791	ZNF395	chr8:28203104-28347784:-	0.13	4.11	4.22E-5	Height	
BRCA	cis	1	rs10450561	chr11:27309956	LGR4	chr11:27387510-27494334:-	-0.14	-4.09	4.69E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10450562	chr11:27310006	LGR4	chr11:27387510-27494334:-	0.14	4.09	4.59E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10454142	chr2:48646399	GTF2A1L	chr2:48844948-48960284:+	-0.22	-5.36	1.03E-7	Sex hormone-binding globulin levels	
BRCA	cis	1	rs10454142	chr2:48646399	KLRAQ1	chr2:48667908-48742524:+	0.2	4.9	1.11E-6	Sex hormone-binding globulin levels	
BRCA	cis	1	rs10454142	chr2:48646399	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.22	-6.17	9.44E-10	Sex hormone-binding globulin levels	
BRCA	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.57	-17.96	3.15E-63	Response to antipsychotic treatment	
BRCA	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.61	-18.58	5.96E-67	Response to antipsychotic treatment	
BRCA	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.57	-18.17	1.84E-64	Response to antipsychotic treatment	
BRCA	cis	1	rs1045574	chr8:143763958	LY6K	chr8:143781529-143785582:+	0.18	5.19	2.47E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
BRCA	cis	1	rs1045574	chr8:143763958	LYNX1	chr8:143845758-143859640:-	-0.29	-9.06	6.01E-19	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
BRCA	cis	1	rs1045574	chr8:143763958	PSCA	chr8:143761875-143764142:+	0.45	15.23	1.57E-47	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
BRCA	cis	1	rs1045574	chr8:143763958	SLURP1	chr8:143822363-143823829:-	-0.18	-6.44	1.77E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
BRCA	cis	1	rs10455768	chr6:159364322	RSPH3	chr6:159398268-159421198:-	0.21	3.79	0.000157	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs10455769	chr6:159374007	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs10455770	chr6:159374304	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs10455772	chr6:159396403	RSPH3	chr6:159398268-159421198:-	0.22	4.01	6.55E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs10455830	chr6:159361236	RSPH3	chr6:159398268-159421198:-	0.2	3.7	0.000228	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs10455832	chr6:159364354	RSPH3	chr6:159398268-159421198:-	0.21	3.79	0.000157	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs10455835	chr6:159392353	RSPH3	chr6:159398268-159421198:-	0.22	3.95	8.17E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs10455836	chr6:159394754	RSPH3	chr6:159398268-159421198:-	0.22	3.97	7.77E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs10456362	chr6:28221816	HIST1H4J	chr6:27791903-27792257:+	0.19	3.82	0.000143	Depression	
BRCA	cis	1	rs10456362	chr6:28221816	ZNF323	chr6:28292517-28324048:-	-0.21	-3.87	0.000113	Depression	
BRCA	cis	1	rs10456362	chr6:28221816	ZNF389	chr6:28129551-28137375:+	0.18	3.48	0.000528	Depression	
BRCA	cis	1	rs10456420	chr6:33754301	IP6K3	chr6:33689443-33714762:-	0.28	4.89	1.16E-6	Obesity (extreme)	
BRCA	cis	1	rs10456622	chr6:49396453	CENPQ	chr6:49431096-49460820:+	-0.19	-6.17	9.68E-10	Folate pathway vitamin levels	
BRCA	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.36	11.19	1.43E-27	Folate pathway vitamin levels	
BRCA	cis	1	rs10457618	chr6:134188626	TCF21	chr6:134210259-134219157:+	0.16	4.27	2.08E-5	Coronary heart disease	
BRCA	cis	1	rs10459253	chr12:62707134	FAM19A2	chr12:62102043-62653925:-	0.17	3.63	0.000301	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10459256	chr12:62812438	FAM19A2	chr12:62102043-62653925:-	0.16	3.51	0.000462	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10459466	chr14:107145272	LOC100133469	chr14:106938455-106951529:+	0.16	3.49	0.0005	Alzheimer's disease (late onset)	
BRCA	cis	1	rs1046073	chr20:25281333	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.27E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1046073	chr20:25281333	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.95E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.75	19.67	9.17E-74	Type 2 diabetes	
BRCA	cis	1	rs10463316	chr5:150746034	SLC36A1	chr5:150816553-150871939:+	0.11	3.94	8.55E-5	Metabolite levels (Pyroglutamine)	
BRCA	cis	1	rs10465756	chr1:93029698	EVI5	chr1:92974255-93257961:-	-0.18	-5.04	5.37E-7	Cholesterol, total	
BRCA	cis	1	rs1046701	chr14:59939804	C14orf149	chr14:59939406-59951126:-	0.29	4.69	3.06E-6	Schizophrenia	
BRCA	cis	1	rs1046701	chr14:59939804	JKAMP	chr14:59951161-59972080:+	-0.18	-3.41	0.000677	Schizophrenia	
BRCA	cis	1	rs1046875	chr17:80685426	FN3K	chr17:80693452-80709073:+	0.15	4.66	3.58E-6	Glycated hemoglobin levels	
BRCA	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.28	7.51	1.26E-13	Glycated hemoglobin levels	
BRCA	cis	1	rs1046896	chr17:80685533	FN3K	chr17:80693452-80709073:+	0.16	4.87	1.31E-6	Glycated hemoglobin levels	
BRCA	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.3	7.94	5.03E-15	Glycated hemoglobin levels	
BRCA	cis	1	rs1046917	chr17:80685655	FN3K	chr17:80693452-80709073:+	0.15	4.65	3.8E-6	Glycated hemoglobin levels	
BRCA	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.28	7.5	1.34E-13	Glycated hemoglobin levels	
BRCA	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.28	-10.46	1.91E-24	Longevity	
BRCA	cis	1	rs1047171	chr20:25428786	FAM182A	chr20:26035250-26067552:+	-0.23	-6.12	1.31E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1047171	chr20:25428786	FAM182B	chr20:25744102-25848786:-	0.24	6.18	9.04E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1047171	chr20:25428786	PYGB	chr20:25228706-25278647:+	-0.13	-3.52	0.000454	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10474093	chr5:82437431	XRCC4	chr5:82373317-82649577:+	-0.12	-3.46	0.000561	Hypertension	
BRCA	cis	1	rs1047796	chr12:122628219	LRRC43	chr12:122652266-122688017:+	0.16	4.56	5.79E-6	Urate levels	
BRCA	cis	1	rs1047813	chr12:122628516	LRRC43	chr12:122652266-122688017:+	-0.17	-4.82	1.63E-6	Urate levels	
BRCA	cis	1	rs10478278	chr5:115452758	COMMD10	chr5:115420727-115628978:+	0.2	4.36	1.45E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs10483863	chr14:75322327	RPS6KL1	chr14:75372347-75389958:-	-0.17	-4.64	3.91E-6	Caffeine consumption	
BRCA	cis	1	rs10484442	chr6:26555879	BTN2A3	chr6:26422317-26431927:+	0.16	5.28	1.6E-7	Educational attainment	
BRCA	cis	1	rs10484442	chr6:26555879	C6orf41	chr6:26924772-26991752:+	-0.13	-4.04	5.62E-5	Educational attainment	
BRCA	cis	1	rs10484442	chr6:26555879	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.42	0.000639	Educational attainment	
BRCA	cis	1	rs10485508	chr20:33605098	MMP24	chr20:33814539-33864804:+	-0.23	-3.93	8.9E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs10485508	chr20:33605098	PROCR	chr20:33758727-33765164:+	-0.25	-5.02	5.99E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs10489249	chr1:171714521	VAMP4	chr1:171669298-171711214:-	0.24	7.16	1.53E-12	Hippocampal atrophy	
BRCA	cis	1	rs10489251	chr1:171717534	VAMP4	chr1:171669298-171711214:-	0.24	6.67	4.18E-11	Hippocampal atrophy	
BRCA	cis	1	rs10490004	chr2:160076140	WDSUB1	chr2:160092305-160143236:-	0.29	3.72	0.00021	Sudden cardiac arrest	
BRCA	cis	1	rs10490005	chr2:160075645	WDSUB1	chr2:160092305-160143236:-	0.29	3.69	0.000237	Sudden cardiac arrest	
BRCA	cis	1	rs10494057	chr1:107576399	NTNG1	chr1:107682629-108024471:+	0.17	3.69	0.000237	AIDS	
BRCA	cis	1	rs10494057	chr1:107576399	PRMT6	chr1:107599267-107601907:+	0.24	4.74	2.42E-6	AIDS	
BRCA	cis	1	rs10494217	chr1:119469188	WARS2	chr1:119573841-119683295:-	0.26	4.89	1.15E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs10494304	chr1:156285764	BGLAP	chr1:156182784-156213112:+	-0.17	-4.78	2.03E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs1049564	chr14:20940606	PNP	chr14:20937542-20945246:+	-0.17	-4.28	2.02E-5	Interferon alpha levels in systemic lupus erythematosus	
BRCA	cis	1	rs10496174	chr2:70153436	ANXA4	chr2:69969127-70053594:+	-0.13	-3.8	0.000155	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs1049887	chr1:10460485	PGD	chr1:10459085-10480200:+	0.24	6.43	1.91E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.61	18.78	3.44E-68	Response to antipsychotic treatment	
BRCA	cis	1	rs10506440	chr12:62707586	FAM19A2	chr12:62102043-62653925:-	0.17	3.63	0.000301	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10509671	chr10:96069054	NOC3L	chr10:96092989-96122683:-	0.13	4.24	2.44E-5	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs10509676	chr10:96523045	HELLS	chr10:96305543-96361855:+	0.12	3.51	0.000463	Migraine	
BRCA	cis	1	rs10509677	chr10:96576110	C10orf129	chr10:96953957-96988685:+	0.33	5.42	7.32E-8	Blood metabolite levels	
BRCA	cis	1	rs10509678	chr10:96576190	C10orf129	chr10:96953957-96988685:+	0.33	5.42	7.32E-8	Blood metabolite levels	
BRCA	cis	1	rs10509744	chr10:102271579	SEC31B	chr10:102246403-102289636:-	-0.31	-11.57	3.15E-29	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10510026	chr10:118862420	KIAA1598	chr10:118644308-118886097:-	0.14	3.53	0.000432	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
BRCA	cis	1	rs10510761	chr3:52965255	NT5DC2	chr3:52558386-52569093:-	0.16	3.67	0.000258	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs10510761	chr3:52965255	RFT1	chr3:53122503-53164470:-	-0.24	-3.64	0.000289	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs10510761	chr3:52965255	TMEM110	chr3:52867139-52931547:-	-0.24	-3.94	8.75E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs10511191	chr3:101645852	LOC152225	chr3:101659703-101716770:+	-0.15	-3.61	0.000317	Psoriasis vulgaris;Psoriasis	
BRCA	cis	1	rs10511393	chr3:119290051	CD80	chr3:119243142-119278481:-	-0.12	-4.19	2.99E-5	Vitiligo	
BRCA	cis	1	rs10514847	chr13:44626749	KIAA1704	chr13:45563687-45607742:+	-0.3	-4.42	1.09E-5	Uric acid levels	
BRCA	cis	1	rs10514847	chr13:44626749	NUFIP1	chr13:45513384-45563613:-	-0.41	-5.42	7.37E-8	Uric acid levels	
BRCA	cis	1	rs10514847	chr13:44626749	TSC22D1	chr13:45007661-45150701:-	-0.25	-3.48	0.000529	Uric acid levels	
BRCA	cis	1	rs10516315	chr4:18016877	NCAPG	chr4:17812525-17846485:+	0.07	3.42	0.000645	Height	
BRCA	cis	1	rs10516526	chr4:106688904	INTS12	chr4:106603787-106629881:-	-0.31	-3.82	0.00014	Post bronchodilator FEV1	
BRCA	cis	1	rs10517825	chr4:165893486	TRIM61	chr4:165875600-165898818:-	-0.26	-8.16	9.39E-16	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs10518693	chr15:40700022	DISP2	chr15:40650434-40663256:+	0.34	8.87	2.96E-18	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs10518693	chr15:40700022	IVD	chr15:40697686-40713512:+	0.16	5.48	5.36E-8	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs10518693	chr15:40700022	OIP5	chr15:41601468-41624819:-	0.08	3.58	0.000358	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs10519203	chr15:78814046	AGPHD1	chr15:78799906-78829714:+	0.15	3.55	0.000408	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs10519203	chr15:78814046	CHRNA5	chr15:78857906-78886458:+	0.16	5.03	5.78E-7	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs1051921	chr7:73007943	MLXIPL	chr7:73007524-73038870:-	0.36	6.83	1.45E-11	Triglycerides	
BRCA	cis	1	rs1052676	chr1:171673054	VAMP4	chr1:171669298-171711214:-	0.19	5.57	3.16E-8	Hippocampal atrophy	
BRCA	cis	1	rs1054029	chr4:103553053	MANBA	chr4:103552644-103682151:-	0.21	5.37	9.79E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs1054037	chr4:103552709	MANBA	chr4:103552644-103682151:-	0.21	5.39	8.62E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs1054399	chr10:102312565	SEC31B	chr10:102246403-102289636:-	-0.27	-10.01	1.37E-22	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs1056667	chr6:26510564	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.18E-8	Educational attainment	
BRCA	cis	1	rs1056667	chr6:26510564	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.46	0.000559	Educational attainment	
BRCA	cis	1	rs1056801	chr2:242292307	ANO7	chr2:242127924-242164791:+	0.21	3.37	0.000768	Prostate cancer	
BRCA	cis	1	rs1057208	chr20:44563007	SLC12A5	chr20:44650329-44688789:+	0.21	3.82	0.00014	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
BRCA	cis	1	rs1060330	chr3:52288945	SPCS1	chr3:52739857-52742195:+	0.12	3.79	0.00016	Electroencephalogram traits	
BRCA	cis	1	rs1061377	chr4:39124750	KLHL5	chr4:39046659-39123828:+	-0.14	-4.45	9.41E-6	Uric acid levels	
BRCA	cis	1	rs1062794	chr20:30381758	COX4I2	chr20:30225691-30232800:+	0.19	7.1	2.31E-12	Subcortical brain region volumes	
BRCA	cis	1	rs1062794	chr20:30381758	MYLK2	chr20:30407178-30422500:+	0.31	8.17	8.46E-16	Subcortical brain region volumes	
BRCA	cis	1	rs1064039	chr20:23618427	CST1	chr20:23728191-23731574:-	0.23	5	6.65E-7	Chronic kidney disease	
BRCA	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.29	7.52	1.15E-13	Pancreatic cancer	
BRCA	cis	1	rs10734389	chr11:27331452	LGR4	chr11:27387510-27494334:-	0.14	4.15	3.57E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10734390	chr11:27332214	LGR4	chr11:27387510-27494334:-	0.15	4.22	2.62E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10734765	chr12:9369385	LOC642846	chr12:9436253-9466684:+	0.14	4.84	1.52E-6	Non-alcoholic fatty liver disease histology (AST)	
BRCA	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.71	23.08	5.87E-96	Homocysteine levels	
BRCA	cis	1	rs10737521	chr1:161932193	ATF6	chr1:161736084-161932960:+	-0.08	-3.48	0.000513	Parkinson's disease (age of onset)	
BRCA	cis	1	rs10737958	chr5:50023374	PARP8	chr5:49961733-50138169:+	-0.13	-3.59	0.000346	Myopia (pathological)	
BRCA	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.27	-7.67	3.82E-14	Hematology traits	
BRCA	cis	1	rs10741741	chr11:18342081	GTF2H1	chr11:18343816-18388590:+	-0.31	-8.32	2.66E-16	Pancreatic cancer	
BRCA	cis	1	rs10741742	chr11:18342160	GTF2H1	chr11:18343816-18388590:+	0.31	8.3	3.04E-16	Pancreatic cancer	
BRCA	cis	1	rs10742172	chr11:27314297	LGR4	chr11:27387510-27494334:-	0.14	4.11	4.25E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10742174	chr11:27332291	LGR4	chr11:27387510-27494334:-	0.15	4.23	2.49E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10742175	chr11:27333897	LGR4	chr11:27387510-27494334:-	0.15	4.23	2.49E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10743422	chr12:8703479	CLEC4D	chr12:8666136-8674958:+	0.12	4.4	1.18E-5	Response to radiotherapy in prostate cancer (overall toxicity)	
BRCA	cis	1	rs10743424	chr12:8704358	CLEC4D	chr12:8666136-8674958:+	0.12	4.36	1.44E-5	Response to radiotherapy in prostate cancer (overall toxicity)	
BRCA	cis	1	rs10743425	chr12:8705164	CLEC4D	chr12:8666136-8674958:+	0.12	4.39	1.26E-5	Response to radiotherapy in prostate cancer (overall toxicity)	
BRCA	cis	1	rs10743579	chr12:26461145	BHLHE41	chr12:26272961-26278003:-	0.13	3.42	0.000649	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs10744177	chr12:122630009	LRRC43	chr12:122652266-122688017:+	0.18	5.02	5.93E-7	Urate levels	
BRCA	cis	1	rs10744335	chr12:122612146	LRRC43	chr12:122652266-122688017:+	0.16	4.51	7.04E-6	Urate levels	
BRCA	cis	1	rs10747783	chr12:58176614	B4GALNT1	chr12:58019551-58026985:-	0.13	3.65	0.000273	Multiple sclerosis	
BRCA	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.43	10.56	7.05E-25	Multiple sclerosis	
BRCA	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.35	-10.37	4.65E-24	Multiple sclerosis	
BRCA	cis	1	rs10747783	chr12:58176614	XRCC6BP1	chr12:58335445-58351051:+	-0.18	-5.02	6.04E-7	Multiple sclerosis	
BRCA	cis	1	rs10748526	chr10:82273079	DYDC1	chr10:82095864-82116511:-	0.16	4.11	4.21E-5	Post bronchodilator FEV1	
BRCA	cis	1	rs10749609	chr10:82249752	DYDC1	chr10:82095864-82116511:-	0.15	3.7	0.000226	Post bronchodilator FEV1	
BRCA	cis	1	rs10749860	chr1:46328210	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.71	7.32E-30	Body mass index	
BRCA	cis	1	rs10749860	chr1:46328210	CCDC17	chr1:46085717-46089729:-	0.11	3.54	0.000424	Body mass index	
BRCA	cis	1	rs10749860	chr1:46328210	MUTYH	chr1:45794915-45806142:-	0.13	5.11	3.87E-7	Body mass index	
BRCA	cis	1	rs10750422	chr11:129692580	NFRKB	chr11:129733671-129765490:-	0.17	3.53	0.000429	Obesity-related traits	
BRCA	cis	1	rs10750422	chr11:129692580	ST14	chr11:130029682-130080256:+	0.18	4.66	3.64E-6	Obesity-related traits	
BRCA	cis	1	rs10750422	chr11:129692580	ZBTB44	chr11:130096576-130184607:-	0.14	3.45	0.000577	Obesity-related traits	
BRCA	cis	1	rs10752615	chr1:156248609	BGLAP	chr1:156182784-156213112:+	0.2	5.36	1.02E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10753559	chr1:19698026	CAPZB	chr1:19665274-19811992:-	-0.12	-3.68	0.000241	Crohn's disease and psoriasis	
BRCA	cis	1	rs10753559	chr1:19698026	NBL1	chr1:19923467-19984945:+	-0.11	-3.72	0.000212	Crohn's disease and psoriasis	
BRCA	cis	1	rs10753559	chr1:19698026	PQLC2	chr1:19638740-19655793:+	-0.1	-3.45	0.000591	Crohn's disease and psoriasis	
BRCA	cis	1	rs1075374	chr10:91376975	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.74	0.000194	Metabolic traits	
BRCA	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.37	10.29	9.3E-24	Height	
BRCA	cis	1	rs10754797	chr1:236032494	GNG4	chr1:235710987-235814054:-	0.18	4.64	4.0E-6	Systemic lupus erythematosus	
BRCA	cis	1	rs10755146	chr3:190985158	UTS2D	chr3:190984945-191048325:-	-0.22	-6.52	1.08E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.28	-7.79	1.53E-14	Hematology traits	
BRCA	cis	1	rs10759927	chr9:100542176	CORO2A	chr9:100883258-100954956:-	-0.13	-3.54	0.000412	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10759927	chr9:100542176	NCBP1	chr9:100395705-100436027:+	-0.13	-4.16	3.41E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10759927	chr9:100542176	TRIM14	chr9:100831569-100881488:-	-0.13	-3.54	0.000413	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10759927	chr9:100542176	TSTD2	chr9:100362364-100395962:-	-0.12	-4.27	2.08E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10760021	chr9:100697648	C9orf156	chr9:100666772-100684852:-	-0.16	-4.51	7.05E-6	Quantitative traits	
BRCA	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.36	-10.27	1.22E-23	Rheumatoid arthritis	
BRCA	cis	1	rs10760118	chr9:123641616	PSMD5	chr9:123578334-123605206:-	-0.11	-3.4	0.000698	Rheumatoid arthritis	
BRCA	cis	1	rs10760118	chr9:123641616	TRAF1	chr9:123664672-123691479:-	0.1	4.54	6.16E-6	Rheumatoid arthritis	
BRCA	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.36	-9.84	6.07E-22	Rheumatoid arthritis	
BRCA	cis	1	rs10760121	chr9:123647915	TRAF1	chr9:123664672-123691479:-	0.11	5.19	2.47E-7	Rheumatoid arthritis	
BRCA	cis	1	rs10761723	chr10:64955581	NRBF2	chr10:64893007-64914785:+	-0.17	-6.06	1.83E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10761727	chr10:64995493	NRBF2	chr10:64893007-64914785:+	-0.16	-5.89	5.31E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10761742	chr10:65085048	NRBF2	chr10:64893007-64914785:+	-0.16	-6.03	2.31E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10767626	chr11:27306545	LGR4	chr11:27387510-27494334:-	0.15	4.1	4.37E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10767628	chr11:27310871	LGR4	chr11:27387510-27494334:-	0.15	4.21	2.82E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10767630	chr11:27314069	LGR4	chr11:27387510-27494334:-	0.14	4.11	4.25E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10767632	chr11:27318465	LGR4	chr11:27387510-27494334:-	0.15	4.15	3.52E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10767633	chr11:27329725	LGR4	chr11:27387510-27494334:-	0.14	4.15	3.57E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10767634	chr11:27332474	LGR4	chr11:27387510-27494334:-	0.15	4.23	2.49E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10767635	chr11:27333438	LGR4	chr11:27387510-27494334:-	0.15	4.23	2.56E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10767636	chr11:27334061	LGR4	chr11:27387510-27494334:-	0.15	4.23	2.49E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10767637	chr11:27336082	LGR4	chr11:27387510-27494334:-	0.15	4.22	2.66E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10767693	chr11:28093926	METT5D1	chr11:28129798-28355054:+	-0.11	-3.58	0.000357	Bipolar disorder	
BRCA	cis	1	rs10767971	chr11:32895664	CCDC73	chr11:32623627-32816187:-	0.21	5.81	8.34E-9	Parkinson's disease (age of onset)	
BRCA	cis	1	rs10767971	chr11:32895664	QSER1	chr11:32914792-33014862:+	0.09	3.8	0.000154	Parkinson's disease (age of onset)	
BRCA	cis	1	rs10767972	chr11:32896419	CCDC73	chr11:32623627-32816187:-	0.21	5.83	7.35E-9	Parkinson's disease (age of onset)	
BRCA	cis	1	rs10767972	chr11:32896419	QSER1	chr11:32914792-33014862:+	0.09	3.88	0.00011	Parkinson's disease (age of onset)	
BRCA	cis	1	rs10770856	chr12:8705406	CLEC4D	chr12:8666136-8674958:+	-0.12	-4.25	2.34E-5	Response to radiotherapy in prostate cancer (overall toxicity)	
BRCA	cis	1	rs10770857	chr12:8705469	CLEC4D	chr12:8666136-8674958:+	0.12	4.42	1.08E-5	Response to radiotherapy in prostate cancer (overall toxicity)	
BRCA	cis	1	rs10771431	chr12:9380859	LOC642846	chr12:9436253-9466684:+	0.15	6.32	3.94E-10	Breast size	
BRCA	cis	1	rs10773037	chr12:122607916	LRRC43	chr12:122652266-122688017:+	-0.17	-4.85	1.42E-6	Urate levels	
BRCA	cis	1	rs1077358	chr4:103553926	MANBA	chr4:103552644-103682151:-	0.21	5.45	6.38E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs10778305	chr12:104311974	HSP90B1	chr12:104324189-104341703:+	-0.13	-3.41	0.000677	Coronary heart disease	
BRCA	cis	1	rs10778305	chr12:104311974	NT5DC3	chr12:104164231-104234975:-	-0.14	-3.4	0.000704	Coronary heart disease	
BRCA	cis	1	rs10778511	chr12:107225331	C12orf23	chr12:107349544-107367811:+	-0.16	-4.25	2.34E-5	Social autistic-like traits	
BRCA	cis	1	rs10778511	chr12:107225331	MTERFD3	chr12:107371069-107380929:-	-0.15	-4.35	1.51E-5	Social autistic-like traits	
BRCA	cis	1	rs1077889	chr20:25267893	FAM182A	chr20:26035250-26067552:+	-0.22	-5.84	6.84E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1077889	chr20:25267893	FAM182B	chr20:25744102-25848786:-	0.22	5.62	2.46E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1077889	chr20:25267893	PYGB	chr20:25228706-25278647:+	-0.13	-3.46	0.000553	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10782922	chr1:92974595	EVI5	chr1:92974255-93257961:-	-0.18	-4.86	1.37E-6	Cholesterol, total	
BRCA	cis	1	rs10783342	chr12:50628466	SMARCD1	chr12:50478983-50494493:+	-0.14	-3.92	9.27E-5	Schizophrenia	
BRCA	cis	1	rs10783847	chr12:58196447	B4GALNT1	chr12:58019551-58026985:-	0.12	3.6	0.000339	Multiple sclerosis	
BRCA	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.42	10.78	8.53E-26	Multiple sclerosis	
BRCA	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.34	-10.39	3.71E-24	Multiple sclerosis	
BRCA	cis	1	rs10783847	chr12:58196447	XRCC6BP1	chr12:58335445-58351051:+	-0.18	-5.22	2.21E-7	Multiple sclerosis	
BRCA	cis	1	rs10783848	chr12:58196528	B4GALNT1	chr12:58019551-58026985:-	0.12	3.63	0.000293	Multiple sclerosis	
BRCA	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.43	11.04	6.59E-27	Multiple sclerosis	
BRCA	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.34	-10.35	5.57E-24	Multiple sclerosis	
BRCA	cis	1	rs10783848	chr12:58196528	XRCC6BP1	chr12:58335445-58351051:+	-0.17	-4.96	8.29E-7	Multiple sclerosis	
BRCA	cis	1	rs10784292	chr12:62740429	FAM19A2	chr12:62102043-62653925:-	0.18	3.95	8.25E-5	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10784295	chr12:62822893	FAM19A2	chr12:62102043-62653925:-	0.16	3.44	0.000614	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10784325	chr12:63440052	PPM1H	chr12:63037763-63328915:-	-0.14	-3.61	0.000324	Obesity-related traits	
BRCA	cis	1	rs10784762	chr12:69523923	YEATS4	chr12:69753532-69784575:+	-0.12	-3.61	0.000316	QRS duration	
BRCA	cis	1	rs10785814	chr1:107610540	NTNG1	chr1:107682629-108024471:+	0.16	3.54	0.000421	AIDS	
BRCA	cis	1	rs10785814	chr1:107610540	PRMT6	chr1:107599267-107601907:+	0.22	4.46	9.1E-6	AIDS	
BRCA	cis	1	rs1078620	chr16:53664597	RPGRIP1L	chr16:53633823-53737771:-	-0.22	-3.56	0.00039	Vitiligo (non-segmental)	
BRCA	cis	1	rs10786596	chr10:102282126	SEC31B	chr10:102246403-102289636:-	-0.29	-10.93	2.05E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10786597	chr10:102291287	SEC31B	chr10:102246403-102289636:-	-0.3	-11.09	3.91E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10786598	chr10:102291579	SEC31B	chr10:102246403-102289636:-	-0.3	-11.09	3.91E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs1078679	chr6:26568741	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.27E-8	Educational attainment	
BRCA	cis	1	rs1078679	chr6:26568741	C6orf41	chr6:26924772-26991752:+	-0.13	-3.94	8.81E-5	Educational attainment	
BRCA	cis	1	rs1078679	chr6:26568741	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.73	0.000201	Educational attainment	
BRCA	cis	1	rs10788473	chr10:87740753	WAPAL	chr10:88195014-88281541:-	0.09	3.47	0.000544	Pancreatic cancer	
BRCA	cis	1	rs10789212	chr1:67128155	TCTEX1D1	chr1:67218140-67244729:+	0.12	3.39	0.000732	Menopause (age at onset)	
BRCA	cis	1	rs10789213	chr1:67128201	TCTEX1D1	chr1:67218140-67244729:+	0.12	3.43	0.000621	Menopause (age at onset)	
BRCA	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.38	-11.47	8.61E-29	Body mass index	
BRCA	cis	1	rs10789475	chr1:46304177	MUTYH	chr1:45794915-45806142:-	0.12	4.93	9.34E-7	Body mass index	
BRCA	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.41	-11.99	3.58E-31	Body mass index	
BRCA	cis	1	rs10789481	chr1:46383583	MUTYH	chr1:45794915-45806142:-	0.13	4.9	1.11E-6	Body mass index	
BRCA	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.9	9.15E-31	Body mass index	
BRCA	cis	1	rs10789487	chr1:46420221	MUTYH	chr1:45794915-45806142:-	0.12	4.8	1.8E-6	Body mass index	
BRCA	cis	1	rs10792320	chr11:61746291	BEST1	chr11:61717356-61731939:+	0.16	4.46	9.17E-6	Phospholipid levels (plasma)	
BRCA	cis	1	rs10794639	chr16:377367	DECR2	chr16:451858-462486:+	0.11	3.94	8.61E-5	Bone mineral density (spine);Bone mineral density	
BRCA	cis	1	rs10797432	chr1:2501338	LOC115110	chr1:2481359-2488450:-	-0.08	-3.72	0.00021	Ulcerative colitis	
BRCA	cis	1	rs10797432	chr1:2501338	MMEL1	chr1:2522081-2564481:-	-0.14	-4.51	7.23E-6	Ulcerative colitis	
BRCA	cis	1	rs10799685	chr1:21465930	SH2D5	chr1:21046225-21059330:-	-0.12	-3.37	0.000767	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs10799686	chr1:21486445	SH2D5	chr1:21046225-21059330:-	-0.13	-3.41	0.000683	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs1080060	chr2:27768808	KRTCAP3	chr2:27665263-27667163:+	-0.13	-3.98	7.37E-5	Oral cavity cancer	
BRCA	cis	1	rs10803116	chr1:236031654	GNG4	chr1:235710987-235814054:-	0.18	4.64	3.96E-6	Systemic lupus erythematosus	
BRCA	cis	1	rs10804111	chr2:202145612	ALS2CR12	chr2:202153148-202222101:-	-0.27	-7.24	8.32E-13	Melanoma;Esophageal squamous cell carcinoma	
BRCA	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.38	12.53	1.03E-33	Height	
BRCA	cis	1	rs10804632	chr3:134294501	CEP63	chr3:134204575-134293852:+	0.14	3.92	9.43E-5	Height	
BRCA	cis	1	rs10806701	chr6:159385223	RSPH3	chr6:159398268-159421198:-	0.25	4.46	9.16E-6	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs1080698	chr10:102295114	SEC31B	chr10:102246403-102289636:-	-0.28	-10.15	3.58E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10807508	chr6:55950812	COL21A1	chr6:55921389-56258892:-	-0.37	-6.84	1.34E-11	Psychosis (atypical)	
BRCA	cis	1	rs10807510	chr6:56006672	COL21A1	chr6:55921389-56258892:-	-0.38	-7.02	3.93E-12	Psychosis (atypical)	
BRCA	cis	1	rs10807701	chr7:65724686	CCT6P1	chr7:65216092-65228661:+	-0.29	-6.39	2.48E-10	Diabetic kidney disease	
BRCA	cis	1	rs10807701	chr7:65724686	CRCP	chr7:65579805-65619551:+	0.21	3.67	0.000255	Diabetic kidney disease	
BRCA	cis	1	rs10807701	chr7:65724686	LOC493754	chr7:65993446-66057363:-	-0.23	-3.98	7.39E-5	Diabetic kidney disease	
BRCA	cis	1	rs10807702	chr7:65767843	CCT6P1	chr7:65216092-65228661:+	0.25	5.39	8.47E-8	Diabetic kidney disease	
BRCA	cis	1	rs10807702	chr7:65767843	CRCP	chr7:65579805-65619551:+	-0.28	-4.76	2.21E-6	Diabetic kidney disease	
BRCA	cis	1	rs10808739	chr8:65640260	CYP7B1	chr8:65508529-65711348:-	-0.12	-3.86	0.000122	HIV-1 susceptibility	
BRCA	cis	1	rs10813961	chr9:33207050	NFX1	chr9:33290510-33371154:+	-0.14	-3.84	0.000129	Diabetic kidney disease	
BRCA	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.36	-10.16	3.29E-23	Rheumatoid arthritis	
BRCA	cis	1	rs10818480	chr9:123643170	TRAF1	chr9:123664672-123691479:-	0.1	4.92	9.77E-7	Rheumatoid arthritis	
BRCA	cis	1	rs10819466	chr9:131881492	SH3GLB2	chr9:131770314-131790579:-	-0.13	-4.86	1.37E-6	Blood metabolite ratios	
BRCA	cis	1	rs10819469	chr9:131882067	SH3GLB2	chr9:131770314-131790579:-	-0.13	-4.79	1.88E-6	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	C9orf119	chr9:131038425-131051267:+	-0.12	-3.65	0.000279	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	CIZ1	chr9:130928345-130966662:-	-0.13	-3.52	0.000442	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	COQ4	chr9:131084791-131096349:+	-0.1	-4.16	3.51E-5	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	DOLK	chr9:131707810-131710012:-	-0.12	-3.4	0.000708	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	DOLPP1	chr9:131843383-131852716:+	-0.13	-3.77	0.000175	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	GLE1	chr9:131266971-131304579:+	-0.16	-4.19	2.97E-5	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	GOLGA2	chr9:131018109-131038268:-	-0.15	-4.04	5.84E-5	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	GPR107	chr9:132815985-132902448:+	-0.13	-3.95	8.22E-5	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	LRRC8A	chr9:131644391-131680315:+	-0.12	-3.38	0.000757	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	METTL11A	chr9:132388435-132397879:+	-0.1	-3.74	0.000191	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	NUP188	chr9:131703724-131769374:+	-0.15	-4.35	1.47E-5	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	ODF2	chr9:131217466-131263238:+	-0.17	-4.64	3.86E-6	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	SET	chr9:131445934-131458674:+	-0.13	-4	6.77E-5	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	SH3GLB2	chr9:131770314-131790579:-	-0.13	-4.85	1.42E-6	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	TBC1D13	chr9:131549510-131572710:+	-0.13	-3.42	0.000648	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	TOR1A	chr9:132575222-132586441:-	-0.14	-3.45	0.000584	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	USP20	chr9:132597696-132644107:+	-0.09	-3.54	0.000418	Blood metabolite ratios	
BRCA	cis	1	rs10819471	chr9:131896325	WDR34	chr9:131395940-131419129:-	-0.1	-3.5	0.000485	Blood metabolite ratios	
BRCA	cis	1	rs10819861	chr9:98867813	C9orf102	chr9:98637900-98767136:+	-0.1	-4.79	1.94E-6	Electrocardiographic traits	
BRCA	cis	1	rs10819861	chr9:98867813	C9orf130	chr9:98568372-98638259:-	-0.19	-5.63	2.37E-8	Electrocardiographic traits	
BRCA	cis	1	rs10822145	chr10:64934548	NRBF2	chr10:64893007-64914785:+	-0.16	-5.72	1.39E-8	Triglycerides	
BRCA	cis	1	rs10822149	chr10:64987412	NRBF2	chr10:64893007-64914785:+	-0.16	-5.89	5.31E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10822161	chr10:65118203	NRBF2	chr10:64893007-64914785:+	-0.16	-5.84	6.91E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10822163	chr10:65124098	NRBF2	chr10:64893007-64914785:+	-0.16	-5.84	6.91E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10832821	chr11:17658845	PIK3C2A	chr11:17099277-17229530:-	-0.11	-3.48	0.000522	Night sleep phenotypes	
BRCA	cis	1	rs10832821	chr11:17658845	RPS13	chr11:17095940-17099220:-	-0.15	-3.85	0.000124	Night sleep phenotypes	
BRCA	cis	1	rs10832921	chr11:18380835	GTF2H1	chr11:18343816-18388590:+	0.31	8.38	1.68E-16	Pancreatic cancer	
BRCA	cis	1	rs10835152	chr11:27311217	LGR4	chr11:27387510-27494334:-	0.14	4.16	3.49E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10835153	chr11:27313863	LGR4	chr11:27387510-27494334:-	0.14	4.11	4.25E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10835154	chr11:27315356	LGR4	chr11:27387510-27494334:-	0.14	4.11	4.18E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10835155	chr11:27317812	LGR4	chr11:27387510-27494334:-	0.14	4.12	4.16E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10835156	chr11:27325218	LGR4	chr11:27387510-27494334:-	0.14	4.15	3.57E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10835157	chr11:27325462	LGR4	chr11:27387510-27494334:-	0.14	4.08	4.75E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10835158	chr11:27331770	LGR4	chr11:27387510-27494334:-	0.15	4.23	2.49E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs10838738	chr11:47663049	ACP2	chr11:47260854-47270457:-	0.14	3.65	0.000277	Subjective well-being	
BRCA	cis	1	rs10838738	chr11:47663049	MADD	chr11:47290927-47351582:+	0.14	4.45	9.56E-6	Subjective well-being	
BRCA	cis	1	rs10838738	chr11:47663049	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.28	2.0E-5	Subjective well-being	
BRCA	cis	1	rs10838747	chr11:47716324	MADD	chr11:47290927-47351582:+	0.14	4.43	1.06E-5	Subjective well-being	
BRCA	cis	1	rs10838747	chr11:47716324	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.1	4.51E-5	Subjective well-being	
BRCA	cis	1	rs10838748	chr11:47716381	MADD	chr11:47290927-47351582:+	0.15	4.66	3.58E-6	Subjective well-being	
BRCA	cis	1	rs10838748	chr11:47716381	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.12	4.16E-5	Subjective well-being	
BRCA	cis	1	rs10838757	chr11:47763016	MADD	chr11:47290927-47351582:+	0.15	4.74	2.43E-6	Subjective well-being	
BRCA	cis	1	rs10838757	chr11:47763016	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.3	1.83E-5	Subjective well-being	
BRCA	cis	1	rs10838909	chr11:5960490	UBQLNL	chr11:5535624-5537956:-	0.15	3.48	0.000515	DNA methylation (variation)	
BRCA	cis	1	rs10842708	chr12:26474867	BHLHE41	chr12:26272961-26278003:-	0.13	3.68	0.000241	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs10842708	chr12:26474867	SSPN	chr12:26348269-26405853:+	0.11	3.57	0.000372	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs10845106	chr12:10472338	KLRD1	chr12:10457050-10469849:+	-0.12	-4.68	3.31E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs10846579	chr12:124407403	DNAH10	chr12:124247042-124420265:+	0.25	6.43	1.87E-10	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs10849462	chr12:6575992	TAPBPL	chr12:6561177-6575601:+	-0.17	-3.9	0.000103	Hip geometry	
BRCA	cis	1	rs10849605	chr12:1064438	RAD52	chr12:1021255-1099219:-	-0.17	-5.44	6.48E-8	Lung cancer	
BRCA	cis	1	rs10849786	chr12:121209302	SPPL3	chr12:121201036-121342151:-	0.21	4.45	9.66E-6	Quantitative traits	
BRCA	cis	1	rs1085243	chr1:46544768	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.8	2.62E-30	Body mass index	
BRCA	cis	1	rs1085243	chr1:46544768	CCDC17	chr1:46085717-46089729:-	0.11	3.39	0.000714	Body mass index	
BRCA	cis	1	rs1085243	chr1:46544768	MUTYH	chr1:45794915-45806142:-	0.12	4.76	2.21E-6	Body mass index	
BRCA	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.72	6.14E-30	Body mass index	
BRCA	cis	1	rs1085244	chr1:46563680	MUTYH	chr1:45794915-45806142:-	0.12	4.83	1.56E-6	Body mass index	
BRCA	cis	1	rs10853751	chr19:41903220	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.4	2.75E-13	Height	
BRCA	cis	1	rs10857811	chr1:110617688	ALX3	chr1:110602998-110613322:-	0.12	3.72	0.00021	Blood metabolite levels	
BRCA	cis	1	rs10857975	chr1:113321594	FAM19A3	chr1:113263189-113269854:+	-0.19	-6.04	2.16E-9	Hyperactive-impulsive symptoms	
BRCA	cis	1	rs10861346	chr12:105473245	NFYB	chr12:104510858-104532040:-	-0.2	-3.72	0.000209	IgG glycosylation	
BRCA	cis	1	rs10862368	chr12:82244514	PPFIA2	chr12:81652880-82153109:-	0.13	3.41	0.00068	Resting heart rate	
BRCA	cis	1	rs10862371	chr12:82249298	PPFIA2	chr12:81652880-82153109:-	0.13	3.38	0.000758	Resting heart rate	
BRCA	cis	1	rs10862372	chr12:82249804	PPFIA2	chr12:81652880-82153109:-	0.13	3.4	0.000705	Resting heart rate	
BRCA	cis	1	rs10864175	chr1:207433349	CR2	chr1:207627670-207663238:+	0.1	3.42	0.000639	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs10864178	chr1:207445678	CR2	chr1:207627670-207663238:+	0.1	3.44	0.000594	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs10865940	chr3:46350367	FYCO1	chr3:45959396-46037307:-	-0.11	-3.57	0.000372	Celiac disease	
BRCA	cis	1	rs10865956	chr3:49581559	AMT	chr3:49454212-49460012:-	0.13	4.54	6.31E-6	Menarche (age at onset)	
BRCA	cis	1	rs10865956	chr3:49581559	CCDC36	chr3:49235861-49295537:+	0.11	4.08	4.9E-5	Menarche (age at onset)	
BRCA	cis	1	rs10865956	chr3:49581559	GMPPB	chr3:49758932-49761384:-	-0.12	-3.53	0.000441	Menarche (age at onset)	
BRCA	cis	1	rs10865956	chr3:49581559	NCKIPSD	chr3:48711280-48723334:-	0.14	3.59	0.000344	Menarche (age at onset)	
BRCA	cis	1	rs10865956	chr3:49581559	P4HTM	chr3:49027341-49044579:+	0.1	4.13	3.91E-5	Menarche (age at onset)	
BRCA	cis	1	rs10865956	chr3:49581559	WDR6	chr3:49044637-49053386:+	-0.14	-4.11	4.25E-5	Menarche (age at onset)	
BRCA	cis	1	rs10865970	chr3:51357501	GRM2	chr3:51741081-51752623:+	-0.18	-3.44	0.000598	Melanoma	
BRCA	cis	1	rs10871290	chr16:74472696	RFWD3	chr16:74655298-74700779:-	0.1	3.97	7.52E-5	Breast cancer	
BRCA	cis	1	rs10872623	chr6:101165047	ASCC3	chr6:100956609-101329224:-	-0.08	-3.44	0.000608	Menarche (age at onset)	
BRCA	cis	1	rs10874122	chr1:75235866	CRYZ	chr1:75171175-75199092:-	-0.39	-10.51	1.13E-24	Resistin levels	
BRCA	cis	1	rs10875746	chr12:48518264	ASB8	chr12:48541575-48551377:-	0.14	4.06	5.37E-5	Longevity (90 years and older)	
BRCA	cis	1	rs10876480	chr12:54066271	ATP5G2	chr12:54058945-54070512:-	0.09	3.37	0.000769	Height	
BRCA	cis	1	rs10876481	chr12:54066743	ATP5G2	chr12:54058945-54070512:-	0.09	3.37	0.000769	Height	
BRCA	cis	1	rs10877012	chr12:58162085	B4GALNT1	chr12:58019551-58026985:-	0.13	3.85	0.000124	Multiple sclerosis	
BRCA	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.41	10.06	8.45E-23	Multiple sclerosis	
BRCA	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.33	-9.69	2.36E-21	Multiple sclerosis	
BRCA	cis	1	rs10877012	chr12:58162085	XRCC6BP1	chr12:58335445-58351051:+	-0.17	-4.65	3.65E-6	Multiple sclerosis	
BRCA	cis	1	rs10877013	chr12:58165085	B4GALNT1	chr12:58019551-58026985:-	0.13	3.79	0.000158	Multiple sclerosis	
BRCA	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.42	10.69	2.04E-25	Multiple sclerosis	
BRCA	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.32	-9.76	1.32E-21	Multiple sclerosis	
BRCA	cis	1	rs10877013	chr12:58165085	XRCC6BP1	chr12:58335445-58351051:+	-0.17	-4.77	2.06E-6	Multiple sclerosis	
BRCA	cis	1	rs10877014	chr12:58167661	B4GALNT1	chr12:58019551-58026985:-	0.13	3.85	0.000124	Multiple sclerosis	
BRCA	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.42	10.8	7.25E-26	Multiple sclerosis	
BRCA	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.32	-9.79	1.01E-21	Multiple sclerosis	
BRCA	cis	1	rs10877014	chr12:58167661	XRCC6BP1	chr12:58335445-58351051:+	-0.17	-4.77	2.14E-6	Multiple sclerosis	
BRCA	cis	1	rs10877015	chr12:58167788	B4GALNT1	chr12:58019551-58026985:-	0.14	3.94	8.75E-5	Multiple sclerosis	
BRCA	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.41	10.16	3.39E-23	Multiple sclerosis	
BRCA	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.33	-9.85	5.67E-22	Multiple sclerosis	
BRCA	cis	1	rs10877015	chr12:58167788	XRCC6BP1	chr12:58335445-58351051:+	-0.17	-4.78	2.01E-6	Multiple sclerosis	
BRCA	cis	1	rs10877019	chr12:58172929	B4GALNT1	chr12:58019551-58026985:-	-0.13	-3.65	0.000274	Multiple sclerosis	
BRCA	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.43	-10.47	1.67E-24	Multiple sclerosis	
BRCA	cis	1	rs10877019	chr12:58172929	RDH16	chr12:57345218-57396703:-	-0.14	-3.43	0.00062	Multiple sclerosis	
BRCA	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.35	10.22	1.93E-23	Multiple sclerosis	
BRCA	cis	1	rs10877019	chr12:58172929	XRCC6BP1	chr12:58335445-58351051:+	0.17	4.66	3.54E-6	Multiple sclerosis	
BRCA	cis	1	rs10877820	chr12:62672756	FAM19A2	chr12:62102043-62653925:-	0.17	3.68	0.000247	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10877826	chr12:62713960	FAM19A2	chr12:62102043-62653925:-	0.18	3.8	0.00015	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10877834	chr12:62788811	FAM19A2	chr12:62102043-62653925:-	0.17	3.66	0.000262	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10877846	chr12:62824366	FAM19A2	chr12:62102043-62653925:-	0.17	3.6	0.000333	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs10877942	chr12:63416152	PPM1H	chr12:63037763-63328915:-	-0.13	-3.43	0.000637	Obesity-related traits	
BRCA	cis	1	rs10877944	chr12:63430109	PPM1H	chr12:63037763-63328915:-	-0.14	-3.67	0.000254	Obesity-related traits	
BRCA	cis	1	rs10878346	chr12:66320873	LLPH	chr12:66516850-66563807:-	0.16	3.93	9.22E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
BRCA	cis	1	rs10881608	chr10:91374649	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.76	0.000178	Metabolic traits	
BRCA	cis	1	rs10881610	chr10:91374833	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.76	0.000178	Metabolic traits	
BRCA	cis	1	rs10882644	chr10:97388579	ENTPD1	chr10:97471536-97637022:+	0.17	5.81	8.05E-9	Blood metabolite levels	
BRCA	cis	1	rs10883492	chr10:102206089	SEC31B	chr10:102246403-102289636:-	-0.28	-10.38	4.08E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883493	chr10:102208188	SEC31B	chr10:102246403-102289636:-	-0.28	-10.32	7.37E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883496	chr10:102221931	SEC31B	chr10:102246403-102289636:-	-0.28	-10.51	1.23E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883497	chr10:102228519	SEC31B	chr10:102246403-102289636:-	-0.28	-10.48	1.6E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883499	chr10:102232188	SEC31B	chr10:102246403-102289636:-	-0.28	-10.31	8.24E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883500	chr10:102238324	SEC31B	chr10:102246403-102289636:-	-0.28	-10.59	5.58E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883501	chr10:102238326	SEC31B	chr10:102246403-102289636:-	-0.28	-10.59	5.58E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883502	chr10:102238343	SEC31B	chr10:102246403-102289636:-	-0.28	-10.59	5.58E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883503	chr10:102275504	SEC31B	chr10:102246403-102289636:-	-0.29	-10.55	7.8E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883504	chr10:102280687	SEC31B	chr10:102246403-102289636:-	-0.29	-10.54	8.88E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883505	chr10:102280772	SEC31B	chr10:102246403-102289636:-	-0.3	-11.07	4.88E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883506	chr10:102289743	SEC31B	chr10:102246403-102289636:-	-0.3	-11.09	3.91E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883507	chr10:102291275	SEC31B	chr10:102246403-102289636:-	-0.3	-11.09	3.91E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883508	chr10:102294413	SEC31B	chr10:102246403-102289636:-	-0.3	-11.17	1.74E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883509	chr10:102296461	SEC31B	chr10:102246403-102289636:-	-0.3	-11.06	5.18E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883510	chr10:102297018	SEC31B	chr10:102246403-102289636:-	-0.3	-10.51	1.15E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883511	chr10:102299407	SEC31B	chr10:102246403-102289636:-	-0.3	-11.08	4.27E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883512	chr10:102308516	SEC31B	chr10:102246403-102289636:-	-0.29	-10.79	8.13E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10883513	chr10:102316964	SEC31B	chr10:102246403-102289636:-	-0.27	-8.9	2.4E-18	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs10888527	chr1:153001363	SPRR1A	chr1:152956557-152958289:+	-0.16	-4.73	2.53E-6	Inflammatory skin disease	
BRCA	cis	1	rs10889636	chr1:67089924	TCTEX1D1	chr1:67218140-67244729:+	-0.12	-3.49	0.000504	Menopause (age at onset)	
BRCA	cis	1	rs10889640	chr1:67127851	TCTEX1D1	chr1:67218140-67244729:+	0.12	3.43	0.000622	Menopause (age at onset)	
BRCA	cis	1	rs10890352	chr1:46283628	CCDC163P	chr1:45960581-45965646:-	-0.41	-12.04	2.25E-31	Body mass index	
BRCA	cis	1	rs10890352	chr1:46283628	CCDC17	chr1:46085717-46089729:-	0.11	3.45	0.000576	Body mass index	
BRCA	cis	1	rs10890352	chr1:46283628	MUTYH	chr1:45794915-45806142:-	0.12	4.79	1.93E-6	Body mass index	
BRCA	cis	1	rs10890354	chr1:46305347	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.81	2.33E-30	Body mass index	
BRCA	cis	1	rs10890354	chr1:46305347	CCDC17	chr1:46085717-46089729:-	0.11	3.42	0.000642	Body mass index	
BRCA	cis	1	rs10890354	chr1:46305347	MUTYH	chr1:45794915-45806142:-	0.13	4.95	8.6E-7	Body mass index	
BRCA	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.34	-10.29	9.25E-24	Body mass index	
BRCA	cis	1	rs10890361	chr1:46346234	CCDC17	chr1:46085717-46089729:-	0.11	3.45	0.000579	Body mass index	
BRCA	cis	1	rs10890361	chr1:46346234	MUTYH	chr1:45794915-45806142:-	0.13	5.41	7.77E-8	Body mass index	
BRCA	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.4	11.94	5.93E-31	Body mass index	
BRCA	cis	1	rs10890363	chr1:46356148	MUTYH	chr1:45794915-45806142:-	-0.13	-4.99	7.03E-7	Body mass index	
BRCA	cis	1	rs10893380	chr11:125311674	DCPS	chr11:126173647-126215643:+	0.16	3.93	9.07E-5	Schizophrenia	
BRCA	cis	1	rs10893380	chr11:125311674	EI24	chr11:125439298-125454574:+	0.16	3.46	0.000556	Schizophrenia	
BRCA	cis	1	rs10893380	chr11:125311674	HYLS1	chr11:125753509-125770540:+	0.2	4.51	7.07E-6	Schizophrenia	
BRCA	cis	1	rs10893380	chr11:125311674	PUS3	chr11:125763380-125773116:-	0.15	3.41	0.000667	Schizophrenia	
BRCA	cis	1	rs10893380	chr11:125311674	SRPR	chr11:126132837-126138750:-	0.16	3.69	0.000239	Schizophrenia	
BRCA	cis	1	rs10893380	chr11:125311674	STT3A	chr11:125462739-125491280:+	0.15	3.58	0.000363	Schizophrenia	
BRCA	cis	1	rs10893380	chr11:125311674	TIRAP	chr11:126152982-126164828:+	0.18	4.22	2.68E-5	Schizophrenia	
BRCA	cis	1	rs10896043	chr11:65543827	CTSW	chr11:65647284-65651212:+	0.17	6.25	5.91E-10	Systemic lupus erythematosus	
BRCA	cis	1	rs10896043	chr11:65543827	SNX32	chr11:65601410-65621170:+	-0.2	-5.2	2.45E-7	Systemic lupus erythematosus	
BRCA	cis	1	rs10896598	chr11:57052007	PRG2	chr11:57151267-57191532:-	-0.21	-3.6	0.000335	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs10897009	chr11:59923194	MS4A4A	chr11:60048139-60076444:+	-0.09	-3.66	0.000269	Alzheimer's disease (late onset)	
BRCA	cis	1	rs10897274	chr11:62200369	C11orf10	chr11:61556603-61560085:-	0.1	3.44	0.000599	Chronic obstructive pulmonary disease-related biomarkers	
BRCA	cis	1	rs10900685	chr5:112707306	YTHDC2	chr5:112849410-112930979:+	0.14	4.09	4.68E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs10901513	chr10:127699936	UROS	chr10:127477148-127511837:-	-0.17	-4.92	9.87E-7	Visceral fat	
BRCA	cis	1	rs10901514	chr10:127700066	UROS	chr10:127477148-127511837:-	-0.17	-4.92	9.87E-7	Visceral fat	
BRCA	cis	1	rs10901520	chr10:127718837	UROS	chr10:127477148-127511837:-	-0.17	-4.8	1.84E-6	Visceral fat	
BRCA	cis	1	rs10902112	chr11:244106	PSMD13	chr11:236808-252984:+	-0.16	-4.58	5.13E-6	Menarche (age at onset)	
BRCA	cis	1	rs10902113	chr11:245523	PSMD13	chr11:236808-252984:+	-0.15	-4.24	2.46E-5	Menarche (age at onset)	
BRCA	cis	1	rs10902114	chr11:246234	PSMD13	chr11:236808-252984:+	-0.15	-4.18	3.15E-5	Menarche (age at onset)	
BRCA	cis	1	rs10902728	chr1:26598281	TRIM63	chr1:26377798-26394121:-	-0.15	-4.32	1.7E-5	Obesity-related traits	
BRCA	cis	1	rs10902728	chr1:26598281	ZNF593	chr1:26496388-26497362:+	0.12	5.15	3.16E-7	Obesity-related traits	
BRCA	cis	1	rs10902853	chr10:124740621	PSTK	chr10:124739556-124749906:+	0.13	3.66	0.00026	Migraine without aura	
BRCA	cis	1	rs10903	chr1:171673236	VAMP4	chr1:171669298-171711214:-	0.19	5.28	1.6E-7	Hippocampal atrophy	
BRCA	cis	1	rs10906982	chr15:84568158	GOLGA6L5	chr15:85047738-85060078:-	-0.13	-4.36	1.41E-5	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs10908353	chr1:37954950	SNIP1	chr1:38002145-38019903:-	-0.19	-3.78	0.000164	Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs10908494	chr1:156263097	BGLAP	chr1:156182784-156213112:+	0.21	5.56	3.35E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10908494	chr1:156263097	C1orf85	chr1:156259882-156265449:-	-0.11	-3.45	0.000576	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10908495	chr1:156263940	BGLAP	chr1:156182784-156213112:+	0.2	5.47	5.65E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10908495	chr1:156263940	C1orf85	chr1:156259882-156265449:-	-0.11	-3.53	0.00044	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10908496	chr1:156264000	BGLAP	chr1:156182784-156213112:+	0.2	5.3	1.44E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10908498	chr1:156278175	BGLAP	chr1:156182784-156213112:+	0.2	5.45	6.15E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10908499	chr1:156279176	BGLAP	chr1:156182784-156213112:+	0.2	5.45	6.15E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10908500	chr1:156280671	BGLAP	chr1:156182784-156213112:+	0.19	5.05	5.11E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10908500	chr1:156280671	C1orf85	chr1:156259882-156265449:-	-0.11	-3.45	0.000588	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10908502	chr1:156300082	BGLAP	chr1:156182784-156213112:+	0.2	5.24	1.92E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10908502	chr1:156300082	CCT3	chr1:156278752-156308195:-	-0.11	-3.56	0.000391	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs10910092	chr1:2501516	LOC115110	chr1:2481359-2488450:-	-0.09	-3.94	8.55E-5	Ulcerative colitis	
BRCA	cis	1	rs10910092	chr1:2501516	MMEL1	chr1:2522081-2564481:-	-0.14	-4.75	2.36E-6	Ulcerative colitis	
BRCA	cis	1	rs10913489	chr1:171653384	VAMP4	chr1:171669298-171711214:-	0.12	3.4	0.00071	Hippocampal atrophy	
BRCA	cis	1	rs10913490	chr1:171653401	VAMP4	chr1:171669298-171711214:-	0.12	3.4	0.00071	Hippocampal atrophy	
BRCA	cis	1	rs10913514	chr1:171670823	VAMP4	chr1:171669298-171711214:-	0.19	5.28	1.59E-7	Hippocampal atrophy	
BRCA	cis	1	rs10913529	chr1:171679465	VAMP4	chr1:171669298-171711214:-	0.21	6.26	5.68E-10	Hippocampal atrophy	
BRCA	cis	1	rs10913565	chr1:171706706	VAMP4	chr1:171669298-171711214:-	0.19	5.47	5.76E-8	Hippocampal atrophy	
BRCA	cis	1	rs10916921	chr1:21334542	HP1BP3	chr1:21069171-21113799:-	0.12	3.6	0.000337	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs10916921	chr1:21334542	SH2D5	chr1:21046225-21059330:-	0.13	3.49	0.000505	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs10917686	chr1:161658490	FCGR2B	chr1:161632940-161647951:+	-0.15	-4.29	1.92E-5	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	
BRCA	cis	1	rs10917688	chr1:161658780	FCGR2B	chr1:161632940-161647951:+	0.14	4.08	4.79E-5	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	
BRCA	cis	1	rs1092015	chr14:58200725	EXOC5	chr14:57669196-57735617:-	-0.18	-3.59	0.000344	Bipolar disorder and schizophrenia	
BRCA	cis	1	rs1092015	chr14:58200725	PSMA3	chr14:58711593-58738726:+	-0.18	-3.53	0.000432	Bipolar disorder and schizophrenia	
BRCA	cis	1	rs10927875	chr1:16299312	CLCNKA	chr1:16345370-16360544:+	0.2	5.31	1.31E-7	Dilated cardiomyopathy	
BRCA	cis	1	rs10929965	chr2:160906931	LY75	chr2:160625141-160761262:-	-0.14	-4.72	2.62E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs10929965	chr2:160906931	PLA2R1	chr2:160798012-160919121:-	-0.15	-5.14	3.31E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs10929966	chr2:160908341	LY75	chr2:160625141-160761262:-	0.14	4.81	1.75E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs10929966	chr2:160908341	PLA2R1	chr2:160798012-160919121:-	0.15	5.11	3.85E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs10932031	chr2:204804494	CD28	chr2:204571198-204602556:+	0.09	3.73	0.000205	Celiac disease	
BRCA	cis	1	rs10932772	chr2:219177148	TMBIM1	chr2:219138917-219157280:-	0.17	5.02	6.09E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs10934254	chr3:113841634	GRAMD1C	chr3:113547029-113666020:+	-0.12	-3.64	0.00029	Personality dimensions	
BRCA	cis	1	rs10934255	chr3:113842444	GRAMD1C	chr3:113547029-113666020:+	-0.12	-3.65	0.000277	Personality dimensions	
BRCA	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.4	-13.33	1.33E-37	Height	
BRCA	cis	1	rs10935120	chr3:134233092	CEP63	chr3:134204575-134293852:+	-0.16	-4.36	1.44E-5	Height	
BRCA	cis	1	rs10935186	chr3:136346206	PCCB	chr3:135969167-136056737:+	0.14	3.8	0.000156	Schizophrenia	
BRCA	cis	1	rs10937463	chr3:190985247	UTS2D	chr3:190984945-191048325:-	0.23	6.65	4.77E-11	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs10937464	chr3:190985274	UTS2D	chr3:190984945-191048325:-	-0.22	-6.45	1.66E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs10937465	chr3:190985279	UTS2D	chr3:190984945-191048325:-	-0.22	-6.45	1.66E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs10938353	chr4:44582487	GUF1	chr4:44680433-44702696:+	-0.16	-3.97	7.63E-5	Body mass index	
BRCA	cis	1	rs10939740	chr4:17617490	MED28	chr4:17616273-17629791:+	0.14	3.69	0.000234	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.56	-17.95	3.91E-63	Response to antipsychotic treatment	
BRCA	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.58	-18.24	6.52E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.57	-17.82	2.27E-62	Response to antipsychotic treatment	
BRCA	cis	1	rs10945582	chr6:159381088	RSPH3	chr6:159398268-159421198:-	-0.19	-3.42	0.00064	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs10946834	chr6:26533664	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.58E-8	Educational attainment	
BRCA	cis	1	rs10946834	chr6:26533664	C6orf41	chr6:26924772-26991752:+	-0.12	-3.7	0.000227	Educational attainment	
BRCA	cis	1	rs10946834	chr6:26533664	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.5	0.000489	Educational attainment	
BRCA	cis	1	rs10946835	chr6:26533757	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.58E-8	Educational attainment	
BRCA	cis	1	rs10946835	chr6:26533757	C6orf41	chr6:26924772-26991752:+	-0.12	-3.7	0.000227	Educational attainment	
BRCA	cis	1	rs10946835	chr6:26533757	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.5	0.000489	Educational attainment	
BRCA	cis	1	rs10947673	chr6:37445079	C6orf129	chr6:37450699-37467700:-	0.12	4.85	1.39E-6	Cognitive performance	
BRCA	cis	1	rs10947673	chr6:37445079	RNF8	chr6:37321748-37362513:+	0.13	3.76	0.00018	Cognitive performance	
BRCA	cis	1	rs10948974	chr6:55992520	COL21A1	chr6:55921389-56258892:-	-0.38	-6.98	5.28E-12	Psychosis (atypical)	
BRCA	cis	1	rs10948975	chr6:55992744	COL21A1	chr6:55921389-56258892:-	-0.38	-6.98	5.28E-12	Psychosis (atypical)	
BRCA	cis	1	rs10950032	chr7:65738591	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.63	5.22E-11	Diabetic kidney disease	
BRCA	cis	1	rs10950032	chr7:65738591	CRCP	chr7:65579805-65619551:+	0.21	3.49	0.000501	Diabetic kidney disease	
BRCA	cis	1	rs10950032	chr7:65738591	LOC493754	chr7:65993446-66057363:-	-0.24	-4.03	5.97E-5	Diabetic kidney disease	
BRCA	cis	1	rs10951192	chr7:28161033	JAZF1	chr7:27870196-28220437:-	-0.13	-4.64	3.93E-6	Rheumatoid arthritis	
BRCA	cis	1	rs10957322	chr8:65670364	CYP7B1	chr8:65508529-65711348:-	0.12	3.83	0.000136	HIV-1 susceptibility	
BRCA	cis	1	rs10957323	chr8:65680494	CYP7B1	chr8:65508529-65711348:-	0.12	3.79	0.000158	HIV-1 susceptibility	
BRCA	cis	1	rs10957375	chr8:67355484	C8orf46	chr8:67405491-67430757:+	-0.17	-4.18	3.17E-5	Blood metabolite levels	
BRCA	cis	1	rs10966	chr20:25282944	FAM182A	chr20:26035250-26067552:+	-0.21	-5.53	3.99E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10966	chr20:25282944	FAM182B	chr20:25744102-25848786:-	0.24	6.35	3.22E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10966	chr20:25282944	PYGB	chr20:25228706-25278647:+	-0.13	-3.54	0.000419	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs10983700	chr9:100537455	CORO2A	chr9:100883258-100954956:-	-0.13	-3.67	0.000251	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10983700	chr9:100537455	NCBP1	chr9:100395705-100436027:+	-0.14	-4.31	1.82E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10983700	chr9:100537455	TRIM14	chr9:100831569-100881488:-	-0.13	-3.6	0.000327	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10983700	chr9:100537455	TSTD2	chr9:100362364-100395962:-	-0.12	-4.44	9.77E-6	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10983701	chr9:100537577	CORO2A	chr9:100883258-100954956:-	-0.13	-3.78	0.000167	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10983701	chr9:100537577	NCBP1	chr9:100395705-100436027:+	-0.14	-4.52	6.9E-6	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10983701	chr9:100537577	TRIM14	chr9:100831569-100881488:-	-0.14	-3.71	0.000215	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10983701	chr9:100537577	TSTD2	chr9:100362364-100395962:-	-0.13	-4.67	3.44E-6	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10983701	chr9:100537577	XPA	chr9:100437192-100459691:-	-0.11	-3.38	0.000739	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10983761	chr9:100553957	NCBP1	chr9:100395705-100436027:+	-0.11	-3.43	0.000636	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10983761	chr9:100553957	TSTD2	chr9:100362364-100395962:-	-0.1	-3.55	0.000404	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs10984361	chr9:100681490	C9orf156	chr9:100666772-100684852:-	-0.17	-4.82	1.68E-6	Quantitative traits	
BRCA	cis	1	rs10984506	chr9:100716140	C9orf156	chr9:100666772-100684852:-	-0.15	-4.09	4.7E-5	Quantitative traits	
BRCA	cis	1	rs10988214	chr9:131883752	NUP188	chr9:131703724-131769374:+	-0.12	-3.47	0.000542	Blood metabolite ratios	
BRCA	cis	1	rs10988214	chr9:131883752	SH3GLB2	chr9:131770314-131790579:-	-0.13	-4.86	1.35E-6	Blood metabolite ratios	
BRCA	cis	1	rs10988223	chr9:131903021	SH3GLB2	chr9:131770314-131790579:-	-0.11	-4.09	4.69E-5	Blood metabolite ratios	
BRCA	cis	1	rs10991437	chr9:107735920	TMEM38B	chr9:108456825-108537444:+	0.24	4.07	5.12E-5	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs11020847	chr11:94323912	FUT4	chr11:94277017-94283062:+	0.11	3.5	0.000481	Attention deficit hyperactivity disorder symptoms (interaction)	
BRCA	cis	1	rs11020847	chr11:94323912	MRE11A	chr11:94150469-94227040:-	0.14	4.12	4.16E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
BRCA	cis	1	rs11024349	chr11:17656148	PIK3C2A	chr11:17099277-17229530:-	0.11	3.52	0.000448	Night sleep phenotypes	
BRCA	cis	1	rs11026412	chr11:22114093	ANO5	chr11:22214722-22304913:+	0.24	5.09	4.15E-7	Parkinson's disease	
BRCA	cis	1	rs11026416	chr11:22125058	ANO5	chr11:22214722-22304913:+	0.27	5.53	4.05E-8	Parkinson's disease	
BRCA	cis	1	rs11029915	chr11:27311468	LGR4	chr11:27387510-27494334:-	0.14	4.13	3.88E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs11029932	chr11:27328254	LGR4	chr11:27387510-27494334:-	0.14	4.15	3.57E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.11	-3.51	0.000461	Subjective well-being	
BRCA	cis	1	rs11039255	chr11:47495746	MADD	chr11:47290927-47351582:+	0.13	4.25	2.37E-5	Subjective well-being	
BRCA	cis	1	rs11039255	chr11:47495746	MYBPC3	chr11:47352958-47374253:-	-0.15	-4.53	6.45E-6	Subjective well-being	
BRCA	cis	1	rs11039390	chr11:47796295	MADD	chr11:47290927-47351582:+	0.15	4.51	7.28E-6	Subjective well-being	
BRCA	cis	1	rs11039390	chr11:47796295	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.29	1.98E-5	Subjective well-being	
BRCA	cis	1	rs11039412	chr11:47841581	MADD	chr11:47290927-47351582:+	0.15	4.5	7.53E-6	Subjective well-being	
BRCA	cis	1	rs11039412	chr11:47841581	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.11	4.28E-5	Subjective well-being	
BRCA	cis	1	rs11039426	chr11:47863119	MADD	chr11:47290927-47351582:+	0.15	4.51	7.22E-6	Subjective well-being	
BRCA	cis	1	rs11039426	chr11:47863119	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.13	3.93E-5	Subjective well-being	
BRCA	cis	1	rs11039787	chr11:5965611	UBQLNL	chr11:5535624-5537956:-	0.15	3.4	0.000692	DNA methylation (variation)	
BRCA	cis	1	rs11040899	chr11:6520015	DNHD1	chr11:6518526-6593252:+	-0.11	-3.38	0.000738	DNA methylation (variation)	
BRCA	cis	1	rs11040899	chr11:6520015	TPP1	chr11:6633997-6640692:-	-0.11	-3.42	0.00065	DNA methylation (variation)	
BRCA	cis	1	rs11048457	chr12:26463174	BHLHE41	chr12:26272961-26278003:-	-0.13	-3.76	0.000178	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs11048457	chr12:26463174	SSPN	chr12:26348269-26405853:+	-0.11	-3.59	0.000344	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs11049516	chr12:28452582	CCDC91	chr12:28332210-28703098:+	0.16	4.06	5.17E-5	Height	
BRCA	cis	1	rs11049532	chr12:28476912	CCDC91	chr12:28332210-28703098:+	0.16	4.15	3.64E-5	Height	
BRCA	cis	1	rs11051970	chr12:32537488	FGD4	chr12:32638906-32798982:+	-0.33	-10.19	2.44E-23	Response to tocilizumab in rheumatoid arthritis	
BRCA	cis	1	rs11057394	chr12:124407676	DNAH10	chr12:124247042-124420265:+	0.25	6.43	1.87E-10	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs11057654	chr12:122608636	LRRC43	chr12:122652266-122688017:+	-0.17	-4.78	2.03E-6	Urate levels	
BRCA	cis	1	rs11057905	chr12:122609131	LRRC43	chr12:122652266-122688017:+	-0.18	-4.9	1.09E-6	Urate levels	
BRCA	cis	1	rs11059094	chr12:122606837	LRRC43	chr12:122652266-122688017:+	-0.17	-4.74	2.47E-6	Urate levels	
BRCA	cis	1	rs11061602	chr12:122615964	LRRC43	chr12:122652266-122688017:+	0.16	4.52	6.77E-6	Urate levels	
BRCA	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.59	13.24	3.65E-37	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs11064210	chr12:6576721	TAPBPL	chr12:6561177-6575601:+	-0.16	-3.81	0.000149	Hip geometry	
BRCA	cis	1	rs11064218	chr12:6586261	TAPBPL	chr12:6561177-6575601:+	-0.15	-3.61	0.00032	Hip geometry	
BRCA	cis	1	rs11064881	chr12:120146925	PRKAB1	chr12:120105757-120119428:+	-0.56	-8.67	1.61E-17	Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs1106565	chr10:102211613	SEC31B	chr10:102246403-102289636:-	-0.27	-10.18	2.74E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11067231	chr12:109993603	MMAB	chr12:109991523-110011358:-	-0.12	-3.71	0.000222	HDL cholesterol	
BRCA	cis	1	rs11067231	chr12:109993603	MYO1H	chr12:109826524-109886176:+	0.25	7.66	4.17E-14	HDL cholesterol	
BRCA	cis	1	rs11070798	chr15:50883263	SPPL2A	chr15:50999739-51057910:-	0.14	5.21	2.22E-7	QT interval	
BRCA	cis	1	rs11072603	chr15:76881138	SCAPER	chr15:76640529-77197744:-	-0.19	-6.77	2.16E-11	Blood metabolite levels	
BRCA	cis	1	rs11072804	chr15:79078486	CTSH	chr15:79214092-79237420:-	0.17	4.84	1.48E-6	Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs11072805	chr15:79078518	CTSH	chr15:79214092-79237420:-	0.17	4.82	1.61E-6	Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs11080357	chr17:33898933	SLFN12L	chr17:33801926-33864880:-	0.08	4.78	2.0E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs11083475	chr19:39188112	LGALS7	chr19:39261608-39264157:-	-0.19	-6.06	1.92E-9	Heart rate	
BRCA	cis	1	rs1108431	chr16:31054607	HSD3B7	chr16:30996519-31000473:+	0.2	6.09	1.59E-9	Response to metformin (IC50)	
BRCA	cis	1	rs1108431	chr16:31054607	MYST1	chr16:31128985-31142713:+	0.18	6.67	4.12E-11	Response to metformin (IC50)	
BRCA	cis	1	rs1108431	chr16:31054607	PRSS53	chr16:31094747-31106276:-	-0.09	-3.42	0.000653	Response to metformin (IC50)	
BRCA	cis	1	rs1108431	chr16:31054607	ZNF689	chr16:30614701-30621682:-	0.13	3.93	8.95E-5	Response to metformin (IC50)	
BRCA	cis	1	rs11084785	chr19:35282054	ZNF181	chr19:35225151-35233774:+	-0.19	-6.49	1.32E-10	Urate levels (BMI interaction)	
BRCA	cis	1	rs11084786	chr19:35282181	ZNF181	chr19:35225151-35233774:+	-0.2	-6.57	7.86E-11	Urate levels (BMI interaction)	
BRCA	cis	1	rs11086102	chr19:18398628	JUND	chr19:18390563-18392432:-	-0.12	-3.73	0.000202	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs11086102	chr19:18398628	KIAA1683	chr19:18367906-18385319:-	-0.17	-5.04	5.52E-7	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs11087520	chr20:25436827	FAM182A	chr20:26035250-26067552:+	-0.23	-6.01	2.49E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs11087520	chr20:25436827	FAM182B	chr20:25744102-25848786:-	0.23	6.08	1.65E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs11087520	chr20:25436827	PYGB	chr20:25228706-25278647:+	-0.13	-3.5	0.000481	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs11087521	chr20:25440648	FAM182A	chr20:26035250-26067552:+	-0.25	-6.47	1.52E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs11087521	chr20:25440648	FAM182B	chr20:25744102-25848786:-	0.23	5.75	1.17E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs11088226	chr21:33925531	TCP10L	chr21:33947152-33957845:-	-0.28	-5.85	6.61E-9	Gastritis	
BRCA	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.29	-10.82	5.75E-26	Longevity	
BRCA	cis	1	rs1109501	chr4:71329490	AMTN	chr4:71384298-71398459:+	0.26	7.61	5.79E-14	Alcoholism (heaviness of drinking)	
BRCA	cis	1	rs11096982	chr4:39134867	KLHL5	chr4:39046659-39123828:+	-0.14	-4.51	7.36E-6	Uric acid levels	
BRCA	cis	1	rs11097912	chr4:107000462	TBCK	chr4:106967233-107237861:-	0.23	7.27	7.08E-13	Airflow obstruction	
BRCA	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.58	12.99	6.52E-36	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs11100	chr20:25281184	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.27E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs11100	chr20:25281184	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.95E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs11101721	chr10:135190358	PAOX	chr10:135192741-135205197:+	-0.2	-3.6	0.00033	Lifespan	
BRCA	cis	1	rs1110183	chr9:38456365	EXOSC3	chr9:37779949-37785067:-	0.18	4.12	4.13E-5	Hypertension	
BRCA	cis	1	rs1110183	chr9:38456365	TOMM5	chr9:37582646-37592636:-	0.12	4.14	3.82E-5	Hypertension	
BRCA	cis	1	rs11110901	chr12:102030113	CHPT1	chr12:102091417-102123424:+	-0.23	-3.6	0.000333	Lung function (FEV1)	
BRCA	cis	1	rs11113118	chr12:107199142	C12orf23	chr12:107349544-107367811:+	-0.17	-4.38	1.33E-5	Social autistic-like traits	
BRCA	cis	1	rs11113118	chr12:107199142	MTERFD3	chr12:107371069-107380929:-	-0.14	-4.09	4.55E-5	Social autistic-like traits	
BRCA	cis	1	rs11115047	chr12:82232773	PPFIA2	chr12:81652880-82153109:-	0.14	3.48	0.000522	Resting heart rate	
BRCA	cis	1	rs11121201	chr1:8632791	RERE	chr1:8412466-8877699:-	0.11	3.53	0.00044	Vitiligo	
BRCA	cis	1	rs1112137	chr1:247215375	ZNF670	chr1:247200087-247242069:-	-0.25	-6.98	5.08E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs11121533	chr1:10292888	PGD	chr1:10459085-10480200:+	0.19	5.55	3.59E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs11121552	chr1:10435324	PGD	chr1:10459085-10480200:+	0.23	6.34	3.31E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.79	-21.3	3.7E-84	Renal function-related traits (BUN)	
BRCA	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.66	-16.85	1.08E-56	Renal function-related traits (BUN)	
BRCA	cis	1	rs111237243	chr14:59991030	C14orf149	chr14:59939406-59951126:-	-0.26	-3.8	0.000153	Schizophrenia	
BRCA	cis	1	rs111237243	chr14:59991030	JKAMP	chr14:59951161-59972080:+	0.32	5.6	2.76E-8	Schizophrenia	
BRCA	cis	1	rs111237645	chr10:96462701	C10orf129	chr10:96953957-96988685:+	0.33	5.44	6.55E-8	Blood metabolite levels	
BRCA	cis	1	rs11124575	chr2:37500435	CEBPZ	chr2:37428778-37458740:-	-0.17	-5.21	2.33E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs111252524	chr2:203199188	NOP58	chr2:203130515-203168382:+	0.15	3.41	0.000665	Urate levels	
BRCA	cis	1	rs11125529	chr2:54475866	C2orf73	chr2:54558071-54588714:+	-0.17	-4.27	2.15E-5	Telomere length	
BRCA	cis	1	rs11125949	chr2:63357876	C2orf86	chr2:63348537-63815851:-	-0.22	-5.4	8.32E-8	Subjective well-being	
BRCA	cis	1	rs11126251	chr2:70163434	ANXA4	chr2:69969127-70053594:+	-0.15	-4.45	9.48E-6	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs11127071	chr2:27838058	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.1	4.45E-5	Oral cavity cancer	
BRCA	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.25	-6.26	5.49E-10	Body mass index	
BRCA	cis	1	rs111295372	chr2:86283357	LOC90784	chr2:86247339-86250991:-	-0.45	-5.46	6.05E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.29	-10.92	2.27E-26	Longevity	
BRCA	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.27	-10.1	5.59E-23	Longevity	
BRCA	cis	1	rs11130190	chr3:49402137	AMT	chr3:49454212-49460012:-	0.14	4.69	3.12E-6	Menarche (age at onset)	
BRCA	cis	1	rs11130190	chr3:49402137	CCDC36	chr3:49235861-49295537:+	0.1	3.93	8.91E-5	Menarche (age at onset)	
BRCA	cis	1	rs11130190	chr3:49402137	NCKIPSD	chr3:48711280-48723334:-	0.15	3.89	0.000105	Menarche (age at onset)	
BRCA	cis	1	rs11130190	chr3:49402137	P4HTM	chr3:49027341-49044579:+	0.1	4.29	1.96E-5	Menarche (age at onset)	
BRCA	cis	1	rs11130190	chr3:49402137	WDR6	chr3:49044637-49053386:+	-0.13	-3.89	0.000109	Menarche (age at onset)	
BRCA	cis	1	rs11130213	chr3:49712297	AMT	chr3:49454212-49460012:-	0.11	3.67	0.000256	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs11130214	chr3:49735746	CCDC36	chr3:49235861-49295537:+	-0.08	-3.39	0.000712	Resting heart rate	
BRCA	cis	1	rs11130214	chr3:49735746	DALRD3	chr3:49052435-49058467:-	-0.12	-4.19	3.07E-5	Resting heart rate	
BRCA	cis	1	rs11130214	chr3:49735746	P4HTM	chr3:49027341-49044579:+	-0.09	-3.98	7.4E-5	Resting heart rate	
BRCA	cis	1	rs11130216	chr3:49736172	CCDC36	chr3:49235861-49295537:+	0.1	3.77	0.000175	Resting heart rate	
BRCA	cis	1	rs11130216	chr3:49736172	DALRD3	chr3:49052435-49058467:-	0.13	4.42	1.1E-5	Resting heart rate	
BRCA	cis	1	rs11130216	chr3:49736172	P4HTM	chr3:49027341-49044579:+	0.09	3.84	0.00013	Resting heart rate	
BRCA	cis	1	rs11132254	chr4:185611592	CASP3	chr4:185548852-185570629:-	0.15	4.34	1.57E-5	Kawasaki disease	
BRCA	cis	1	rs11132254	chr4:185611592	CCDC111	chr4:185570767-185616112:+	0.16	4.49	7.85E-6	Kawasaki disease	
BRCA	cis	1	rs11132254	chr4:185611592	IRF2	chr4:185308878-185395726:-	0.13	3.7	0.000224	Kawasaki disease	
BRCA	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.41	-16.03	5.28E-52	Kawasaki disease	
BRCA	cis	1	rs111485167	chr10:96394254	C10orf129	chr10:96953957-96988685:+	0.34	5.4	8.04E-8	Blood metabolite levels	
BRCA	cis	1	rs111489600	chr14:59993021	C14orf149	chr14:59939406-59951126:-	-0.26	-3.8	0.000153	Schizophrenia	
BRCA	cis	1	rs111489600	chr14:59993021	JKAMP	chr14:59951161-59972080:+	0.32	5.6	2.76E-8	Schizophrenia	
BRCA	cis	1	rs11149710	chr16:74472546	RFWD3	chr16:74655298-74700779:-	0.09	3.73	0.000198	Breast cancer	
BRCA	cis	1	rs111501284	chr10:96392063	C10orf129	chr10:96953957-96988685:+	0.34	5.4	8.04E-8	Blood metabolite levels	
BRCA	cis	1	rs11153170	chr6:109652528	PPIL6	chr6:109711419-109761990:-	0.26	4.32	1.74E-5	Hematological parameters	
BRCA	cis	1	rs111547017	chr6:43341689	ZNF318	chr6:43278872-43337181:-	0.19	3.94	8.67E-5	Schizophrenia	
BRCA	cis	1	rs111563630	chr7:123412203	HYAL4	chr7:123485223-123517529:+	0.29	4.11	4.29E-5	Platelet count	
BRCA	cis	1	rs11157696	chr14:50105746	RPL36AL	chr14:50085407-50087349:-	-0.17	-5.55	3.68E-8	Carotid intima media thickness	
BRCA	cis	1	rs11159086	chr14:74962275	TMEM90A	chr14:74872596-74892805:-	-0.16	-3.74	0.000197	Advanced glycation end-product levels	
BRCA	cis	1	rs111596617	chr6:26191678	HIST1H3E	chr6:26224427-26226589:+	0.35	6.81	1.61E-11	Renal underexcretion gout;Gout	
BRCA	cis	1	rs11164654	chr1:92968312	EVI5	chr1:92974255-93257961:-	-0.16	-4.38	1.28E-5	Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs1116547	chr5:112680337	YTHDC2	chr5:112849410-112930979:+	0.15	4.29	1.96E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs11167260	chr20:33775200	PROCR	chr20:33758727-33765164:+	-0.26	-5.15	3.16E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.34	7.81	1.35E-14	Crohn's disease	
BRCA	cis	1	rs11168618	chr12:48933233	TROAP	chr12:49716971-49725513:+	-0.06	-3.62	0.000314	Adiponectin levels	
BRCA	cis	1	rs111696803	chr9:100696636	C9orf156	chr9:100666772-100684852:-	-0.17	-4.62	4.26E-6	Quantitative traits	
BRCA	cis	1	rs11170737	chr12:54279604	LOC400043	chr12:54519855-54526619:+	-0.13	-3.46	0.000558	Biliary atresia	
BRCA	cis	1	rs11171803	chr12:56718422	COQ10A	chr12:56660642-56664748:+	-0.28	-3.89	0.000105	Psoriasis vulgaris	
BRCA	cis	1	rs11171803	chr12:56718422	RPS26	chr12:56435686-56438005:+	-0.3	-3.82	0.00014	Psoriasis vulgaris	
BRCA	cis	1	rs11171803	chr12:56718422	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.67	0.000255	Psoriasis vulgaris	
BRCA	cis	1	rs11171806	chr12:56733531	COQ10A	chr12:56660642-56664748:+	0.29	4.02	6.24E-5	Psoriasis vulgaris	
BRCA	cis	1	rs11171806	chr12:56733531	SLC39A5	chr12:56623820-56631627:+	0.25	3.74	0.000197	Psoriasis vulgaris	
BRCA	cis	1	rs11171846	chr12:56828056	TIMELESS	chr12:56810157-56843200:-	-0.22	-5.36	1.03E-7	Immune reponse to smallpox (secreted IFN-alpha)	
BRCA	cis	1	rs11172333	chr12:58170335	B4GALNT1	chr12:58019551-58026985:-	0.13	3.72	0.000209	Multiple sclerosis	
BRCA	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.43	10.65	3.16E-25	Multiple sclerosis	
BRCA	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.35	-10.15	3.65E-23	Multiple sclerosis	
BRCA	cis	1	rs11172333	chr12:58170335	XRCC6BP1	chr12:58335445-58351051:+	-0.18	-5.08	4.42E-7	Multiple sclerosis	
BRCA	cis	1	rs11172335	chr12:58175201	B4GALNT1	chr12:58019551-58026985:-	0.12	3.51	0.00047	Multiple sclerosis	
BRCA	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.43	10.52	1.07E-24	Multiple sclerosis	
BRCA	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.36	-10.5	1.35E-24	Multiple sclerosis	
BRCA	cis	1	rs11172335	chr12:58175201	XRCC6BP1	chr12:58335445-58351051:+	-0.19	-5.11	3.78E-7	Multiple sclerosis	
BRCA	cis	1	rs11172342	chr12:58187758	B4GALNT1	chr12:58019551-58026985:-	0.12	3.49	0.000504	Multiple sclerosis	
BRCA	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.43	10.52	1.09E-24	Multiple sclerosis	
BRCA	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.36	-10.51	1.19E-24	Multiple sclerosis	
BRCA	cis	1	rs11172342	chr12:58187758	XRCC6BP1	chr12:58335445-58351051:+	-0.19	-5.1	3.94E-7	Multiple sclerosis	
BRCA	cis	1	rs11172343	chr12:58188157	B4GALNT1	chr12:58019551-58026985:-	0.12	3.49	0.000504	Multiple sclerosis	
BRCA	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.43	10.52	1.09E-24	Multiple sclerosis	
BRCA	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.36	-10.51	1.19E-24	Multiple sclerosis	
BRCA	cis	1	rs11172343	chr12:58188157	XRCC6BP1	chr12:58335445-58351051:+	-0.19	-5.1	3.94E-7	Multiple sclerosis	
BRCA	cis	1	rs11172344	chr12:58193448	B4GALNT1	chr12:58019551-58026985:-	0.12	3.63	0.000293	Multiple sclerosis	
BRCA	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.43	11.04	6.59E-27	Multiple sclerosis	
BRCA	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.34	-10.35	5.57E-24	Multiple sclerosis	
BRCA	cis	1	rs11172344	chr12:58193448	XRCC6BP1	chr12:58335445-58351051:+	-0.17	-4.96	8.29E-7	Multiple sclerosis	
BRCA	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.42	10.14	3.77E-23	Multiple sclerosis	
BRCA	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.35	-10.31	7.72E-24	Multiple sclerosis	
BRCA	cis	1	rs11172349	chr12:58212528	XRCC6BP1	chr12:58335445-58351051:+	-0.19	-5.28	1.55E-7	Multiple sclerosis	
BRCA	cis	1	rs1117367	chr15:76872330	SCAPER	chr15:76640529-77197744:-	-0.18	-6.41	2.22E-10	Blood metabolite levels	
BRCA	cis	1	rs11174399	chr12:62646556	FAM19A2	chr12:62102043-62653925:-	0.16	3.62	0.000312	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs11174409	chr12:62669178	FAM19A2	chr12:62102043-62653925:-	0.17	3.79	0.000158	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs11174410	chr12:62671564	FAM19A2	chr12:62102043-62653925:-	0.17	3.78	0.000168	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs11174436	chr12:62743348	FAM19A2	chr12:62102043-62653925:-	0.18	3.88	0.000113	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs11174437	chr12:62744626	FAM19A2	chr12:62102043-62653925:-	0.18	3.88	0.000113	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs11174458	chr12:62788098	FAM19A2	chr12:62102043-62653925:-	0.17	3.66	0.000262	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs11175967	chr12:66321344	LLPH	chr12:66516850-66563807:-	0.15	3.81	0.000144	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
BRCA	cis	1	rs111773762	chr5:56269336	MAP3K1	chr5:56110900-56191976:+	-0.25	-4.23	2.59E-5	Breast cancer (early onset)	
BRCA	cis	1	rs111803315	chr14:59965293	C14orf149	chr14:59939406-59951126:-	-0.24	-3.49	0.000507	Schizophrenia	
BRCA	cis	1	rs111803315	chr14:59965293	JKAMP	chr14:59951161-59972080:+	0.33	5.73	1.28E-8	Schizophrenia	
BRCA	cis	1	rs11185056	chr1:107578610	PRMT6	chr1:107599267-107601907:+	0.22	4.06	5.23E-5	AIDS	
BRCA	cis	1	rs11185057	chr1:107596964	NTNG1	chr1:107682629-108024471:+	0.17	3.74	0.000197	AIDS	
BRCA	cis	1	rs11185057	chr1:107596964	PRMT6	chr1:107599267-107601907:+	0.23	4.61	4.53E-6	AIDS	
BRCA	cis	1	rs11185058	chr1:107603269	PRMT6	chr1:107599267-107601907:+	0.18	3.74	0.000193	AIDS	
BRCA	cis	1	rs11185773	chr10:91349331	FLJ37201	chr10:91451057-91457685:-	-0.2	-4.32	1.7E-5	Metabolic traits	
BRCA	cis	1	rs11185780	chr10:91363624	FLJ37201	chr10:91451057-91457685:-	0.21	4.49	7.79E-6	Metabolic traits	
BRCA	cis	1	rs11185790	chr10:91372533	FLJ37201	chr10:91451057-91457685:-	0.16	3.55	0.000398	Metabolic traits	
BRCA	cis	1	rs11185792	chr10:91374967	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.73	0.0002	Metabolic traits	
BRCA	cis	1	rs11185793	chr10:91375224	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.76	0.000178	Metabolic traits	
BRCA	cis	1	rs11185794	chr10:91375419	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.76	0.000178	Metabolic traits	
BRCA	cis	1	rs11185795	chr10:91375429	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.76	0.000178	Metabolic traits	
BRCA	cis	1	rs11185796	chr10:91375482	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.76	0.000178	Metabolic traits	
BRCA	cis	1	rs11185797	chr10:91375798	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.76	0.000178	Metabolic traits	
BRCA	cis	1	rs11185798	chr10:91375968	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.76	0.000178	Metabolic traits	
BRCA	cis	1	rs11185799	chr10:91377466	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.72	0.000213	Metabolic traits	
BRCA	cis	1	rs11185800	chr10:91378080	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.89	0.000106	Metabolic traits	
BRCA	cis	1	rs11185801	chr10:91378716	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.85	0.000126	Metabolic traits	
BRCA	cis	1	rs11185802	chr10:91378754	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.84	0.000129	Metabolic traits	
BRCA	cis	1	rs11185804	chr10:91379093	FLJ37201	chr10:91451057-91457685:-	0.17	3.75	0.000185	Metabolic traits	
BRCA	cis	1	rs11185806	chr10:91380215	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.74	0.000192	Metabolic traits	
BRCA	cis	1	rs11185808	chr10:91381110	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.74	0.000196	Metabolic traits	
BRCA	cis	1	rs11185809	chr10:91381231	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.74	0.000192	Metabolic traits	
BRCA	cis	1	rs11185810	chr10:91381481	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.74	0.000197	Metabolic traits	
BRCA	cis	1	rs11187851	chr10:96069875	NOC3L	chr10:96092989-96122683:-	0.13	4.14	3.68E-5	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs111882043	chr14:59899356	C14orf149	chr14:59939406-59951126:-	-0.3	-4.29	1.98E-5	Schizophrenia	
BRCA	cis	1	rs111882043	chr14:59899356	JKAMP	chr14:59951161-59972080:+	0.31	5.36	1.04E-7	Schizophrenia	
BRCA	cis	1	rs11188394	chr10:97365458	ENTPD1	chr10:97471536-97637022:+	0.15	5.08	4.53E-7	Blood metabolite levels	
BRCA	cis	1	rs11188396	chr10:97367510	ENTPD1	chr10:97471536-97637022:+	0.17	5.79	9.16E-9	Blood metabolite levels	
BRCA	cis	1	rs11188398	chr10:97369093	ENTPD1	chr10:97471536-97637022:+	0.17	5.84	7.09E-9	Blood metabolite levels	
BRCA	cis	1	rs11188400	chr10:97371327	ENTPD1	chr10:97471536-97637022:+	0.17	5.8	8.63E-9	Blood metabolite levels	
BRCA	cis	1	rs11188406	chr10:97390195	ENTPD1	chr10:97471536-97637022:+	0.17	5.81	8.05E-9	Blood metabolite levels	
BRCA	cis	1	rs11188407	chr10:97390533	ENTPD1	chr10:97471536-97637022:+	0.17	5.83	7.23E-9	Blood metabolite levels	
BRCA	cis	1	rs11188411	chr10:97397344	ENTPD1	chr10:97471536-97637022:+	0.16	5.6	2.75E-8	Blood metabolite levels	
BRCA	cis	1	rs11188417	chr10:97411680	ENTPD1	chr10:97471536-97637022:+	-0.18	-6.18	9.36E-10	Blood metabolite levels	
BRCA	cis	1	rs111901203	chr11:58297542	CNTF	chr11:58390146-58393203:+	0.17	3.61	0.000319	Lymphoma	
BRCA	cis	1	rs11190466	chr10:102061908	PKD2L1	chr10:102047903-102090243:-	0.22	4.33	1.67E-5	Obesity-related traits	
BRCA	cis	1	rs11190540	chr10:102202629	SEC31B	chr10:102246403-102289636:-	-0.28	-10.46	2.0E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190541	chr10:102203071	SEC31B	chr10:102246403-102289636:-	-0.28	-10.35	5.68E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190551	chr10:102204734	SEC31B	chr10:102246403-102289636:-	-0.28	-10.43	2.53E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190552	chr10:102206607	SEC31B	chr10:102246403-102289636:-	-0.28	-10.23	1.66E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190555	chr10:102209160	SEC31B	chr10:102246403-102289636:-	-0.28	-10.32	7.37E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190556	chr10:102209223	SEC31B	chr10:102246403-102289636:-	-0.28	-10.32	7.37E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190557	chr10:102209369	SEC31B	chr10:102246403-102289636:-	-0.28	-10.32	7.37E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190558	chr10:102209397	SEC31B	chr10:102246403-102289636:-	-0.28	-10.32	7.37E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190569	chr10:102227409	SEC31B	chr10:102246403-102289636:-	-0.28	-10.58	6.06E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190570	chr10:102227702	SEC31B	chr10:102246403-102289636:-	-0.28	-10.47	1.71E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190572	chr10:102232879	SEC31B	chr10:102246403-102289636:-	-0.28	-10.5	1.3E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190578	chr10:102238953	SEC31B	chr10:102246403-102289636:-	-0.28	-10.23	1.76E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190587	chr10:102266638	SEC31B	chr10:102246403-102289636:-	-0.3	-10.58	6.02E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190589	chr10:102275471	SEC31B	chr10:102246403-102289636:-	-0.3	-11.13	2.69E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190592	chr10:102291059	SEC31B	chr10:102246403-102289636:-	-0.3	-11.09	3.91E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190595	chr10:102291761	SEC31B	chr10:102246403-102289636:-	-0.3	-11.09	3.91E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190597	chr10:102293676	SEC31B	chr10:102246403-102289636:-	-0.3	-11.16	1.98E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190599	chr10:102295420	SEC31B	chr10:102246403-102289636:-	-0.3	-11.18	1.69E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190601	chr10:102296730	SEC31B	chr10:102246403-102289636:-	-0.3	-11.24	8.88E-28	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190602	chr10:102297256	SEC31B	chr10:102246403-102289636:-	-0.3	-11.22	1.05E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190604	chr10:102302457	SEC31B	chr10:102246403-102289636:-	-0.28	-10.2	2.19E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190607	chr10:102303614	SEC31B	chr10:102246403-102289636:-	-0.29	-10.75	1.18E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11190613	chr10:102313997	SEC31B	chr10:102246403-102289636:-	0.28	10.52	1.08E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11191416	chr10:104604916	SFXN2	chr10:104474298-104498946:+	0.24	4.71	2.8E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs11191416	chr10:104604916	TMEM180	chr10:104221170-104238858:+	-0.22	-4.05	5.55E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs11191419	chr10:104612335	AS3MT	chr10:104613967-104661653:+	-0.25	-6.92	7.63E-12	Schizophrenia	
BRCA	cis	1	rs11191419	chr10:104612335	C10orf32	chr10:104613967-104624718:+	-0.25	-9.18	2.21E-19	Schizophrenia	
BRCA	cis	1	rs11191419	chr10:104612335	SFXN2	chr10:104474298-104498946:+	-0.12	-3.53	0.000437	Schizophrenia	
BRCA	cis	1	rs11191425	chr10:104625970	SFXN2	chr10:104474298-104498946:+	-0.23	-4.34	1.59E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs11191425	chr10:104625970	TMEM180	chr10:104221170-104238858:+	0.2	3.62	0.000304	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs11197899	chr10:118861724	KIAA1598	chr10:118644308-118886097:-	0.14	3.47	0.000535	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
BRCA	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-0.53	-9.46	1.89E-20	Chronic obstructive pulmonary disease-related biomarkers	
BRCA	cis	1	rs112032073	chr5:56270717	MAP3K1	chr5:56110900-56191976:+	-0.25	-4.18	3.16E-5	Breast cancer (early onset)	
BRCA	cis	1	rs11208927	chr1:67089561	TCTEX1D1	chr1:67218140-67244729:+	0.12	3.53	0.000428	Menopause (age at onset)	
BRCA	cis	1	rs11208928	chr1:67089562	TCTEX1D1	chr1:67218140-67244729:+	0.13	3.82	0.000139	Menopause (age at onset)	
BRCA	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.82	-27.84	1.06E-128	Homocysteine levels	
BRCA	cis	1	rs11211132	chr1:45990516	MMACHC	chr1:45965856-45976737:+	-0.15	-4.31	1.78E-5	Homocysteine levels	
BRCA	cis	1	rs11211199	chr1:46287869	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.78	3.2E-30	Body mass index	
BRCA	cis	1	rs11211199	chr1:46287869	CCDC17	chr1:46085717-46089729:-	0.11	3.44	0.000595	Body mass index	
BRCA	cis	1	rs11211199	chr1:46287869	MUTYH	chr1:45794915-45806142:-	0.13	5.05	5.23E-7	Body mass index	
BRCA	cis	1	rs11211208	chr1:46334256	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.66	1.17E-29	Body mass index	
BRCA	cis	1	rs11211208	chr1:46334256	CCDC17	chr1:46085717-46089729:-	0.11	3.51	0.000471	Body mass index	
BRCA	cis	1	rs11211208	chr1:46334256	MUTYH	chr1:45794915-45806142:-	0.13	5.19	2.49E-7	Body mass index	
BRCA	cis	1	rs112112261	chr10:96650048	C10orf129	chr10:96953957-96988685:+	0.34	5.47	5.73E-8	Blood metabolite levels	
BRCA	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.8	2.8E-30	Body mass index	
BRCA	cis	1	rs11211230	chr1:46406767	CCDC17	chr1:46085717-46089729:-	0.11	3.49	0.000496	Body mass index	
BRCA	cis	1	rs11211230	chr1:46406767	MUTYH	chr1:45794915-45806142:-	0.13	5.06	5.03E-7	Body mass index	
BRCA	cis	1	rs11211234	chr1:46438787	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.75	4.73E-30	Body mass index	
BRCA	cis	1	rs11211234	chr1:46438787	CCDC17	chr1:46085717-46089729:-	0.11	3.38	0.000746	Body mass index	
BRCA	cis	1	rs11211234	chr1:46438787	MUTYH	chr1:45794915-45806142:-	0.13	5.02	6.01E-7	Body mass index	
BRCA	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.78	3.42E-30	Body mass index	
BRCA	cis	1	rs11211241	chr1:46452683	CCDC17	chr1:46085717-46089729:-	0.11	3.44	0.000607	Body mass index	
BRCA	cis	1	rs11211241	chr1:46452683	MUTYH	chr1:45794915-45806142:-	0.13	5	6.64E-7	Body mass index	
BRCA	cis	1	rs11216186	chr11:116784692	SIDT2	chr11:117049939-117068161:+	0.23	3.37	0.000771	Infantile hypertrophic pyloric stenosis	
BRCA	cis	1	rs1121	chr16:15131076	C16orf63	chr16:15959577-15982447:-	0.13	3.56	0.00039	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs11223996	chr11:134626887	ACAD8	chr11:134123434-134135744:+	0.22	4.45	9.67E-6	Myopia (pathological)	
BRCA	cis	1	rs11223996	chr11:134626887	NCAPD3	chr11:134022337-134094471:-	0.17	4	6.85E-5	Myopia (pathological)	
BRCA	cis	1	rs11223996	chr11:134626887	THYN1	chr11:134118175-134123260:-	0.16	3.8	0.000155	Myopia (pathological)	
BRCA	cis	1	rs11223996	chr11:134626887	VPS26B	chr11:134094561-134117684:+	0.24	4.63	4.14E-6	Myopia (pathological)	
BRCA	cis	1	rs11227284	chr11:65503224	CTSW	chr11:65647284-65651212:+	-0.21	-7.17	1.43E-12	Systemic lupus erythematosus	
BRCA	cis	1	rs11227284	chr11:65503224	SNX32	chr11:65601410-65621170:+	0.22	5.18	2.6E-7	Systemic lupus erythematosus	
BRCA	cis	1	rs11227288	chr11:65516588	CTSW	chr11:65647284-65651212:+	-0.18	-6.43	1.97E-10	Systemic lupus erythematosus	
BRCA	cis	1	rs11227288	chr11:65516588	RNASEH2C	chr11:65485146-65488409:-	-0.12	-3.39	0.000714	Systemic lupus erythematosus	
BRCA	cis	1	rs11227288	chr11:65516588	SNX32	chr11:65601410-65621170:+	0.21	5.11	3.87E-7	Systemic lupus erythematosus	
BRCA	cis	1	rs11228973	chr11:57030244	PRG2	chr11:57151267-57191532:-	-0.23	-3.87	0.000116	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs11229003	chr11:57108291	PRG2	chr11:57151267-57191532:-	-0.18	-3.38	0.000738	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs112293138	chr1:171714002	VAMP4	chr1:171669298-171711214:-	0.25	7.35	3.91E-13	Hippocampal atrophy	
BRCA	cis	1	rs11229535	chr11:58348386	CNTF	chr11:58390146-58393203:+	0.17	3.65	0.000279	Lymphoma	
BRCA	cis	1	rs11230147	chr11:59877394	MS4A4A	chr11:60048139-60076444:+	-0.11	-4.42	1.09E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs11230155	chr11:59904959	MS4A4A	chr11:60048139-60076444:+	-0.1	-4.16	3.49E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs11230161	chr11:59920231	MS4A4A	chr11:60048139-60076444:+	0.1	4.05	5.53E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs11230161	chr11:59920231	PRPF19	chr11:60658021-60674061:-	0.14	3.76	0.00018	Alzheimer's disease (late onset)	
BRCA	cis	1	rs112306637	chr2:203198918	NOP58	chr2:203130515-203168382:+	0.15	3.46	0.000567	Urate levels	
BRCA	cis	1	rs11231757	chr11:64106317	C11orf20	chr11:64067863-64072238:+	0.13	3.4	0.000692	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
BRCA	cis	1	rs11231757	chr11:64106317	CCDC88B	chr11:64107695-64125005:+	-0.09	-4.51	7.07E-6	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
BRCA	cis	1	rs11233977	chr11:71221605	DHCR7	chr11:71145459-71159477:-	-0.16	-3.84	0.000132	Vitamin D levels	
BRCA	cis	1	rs11239930	chr1:146560564	CHD1L	chr1:146714291-146767441:+	-0.13	-4.16	3.37E-5	AIDS progression	
BRCA	cis	1	rs11241206	chr5:112736692	YTHDC2	chr5:112849410-112930979:+	0.13	3.86	0.000118	Cerebral amyloid angiopathy	
BRCA	cis	1	rs11241209	chr5:112768936	YTHDC2	chr5:112849410-112930979:+	0.14	4.13	3.86E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs112476368	chr14:59991452	C14orf149	chr14:59939406-59951126:-	-0.26	-3.8	0.000153	Schizophrenia	
BRCA	cis	1	rs112476368	chr14:59991452	JKAMP	chr14:59951161-59972080:+	0.32	5.6	2.76E-8	Schizophrenia	
BRCA	cis	1	rs1124769	chr15:51352249	AP4E1	chr15:51200946-51298097:+	0.13	3.99	7.13E-5	Cognitive performance	
BRCA	cis	1	rs1124769	chr15:51352249	LOC100132724	chr15:51236326-51238760:+	0.2	4.34	1.56E-5	Cognitive performance	
BRCA	cis	1	rs1124769	chr15:51352249	SPPL2A	chr15:50999739-51057910:-	0.16	4.63	4.14E-6	Cognitive performance	
BRCA	cis	1	rs11247915	chr1:26650550	ZNF593	chr1:26496388-26497362:+	0.08	3.7	0.000227	Obesity-related traits	
BRCA	cis	1	rs11247973	chr4:1094314	CRIPAK	chr4:1385340-1389782:+	0.11	3.57	0.000368	Recombination rate (males)	
BRCA	cis	1	rs11247973	chr4:1094314	KIAA1530	chr4:1341104-1381836:+	0.12	3.92	9.31E-5	Recombination rate (males)	
BRCA	cis	1	rs11248348	chr10:124730840	PSTK	chr10:124739556-124749906:+	0.13	3.51	0.000469	Migraine without aura	
BRCA	cis	1	rs11248850	chr16:163598	NPRL3	chr16:134273-188672:-	0.13	3.74	0.000192	Red blood cell traits	
BRCA	cis	1	rs11248850	chr16:163598	SNRNP25	chr16:103829-107668:+	-0.1	-3.38	0.000753	Red blood cell traits	
BRCA	cis	1	rs11249502	chr4:71341161	AMTN	chr4:71384298-71398459:+	0.26	7.57	7.8E-14	Alcoholism (heaviness of drinking)	
BRCA	cis	1	rs112528936	chr4:106633029	INTS12	chr4:106603787-106629881:-	-0.3	-3.65	0.000271	Post bronchodilator FEV1	
BRCA	cis	1	rs112529587	chr8:96060035	C8orf38	chr8:95908040-96088396:+	-0.21	-4.7	2.93E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs1125349	chr4:54515510	LNX1	chr4:54326439-54518682:-	0.13	3.66	0.000266	Beard thickness	
BRCA	cis	1	rs112555934	chr14:59977232	C14orf149	chr14:59939406-59951126:-	-0.26	-3.8	0.000153	Schizophrenia	
BRCA	cis	1	rs112555934	chr14:59977232	JKAMP	chr14:59951161-59972080:+	0.32	5.6	2.76E-8	Schizophrenia	
BRCA	cis	1	rs112573749	chr10:96547736	C10orf129	chr10:96953957-96988685:+	0.32	5.36	1.03E-7	Blood metabolite levels	
BRCA	cis	1	rs11258317	chr10:6407737	RBM17	chr10:6130949-6159420:+	0.11	3.57	0.000376	Bipolar disorder and schizophrenia	
BRCA	cis	1	rs11259936	chr15:84580582	GOLGA6L5	chr15:85047738-85060078:-	0.13	4.31	1.78E-5	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs11259936	chr15:84580582	LOC388152	chr15:84867600-84898920:-	0.12	3.82	0.000144	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs11264462	chr1:156241728	BGLAP	chr1:156182784-156213112:+	0.18	4.68	3.25E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs11264464	chr1:156250887	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs11264464	chr1:156250887	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs11264467	chr1:156273061	BGLAP	chr1:156182784-156213112:+	-0.12	-3.39	0.000722	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs11264467	chr1:156273061	C1orf85	chr1:156259882-156265449:-	0.12	4.09	4.64E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs11264468	chr1:156274585	BGLAP	chr1:156182784-156213112:+	0.2	5.21	2.27E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs11264468	chr1:156274585	C1orf85	chr1:156259882-156265449:-	-0.11	-3.44	0.000613	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs11264468	chr1:156274585	CCT3	chr1:156278752-156308195:-	-0.11	-3.45	0.000576	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs112661971	chr14:59901054	C14orf149	chr14:59939406-59951126:-	-0.3	-4.29	1.98E-5	Schizophrenia	
BRCA	cis	1	rs112661971	chr14:59901054	JKAMP	chr14:59951161-59972080:+	0.31	5.36	1.04E-7	Schizophrenia	
BRCA	cis	1	rs112732395	chr10:96533173	C10orf129	chr10:96953957-96988685:+	0.32	5.36	1.03E-7	Blood metabolite levels	
BRCA	cis	1	rs1127489	chr6:170107702	WDR27	chr6:169857307-170102159:-	-0.12	-3.47	0.000534	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs112751982	chr6:26191958	HIST1H3E	chr6:26224427-26226589:+	0.35	6.81	1.61E-11	Renal underexcretion gout;Gout	
BRCA	cis	1	rs112753638	chr2:203199219	NOP58	chr2:203130515-203168382:+	0.15	3.41	0.000665	Urate levels	
BRCA	cis	1	rs112777695	chr20:33693177	MMP24	chr20:33814539-33864804:+	-0.19	-3.44	0.000595	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs112777695	chr20:33693177	PROCR	chr20:33758727-33765164:+	-0.23	-4.8	1.81E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs112779036	chr10:96498813	C10orf129	chr10:96953957-96988685:+	0.33	5.5	4.85E-8	Blood metabolite levels	
BRCA	cis	1	rs1128320	chr11:244167	PSMD13	chr11:236808-252984:+	-0.16	-4.58	5.13E-6	Menarche (age at onset)	
BRCA	cis	1	rs1128322	chr11:244197	PSMD13	chr11:236808-252984:+	0.16	4.4	1.2E-5	Menarche (age at onset)	
BRCA	cis	1	rs11292	chr10:102313607	SEC31B	chr10:102246403-102289636:-	-0.27	-10.05	9.35E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs1129448	chr22:38170026	TRIOBP	chr22:38082344-38172562:+	0.16	5.43	7.07E-8	Optic cup area;Vertical cup-disc ratio	
BRCA	cis	1	rs1130650	chr14:20940626	PNP	chr14:20937542-20945246:+	-0.17	-4.26	2.23E-5	Interferon alpha levels in systemic lupus erythematosus	
BRCA	cis	1	rs113089853	chr10:96545632	C10orf129	chr10:96953957-96988685:+	0.32	5.36	1.03E-7	Blood metabolite levels	
BRCA	cis	1	rs113103955	chr10:96414633	C10orf129	chr10:96953957-96988685:+	0.33	5.32	1.25E-7	Blood metabolite levels	
BRCA	cis	1	rs1131095	chr3:49714225	AMT	chr3:49454212-49460012:-	0.11	3.67	0.000256	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs113112586	chr14:59969142	C14orf149	chr14:59939406-59951126:-	-0.24	-3.49	0.000507	Schizophrenia	
BRCA	cis	1	rs113112586	chr14:59969142	JKAMP	chr14:59951161-59972080:+	0.33	5.73	1.28E-8	Schizophrenia	
BRCA	cis	1	rs113143821	chr5:127893353	FBN2	chr5:127593602-127873916:-	0.28	5.2	2.33E-7	Multiple system atrophy	
BRCA	cis	1	rs113146460	chr7:1105164	ZFAND2A	chr7:1192544-1199855:-	-0.31	-6.05	2.01E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs113244272	chr10:96400221	C10orf129	chr10:96953957-96988685:+	0.34	5.4	8.04E-8	Blood metabolite levels	
BRCA	cis	1	rs113251361	chr10:96626220	C10orf129	chr10:96953957-96988685:+	0.37	5.96	3.52E-9	Blood metabolite levels	
BRCA	cis	1	rs113315674	chr9:100720053	C9orf156	chr9:100666772-100684852:-	-0.16	-4.44	9.82E-6	Quantitative traits	
BRCA	cis	1	rs1133353	chr2:241522267	CAPN10	chr2:241526145-241557122:+	0.11	3.77	0.000174	Bipolar disorder	
BRCA	cis	1	rs113337957	chr14:59967329	C14orf149	chr14:59939406-59951126:-	-0.24	-3.49	0.000507	Schizophrenia	
BRCA	cis	1	rs113337957	chr14:59967329	JKAMP	chr14:59951161-59972080:+	0.33	5.73	1.28E-8	Schizophrenia	
BRCA	cis	1	rs11344	chr16:29910518	ALDOA	chr16:30064472-30081734:+	0.11	3.8	0.000152	Response to taxane treatment (placlitaxel)	
BRCA	cis	1	rs11344	chr16:29910518	LOC440356	chr16:29875004-29879374:+	-0.23	-6.4	2.34E-10	Response to taxane treatment (placlitaxel)	
BRCA	cis	1	rs11344	chr16:29910518	TBX6	chr16:30097117-30103208:-	0.15	4.41	1.13E-5	Response to taxane treatment (placlitaxel)	
BRCA	cis	1	rs113491584	chr2:203196447	NOP58	chr2:203130515-203168382:+	0.15	3.47	0.000543	Urate levels	
BRCA	cis	1	rs113546720	chr10:96561988	C10orf129	chr10:96953957-96988685:+	0.32	5.35	1.1E-7	Blood metabolite levels	
BRCA	cis	1	rs113575110	chr7:1084394	ZFAND2A	chr7:1192544-1199855:-	-0.33	-6.43	1.94E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs1135999	chr16:15131962	C16orf63	chr16:15959577-15982447:-	0.13	3.55	0.000397	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs1136001	chr16:15131974	C16orf63	chr16:15959577-15982447:-	0.13	3.57	0.000373	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs113613442	chr14:59972563	C14orf149	chr14:59939406-59951126:-	-0.24	-3.49	0.000507	Schizophrenia	
BRCA	cis	1	rs113613442	chr14:59972563	JKAMP	chr14:59951161-59972080:+	0.33	5.73	1.28E-8	Schizophrenia	
BRCA	cis	1	rs1136377	chr5:178513141	ZNF354C	chr5:178487607-178507689:+	-0.12	-4.06	5.25E-5	Height	
BRCA	cis	1	rs113739251	chr10:96502658	C10orf129	chr10:96953957-96988685:+	0.33	5.5	4.85E-8	Blood metabolite levels	
BRCA	cis	1	rs113767110	chr4:106599814	INTS12	chr4:106603787-106629881:-	-0.28	-3.47	0.000532	Post bronchodilator FEV1	
BRCA	cis	1	rs113770724	chr6:159370137	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.42	13.98	6.36E-41	Height	
BRCA	cis	1	rs1138273	chr3:134261437	CEP63	chr3:134204575-134293852:+	0.14	3.67	0.000251	Height	
BRCA	cis	1	rs113877751	chr2:203194721	NOP58	chr2:203130515-203168382:+	0.15	3.47	0.000543	Urate levels	
BRCA	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.3	7.8	1.49E-14	Pancreatic cancer	
BRCA	cis	1	rs114007205	chr20:33647503	MMP24	chr20:33814539-33864804:+	-0.22	-3.85	0.000123	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs114007205	chr20:33647503	PROCR	chr20:33758727-33765164:+	-0.25	-5.04	5.59E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs114121665	chr10:96533587	C10orf129	chr10:96953957-96988685:+	0.22	4.09	4.54E-5	Blood metabolite levels	
BRCA	cis	1	rs1141321	chr6:49412433	CENPQ	chr6:49431096-49460820:+	-0.22	-7.04	3.33E-12	Folate pathway vitamin levels	
BRCA	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.34	10.4	3.35E-24	Folate pathway vitamin levels	
BRCA	cis	1	rs114171212	chr4:106616191	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs1144333	chr1:76275100	ACADM	chr1:76190043-76229353:+	0.21	4.08	4.76E-5	Attention function in attention deficit hyperactive disorder	
BRCA	cis	1	rs114707452	chr3:119287090	CD80	chr3:119243142-119278481:-	0.12	4.12	4.11E-5	Vitiligo	
BRCA	cis	1	rs1147610	chr10:105941167	C10orf79	chr10:105889647-105992120:-	0.14	5.03	5.71E-7	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs114832687	chr18:51836446	POLI	chr18:51795849-51824602:+	0.13	4.03	5.85E-5	Psoriasis	
BRCA	cis	1	rs114931426	chr10:96552327	C10orf129	chr10:96953957-96988685:+	0.23	4.12	4.08E-5	Blood metabolite levels	
BRCA	cis	1	rs114948279	chr20:33733641	MMP24	chr20:33814539-33864804:+	-0.24	-4.1	4.44E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs114948279	chr20:33733641	PROCR	chr20:33758727-33765164:+	-0.28	-5.51	4.47E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11495981	chr7:28177301	JAZF1	chr7:27870196-28220437:-	-0.15	-4.98	7.36E-7	Rheumatoid arthritis	
BRCA	cis	1	rs1150830	chr6:588336	DUSP22	chr6:292101-351353:+	-0.21	-3.42	0.000655	Sitting height ratio	
BRCA	cis	1	rs11519754	chr12:82209181	PPFIA2	chr12:81652880-82153109:-	0.13	3.47	0.000547	Resting heart rate	
BRCA	cis	1	rs11538349	chr7:65421871	CCT6P1	chr7:65216092-65228661:+	0.33	7.3	5.42E-13	Diabetic kidney disease	
BRCA	cis	1	rs11538349	chr7:65421871	LOC493754	chr7:65993446-66057363:-	0.21	3.62	0.000305	Diabetic kidney disease	
BRCA	cis	1	rs11538349	chr7:65421871	ZNF117	chr7:64434830-64467121:-	-0.26	-4.86	1.37E-6	Diabetic kidney disease	
BRCA	cis	1	rs11538549	chr1:27248283	GPATCH3	chr1:27216980-27226962:-	0.23	3.83	0.000136	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs1154435	chr4:100285148	ADH1C	chr4:100257651-100273917:-	-0.21	-6.67	4.1E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1154435	chr4:100285148	ADH4	chr4:100044835-100065449:-	-0.11	-3.38	0.000743	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs115515961	chr18:51836253	POLI	chr18:51795849-51824602:+	0.14	4.52	6.99E-6	Psoriasis	
BRCA	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.7	-20.75	1.33E-80	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs11555809	chr1:27216669	GPATCH3	chr1:27216980-27226962:-	0.23	3.97	7.71E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs11568732	chr10:96521574	C10orf129	chr10:96953957-96988685:+	0.25	4.51	7.28E-6	Blood metabolite levels	
BRCA	cis	1	rs11576866	chr1:10414432	PGD	chr1:10459085-10480200:+	0.23	6.35	3.22E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs11577073	chr1:171716724	VAMP4	chr1:171669298-171711214:-	-0.21	-6.29	4.59E-10	Hippocampal atrophy	
BRCA	cis	1	rs11577745	chr1:171720909	VAMP4	chr1:171669298-171711214:-	0.23	6.61	5.88E-11	Hippocampal atrophy	
BRCA	cis	1	rs11578699	chr1:171719769	VAMP4	chr1:171669298-171711214:-	0.23	6.41	2.2E-10	Hippocampal atrophy	
BRCA	cis	1	rs11578788	chr1:10422958	PGD	chr1:10459085-10480200:+	0.23	6.35	3.1E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.39	11.67	1.11E-29	Body mass index	
BRCA	cis	1	rs11579634	chr1:46466391	MUTYH	chr1:45794915-45806142:-	-0.11	-4.35	1.5E-5	Body mass index	
BRCA	cis	1	rs11580382	chr1:207418392	C4BPA	chr1:207277511-207318308:+	0.15	4.41	1.12E-5	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs11580387	chr1:207418408	C4BPA	chr1:207277511-207318308:+	0.16	4.49	7.79E-6	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs11580415	chr1:171666832	VAMP4	chr1:171669298-171711214:-	0.12	3.48	0.000523	Hippocampal atrophy	
BRCA	cis	1	rs11580522	chr1:171720978	VAMP4	chr1:171669298-171711214:-	-0.25	-7.17	1.37E-12	Hippocampal atrophy	
BRCA	cis	1	rs11583920	chr1:171683611	VAMP4	chr1:171669298-171711214:-	0.19	5.57	3.15E-8	Hippocampal atrophy	
BRCA	cis	1	rs115852057	chr6:55983101	COL21A1	chr6:55921389-56258892:-	-0.37	-6.86	1.14E-11	Psychosis (atypical)	
BRCA	cis	1	rs11588062	chr1:46779764	NSUN4	chr1:46806390-46830690:+	0.18	4.3	1.87E-5	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs11589562	chr1:46466721	CCDC163P	chr1:45960581-45965646:-	0.35	9.99	1.65E-22	Body mass index	
BRCA	cis	1	rs11589562	chr1:46466721	GPBP1L1	chr1:46092978-46152302:-	-0.12	-3.53	0.000439	Body mass index	
BRCA	cis	1	rs11589562	chr1:46466721	MUTYH	chr1:45794915-45806142:-	-0.15	-5.81	8.15E-9	Body mass index	
BRCA	cis	1	rs11590090	chr1:113313563	FAM19A3	chr1:113263189-113269854:+	0.2	6.31	4.19E-10	Hyperactive-impulsive symptoms	
BRCA	cis	1	rs11590526	chr1:116427567	TSPAN2	chr1:115590635-115632115:-	0.2	3.59	0.000341	Educational attainment	
BRCA	cis	1	rs11590680	chr1:171716574	VAMP4	chr1:171669298-171711214:-	0.23	6.79	1.85E-11	Hippocampal atrophy	
BRCA	cis	1	rs11590714	chr1:171716779	VAMP4	chr1:171669298-171711214:-	0.24	6.62	5.81E-11	Hippocampal atrophy	
BRCA	cis	1	rs11591183	chr1:95561706	CNN3	chr1:95362509-95392735:-	0.12	3.5	0.000485	Phospholipid levels (plasma)	
BRCA	cis	1	rs11592213	chr10:97396103	ENTPD1	chr10:97471536-97637022:+	0.17	5.86	6.16E-9	Blood metabolite levels	
BRCA	cis	1	rs11600716	chr11:59924422	MS4A4A	chr11:60048139-60076444:+	-0.09	-3.61	0.000317	Alzheimer's disease (late onset)	
BRCA	cis	1	rs11602266	chr11:57094509	PRG2	chr11:57151267-57191532:-	-0.21	-3.66	0.000264	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs11603691	chr11:57107617	PRG2	chr11:57151267-57191532:-	-0.2	-3.44	0.000607	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs11603799	chr11:28196488	METT5D1	chr11:28129798-28355054:+	-0.12	-3.44	0.000595	Bipolar disorder	
BRCA	cis	1	rs11604149	chr11:6519642	TPP1	chr11:6633997-6640692:-	0.11	3.55	0.000399	DNA methylation (variation)	
BRCA	cis	1	rs11605774	chr11:47832793	MADD	chr11:47290927-47351582:+	0.13	4.08	4.83E-5	Subjective well-being	
BRCA	cis	1	rs11605774	chr11:47832793	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.05	5.55E-5	Subjective well-being	
BRCA	cis	1	rs11606862	chr11:57012742	PRG2	chr11:57151267-57191532:-	0.22	3.72	0.000213	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs11607950	chr11:57107361	PRG2	chr11:57151267-57191532:-	-0.18	-3.37	0.00077	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs11608788	chr12:122608155	LRRC43	chr12:122652266-122688017:+	-0.17	-4.85	1.42E-6	Urate levels	
BRCA	cis	1	rs11608792	chr12:122608209	LRRC43	chr12:122652266-122688017:+	-0.17	-4.76	2.19E-6	Urate levels	
BRCA	cis	1	rs11609875	chr12:122608502	LRRC43	chr12:122652266-122688017:+	-0.18	-4.91	1.08E-6	Urate levels	
BRCA	cis	1	rs11611670	chr12:9385535	LOC642846	chr12:9436253-9466684:+	0.17	7.01	4.13E-12	Breast size	
BRCA	cis	1	rs11612335	chr12:10474096	KLRD1	chr12:10457050-10469849:+	0.11	4.25	2.31E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs11622475	chr14:104509076	TDRD9	chr14:104394817-104519002:+	0.35	7.78	1.67E-14	Bipolar disorder	
BRCA	cis	1	rs11622962	chr14:65299145	CHURC1	chr14:65381140-65411309:+	0.33	5.08	4.51E-7	Daytime sleep phenotypes	
BRCA	cis	1	rs11623413	chr14:75588824	EIF2B2	chr14:75469612-75476292:+	-0.16	-4.44	9.9E-6	Height	
BRCA	cis	1	rs11623413	chr14:75588824	MLH3	chr14:75480467-75518235:-	-0.18	-5.76	1.13E-8	Height	
BRCA	cis	1	rs11625697	chr14:104464800	TDRD9	chr14:104394817-104519002:+	0.42	10.69	2.1E-25	Bipolar disorder	
BRCA	cis	1	rs11630417	chr15:68012609	IQCH	chr15:67547188-67794139:+	0.14	5.08	4.44E-7	Motion sickness	
BRCA	cis	1	rs11630417	chr15:68012609	LBXCOR1	chr15:68117941-68126174:+	0.12	3.7	0.000224	Motion sickness	
BRCA	cis	1	rs11631963	chr15:83318202	FAM154B	chr15:82555152-82577265:+	0.13	3.91	9.89E-5	Schizophrenia	
BRCA	cis	1	rs11631963	chr15:83318202	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.1	3.63	0.000302	Schizophrenia	
BRCA	cis	1	rs11633301	chr15:84585038	GOLGA6L5	chr15:85047738-85060078:-	0.14	4.7	2.87E-6	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs11633958	chr15:78862064	AGPHD1	chr15:78799906-78829714:+	-0.16	-3.47	0.000545	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs11633958	chr15:78862064	CHRNA5	chr15:78857906-78886458:+	-0.21	-5.95	3.74E-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs11637027	chr15:67937755	IQCH	chr15:67547188-67794139:+	0.14	4.85	1.39E-6	Motion sickness	
BRCA	cis	1	rs11637433	chr15:83321336	FAM154B	chr15:82555152-82577265:+	0.14	4.15	3.52E-5	Schizophrenia	
BRCA	cis	1	rs11637433	chr15:83321336	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.1	3.67	0.000257	Schizophrenia	
BRCA	cis	1	rs11638815	chr15:83352282	GOLGA6L10	chr15:82633124-82637131:-;chr15	0.1	3.38	0.000751	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	
BRCA	cis	1	rs11638815	chr15:83352282	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.2	6.15	1.08E-9	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	
BRCA	cis	1	rs116434420	chr5:115582971	COMMD10	chr5:115420727-115628978:+	0.24	4.6	4.75E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs11653310	chr17:33893378	SLFN12L	chr17:33801926-33864880:-	-0.08	-4.69	3.06E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs11653	chr7:128409580	OPN1SW	chr7:128412545-128415844:-	0.16	3.94	8.56E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
BRCA	cis	1	rs11656138	chr17:33910218	SLFN12L	chr17:33801926-33864880:-	0.09	4.86	1.34E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs11663558	chr18:21133937	NPC1	chr18:21108363-21166581:-	0.14	4.34	1.53E-5	Body mass index	
BRCA	cis	1	rs116644267	chr12:62760067	FAM19A2	chr12:62102043-62653925:-	0.2	4.05	5.54E-5	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs11665924	chr19:44286982	ZNF155	chr19:44488355-44502477:+	-0.14	-3.77	0.00017	Breast cancer	
BRCA	cis	1	rs11665924	chr19:44286982	ZNF404	chr19:44376516-44384288:-	-0.22	-6.04	2.12E-9	Breast cancer	
BRCA	cis	1	rs11667192	chr19:9975970	OLFM2	chr19:9964395-10047070:-	0.17	5.8	8.56E-9	Sleep duration	
BRCA	cis	1	rs11668269	chr19:22513960	ZNF98	chr19:22573899-22605148:-	0.14	3.83	0.000136	Telomere length	
BRCA	cis	1	rs11669175	chr19:44289824	LYPD5	chr19:44300080-44324808:-	-0.13	-3.73	0.000199	Breast cancer	
BRCA	cis	1	rs11669175	chr19:44289824	ZNF155	chr19:44488355-44502477:+	-0.15	-3.99	6.94E-5	Breast cancer	
BRCA	cis	1	rs11669175	chr19:44289824	ZNF404	chr19:44376516-44384288:-	-0.22	-5.95	3.54E-9	Breast cancer	
BRCA	cis	1	rs11670668	chr19:41920454	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.29	6.01E-13	Height	
BRCA	cis	1	rs11670757	chr19:41913431	B3GNT8	chr19:41931265-41934635:-	-0.21	-6.56	8.3E-11	Height	
BRCA	cis	1	rs11673344	chr19:37684966	SIPA1L3	chr19:38397868-38699006:+	-0.13	-3.66	0.000265	Obesity-related traits	
BRCA	cis	1	rs11673344	chr19:37684966	ZNF568	chr19:37407234-37488834:+	-0.14	-4.41	1.14E-5	Obesity-related traits	
BRCA	cis	1	rs11673344	chr19:37684966	ZNF781	chr19:38158650-38183216:-	-0.22	-6.31	4.05E-10	Obesity-related traits	
BRCA	cis	1	rs11673344	chr19:37684966	ZNF793	chr19:37997841-38034237:+	-0.2	-5.68	1.73E-8	Obesity-related traits	
BRCA	cis	1	rs1167613	chr7:65487439	CCT6P1	chr7:65216092-65228661:+	0.31	6.75	2.49E-11	Diabetic kidney disease	
BRCA	cis	1	rs1167613	chr7:65487439	LOC493754	chr7:65993446-66057363:-	0.2	3.4	0.000703	Diabetic kidney disease	
BRCA	cis	1	rs1167725	chr12:120968559	POP5	chr12:121016849-121019201:-	-0.14	-3.52	0.000444	Type 1 diabetes nephropathy	
BRCA	cis	1	rs1167726	chr12:120967364	GATC	chr12:120884284-120897761:+	0.13	3.63	0.000295	Type 1 diabetes nephropathy	
BRCA	cis	1	rs1167726	chr12:120967364	POP5	chr12:121016849-121019201:-	0.15	3.88	0.00011	Type 1 diabetes nephropathy	
BRCA	cis	1	rs1167727	chr12:120965508	GATC	chr12:120884284-120897761:+	-0.13	-3.38	0.000748	Type 1 diabetes nephropathy	
BRCA	cis	1	rs1167727	chr12:120965508	POP5	chr12:121016849-121019201:-	-0.15	-3.74	0.00019	Type 1 diabetes nephropathy	
BRCA	cis	1	rs1167827	chr7:75163169	NCF1C	chr7:74572446-74587759:-	0.09	3.85	0.000126	Body mass index	
BRCA	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.39	-13.39	6.6E-38	Body mass index	
BRCA	cis	1	rs1167827	chr7:75163169	POM121C	chr7:75046066-75115568:-	-0.19	-5.16	2.89E-7	Body mass index	
BRCA	cis	1	rs1167827	chr7:75163169	SPDYE5	chr7:75124299-75133627:+	0.12	3.44	0.000605	Body mass index	
BRCA	cis	1	rs1167827	chr7:75163169	STAG3L1	chr7:74988447-75026250:+	-0.3	-8.46	8.78E-17	Body mass index	
BRCA	cis	1	rs11681497	chr2:242344333	SEPT2	chr2:242254723-242293439:+	0.37	6.8	1.76E-11	Chronic lymphocytic leukemia	
BRCA	cis	1	rs116849218	chr12:56683975	COQ10A	chr12:56660642-56664748:+	-0.29	-3.95	8.18E-5	Psoriasis vulgaris	
BRCA	cis	1	rs116849218	chr12:56683975	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.00019	Psoriasis vulgaris	
BRCA	cis	1	rs116849218	chr12:56683975	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.61	0.000316	Psoriasis vulgaris	
BRCA	cis	1	rs11685222	chr2:120748571	TMEM177	chr2:120436743-120481191:+	-0.34	-6.56	8.38E-11	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
BRCA	cis	1	rs11685475	chr2:40665795	SLC8A1	chr2:40339287-40739575:-	-0.1	-3.51	0.000458	Obesity-related traits	
BRCA	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.25	6.17	9.72E-10	Body mass index	
BRCA	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.25	6.09	1.56E-9	Body mass index	
BRCA	cis	1	rs11695244	chr2:242176706	SEPT2	chr2:242254723-242293439:+	-0.15	-3.68	0.000244	Chronic lymphocytic leukemia	
BRCA	cis	1	rs11696845	chr20:43371320	KCNK15	chr20:43374488-43379666:+	0.13	4.67	3.42E-6	Obesity-related traits	
BRCA	cis	1	rs116988415	chr14:65292145	CHURC1	chr14:65381140-65411309:+	0.33	5.15	3.16E-7	Daytime sleep phenotypes	
BRCA	cis	1	rs11699551	chr20:55087964	C20orf43	chr20:55043647-55093942:+	0.16	4.47	8.59E-6	Refractive astigmatism	
BRCA	cis	1	rs11701091	chr21:33920244	TCP10L	chr21:33947152-33957845:-	-0.27	-5.52	4.26E-8	Gastritis	
BRCA	cis	1	rs11701627	chr21:33927794	TCP10L	chr21:33947152-33957845:-	-0.29	-6.04	2.14E-9	Gastritis	
BRCA	cis	1	rs11704021	chr22:39074716	APOBEC3C	chr22:39410265-39414823:+	-0.09	-3.43	0.000627	Resting heart rate	
BRCA	cis	1	rs11704021	chr22:39074716	DDX17	chr22:38879445-38903665:-	-0.1	-3.38	0.000764	Resting heart rate	
BRCA	cis	1	rs11704021	chr22:39074716	JOSD1	chr22:39081549-39096459:-	-0.13	-4.18	3.09E-5	Resting heart rate	
BRCA	cis	1	rs11704021	chr22:39074716	TOMM22	chr22:39077954-39080763:+	-0.1	-3.39	0.000724	Resting heart rate	
BRCA	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.42	13.61	5.22E-39	Height	
BRCA	cis	1	rs11706117	chr3:134212526	CEP63	chr3:134204575-134293852:+	0.15	4.06	5.33E-5	Height	
BRCA	cis	1	rs11707780	chr3:53084326	NT5DC2	chr3:52558386-52569093:-	0.16	4.39	1.26E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.43	14.46	2.02E-43	Height	
BRCA	cis	1	rs11708531	chr3:134224902	CEP63	chr3:134204575-134293852:+	0.15	4.2	2.89E-5	Height	
BRCA	cis	1	rs11709525	chr3:49690496	AMT	chr3:49454212-49460012:-	0.11	3.52	0.000444	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs11710077	chr3:38657899	SCN5A	chr3:38589554-38691164:-	0.12	3.43	0.000634	QRS duration;QT interval	
BRCA	cis	1	rs11710136	chr3:190985993	UTS2D	chr3:190984945-191048325:-	-0.22	-6.49	1.34E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs117104023	chr10:96515342	C10orf129	chr10:96953957-96988685:+	0.33	5.38	9.15E-8	Blood metabolite levels	
BRCA	cis	1	rs11710434	chr3:49346130	AMT	chr3:49454212-49460012:-	0.13	4.58	5.14E-6	Menarche (age at onset)	
BRCA	cis	1	rs11710434	chr3:49346130	CCDC36	chr3:49235861-49295537:+	0.1	3.93	9.18E-5	Menarche (age at onset)	
BRCA	cis	1	rs11710434	chr3:49346130	NCKIPSD	chr3:48711280-48723334:-	0.17	4.22	2.61E-5	Menarche (age at onset)	
BRCA	cis	1	rs11710434	chr3:49346130	P4HTM	chr3:49027341-49044579:+	0.1	4.45	9.54E-6	Menarche (age at onset)	
BRCA	cis	1	rs11710434	chr3:49346130	WDR6	chr3:49044637-49053386:+	-0.12	-3.7	0.00023	Menarche (age at onset)	
BRCA	cis	1	rs11710497	chr3:11045896	SLC6A1	chr3:11034420-11080934:+	0.2	4.16	3.47E-5	Longitudinal alcohol consumption	
BRCA	cis	1	rs11710675	chr3:49751900	CCDC36	chr3:49235861-49295537:+	0.09	3.71	0.000222	Resting heart rate	
BRCA	cis	1	rs11710675	chr3:49751900	DALRD3	chr3:49052435-49058467:-	0.13	4.52	6.95E-6	Resting heart rate	
BRCA	cis	1	rs11710675	chr3:49751900	P4HTM	chr3:49027341-49044579:+	0.09	4.09	4.73E-5	Resting heart rate	
BRCA	cis	1	rs11711054	chr3:46345611	FYCO1	chr3:45959396-46037307:-	-0.11	-3.67	0.000251	Celiac disease	
BRCA	cis	1	rs1171112	chr6:84226568	PRSS35	chr6:84222274-84235419:+	0.14	4.02	6.35E-5	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs1171112	chr6:84226568	SNAP91	chr6:84262607-84419127:-	-0.15	-3.93	9.16E-5	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs1171113	chr6:84226595	PRSS35	chr6:84222274-84235419:+	0.14	4.02	6.35E-5	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs1171113	chr6:84226595	SNAP91	chr6:84262607-84419127:-	-0.15	-3.93	9.16E-5	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs1171115	chr6:84229623	PRSS35	chr6:84222274-84235419:+	0.14	4.01	6.61E-5	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs1171115	chr6:84229623	SNAP91	chr6:84262607-84419127:-	-0.13	-3.41	0.000674	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs11712111	chr3:156608940	LEKR1	chr3:156544076-156763918:+	0.19	5	6.61E-7	Multiple sclerosis (severity)	
BRCA	cis	1	rs11712561	chr3:48435272	ATRIP	chr3:48488141-48507708:+	0.1	3.45	0.000591	Longevity	
BRCA	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.28	-10.62	4.27E-25	Longevity	
BRCA	cis	1	rs11712653	chr3:53070875	NT5DC2	chr3:52558386-52569093:-	0.18	4.15	3.61E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11713230	chr3:160355942	TRIM59	chr3:160153292-160167626:-	0.14	4.11	4.26E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs11713859	chr3:53042080	NT5DC2	chr3:52558386-52569093:-	-0.21	-4.33	1.61E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11713859	chr3:53042080	RFT1	chr3:53122503-53164470:-	0.27	3.78	0.000167	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11713859	chr3:53042080	TMEM110	chr3:52867139-52931547:-	0.27	4.15	3.63E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.28	7.24	8.66E-13	Cognitive performance	
BRCA	cis	1	rs11714406	chr3:121372513	SLC15A2	chr3:121613171-121663034:+	-0.13	-3.83	0.000134	Cognitive performance	
BRCA	cis	1	rs11717256	chr3:49868520	DALRD3	chr3:49052435-49058467:-	0.12	3.97	7.6E-5	Resting heart rate	
BRCA	cis	1	rs11717256	chr3:49868520	P4HTM	chr3:49027341-49044579:+	0.08	3.4	0.000688	Resting heart rate	
BRCA	cis	1	rs11717619	chr3:53003179	NT5DC2	chr3:52558386-52569093:-	-0.15	-3.44	0.000611	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11717619	chr3:53003179	RFT1	chr3:53122503-53164470:-	0.26	4.1	4.37E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11717619	chr3:53003179	TMEM110	chr3:52867139-52931547:-	0.25	4.17	3.36E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11718165	chr3:49696797	AMT	chr3:49454212-49460012:-	0.12	3.9	0.000102	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs11718165	chr3:49696797	GMPPB	chr3:49758932-49761384:-	-0.12	-3.53	0.000425	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs11718834	chr3:52963668	NT5DC2	chr3:52558386-52569093:-	-0.16	-3.53	0.000438	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11718834	chr3:52963668	RFT1	chr3:53122503-53164470:-	0.26	3.8	0.000155	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11718834	chr3:52963668	TMEM110	chr3:52867139-52931547:-	0.27	4.41	1.16E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.29	7.33	4.47E-13	Cognitive performance	
BRCA	cis	1	rs11719458	chr3:121382005	SLC15A2	chr3:121613171-121663034:+	-0.14	-3.93	9.07E-5	Cognitive performance	
BRCA	cis	1	rs11719762	chr3:49409002	AMT	chr3:49454212-49460012:-	0.14	4.93	9.47E-7	Menarche (age at onset)	
BRCA	cis	1	rs11719762	chr3:49409002	CCDC36	chr3:49235861-49295537:+	0.1	3.87	0.000115	Menarche (age at onset)	
BRCA	cis	1	rs11719762	chr3:49409002	NCKIPSD	chr3:48711280-48723334:-	0.17	4.26	2.22E-5	Menarche (age at onset)	
BRCA	cis	1	rs11719762	chr3:49409002	P4HTM	chr3:49027341-49044579:+	0.1	4.13	3.96E-5	Menarche (age at onset)	
BRCA	cis	1	rs11719762	chr3:49409002	WDR6	chr3:49044637-49053386:+	-0.14	-4.36	1.4E-5	Menarche (age at onset)	
BRCA	cis	1	rs11720542	chr3:49357427	AMT	chr3:49454212-49460012:-	0.13	4.33	1.65E-5	Menarche (age at onset)	
BRCA	cis	1	rs11720542	chr3:49357427	CCDC36	chr3:49235861-49295537:+	0.1	3.97	7.69E-5	Menarche (age at onset)	
BRCA	cis	1	rs11720542	chr3:49357427	NCKIPSD	chr3:48711280-48723334:-	0.16	4.02	6.3E-5	Menarche (age at onset)	
BRCA	cis	1	rs11720542	chr3:49357427	P4HTM	chr3:49027341-49044579:+	0.11	4.59	4.93E-6	Menarche (age at onset)	
BRCA	cis	1	rs11720542	chr3:49357427	TREX1	chr3:48501186-48509043:+	-0.11	-3.55	0.000398	Menarche (age at onset)	
BRCA	cis	1	rs11720542	chr3:49357427	WDR6	chr3:49044637-49053386:+	-0.13	-3.98	7.36E-5	Menarche (age at onset)	
BRCA	cis	1	rs11721318	chr3:121429485	IQCB1	chr3:121488610-121553926:-	0.27	7.08	2.54E-12	Cognitive performance	
BRCA	cis	1	rs11721318	chr3:121429485	SLC15A2	chr3:121613171-121663034:+	-0.13	-3.86	0.00012	Cognitive performance	
BRCA	cis	1	rs117215113	chr10:96406092	C10orf129	chr10:96953957-96988685:+	0.34	5.4	8.04E-8	Blood metabolite levels	
BRCA	cis	1	rs11722197	chr4:281707	ZNF718	chr4:53272-156488:+	0.34	7.27	6.78E-13	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs11722225	chr4:106766430	INTS12	chr4:106603787-106629881:-	-0.28	-3.5	0.000478	Post bronchodilator FEV1	
BRCA	cis	1	rs11722521	chr4:276765	ZNF718	chr4:53272-156488:+	0.34	7.29	5.93E-13	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs11723120	chr4:103502551	MANBA	chr4:103552644-103682151:-	0.16	3.98	7.22E-5	Ulcerative colitis	
BRCA	cis	1	rs11723261	chr4:282499	ZNF718	chr4:53272-156488:+	0.34	7.27	6.78E-13	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs11723615	chr4:276983	ZNF718	chr4:53272-156488:+	0.35	7.43	2.19E-13	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs11724614	chr4:103550248	MANBA	chr4:103552644-103682151:-	0.21	5.5	4.83E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs11724839	chr4:106638256	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs11724884	chr4:106677384	INTS12	chr4:106603787-106629881:-	-0.31	-3.85	0.000125	Post bronchodilator FEV1	
BRCA	cis	1	rs117249133	chr20:33773630	PROCR	chr20:33758727-33765164:+	-0.25	-4.84	1.5E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11725470	chr4:55006128	FIP1L1	chr4:54243820-54326102:+	-0.16	-3.45	0.00058	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs11726124	chr4:106766496	INTS12	chr4:106603787-106629881:-	0.27	3.45	0.000577	Post bronchodilator FEV1	
BRCA	cis	1	rs11726569	chr4:106606608	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs11727189	chr4:106619140	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs11727348	chr4:106679848	INTS12	chr4:106603787-106629881:-	-0.31	-3.82	0.00014	Post bronchodilator FEV1	
BRCA	cis	1	rs11727546	chr4:103557664	MANBA	chr4:103552644-103682151:-	0.22	5.64	2.2E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs11727745	chr4:106716527	INTS12	chr4:106603787-106629881:-	-0.3	-3.86	0.000121	Post bronchodilator FEV1	
BRCA	cis	1	rs11727803	chr4:88213158	HSD17B11	chr4:88257691-88312455:-	0.11	4.06	5.23E-5	Platelet count	
BRCA	cis	1	rs11727835	chr4:88213244	HSD17B11	chr4:88257691-88312455:-	0.11	4.08	4.92E-5	Platelet count	
BRCA	cis	1	rs11727875	chr4:39135319	KLHL5	chr4:39046659-39123828:+	-0.14	-4.51	7.36E-6	Uric acid levels	
BRCA	cis	1	rs11728044	chr4:106604786	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs11729365	chr4:272524	ZNF718	chr4:53272-156488:+	0.35	7.38	3.13E-13	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs11731017	chr4:55007537	FIP1L1	chr4:54243820-54326102:+	-0.16	-3.42	0.000656	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs11731060	chr4:55007690	FIP1L1	chr4:54243820-54326102:+	-0.16	-3.42	0.000656	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs11731386	chr4:106600338	INTS12	chr4:106603787-106629881:-	-0.28	-3.47	0.000532	Post bronchodilator FEV1	
BRCA	cis	1	rs117316403	chr20:33693175	MMP24	chr20:33814539-33864804:+	-0.21	-3.74	0.000196	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs117316403	chr20:33693175	PROCR	chr20:33758727-33765164:+	-0.23	-4.78	2.04E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11731714	chr4:106675946	INTS12	chr4:106603787-106629881:-	-0.31	-3.82	0.00014	Post bronchodilator FEV1	
BRCA	cis	1	rs117317596	chr10:96573396	C10orf129	chr10:96953957-96988685:+	0.33	5.42	7.28E-8	Blood metabolite levels	
BRCA	cis	1	rs11732298	chr4:106701679	INTS12	chr4:106603787-106629881:-	0.28	3.47	0.000544	Post bronchodilator FEV1	
BRCA	cis	1	rs11733124	chr4:106677541	INTS12	chr4:106603787-106629881:-	-0.31	-3.82	0.00014	Post bronchodilator FEV1	
BRCA	cis	1	rs11733223	chr4:106765525	INTS12	chr4:106603787-106629881:-	0.26	3.54	0.000422	Post bronchodilator FEV1	
BRCA	cis	1	rs11733284	chr4:48028097	CNGA1	chr4:47937996-48018610:-	0.22	7.6	6.55E-14	Renal underexcretion gout;Gout	
BRCA	cis	1	rs11733284	chr4:48028097	NIPAL1	chr4:48018791-48039078:+	0.11	3.55	0.000409	Renal underexcretion gout;Gout	
BRCA	cis	1	rs11733287	chr4:106705339	INTS12	chr4:106603787-106629881:-	-0.3	-3.69	0.000237	Post bronchodilator FEV1	
BRCA	cis	1	rs11734039	chr4:54264428	SCFD2	chr4:53739152-54232242:-	0.13	3.38	0.000748	DNA methylation (variation)	
BRCA	cis	1	rs11734571	chr4:106703557	INTS12	chr4:106603787-106629881:-	-0.3	-3.72	0.000212	Post bronchodilator FEV1	
BRCA	cis	1	rs11735092	chr4:88226231	HSD17B11	chr4:88257691-88312455:-	0.14	5.14	3.3E-7	Platelet count	
BRCA	cis	1	rs11735213	chr4:106527508	INTS12	chr4:106603787-106629881:-	-0.27	-3.55	0.000397	Post bronchodilator FEV1	
BRCA	cis	1	rs11735527	chr4:106679692	INTS12	chr4:106603787-106629881:-	-0.31	-3.82	0.00014	Post bronchodilator FEV1	
BRCA	cis	1	rs11736859	chr4:106708785	INTS12	chr4:106603787-106629881:-	-0.3	-3.72	0.000212	Post bronchodilator FEV1	
BRCA	cis	1	rs11737950	chr5:156436211	TIMD4	chr5:156346293-156390266:-	-0.16	-4.16	3.44E-5	Hypertriglyceridemia	
BRCA	cis	1	rs117381226	chr10:96553520	C10orf129	chr10:96953957-96988685:+	0.25	4.5	7.66E-6	Blood metabolite levels	
BRCA	cis	1	rs11738215	chr5:112719477	YTHDC2	chr5:112849410-112930979:+	-0.12	-3.65	0.000279	Cerebral amyloid angiopathy	
BRCA	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.77	19.51	9.38E-73	Type 2 diabetes	
BRCA	cis	1	rs117395468	chr10:96529544	C10orf129	chr10:96953957-96988685:+	0.21	3.91	9.94E-5	Blood metabolite levels	
BRCA	cis	1	rs11739699	chr5:160450185	SLU7	chr5:159828649-159846168:-	0.14	4.02	6.22E-5	Post-traumatic stress disorder	
BRCA	cis	1	rs11740478	chr5:82446386	XRCC4	chr5:82373317-82649577:+	-0.12	-3.53	0.000433	Hypertension	
BRCA	cis	1	rs11740496	chr5:156435402	TIMD4	chr5:156346293-156390266:-	0.15	3.91	0.0001	Hypertriglyceridemia	
BRCA	cis	1	rs11740499	chr5:156431741	TIMD4	chr5:156346293-156390266:-	-0.15	-4.02	6.2E-5	Hypertriglyceridemia	
BRCA	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.43	-8.97	1.33E-18	Crohn's disease	
BRCA	cis	1	rs11741963	chr5:112702773	YTHDC2	chr5:112849410-112930979:+	0.14	4.05	5.53E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs11746128	chr5:156421250	TIMD4	chr5:156346293-156390266:-	-0.17	-4.82	1.65E-6	Hypertriglyceridemia	
BRCA	cis	1	rs117497302	chr11:57009807	PRG2	chr11:57151267-57191532:-	-0.24	-3.89	0.000107	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs11750568	chr5:178535713	ZNF354C	chr5:178487607-178507689:+	-0.11	-3.77	0.000174	Height	
BRCA	cis	1	rs11750945	chr5:112710755	YTHDC2	chr5:112849410-112930979:+	0.14	4.11	4.24E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs11751207	chr6:166018383	PDE10A	chr6:165740779-166075584:-	0.19	4.3	1.86E-5	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs11751732	chr6:26044064	HIST1H3B	chr6:26031817-26032288:-	0.15	3.47	0.000538	HIV-1 viral setpoint	
BRCA	cis	1	rs117530406	chr10:96397876	C10orf129	chr10:96953957-96988685:+	0.34	5.4	8.04E-8	Blood metabolite levels	
BRCA	cis	1	rs11753083	chr6:33761111	C6orf125	chr6:33662057-33679504:-	0.11	3.42	0.000651	Body mass index	
BRCA	cis	1	rs11753083	chr6:33761111	LEMD2	chr6:33738991-33756906:-	0.17	5.22	2.15E-7	Body mass index	
BRCA	cis	1	rs11753937	chr6:133663589	EYA4	chr6:133561736-133853257:+	-0.15	-4.09	4.64E-5	Response to angiotensin II receptor blocker therapy	
BRCA	cis	1	rs11754690	chr6:33744157	C6orf125	chr6:33662057-33679504:-	0.11	3.56	0.000385	Body mass index	
BRCA	cis	1	rs11754690	chr6:33744157	LEMD2	chr6:33738991-33756906:-	0.18	5.49	5.0E-8	Body mass index	
BRCA	cis	1	rs11754744	chr6:26202605	HIST1H3E	chr6:26224427-26226589:+	0.36	7.01	4.11E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs11755210	chr6:26202768	HIST1H3E	chr6:26224427-26226589:+	0.36	7.01	4.11E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs11755593	chr6:33740325	C6orf125	chr6:33662057-33679504:-	0.11	3.54	0.000423	Body mass index	
BRCA	cis	1	rs11755593	chr6:33740325	LEMD2	chr6:33738991-33756906:-	0.18	5.59	2.85E-8	Body mass index	
BRCA	cis	1	rs11756120	chr6:26529808	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.58E-8	Educational attainment	
BRCA	cis	1	rs11756120	chr6:26529808	C6orf41	chr6:26924772-26991752:+	-0.12	-3.7	0.000227	Educational attainment	
BRCA	cis	1	rs11756120	chr6:26529808	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.5	0.000489	Educational attainment	
BRCA	cis	1	rs11756783	chr6:101118109	ASCC3	chr6:100956609-101329224:-	0.12	4.83	1.54E-6	Menarche (age at onset)	
BRCA	cis	1	rs117573845	chr20:33651621	MMP24	chr20:33814539-33864804:+	-0.22	-3.85	0.000126	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs117573845	chr20:33651621	PROCR	chr20:33758727-33765164:+	-0.25	-4.97	7.73E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11758152	chr6:42496494	PRPH2	chr6:42664334-42690358:-	0.14	3.44	0.000614	Obesity-related traits	
BRCA	cis	1	rs11758351	chr6:26203910	HIST1H3E	chr6:26224427-26226589:+	0.36	7.24	8.38E-13	Renal underexcretion gout;Gout	
BRCA	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.5	-14.57	5.29E-44	Response to antipsychotic treatment	
BRCA	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.59	-18.42	5.21E-66	Response to antipsychotic treatment	
BRCA	cis	1	rs11763147	chr7:65326821	CCT6P1	chr7:65216092-65228661:+	0.12	4.03	6.1E-5	Corneal structure	
BRCA	cis	1	rs11763147	chr7:65326821	CRCP	chr7:65579805-65619551:+	0.16	4.43	1.05E-5	Corneal structure	
BRCA	cis	1	rs11763147	chr7:65326821	VKORC1L1	chr7:65338257-65423532:+	0.11	3.39	0.000714	Corneal structure	
BRCA	cis	1	rs11765693	chr7:75985373	UPK3B	chr7:76139745-76157197:+	-0.24	-6.3	4.43E-10	Multiple sclerosis	
BRCA	cis	1	rs11765986	chr7:77357274	PHTF2	chr7:77428109-77586818:+	-0.16	-4.45	9.57E-6	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs11766175	chr7:128405013	OPN1SW	chr7:128412545-128415844:-	0.16	3.88	0.000109	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
BRCA	cis	1	rs11766526	chr7:1101433	ZFAND2A	chr7:1192544-1199855:-	-0.3	-5.87	5.65E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs11767651	chr7:77390380	PHTF2	chr7:77428109-77586818:+	-0.16	-4.63	4.17E-6	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs117683816	chr12:56638267	COQ10A	chr12:56660642-56664748:+	-0.29	-4.09	4.65E-5	Psoriasis vulgaris	
BRCA	cis	1	rs117683816	chr12:56638267	RPS26	chr12:56435686-56438005:+	-0.29	-3.69	0.000233	Psoriasis vulgaris	
BRCA	cis	1	rs117683816	chr12:56638267	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.9	0.000102	Psoriasis vulgaris	
BRCA	cis	1	rs11770446	chr7:77358072	PHTF2	chr7:77428109-77586818:+	-0.16	-4.43	1.04E-5	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs11770909	chr7:1086716	ZFAND2A	chr7:1192544-1199855:-	-0.34	-6.66	4.43E-11	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs11773829	chr7:66141074	TYW1	chr7:66461817-66704496:+	-0.15	-4.01	6.39E-5	Aortic root size	
BRCA	cis	1	rs117756203	chr10:96601144	C10orf129	chr10:96953957-96988685:+	0.33	5.42	7.28E-8	Blood metabolite levels	
BRCA	cis	1	rs117802529	chr20:33786677	MMP24	chr20:33814539-33864804:+	-0.22	-3.7	0.000227	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs117802529	chr20:33786677	PROCR	chr20:33758727-33765164:+	-0.25	-4.88	1.23E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11780499	chr8:15534249	TUSC3	chr8:15397730-15621993:+	-0.18	-4.23	2.57E-5	Pulmonary function decline	
BRCA	cis	1	rs11780931	chr8:96043829	C8orf38	chr8:95908040-96088396:+	-0.18	-4.39	1.26E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs11781040	chr8:96041746	C8orf38	chr8:95908040-96088396:+	-0.18	-4.46	9.09E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs11782652	chr8:82653644	CHMP4C	chr8:82644688-82671746:+	-0.76	-13.98	6.9E-41	Epithelial ovarian cancer;Ovarian cancer	
BRCA	cis	1	rs11786878	chr8:96033292	C8orf38	chr8:95908040-96088396:+	-0.18	-3.98	7.29E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs117897483	chr10:96471787	HELLS	chr10:96305543-96361855:+	0.12	3.48	0.000528	Migraine	
BRCA	cis	1	rs1178977	chr7:72857049	MLXIPL	chr7:73007524-73038870:-	0.24	4.31	1.78E-5	Triglycerides	
BRCA	cis	1	rs11789898	chr9:136925663	BRD3	chr9:136895454-136933655:-	0.22	5.45	6.13E-8	Platelet count	
BRCA	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.59	-19.33	1.23E-71	Response to antipsychotic treatment	
BRCA	cis	1	rs11792861	chr9:111809295	C9orf5	chr9:111777416-111882225:-	0.17	5.14	3.32E-7	Menarche (age at onset)	
BRCA	cis	1	rs117981067	chr11:57064112	PRG2	chr11:57151267-57191532:-	-0.21	-3.53	0.000434	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs11799420	chr1:171652978	VAMP4	chr1:171669298-171711214:-	-0.12	-3.47	0.000546	Hippocampal atrophy	
BRCA	cis	1	rs11801695	chr1:205916175	PM20D1	chr1:205797154-205819245:-	-0.2	-6.07	1.79E-9	Cystic fibrosis-related diabetes	
BRCA	cis	1	rs11801846	chr1:171674241	VAMP4	chr1:171669298-171711214:-	0.19	5.42	7.51E-8	Hippocampal atrophy	
BRCA	cis	1	rs11802265	chr1:171649936	VAMP4	chr1:171669298-171711214:-	0.16	4.71	2.79E-6	Hippocampal atrophy	
BRCA	cis	1	rs11803174	chr1:171674338	VAMP4	chr1:171669298-171711214:-	0.19	5.42	7.51E-8	Hippocampal atrophy	
BRCA	cis	1	rs11807824	chr1:27270338	GPATCH3	chr1:27216980-27226962:-	0.2	3.94	8.6E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs11810577	chr1:110138109	AMIGO1	chr1:110049447-110052336:-	0.18	4.81	1.76E-6	Major depressive disorder	
BRCA	cis	1	rs11810993	chr1:46478793	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.77	3.8E-30	Body mass index	
BRCA	cis	1	rs11810993	chr1:46478793	CCDC17	chr1:46085717-46089729:-	0.11	3.47	0.000535	Body mass index	
BRCA	cis	1	rs11810993	chr1:46478793	MUTYH	chr1:45794915-45806142:-	0.12	4.86	1.33E-6	Body mass index	
BRCA	cis	1	rs118130855	chr12:56677979	COQ10A	chr12:56660642-56664748:+	-0.29	-4	6.83E-5	Psoriasis vulgaris	
BRCA	cis	1	rs118130855	chr12:56677979	RPS26	chr12:56435686-56438005:+	-0.3	-3.86	0.000119	Psoriasis vulgaris	
BRCA	cis	1	rs118130855	chr12:56677979	SLC39A5	chr12:56623820-56631627:+	-0.26	-3.78	0.000166	Psoriasis vulgaris	
BRCA	cis	1	rs118161033	chr10:96389223	C10orf129	chr10:96953957-96988685:+	0.26	4.72	2.71E-6	Blood metabolite levels	
BRCA	cis	1	rs11816840	chr10:102309220	SEC31B	chr10:102246403-102289636:-	-0.29	-10.58	6.01E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs11825685	chr11:134573810	THYN1	chr11:134118175-134123260:-	-0.17	-3.59	0.000349	IgG glycosylation	
BRCA	cis	1	rs11826771	chr11:58508972	OSBP	chr11:59341871-59383617:-	0.24	3.67	0.000253	Body mass (lean)	
BRCA	cis	1	rs11826771	chr11:58508972	ZFP91	chr11:58346587-58388513:+	0.23	4.31	1.76E-5	Body mass (lean)	
BRCA	cis	1	rs11826837	chr11:28322566	METT5D1	chr11:28129798-28355054:+	0.14	4.06	5.32E-5	Bipolar disorder	
BRCA	cis	1	rs11830157	chr12:118265441	FBXW8	chr12:117348761-117470180:+	0.14	4.02	6.17E-5	Coronary artery disease	
BRCA	cis	1	rs11833002	chr12:124446616	DNAH10	chr12:124247042-124420265:+	0.26	6.91	8.5E-12	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs11835839	chr12:124431049	DNAH10	chr12:124247042-124420265:+	0.26	6.78	1.92E-11	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs11844747	chr14:65870128	LOC645431	chr14:65877313-65879335:-	0.31	6.53	1.04E-10	Ischemic stroke	
BRCA	cis	1	rs11845269	chr14:107139868	LOC100133469	chr14:106938455-106951529:+	0.15	3.59	0.000349	Alzheimer's disease (late onset)	
BRCA	cis	1	rs11851274	chr14:85791952	FLRT2	chr14:85996488-86094269:+	-0.08	-3.39	0.000717	Heart rate	
BRCA	cis	1	rs11858210	chr15:79078358	CTSH	chr15:79214092-79237420:-	0.17	4.91	1.08E-6	Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs11858714	chr15:40717447	C15orf23	chr15:40674922-40686488:+	0.4	10.68	2.37E-25	Heschl's gyrus morphology	
BRCA	cis	1	rs11858714	chr15:40717447	C15orf57	chr15:40823540-40857252:-	0.19	3.93	9.19E-5	Heschl's gyrus morphology	
BRCA	cis	1	rs11862083	chr16:4649720	NMRAL1	chr16:4511696-4526307:-	-0.28	-5.45	6.25E-8	Obesity-related traits	
BRCA	cis	1	rs11862744	chr16:31057800	HSD3B7	chr16:30996519-31000473:+	0.23	7.19	1.23E-12	Response to metformin (IC50)	
BRCA	cis	1	rs11862744	chr16:31057800	MYST1	chr16:31128985-31142713:+	0.2	7.38	3.17E-13	Response to metformin (IC50)	
BRCA	cis	1	rs11862744	chr16:31057800	ORAI3	chr16:30960405-30966258:+	0.1	3.54	0.000419	Response to metformin (IC50)	
BRCA	cis	1	rs11862744	chr16:31057800	SETD1A	chr16:30968615-30995981:+	0.11	3.46	0.000567	Response to metformin (IC50)	
BRCA	cis	1	rs11862744	chr16:31057800	ZNF689	chr16:30614701-30621682:-	0.11	3.52	0.000442	Response to metformin (IC50)	
BRCA	cis	1	rs11865131	chr16:163667	NPRL3	chr16:134273-188672:-	0.13	3.82	0.000139	Red blood cell traits	
BRCA	cis	1	rs11865131	chr16:163667	SNRNP25	chr16:103829-107668:+	-0.1	-3.43	0.000629	Red blood cell traits	
BRCA	cis	1	rs11870935	chr17:45732605	C17orf57	chr17:45401142-45518675:+	-0.29	-10.24	1.61E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs11870935	chr17:45732605	TBKBP1	chr17:45772630-45789427:+	0.14	4.33	1.63E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs1187446	chr14:104409896	TDRD9	chr14:104394817-104519002:+	0.43	10.87	3.47E-26	Bipolar disorder	
BRCA	cis	1	rs1187448	chr14:104406627	TDRD9	chr14:104394817-104519002:+	0.39	10.14	3.91E-23	Bipolar disorder	
BRCA	cis	1	rs11875806	chr18:20777414	C18orf45	chr18:20777720-21017925:-	-0.2	-3.85	0.000126	Breast cancer	
BRCA	cis	1	rs11875806	chr18:20777414	NPC1	chr18:21108363-21166581:-	-0.21	-4.89	1.19E-6	Breast cancer	
BRCA	cis	1	rs11875806	chr18:20777414	RBBP8	chr18:20513295-20606445:+	-0.15	-3.6	0.000337	Breast cancer	
BRCA	cis	1	rs11879853	chr19:23029434	ZNF492	chr19:22817126-22850472:+	0.24	5.55	3.7E-8	Bronchopulmonary dysplasia	
BRCA	cis	1	rs11880539	chr19:41918949	B3GNT8	chr19:41931265-41934635:-	0.22	6.84	1.37E-11	Height	
BRCA	cis	1	rs11880637	chr19:11655010	ELOF1	chr19:11663858-11670051:-	0.19	3.42	0.000652	IgG glycosylation	
BRCA	cis	1	rs11880637	chr19:11655010	ILF3	chr19:10764937-10803093:+	0.17	3.41	0.000679	IgG glycosylation	
BRCA	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.5	14.66	1.89E-44	Schizophrenia	
BRCA	cis	1	rs11882498	chr19:23060012	ZNF492	chr19:22817126-22850472:+	-0.21	-4.64	3.86E-6	Bronchopulmonary dysplasia	
BRCA	cis	1	rs11883104	chr19:41923799	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.34	4.37E-13	Height	
BRCA	cis	1	rs11887056	chr2:99243861	UNC50	chr2:99225042-99234975:+	-0.2	-4.12	4.1E-5	Bipolar disorder	
BRCA	cis	1	rs11893118	chr2:241828308	C2orf54	chr2:241825466-241835573:-	0.3	8.75	8.31E-18	Urinary metabolites	
BRCA	cis	1	rs11893500	chr2:70154187	ANXA4	chr2:69969127-70053594:+	-0.13	-3.82	0.000138	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.6	-10.87	3.73E-26	Plasma clusterin levels	
BRCA	cis	1	rs11896604	chr2:54479199	C2orf73	chr2:54558071-54588714:+	-0.15	-3.81	0.000148	Telomere length	
BRCA	cis	1	rs11898716	chr2:241828311	C2orf54	chr2:241825466-241835573:-	0.27	7.61	5.93E-14	Urinary metabolites	
BRCA	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.23	5.65	2.08E-8	Metabolite levels	
BRCA	cis	1	rs11902198	chr2:70144596	ANXA4	chr2:69969127-70053594:+	-0.14	-3.95	8.45E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs11902198	chr2:70144596	FAM136A	chr2:70523109-70529220:-	-0.09	-3.43	0.000624	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs11903934	chr2:160122538	WDSUB1	chr2:160092305-160143236:-	0.33	3.96	7.86E-5	Sudden cardiac arrest	
BRCA	cis	1	rs1190447	chr2:233420052	EIF4E2	chr2:233415357-233448349:+	0.19	4.38	1.29E-5	Height	
BRCA	cis	1	rs1190447	chr2:233420052	TIGD1	chr2:233412779-233415226:-	0.13	3.44	0.000595	Height	
BRCA	cis	1	rs1190450	chr2:233418302	EIF4E2	chr2:233415357-233448349:+	0.18	4.14	3.82E-5	Height	
BRCA	cis	1	rs1190450	chr2:233418302	TIGD1	chr2:233412779-233415226:-	0.14	3.57	0.000377	Height	
BRCA	cis	1	rs1190553	chr14:102915331	ANKRD9	chr14:102973198-102976128:-	-0.13	-3.93	9.01E-5	QT interval	
BRCA	cis	1	rs1190554	chr14:102918686	ANKRD9	chr14:102973198-102976128:-	0.12	3.81	0.000145	QT interval	
BRCA	cis	1	rs11906148	chr20:33784021	MMP24	chr20:33814539-33864804:+	-0.22	-3.71	0.00022	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11906148	chr20:33784021	PROCR	chr20:33758727-33765164:+	-0.25	-4.89	1.14E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11907010	chr20:33737661	MMP24	chr20:33814539-33864804:+	-0.24	-3.97	7.78E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11907010	chr20:33737661	PROCR	chr20:33758727-33765164:+	-0.28	-5.42	7.52E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11907011	chr20:33767770	PROCR	chr20:33758727-33765164:+	-0.24	-4.78	1.96E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11908683	chr20:33720920	MMP24	chr20:33814539-33864804:+	-0.22	-3.77	0.000172	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11908683	chr20:33720920	PROCR	chr20:33758727-33765164:+	-0.28	-5.54	3.88E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs11917697	chr3:156967568	LEKR1	chr3:156544076-156763918:+	-0.24	-3.44	0.000609	Smoking cessation in chronic obstructive pulmonary disease;Diabetic retinopathy	
BRCA	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.17	8.07E-37	Height	
BRCA	cis	1	rs11919350	chr3:134235970	CEP63	chr3:134204575-134293852:+	-0.14	-3.69	0.000238	Height	
BRCA	cis	1	rs11920570	chr3:122090102	WDR5B	chr3:122130700-122134882:-	0.18	5.1	3.98E-7	Resting heart rate	
BRCA	cis	1	rs11920900	chr3:49823024	CCDC36	chr3:49235861-49295537:+	0.09	3.53	0.000437	Resting heart rate	
BRCA	cis	1	rs11920900	chr3:49823024	DALRD3	chr3:49052435-49058467:-	0.13	4.22	2.68E-5	Resting heart rate	
BRCA	cis	1	rs11920900	chr3:49823024	P4HTM	chr3:49027341-49044579:+	0.08	3.6	0.000336	Resting heart rate	
BRCA	cis	1	rs11921451	chr3:126787159	CHST13	chr3:126243176-126262133:+	0.15	3.47	0.000535	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.19	6.77E-37	Height	
BRCA	cis	1	rs11927068	chr3:134266321	CEP63	chr3:134204575-134293852:+	-0.14	-3.72	0.000212	Height	
BRCA	cis	1	rs11928090	chr3:49604904	AMT	chr3:49454212-49460012:-	0.13	4.5	7.55E-6	Menarche (age at onset)	
BRCA	cis	1	rs11928090	chr3:49604904	CCDC36	chr3:49235861-49295537:+	0.11	4	6.76E-5	Menarche (age at onset)	
BRCA	cis	1	rs11928090	chr3:49604904	GMPPB	chr3:49758932-49761384:-	-0.12	-3.45	0.000575	Menarche (age at onset)	
BRCA	cis	1	rs11928090	chr3:49604904	NCKIPSD	chr3:48711280-48723334:-	0.17	4.2	2.92E-5	Menarche (age at onset)	
BRCA	cis	1	rs11928090	chr3:49604904	P4HTM	chr3:49027341-49044579:+	0.09	3.99	7.03E-5	Menarche (age at onset)	
BRCA	cis	1	rs11928090	chr3:49604904	WDR6	chr3:49044637-49053386:+	-0.16	-4.67	3.32E-6	Menarche (age at onset)	
BRCA	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.41	4.97E-38	Height	
BRCA	cis	1	rs11928499	chr3:134232350	CEP63	chr3:134204575-134293852:+	-0.15	-4.06	5.32E-5	Height	
BRCA	cis	1	rs11930105	chr4:17972078	NCAPG	chr4:17812525-17846485:+	0.1	4.5	7.38E-6	Height	
BRCA	cis	1	rs11930366	chr4:17960168	NCAPG	chr4:17812525-17846485:+	0.09	4.31	1.81E-5	Height	
BRCA	cis	1	rs11932207	chr4:71330534	AMTN	chr4:71384298-71398459:+	0.26	7.59	7.15E-14	Alcoholism (heaviness of drinking)	
BRCA	cis	1	rs11933575	chr4:17971138	NCAPG	chr4:17812525-17846485:+	0.09	4.4	1.21E-5	Height	
BRCA	cis	1	rs11933767	chr4:17967896	NCAPG	chr4:17812525-17846485:+	0.1	4.42	1.08E-5	Height	
BRCA	cis	1	rs11936911	chr4:17948668	NCAPG	chr4:17812525-17846485:+	0.08	3.63	0.0003	Height	
BRCA	cis	1	rs11936915	chr4:17948497	NCAPG	chr4:17812525-17846485:+	0.09	4.06	5.19E-5	Height	
BRCA	cis	1	rs11938188	chr4:17973698	NCAPG	chr4:17812525-17846485:+	0.09	4.4	1.21E-5	Height	
BRCA	cis	1	rs11938970	chr4:119660152	METTL14	chr4:119606574-119632075:+	-0.24	-5	6.76E-7	Cannabis dependence	
BRCA	cis	1	rs11939380	chr4:1086871	CRIPAK	chr4:1385340-1389782:+	-0.12	-3.79	0.00016	Recombination rate (males)	
BRCA	cis	1	rs11939380	chr4:1086871	KIAA1530	chr4:1341104-1381836:+	-0.12	-4.16	3.48E-5	Recombination rate (males)	
BRCA	cis	1	rs11942153	chr4:106960172	TBCK	chr4:106967233-107237861:-	0.25	7.76	1.97E-14	Airflow obstruction	
BRCA	cis	1	rs11945359	chr4:17960008	NCAPG	chr4:17812525-17846485:+	0.1	4.44	1.01E-5	Height	
BRCA	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.34	-7.87	8.62E-15	Crohn's disease	
BRCA	cis	1	rs11961560	chr6:170130121	WDR27	chr6:169857307-170102159:-	-0.12	-3.63	0.000302	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs11962024	chr6:25610203	SCGN	chr6:25652429-25702006:+	0.19	5.27	1.67E-7	Uric acid levels	
BRCA	cis	1	rs11965538	chr6:28239915	HIST1H4J	chr6:27791903-27792257:+	-0.18	-3.51	0.000465	Depression	
BRCA	cis	1	rs11965538	chr6:28239915	ZNF323	chr6:28292517-28324048:-	0.2	3.64	0.000284	Depression	
BRCA	cis	1	rs11965538	chr6:28239915	ZNF389	chr6:28129551-28137375:+	-0.2	-3.6	0.000338	Depression	
BRCA	cis	1	rs11974384	chr7:12256540	VWDE	chr7:12370509-12443852:-	-0.13	-3.44	0.000599	Response to amphetamines	
BRCA	cis	1	rs11974409	chr7:72989390	MLXIPL	chr7:73007524-73038870:-	0.35	6.87	1.08E-11	Triglycerides	
BRCA	cis	1	rs11975942	chr7:143740580	ARHGEF35	chr7:143883677-143892736:-	-0.43	-10.19	2.51E-23	Obesity-related traits	
BRCA	cis	1	rs11975942	chr7:143740580	OR2A7	chr7:143955790-143974852:-	0.22	4.99	6.95E-7	Obesity-related traits	
BRCA	cis	1	rs11975942	chr7:143740580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.41	0.000685	Obesity-related traits	
BRCA	cis	1	rs11976020	chr7:72247800	SBDSP1	chr7:72299952-72307976:+	-0.22	-5.21	2.3E-7	Educational attainment (years of education)	
BRCA	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	1.02	29.56	8.46E-141	Educational attainment (years of education)	
BRCA	cis	1	rs11976037	chr7:143741024	ARHGEF35	chr7:143883677-143892736:-	-0.42	-10.12	4.81E-23	Obesity-related traits	
BRCA	cis	1	rs11976037	chr7:143741024	OR2A7	chr7:143955790-143974852:-	0.23	5.14	3.19E-7	Obesity-related traits	
BRCA	cis	1	rs11976180	chr7:143741580	ARHGEF35	chr7:143883677-143892736:-	-0.43	-10.22	1.81E-23	Obesity-related traits	
BRCA	cis	1	rs11976180	chr7:143741580	OR2A7	chr7:143955790-143974852:-	0.22	4.97	7.66E-7	Obesity-related traits	
BRCA	cis	1	rs11976180	chr7:143741580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.49	0.000501	Obesity-related traits	
BRCA	cis	1	rs11980407	chr7:50471613	FIGNL1	chr7:50511834-50518088:-	-0.11	-3.5	0.000479	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs11992601	chr8:65696040	CYP7B1	chr8:65508529-65711348:-	0.12	3.84	0.000131	HIV-1 susceptibility	
BRCA	cis	1	rs11996540	chr8:65668267	CYP7B1	chr8:65508529-65711348:-	0.11	3.45	0.000584	HIV-1 susceptibility	
BRCA	cis	1	rs1201451	chr2:233419396	EIF4E2	chr2:233415357-233448349:+	0.19	4.34	1.53E-5	Height	
BRCA	cis	1	rs12021578	chr1:107597501	NTNG1	chr1:107682629-108024471:+	0.16	3.56	0.000389	AIDS	
BRCA	cis	1	rs12021578	chr1:107597501	PRMT6	chr1:107599267-107601907:+	0.22	4.45	9.3E-6	AIDS	
BRCA	cis	1	rs12021587	chr1:46472759	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.7	7.61E-30	Body mass index	
BRCA	cis	1	rs12021587	chr1:46472759	CCDC17	chr1:46085717-46089729:-	0.11	3.53	0.000435	Body mass index	
BRCA	cis	1	rs12021587	chr1:46472759	MUTYH	chr1:45794915-45806142:-	0.13	5.07	4.6E-7	Body mass index	
BRCA	cis	1	rs12022194	chr1:156312331	BGLAP	chr1:156182784-156213112:+	0.18	4.85	1.4E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12022194	chr1:156312331	CCT3	chr1:156278752-156308195:-	-0.12	-3.68	0.000245	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12023438	chr1:156254358	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12023438	chr1:156254358	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12023704	chr1:156294149	BGLAP	chr1:156182784-156213112:+	0.2	5.19	2.58E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12024813	chr1:156224529	BGLAP	chr1:156182784-156213112:+	0.18	4.66	3.63E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12024813	chr1:156224529	C1orf85	chr1:156259882-156265449:-	-0.12	-3.61	0.000319	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12027103	chr1:156244856	BGLAP	chr1:156182784-156213112:+	0.2	5.36	1.02E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12027741	chr1:156248148	BGLAP	chr1:156182784-156213112:+	0.2	5.36	1.02E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.56	11.74	5.15E-30	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.56	11.74	5.15E-30	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs1203156	chr6:88079694	C6orf163	chr6:88057220-88075180:+	0.19	4.77	2.1E-6	Depressive episodes in bipolar disorder	
BRCA	cis	1	rs12033376	chr1:110130641	AMIGO1	chr1:110049447-110052336:-	0.18	4.83	1.55E-6	Major depressive disorder	
BRCA	cis	1	rs12038203	chr1:156248265	BGLAP	chr1:156182784-156213112:+	0.2	5.36	1.02E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12038217	chr1:156248297	BGLAP	chr1:156182784-156213112:+	0.2	5.36	1.02E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12038481	chr1:156284815	BGLAP	chr1:156182784-156213112:+	0.19	5.17	2.73E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12038826	chr1:230922951	C1orf124	chr1:231473682-231489988:+	0.16	3.46	0.00056	Myopia (pathological)	
BRCA	cis	1	rs12040868	chr1:156284803	BGLAP	chr1:156182784-156213112:+	0.2	5.27	1.63E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.55	11.63	1.57E-29	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs12041164	chr1:156279811	BGLAP	chr1:156182784-156213112:+	0.2	5.48	5.4E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12045339	chr1:156294211	BGLAP	chr1:156182784-156213112:+	0.2	5.26	1.75E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12046643	chr1:8547866	RERE	chr1:8412466-8877699:-	0.1	3.41	0.000678	Vitiligo	
BRCA	cis	1	rs12049588	chr1:46472422	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.7	7.61E-30	Body mass index	
BRCA	cis	1	rs12049588	chr1:46472422	CCDC17	chr1:46085717-46089729:-	0.11	3.53	0.000435	Body mass index	
BRCA	cis	1	rs12049588	chr1:46472422	MUTYH	chr1:45794915-45806142:-	0.13	5.07	4.6E-7	Body mass index	
BRCA	cis	1	rs12052257	chr2:202241594	ALS2CR12	chr2:202153148-202222101:-	0.18	4.82	1.64E-6	Basal cell carcinoma	
BRCA	cis	1	rs12053514	chr2:219167965	GPBAR1	chr2:219125738-219128582:+	0.12	4.17	3.27E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs12053514	chr2:219167965	TMBIM1	chr2:219138917-219157280:-	-0.13	-3.91	9.99E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs12055786	chr6:153431125	RGS17	chr6:153332041-153452389:-	-0.11	-3.38	0.000758	Prostate cancer	
BRCA	cis	1	rs12075799	chr1:115826112	AMPD1	chr1:115215722-115238176:-	-0.12	-4	6.64E-5	Migraine	
BRCA	cis	1	rs12082448	chr1:76353225	ACADM	chr1:76190043-76229353:+	-0.21	-4.19	2.96E-5	Attention function in attention deficit hyperactive disorder	
BRCA	cis	1	rs12097357	chr1:168468931	BLZF1	chr1:169337194-169365778:+	0.15	3.57	0.000373	Emphysema imaging phenotypes	
BRCA	cis	1	rs12101255	chr14:81451052	TSHR	chr14:81421869-81612646:+	-0.12	-3.59	0.000348	Graves' disease	
BRCA	cis	1	rs12107539	chr3:151042464	P2RY14	chr3:150929905-150996230:-	-0.08	-3.54	0.000411	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
BRCA	cis	1	rs12107673	chr3:167454002	SERPINI1	chr3:167453432-167543356:+	0.13	3.42	0.000642	Visceral fat	
BRCA	cis	1	rs12117903	chr1:156311165	BGLAP	chr1:156182784-156213112:+	0.19	5.05	5.16E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12117903	chr1:156311165	CCT3	chr1:156278752-156308195:-	-0.11	-3.63	0.000301	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12117947	chr1:156244058	BGLAP	chr1:156182784-156213112:+	0.21	5.57	3.26E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12117951	chr1:156305286	BGLAP	chr1:156182784-156213112:+	0.19	5.04	5.36E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12117951	chr1:156305286	CCT3	chr1:156278752-156308195:-	-0.11	-3.61	0.000322	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12118238	chr1:156235221	BGLAP	chr1:156182784-156213112:+	0.19	4.92	1.01E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12118238	chr1:156235221	C1orf85	chr1:156259882-156265449:-	-0.12	-3.47	0.000532	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12118238	chr1:156235221	CCT3	chr1:156278752-156308195:-	-0.11	-3.37	0.000765	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12118297	chr1:87779217	HS2ST1	chr1:87380335-87575680:+	0.13	3.52	0.000456	Breast cancer	
BRCA	cis	1	rs12118323	chr1:10469641	PGD	chr1:10459085-10480200:+	0.22	6.29	4.5E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.56	11.75	4.59E-30	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs12121805	chr1:156257876	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12121805	chr1:156257876	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12122100	chr1:146508934	LOC728989	chr1:146490895-146514599:-	-0.13	-3.59	0.000341	HIV-1 control	
BRCA	cis	1	rs12122180	chr1:156244559	BGLAP	chr1:156182784-156213112:+	0.2	5.31	1.31E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12122290	chr1:247215810	ZNF670	chr1:247200087-247242069:-	-0.25	-7.03	3.75E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.54	11.43	1.26E-28	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs12128536	chr1:171674607	VAMP4	chr1:171669298-171711214:-	0.2	5.67	1.79E-8	Hippocampal atrophy	
BRCA	cis	1	rs12129035	chr1:10291166	PGD	chr1:10459085-10480200:+	0.19	5.55	3.59E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs12130220	chr1:10359944	PGD	chr1:10459085-10480200:+	0.2	5.72	1.39E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.55	11.63	1.57E-29	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs12130361	chr1:156260301	BGLAP	chr1:156182784-156213112:+	0.2	5.36	1.02E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12130629	chr1:166953284	TADA1	chr1:166825751-166845654:-	-0.1	-3.4	0.000688	Refractive astigmatism	
BRCA	cis	1	rs12132221	chr1:171685694	VAMP4	chr1:171669298-171711214:-	0.19	5.4	8.35E-8	Hippocampal atrophy	
BRCA	cis	1	rs12132635	chr1:10430479	PGD	chr1:10459085-10480200:+	0.23	6.31	4.09E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs12132794	chr1:156281020	BGLAP	chr1:156182784-156213112:+	-0.2	-5.33	1.17E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.58	12.99	6.34E-36	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs12133780	chr1:21270808	SH2D5	chr1:21046225-21059330:-	0.13	3.51	0.000468	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs12133933	chr1:37958389	SNIP1	chr1:38002145-38019903:-	-0.19	-3.81	0.000148	Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs12133982	chr1:119464002	WARS2	chr1:119573841-119683295:-	0.25	4.78	2.04E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12134073	chr1:41689283	SCMH1	chr1:41492875-41707788:-	-0.12	-3.4	0.00069	Height	
BRCA	cis	1	rs12134163	chr1:119466993	WARS2	chr1:119573841-119683295:-	0.25	4.82	1.66E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12134983	chr1:156290409	BGLAP	chr1:156182784-156213112:+	0.19	5.12	3.57E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12135657	chr1:119470813	WARS2	chr1:119573841-119683295:-	0.26	4.89	1.15E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12136376	chr1:10296452	PGD	chr1:10459085-10480200:+	0.19	5.51	4.42E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs12137080	chr1:66766185	PDE4B	chr1:66258193-66840261:+	-0.13	-3.63	0.000298	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs12138117	chr1:16305279	CLCNKA	chr1:16345370-16360544:+	-0.21	-5.27	1.67E-7	Dilated cardiomyopathy	
BRCA	cis	1	rs12138343	chr1:119495317	WARS2	chr1:119573841-119683295:-	0.26	4.81	1.75E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12139321	chr1:156230429	BGLAP	chr1:156182784-156213112:+	0.18	4.61	4.59E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12139321	chr1:156230429	C1orf85	chr1:156259882-156265449:-	-0.12	-3.62	0.000304	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12139321	chr1:156230429	CCT3	chr1:156278752-156308195:-	-0.12	-3.55	0.000402	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12139630	chr1:46350935	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.84	1.73E-30	Body mass index	
BRCA	cis	1	rs12139630	chr1:46350935	CCDC17	chr1:46085717-46089729:-	0.11	3.57	0.000371	Body mass index	
BRCA	cis	1	rs12139630	chr1:46350935	MUTYH	chr1:45794915-45806142:-	0.13	4.98	7.32E-7	Body mass index	
BRCA	cis	1	rs12139690	chr1:119491316	WARS2	chr1:119573841-119683295:-	0.27	4.96	8.21E-7	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12140848	chr1:227776942	ZNF678	chr1:227751244-227910352:+	0.08	3.54	0.000412	Height	
BRCA	cis	1	rs12141236	chr1:156302575	BGLAP	chr1:156182784-156213112:+	0.2	5.24	1.92E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12141236	chr1:156302575	CCT3	chr1:156278752-156308195:-	-0.11	-3.56	0.000391	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12141416	chr1:10327867	PGD	chr1:10459085-10480200:+	0.19	5.73	1.31E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs12141651	chr1:119492703	WARS2	chr1:119573841-119683295:-	0.26	4.81	1.7E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12142808	chr1:156230546	BGLAP	chr1:156182784-156213112:+	0.18	4.72	2.68E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12142808	chr1:156230546	C1orf85	chr1:156259882-156265449:-	-0.12	-3.47	0.000546	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12142808	chr1:156230546	CCT3	chr1:156278752-156308195:-	-0.12	-3.59	0.000352	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12143789	chr1:119497154	WARS2	chr1:119573841-119683295:-	-0.22	-4.14	3.75E-5	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12144263	chr1:46352446	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.84	1.85E-30	Body mass index	
BRCA	cis	1	rs12144263	chr1:46352446	CCDC17	chr1:46085717-46089729:-	0.11	3.57	0.000378	Body mass index	
BRCA	cis	1	rs12144263	chr1:46352446	MUTYH	chr1:45794915-45806142:-	0.13	4.98	7.38E-7	Body mass index	
BRCA	cis	1	rs12144610	chr1:119501103	WARS2	chr1:119573841-119683295:-	0.25	4.61	4.5E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12145743	chr1:156700651	C1orf66	chr1:156698263-156706751:+	0.09	3.42	0.000654	HDL cholesterol	
BRCA	cis	1	rs12145833	chr1:243483754	SDCCAG8	chr1:243419320-243663392:+	0.23	4.88	1.24E-6	Obesity (early onset extreme)	
BRCA	cis	1	rs12148239	chr15:84641018	LOC388152	chr15:84867600-84898920:-	-0.19	-5.21	2.26E-7	Sitting height ratio	
BRCA	cis	1	rs12148786	chr15:76800362	SCAPER	chr15:76640529-77197744:-	-0.17	-5.99	2.87E-9	Blood metabolite levels	
BRCA	cis	1	rs12149862	chr16:69497203	CYB5B	chr16:69458498-69500167:+	0.18	4.57	5.36E-6	Blood pressure (smoking interaction)	
BRCA	cis	1	rs12149862	chr16:69497203	PDF	chr16:69362524-69364498:-	0.13	3.57	0.000368	Blood pressure (smoking interaction)	
BRCA	cis	1	rs12149862	chr16:69497203	TERF2	chr16:69389535-69419873:-	0.14	3.45	0.000578	Blood pressure (smoking interaction)	
BRCA	cis	1	rs12149862	chr16:69497203	VPS4A	chr16:69345287-69358945:+	0.12	3.76	0.000178	Blood pressure (smoking interaction)	
BRCA	cis	1	rs12152964	chr5:115609965	COMMD10	chr5:115420727-115628978:+	0.24	4.47	8.82E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12153717	chr5:115571914	COMMD10	chr5:115420727-115628978:+	0.23	4.37	1.39E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12153877	chr6:33765465	IP6K3	chr6:33689443-33714762:-	0.29	5	6.66E-7	Obesity (extreme)	
BRCA	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.56	-17.95	3.91E-63	Response to antipsychotic treatment	
BRCA	cis	1	rs12184327	chr1:207978780	C4BPA	chr1:207277511-207318308:+	-0.13	-3.82	0.000142	Schizophrenia	
BRCA	cis	1	rs12188300	chr5:158829527	TTC1	chr5:159436180-159492549:+	-0.23	-3.65	0.000279	Psoriatic arthritis	
BRCA	cis	1	rs12189567	chr6:55933942	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs12189571	chr6:55933987	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs12189725	chr6:33703394	IP6K3	chr6:33689443-33714762:-	0.25	4.54	6.23E-6	Obesity (extreme)	
BRCA	cis	1	rs12190146	chr6:159414155	RSPH3	chr6:159398268-159421198:-	0.23	4.07	4.95E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.56	-16.96	2.68E-57	Response to antipsychotic treatment	
BRCA	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.59	-18.06	7.99E-64	Response to antipsychotic treatment	
BRCA	cis	1	rs12190671	chr6:55959857	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs12190695	chr6:55943429	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs12190930	chr6:55977027	COL21A1	chr6:55921389-56258892:-	-0.37	-6.84	1.31E-11	Psychosis (atypical)	
BRCA	cis	1	rs12190954	chr6:33746618	IP6K3	chr6:33689443-33714762:-	0.25	4.41	1.13E-5	Obesity (extreme)	
BRCA	cis	1	rs12191865	chr6:56014006	COL21A1	chr6:55921389-56258892:-	-0.37	-6.89	9.79E-12	Psychosis (atypical)	
BRCA	cis	1	rs12192279	chr6:110055313	AKD1	chr6:109814059-110012415:-	0.26	4.2	2.83E-5	Hematological parameters	
BRCA	cis	1	rs12192279	chr6:110055313	ARMC2	chr6:109169619-109295350:+	0.24	3.77	0.00017	Hematological parameters	
BRCA	cis	1	rs12192279	chr6:110055313	FIG4	chr6:110012424-110146634:+	0.26	3.74	0.000192	Hematological parameters	
BRCA	cis	1	rs12192279	chr6:110055313	PPIL6	chr6:109711419-109761990:-	0.31	5.01	6.5E-7	Hematological parameters	
BRCA	cis	1	rs12192279	chr6:110055313	ZBTB24	chr6:109783719-109804440:-	0.2	3.42	0.000652	Hematological parameters	
BRCA	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.6	-18.71	8.84E-68	Response to antipsychotic treatment	
BRCA	cis	1	rs12193658	chr6:33705528	IP6K3	chr6:33689443-33714762:-	0.25	4.35	1.52E-5	Obesity (extreme)	
BRCA	cis	1	rs12193911	chr6:55966889	COL21A1	chr6:55921389-56258892:-	-0.37	-6.81	1.58E-11	Psychosis (atypical)	
BRCA	cis	1	rs12194192	chr6:55954089	COL21A1	chr6:55921389-56258892:-	-0.37	-6.84	1.34E-11	Psychosis (atypical)	
BRCA	cis	1	rs12194997	chr6:55970434	COL21A1	chr6:55921389-56258892:-	-0.37	-6.77	2.07E-11	Psychosis (atypical)	
BRCA	cis	1	rs12195340	chr6:55967008	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs12195409	chr6:33757482	IP6K3	chr6:33689443-33714762:-	0.28	4.89	1.16E-6	Obesity (extreme)	
BRCA	cis	1	rs12195417	chr6:84173028	PRSS35	chr6:84222274-84235419:+	-0.11	-3.5	0.000491	Schizophrenia	
BRCA	cis	1	rs12196050	chr6:55985113	COL21A1	chr6:55921389-56258892:-	-0.37	-6.84	1.36E-11	Psychosis (atypical)	
BRCA	cis	1	rs12196213	chr6:55932547	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs12196526	chr6:55955754	COL21A1	chr6:55921389-56258892:-	0.34	6.33	3.49E-10	Psychosis (atypical)	
BRCA	cis	1	rs12196670	chr6:55941044	COL21A1	chr6:55921389-56258892:-	-0.37	-6.91	8.37E-12	Psychosis (atypical)	
BRCA	cis	1	rs12196709	chr6:55941100	COL21A1	chr6:55921389-56258892:-	-0.37	-6.91	8.37E-12	Psychosis (atypical)	
BRCA	cis	1	rs12196860	chr6:55950374	COL21A1	chr6:55921389-56258892:-	-0.35	-6.49	1.28E-10	Psychosis (atypical)	
BRCA	cis	1	rs12196937	chr6:49382808	CENPQ	chr6:49431096-49460820:+	-0.23	-7.34	4.22E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.32	10.1	5.83E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs12196944	chr6:55941564	COL21A1	chr6:55921389-56258892:-	-0.37	-6.91	8.37E-12	Psychosis (atypical)	
BRCA	cis	1	rs12197114	chr6:109735498	AKD1	chr6:109814059-110012415:-	-0.13	-3.64	0.000281	Height	
BRCA	cis	1	rs12197114	chr6:109735498	SMPD2	chr6:109761931-109765121:+	0.23	6.91	8.54E-12	Height	
BRCA	cis	1	rs12197419	chr6:1709037	FOXF2	chr6:1390069-1395831:+	-0.11	-3.72	0.000212	Monobrow thickness	
BRCA	cis	1	rs12197951	chr6:55946916	COL21A1	chr6:55921389-56258892:-	-0.38	-7.07	2.85E-12	Psychosis (atypical)	
BRCA	cis	1	rs12198225	chr6:55947475	COL21A1	chr6:55921389-56258892:-	-0.38	-7.01	4.22E-12	Psychosis (atypical)	
BRCA	cis	1	rs12198637	chr6:55981400	COL21A1	chr6:55921389-56258892:-	-0.36	-6.64	5.09E-11	Psychosis (atypical)	
BRCA	cis	1	rs12199132	chr6:33708250	IP6K3	chr6:33689443-33714762:-	0.24	4.21	2.74E-5	Obesity (extreme)	
BRCA	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.59	-18.48	2.18E-66	Response to antipsychotic treatment	
BRCA	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.59	-18.47	2.46E-66	Response to antipsychotic treatment	
BRCA	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.61	-18.81	2.08E-68	Response to antipsychotic treatment	
BRCA	cis	1	rs12200525	chr6:55982301	COL21A1	chr6:55921389-56258892:-	-0.37	-6.86	1.14E-11	Psychosis (atypical)	
BRCA	cis	1	rs12200667	chr6:55982461	COL21A1	chr6:55921389-56258892:-	-0.37	-6.86	1.14E-11	Psychosis (atypical)	
BRCA	cis	1	rs12201413	chr6:55933348	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.59	-18.42	5.21E-66	Response to antipsychotic treatment	
BRCA	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.57	-18.08	6.09E-64	Response to antipsychotic treatment	
BRCA	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.56	-17.68	1.46E-61	Response to antipsychotic treatment	
BRCA	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.56	-17.95	3.91E-63	Response to antipsychotic treatment	
BRCA	cis	1	rs12202075	chr6:49427655	CENPQ	chr6:49431096-49460820:+	-0.24	-7.97	4.15E-15	Folate pathway vitamin levels	
BRCA	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.32	10.25	1.42E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs12202783	chr6:159388629	RSPH3	chr6:159398268-159421198:-	0.22	4.01	6.55E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12203179	chr6:55994237	COL21A1	chr6:55921389-56258892:-	0.35	7.04	3.46E-12	Psychosis (atypical)	
BRCA	cis	1	rs12203286	chr6:55994438	COL21A1	chr6:55921389-56258892:-	-0.37	-6.91	8.51E-12	Psychosis (atypical)	
BRCA	cis	1	rs12203407	chr6:55994431	COL21A1	chr6:55921389-56258892:-	-0.38	-6.92	7.52E-12	Psychosis (atypical)	
BRCA	cis	1	rs12203464	chr6:55934339	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs12203483	chr6:159386228	RSPH3	chr6:159398268-159421198:-	0.21	3.79	0.000159	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12203653	chr6:55964693	COL21A1	chr6:55921389-56258892:-	-0.36	-6.58	7.13E-11	Psychosis (atypical)	
BRCA	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.6	-19.55	5.73E-73	Response to antipsychotic treatment	
BRCA	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.58	-18.37	1.04E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs12204789	chr6:55947818	COL21A1	chr6:55921389-56258892:-	-0.38	-7.01	4.22E-12	Psychosis (atypical)	
BRCA	cis	1	rs12204992	chr6:33741724	IP6K3	chr6:33689443-33714762:-	0.27	4.72	2.61E-6	Obesity (extreme)	
BRCA	cis	1	rs12205230	chr6:55995496	COL21A1	chr6:55921389-56258892:-	-0.37	-6.82	1.48E-11	Psychosis (atypical)	
BRCA	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.6	-18.36	1.26E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs12205653	chr6:55960169	COL21A1	chr6:55921389-56258892:-	-0.36	-6.71	3.25E-11	Psychosis (atypical)	
BRCA	cis	1	rs12205903	chr6:55960583	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs12206610	chr6:166016800	PDE10A	chr6:165740779-166075584:-	-0.18	-4.26	2.24E-5	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs12206920	chr6:55966027	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs12207120	chr6:55936134	COL21A1	chr6:55921389-56258892:-	-0.37	-6.99	4.96E-12	Psychosis (atypical)	
BRCA	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.58	-18.36	1.31E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.57	-17.75	6.04E-62	Response to antipsychotic treatment	
BRCA	cis	1	rs12207665	chr6:55991330	COL21A1	chr6:55921389-56258892:-	-0.38	-6.98	5.28E-12	Psychosis (atypical)	
BRCA	cis	1	rs12207772	chr6:134189834	TCF21	chr6:134210259-134219157:+	0.16	4.27	2.1E-5	Coronary heart disease	
BRCA	cis	1	rs12207795	chr6:159366261	RSPH3	chr6:159398268-159421198:-	0.19	3.52	0.000448	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.61	-18.94	3.26E-69	Response to antipsychotic treatment	
BRCA	cis	1	rs12208500	chr6:55933259	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs12208615	chr6:55933489	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs12208823	chr6:55966902	COL21A1	chr6:55921389-56258892:-	-0.37	-6.81	1.58E-11	Psychosis (atypical)	
BRCA	cis	1	rs12208892	chr6:159371192	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12208901	chr6:159371238	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.6	-18.36	1.26E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs12209192	chr6:55967702	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs12209420	chr6:55937876	COL21A1	chr6:55921389-56258892:-	-0.37	-6.91	8.37E-12	Psychosis (atypical)	
BRCA	cis	1	rs12209464	chr6:55985189	COL21A1	chr6:55921389-56258892:-	-0.37	-6.81	1.58E-11	Psychosis (atypical)	
BRCA	cis	1	rs12209509	chr6:55962183	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs12209529	chr6:55932278	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs12210218	chr6:159377219	RSPH3	chr6:159398268-159421198:-	0.2	3.68	0.000249	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12210228	chr6:55973083	COL21A1	chr6:55921389-56258892:-	-0.36	-6.71	3.25E-11	Psychosis (atypical)	
BRCA	cis	1	rs12210402	chr6:55943418	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs12210468	chr6:55934393	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs12211223	chr6:55959848	COL21A1	chr6:55921389-56258892:-	-0.37	-6.89	9.52E-12	Psychosis (atypical)	
BRCA	cis	1	rs12211490	chr6:33725528	IP6K3	chr6:33689443-33714762:-	0.26	4.49	8.06E-6	Obesity (extreme)	
BRCA	cis	1	rs12211554	chr6:33725788	IP6K3	chr6:33689443-33714762:-	0.26	4.41	1.13E-5	Obesity (extreme)	
BRCA	cis	1	rs12211565	chr6:33725852	IP6K3	chr6:33689443-33714762:-	0.26	4.49	8.06E-6	Obesity (extreme)	
BRCA	cis	1	rs12211619	chr6:56014005	COL21A1	chr6:55921389-56258892:-	-0.37	-6.89	9.79E-12	Psychosis (atypical)	
BRCA	cis	1	rs12212032	chr6:56005703	COL21A1	chr6:55921389-56258892:-	-0.37	-6.92	7.55E-12	Psychosis (atypical)	
BRCA	cis	1	rs12212090	chr6:37431808	C6orf129	chr6:37450699-37467700:-	0.12	4.67	3.37E-6	Cognitive performance	
BRCA	cis	1	rs12212090	chr6:37431808	RNF8	chr6:37321748-37362513:+	0.12	3.61	0.000316	Cognitive performance	
BRCA	cis	1	rs12212135	chr6:55965006	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs12212143	chr6:55965055	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs12212211	chr6:55995226	COL21A1	chr6:55921389-56258892:-	-0.37	-6.82	1.48E-11	Psychosis (atypical)	
BRCA	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.59	-18.19	1.31E-64	Response to antipsychotic treatment	
BRCA	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.61	-18.94	3.26E-69	Response to antipsychotic treatment	
BRCA	cis	1	rs12213291	chr6:55957074	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs12213434	chr6:159369128	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12213571	chr6:55957493	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.57	-17.89	8.03E-63	Response to antipsychotic treatment	
BRCA	cis	1	rs12214519	chr6:55966884	COL21A1	chr6:55921389-56258892:-	-0.37	-6.81	1.58E-11	Psychosis (atypical)	
BRCA	cis	1	rs12214594	chr6:56010824	COL21A1	chr6:55921389-56258892:-	-0.37	-6.83	1.44E-11	Psychosis (atypical)	
BRCA	cis	1	rs12214813	chr6:159362013	RSPH3	chr6:159398268-159421198:-	0.21	3.79	0.000157	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12214878	chr6:159362118	RSPH3	chr6:159398268-159421198:-	0.21	3.79	0.000157	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.6	-18.12	3.43E-64	Response to antipsychotic treatment	
BRCA	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.56	-17.54	1.09E-60	Response to antipsychotic treatment	
BRCA	cis	1	rs12215913	chr6:55996995	COL21A1	chr6:55921389-56258892:-	-0.37	-6.82	1.48E-11	Psychosis (atypical)	
BRCA	cis	1	rs12215936	chr6:159371324	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.6	-18.5	1.83E-66	Response to antipsychotic treatment	
BRCA	cis	1	rs12216314	chr6:55997673	COL21A1	chr6:55921389-56258892:-	-0.37	-6.82	1.48E-11	Psychosis (atypical)	
BRCA	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.6	-18.93	4.05E-69	Response to antipsychotic treatment	
BRCA	cis	1	rs12216499	chr6:159368524	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12219158	chr10:102302923	SEC31B	chr10:102246403-102289636:-	-0.29	-10.82	6.07E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs12219789	chr10:102213778	SEC31B	chr10:102246403-102289636:-	-0.28	-10.23	1.66E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs12219790	chr10:91375491	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.76	0.000178	Metabolic traits	
BRCA	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-0.44	-7.72	2.58E-14	Chronic obstructive pulmonary disease-related biomarkers	
BRCA	cis	1	rs12232914	chr2:70117176	ANXA4	chr2:69969127-70053594:+	-0.13	-3.85	0.000124	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs12237653	chr9:2551654	FLJ35024	chr9:2422702-2622373:-	0.37	8.22	5.98E-16	Gambling	
BRCA	cis	1	rs12243096	chr10:101812302	CWF19L1	chr10:101992055-102027437:-	0.13	3.67	0.000253	Bone mineral density	
BRCA	cis	1	rs12277962	chr11:17655839	PIK3C2A	chr11:17099277-17229530:-	0.11	3.44	0.000604	Night sleep phenotypes	
BRCA	cis	1	rs1228632	chr11:83325114	CCDC90B	chr11:82972506-82997414:-	-0.18	-4.87	1.29E-6	Subcortical brain region volumes	
BRCA	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.3	7.75	2.09E-14	Pancreatic cancer	
BRCA	cis	1	rs12287732	chr11:28120845	METT5D1	chr11:28129798-28355054:+	-0.11	-3.37	0.000773	Bipolar disorder	
BRCA	cis	1	rs12295403	chr11:18689653	LDHC	chr11:18433853-18472792:+	-0.2	-4.6	4.77E-6	Ovarian reserve	
BRCA	cis	1	rs12297480	chr12:62795587	FAM19A2	chr12:62102043-62653925:-	0.17	3.75	0.000185	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs1229854	chr4:100282550	ADH1C	chr4:100257651-100273917:-	-0.21	-6.72	3.03E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1229978	chr4:100256199	ADH1C	chr4:100257651-100273917:-	-0.2	-6.32	3.91E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1229978	chr4:100256199	ADH4	chr4:100044835-100065449:-	-0.11	-3.38	0.000762	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs12301299	chr12:991710	RAD52	chr12:1021255-1099219:-	-0.3	-6.57	7.97E-11	Colorectal cancer	
BRCA	cis	1	rs12303914	chr12:10471050	KLRD1	chr12:10457050-10469849:+	-0.12	-4.55	6.11E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs12310651	chr12:62730305	FAM19A2	chr12:62102043-62653925:-	0.18	3.87	0.000115	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs12311259	chr12:62739008	FAM19A2	chr12:62102043-62653925:-	0.18	3.95	8.25E-5	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs12311279	chr12:62695332	FAM19A2	chr12:62102043-62653925:-	0.17	3.65	0.00027	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs12312603	chr12:988269	RAD52	chr12:1021255-1099219:-	-0.33	-7.45	1.9E-13	Colorectal cancer	
BRCA	cis	1	rs12315645	chr12:62705895	FAM19A2	chr12:62102043-62653925:-	0.17	3.65	0.00027	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs12317176	chr12:124404718	DNAH10	chr12:124247042-124420265:+	0.26	6.51	1.14E-10	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12317437	chr12:62738833	FAM19A2	chr12:62102043-62653925:-	0.18	3.95	8.25E-5	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs12318287	chr12:62726856	FAM19A2	chr12:62102043-62653925:-	0.18	3.87	0.000115	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs12324805	chr15:82352200	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.11	3.85	0.000125	Body mass index	
BRCA	cis	1	rs12324805	chr15:82352200	LOC80154	chr15:82944795-82975797:+;chr15	0.15	4.55	5.92E-6	Body mass index	
BRCA	cis	1	rs12332489	chr5:115579386	COMMD10	chr5:115420727-115628978:+	0.21	4.47	8.66E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12332585	chr5:115581395	COMMD10	chr5:115420727-115628978:+	0.21	4.47	8.66E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12332633	chr5:41233698	C7	chr5:40909599-40983039:+	-0.11	-4.63	4.13E-6	Response to fenofibrate (adiponectin levels)	
BRCA	cis	1	rs12332658	chr5:115545606	COMMD10	chr5:115420727-115628978:+	0.24	5	6.85E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs1235415	chr4:100281159	ADH1C	chr4:100257651-100273917:-	-0.21	-6.72	3.03E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs12354411	chr10:102294537	SEC31B	chr10:102246403-102289636:-	-0.3	-11.18	1.69E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs12354486	chr10:104124055	PITX3	chr10:103989946-104001231:-	0.16	3.57	0.000372	Educational attainment (college completion)	
BRCA	cis	1	rs12355721	chr10:102244911	SEC31B	chr10:102246403-102289636:-	-0.29	-10.43	2.65E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs12355784	chr10:65121565	NRBF2	chr10:64893007-64914785:+	-0.15	-5.64	2.12E-8	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs12358187	chr10:102284449	SEC31B	chr10:102246403-102289636:-	-0.3	-11.07	4.88E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs12359272	chr10:97365163	ENTPD1	chr10:97471536-97637022:+	0.15	4.91	1.03E-6	Blood metabolite levels	
BRCA	cis	1	rs12361031	chr11:47783076	MADD	chr11:47290927-47351582:+	0.15	4.51	7.28E-6	Subjective well-being	
BRCA	cis	1	rs12361031	chr11:47783076	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.29	1.98E-5	Subjective well-being	
BRCA	cis	1	rs12363232	chr11:47623890	MADD	chr11:47290927-47351582:+	0.13	4.04	5.75E-5	Subjective well-being	
BRCA	cis	1	rs12363232	chr11:47623890	MYBPC3	chr11:47352958-47374253:-	-0.15	-4.39	1.22E-5	Subjective well-being	
BRCA	cis	1	rs12365551	chr11:58358368	CNTF	chr11:58390146-58393203:+	0.17	3.63	0.000291	Lymphoma	
BRCA	cis	1	rs12366580	chr12:82222784	PPFIA2	chr12:81652880-82153109:-	0.14	3.51	0.000467	Resting heart rate	
BRCA	cis	1	rs12366611	chr12:122607487	LRRC43	chr12:122652266-122688017:+	-0.17	-4.87	1.31E-6	Urate levels	
BRCA	cis	1	rs12367791	chr12:82237278	PPFIA2	chr12:81652880-82153109:-	0.13	3.39	0.000724	Resting heart rate	
BRCA	cis	1	rs12377604	chr9:100697287	C9orf156	chr9:100666772-100684852:-	-0.17	-4.62	4.3E-6	Quantitative traits	
BRCA	cis	1	rs1238015	chr4:100281134	ADH1C	chr4:100257651-100273917:-	-0.21	-6.72	3.03E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs12402052	chr1:10318652	PGD	chr1:10459085-10480200:+	0.2	5.52	4.32E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.82	2.23E-30	Body mass index	
BRCA	cis	1	rs12405451	chr1:46384326	CCDC17	chr1:46085717-46089729:-	0.11	3.38	0.000753	Body mass index	
BRCA	cis	1	rs12405451	chr1:46384326	MUTYH	chr1:45794915-45806142:-	0.12	4.86	1.33E-6	Body mass index	
BRCA	cis	1	rs12407992	chr1:10311983	PGD	chr1:10459085-10480200:+	0.14	4.1	4.41E-5	Hepatocellular carcinoma	
BRCA	cis	1	rs12409773	chr1:46358831	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.79	2.88E-30	Body mass index	
BRCA	cis	1	rs12409773	chr1:46358831	CCDC17	chr1:46085717-46089729:-	0.11	3.48	0.000529	Body mass index	
BRCA	cis	1	rs12409773	chr1:46358831	MUTYH	chr1:45794915-45806142:-	0.13	4.97	7.79E-7	Body mass index	
BRCA	cis	1	rs12410060	chr1:75245848	CRYZ	chr1:75171175-75199092:-	-0.38	-10.24	1.58E-23	Resistin levels	
BRCA	cis	1	rs12410071	chr1:46358886	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.79	2.88E-30	Body mass index	
BRCA	cis	1	rs12410071	chr1:46358886	CCDC17	chr1:46085717-46089729:-	0.11	3.48	0.000529	Body mass index	
BRCA	cis	1	rs12410071	chr1:46358886	MUTYH	chr1:45794915-45806142:-	0.13	4.97	7.79E-7	Body mass index	
BRCA	cis	1	rs12410786	chr1:207976205	C4BPA	chr1:207277511-207318308:+	-0.12	-3.65	0.00027	Schizophrenia	
BRCA	cis	1	rs12411269	chr1:46271052	CCDC163P	chr1:45960581-45965646:-	-0.41	-12.06	1.82E-31	Body mass index	
BRCA	cis	1	rs12411269	chr1:46271052	CCDC17	chr1:46085717-46089729:-	0.11	3.46	0.000568	Body mass index	
BRCA	cis	1	rs12411269	chr1:46271052	MUTYH	chr1:45794915-45806142:-	0.12	4.86	1.36E-6	Body mass index	
BRCA	cis	1	rs12416687	chr10:104629011	AS3MT	chr10:104613967-104661653:+	-0.23	-5.73	1.29E-8	Arsenic metabolism	
BRCA	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.37	-12.54	9.4E-34	Arsenic metabolism	
BRCA	cis	1	rs12418639	chr11:473300	RNH1	chr11:494512-507273:-	0.17	4.25	2.34E-5	Body mass index	
BRCA	cis	1	rs12418852	chr11:47868853	MADD	chr11:47290927-47351582:+	0.14	4.44	9.81E-6	Subjective well-being	
BRCA	cis	1	rs12418852	chr11:47868853	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.14	3.74E-5	Subjective well-being	
BRCA	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.11	3.51	0.00047	Subjective well-being	
BRCA	cis	1	rs12419692	chr11:47624714	MADD	chr11:47290927-47351582:+	-0.11	-3.39	0.000729	Subjective well-being	
BRCA	cis	1	rs12419692	chr11:47624714	MYBPC3	chr11:47352958-47374253:-	0.13	3.79	0.000159	Subjective well-being	
BRCA	cis	1	rs12421210	chr11:47779586	MADD	chr11:47290927-47351582:+	0.15	4.51	7.28E-6	Subjective well-being	
BRCA	cis	1	rs12421210	chr11:47779586	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.29	1.98E-5	Subjective well-being	
BRCA	cis	1	rs12424054	chr12:107186747	C12orf23	chr12:107349544-107367811:+	0.15	3.48	0.000531	Social autistic-like traits	
BRCA	cis	1	rs12424054	chr12:107186747	MTERFD3	chr12:107371069-107380929:-	0.16	4.24	2.45E-5	Social autistic-like traits	
BRCA	cis	1	rs12425790	chr12:121452504	HNF1A	chr12:121416549-121440312:+	-0.19	-3.57	0.000379	Type 2 diabetes	
BRCA	cis	1	rs12428	chr20:25433821	FAM182A	chr20:26035250-26067552:+	0.22	5.74	1.21E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs12428	chr20:25433821	FAM182B	chr20:25744102-25848786:-	-0.24	-6.26	5.41E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs12433827	chr14:66055610	LOC645431	chr14:65877313-65879335:-	-0.27	-5.39	8.62E-8	Ischemic stroke	
BRCA	cis	1	rs12435908	chr14:66121468	LOC645431	chr14:65877313-65879335:-	0.21	4.51	7.18E-6	Ischemic stroke	
BRCA	cis	1	rs12436436	chr14:24381515	DHRS4	chr14:24422965-24475615:+	-0.17	-3.45	0.00058	Bipolar disorder	
BRCA	cis	1	rs12436436	chr14:24381515	NGDN	chr14:23938898-23947401:+	-0.19	-3.42	0.00066	Bipolar disorder	
BRCA	cis	1	rs12438305	chr15:50912454	SPPL2A	chr15:50999739-51057910:-	0.15	5.38	9.32E-8	QT interval	
BRCA	cis	1	rs12441433	chr15:76816015	SCAPER	chr15:76640529-77197744:-	-0.18	-6.32	3.89E-10	Blood metabolite levels	
BRCA	cis	1	rs12443137	chr15:76840832	SCAPER	chr15:76640529-77197744:-	-0.16	-5.84	6.89E-9	Blood metabolite levels	
BRCA	cis	1	rs12445650	chr16:31044897	HSD3B7	chr16:30996519-31000473:+	0.24	7.38	3.28E-13	Response to metformin (IC50)	
BRCA	cis	1	rs12445650	chr16:31044897	MYST1	chr16:31128985-31142713:+	0.2	7.37	3.44E-13	Response to metformin (IC50)	
BRCA	cis	1	rs12445650	chr16:31044897	ORAI3	chr16:30960405-30966258:+	0.1	3.63	0.000302	Response to metformin (IC50)	
BRCA	cis	1	rs12445650	chr16:31044897	SETD1A	chr16:30968615-30995981:+	0.11	3.46	0.000563	Response to metformin (IC50)	
BRCA	cis	1	rs12445650	chr16:31044897	ZNF689	chr16:30614701-30621682:-	0.11	3.54	0.00041	Response to metformin (IC50)	
BRCA	cis	1	rs12457810	chr18:9088650	TWSG1	chr18:9334765-9402417:+	0.21	3.96	7.94E-5	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs12460161	chr19:44293986	LYPD5	chr19:44300080-44324808:-	-0.16	-4.41	1.16E-5	Breast cancer	
BRCA	cis	1	rs12460161	chr19:44293986	ZNF155	chr19:44488355-44502477:+	-0.14	-3.74	0.000194	Breast cancer	
BRCA	cis	1	rs12460161	chr19:44293986	ZNF404	chr19:44376516-44384288:-	-0.21	-5.69	1.62E-8	Breast cancer	
BRCA	cis	1	rs12462270	chr19:39201488	LGALS7	chr19:39261608-39264157:-	-0.19	-5.88	5.33E-9	Heart rate	
BRCA	cis	1	rs12464559	chr2:152597660	ARL5A	chr2:152645593-152685009:-	-0.24	-4	6.88E-5	Response to cognitive-behavioural therapy in anxiety disorder	
BRCA	cis	1	rs12464737	chr2:56029838	EFEMP1	chr2:56093103-56150932:-	-0.18	-4.53	6.51E-6	Height	
BRCA	cis	1	rs12470864	chr2:102926362	IL18R1	chr2:102927962-103015215:+	0.11	4.91	1.03E-6	Serum protein levels (sST2)	
BRCA	cis	1	rs12472278	chr2:108873433	SULT1C2	chr2:108905095-108926370:+	-0.29	-7.04	3.54E-12	Blood pressure	
BRCA	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.67	-12.88	2.12E-35	Plasma clusterin levels	
BRCA	cis	1	rs12473894	chr2:63376570	C2orf86	chr2:63348537-63815851:-	-0.2	-4.93	9.53E-7	Subjective well-being	
BRCA	cis	1	rs12475563	chr2:64384515	C2orf86	chr2:63348537-63815851:-	-0.12	-3.77	0.000173	Neuroticism	
BRCA	cis	1	rs12475563	chr2:64384515	CEP68	chr2:65283495-65314141:+	-0.11	-3.53	0.000431	Neuroticism	
BRCA	cis	1	rs12478744	chr2:23947589	LOC375190	chr2:24299728-24397519:+	0.2	5.99	2.83E-9	Obesity-related traits	
BRCA	cis	1	rs12479210	chr2:102949161	IL18R1	chr2:102927962-103015215:+	0.11	4.75	2.29E-6	Serum protein levels (sST2)	
BRCA	cis	1	rs12479491	chr20:30265450	COX4I2	chr20:30225691-30232800:+	0.18	6.72	2.91E-11	Subcortical brain region volumes	
BRCA	cis	1	rs12479491	chr20:30265450	MYLK2	chr20:30407178-30422500:+	0.31	8.11	1.36E-15	Subcortical brain region volumes	
BRCA	cis	1	rs12487080	chr3:119294482	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs12487334	chr3:119291419	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs12487335	chr3:119291425	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs12487430	chr3:119291791	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.27	-10.18	2.77E-23	Longevity	
BRCA	cis	1	rs12488768	chr3:53086234	ITIH4	chr3:52847007-52866554:-	0.11	3.87	0.000116	Ulcerative colitis	
BRCA	cis	1	rs12489080	chr3:119293183	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs12489891	chr3:46310518	TDGF1	chr3:46619180-46623950:+	0.14	3.84	0.000133	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.43	14.44	2.78E-43	Height	
BRCA	cis	1	rs12490835	chr3:134223730	CEP63	chr3:134204575-134293852:+	0.15	4.04	5.82E-5	Height	
BRCA	cis	1	rs12495108	chr3:6254653	GRM7	chr3:6902802-7783218:+	0.16	3.9	0.000101	Response to tocilizumab in rheumatoid arthritis	
BRCA	cis	1	rs12496520	chr3:119294316	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs12498722	chr4:103554522	MANBA	chr4:103552644-103682151:-	0.21	5.4	8.35E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs12498808	chr4:165906905	TRIM61	chr4:165875600-165898818:-	0.25	8.1	1.44E-15	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs12499266	chr4:39119753	KLHL5	chr4:39046659-39123828:+	0.16	5.09	4.18E-7	Uric acid levels	
BRCA	cis	1	rs12503997	chr4:17948089	NCAPG	chr4:17812525-17846485:+	-0.08	-3.8	0.00015	Height	
BRCA	cis	1	rs12505749	chr4:57334112	SRP72	chr4:57333762-57369846:+	-0.26	-4.86	1.37E-6	Airflow obstruction	
BRCA	cis	1	rs12506752	chr4:17948352	NCAPG	chr4:17812525-17846485:+	0.09	4.06	5.19E-5	Height	
BRCA	cis	1	rs12507142	chr4:17656103	MED28	chr4:17616273-17629791:+	0.13	3.38	0.000754	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs12509366	chr4:107003343	TBCK	chr4:106967233-107237861:-	0.26	7.92	5.88E-15	Airflow obstruction	
BRCA	cis	1	rs12509640	chr4:106996677	TBCK	chr4:106967233-107237861:-	-0.23	-6.96	5.84E-12	Airflow obstruction	
BRCA	cis	1	rs12510966	chr4:106983604	TBCK	chr4:106967233-107237861:-	0.26	7.98	3.68E-15	Airflow obstruction	
BRCA	cis	1	rs12511456	chr4:17975603	NCAPG	chr4:17812525-17846485:+	0.09	4.4	1.21E-5	Height	
BRCA	cis	1	rs12511600	chr4:17939921	NCAPG	chr4:17812525-17846485:+	0.08	3.96	8.13E-5	Height	
BRCA	cis	1	rs12512002	chr4:55016790	FIP1L1	chr4:54243820-54326102:+	-0.19	-4.25	2.37E-5	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs12512283	chr4:165908927	TRIM61	chr4:165875600-165898818:-	0.24	7.55	9.01E-14	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs12512683	chr4:106999471	TBCK	chr4:106967233-107237861:-	0.23	7.18	1.27E-12	Airflow obstruction	
BRCA	cis	1	rs12513324	chr4:18006951	NCAPG	chr4:17812525-17846485:+	0.08	3.73	0.000204	Height	
BRCA	cis	1	rs12514600	chr5:115470655	COMMD10	chr5:115420727-115628978:+	0.27	5.11	3.81E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12515308	chr5:115450441	COMMD10	chr5:115420727-115628978:+	0.22	4.75	2.28E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12515466	chr5:115591877	COMMD10	chr5:115420727-115628978:+	0.21	4.57	5.47E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12515585	chr5:156430150	TIMD4	chr5:156346293-156390266:-	-0.16	-4.15	3.54E-5	Hypertriglyceridemia	
BRCA	cis	1	rs12516100	chr5:115451750	COMMD10	chr5:115420727-115628978:+	0.24	4.77	2.08E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12516418	chr5:112707789	YTHDC2	chr5:112849410-112930979:+	0.14	4.09	4.71E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs12517410	chr5:137736611	CDC25C	chr5:137620959-137674044:-	0.09	3.71	0.00022	Schizophrenia	
BRCA	cis	1	rs12517431	chr5:156392248	TIMD4	chr5:156346293-156390266:-	-0.34	-10.96	1.53E-26	Triglycerides;Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs12517508	chr5:115423574	COMMD10	chr5:115420727-115628978:+	0.23	4.87	1.29E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12519753	chr5:112687407	YTHDC2	chr5:112849410-112930979:+	0.13	3.71	0.000221	Cerebral amyloid angiopathy	
BRCA	cis	1	rs12519818	chr5:112772041	YTHDC2	chr5:112849410-112930979:+	0.14	4.1	4.53E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs12519989	chr5:115562642	COMMD10	chr5:115420727-115628978:+	0.23	4.93	9.54E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12520076	chr5:115458830	COMMD10	chr5:115420727-115628978:+	0.25	4.86	1.34E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12520568	chr5:115621505	COMMD10	chr5:115420727-115628978:+	0.19	3.96	7.93E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12520632	chr5:115591766	COMMD10	chr5:115420727-115628978:+	0.26	4.86	1.34E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12521612	chr5:115582605	COMMD10	chr5:115420727-115628978:+	0.24	4.6	4.75E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12522027	chr5:115616531	COMMD10	chr5:115420727-115628978:+	0.22	4.31	1.77E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12522248	chr5:156479426	TIMD4	chr5:156346293-156390266:-	-0.15	-4.16	3.38E-5	Hypertriglyceridemia	
BRCA	cis	1	rs12523255	chr5:112722085	YTHDC2	chr5:112849410-112930979:+	0.14	4.25	2.35E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs12523347	chr5:115572395	COMMD10	chr5:115420727-115628978:+	0.21	4.49	7.77E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs12524423	chr6:159375364	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs12524768	chr6:33760478	LEMD2	chr6:33738991-33756906:-	0.14	4.75	2.34E-6	Body mass index	
BRCA	cis	1	rs12524835	chr6:33730843	C6orf125	chr6:33662057-33679504:-	0.12	4.07	5.05E-5	Body mass index	
BRCA	cis	1	rs12524835	chr6:33730843	LEMD2	chr6:33738991-33756906:-	0.18	5.68	1.69E-8	Body mass index	
BRCA	cis	1	rs12524865	chr6:134196674	TCF21	chr6:134210259-134219157:+	0.14	3.76	0.00018	Coronary heart disease	
BRCA	cis	1	rs12525128	chr6:101174245	ASCC3	chr6:100956609-101329224:-	0.13	4.91	1.06E-6	Menarche (age at onset)	
BRCA	cis	1	rs12526680	chr6:26550954	BTN2A3	chr6:26422317-26431927:+	0.17	5.68	1.77E-8	Educational attainment	
BRCA	cis	1	rs12526680	chr6:26550954	C6orf41	chr6:26924772-26991752:+	-0.13	-3.8	0.00015	Educational attainment	
BRCA	cis	1	rs12527396	chr6:159389017	RSPH3	chr6:159398268-159421198:-	0.23	4.02	6.17E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs1253107	chr14:59952947	C14orf149	chr14:59939406-59951126:-	-0.24	-3.97	7.52E-5	Schizophrenia	
BRCA	cis	1	rs1253107	chr14:59952947	JKAMP	chr14:59951161-59972080:+	0.23	4.45	9.32E-6	Schizophrenia	
BRCA	cis	1	rs12532143	chr7:111025948	IMMP2L	chr7:110303110-111202538:-	0.13	3.59	0.000348	Schizophrenia	
BRCA	cis	1	rs12540874	chr7:50664922	FIGNL1	chr7:50511834-50518088:-	0.13	4.46	8.92E-6	Systemic sclerosis	
BRCA	cis	1	rs12545109	chr8:57313906	PENK	chr8:57353513-57359282:-	-0.13	-3.56	0.000388	Obesity-related traits	
BRCA	cis	1	rs12547941	chr8:29980332	MBOAT4	chr8:29989188-30002200:-	0.25	4.94	8.96E-7	Migraine	
BRCA	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.9	9.16E-31	Body mass index	
BRCA	cis	1	rs12561806	chr1:46396776	MUTYH	chr1:45794915-45806142:-	0.13	4.93	9.66E-7	Body mass index	
BRCA	cis	1	rs12563631	chr1:156258953	BGLAP	chr1:156182784-156213112:+	0.2	5.47	5.73E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12563631	chr1:156258953	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000447	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.87	1.37E-30	Body mass index	
BRCA	cis	1	rs12564541	chr1:46380237	CCDC17	chr1:46085717-46089729:-	0.11	3.54	0.000425	Body mass index	
BRCA	cis	1	rs12564541	chr1:46380237	MUTYH	chr1:45794915-45806142:-	0.13	5.02	5.92E-7	Body mass index	
BRCA	cis	1	rs12567136	chr1:11883731	CLCN6	chr1:11866207-11907674:+	-0.25	-6.46	1.56E-10	QRS complex (12-leadsum)	
BRCA	cis	1	rs12570188	chr10:100855702	ABCC2	chr10:101542463-101611662:+	-0.28	-3.75	0.000189	Asthma (childhood onset)	
BRCA	cis	1	rs12570188	chr10:100855702	C10orf28	chr10:99894381-100004653:+	-0.33	-4.46	9.1E-6	Asthma (childhood onset)	
BRCA	cis	1	rs12570188	chr10:100855702	COX15	chr10:101468507-101492423:-	-0.48	-6.59	6.85E-11	Asthma (childhood onset)	
BRCA	cis	1	rs12570188	chr10:100855702	CUTC	chr10:101491958-101515893:+	-0.48	-7.12	1.98E-12	Asthma (childhood onset)	
BRCA	cis	1	rs12570188	chr10:100855702	ENTPD7	chr10:101419263-101471001:+	-0.23	-4.12	4.04E-5	Asthma (childhood onset)	
BRCA	cis	1	rs12570188	chr10:100855702	GOT1	chr10:101156628-101190530:-	-0.33	-4.5	7.53E-6	Asthma (childhood onset)	
BRCA	cis	1	rs12570188	chr10:100855702	SLC25A28	chr10:101370275-101418994:-	-0.37	-6.61	6.07E-11	Asthma (childhood onset)	
BRCA	cis	1	rs12571421	chr10:96541982	HELLS	chr10:96305543-96361855:+	0.12	3.38	0.000751	Migraine	
BRCA	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.38	-9.86	5.24E-22	Forced vital capacity	
BRCA	cis	1	rs12580330	chr12:82241280	PPFIA2	chr12:81652880-82153109:-	0.13	3.41	0.00068	Resting heart rate	
BRCA	cis	1	rs12583	chr3:49571462	AMT	chr3:49454212-49460012:-	-0.14	-4.6	4.71E-6	Menarche (age at onset)	
BRCA	cis	1	rs12583	chr3:49571462	CCDC36	chr3:49235861-49295537:+	-0.1	-3.86	0.000119	Menarche (age at onset)	
BRCA	cis	1	rs12583	chr3:49571462	GMPPB	chr3:49758932-49761384:-	0.12	3.57	0.000368	Menarche (age at onset)	
BRCA	cis	1	rs12583	chr3:49571462	NCKIPSD	chr3:48711280-48723334:-	-0.15	-3.76	0.00018	Menarche (age at onset)	
BRCA	cis	1	rs12583	chr3:49571462	P4HTM	chr3:49027341-49044579:+	-0.09	-3.89	0.000104	Menarche (age at onset)	
BRCA	cis	1	rs12583	chr3:49571462	WDR6	chr3:49044637-49053386:+	0.14	4.23	2.5E-5	Menarche (age at onset)	
BRCA	cis	1	rs12590407	chr14:24835115	ADCY4	chr14:24787571-24804277:-	0.09	4.49	7.94E-6	Height	
BRCA	cis	1	rs1259180	chr15:83244680	FAM154B	chr15:82555152-82577265:+	-0.13	-3.74	0.000195	Schizophrenia	
BRCA	cis	1	rs1259180	chr15:83244680	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.1	-3.68	0.000242	Schizophrenia	
BRCA	cis	1	rs12594212	chr15:76802014	SCAPER	chr15:76640529-77197744:-	-0.17	-6.01	2.49E-9	Blood metabolite levels	
BRCA	cis	1	rs12594541	chr15:76834368	SCAPER	chr15:76640529-77197744:-	-0.16	-5.69	1.64E-8	Blood metabolite levels	
BRCA	cis	1	rs12597023	chr16:50013967	TMEM188	chr16:50059189-50070998:+	0.16	3.72	0.000212	Electroencephalogram traits	
BRCA	cis	1	rs12598978	chr16:30482540	LOC595101	chr16:30278914-30346695:-	0.16	4.07	5.12E-5	Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs12605316	chr18:77693600	PQLC1	chr18:77662420-77711653:-	-0.09	-3.44	0.000605	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
BRCA	cis	1	rs12609594	chr19:9972417	OLFM2	chr19:9964395-10047070:-	-0.18	-6.22	7.13E-10	Sleep duration	
BRCA	cis	1	rs12610373	chr19:18398284	JUND	chr19:18390563-18392432:-	-0.11	-3.55	0.000395	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12610373	chr19:18398284	KIAA1683	chr19:18367906-18385319:-	-0.15	-4.59	4.98E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12611088	chr19:44072802	ZNF575	chr19:44029649-44040282:+	-0.12	-3.49	0.000509	Plasma amyloid beta peptide concentrations (ABx-42)	
BRCA	cis	1	rs12613947	chr2:70161342	ANXA4	chr2:69969127-70053594:+	-0.13	-3.83	0.000135	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs12615749	chr2:54475885	C2orf73	chr2:54558071-54588714:+	0.14	3.5	0.000477	Telomere length	
BRCA	cis	1	rs12617363	chr2:233440296	EIF4E2	chr2:233415357-233448349:+	-0.19	-4.22	2.66E-5	Height	
BRCA	cis	1	rs12617363	chr2:233440296	TIGD1	chr2:233412779-233415226:-	-0.15	-3.67	0.000256	Height	
BRCA	cis	1	rs12617717	chr2:86342303	LOC90784	chr2:86247339-86250991:-	-0.33	-4.1	4.47E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs12617717	chr2:86342303	ST3GAL5	chr2:86066271-86116157:-	0.31	4.18	3.22E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs12618262	chr2:190708073	ORMDL1	chr2:190634994-190649097:-	-0.23	-3.68	0.000248	Subcutaneous adipose tissue	
BRCA	cis	1	rs12618769	chr2:99239931	UNC50	chr2:99225042-99234975:+	0.2	4.26	2.23E-5	Bipolar disorder	
BRCA	cis	1	rs12620432	chr2:207636518	MDH1B	chr2:207598943-207630050:-	-0.21	-4.7	2.98E-6	Height	
BRCA	cis	1	rs12620810	chr2:86391481	LOC90784	chr2:86247339-86250991:-	-0.27	-3.49	0.0005	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs12620810	chr2:86391481	ST3GAL5	chr2:86066271-86116157:-	0.32	4.49	7.79E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs12621280	chr2:232132984	ARMC9	chr2:232063342-232238606:+	0.17	4.98	7.48E-7	Food antigen IgG levels	
BRCA	cis	1	rs12621280	chr2:232132984	HTR2B	chr2:231972952-231989824:-	0.18	5.95	3.69E-9	Food antigen IgG levels	
BRCA	cis	1	rs1262174	chr14:60887194	DHRS7	chr14:60611502-60636561:-	0.18	3.5	0.000481	Gut microbiota (bacterial taxa)	
BRCA	cis	1	rs12623494	chr2:99245917	UNC50	chr2:99225042-99234975:+	-0.2	-4.16	3.48E-5	Bipolar disorder	
BRCA	cis	1	rs12624	chr6:49660418	CRISP3	chr6:49695092-49712056:-	0.14	3.69	0.000238	Bone mineral density (hip) and age at menarche	
BRCA	cis	1	rs12631016	chr3:72130202	GXYLT2	chr3:72937385-73024520:+	0.1	3.39	0.000734	Venous thromboembolism (SNP x SNP interaction)	
BRCA	cis	1	rs12632274	chr3:160343281	TRIM59	chr3:160153292-160167626:-	0.13	3.98	7.49E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs12632654	chr3:122053941	LOC100129550	chr3:122605360-122611262:+	-0.24	-4.42	1.11E-5	Calcium levels	
BRCA	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.19	6.77E-37	Height	
BRCA	cis	1	rs12637751	chr3:134266124	CEP63	chr3:134204575-134293852:+	-0.14	-3.72	0.000212	Height	
BRCA	cis	1	rs12638253	chr3:156626091	LEKR1	chr3:156544076-156763918:+	-0.18	-4.83	1.59E-6	Multiple sclerosis (severity)	
BRCA	cis	1	rs12642900	chr4:107010329	TBCK	chr4:106967233-107237861:-	0.23	7.14	1.74E-12	Airflow obstruction	
BRCA	cis	1	rs12644381	chr4:103552430	MANBA	chr4:103552644-103682151:-	0.21	5.39	8.62E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs12646251	chr4:39134371	KLHL5	chr4:39046659-39123828:+	-0.14	-4.18	3.09E-5	Uric acid levels	
BRCA	cis	1	rs12646758	chr4:154731625	RNF175	chr4:154631313-154681387:-	-0.13	-3.63	0.0003	Electrocardiographic conduction measures	
BRCA	cis	1	rs12647929	chr4:1092019	CRIPAK	chr4:1385340-1389782:+	0.11	3.43	0.000618	Recombination rate (males)	
BRCA	cis	1	rs12647929	chr4:1092019	KIAA1530	chr4:1341104-1381836:+	0.11	3.58	0.00036	Recombination rate (males)	
BRCA	cis	1	rs12648383	chr4:55009315	FIP1L1	chr4:54243820-54326102:+	0.15	3.56	0.000392	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.36	8.09	1.6E-15	Crohn's disease	
BRCA	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.37	8.47	8.36E-17	Crohn's disease	
BRCA	cis	1	rs12657266	chr5:156396003	TIMD4	chr5:156346293-156390266:-	-0.37	-12.06	1.73E-31	Triglycerides;Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs12660955	chr6:33760320	IP6K3	chr6:33689443-33714762:-	0.28	4.8	1.85E-6	Obesity (extreme)	
BRCA	cis	1	rs12662447	chr6:33714673	IP6K3	chr6:33689443-33714762:-	0.24	4.17	3.29E-5	Obesity (extreme)	
BRCA	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.58	-18.37	1.04E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.56	17.67	1.77E-61	Response to antipsychotic treatment	
BRCA	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.56	17.59	5.09E-61	Response to antipsychotic treatment	
BRCA	cis	1	rs12666249	chr7:12260546	VWDE	chr7:12370509-12443852:-	-0.13	-3.44	0.000609	Response to amphetamines	
BRCA	cis	1	rs12666309	chr7:123412964	HYAL4	chr7:123485223-123517529:+	0.29	4.11	4.29E-5	Platelet count	
BRCA	cis	1	rs12666411	chr7:123406061	HYAL4	chr7:123485223-123517529:+	0.3	4.27	2.17E-5	Platelet count	
BRCA	cis	1	rs12667932	chr7:123423923	HYAL4	chr7:123485223-123517529:+	0.28	4.09	4.62E-5	Platelet count	
BRCA	cis	1	rs12668254	chr7:123436850	HYAL4	chr7:123485223-123517529:+	-0.23	-3.75	0.000184	Platelet count	
BRCA	cis	1	rs12670684	chr7:123405942	HYAL4	chr7:123485223-123517529:+	0.29	4.24	2.45E-5	Platelet count	
BRCA	cis	1	rs12671376	chr7:123407146	HYAL4	chr7:123485223-123517529:+	0.29	4.11	4.2E-5	Platelet count	
BRCA	cis	1	rs12671766	chr7:123420010	HYAL4	chr7:123485223-123517529:+	0.28	4.09	4.62E-5	Platelet count	
BRCA	cis	1	rs12672953	chr7:150539695	TMEM176A	chr7:150497854-150502208:+	-0.15	-3.42	0.000642	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs12672953	chr7:150539695	TMEM176B	chr7:150488378-150498448:-	-0.16	-3.63	0.000293	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs1267657	chr15:83215251	FAM154B	chr15:82555152-82577265:+	-0.13	-3.81	0.000146	Schizophrenia	
BRCA	cis	1	rs1267657	chr15:83215251	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.1	-3.79	0.000162	Schizophrenia	
BRCA	cis	1	rs1267817	chr7:66110040	CCT6P1	chr7:65216092-65228661:+	0.32	6.71	3.15E-11	Gout	
BRCA	cis	1	rs1267817	chr7:66110040	LOC493754	chr7:65993446-66057363:-	0.24	4.03	6.03E-5	Gout	
BRCA	cis	1	rs1267818	chr7:66107024	CCT6P1	chr7:65216092-65228661:+	0.32	6.82	1.54E-11	Gout	
BRCA	cis	1	rs1267818	chr7:66107024	LOC493754	chr7:65993446-66057363:-	0.25	4.13	3.85E-5	Gout	
BRCA	cis	1	rs1267820	chr7:66050295	CCT6P1	chr7:65216092-65228661:+	0.32	6.69	3.59E-11	Diabetic kidney disease	
BRCA	cis	1	rs1267820	chr7:66050295	LOC493754	chr7:65993446-66057363:-	0.24	4.06	5.29E-5	Diabetic kidney disease	
BRCA	cis	1	rs12691307	chr16:29939877	ALDOA	chr16:30064472-30081734:+	0.11	3.71	0.000215	Schizophrenia	
BRCA	cis	1	rs12691307	chr16:29939877	BOLA2	chr16:29454226-29466285:-;chr16	-0.12	-4.68	3.17E-6	Schizophrenia	
BRCA	cis	1	rs12691307	chr16:29939877	GDPD3	chr16:30116132-30124878:-	-0.12	-3.62	0.000307	Schizophrenia	
BRCA	cis	1	rs12691307	chr16:29939877	LOC595101	chr16:30278914-30346695:-	-0.16	-4.16	3.44E-5	Schizophrenia	
BRCA	cis	1	rs12691307	chr16:29939877	MAPK3	chr16:30125427-30134630:-	-0.12	-3.7	0.000226	Schizophrenia	
BRCA	cis	1	rs12691307	chr16:29939877	RUNDC2C	chr16:29339874-29418349:+	0.12	3.99	6.98E-5	Schizophrenia	
BRCA	cis	1	rs12692737	chr2:165554309	SLC38A11	chr2:165754812-165812035:-	0.17	5.11	3.75E-7	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
BRCA	cis	1	rs12698509	chr7:65418876	CCT6P1	chr7:65216092-65228661:+	0.32	7.24	8.88E-13	Diabetic kidney disease	
BRCA	cis	1	rs12698509	chr7:65418876	LOC493754	chr7:65993446-66057363:-	0.21	3.58	0.000357	Diabetic kidney disease	
BRCA	cis	1	rs12698509	chr7:65418876	ZNF117	chr7:64434830-64467121:-	-0.25	-4.75	2.33E-6	Diabetic kidney disease	
BRCA	cis	1	rs12699336	chr7:12283250	VWDE	chr7:12370509-12443852:-	-0.14	-3.8	0.000153	Response to amphetamines	
BRCA	cis	1	rs12701600	chr7:37998848	EPDR1	chr7:37960163-37991539:+	-0.2	-3.48	0.000527	Myopia (pathological)	
BRCA	cis	1	rs12705762	chr7:111039799	IMMP2L	chr7:110303110-111202538:-	0.14	3.69	0.000237	Schizophrenia	
BRCA	cis	1	rs12710454	chr21:40656919	HMGN1	chr21:40714247-40721270:-	-0.18	-4.66	3.53E-6	Cognitive function	
BRCA	cis	1	rs12710454	chr21:40656919	PSMG1	chr21:40547390-40555440:-	-0.2	-6.7	3.39E-11	Cognitive function	
BRCA	cis	1	rs12712530	chr2:37505561	CEBPZ	chr2:37428778-37458740:-	-0.16	-5.03	5.83E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs12712612	chr2:38907605	GALM	chr2:38893052-38961908:+	0.37	6.43	1.87E-10	5-HTT brain serotonin transporter levels	
BRCA	cis	1	rs12713419	chr2:25121853	LOC375190	chr2:24299728-24397519:+	-0.13	-3.69	0.000239	Body mass index	
BRCA	cis	1	rs12719140	chr5:111602603	FLJ11235	chr5:111755280-111756673:+	0.13	3.84	0.000131	Suicide ideation score in major depressive disorder	
BRCA	cis	1	rs12725198	chr1:16080171	SLC25A34	chr1:16062809-16067885:+	0.13	4.13	3.84E-5	Cardiac Troponin-T levels	
BRCA	cis	1	rs12727982	chr1:9150789	SLC2A5	chr1:9097007-9148510:-	-0.16	-3.5	0.000483	Response to antidepressant treatment (citalopram)	
BRCA	cis	1	rs1273153	chr14:59946459	C14orf149	chr14:59939406-59951126:-	0.27	4.83	1.56E-6	Schizophrenia	
BRCA	cis	1	rs1273153	chr14:59946459	JKAMP	chr14:59951161-59972080:+	-0.17	-3.55	0.000403	Schizophrenia	
BRCA	cis	1	rs12732455	chr1:113310684	FAM19A3	chr1:113263189-113269854:+	0.21	6.46	1.56E-10	Hyperactive-impulsive symptoms	
BRCA	cis	1	rs12732455	chr1:113310684	LRIG2	chr1:113615831-113667342:+	-0.11	-3.42	0.000644	Hyperactive-impulsive symptoms	
BRCA	cis	1	rs12733192	chr1:113310418	FAM19A3	chr1:113263189-113269854:+	0.19	6.1	1.49E-9	Hyperactive-impulsive symptoms	
BRCA	cis	1	rs12733192	chr1:113310418	LRIG2	chr1:113615831-113667342:+	-0.12	-4.09	4.71E-5	Hyperactive-impulsive symptoms	
BRCA	cis	1	rs12734068	chr1:10376803	PGD	chr1:10459085-10480200:+	0.22	6.19	8.81E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs12734551	chr1:10391536	PGD	chr1:10459085-10480200:+	0.21	6	2.71E-9	Hepatocellular carcinoma	
BRCA	cis	1	rs12739698	chr1:27230033	GPATCH3	chr1:27216980-27226962:-	0.24	3.97	7.76E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs12741472	chr1:27221609	GPATCH3	chr1:27216980-27226962:-	0.23	4.12	4.02E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs12742376	chr1:27285195	GPATCH3	chr1:27216980-27226962:-	0.22	3.92	9.59E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs12752711	chr1:27250258	GPATCH3	chr1:27216980-27226962:-	0.22	3.99	6.94E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs12754089	chr1:37965304	SNIP1	chr1:38002145-38019903:-	-0.19	-3.75	0.000184	Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs12754423	chr1:37965549	SNIP1	chr1:38002145-38019903:-	-0.19	-3.75	0.000184	Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs1275468	chr12:75935157	GLIPR1L2	chr12:75784889-75825591:+	-0.24	-7.35	4.04E-13	Polycystic ovary syndrome	
BRCA	cis	1	rs12755094	chr1:10305711	PGD	chr1:10459085-10480200:+	0.18	5.24	1.98E-7	Hepatocellular carcinoma	
BRCA	cis	1	rs12758837	chr1:113311633	FAM19A3	chr1:113263189-113269854:+	0.21	6.28	5.04E-10	Hyperactive-impulsive symptoms	
BRCA	cis	1	rs12758837	chr1:113311633	LRIG2	chr1:113615831-113667342:+	-0.11	-3.38	0.000748	Hyperactive-impulsive symptoms	
BRCA	cis	1	rs12759356	chr1:37957194	SNIP1	chr1:38002145-38019903:-	-0.2	-3.83	0.000138	Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs12760759	chr1:27158344	PIGV	chr1:27114455-27124886:+	0.22	3.74	0.000192	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs12763230	chr10:96629341	HELLS	chr10:96305543-96361855:+	0.12	3.39	0.000719	Migraine	
BRCA	cis	1	rs12767633	chr10:102056440	PKD2L1	chr10:102047903-102090243:-	-0.23	-4.25	2.28E-5	Obesity-related traits	
BRCA	cis	1	rs12774450	chr10:96401654	HELLS	chr10:96305543-96361855:+	0.13	3.78	0.000168	Migraine	
BRCA	cis	1	rs12777800	chr10:1070361	IDI2	chr10:1064847-1071799:-	-0.18	-3.46	0.000571	Response to angiotensin II receptor blocker therapy	
BRCA	cis	1	rs12781019	chr10:102057568	PKD2L1	chr10:102047903-102090243:-	0.22	4.18	3.13E-5	Obesity-related traits	
BRCA	cis	1	rs12781477	chr10:96472925	HELLS	chr10:96305543-96361855:+	0.12	3.44	0.000595	Migraine	
BRCA	cis	1	rs12787330	chr11:47812311	MADD	chr11:47290927-47351582:+	0.15	4.51	7.35E-6	Subjective well-being	
BRCA	cis	1	rs12787330	chr11:47812311	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.27	2.12E-5	Subjective well-being	
BRCA	cis	1	rs12787909	chr11:117546482	ARCN1	chr11:118443102-118473745:+	0.2	3.41	0.00067	Lipoprotein (a) - cholesterol levels	
BRCA	cis	1	rs12787909	chr11:117546482	ATP5L	chr11:118272104-118280561:+	0.28	5.66	1.93E-8	Lipoprotein (a) - cholesterol levels	
BRCA	cis	1	rs12787909	chr11:117546482	CEP164	chr11:117192432-117283980:+	0.29	4.74	2.46E-6	Lipoprotein (a) - cholesterol levels	
BRCA	cis	1	rs12787909	chr11:117546482	MLL	chr11:118307205-118397538:+	0.16	3.58	0.000358	Lipoprotein (a) - cholesterol levels	
BRCA	cis	1	rs12787909	chr11:117546482	RNF214	chr11:117103404-117156402:+	0.35	5.15	3.18E-7	Lipoprotein (a) - cholesterol levels	
BRCA	cis	1	rs12787909	chr11:117546482	TMEM25	chr11:118401803-118417313:+	0.21	4.08	4.87E-5	Lipoprotein (a) - cholesterol levels	
BRCA	cis	1	rs12787909	chr11:117546482	UBE4A	chr11:118230302-118269924:+	0.25	4.26	2.27E-5	Lipoprotein (a) - cholesterol levels	
BRCA	cis	1	rs12789252	chr11:18690389	LDHC	chr11:18433853-18472792:+	-0.2	-4.73	2.59E-6	Ovarian reserve	
BRCA	cis	1	rs12790932	chr11:28046189	METT5D1	chr11:28129798-28355054:+	-0.12	-3.47	0.000545	Bipolar disorder	
BRCA	cis	1	rs12791341	chr11:28335452	METT5D1	chr11:28129798-28355054:+	-0.13	-3.7	0.000224	Bipolar disorder	
BRCA	cis	1	rs12794284	chr11:477623	RNH1	chr11:494512-507273:-	-0.18	-4.29	1.96E-5	Body mass index	
BRCA	cis	1	rs12809125	chr12:124407991	DNAH10	chr12:124247042-124420265:+	0.25	6.43	1.87E-10	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12811607	chr12:82233619	PPFIA2	chr12:81652880-82153109:-	0.13	3.4	0.000688	Resting heart rate	
BRCA	cis	1	rs1282551	chr6:153009944	SYNE1	chr6:152442823-152958534:-	0.09	3.56	0.000394	Tonometry	
BRCA	cis	1	rs1282551	chr6:153009944	VIP	chr6:153071933-153080898:+	-0.13	-4.22	2.68E-5	Tonometry	
BRCA	cis	1	rs12827923	chr12:82242067	PPFIA2	chr12:81652880-82153109:-	0.13	3.41	0.00068	Resting heart rate	
BRCA	cis	1	rs12828040	chr12:7326541	PEX5	chr12:7341759-7371167:+	0.21	6.09	1.56E-9	IgG glycosylation	
BRCA	cis	1	rs12828421	chr12:7335217	PEX5	chr12:7341759-7371167:+	-0.22	-6.38	2.66E-10	IgG glycosylation	
BRCA	cis	1	rs12830268	chr12:82233627	PPFIA2	chr12:81652880-82153109:-	0.13	3.4	0.000688	Resting heart rate	
BRCA	cis	1	rs12866839	chr13:42152254	NAA16	chr13:41885341-41951166:+	0.15	3.61	0.000322	Multiple sclerosis	
BRCA	cis	1	rs12888114	chr14:53401261	STYX	chr14:53196883-53241703:+	0.12	3.46	0.000559	Glaucoma (primary angle closure)	
BRCA	cis	1	rs12889168	chr14:104481957	TDRD9	chr14:104394817-104519002:+	0.42	10.62	4.02E-25	Bipolar disorder	
BRCA	cis	1	rs12889472	chr14:75543979	EIF2B2	chr14:75469612-75476292:+	0.18	4.9	1.12E-6	Height	
BRCA	cis	1	rs12889472	chr14:75543979	MLH3	chr14:75480467-75518235:-	0.2	6.17	9.77E-10	Height	
BRCA	cis	1	rs12898430	chr15:76874923	SCAPER	chr15:76640529-77197744:-	-0.19	-6.75	2.4E-11	Blood metabolite levels	
BRCA	cis	1	rs12900658	chr15:51016364	AP4E1	chr15:51200946-51298097:+	-0.1	-3.86	0.00012	Alzheimer's disease (late onset)	
BRCA	cis	1	rs12900658	chr15:51016364	SPPL2A	chr15:50999739-51057910:-	-0.11	-4.07	4.95E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs1290296	chr6:153010088	SYNE1	chr6:152442823-152958534:-	0.09	3.56	0.000394	Tonometry	
BRCA	cis	1	rs1290296	chr6:153010088	VIP	chr6:153071933-153080898:+	-0.13	-4.22	2.68E-5	Tonometry	
BRCA	cis	1	rs12903474	chr15:58276747	ALDH1A2	chr15:58245628-58571462:-	-0.09	-3.4	0.000708	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	
BRCA	cis	1	rs12907055	chr15:31204294	MTMR15	chr15:31196055-31235307:+	0.15	3.58	0.000353	Hypertriglyceridemia	
BRCA	cis	1	rs12908406	chr15:102004046	ASB7	chr15:101142755-101191902:+	-0.14	-3.57	0.000367	Diabetic kidney disease	
BRCA	cis	1	rs12909095	chr15:43558142	STRC	chr15:43891762-43924561:-	0.17	4.27	2.11E-5	Lung cancer	
BRCA	cis	1	rs12909280	chr15:85429356	LOC388152	chr15:84867600-84898920:-	-0.17	-4.33	1.6E-5	Alzheimer's disease (age of onset)	
BRCA	cis	1	rs12909280	chr15:85429356	SLC28A1	chr15:85427913-85518876:+	-0.17	-4.19	2.96E-5	Alzheimer's disease (age of onset)	
BRCA	cis	1	rs12911132	chr15:43560436	STRC	chr15:43891762-43924561:-	0.17	4.14	3.77E-5	Lung cancer	
BRCA	cis	1	rs12914773	chr15:68019958	IQCH	chr15:67547188-67794139:+	0.14	5.08	4.54E-7	Motion sickness	
BRCA	cis	1	rs12914773	chr15:68019958	LBXCOR1	chr15:68117941-68126174:+	0.12	3.73	0.000201	Motion sickness	
BRCA	cis	1	rs12917429	chr15:85425097	LOC388152	chr15:84867600-84898920:-	0.16	3.94	8.6E-5	Alzheimer's disease (age of onset)	
BRCA	cis	1	rs12917429	chr15:85425097	SLC28A1	chr15:85427913-85518876:+	0.17	4.01	6.47E-5	Alzheimer's disease (age of onset)	
BRCA	cis	1	rs12948909	chr17:40570602	NAGLU	chr17:40687951-40696464:+	-0.11	-3.52	0.000446	Crohn's disease	
BRCA	cis	1	rs12971120	chr18:72174023	CNDP2	chr18:72163597-72188356:+	0.22	4.73	2.59E-6	Refractive error	
BRCA	cis	1	rs12971799	chr19:53667126	ZNF525	chr19:53868968-53889834:+	-0.13	-3.94	8.56E-5	Yu-Zhi constitution type in type 2 diabetes	
BRCA	cis	1	rs12973620	chr19:58249643	ZNF419	chr19:57999079-58006048:+	-0.16	-3.42	0.000656	Allergic rhinitis	
BRCA	cis	1	rs12973620	chr19:58249643	ZNF530	chr19:58111253-58124087:+	-0.18	-3.91	9.65E-5	Allergic rhinitis	
BRCA	cis	1	rs12980225	chr19:23026745	ZNF492	chr19:22817126-22850472:+	-0.23	-5.13	3.52E-7	Bronchopulmonary dysplasia	
BRCA	cis	1	rs12980403	chr19:18398139	JUND	chr19:18390563-18392432:-	-0.11	-3.56	0.00039	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12980403	chr19:18398139	KIAA1683	chr19:18367906-18385319:-	-0.15	-4.6	4.78E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs12982273	chr19:19830144	ZNF14	chr19:19821281-19843921:-	0.18	4.78	1.97E-6	Toenail selenium levels	
BRCA	cis	1	rs12983770	chr19:23023614	ZNF492	chr19:22817126-22850472:+	-0.23	-5.14	3.25E-7	Bronchopulmonary dysplasia	
BRCA	cis	1	rs12988385	chr2:231036311	SP110	chr2:231033645-231084827:-	0.21	3.97	7.67E-5	Obesity-related traits	
BRCA	cis	1	rs12992201	chr2:218312036	DIRC3	chr2:218148748-218621316:-	-0.2	-4.27	2.11E-5	Metabolite levels (MHPG)	
BRCA	cis	1	rs12994971	chr2:234178453	SAG	chr2:234216309-234255701:+	0.12	3.92	9.55E-5	Crohn's disease	
BRCA	cis	1	rs12994997	chr2:234173503	SAG	chr2:234216309-234255701:+	0.13	3.98	7.21E-5	Crohn's disease	
BRCA	cis	1	rs12995491	chr2:88527414	THNSL2	chr2:88469835-88486145:+	-0.37	-10.15	3.69E-23	Response to metformin (IC50)	
BRCA	cis	1	rs12995739	chr2:231037481	SP110	chr2:231033645-231084827:-	0.22	4.02	6.33E-5	Obesity-related traits	
BRCA	cis	1	rs12999430	chr2:70306785	FAM136A	chr2:70523109-70529220:-	-0.11	-3.68	0.00024	Obesity-related traits	
BRCA	cis	1	rs13000817	chr2:70273707	FAM136A	chr2:70523109-70529220:-	-0.11	-3.5	0.000484	Obesity-related traits	
BRCA	cis	1	rs13001325	chr2:102939036	IL18R1	chr2:102927962-103015215:+	0.11	4.89	1.15E-6	Serum protein levels (sST2)	
BRCA	cis	1	rs13004237	chr2:172833139	SLC25A12	chr2:172639915-172750813:-	0.13	3.6	0.000332	Schizophrenia	
BRCA	cis	1	rs13004848	chr2:127887560	BIN1	chr2:127805607-127864864:-	0.19	4.85	1.39E-6	Alzheimer's disease (late onset)	
BRCA	cis	1	rs13008738	chr2:61078921	AHSA2	chr2:61404553-61414058:+	-0.13	-5.2	2.38E-7	Inflammatory skin disease	
BRCA	cis	1	rs13008738	chr2:61078921	C2orf74	chr2:61372243-61391964:+	0.28	5.93	4.1E-9	Inflammatory skin disease	
BRCA	cis	1	rs13010998	chr2:231035729	SP110	chr2:231033645-231084827:-	0.2	3.76	0.000181	Obesity-related traits	
BRCA	cis	1	rs13014235	chr2:202215492	ALS2CR12	chr2:202153148-202222101:-	-0.2	-5.25	1.81E-7	Basal cell carcinoma	
BRCA	cis	1	rs13014235	chr2:202215492	PPIL3	chr2:201735680-201753999:-	-0.18	-4.94	9.2E-7	Basal cell carcinoma	
BRCA	cis	1	rs13015457	chr2:70125763	ANXA4	chr2:69969127-70053594:+	-0.14	-4.02	6.35E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs13015457	chr2:70125763	FAM136A	chr2:70523109-70529220:-	-0.09	-3.51	0.000459	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs13016963	chr2:202162811	ALS2CR12	chr2:202153148-202222101:-	-0.24	-6.18	9.24E-10	Melanoma;Esophageal squamous cell carcinoma	
BRCA	cis	1	rs13019081	chr2:102950822	IL18R1	chr2:102927962-103015215:+	-0.1	-4.35	1.49E-5	Serum protein levels (sST2)	
BRCA	cis	1	rs13025209	chr2:231038169	SP110	chr2:231033645-231084827:-	0.2	3.82	0.00014	Obesity-related traits	
BRCA	cis	1	rs13025520	chr2:231038029	SP110	chr2:231033645-231084827:-	0.21	3.95	8.49E-5	Obesity-related traits	
BRCA	cis	1	rs13026323	chr2:231038403	GPR55	chr2:231772034-231825691:-	-0.13	-3.43	0.000629	Obesity-related traits	
BRCA	cis	1	rs13026323	chr2:231038403	SP110	chr2:231033645-231084827:-	-0.21	-4.06	5.33E-5	Obesity-related traits	
BRCA	cis	1	rs13026621	chr2:27807624	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.12	4.06E-5	Oral cavity cancer	
BRCA	cis	1	rs13028508	chr2:70118427	ANXA4	chr2:69969127-70053594:+	0.14	4.03	6.03E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs13037594	chr20:55040168	C20orf43	chr20:55043647-55093942:+	0.16	4.32	1.72E-5	Refractive astigmatism	
BRCA	cis	1	rs13037759	chr20:43370692	KCNK15	chr20:43374488-43379666:+	0.13	4.51	7.33E-6	Obesity-related traits	
BRCA	cis	1	rs13038016	chr20:43370497	KCNK15	chr20:43374488-43379666:+	0.13	4.51	7.33E-6	Obesity-related traits	
BRCA	cis	1	rs13038305	chr20:23610262	CST1	chr20:23728191-23731574:-	0.21	4.62	4.34E-6	Chronic kidney disease	
BRCA	cis	1	rs13038834	chr20:25441433	FAM182A	chr20:26035250-26067552:+	-0.25	-6.43	1.93E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs13038834	chr20:25441433	FAM182B	chr20:25744102-25848786:-	0.23	5.78	9.94E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs13038834	chr20:25441433	PYGB	chr20:25228706-25278647:+	-0.13	-3.38	0.000738	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs13039536	chr20:23612305	CST1	chr20:23728191-23731574:-	0.22	4.69	3.07E-6	Chronic kidney disease	
BRCA	cis	1	rs13041070	chr20:23614261	CST1	chr20:23728191-23731574:-	0.23	4.81	1.7E-6	Chronic kidney disease	
BRCA	cis	1	rs13041953	chr20:55081353	C20orf43	chr20:55043647-55093942:+	0.18	4.88	1.22E-6	Refractive astigmatism	
BRCA	cis	1	rs13043526	chr20:55088798	C20orf43	chr20:55043647-55093942:+	0.16	4.54	6.38E-6	Refractive astigmatism	
BRCA	cis	1	rs13053175	chr22:37613309	ANKRD54	chr22:38226863-38240303:-	0.11	3.49	0.000506	Longevity	
BRCA	cis	1	rs13053175	chr22:37613309	NOL12	chr22:38082344-38089484:+	0.09	3.5	0.000489	Longevity	
BRCA	cis	1	rs13053175	chr22:37613309	PICK1	chr22:38453262-38471707:+	0.1	3.62	0.000306	Longevity	
BRCA	cis	1	rs13053175	chr22:37613309	TXN2	chr22:36863093-36877687:-	0.1	3.42	0.000657	Longevity	
BRCA	cis	1	rs13054985	chr22:23458577	RTDR1	chr22:23401594-23484241:-	-0.17	-4.43	1.04E-5	Bone mineral density	
BRCA	cis	1	rs13058817	chr3:53024139	NT5DC2	chr3:52558386-52569093:-	-0.18	-3.8	0.000154	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs13058817	chr3:53024139	RFT1	chr3:53122503-53164470:-	0.31	4.38	1.33E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs13058817	chr3:53024139	TMEM110	chr3:52867139-52931547:-	0.31	4.87	1.3E-6	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.31	1.63E-37	Height	
BRCA	cis	1	rs13059720	chr3:134242021	CEP63	chr3:134204575-134293852:+	-0.14	-3.78	0.000166	Height	
BRCA	cis	1	rs13065269	chr3:160352319	TRIM59	chr3:160153292-160167626:-	0.13	3.91	9.83E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs13067306	chr3:94243713	DHFRL1	chr3:93776770-93782067:-	-0.16	-3.71	0.000221	Blood pressure measurement (high sodium intervention)	
BRCA	cis	1	rs13069054	chr3:127855982	RUVBL1	chr3:127783627-127872757:-	0.14	3.39	0.000724	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.27	-10.14	3.92E-23	Longevity	
BRCA	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.4	-12.92	1.35E-35	Height	
BRCA	cis	1	rs13071551	chr3:134310867	CEP63	chr3:134204575-134293852:+	-0.13	-3.57	0.00038	Height	
BRCA	cis	1	rs13072395	chr3:52980573	NT5DC2	chr3:52558386-52569093:-	-0.17	-3.42	0.000644	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs13072395	chr3:52980573	RFT1	chr3:53122503-53164470:-	0.33	4.53	6.47E-6	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs13072395	chr3:52980573	TMEM110	chr3:52867139-52931547:-	0.33	5	6.85E-7	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs13072809	chr3:38468171	LOC100128640	chr3:38492524-38496311:-	0.13	3.49	0.000509	Electrocardiographic conduction measures	
BRCA	cis	1	rs13072809	chr3:38468171	XYLB	chr3:38388251-38456467:+	0.2	5.96	3.41E-9	Electrocardiographic conduction measures	
BRCA	cis	1	rs13074025	chr3:38455704	LOC100128640	chr3:38492524-38496311:-	0.13	3.5	0.000485	Electrocardiographic conduction measures	
BRCA	cis	1	rs13074025	chr3:38455704	XYLB	chr3:38388251-38456467:+	0.21	6.11	1.37E-9	Electrocardiographic conduction measures	
BRCA	cis	1	rs13074160	chr3:38455650	LOC100128640	chr3:38492524-38496311:-	0.13	3.5	0.000485	Electrocardiographic conduction measures	
BRCA	cis	1	rs13074160	chr3:38455650	XYLB	chr3:38388251-38456467:+	0.21	6.11	1.37E-9	Electrocardiographic conduction measures	
BRCA	cis	1	rs13074231	chr3:160355428	TRIM59	chr3:160153292-160167626:-	0.13	4.04	5.65E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs13075270	chr3:46253789	CCR5	chr3:46411633-46417690:+	-0.07	-3.7	0.000231	Celiac disease	
BRCA	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.26	-10.02	1.15E-22	Longevity	
BRCA	cis	1	rs1307667	chr2:233419972	EIF4E2	chr2:233415357-233448349:+	-0.17	-3.96	7.93E-5	Height	
BRCA	cis	1	rs1307667	chr2:233419972	TIGD1	chr2:233412779-233415226:-	-0.14	-3.56	0.000381	Height	
BRCA	cis	1	rs13079757	chr3:38491444	XYLB	chr3:38388251-38456467:+	0.19	5.45	6.36E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.4	-13.04	3.4E-36	Height	
BRCA	cis	1	rs13081177	chr3:134289860	CEP63	chr3:134204575-134293852:+	-0.14	-3.68	0.000243	Height	
BRCA	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.26	2.87E-37	Height	
BRCA	cis	1	rs13081688	chr3:134259954	CEP63	chr3:134204575-134293852:+	-0.14	-3.8	0.000155	Height	
BRCA	cis	1	rs13083794	chr3:121464928	IQCB1	chr3:121488610-121553926:-	0.27	7.08	2.54E-12	Cognitive performance	
BRCA	cis	1	rs13083794	chr3:121464928	SLC15A2	chr3:121613171-121663034:+	-0.13	-3.86	0.00012	Cognitive performance	
BRCA	cis	1	rs13085791	chr3:49721798	AMT	chr3:49454212-49460012:-	0.1	3.38	0.000764	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs13085791	chr3:49721798	GMPPB	chr3:49758932-49761384:-	-0.13	-3.9	0.000101	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs13087299	chr3:94229344	DHFRL1	chr3:93776770-93782067:-	-0.18	-4.16	3.39E-5	Blood pressure measurement (high sodium intervention)	
BRCA	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.28	7.14	1.76E-12	Cognitive performance	
BRCA	cis	1	rs13087578	chr3:121369207	SLC15A2	chr3:121613171-121663034:+	-0.14	-3.91	9.79E-5	Cognitive performance	
BRCA	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.2	5.95E-37	Height	
BRCA	cis	1	rs13087875	chr3:134261123	CEP63	chr3:134204575-134293852:+	-0.14	-3.72	0.000208	Height	
BRCA	cis	1	rs13088281	chr3:53147576	TMEM110	chr3:52867139-52931547:-	-0.27	-4.62	4.29E-6	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs13088309	chr3:49368317	AMT	chr3:49454212-49460012:-	0.14	4.75	2.3E-6	Menarche (age at onset)	
BRCA	cis	1	rs13088309	chr3:49368317	CCDC36	chr3:49235861-49295537:+	0.1	3.87	0.000117	Menarche (age at onset)	
BRCA	cis	1	rs13088309	chr3:49368317	NCKIPSD	chr3:48711280-48723334:-	0.16	3.96	8.06E-5	Menarche (age at onset)	
BRCA	cis	1	rs13088309	chr3:49368317	P4HTM	chr3:49027341-49044579:+	0.11	4.54	6.25E-6	Menarche (age at onset)	
BRCA	cis	1	rs13088309	chr3:49368317	TREX1	chr3:48501186-48509043:+	-0.11	-3.62	0.000312	Menarche (age at onset)	
BRCA	cis	1	rs13088309	chr3:49368317	WDR6	chr3:49044637-49053386:+	-0.14	-4.04	5.79E-5	Menarche (age at onset)	
BRCA	cis	1	rs13088455	chr3:53087482	ITIH4	chr3:52847007-52866554:-	0.11	3.85	0.000125	Ulcerative colitis	
BRCA	cis	1	rs13089394	chr3:38446309	LOC100128640	chr3:38492524-38496311:-	0.13	3.56	0.000382	Electrocardiographic conduction measures	
BRCA	cis	1	rs13089394	chr3:38446309	XYLB	chr3:38388251-38456467:+	0.21	6.02	2.41E-9	Electrocardiographic conduction measures	
BRCA	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.19	6.77E-37	Height	
BRCA	cis	1	rs13089966	chr3:134279197	CEP63	chr3:134204575-134293852:+	-0.14	-3.72	0.000212	Height	
BRCA	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.4	-12.86	2.65E-35	Height	
BRCA	cis	1	rs13090969	chr3:134307257	CEP63	chr3:134204575-134293852:+	-0.13	-3.58	0.000362	Height	
BRCA	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.29	-11.03	7.38E-27	Longevity	
BRCA	cis	1	rs13092160	chr3:46254791	LARS2	chr3:45430075-45590328:+	-0.2	-3.75	0.000187	Celiac disease	
BRCA	cis	1	rs13092160	chr3:46254791	SACM1L	chr3:45730754-45786900:+	-0.17	-3.88	0.000109	Celiac disease	
BRCA	cis	1	rs13095946	chr3:46253812	CCR5	chr3:46411633-46417690:+	-0.11	-4.37	1.38E-5	Celiac disease	
BRCA	cis	1	rs13096474	chr3:49443081	AMT	chr3:49454212-49460012:-	-0.14	-4.9	1.11E-6	Menarche (age at onset)	
BRCA	cis	1	rs13096474	chr3:49443081	CCDC36	chr3:49235861-49295537:+	-0.1	-3.66	0.000267	Menarche (age at onset)	
BRCA	cis	1	rs13096474	chr3:49443081	NCKIPSD	chr3:48711280-48723334:-	-0.18	-4.51	7.21E-6	Menarche (age at onset)	
BRCA	cis	1	rs13096474	chr3:49443081	P4HTM	chr3:49027341-49044579:+	-0.09	-3.69	0.000232	Menarche (age at onset)	
BRCA	cis	1	rs13096474	chr3:49443081	WDR6	chr3:49044637-49053386:+	0.14	4.28	2.07E-5	Menarche (age at onset)	
BRCA	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.25	3.28E-37	Height	
BRCA	cis	1	rs13096604	chr3:134250099	CEP63	chr3:134204575-134293852:+	-0.14	-3.79	0.000158	Height	
BRCA	cis	1	rs13099	chr14:75599155	EIF2B2	chr14:75469612-75476292:+	-0.18	-5.1	4.12E-7	Height	
BRCA	cis	1	rs13099	chr14:75599155	MLH3	chr14:75480467-75518235:-	-0.22	-6.88	1.03E-11	Height	
BRCA	cis	1	rs13104111	chr4:17935045	NCAPG	chr4:17812525-17846485:+	0.11	4.47	8.8E-6	Height	
BRCA	cis	1	rs13105471	chr4:17959776	NCAPG	chr4:17812525-17846485:+	0.09	4.18	3.1E-5	Height	
BRCA	cis	1	rs13109200	chr4:39126016	KLHL5	chr4:39046659-39123828:+	-0.14	-4.45	9.49E-6	Uric acid levels	
BRCA	cis	1	rs13110633	chr4:48470296	SLC10A4	chr4:48485360-48491541:+	-0.16	-3.57	0.000371	Schizophrenia	
BRCA	cis	1	rs13112545	chr4:18020822	NCAPG	chr4:17812525-17846485:+	0.08	3.53	0.000429	Height	
BRCA	cis	1	rs13112557	chr4:103552253	MANBA	chr4:103552644-103682151:-	0.21	5.47	5.53E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs13116230	chr4:18004014	NCAPG	chr4:17812525-17846485:+	0.08	3.68	0.000242	Height	
BRCA	cis	1	rs13118159	chr4:1365127	ATP5I	chr4:666226-668122:-	0.1	3.54	0.000412	Longevity	
BRCA	cis	1	rs13118159	chr4:1365127	CRIPAK	chr4:1385340-1389782:+	0.23	7.39	2.93E-13	Longevity	
BRCA	cis	1	rs13118159	chr4:1365127	GAK	chr4:843066-926174:-	0.1	3.52	0.000447	Longevity	
BRCA	cis	1	rs13118159	chr4:1365127	KIAA1530	chr4:1341104-1381836:+	0.14	5	6.82E-7	Longevity	
BRCA	cis	1	rs13118159	chr4:1365127	TMEM175	chr4:926262-952441:+	0.09	3.47	0.000543	Longevity	
BRCA	cis	1	rs13120847	chr4:48030036	CNGA1	chr4:47937996-48018610:-	0.22	7.6	6.43E-14	Renal underexcretion gout;Gout	
BRCA	cis	1	rs13120847	chr4:48030036	NIPAL1	chr4:48018791-48039078:+	0.11	3.67	0.000255	Renal underexcretion gout;Gout	
BRCA	cis	1	rs13123545	chr4:76535466	G3BP2	chr4:76567955-76598667:-	-0.12	-3.99	7.08E-5	Magnesium levels	
BRCA	cis	1	rs13123703	chr4:18029165	NCAPG	chr4:17812525-17846485:+	0.11	4.45	9.64E-6	Height	
BRCA	cis	1	rs13125804	chr4:17998043	NCAPG	chr4:17812525-17846485:+	0.1	4.17	3.29E-5	Height	
BRCA	cis	1	rs13125949	chr4:48026560	CNGA1	chr4:47937996-48018610:-	0.22	7.55	9.55E-14	Renal underexcretion gout;Gout	
BRCA	cis	1	rs13125949	chr4:48026560	NIPAL1	chr4:48018791-48039078:+	0.1	3.47	0.000532	Renal underexcretion gout;Gout	
BRCA	cis	1	rs13127416	chr4:17976779	NCAPG	chr4:17812525-17846485:+	0.1	4.42	1.08E-5	Height	
BRCA	cis	1	rs13131948	chr4:55012652	FIP1L1	chr4:54243820-54326102:+	-0.19	-4.18	3.2E-5	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs13132994	chr4:17990181	NCAPG	chr4:17812525-17846485:+	0.1	4.48	8.33E-6	Height	
BRCA	cis	1	rs13133311	chr4:88217223	HSD17B11	chr4:88257691-88312455:-	0.11	3.93	9.19E-5	Platelet count	
BRCA	cis	1	rs13133638	chr4:55007426	FIP1L1	chr4:54243820-54326102:+	-0.16	-3.46	0.000566	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs13134489	chr4:165889437	TRIM61	chr4:165875600-165898818:-	0.25	7.85	9.85E-15	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs13134680	chr4:54527026	LNX1	chr4:54326439-54518682:-	0.13	3.6	0.000336	Beard thickness	
BRCA	cis	1	rs13136090	chr4:76534792	G3BP2	chr4:76567955-76598667:-	-0.12	-4.04	5.73E-5	Magnesium levels	
BRCA	cis	1	rs13140968	chr4:48025095	CNGA1	chr4:47937996-48018610:-	0.23	7.8	1.46E-14	Renal underexcretion gout;Gout	
BRCA	cis	1	rs13140968	chr4:48025095	NIPAL1	chr4:48018791-48039078:+	0.11	3.62	0.000305	Renal underexcretion gout;Gout	
BRCA	cis	1	rs13142655	chr4:88195494	HSD17B11	chr4:88257691-88312455:-	0.13	4.85	1.44E-6	Platelet count	
BRCA	cis	1	rs13142905	chr4:48025298	CNGA1	chr4:47937996-48018610:-	0.22	7.53	1.04E-13	Renal underexcretion gout;Gout	
BRCA	cis	1	rs13142905	chr4:48025298	NIPAL1	chr4:48018791-48039078:+	0.1	3.47	0.000536	Renal underexcretion gout;Gout	
BRCA	cis	1	rs13144223	chr4:17872707	NCAPG	chr4:17812525-17846485:+	0.11	4.22	2.66E-5	Height	
BRCA	cis	1	rs13144374	chr4:39130479	KLHL5	chr4:39046659-39123828:+	-0.14	-4.45	9.49E-6	Uric acid levels	
BRCA	cis	1	rs13144742	chr4:17974181	NCAPG	chr4:17812525-17846485:+	0.1	4.48	8.1E-6	Height	
BRCA	cis	1	rs13146880	chr4:48031499	CNGA1	chr4:47937996-48018610:-	0.21	7.11	2.19E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs13148062	chr4:55005973	FIP1L1	chr4:54243820-54326102:+	-0.16	-3.47	0.000551	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs13148900	chr4:71361114	AMTN	chr4:71384298-71398459:+	-0.25	-7.24	8.74E-13	Alcoholism (heaviness of drinking)	
BRCA	cis	1	rs13151390	chr4:68422349	STAP1	chr4:68424446-68473053:+	-0.18	-5.91	4.62E-9	Parkinson's disease	
BRCA	cis	1	rs13151431	chr4:17959581	NCAPG	chr4:17812525-17846485:+	0.09	4.18	3.1E-5	Height	
BRCA	cis	1	rs13151620	chr4:17991679	NCAPG	chr4:17812525-17846485:+	0.12	4.69	3.06E-6	Height	
BRCA	cis	1	rs13152352	chr4:17976846	NCAPG	chr4:17812525-17846485:+	0.1	4.42	1.08E-5	Height	
BRCA	cis	1	rs13153099	chr5:156436195	TIMD4	chr5:156346293-156390266:-	-0.16	-4.16	3.39E-5	Hypertriglyceridemia	
BRCA	cis	1	rs13167641	chr5:41232291	C7	chr5:40909599-40983039:+	-0.11	-4.63	4.13E-6	Response to fenofibrate (adiponectin levels)	
BRCA	cis	1	rs1316829	chr1:25051225	CLIC4	chr1:25071760-25170815:+	-0.09	-3.66	0.000267	Height	
BRCA	cis	1	rs13168670	chr5:140146899	HARS2	chr5:140071018-140078889:+	-0.13	-3.56	0.000386	Schizophrenia	
BRCA	cis	1	rs13168670	chr5:140146899	PCDHA10	chr5:140235634-140391929:+	-0.14	-3.65	0.000272	Schizophrenia	
BRCA	cis	1	rs13168670	chr5:140146899	WDR55	chr5:140044384-140050551:+	-0.18	-5.01	6.26E-7	Schizophrenia	
BRCA	cis	1	rs13168670	chr5:140146899	ZMAT2	chr5:140080032-140086239:+	-0.17	-5.05	5.17E-7	Schizophrenia	
BRCA	cis	1	rs13169155	chr5:156426663	TIMD4	chr5:156346293-156390266:-	-0.15	-4.06	5.25E-5	Hypertriglyceridemia	
BRCA	cis	1	rs13169465	chr5:156426916	TIMD4	chr5:156346293-156390266:-	-0.15	-3.89	0.000109	Hypertriglyceridemia	
BRCA	cis	1	rs13169621	chr5:156426974	TIMD4	chr5:156346293-156390266:-	-0.16	-4.16	3.37E-5	Hypertriglyceridemia	
BRCA	cis	1	rs1317149	chr11:47486885	ACP2	chr11:47260854-47270457:-	0.13	3.42	0.00065	Subjective well-being	
BRCA	cis	1	rs1317149	chr11:47486885	MADD	chr11:47290927-47351582:+	0.14	4.3	1.87E-5	Subjective well-being	
BRCA	cis	1	rs1317149	chr11:47486885	MYBPC3	chr11:47352958-47374253:-	-0.15	-4.38	1.31E-5	Subjective well-being	
BRCA	cis	1	rs131801	chr22:50966634	SCO2	chr22:50961999-50964034:-	-0.19	-7.22	1.02E-12	Mean corpuscular hemoglobin	
BRCA	cis	1	rs13181803	chr5:156429177	TIMD4	chr5:156346293-156390266:-	-0.16	-4.21	2.74E-5	Hypertriglyceridemia	
BRCA	cis	1	rs13182402	chr5:125918148	ALDH7A1	chr5:125878918-125931082:-	-0.19	-3.65	0.00028	Osteoporosis	
BRCA	cis	1	rs13182402	chr5:125918148	PHAX	chr5:125936633-125961080:+	-0.14	-3.56	0.000383	Osteoporosis	
BRCA	cis	1	rs13182	chr4:39122913	KLHL5	chr4:39046659-39123828:+	-0.15	-4.65	3.8E-6	Uric acid levels	
BRCA	cis	1	rs13190742	chr6:163008758	PACRG	chr6:163148164-163736523:+	0.23	4.37	1.36E-5	Body mass index	
BRCA	cis	1	rs13191362	chr6:163033350	PACRG	chr6:163148164-163736523:+	0.23	4.09	4.64E-5	Body mass index	
BRCA	cis	1	rs13193282	chr6:163015442	PACRG	chr6:163148164-163736523:+	0.24	4.59	5.02E-6	Body mass index	
BRCA	cis	1	rs13193931	chr6:148940808	UST	chr6:149068271-149398125:+	0.35	6.32	3.93E-10	Migraine	
BRCA	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.59	-18.56	7.27E-67	Response to antipsychotic treatment	
BRCA	cis	1	rs13195226	chr6:163006421	PACRG	chr6:163148164-163736523:+	0.2	3.93	8.9E-5	Body mass index	
BRCA	cis	1	rs13195401	chr6:26463574	BTN3A2	chr6:26365398-26378546:+	-0.84	-14.25	2.51E-42	Schizophrenia	
BRCA	cis	1	rs13195401	chr6:26463574	ZNF391	chr6:27356524-27369227:+	0.24	3.49	0.000497	Schizophrenia	
BRCA	cis	1	rs13195402	chr6:26463575	BTN3A2	chr6:26365398-26378546:+	-0.84	-14.25	2.51E-42	Schizophrenia	
BRCA	cis	1	rs13195402	chr6:26463575	ZNF391	chr6:27356524-27369227:+	0.24	3.49	0.000497	Schizophrenia	
BRCA	cis	1	rs13196614	chr6:148923789	UST	chr6:149068271-149398125:+	-0.26	-5.12	3.59E-7	Migraine	
BRCA	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.61	-18.45	3.39E-66	Response to antipsychotic treatment	
BRCA	cis	1	rs13197062	chr6:148938030	UST	chr6:149068271-149398125:+	0.35	6.36	3.04E-10	Migraine	
BRCA	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.58	-19.32	1.53E-71	Response to antipsychotic treatment	
BRCA	cis	1	rs13199223	chr6:163001083	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.06E-6	Body mass index	
BRCA	cis	1	rs1319987	chr6:118782236	C6orf204	chr6:118786239-119031238:-	-0.11	-3.47	0.000543	Renal cell carcinoma	
BRCA	cis	1	rs1319988	chr6:118782379	C6orf204	chr6:118786239-119031238:-	-0.11	-3.47	0.000543	Renal cell carcinoma	
BRCA	cis	1	rs13200063	chr6:33730171	IP6K3	chr6:33689443-33714762:-	0.27	4.61	4.51E-6	Obesity (extreme)	
BRCA	cis	1	rs13200329	chr6:163004418	PACRG	chr6:163148164-163736523:+	0.21	4.14	3.82E-5	Body mass index	
BRCA	cis	1	rs13200462	chr6:28218199	HIST1H4J	chr6:27791903-27792257:+	-0.19	-3.58	0.000358	Depression	
BRCA	cis	1	rs13200462	chr6:28218199	ZNF389	chr6:28129551-28137375:+	-0.2	-3.48	0.000531	Depression	
BRCA	cis	1	rs13200462	chr6:28218199	ZSCAN23	chr6:28393287-28411279:-	0.17	3.56	0.000387	Depression	
BRCA	cis	1	rs13201023	chr6:162981381	PACRG	chr6:163148164-163736523:+	0.25	4.6	4.73E-6	Body mass index	
BRCA	cis	1	rs13201083	chr6:89918597	GABRR1	chr6:89887223-89927496:-	0.17	3.44	0.000595	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs13202339	chr6:163081812	PACRG	chr6:163148164-163736523:+	0.26	4.59	5.06E-6	Body mass index	
BRCA	cis	1	rs13204013	chr6:163002480	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.06E-6	Body mass index	
BRCA	cis	1	rs13204439	chr6:163015358	PACRG	chr6:163148164-163736523:+	-0.21	-4.16	3.41E-5	Body mass index	
BRCA	cis	1	rs13207239	chr6:163008772	PACRG	chr6:163148164-163736523:+	0.23	4.39	1.24E-5	Body mass index	
BRCA	cis	1	rs13207671	chr6:162979056	PACRG	chr6:163148164-163736523:+	0.25	4.56	5.64E-6	Body mass index	
BRCA	cis	1	rs1320893	chr7:143752112	ARHGEF35	chr7:143883677-143892736:-	-0.38	-9.62	4.55E-21	Obesity-related traits	
BRCA	cis	1	rs1320893	chr7:143752112	OR2A7	chr7:143955790-143974852:-	0.21	5.19	2.54E-7	Obesity-related traits	
BRCA	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.21	2.09E-23	Obesity-related traits	
BRCA	cis	1	rs1320894	chr7:143751802	OR2A7	chr7:143955790-143974852:-	0.19	4.58	5.22E-6	Obesity-related traits	
BRCA	cis	1	rs1320894	chr7:143751802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.13	-3.41	0.000681	Obesity-related traits	
BRCA	cis	1	rs13209728	chr6:162997533	PACRG	chr6:163148164-163736523:+	0.22	4.35	1.52E-5	Body mass index	
BRCA	cis	1	rs1320996	chr6:56100431	COL21A1	chr6:55921389-56258892:-	0.68	21.44	4.49E-85	Pulse pressure	
BRCA	cis	1	rs13210412	chr6:163019478	PACRG	chr6:163148164-163736523:+	0.22	4.33	1.62E-5	Body mass index	
BRCA	cis	1	rs13210756	chr6:163009030	PACRG	chr6:163148164-163736523:+	0.2	4.02	6.15E-5	Body mass index	
BRCA	cis	1	rs1321252	chr6:25616232	SCGN	chr6:25652429-25702006:+	0.19	5.19	2.55E-7	Uric acid levels	
BRCA	cis	1	rs13212608	chr6:163032128	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.01E-6	Body mass index	
BRCA	cis	1	rs13213285	chr6:88329942	C6orf162	chr6:88032306-88052043:+	-0.24	-3.54	0.000424	Obesity-related traits	
BRCA	cis	1	rs13213285	chr6:88329942	ZNF292	chr6:87862551-87973404:+	-0.18	-3.54	0.000415	Obesity-related traits	
BRCA	cis	1	rs13213408	chr6:162998049	PACRG	chr6:163148164-163736523:+	0.24	4.58	5.31E-6	Body mass index	
BRCA	cis	1	rs13213522	chr6:111705341	KIAA1919	chr6:111580482-111590259:+	0.32	4.52	6.96E-6	Psoriasis	
BRCA	cis	1	rs1321366	chr6:117240593	FAM162B	chr6:117073360-117086886:-	-0.09	-3.46	0.000554	Prostate cancer	
BRCA	cis	1	rs1321371	chr6:117235656	FAM162B	chr6:117073360-117086886:-	-0.1	-3.48	0.000525	Prostate cancer	
BRCA	cis	1	rs1321372	chr6:117237524	FAM162B	chr6:117073360-117086886:-	-0.09	-3.45	0.000577	Prostate cancer	
BRCA	cis	1	rs13214516	chr6:163121583	PACRG	chr6:163148164-163736523:+	0.24	4.15	3.57E-5	Body mass index	
BRCA	cis	1	rs1321479	chr6:26501897	BTN2A3	chr6:26422317-26431927:+	-0.15	-5.04	5.37E-7	Educational attainment	
BRCA	cis	1	rs1321479	chr6:26501897	C6orf41	chr6:26924772-26991752:+	0.12	3.73	0.000199	Educational attainment	
BRCA	cis	1	rs1321479	chr6:26501897	ZNF322A	chr6:26634612-26659963:-	0.11	4.18	3.09E-5	Educational attainment	
BRCA	cis	1	rs1321480	chr6:26532742	BTN2A3	chr6:26422317-26431927:+	0.16	5.48	5.33E-8	Educational attainment	
BRCA	cis	1	rs1321480	chr6:26532742	C6orf41	chr6:26924772-26991752:+	-0.12	-3.63	0.000299	Educational attainment	
BRCA	cis	1	rs1321480	chr6:26532742	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.43	0.000629	Educational attainment	
BRCA	cis	1	rs1321481	chr6:26538210	BTN2A3	chr6:26422317-26431927:+	0.16	5.48	5.38E-8	Educational attainment	
BRCA	cis	1	rs1321481	chr6:26538210	C6orf41	chr6:26924772-26991752:+	-0.12	-3.75	0.00019	Educational attainment	
BRCA	cis	1	rs1321481	chr6:26538210	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.72	0.000207	Educational attainment	
BRCA	cis	1	rs13215017	chr6:89918264	GABRR1	chr6:89887223-89927496:-	0.17	3.44	0.000595	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs13215491	chr6:163010325	PACRG	chr6:163148164-163736523:+	0.23	4.37	1.36E-5	Body mass index	
BRCA	cis	1	rs13215566	chr6:89918638	MDN1	chr6:90353231-90529442:-	0.1	3.46	0.000564	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.6	-18.92	4.69E-69	Response to antipsychotic treatment	
BRCA	cis	1	rs1321798	chr6:117731192	ROS1	chr6:117609530-117747018:-	-0.14	-4.85	1.45E-6	Lung cancer	
BRCA	cis	1	rs1321799	chr6:117731177	ROS1	chr6:117609530-117747018:-	0.14	4.5	7.4E-6	Lung cancer	
BRCA	cis	1	rs13218281	chr6:134193714	TCF21	chr6:134210259-134219157:+	0.16	4.13	3.92E-5	Coronary heart disease	
BRCA	cis	1	rs13218900	chr6:163081638	PACRG	chr6:163148164-163736523:+	0.26	4.58	5.14E-6	Body mass index	
BRCA	cis	1	rs13220048	chr6:163004325	PACRG	chr6:163148164-163736523:+	0.24	4.45	9.5E-6	Body mass index	
BRCA	cis	1	rs13220181	chr6:163004401	PACRG	chr6:163148164-163736523:+	0.21	4.14	3.82E-5	Body mass index	
BRCA	cis	1	rs13220495	chr6:26441640	BTN3A2	chr6:26365398-26378546:+	-0.83	-14.1	1.67E-41	Schizophrenia	
BRCA	cis	1	rs13220495	chr6:26441640	ZNF391	chr6:27356524-27369227:+	0.24	3.58	0.000361	Schizophrenia	
BRCA	cis	1	rs13220510	chr6:56779141	BEND6	chr6:56819773-56892138:+	-0.33	-8.92	2.04E-18	Menarche (age at onset)	
BRCA	cis	1	rs13220510	chr6:56779141	KIAA1586	chr6:56911384-56920021:+	-0.18	-3.66	0.000265	Menarche (age at onset)	
BRCA	cis	1	rs13220979	chr7:65363204	CCT6P1	chr7:65216092-65228661:+	0.31	6.88	1.01E-11	Diabetic kidney disease	
BRCA	cis	1	rs13220979	chr7:65363204	LOC493754	chr7:65993446-66057363:-	0.21	3.51	0.000474	Diabetic kidney disease	
BRCA	cis	1	rs13220979	chr7:65363204	ZNF117	chr7:64434830-64467121:-	-0.27	-4.9	1.11E-6	Diabetic kidney disease	
BRCA	cis	1	rs1322179	chr10:96575242	HELLS	chr10:96305543-96361855:+	0.12	3.38	0.000739	Migraine	
BRCA	cis	1	rs1322512	chr6:152947953	VIP	chr6:153071933-153080898:+	0.12	4.04	5.66E-5	Tonometry	
BRCA	cis	1	rs13226728	chr7:143746578	ARHGEF35	chr7:143883677-143892736:-	-0.4	-10.1	5.67E-23	Obesity-related traits	
BRCA	cis	1	rs13226728	chr7:143746578	OR2A7	chr7:143955790-143974852:-	0.2	4.67	3.41E-6	Obesity-related traits	
BRCA	cis	1	rs13235972	chr7:65883605	CCT6P1	chr7:65216092-65228661:+	0.31	6.53	1.02E-10	Diabetic kidney disease	
BRCA	cis	1	rs13235972	chr7:65883605	CRCP	chr7:65579805-65619551:+	-0.21	-3.51	0.00046	Diabetic kidney disease	
BRCA	cis	1	rs13235972	chr7:65883605	LOC493754	chr7:65993446-66057363:-	0.22	3.7	0.000228	Diabetic kidney disease	
BRCA	cis	1	rs13237037	chr7:65997882	CCT6P1	chr7:65216092-65228661:+	0.31	6.67	4.12E-11	Diabetic kidney disease	
BRCA	cis	1	rs13237037	chr7:65997882	LOC493754	chr7:65993446-66057363:-	0.24	4.06	5.38E-5	Diabetic kidney disease	
BRCA	cis	1	rs13238274	chr7:29180335	CPVL	chr7:29035249-29234892:-	-0.16	-4.79	1.9E-6	Diabetes related insulin traits	
BRCA	cis	1	rs13239254	chr7:110917686	IMMP2L	chr7:110303110-111202538:-	0.16	4.29	1.95E-5	Schizophrenia	
BRCA	cis	1	rs13239306	chr7:66136017	TYW1	chr7:66461817-66704496:+	-0.16	-4.29	1.98E-5	Aortic root size	
BRCA	cis	1	rs13240464	chr7:110898915	IMMP2L	chr7:110303110-111202538:-	0.15	4.04	5.79E-5	Schizophrenia	
BRCA	cis	1	rs13243677	chr7:143746572	ARHGEF35	chr7:143883677-143892736:-	-0.4	-9.98	1.72E-22	Obesity-related traits	
BRCA	cis	1	rs13243677	chr7:143746572	OR2A7	chr7:143955790-143974852:-	0.2	4.8	1.8E-6	Obesity-related traits	
BRCA	cis	1	rs13245225	chr7:29181626	CPVL	chr7:29035249-29234892:-	-0.17	-5.04	5.51E-7	Diabetes related insulin traits	
BRCA	cis	1	rs13247184	chr7:65358928	CCT6P1	chr7:65216092-65228661:+	0.33	7.02	3.88E-12	Diabetic kidney disease	
BRCA	cis	1	rs13247184	chr7:65358928	LOC493754	chr7:65993446-66057363:-	0.2	3.38	0.00075	Diabetic kidney disease	
BRCA	cis	1	rs13247184	chr7:65358928	ZNF117	chr7:64434830-64467121:-	-0.27	-4.92	9.85E-7	Diabetic kidney disease	
BRCA	cis	1	rs1325195	chr1:179071756	ABL2	chr1:179068463-179198819:-	-0.17	-6.47	1.51E-10	IgE grass sensitization	
BRCA	cis	1	rs1325195	chr1:179071756	TOR3A	chr1:179051112-179065127:+	-0.14	-4.88	1.25E-6	IgE grass sensitization	
BRCA	cis	1	rs13252013	chr8:90759109	RIPK2	chr8:90769975-90803291:+	0.16	6.08	1.65E-9	Leprosy	
BRCA	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.88	31.82	8.33E-157	Bone mineral density	
BRCA	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.86	31.13	6.88E-152	Bone mineral density	
BRCA	cis	1	rs13265280	chr8:65702121	CYP7B1	chr8:65508529-65711348:-	0.12	3.8	0.000155	HIV-1 susceptibility	
BRCA	cis	1	rs13271746	chr8:65677873	CYP7B1	chr8:65508529-65711348:-	0.13	4.02	6.34E-5	HIV-1 susceptibility	
BRCA	cis	1	rs13272719	chr8:65663801	CYP7B1	chr8:65508529-65711348:-	0.11	3.45	0.000584	HIV-1 susceptibility	
BRCA	cis	1	rs13276710	chr8:15537675	TUSC3	chr8:15397730-15621993:+	0.22	4.89	1.18E-6	Pulmonary function decline	
BRCA	cis	1	rs13277232	chr8:15537825	TUSC3	chr8:15397730-15621993:+	0.22	4.89	1.16E-6	Pulmonary function decline	
BRCA	cis	1	rs13279023	chr8:90761044	RIPK2	chr8:90769975-90803291:+	0.16	6.09	1.54E-9	Leprosy	
BRCA	cis	1	rs13310597	chr7:65598540	CCT6P1	chr7:65216092-65228661:+	0.33	6.95	6.39E-12	Diabetic kidney disease	
BRCA	cis	1	rs13310597	chr7:65598540	LOC493754	chr7:65993446-66057363:-	0.25	4.09	4.59E-5	Diabetic kidney disease	
BRCA	cis	1	rs1331215	chr20:3376565	ITPA	chr20:3190056-3204504:+	-0.13	-3.82	0.000139	IFN-related cytopenia	
BRCA	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.28	10.57	6.51E-25	Longevity	
BRCA	cis	1	rs13314673	chr3:101661383	LOC152225	chr3:101659703-101716770:+	-0.15	-3.64	0.000287	Psoriasis vulgaris;Psoriasis	
BRCA	cis	1	rs13316695	chr3:49684917	AMT	chr3:49454212-49460012:-	0.11	3.57	0.000373	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs13316695	chr3:49684917	GMPPB	chr3:49758932-49761384:-	-0.12	-3.49	0.000499	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.39	12.59	5.21E-34	Height	
BRCA	cis	1	rs13322305	chr3:134310791	CEP63	chr3:134204575-134293852:+	0.14	3.81	0.000146	Height	
BRCA	cis	1	rs13322887	chr3:49555583	AMT	chr3:49454212-49460012:-	-0.13	-4.37	1.37E-5	Menarche (age at onset)	
BRCA	cis	1	rs13322887	chr3:49555583	CCDC36	chr3:49235861-49295537:+	-0.1	-3.88	0.000111	Menarche (age at onset)	
BRCA	cis	1	rs13322887	chr3:49555583	GMPPB	chr3:49758932-49761384:-	0.13	3.8	0.000156	Menarche (age at onset)	
BRCA	cis	1	rs13322887	chr3:49555583	NCKIPSD	chr3:48711280-48723334:-	-0.14	-3.66	0.000268	Menarche (age at onset)	
BRCA	cis	1	rs13322887	chr3:49555583	P4HTM	chr3:49027341-49044579:+	-0.09	-3.97	7.75E-5	Menarche (age at onset)	
BRCA	cis	1	rs13322887	chr3:49555583	WDR6	chr3:49044637-49053386:+	0.14	4.15	3.51E-5	Menarche (age at onset)	
BRCA	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.51	14.02	4.1E-41	Diastolic blood pressure	
BRCA	cis	1	rs13331733	chr16:29848417	LOC440356	chr16:29875004-29879374:+	-0.26	-5.38	9.23E-8	Multiple sclerosis	
BRCA	cis	1	rs13332078	chr16:29850705	LOC440356	chr16:29875004-29879374:+	-0.28	-5.68	1.77E-8	Multiple sclerosis	
BRCA	cis	1	rs1333963	chr6:163192571	PACRG	chr6:163148164-163736523:+	0.21	3.43	0.000632	Body mass index	
BRCA	cis	1	rs13344563	chr19:41945904	B3GNT8	chr19:41931265-41934635:-	0.2	6	2.74E-9	Height	
BRCA	cis	1	rs13358904	chr5:111602713	FLJ11235	chr5:111755280-111756673:+	0.13	3.65	0.000279	Suicide ideation score in major depressive disorder	
BRCA	cis	1	rs13362043	chr5:115596262	COMMD10	chr5:115420727-115628978:+	0.22	4.58	5.21E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs13376333	chr1:154814353	RAG1AP1	chr1:155108288-155357080:+	-0.12	-3.95	8.44E-5	Atrial fibrillation	
BRCA	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.57	-17.75	6.06E-62	Response to antipsychotic treatment	
BRCA	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.6	-18.65	2.04E-67	Response to antipsychotic treatment	
BRCA	cis	1	rs13383762	chr2:38907001	GALM	chr2:38893052-38961908:+	0.34	6.08	1.64E-9	5-HTT brain serotonin transporter levels	
BRCA	cis	1	rs13384952	chr2:73723959	ALMS1P	chr2:73872046-73912692:+	-0.21	-4.77	2.13E-6	Metabolite levels	
BRCA	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.54	-11.64	1.39E-29	Prostate cancer	
BRCA	cis	1	rs13387221	chr2:44135314	LRPPRC	chr2:44113363-44223144:-	-0.13	-3.93	9.17E-5	Intelligence (childhood)	
BRCA	cis	1	rs13389798	chr2:203213093	NOP58	chr2:203130515-203168382:+	0.15	3.55	0.000401	Urate levels	
BRCA	cis	1	rs13391356	chr2:234170369	SAG	chr2:234216309-234255701:+	0.13	4.09	4.55E-5	Crohn's disease	
BRCA	cis	1	rs13393692	chr2:233442016	EIF4E2	chr2:233415357-233448349:+	-0.2	-4.54	6.27E-6	Height	
BRCA	cis	1	rs13393692	chr2:233442016	TIGD1	chr2:233412779-233415226:-	-0.14	-3.68	0.000247	Height	
BRCA	cis	1	rs13393800	chr2:233442091	EIF4E2	chr2:233415357-233448349:+	-0.19	-4.31	1.78E-5	Height	
BRCA	cis	1	rs13393800	chr2:233442091	TIGD1	chr2:233412779-233415226:-	-0.15	-3.73	0.000202	Height	
BRCA	cis	1	rs1339458	chr1:10328338	PGD	chr1:10459085-10480200:+	0.2	5.6	2.7E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs13395766	chr2:160114186	WDSUB1	chr2:160092305-160143236:-	0.32	3.96	8.15E-5	Sudden cardiac arrest	
BRCA	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.48	8.18	8.0E-16	Rheumatoid arthritis	
BRCA	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.26	6.6	6.35E-11	Metabolite levels	
BRCA	cis	1	rs13401391	chr2:137340034	THSD7B	chr2:137523115-138435287:+	0.13	3.42	0.00066	Cognitive test performance	
BRCA	cis	1	rs13403995	chr2:206334657	NRP2	chr2:206547224-206662856:+	0.14	3.63	0.000291	AIDS progression	
BRCA	cis	1	rs13404123	chr2:219916797	GLB1L	chr2:220101505-220110131:-	0.21	3.79	0.000157	Height	
BRCA	cis	1	rs13407368	chr2:160105007	WDSUB1	chr2:160092305-160143236:-	0.33	4.06	5.24E-5	Sudden cardiac arrest	
BRCA	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.45	-8.74	8.57E-18	Rheumatoid arthritis	
BRCA	cis	1	rs13409250	chr2:37463642	CEBPZ	chr2:37428778-37458740:-	-0.19	-6.04	2.11E-9	Chronic lymphocytic leukemia	
BRCA	cis	1	rs13409911	chr2:160083068	WDSUB1	chr2:160092305-160143236:-	0.3	3.78	0.000165	Sudden cardiac arrest	
BRCA	cis	1	rs13410658	chr2:206342082	NRP2	chr2:206547224-206662856:+	-0.14	-3.73	0.000199	AIDS progression	
BRCA	cis	1	rs13413691	chr2:160084236	WDSUB1	chr2:160092305-160143236:-	0.31	3.82	0.000142	Sudden cardiac arrest	
BRCA	cis	1	rs1341759	chr6:26195502	HIST1H3E	chr6:26224427-26226589:+	0.35	6.74	2.58E-11	Renal underexcretion gout;Gout	
BRCA	cis	1	rs13421084	chr2:160086468	WDSUB1	chr2:160092305-160143236:-	0.29	3.69	0.000237	Sudden cardiac arrest	
BRCA	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.27	6.7	3.41E-11	Metabolite levels	
BRCA	cis	1	rs13424612	chr2:240900121	NDUFA10	chr2:240900158-240964798:-	0.27	7.09	2.41E-12	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs13429638	chr2:160095145	WDSUB1	chr2:160092305-160143236:-	0.36	4.4	1.17E-5	Sudden cardiac arrest	
BRCA	cis	1	rs13429940	chr2:70379868	FAM136A	chr2:70523109-70529220:-	-0.11	-3.59	0.000343	Obesity-related traits	
BRCA	cis	1	rs13431025	chr2:160092405	WDSUB1	chr2:160092305-160143236:-	0.34	4.2	2.91E-5	Sudden cardiac arrest	
BRCA	cis	1	rs13437605	chr6:118899014	C6orf204	chr6:118786239-119031238:-	-0.11	-3.47	0.000534	Renal cell carcinoma	
BRCA	cis	1	rs1346719	chr3:53077372	NT5DC2	chr3:52558386-52569093:-	-0.14	-3.5	0.000478	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs1346719	chr3:53077372	RFT1	chr3:53122503-53164470:-	0.2	3.44	0.000611	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs1357481	chr4:8496221	C4orf23	chr4:8440604-8495258:+	-0.15	-3.94	8.61E-5	Response to antineoplastic agents	
BRCA	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.4	13.43	3.94E-38	Height	
BRCA	cis	1	rs1357762	chr3:134264859	CEP63	chr3:134204575-134293852:+	0.15	3.98	7.5E-5	Height	
BRCA	cis	1	rs1359582	chr10:90330483	LIPF	chr10:90424094-90438572:+	0.13	3.39	0.000713	Depressive and manic episodes in bipolar disorder	
BRCA	cis	1	rs1364989	chr4:55011769	FIP1L1	chr4:54243820-54326102:+	0.17	4.09	4.71E-5	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.49	-13.05	3.34E-36	Type 2 diabetes	
BRCA	cis	1	rs1374469	chr4:1724799	FAM53A	chr4:1641609-1685854:-	-0.21	-5.47	5.64E-8	Urinary bladder cancer;Bladder cancer	
BRCA	cis	1	rs1376260	chr7:37991523	EPDR1	chr7:37960163-37991539:+	-0.25	-4.29	1.97E-5	Myopia (pathological)	
BRCA	cis	1	rs1376261	chr7:37991389	EPDR1	chr7:37960163-37991539:+	-0.25	-4.33	1.66E-5	Myopia (pathological)	
BRCA	cis	1	rs1380293	chr4:18027235	NCAPG	chr4:17812525-17846485:+	0.09	4.14	3.74E-5	Height	
BRCA	cis	1	rs1382339	chr5:115558163	COMMD10	chr5:115420727-115628978:+	0.24	5.06	4.95E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs1382340	chr5:115558161	COMMD10	chr5:115420727-115628978:+	0.24	5.06	4.95E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs1382369	chr5:82441429	XRCC4	chr5:82373317-82649577:+	-0.12	-3.54	0.000411	Hypertension	
BRCA	cis	1	rs1382371	chr5:82441119	XRCC4	chr5:82373317-82649577:+	-0.12	-3.54	0.000411	Hypertension	
BRCA	cis	1	rs1382372	chr5:82441056	XRCC4	chr5:82373317-82649577:+	-0.12	-3.54	0.000411	Hypertension	
BRCA	cis	1	rs138544659	chr15:78900701	AGPHD1	chr15:78799906-78829714:+	-0.16	-3.73	0.000198	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs138544659	chr15:78900701	CHRNA5	chr15:78857906-78886458:+	-0.2	-6.06	1.93E-9	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs1385884	chr3:113841625	GRAMD1C	chr3:113547029-113666020:+	0.11	3.39	0.000714	Personality dimensions	
BRCA	cis	1	rs138702	chr22:39132601	APOBEC3C	chr22:39410265-39414823:+	0.11	4.03	5.89E-5	Resting heart rate	
BRCA	cis	1	rs138702	chr22:39132601	JOSD1	chr22:39081549-39096459:-	0.14	4.62	4.35E-6	Resting heart rate	
BRCA	cis	1	rs138702	chr22:39132601	TOMM22	chr22:39077954-39080763:+	0.11	3.81	0.000149	Resting heart rate	
BRCA	cis	1	rs138712	chr22:39141600	LOC646851	chr22:38974125-39052634:-	0.16	4.71	2.75E-6	Resting heart rate	
BRCA	cis	1	rs138713	chr22:39142615	LOC646851	chr22:38974125-39052634:-	0.14	4.16	3.44E-5	Resting heart rate	
BRCA	cis	1	rs138716	chr22:39146527	LOC646851	chr22:38974125-39052634:-	0.14	3.91	9.88E-5	Resting heart rate	
BRCA	cis	1	rs1388527	chr11:6948441	ZNF215	chr11:6947654-7005861:+	-0.32	-6.72	2.89E-11	Response to cytadine analogues (cytosine arabinoside)	
BRCA	cis	1	rs1392104	chr7:65759107	CCT6P1	chr7:65216092-65228661:+	-0.29	-6.23	6.55E-10	Diabetic kidney disease	
BRCA	cis	1	rs1392104	chr7:65759107	CRCP	chr7:65579805-65619551:+	0.22	3.79	0.000157	Diabetic kidney disease	
BRCA	cis	1	rs1392104	chr7:65759107	LOC493754	chr7:65993446-66057363:-	-0.21	-3.57	0.000377	Diabetic kidney disease	
BRCA	cis	1	rs139388	chr22:39531732	APOBEC3H	chr22:39493290-39500070:+	-0.12	-5.51	4.52E-8	Multiple myeloma	
BRCA	cis	1	rs139396	chr22:39538485	APOBEC3H	chr22:39493290-39500070:+	-0.12	-5.14	3.33E-7	Multiple myeloma	
BRCA	cis	1	rs139401	chr22:39546074	APOBEC3H	chr22:39493290-39500070:+	-0.12	-5.57	3.31E-8	Multiple myeloma	
BRCA	cis	1	rs139402	chr22:39546145	APOBEC3H	chr22:39493290-39500070:+	-0.13	-5.71	1.5E-8	Multiple myeloma	
BRCA	cis	1	rs139404	chr22:39547201	APOBEC3H	chr22:39493290-39500070:+	-0.12	-5.43	7.0E-8	Multiple myeloma	
BRCA	cis	1	rs139413	chr22:39553772	APOBEC3H	chr22:39493290-39500070:+	0.11	4.78	1.99E-6	Multiple myeloma	
BRCA	cis	1	rs139413	chr22:39553772	SYNGR1	chr22:39745954-39781591:+	-0.11	-3.5	0.00049	Multiple myeloma	
BRCA	cis	1	rs1395297	chr15:50878509	SPPL2A	chr15:50999739-51057910:-	-0.16	-5.92	4.34E-9	QT interval	
BRCA	cis	1	rs1395381	chr7:123432100	HYAL4	chr7:123485223-123517529:+	0.21	3.44	0.000594	Platelet count	
BRCA	cis	1	rs1396626	chr1:96025546	CNN3	chr1:95362509-95392735:-	0.13	3.77	0.000175	Diabetic kidney disease	
BRCA	cis	1	rs1398676	chr12:26459420	BHLHE41	chr12:26272961-26278003:-	0.13	3.42	0.000645	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs1401492	chr3:53680124	ACTR8	chr3:53901156-53916187:-	-0.31	-4	6.87E-5	Insulin resistance/response	
BRCA	cis	1	rs1401492	chr3:53680124	NEK4	chr3:52744803-52804951:-	-0.21	-3.47	0.000533	Insulin resistance/response	
BRCA	cis	1	rs1401492	chr3:53680124	PBRM1	chr3:52579368-52719866:-	-0.23	-3.92	9.52E-5	Insulin resistance/response	
BRCA	cis	1	rs1403284	chr2:73726662	ALMS1P	chr2:73872046-73912692:+	-0.22	-5.54	3.79E-8	Metabolite levels	
BRCA	cis	1	rs140330585	chr15:78866445	AGPHD1	chr15:78799906-78829714:+	-0.15	-3.41	0.000664	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs140330585	chr15:78866445	CHRNA5	chr15:78857906-78886458:+	-0.2	-5.96	3.5E-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs1405694	chr6:152946561	VIP	chr6:153071933-153080898:+	0.12	4.1	4.5E-5	Tonometry	
BRCA	cis	1	rs1406947	chr20:33969530	CPNE1	chr20:34213968-34262539:-	0.23	6.19	8.39E-10	Height	
BRCA	cis	1	rs1406947	chr20:33969530	MMP24	chr20:33814539-33864804:+	0.16	4.42	1.1E-5	Height	
BRCA	cis	1	rs1406947	chr20:33969530	UQCC	chr20:33890383-33999833:-	0.31	9.38	3.73E-20	Height	
BRCA	cis	1	rs1407185	chr6:117733650	ROS1	chr6:117609530-117747018:-	-0.14	-4.84	1.45E-6	Lung cancer	
BRCA	cis	1	rs1407488	chr6:152945777	VIP	chr6:153071933-153080898:+	0.12	4.04	5.66E-5	Tonometry	
BRCA	cis	1	rs1408916	chr1:92992627	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs1409360	chr10:91385304	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.89	0.000105	Metabolic traits	
BRCA	cis	1	rs1409657	chr10:96414628	HELLS	chr10:96305543-96361855:+	0.12	3.59	0.000343	Migraine	
BRCA	cis	1	rs1412444	chr10:91002927	LIPA	chr10:90973328-91174382:-	0.2	7.02	3.96E-12	Fibrinogen levels	
BRCA	cis	1	rs1412445	chr10:91002804	LIPA	chr10:90973328-91174382:-	0.2	6.92	8.02E-12	Fibrinogen levels	
BRCA	cis	1	rs141518190	chr15:78900647	AGPHD1	chr15:78799906-78829714:+	-0.16	-3.73	0.000198	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs141518190	chr15:78900647	CHRNA5	chr15:78857906-78886458:+	-0.2	-6.06	1.93E-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs1417823	chr10:102227886	SEC31B	chr10:102246403-102289636:-	0.28	10.94	1.79E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs1419183	chr6:28242794	HIST1H4J	chr6:27791903-27792257:+	-0.17	-3.4	0.000702	Depression	
BRCA	cis	1	rs1419183	chr6:28242794	ZNF187	chr6:28234788-28245978:+	-0.15	-3.59	0.000348	Depression	
BRCA	cis	1	rs1419183	chr6:28242794	ZNF323	chr6:28292517-28324048:-	0.2	3.52	0.000447	Depression	
BRCA	cis	1	rs1419183	chr6:28242794	ZNF389	chr6:28129551-28137375:+	-0.2	-3.64	0.000282	Depression	
BRCA	cis	1	rs1419183	chr6:28242794	ZSCAN23	chr6:28393287-28411279:-	0.17	3.53	0.000439	Depression	
BRCA	cis	1	rs1420101	chr2:102957716	IL18R1	chr2:102927962-103015215:+	0.09	4.07	5.0E-5	Serum protein levels (sST2)	
BRCA	cis	1	rs142039564	chr1:119056258	WARS2	chr1:119573841-119683295:-	-0.15	-3.51	0.00046	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	
BRCA	cis	1	rs1422500	chr5:115569312	COMMD10	chr5:115420727-115628978:+	0.24	4.5	7.45E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.72	18.49	1.84E-66	Type 2 diabetes	
BRCA	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.72	19.15	1.78E-70	Type 2 diabetes	
BRCA	cis	1	rs143000161	chr2:165710540	SLC38A11	chr2:165754812-165812035:-	0.28	5.67	1.89E-8	Heschl's gyrus morphology	
BRCA	cis	1	rs14347	chr16:15133889	C16orf63	chr16:15959577-15982447:-	0.14	3.9	0.000104	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs1443438	chr9:100550028	NCBP1	chr9:100395705-100436027:+	-0.12	-3.57	0.000368	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs1443438	chr9:100550028	TSTD2	chr9:100362364-100395962:-	-0.1	-3.68	0.000249	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs1445845	chr5:178507090	ZNF354C	chr5:178487607-178507689:+	-0.11	-3.91	9.85E-5	Height	
BRCA	cis	1	rs1445846	chr5:178507069	ZNF354C	chr5:178487607-178507689:+	-0.12	-4.24	2.48E-5	Height	
BRCA	cis	1	rs1450849	chr7:37992877	EPDR1	chr7:37960163-37991539:+	-0.24	-4.15	3.65E-5	Myopia (pathological)	
BRCA	cis	1	rs1451374	chr7:50622653	FIGNL1	chr7:50511834-50518088:-	-0.13	-4.35	1.51E-5	Malaria	
BRCA	cis	1	rs1451375	chr7:50622712	FIGNL1	chr7:50511834-50518088:-	0.12	3.92	9.24E-5	Malaria	
BRCA	cis	1	rs1451707	chr6:56801877	BEND6	chr6:56819773-56892138:+	-0.36	-9.72	1.91E-21	Menarche (age at onset)	
BRCA	cis	1	rs1451707	chr6:56801877	KIAA1586	chr6:56911384-56920021:+	-0.19	-3.72	0.000212	Menarche (age at onset)	
BRCA	cis	1	rs1451708	chr6:56802201	BEND6	chr6:56819773-56892138:+	-0.36	-9.71	2.11E-21	Menarche (age at onset)	
BRCA	cis	1	rs1451708	chr6:56802201	KIAA1586	chr6:56911384-56920021:+	-0.18	-3.65	0.000274	Menarche (age at onset)	
BRCA	cis	1	rs1453414	chr11:5829084	OR56A3	chr11:5968577-5969522:+	0.15	3.4	0.000704	Oropharynx cancer;Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1453414	chr11:5829084	UBQLNL	chr11:5535624-5537956:-	0.22	3.78	0.000167	Oropharynx cancer;Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1453605	chr4:1075771	CRIPAK	chr4:1385340-1389782:+	0.11	3.42	0.000649	Recombination rate (males)	
BRCA	cis	1	rs1453605	chr4:1075771	KIAA1530	chr4:1341104-1381836:+	0.11	3.65	0.00028	Recombination rate (males)	
BRCA	cis	1	rs1459242	chr3:48413537	ATRIP	chr3:48488141-48507708:+	-0.1	-3.52	0.000453	Longevity	
BRCA	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.25	9.49	1.46E-20	Longevity	
BRCA	cis	1	rs1460561	chr6:56797574	BEND6	chr6:56819773-56892138:+	-0.34	-9.09	4.59E-19	Menarche (age at onset)	
BRCA	cis	1	rs1460561	chr6:56797574	KIAA1586	chr6:56911384-56920021:+	-0.17	-3.41	0.000665	Menarche (age at onset)	
BRCA	cis	1	rs1463050	chr1:8597042	RERE	chr1:8412466-8877699:-	0.11	3.56	0.000381	Vitiligo	
BRCA	cis	1	rs1463051	chr1:8596893	RERE	chr1:8412466-8877699:-	-0.11	-3.61	0.00032	Vitiligo	
BRCA	cis	1	rs1463104	chr4:88799710	SPP1	chr4:88896802-88904562:+	0.13	4.02	6.23E-5	Bone mineral density	
BRCA	cis	1	rs1463679	chr12:26470169	BHLHE41	chr12:26272961-26278003:-	0.14	3.83	0.000137	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs1463679	chr12:26470169	SSPN	chr12:26348269-26405853:+	0.12	3.61	0.000315	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs1464569	chr3:49460350	AMT	chr3:49454212-49460012:-	0.14	4.69	3.13E-6	Menarche (age at onset)	
BRCA	cis	1	rs1464569	chr3:49460350	CCDC36	chr3:49235861-49295537:+	0.1	3.66	0.000268	Menarche (age at onset)	
BRCA	cis	1	rs1464569	chr3:49460350	GMPPB	chr3:49758932-49761384:-	-0.12	-3.7	0.000225	Menarche (age at onset)	
BRCA	cis	1	rs1464569	chr3:49460350	NCKIPSD	chr3:48711280-48723334:-	0.16	3.99	6.95E-5	Menarche (age at onset)	
BRCA	cis	1	rs1464569	chr3:49460350	P4HTM	chr3:49027341-49044579:+	0.09	3.64	0.000285	Menarche (age at onset)	
BRCA	cis	1	rs1464569	chr3:49460350	TREX1	chr3:48501186-48509043:+	-0.12	-3.85	0.000124	Menarche (age at onset)	
BRCA	cis	1	rs1464569	chr3:49460350	WDR6	chr3:49044637-49053386:+	-0.17	-5	6.58E-7	Menarche (age at onset)	
BRCA	cis	1	rs1465880	chr2:240932326	NDUFA10	chr2:240900158-240964798:-	0.26	6.72	2.91E-11	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs1466215	chr4:1072220	CRIPAK	chr4:1385340-1389782:+	0.11	3.4	0.000708	Recombination rate (males)	
BRCA	cis	1	rs1466215	chr4:1072220	KIAA1530	chr4:1341104-1381836:+	0.11	3.64	0.000289	Recombination rate (males)	
BRCA	cis	1	rs1466788	chr1:110618730	ALX3	chr1:110602998-110613322:-	-0.13	-3.89	0.000108	Blood metabolite levels	
BRCA	cis	1	rs1467472	chr20:43371551	KCNK15	chr20:43374488-43379666:+	0.13	4.54	6.16E-6	Obesity-related traits	
BRCA	cis	1	rs1469712	chr19:19528821	CILP2	chr19:19649074-19657466:+	0.1	3.78	0.000166	Schizophrenia	
BRCA	cis	1	rs1469712	chr19:19528821	HAPLN4	chr19:19366453-19384074:-	0.21	6.86	1.19E-11	Schizophrenia	
BRCA	cis	1	rs1471399	chr4:88774073	SPP1	chr4:88896802-88904562:+	-0.18	-5.8	8.64E-9	Bone mineral density;Bone mineral density (paediatric, total body less head)	
BRCA	cis	1	rs1471401	chr4:88774340	SPP1	chr4:88896802-88904562:+	-0.19	-6.16	1.02E-9	Bone mineral density;Bone mineral density (paediatric, total body less head)	
BRCA	cis	1	rs1471403	chr4:88775243	SPP1	chr4:88896802-88904562:+	0.18	6.08	1.7E-9	Bone mineral density;Bone mineral density (paediatric, total body less head)	
BRCA	cis	1	rs147144681	chr15:78900908	CHRNA5	chr15:78857906-78886458:+	-0.19	-5.69	1.64E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs1472174	chr4:145655532	ABCE1	chr4:146019156-146050675:+	0.09	3.55	0.0004	Height	
BRCA	cis	1	rs1472750	chr10:115235114	CASP7	chr10:115438935-115490662:+	-0.22	-4.31	1.77E-5	Migraine without aura	
BRCA	cis	1	rs1472750	chr10:115235114	DCLRE1A	chr10:115594484-115613859:-	-0.21	-4.63	4.18E-6	Migraine without aura	
BRCA	cis	1	rs1472750	chr10:115235114	LOC143188	chr10:114610673-114615127:+	-0.28	-4.98	7.32E-7	Migraine without aura	
BRCA	cis	1	rs1472750	chr10:115235114	NHLRC2	chr10:115614420-115668452:+	-0.14	-3.85	0.000123	Migraine without aura	
BRCA	cis	1	rs1472852	chr4:17910236	NCAPG	chr4:17812525-17846485:+	0.09	4.08	4.83E-5	Height	
BRCA	cis	1	rs1473248	chr19:41923314	B3GNT8	chr19:41931265-41934635:-	0.25	7.52	1.18E-13	Height	
BRCA	cis	1	rs1473420	chr1:8616838	RERE	chr1:8412466-8877699:-	0.1	3.44	0.000606	Vitiligo	
BRCA	cis	1	rs1473857	chr3:101635645	LOC152225	chr3:101659703-101716770:+	-0.15	-3.61	0.000321	Psoriasis vulgaris;Psoriasis	
BRCA	cis	1	rs1474382	chr15:31214649	MTMR10	chr15:31231144-31283807:-	0.13	3.67	0.000257	Hypertriglyceridemia	
BRCA	cis	1	rs1474382	chr15:31214649	MTMR15	chr15:31196055-31235307:+	0.16	3.74	0.000192	Hypertriglyceridemia	
BRCA	cis	1	rs1474698	chr6:56064197	COL21A1	chr6:55921389-56258892:-	-0.69	-22.05	4.32E-89	Pulse pressure	
BRCA	cis	1	rs147499554	chr15:78900650	AGPHD1	chr15:78799906-78829714:+	-0.16	-3.73	0.000198	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs147499554	chr15:78900650	CHRNA5	chr15:78857906-78886458:+	-0.2	-6.06	1.93E-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs1475695	chr9:100691168	C9orf156	chr9:100666772-100684852:-	-0.17	-4.62	4.26E-6	Quantitative traits	
BRCA	cis	1	rs1475696	chr9:100691397	C9orf156	chr9:100666772-100684852:-	-0.17	-4.62	4.26E-6	Quantitative traits	
BRCA	cis	1	rs1477880	chr4:54539972	LNX1	chr4:54326439-54518682:-	-0.13	-3.62	0.000305	Beard thickness	
BRCA	cis	1	rs1477881	chr4:54529221	LNX1	chr4:54326439-54518682:-	0.13	3.64	0.000285	Beard thickness	
BRCA	cis	1	rs1480354	chr3:51364458	GRM2	chr3:51741081-51752623:+	-0.18	-3.44	0.000597	Melanoma	
BRCA	cis	1	rs1480823	chr15:84585746	GOLGA6L5	chr15:85047738-85060078:-	-0.13	-4.52	6.78E-6	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs1480823	chr15:84585746	LOC388152	chr15:84867600-84898920:-	-0.12	-3.81	0.000145	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs1484994	chr20:30305975	COX4I2	chr20:30225691-30232800:+	0.17	6.62	5.67E-11	Subcortical brain region volumes	
BRCA	cis	1	rs1484994	chr20:30305975	MYLK2	chr20:30407178-30422500:+	0.31	8.15	1.0E-15	Subcortical brain region volumes	
BRCA	cis	1	rs148734725	chr3:49406708	GMPPB	chr3:49758932-49761384:-	-0.13	-3.92	9.58E-5	Educational attainment (college completion)	
BRCA	cis	1	rs148734725	chr3:49406708	TREX1	chr3:48501186-48509043:+	-0.18	-5.86	6.12E-9	Educational attainment (college completion)	
BRCA	cis	1	rs1497266	chr3:139283462	RBP1	chr3:139236276-139258671:-	0.12	3.43	0.000631	Gut microbiota (functional units)	
BRCA	cis	1	rs14978	chr7:12273152	VWDE	chr7:12370509-12443852:-	-0.13	-3.63	0.000293	Response to amphetamines	
BRCA	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.41	13.73	1.2E-39	Height	
BRCA	cis	1	rs1498718	chr3:134205920	CEP63	chr3:134204575-134293852:+	0.16	4.47	8.53E-6	Height	
BRCA	cis	1	rs1499613	chr7:65730860	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.67	4.19E-11	Diabetic kidney disease	
BRCA	cis	1	rs1499613	chr7:65730860	CRCP	chr7:65579805-65619551:+	0.2	3.49	0.000495	Diabetic kidney disease	
BRCA	cis	1	rs1499613	chr7:65730860	LOC493754	chr7:65993446-66057363:-	-0.24	-4.11	4.32E-5	Diabetic kidney disease	
BRCA	cis	1	rs1499614	chr7:65730798	CCT6P1	chr7:65216092-65228661:+	0.3	6.6	6.39E-11	Diabetic kidney disease	
BRCA	cis	1	rs1499614	chr7:65730798	CRCP	chr7:65579805-65619551:+	-0.2	-3.5	0.000483	Diabetic kidney disease	
BRCA	cis	1	rs1499614	chr7:65730798	LOC493754	chr7:65993446-66057363:-	0.24	4.03	5.97E-5	Diabetic kidney disease	
BRCA	cis	1	rs1501908	chr5:156398169	TIMD4	chr5:156346293-156390266:-	0.37	12.36	6.7E-33	Triglycerides;Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs1502007	chr16:55613522	LPCAT2	chr16:55542913-55620581:+	0.11	3.68	0.000245	Thyroid hormone levels	
BRCA	cis	1	rs1502696	chr9:91545220	C9orf47	chr9:91605778-91611055:+	0.13	3.73	0.000205	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs1502697	chr9:91545316	C9orf47	chr9:91605778-91611055:+	0.13	3.69	0.000238	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs1509123	chr17:6683878	FBXO39	chr17:6679552-6700420:+	0.37	4.9	1.13E-6	Blood metabolite levels	
BRCA	cis	1	rs1509460	chr5:42433819	CCDC152	chr5:42756920-42802539:+	-0.12	-3.66	0.000264	Systemic lupus erythematosus	
BRCA	cis	1	rs1509461	chr5:42407860	OXCT1	chr5:41730168-41870791:-	0.15	4.14	3.81E-5	Systemic lupus erythematosus	
BRCA	cis	1	rs1511218	chr2:160906390	LY75	chr2:160625141-160761262:-	0.14	4.86	1.38E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs1511218	chr2:160906390	PLA2R1	chr2:160798012-160919121:-	0.15	5.05	5.1E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs151222	chr16:20674492	ACSM1	chr16:20634559-20709066:-	-0.36	-7.02	4.04E-12	Schizophrenia	
BRCA	cis	1	rs1517209	chr5:112725997	YTHDC2	chr5:112849410-112930979:+	0.14	4.15	3.58E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs1519466	chr9:111860797	C9orf5	chr9:111777416-111882225:-	-0.19	-4.72	2.64E-6	Information processing speed	
BRCA	cis	1	rs1519466	chr9:111860797	PTPN3	chr9:112137974-112260593:-	-0.18	-3.42	0.000659	Information processing speed	
BRCA	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.5	-18.28	3.5E-65	Ankylosing spondylitis	
BRCA	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.4	10.74	1.25E-25	Ankylosing spondylitis	
BRCA	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.29	-7.67	3.89E-14	Pancreatic cancer	
BRCA	cis	1	rs1521418	chr3:116761660	LSAMP	chr3:115521222-115524018:-;chr3	-0.19	-3.46	0.000571	Cognitive function	
BRCA	cis	1	rs1528402	chr2:27857517	KRTCAP3	chr2:27665263-27667163:+	-0.12	-3.84	0.00013	Oral cavity cancer	
BRCA	cis	1	rs1528404	chr2:27846603	KRTCAP3	chr2:27665263-27667163:+	0.13	4.03	5.89E-5	Oral cavity cancer	
BRCA	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.03	1.11E-22	Obesity-related traits	
BRCA	cis	1	rs1533266	chr7:143766714	OR2A7	chr7:143955790-143974852:-	0.2	4.78	2.03E-6	Obesity-related traits	
BRCA	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.15	3.73E-23	Obesity-related traits	
BRCA	cis	1	rs1533267	chr7:143766440	OR2A7	chr7:143955790-143974852:-	0.21	4.84	1.5E-6	Obesity-related traits	
BRCA	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.12	4.57E-23	Obesity-related traits	
BRCA	cis	1	rs1533268	chr7:143766358	OR2A7	chr7:143955790-143974852:-	0.21	4.88	1.25E-6	Obesity-related traits	
BRCA	cis	1	rs1533642	chr9:111903349	C9orf5	chr9:111777416-111882225:-	0.15	3.39	0.00073	Information processing speed	
BRCA	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.4	-12.93	1.18E-35	Height	
BRCA	cis	1	rs1534025	chr3:134313304	CEP63	chr3:134204575-134293852:+	-0.14	-3.59	0.000351	Height	
BRCA	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.41	13.7	1.72E-39	Height	
BRCA	cis	1	rs1534026	chr3:134284767	CEP63	chr3:134204575-134293852:+	0.14	3.79	0.000161	Height	
BRCA	cis	1	rs1534696	chr7:26397239	SNX10	chr7:26331515-26413937:+	-0.13	-4.16	3.37E-5	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs1535277	chr6:26567802	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.27E-8	Educational attainment	
BRCA	cis	1	rs1535277	chr6:26567802	C6orf41	chr6:26924772-26991752:+	-0.13	-3.94	8.81E-5	Educational attainment	
BRCA	cis	1	rs1535277	chr6:26567802	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.73	0.000201	Educational attainment	
BRCA	cis	1	rs1536263	chr1:10378914	PGD	chr1:10459085-10480200:+	0.22	6.16	1.01E-9	Hepatocellular carcinoma	
BRCA	cis	1	rs1537059	chr1:87770460	HS2ST1	chr1:87380335-87575680:+	-0.14	-3.59	0.00034	Breast cancer	
BRCA	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.4	-9.56	7.52E-21	Obesity-related traits	
BRCA	cis	1	rs1540894	chr7:143767676	OR2A7	chr7:143955790-143974852:-	0.22	5.19	2.5E-7	Obesity-related traits	
BRCA	cis	1	rs1540927	chr20:33931344	CPNE1	chr20:34213968-34262539:-	0.24	6.44	1.81E-10	Height	
BRCA	cis	1	rs1540927	chr20:33931344	MMP24	chr20:33814539-33864804:+	0.16	4.71	2.76E-6	Height	
BRCA	cis	1	rs1540927	chr20:33931344	UQCC	chr20:33890383-33999833:-	0.32	9.92	3.06E-22	Height	
BRCA	cis	1	rs154136	chr5:50071565	PARP8	chr5:49961733-50138169:+	0.13	3.73	0.000203	Myopia (pathological)	
BRCA	cis	1	rs1542173	chr2:215657560	BARD1	chr2:215593275-215674428:-	0.12	4.37	1.38E-5	Neuroblastoma	
BRCA	cis	1	rs1546059	chr7:65654709	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.39	2.49E-10	Diabetic kidney disease	
BRCA	cis	1	rs1546059	chr7:65654709	CRCP	chr7:65579805-65619551:+	0.21	3.61	0.000322	Diabetic kidney disease	
BRCA	cis	1	rs1546059	chr7:65654709	LOC493754	chr7:65993446-66057363:-	-0.22	-3.65	0.000279	Diabetic kidney disease	
BRCA	cis	1	rs1546977	chr6:84314423	SNAP91	chr6:84262607-84419127:-	-0.14	-4.02	6.19E-5	Schizophrenia	
BRCA	cis	1	rs1548226	chr20:43983777	SYS1	chr20:43991701-44004724:+	0.19	4.96	8.15E-7	Psoriasis	
BRCA	cis	1	rs1548885	chr7:12279559	VWDE	chr7:12370509-12443852:-	-0.13	-3.58	0.000358	Response to amphetamines	
BRCA	cis	1	rs1549829	chr3:150879527	P2RY12	chr3:151055238-151102544:-	0.17	4.29	1.97E-5	Heschl's gyrus morphology	
BRCA	cis	1	rs1553174	chr7:65731194	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.63	5.22E-11	Diabetic kidney disease	
BRCA	cis	1	rs1553174	chr7:65731194	CRCP	chr7:65579805-65619551:+	0.21	3.49	0.000501	Diabetic kidney disease	
BRCA	cis	1	rs1553174	chr7:65731194	LOC493754	chr7:65993446-66057363:-	-0.24	-4.03	5.97E-5	Diabetic kidney disease	
BRCA	cis	1	rs1553609	chr7:66197139	CRCP	chr7:65579805-65619551:+	-0.14	-3.69	0.000232	Aortic root size	
BRCA	cis	1	rs1553609	chr7:66197139	LOC493754	chr7:65993446-66057363:-	-0.13	-3.38	0.000762	Aortic root size	
BRCA	cis	1	rs1553609	chr7:66197139	TYW1	chr7:66461817-66704496:+	0.14	3.82	0.000141	Aortic root size	
BRCA	cis	1	rs1553610	chr7:66197233	CRCP	chr7:65579805-65619551:+	-0.14	-3.69	0.000239	Aortic root size	
BRCA	cis	1	rs1553610	chr7:66197233	TYW1	chr7:66461817-66704496:+	0.14	3.72	0.000208	Aortic root size	
BRCA	cis	1	rs1555095	chr6:56003683	COL21A1	chr6:55921389-56258892:-	-0.36	-6.9	8.83E-12	Psychosis (atypical)	
BRCA	cis	1	rs1555299	chr20:43370106	KCNK15	chr20:43374488-43379666:+	0.13	4.51	7.33E-6	Obesity-related traits	
BRCA	cis	1	rs1555322	chr20:33849179	CPNE1	chr20:34213968-34262539:-	-0.22	-4.18	3.18E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs1555322	chr20:33849179	MMP24	chr20:33814539-33864804:+	-0.17	-3.5	0.000476	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs1556562	chr1:93034023	EVI5	chr1:92974255-93257961:-	0.17	4.65	3.8E-6	Cholesterol, total	
BRCA	cis	1	rs1558299	chr7:151121676	NUB1	chr7:151038858-151075530:+	0.17	3.57	0.000371	Coronary heart disease	
BRCA	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.72	18.53	1.14E-66	Type 2 diabetes	
BRCA	cis	1	rs1560396	chr4:39113712	KLHL5	chr4:39046659-39123828:+	-0.16	-4.91	1.06E-6	Uric acid levels	
BRCA	cis	1	rs1560397	chr4:39113885	KLHL5	chr4:39046659-39123828:+	-0.16	-4.91	1.06E-6	Uric acid levels	
BRCA	cis	1	rs1561288	chr2:25369002	POMC	chr2:25383722-25391559:-	0.14	4.47	8.62E-6	Body mass index	
BRCA	cis	1	rs1561289	chr2:25369040	POMC	chr2:25383722-25391559:-	-0.17	-5.32	1.25E-7	Body mass index	
BRCA	cis	1	rs1561962	chr9:100546219	NCBP1	chr9:100395705-100436027:+	-0.13	-4	6.85E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs1561962	chr9:100546219	TSTD2	chr9:100362364-100395962:-	-0.11	-3.92	9.39E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.27	-10.17	3.1E-23	Longevity	
BRCA	cis	1	rs156407	chr7:23315639	GPNMB	chr7:23286316-23314728:+	-0.12	-4.56	5.74E-6	Parkinson's disease	
BRCA	cis	1	rs156421	chr7:23312487	GPNMB	chr7:23286316-23314728:+	-0.12	-4.5	7.39E-6	Parkinson's disease	
BRCA	cis	1	rs156425	chr7:23309119	GPNMB	chr7:23286316-23314728:+	0.12	4.42	1.11E-5	Parkinson's disease	
BRCA	cis	1	rs1564472	chr15:84569793	GOLGA6L5	chr15:85047738-85060078:-	-0.11	-3.54	0.000411	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs15655	chr1:171673272	VAMP4	chr1:171669298-171711214:-	0.19	5.27	1.65E-7	Hippocampal atrophy	
BRCA	cis	1	rs1568657	chr15:83726179	C15orf40	chr15:83657724-83680393:-	0.21	4.63	4.17E-6	Kawasaki disease	
BRCA	cis	1	rs1569483	chr6:25614595	SCGN	chr6:25652429-25702006:+	0.19	5.23	2.03E-7	Uric acid levels	
BRCA	cis	1	rs1570004	chr20:33958253	CPNE1	chr20:34213968-34262539:-	0.26	7	4.37E-12	Height	
BRCA	cis	1	rs1570004	chr20:33958253	ERGIC3	chr20:34129778-34145404:+	0.13	3.63	0.000295	Height	
BRCA	cis	1	rs1570004	chr20:33958253	MMP24	chr20:33814539-33864804:+	0.18	5.15	3.07E-7	Height	
BRCA	cis	1	rs1570004	chr20:33958253	UQCC	chr20:33890383-33999833:-	0.35	10.7	1.83E-25	Height	
BRCA	cis	1	rs1570836	chr1:92972457	EVI5	chr1:92974255-93257961:-	-0.18	-4.83	1.55E-6	Cholesterol, total	
BRCA	cis	1	rs1570837	chr1:93006816	EVI5	chr1:92974255-93257961:-	-0.18	-4.88	1.2E-6	Cholesterol, total	
BRCA	cis	1	rs1570979	chr13:24441561	PCOTH	chr13:24463028-24466241:+	-0.29	-3.6	0.000339	3-hydroxypropylmercapturic acid levels in smokers	
BRCA	cis	1	rs1581702	chr10:43344246	LOC84856	chr10:42970939-42990784:+	0.16	3.82	0.000143	Progressive supranuclear palsy	
BRCA	cis	1	rs1585333	chr4:18019025	NCAPG	chr4:17812525-17846485:+	0.08	3.6	0.000332	Height	
BRCA	cis	1	rs1585334	chr4:18018944	NCAPG	chr4:17812525-17846485:+	0.08	3.6	0.000332	Height	
BRCA	cis	1	rs1586936	chr1:76366877	ACADM	chr1:76190043-76229353:+	-0.21	-3.91	9.62E-5	Attention function in attention deficit hyperactive disorder	
BRCA	cis	1	rs1586943	chr5:112686205	YTHDC2	chr5:112849410-112930979:+	0.14	3.87	0.000116	Cerebral amyloid angiopathy	
BRCA	cis	1	rs1588635	chr9:100537802	CORO2A	chr9:100883258-100954956:-	-0.14	-3.92	9.48E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs1588635	chr9:100537802	NCBP1	chr9:100395705-100436027:+	-0.16	-4.81	1.7E-6	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs1588635	chr9:100537802	TRIM14	chr9:100831569-100881488:-	-0.13	-3.5	0.000488	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs1588635	chr9:100537802	TSTD2	chr9:100362364-100395962:-	-0.12	-4.43	1.06E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs1592917	chr5:115569414	COMMD10	chr5:115420727-115628978:+	0.23	4.43	1.06E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs1598859	chr4:103506444	MANBA	chr4:103552644-103682151:-	0.17	4.35	1.52E-5	Ulcerative colitis	
BRCA	cis	1	rs1599280	chr6:56792576	BEND6	chr6:56819773-56892138:+	-0.33	-8.92	2.04E-18	Menarche (age at onset)	
BRCA	cis	1	rs1599280	chr6:56792576	KIAA1586	chr6:56911384-56920021:+	-0.2	-4	6.8E-5	Menarche (age at onset)	
BRCA	cis	1	rs1599281	chr6:56789311	BEND6	chr6:56819773-56892138:+	0.23	7.04	3.43E-12	Menarche (age at onset)	
BRCA	cis	1	rs1599281	chr6:56789311	KIAA1586	chr6:56911384-56920021:+	0.17	3.93	9.2E-5	Menarche (age at onset)	
BRCA	cis	1	rs1599932	chr12:58177943	B4GALNT1	chr12:58019551-58026985:-	0.12	3.51	0.00047	Multiple sclerosis	
BRCA	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.43	10.52	1.07E-24	Multiple sclerosis	
BRCA	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.36	-10.5	1.35E-24	Multiple sclerosis	
BRCA	cis	1	rs1599932	chr12:58177943	XRCC6BP1	chr12:58335445-58351051:+	-0.19	-5.11	3.78E-7	Multiple sclerosis	
BRCA	cis	1	rs160633	chr7:65528228	CCT6P1	chr7:65216092-65228661:+	0.34	6.91	8.4E-12	Diabetic kidney disease	
BRCA	cis	1	rs160633	chr7:65528228	LOC493754	chr7:65993446-66057363:-	0.24	3.8	0.000156	Diabetic kidney disease	
BRCA	cis	1	rs160634	chr7:65528664	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.59	6.72E-11	Diabetic kidney disease	
BRCA	cis	1	rs160634	chr7:65528664	LOC493754	chr7:65993446-66057363:-	-0.2	-3.47	0.000532	Diabetic kidney disease	
BRCA	cis	1	rs160637	chr7:65584318	CCT6P1	chr7:65216092-65228661:+	0.32	6.8	1.79E-11	Diabetic kidney disease	
BRCA	cis	1	rs160637	chr7:65584318	CRCP	chr7:65579805-65619551:+	-0.21	-3.5	0.000477	Diabetic kidney disease	
BRCA	cis	1	rs160637	chr7:65584318	LOC493754	chr7:65993446-66057363:-	0.23	3.83	0.000133	Diabetic kidney disease	
BRCA	cis	1	rs160639	chr7:65579987	CCT6P1	chr7:65216092-65228661:+	0.3	6.36	2.97E-10	Diabetic kidney disease	
BRCA	cis	1	rs160639	chr7:65579987	CRCP	chr7:65579805-65619551:+	-0.22	-3.63	0.000302	Diabetic kidney disease	
BRCA	cis	1	rs160639	chr7:65579987	LOC493754	chr7:65993446-66057363:-	0.24	3.92	9.37E-5	Diabetic kidney disease	
BRCA	cis	1	rs160642	chr7:65558373	CCT6P1	chr7:65216092-65228661:+	0.31	6.65	4.57E-11	Diabetic kidney disease	
BRCA	cis	1	rs160642	chr7:65558373	LOC493754	chr7:65993446-66057363:-	0.23	3.85	0.000123	Diabetic kidney disease	
BRCA	cis	1	rs160643	chr7:65558222	CCT6P1	chr7:65216092-65228661:+	0.28	6.35	3.27E-10	Diabetic kidney disease	
BRCA	cis	1	rs160643	chr7:65558222	LOC493754	chr7:65993446-66057363:-	0.21	3.75	0.000184	Diabetic kidney disease	
BRCA	cis	1	rs160644	chr7:65558186	CCT6P1	chr7:65216092-65228661:+	0.31	6.65	4.57E-11	Diabetic kidney disease	
BRCA	cis	1	rs160644	chr7:65558186	LOC493754	chr7:65993446-66057363:-	0.23	3.85	0.000123	Diabetic kidney disease	
BRCA	cis	1	rs160646	chr7:65556280	CCT6P1	chr7:65216092-65228661:+	0.32	6.75	2.49E-11	Diabetic kidney disease	
BRCA	cis	1	rs160646	chr7:65556280	LOC493754	chr7:65993446-66057363:-	0.23	3.78	0.000162	Diabetic kidney disease	
BRCA	cis	1	rs160648	chr7:65543384	CCT6P1	chr7:65216092-65228661:+	0.34	6.98	5.01E-12	Diabetic kidney disease	
BRCA	cis	1	rs160652	chr7:65538431	CCT6P1	chr7:65216092-65228661:+	0.34	6.94	6.92E-12	Diabetic kidney disease	
BRCA	cis	1	rs160652	chr7:65538431	CRCP	chr7:65579805-65619551:+	-0.21	-3.41	0.000681	Diabetic kidney disease	
BRCA	cis	1	rs160652	chr7:65538431	LOC493754	chr7:65993446-66057363:-	0.24	3.76	0.000178	Diabetic kidney disease	
BRCA	cis	1	rs160655	chr7:65533214	CCT6P1	chr7:65216092-65228661:+	0.33	6.92	7.75E-12	Diabetic kidney disease	
BRCA	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.36	-10.2	2.27E-23	Rheumatoid arthritis	
BRCA	cis	1	rs1609810	chr9:123642351	TRAF1	chr9:123664672-123691479:-	0.11	4.91	1.04E-6	Rheumatoid arthritis	
BRCA	cis	1	rs1612735	chr4:100258007	ADH1C	chr4:100257651-100273917:-	-0.2	-6.32	3.93E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1614223	chr12:120964043	POP5	chr12:121016849-121019201:-	-0.15	-3.7	0.000224	Type 1 diabetes nephropathy	
BRCA	cis	1	rs1618893	chr7:66096119	CCT6P1	chr7:65216092-65228661:+	0.19	4.18	3.14E-5	Diabetic kidney disease	
BRCA	cis	1	rs1618893	chr7:66096119	CRCP	chr7:65579805-65619551:+	-0.25	-4.39	1.24E-5	Diabetic kidney disease	
BRCA	cis	1	rs1619560	chr7:38007222	EPDR1	chr7:37960163-37991539:+	-0.22	-3.87	0.000113	Myopia (pathological)	
BRCA	cis	1	rs1621407	chr7:37998207	EPDR1	chr7:37960163-37991539:+	-0.22	-3.88	0.000109	Myopia (pathological)	
BRCA	cis	1	rs162312	chr20:55802858	RBM38	chr20:55966463-55984384:+	-0.12	-3.6	0.00033	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
BRCA	cis	1	rs1625439	chr4:100265325	ADH1C	chr4:100257651-100273917:-	-0.2	-6.47	1.5E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1629270	chr4:100271306	ADH1C	chr4:100257651-100273917:-	-0.2	-6.48	1.39E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1631457	chr6:152946514	VIP	chr6:153071933-153080898:+	0.12	3.98	7.22E-5	Tonometry	
BRCA	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.3	-7.97	4.1E-15	Rheumatoid arthritis	
BRCA	cis	1	rs1633360	chr12:58108052	SLC26A10	chr12:58013693-58019933:+	-0.11	-3.46	0.000562	Rheumatoid arthritis	
BRCA	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.22	6.93	7.47E-12	Rheumatoid arthritis	
BRCA	cis	1	rs1637214	chr7:23236842	NUPL2	chr7:23221446-23240629:+	-0.25	-3.46	0.000561	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs1637224	chr7:23228400	NUPL2	chr7:23221446-23240629:+	-0.25	-3.46	0.000567	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs1638731	chr7:66144679	CCT6P1	chr7:65216092-65228661:+	0.3	6.37	2.82E-10	Gout	
BRCA	cis	1	rs1638731	chr7:66144679	CRCP	chr7:65579805-65619551:+	-0.21	-3.5	0.000482	Gout	
BRCA	cis	1	rs1638731	chr7:66144679	LOC493754	chr7:65993446-66057363:-	0.23	3.73	0.000202	Gout	
BRCA	cis	1	rs1638734	chr7:66097539	CCT6P1	chr7:65216092-65228661:+	0.32	6.84	1.3E-11	Diabetic kidney disease	
BRCA	cis	1	rs1638734	chr7:66097539	LOC493754	chr7:65993446-66057363:-	0.25	4.17	3.36E-5	Diabetic kidney disease	
BRCA	cis	1	rs1662039	chr4:100279684	ADH1C	chr4:100257651-100273917:-	-0.21	-6.72	3.03E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1662049	chr4:100271849	ADH1C	chr4:100257651-100273917:-	-0.21	-6.72	3.03E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1662051	chr4:100267239	ADH1C	chr4:100257651-100273917:-	-0.2	-6.48	1.39E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1662058	chr4:100262759	ADH1C	chr4:100257651-100273917:-	-0.2	-6.32	3.73E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1662059	chr4:100260378	ADH1C	chr4:100257651-100273917:-	-0.2	-6.34	3.38E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1665366	chr4:1728381	FAM53A	chr4:1641609-1685854:-	0.2	5.23	2.05E-7	Urinary bladder cancer;Bladder cancer	
BRCA	cis	1	rs1665650	chr10:118487100	C10orf82	chr10:118423208-118429775:-	-0.14	-4.26	2.26E-5	Colorectal cancer	
BRCA	cis	1	rs1665982	chr3:47905079	CDC25A	chr3:48198668-48229801:-	-0.08	-3.5	0.000488	Educational attainment (years of education)	
BRCA	cis	1	rs1665982	chr3:47905079	NME6	chr3:48335591-48342886:-	0.15	3.43	0.000621	Educational attainment (years of education)	
BRCA	cis	1	rs1665982	chr3:47905079	ZNF589	chr3:48282596-48329113:+	-0.13	-3.45	0.000581	Educational attainment (years of education)	
BRCA	cis	1	rs166663	chr7:23316742	GPNMB	chr7:23286316-23314728:+	-0.12	-4.43	1.05E-5	Parkinson's disease	
BRCA	cis	1	rs1668348	chr7:38010747	EPDR1	chr7:37960163-37991539:+	-0.23	-3.82	0.000139	Myopia (pathological)	
BRCA	cis	1	rs1668353	chr7:38007650	EPDR1	chr7:37960163-37991539:+	-0.22	-3.77	0.00017	Myopia (pathological)	
BRCA	cis	1	rs1668361	chr7:37999434	EPDR1	chr7:37960163-37991539:+	-0.22	-3.74	0.000194	Myopia (pathological)	
BRCA	cis	1	rs1668363	chr7:37996890	EPDR1	chr7:37960163-37991539:+	-0.24	-4.08	4.88E-5	Myopia (pathological)	
BRCA	cis	1	rs166863	chr5:50037451	PARP8	chr5:49961733-50138169:+	-0.14	-4.09	4.69E-5	Myopia (pathological)	
BRCA	cis	1	rs166870	chr15:80069762	MTHFS	chr15:80137320-80189370:-	0.18	4.78	1.97E-6	Disease-free survival in breast cancer	
BRCA	cis	1	rs166925	chr19:41926098	B3GNT8	chr19:41931265-41934635:-	-0.25	-7.65	4.59E-14	Height	
BRCA	cis	1	rs1671656	chr17:33939661	SLFN12L	chr17:33801926-33864880:-	-0.09	-4.75	2.26E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs1678542	chr12:57968715	FAM119B	chr12:58166383-58176323:+	-0.16	-4.1	4.39E-5	Rheumatoid arthritis	
BRCA	cis	1	rs1678542	chr12:57968715	TSFM	chr12:58176536-58191367:+	0.14	4.21	2.82E-5	Rheumatoid arthritis	
BRCA	cis	1	rs1679709	chr6:28228342	HIST1H4J	chr6:27791903-27792257:+	0.19	3.65	0.000279	Depression	
BRCA	cis	1	rs1679709	chr6:28228342	ZNF187	chr6:28234788-28245978:+	0.17	3.89	0.000105	Depression	
BRCA	cis	1	rs1679709	chr6:28228342	ZNF323	chr6:28292517-28324048:-	-0.2	-3.5	0.000483	Depression	
BRCA	cis	1	rs1679709	chr6:28228342	ZNF389	chr6:28129551-28137375:+	0.19	3.49	0.0005	Depression	
BRCA	cis	1	rs1679732	chr6:28221264	HIST1H4J	chr6:27791903-27792257:+	0.18	3.66	0.000268	Depression	
BRCA	cis	1	rs1679732	chr6:28221264	ZNF187	chr6:28234788-28245978:+	0.16	3.78	0.000166	Depression	
BRCA	cis	1	rs1679732	chr6:28221264	ZNF323	chr6:28292517-28324048:-	-0.2	-3.53	0.000429	Depression	
BRCA	cis	1	rs1679732	chr6:28221264	ZNF389	chr6:28129551-28137375:+	0.2	3.69	0.000239	Depression	
BRCA	cis	1	rs16823934	chr3:115335684	GAP43	chr3:115342151-115440334:+	-0.19	-4.43	1.06E-5	Response to cognitive-behavioural therapy in anxiety disorder	
BRCA	cis	1	rs16829945	chr1:25040315	CLIC4	chr1:25071760-25170815:+	-0.1	-3.91	9.67E-5	Height	
BRCA	cis	1	rs16829980	chr3:119278468	CD80	chr3:119243142-119278481:-	0.12	4.08	4.77E-5	Vitiligo	
BRCA	cis	1	rs16829988	chr3:119280390	CD80	chr3:119243142-119278481:-	0.12	4.23	2.57E-5	Vitiligo	
BRCA	cis	1	rs16830002	chr3:119290708	CD80	chr3:119243142-119278481:-	-0.12	-4.39	1.25E-5	Vitiligo	
BRCA	cis	1	rs16830004	chr3:119290823	CD80	chr3:119243142-119278481:-	-0.11	-3.94	8.78E-5	Vitiligo	
BRCA	cis	1	rs16830008	chr3:119291252	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs16830945	chr2:135471748	TMEM163	chr2:135213331-135525334:-	0.25	5.08	4.42E-7	Gut microbiome composition (winter)	
BRCA	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.55	10.08	7.01E-23	Rheumatoid arthritis	
BRCA	cis	1	rs16839077	chr2:203208693	NOP58	chr2:203130515-203168382:+	0.15	3.41	0.00068	Urate levels	
BRCA	cis	1	rs16839090	chr2:203213061	NOP58	chr2:203130515-203168382:+	0.15	3.52	0.000444	Urate levels	
BRCA	cis	1	rs16839793	chr3:132622657	NPHP3	chr3:132363641-132441276:-	-0.1	-3.46	0.000551	Number of pregnancies	
BRCA	cis	1	rs16843245	chr2:242032709	MTERFD2	chr2:242034545-242041747:-	-0.23	-3.44	0.000605	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
BRCA	cis	1	rs16843267	chr2:242039589	MTERFD2	chr2:242034545-242041747:-	0.26	4.1	4.42E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
BRCA	cis	1	rs16844715	chr2:160915106	LY75	chr2:160625141-160761262:-	-0.14	-4.9	1.13E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs16844715	chr2:160915106	PLA2R1	chr2:160798012-160919121:-	-0.15	-5.08	4.44E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs1684942	chr3:47900703	CSPG5	chr3:47603729-47621730:-	0.17	4.12	4.03E-5	Educational attainment (years of education)	
BRCA	cis	1	rs1684942	chr3:47900703	ZNF589	chr3:48282596-48329113:+	0.14	4.26	2.19E-5	Educational attainment (years of education)	
BRCA	cis	1	rs16862426	chr1:19321495	UBR4	chr1:19398604-19536746:-	0.2	3.62	0.000308	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
BRCA	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.6	-19.71	5.53E-74	Response to antipsychotic treatment	
BRCA	cis	1	rs16881242	chr8:33644118	RNF122	chr8:33405273-33424643:-	-0.19	-3.43	0.000633	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs16889317	chr6:159414843	RSPH3	chr6:159398268-159421198:-	0.27	4.8	1.78E-6	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs16889320	chr6:159414899	RSPH3	chr6:159398268-159421198:-	0.27	4.8	1.78E-6	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs16889325	chr6:159417132	RSPH3	chr6:159398268-159421198:-	0.26	4.55	6.05E-6	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs16889440	chr6:24544967	ALDH5A1	chr6:24495197-24537434:+	-0.17	-3.48	0.000531	Radiation response	
BRCA	cis	1	rs16889440	chr6:24544967	GPLD1	chr6:24428405-24489850:-	-0.27	-5.51	4.52E-8	Radiation response	
BRCA	cis	1	rs16891378	chr6:26188864	HIST1H3E	chr6:26224427-26226589:+	0.38	7.49	1.48E-13	Renal underexcretion gout;Gout	
BRCA	cis	1	rs16891397	chr6:26200256	HIST1H3E	chr6:26224427-26226589:+	0.35	6.99	4.67E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs16891401	chr6:26202337	HIST1H3E	chr6:26224427-26226589:+	0.35	6.98	5.05E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs16891405	chr6:26204506	HIST1H3E	chr6:26224427-26226589:+	0.39	7.67	3.72E-14	Renal underexcretion gout;Gout	
BRCA	cis	1	rs16894959	chr6:34825662	C6orf127	chr6:35748831-35755840:+	-0.19	-3.86	0.000121	Pubertal anthropometrics	
BRCA	cis	1	rs16894959	chr6:34825662	UHRF1BP1	chr6:34759794-34853117:+	0.15	4.19	3.0E-5	Pubertal anthropometrics	
BRCA	cis	1	rs16896068	chr4:17944840	NCAPG	chr4:17812525-17846485:+	0.08	3.66	0.000261	Height	
BRCA	cis	1	rs16896074	chr4:17947873	NCAPG	chr4:17812525-17846485:+	0.08	3.95	8.24E-5	Height	
BRCA	cis	1	rs16896101	chr4:17950626	NCAPG	chr4:17812525-17846485:+	0.09	4.05	5.59E-5	Height	
BRCA	cis	1	rs16896128	chr4:17953590	NCAPG	chr4:17812525-17846485:+	0.08	3.56	0.000395	Height	
BRCA	cis	1	rs16896164	chr4:17967094	NCAPG	chr4:17812525-17846485:+	0.09	4.4	1.18E-5	Height	
BRCA	cis	1	rs16896182	chr4:17973899	NCAPG	chr4:17812525-17846485:+	0.1	4.48	8.1E-6	Height	
BRCA	cis	1	rs16896210	chr4:17992332	NCAPG	chr4:17812525-17846485:+	0.1	4.66	3.59E-6	Height	
BRCA	cis	1	rs16896213	chr4:17994661	NCAPG	chr4:17812525-17846485:+	0.08	3.76	0.000179	Height	
BRCA	cis	1	rs16896215	chr4:17995312	NCAPG	chr4:17812525-17846485:+	0.08	3.71	0.000221	Height	
BRCA	cis	1	rs16896229	chr4:18002583	NCAPG	chr4:17812525-17846485:+	0.08	3.68	0.000242	Height	
BRCA	cis	1	rs16896236	chr4:18003812	NCAPG	chr4:17812525-17846485:+	0.08	3.77	0.000173	Height	
BRCA	cis	1	rs16896245	chr4:18005608	NCAPG	chr4:17812525-17846485:+	0.08	3.8	0.000154	Height	
BRCA	cis	1	rs16896271	chr4:18012454	NCAPG	chr4:17812525-17846485:+	0.08	3.61	0.000321	Height	
BRCA	cis	1	rs16896312	chr4:18030853	NCAPG	chr4:17812525-17846485:+	0.09	4.14	3.77E-5	Height	
BRCA	cis	1	rs16899276	chr5:81165704	ATP6AP1L	chr5:81575281-81614146:+	0.13	3.9	0.000103	Cognitive function	
BRCA	cis	1	rs16899788	chr6:167431326	BRP44L	chr6:166778410-166796486:-	0.29	4.07	5.13E-5	Smooth-surface caries	
BRCA	cis	1	rs16899788	chr6:167431326	C6orf124	chr6:168224570-168227476:-	0.31	4.16	3.5E-5	Smooth-surface caries	
BRCA	cis	1	rs16899788	chr6:167431326	FGFR1OP	chr6:167412816-167454065:+	0.37	4.51	7.17E-6	Smooth-surface caries	
BRCA	cis	1	rs16899788	chr6:167431326	MLLT4	chr6:168227671-168372702:+	0.37	4.95	8.73E-7	Smooth-surface caries	
BRCA	cis	1	rs16899788	chr6:167431326	SFT2D1	chr6:166733519-166755991:-	0.36	4.65	3.76E-6	Smooth-surface caries	
BRCA	cis	1	rs16916041	chr10:63146547	C10orf107	chr10:63422719-63526089:+	-0.35	-6.28	5.01E-10	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	
BRCA	cis	1	rs16917224	chr8:96030110	C8orf38	chr8:95908040-96088396:+	-0.15	-3.5	0.000493	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs16917233	chr8:96044967	C8orf38	chr8:95908040-96088396:+	0.17	4.08	4.88E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs16928809	chr11:2936952	SLC22A18	chr11:2920951-2946475:+	-0.45	-10.72	1.5E-25	Bilirubin levels	
BRCA	cis	1	rs16930343	chr10:29800468	LOC387647	chr10:29698483-29776785:+	0.15	4.01	6.62E-5	Platelet thrombus formation	
BRCA	cis	1	rs1693424	chr4:100265236	ADH1C	chr4:100257651-100273917:-	-0.2	-6.32	3.77E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1693426	chr4:100266330	ADH1C	chr4:100257651-100273917:-	-0.2	-6.51	1.12E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1693430	chr4:100267668	ADH1C	chr4:100257651-100273917:-	-0.2	-6.48	1.39E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1693470	chr4:100279489	ADH1C	chr4:100257651-100273917:-	-0.21	-6.72	2.93E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1693471	chr4:100261952	ADH1C	chr4:100257651-100273917:-	-0.2	-6.38	2.71E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1693476	chr4:100260274	ADH1C	chr4:100257651-100273917:-	0.19	6.26	5.48E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1693476	chr4:100260274	ADH4	chr4:100044835-100065449:-	0.11	3.53	0.000434	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1693477	chr4:100263062	ADH1C	chr4:100257651-100273917:-	-0.2	-6.32	3.73E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1693483	chr4:100264946	ADH1C	chr4:100257651-100273917:-	-0.2	-6.46	1.61E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs16935432	chr11:18470487	LDHC	chr11:18433853-18472792:+	-0.3	-5.29	1.49E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs16942155	chr15:60418758	GTF2A2	chr15:59930263-59949737:-	0.32	5.94	3.94E-9	Type 2 diabetes	
BRCA	cis	1	rs16942155	chr15:60418758	NARG2	chr15:60711809-60771344:-	0.21	4.54	6.17E-6	Type 2 diabetes	
BRCA	cis	1	rs16945894	chr16:48180110	ITFG1	chr16:47189300-47495135:-	-0.15	-3.61	0.000319	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs16945894	chr16:48180110	LONP2	chr16:48278211-48387407:+	-0.17	-3.98	7.37E-5	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs16945894	chr16:48180110	N4BP1	chr16:48572639-48644120:-	-0.21	-4.33	1.61E-5	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs16945894	chr16:48180110	PHKB	chr16:47495210-47735433:+	-0.19	-4.25	2.37E-5	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs16948048	chr17:47440466	GNGT2	chr17:47283597-47286743:-	-0.09	-5.25	1.83E-7	Diastolic blood pressure	
BRCA	cis	1	rs16952611	chr18:48382668	MRO	chr18:48321491-48351754:-	-0.32	-7.61	5.87E-14	Entorhinal cortical thickness	
BRCA	cis	1	rs16958432	chr18:44631773	HDHD2	chr18:44633782-44676871:-	0.3	5.17	2.85E-7	Sitting height ratio	
BRCA	cis	1	rs16958440	chr18:44632884	HDHD2	chr18:44633782-44676871:-	0.3	5.17	2.85E-7	Sitting height ratio	
BRCA	cis	1	rs16958445	chr15:74176557	ARID3B	chr15:74833548-74890470:+	0.32	4.2	2.83E-5	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	CD276	chr15:73976622-74006859:+	0.27	4.39	1.26E-5	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	CLK3	chr15:74890843-74922541:+	0.36	5.83	7.39E-9	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	CSK	chr15:75074425-75095539:+	0.28	5.45	6.23E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	EDC3	chr15:74922900-74988386:-	0.57	6.83	1.47E-11	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	NEO1	chr15:73344875-73597543:+	0.28	3.86	0.000118	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	NPTN	chr15:73852345-73925753:-	0.3	4.15	3.57E-5	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	PML	chr15:74287014-74340153:+	0.27	4.9	1.11E-6	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	SCAMP2	chr15:75136073-75165670:-	0.44	5.72	1.42E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	STOML1	chr15:74275561-74286949:-	0.33	5.19	2.51E-7	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	UBL7	chr15:74738318-74753529:-	0.49	7.64	4.8E-14	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958445	chr15:74176557	ULK3	chr15:75128459-75135552:-	0.39	5.65	2.02E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	cis	1	rs16958701	chr18:44655241	HDHD2	chr18:44633782-44676871:-	0.29	5.13	3.5E-7	Sitting height ratio	
BRCA	cis	1	rs16959799	chr16:58229628	C16orf80	chr16:58147497-58163296:-	0.2	5.2	2.41E-7	Telomere length	
BRCA	cis	1	rs16966947	chr16:15141045	C16orf63	chr16:15959577-15982447:-	0.13	3.64	0.000286	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs16966952	chr16:15135943	C16orf63	chr16:15959577-15982447:-	0.14	3.92	9.45E-5	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs16966953	chr16:15135854	C16orf63	chr16:15959577-15982447:-	0.15	4.13	3.95E-5	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs16970287	chr15:79228257	CTSH	chr15:79214092-79237420:-	-0.26	-4.84	1.48E-6	Bipolar disorder	
BRCA	cis	1	rs16972767	chr19:39153044	LGALS7	chr19:39261608-39264157:-	-0.18	-5.49	5.07E-8	Heart rate	
BRCA	cis	1	rs16975963	chr19:38325536	WDR87	chr19:38375472-38397317:-	-0.24	-5.39	8.89E-8	Longevity	
BRCA	cis	1	rs16979304	chr19:13800408	CC2D1A	chr19:14016956-14041693:+	-0.12	-3.79	0.00016	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs16979304	chr19:13800408	DCAF15	chr19:14063319-14072254:+	-0.11	-3.83	0.000133	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs16979304	chr19:13800408	MRI1	chr19:13875337-13885095:+	-0.17	-4.56	5.84E-6	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs16979306	chr19:13802760	MRI1	chr19:13875337-13885095:+	-0.17	-4.42	1.08E-5	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs16979973	chr20:55056589	C20orf43	chr20:55043647-55093942:+	0.14	3.85	0.000124	Refractive astigmatism	
BRCA	cis	1	rs16983290	chr20:61478894	C20orf195	chr20:62184373-62188033:+	0.23	4.07	5.01E-5	Obesity-related traits	
BRCA	cis	1	rs16995986	chr4:86693317	WDFY3	chr4:85590697-85887544:-	-0.26	-5.62	2.38E-8	Diisocyanate-induced asthma	
BRCA	cis	1	rs16996444	chr19:9997238	OLFM2	chr19:9964395-10047070:-	-0.12	-3.9	0.0001	Menarche (age at onset)	
BRCA	cis	1	rs16996969	chr4:109382668	SEC24B	chr4:110354971-110461614:+	0.12	3.5	0.000487	Gut microbiome composition (summer)	
BRCA	cis	1	rs1700490	chr5:176402401	MXD3	chr5:176732501-176739292:-	-0.08	-3.75	0.000183	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs1701750	chr7:65467145	CCT6P1	chr7:65216092-65228661:+	0.34	7.33	4.65E-13	Diabetic kidney disease	
BRCA	cis	1	rs1701750	chr7:65467145	LOC493754	chr7:65993446-66057363:-	0.21	3.53	0.00043	Diabetic kidney disease	
BRCA	cis	1	rs1701758	chr7:65470201	CCT6P1	chr7:65216092-65228661:+	0.34	7.34	4.23E-13	Diabetic kidney disease	
BRCA	cis	1	rs1701758	chr7:65470201	LOC493754	chr7:65993446-66057363:-	0.21	3.54	0.000422	Diabetic kidney disease	
BRCA	cis	1	rs170213	chr17:3660864	ZMYND15	chr17:4643319-4649410:+	-0.1	-3.66	0.000267	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs17026729	chr2:86102178	POLR1A	chr2:86253453-86333278:-	-0.22	-3.76	0.000182	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs17026902	chr3:31040041	STT3B	chr3:31574491-31677554:+	0.1	3.5	0.000483	Eating disorders (purging via substances)	
BRCA	cis	1	rs17027011	chr2:86406556	LOC90784	chr2:86247339-86250991:-	-0.27	-3.65	0.000271	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs17027011	chr2:86406556	ST3GAL5	chr2:86066271-86116157:-	0.31	4.53	6.68E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.55	11.56	3.17E-29	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.55	11.74	5.06E-30	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs17032850	chr4:103507703	MANBA	chr4:103552644-103682151:-	0.17	4.18	3.12E-5	Ulcerative colitis	
BRCA	cis	1	rs17036120	chr4:106621508	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs17036123	chr4:106622190	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs17036125	chr4:106623674	INTS12	chr4:106603787-106629881:-	-0.28	-3.49	0.000502	Post bronchodilator FEV1	
BRCA	cis	1	rs17036139	chr4:106632657	INTS12	chr4:106603787-106629881:-	-0.31	-3.93	8.91E-5	Post bronchodilator FEV1	
BRCA	cis	1	rs17036189	chr4:106687959	INTS12	chr4:106603787-106629881:-	-0.31	-3.82	0.00014	Post bronchodilator FEV1	
BRCA	cis	1	rs17036225	chr4:106710092	INTS12	chr4:106603787-106629881:-	-0.26	-3.39	0.000716	Post bronchodilator FEV1	
BRCA	cis	1	rs17036230	chr4:106715148	INTS12	chr4:106603787-106629881:-	-0.33	-4.2	2.84E-5	Post bronchodilator FEV1	
BRCA	cis	1	rs17037427	chr1:11873416	CLCN6	chr1:11866207-11907674:+	0.16	4.63	4.13E-6	QRS complex (12-leadsum)	
BRCA	cis	1	rs17037429	chr1:11873787	CLCN6	chr1:11866207-11907674:+	-0.17	-4.98	7.5E-7	QRS complex (12-leadsum)	
BRCA	cis	1	rs17037452	chr1:11895675	CLCN6	chr1:11866207-11907674:+	0.17	4.74	2.37E-6	QRS complex (12-leadsum)	
BRCA	cis	1	rs17045711	chr2:54476678	C2orf73	chr2:54558071-54588714:+	0.17	4.17	3.29E-5	Telomere length	
BRCA	cis	1	rs17062991	chr6:134193910	TCF21	chr6:134210259-134219157:+	0.16	4.13	3.92E-5	Coronary heart disease	
BRCA	cis	1	rs17072683	chr6:111731210	KIAA1919	chr6:111580482-111590259:+	0.31	4.42	1.08E-5	Psoriasis	
BRCA	cis	1	rs1707304	chr1:46598269	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.77	3.81E-30	Body mass index	
BRCA	cis	1	rs1707304	chr1:46598269	MUTYH	chr1:45794915-45806142:-	0.12	4.49	7.93E-6	Body mass index	
BRCA	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.77	3.63E-30	Body mass index	
BRCA	cis	1	rs1707321	chr1:46505309	MUTYH	chr1:45794915-45806142:-	0.12	4.6	4.77E-6	Body mass index	
BRCA	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.72	6.14E-30	Body mass index	
BRCA	cis	1	rs1707335	chr1:46571921	MUTYH	chr1:45794915-45806142:-	0.12	4.83	1.56E-6	Body mass index	
BRCA	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.57	3.11E-29	Body mass index	
BRCA	cis	1	rs1707336	chr1:46493460	CCDC17	chr1:46085717-46089729:-	0.11	3.59	0.000347	Body mass index	
BRCA	cis	1	rs1707336	chr1:46493460	MUTYH	chr1:45794915-45806142:-	0.12	4.72	2.69E-6	Body mass index	
BRCA	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.71	7.11E-30	Body mass index	
BRCA	cis	1	rs1707340	chr1:46514942	MUTYH	chr1:45794915-45806142:-	0.12	4.7	3.0E-6	Body mass index	
BRCA	cis	1	rs17077968	chr6:116769598	FAM26F	chr6:116782556-116784933:+	-0.13	-4.12	4.12E-5	Otitis media (recurrent);Otitis media	
BRCA	cis	1	rs17079773	chr13:24598384	CENPJ	chr13:25456414-25497085:-	0.15	3.6	0.000328	Inattentive symptoms	
BRCA	cis	1	rs17090837	chr6:111751853	KIAA1919	chr6:111580482-111590259:+	0.32	4.51	7.31E-6	Psoriasis	
BRCA	cis	1	rs17092215	chr20:33595913	PROCR	chr20:33758727-33765164:+	-0.18	-4.26	2.22E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs17094246	chr14:97098013	ATG2B	chr14:96747596-96829678:-	-0.12	-3.45	0.000587	Tanning	
BRCA	cis	1	rs17095456	chr14:107132575	LOC100133469	chr14:106938455-106951529:+	0.15	3.41	0.000679	Alzheimer's disease (late onset)	
BRCA	cis	1	rs17101854	chr14:64906265	PPP2R5E	chr14:63841355-64010079:-	0.19	3.89	0.000107	Cognitive performance	
BRCA	cis	1	rs17103138	chr10:123913330	ATE1	chr10:123502626-123688217:-	0.14	3.88	0.000111	Myopia (pathological)	
BRCA	cis	1	rs17103138	chr10:123913330	PLEKHA1	chr10:124134220-124191866:+	0.17	3.41	0.000678	Myopia (pathological)	
BRCA	cis	1	rs17109512	chr10:100127551	PYROXD2	chr10:100143323-100174978:-	0.37	4.85	1.44E-6	Aspartate aminotransferase	
BRCA	cis	1	rs17110192	chr10:96441927	C10orf129	chr10:96953957-96988685:+	-0.32	-5.22	2.12E-7	Blood metabolite levels	
BRCA	cis	1	rs17110194	chr10:96441949	C10orf129	chr10:96953957-96988685:+	0.36	5.72	1.41E-8	Blood metabolite levels	
BRCA	cis	1	rs17110236	chr10:96493332	C10orf129	chr10:96953957-96988685:+	0.33	5.44	6.64E-8	Blood metabolite levels	
BRCA	cis	1	rs17110314	chr10:96633434	C10orf129	chr10:96953957-96988685:+	0.35	5.71	1.45E-8	Blood metabolite levels	
BRCA	cis	1	rs17110317	chr10:96634735	C10orf129	chr10:96953957-96988685:+	0.35	5.71	1.45E-8	Blood metabolite levels	
BRCA	cis	1	rs17110321	chr10:96639896	C10orf129	chr10:96953957-96988685:+	0.31	5.4	8.03E-8	Blood metabolite levels	
BRCA	cis	1	rs17111346	chr14:81452172	TSHR	chr14:81421869-81612646:+	-0.13	-3.8	0.000155	Graves' disease	
BRCA	cis	1	rs17112901	chr10:102066185	PKD2L1	chr10:102047903-102090243:-	-0.21	-4.32	1.74E-5	Obesity-related traits	
BRCA	cis	1	rs17113137	chr10:102241998	SEC31B	chr10:102246403-102289636:-	-0.28	-10.3	8.62E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs17115100	chr10:104591393	SFXN2	chr10:104474298-104498946:+	-0.25	-4.82	1.68E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs17115100	chr10:104591393	TMEM180	chr10:104221170-104238858:+	0.21	3.81	0.000147	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs17116334	chr11:113961762	RBM7	chr11:114271384-114279632:+	-0.15	-4.62	4.39E-6	Conduct disorder (interaction)	
BRCA	cis	1	rs17116334	chr11:113961762	REXO2	chr11:114310108-114320998:+	-0.14	-4.01	6.51E-5	Conduct disorder (interaction)	
BRCA	cis	1	rs17116334	chr11:113961762	USP28	chr11:113668598-113746256:-	-0.17	-4.46	9.03E-6	Conduct disorder (interaction)	
BRCA	cis	1	rs17116334	chr11:113961762	ZW10	chr11:113603911-113644425:-	-0.2	-5.37	9.62E-8	Conduct disorder (interaction)	
BRCA	cis	1	rs17118403	chr12:56630067	COQ10A	chr12:56660642-56664748:+	-0.29	-4.08	4.78E-5	Psoriasis vulgaris	
BRCA	cis	1	rs17118403	chr12:56630067	RPS26	chr12:56435686-56438005:+	-0.29	-3.72	0.000212	Psoriasis vulgaris	
BRCA	cis	1	rs17118403	chr12:56630067	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.91	9.88E-5	Psoriasis vulgaris	
BRCA	cis	1	rs17118409	chr12:56630764	COQ10A	chr12:56660642-56664748:+	-0.29	-4.08	4.78E-5	Psoriasis vulgaris	
BRCA	cis	1	rs17118409	chr12:56630764	RPS26	chr12:56435686-56438005:+	-0.29	-3.72	0.000212	Psoriasis vulgaris	
BRCA	cis	1	rs17118409	chr12:56630764	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.91	9.88E-5	Psoriasis vulgaris	
BRCA	cis	1	rs17118439	chr12:56667604	COQ10A	chr12:56660642-56664748:+	0.25	3.55	0.000396	Psoriasis vulgaris	
BRCA	cis	1	rs17118439	chr12:56667604	RPS26	chr12:56435686-56438005:+	0.28	3.77	0.000175	Psoriasis vulgaris	
BRCA	cis	1	rs17118439	chr12:56667604	SLC39A5	chr12:56623820-56631627:+	0.23	3.44	0.000601	Psoriasis vulgaris	
BRCA	cis	1	rs17121622	chr1:100377744	LRRC39	chr1:100614413-100643800:-	0.33	3.89	0.000105	Carotid intima media thickness	
BRCA	cis	1	rs17122021	chr11:118145686	AMICA1	chr11:118064442-118095809:-	0.06	4.11	4.29E-5	Pain	
BRCA	cis	1	rs17122021	chr11:118145686	SCN2B	chr11:118033519-118047337:-	0.09	4.1	4.4E-5	Pain	
BRCA	cis	1	rs17125944	chr14:53400629	FERMT2	chr14:53323990-53417815:-	-0.14	-3.54	0.000419	Alzheimer's disease (late onset)	
BRCA	cis	1	rs17126180	chr12:52263956	C12orf44	chr12:52463758-52471278:+	0.18	3.59	0.000346	Response to antipsychotic treatment in schizophrenia (reasoning)	
BRCA	cis	1	rs17126902	chr10:111710381	XPNPEP1	chr10:111624524-111683202:-	-0.16	-3.7	0.000226	Biliary atresia	
BRCA	cis	1	rs17131613	chr1:84812664	DNASE2B	chr1:84864215-84880691:+	0.31	4.42	1.1E-5	Obesity-related traits	
BRCA	cis	1	rs1713422	chr14:20940834	PNP	chr14:20937542-20945246:+	-0.18	-4.45	9.58E-6	Interferon alpha levels in systemic lupus erythematosus	
BRCA	cis	1	rs17134750	chr10:5343563	AKR1C3	chr10:5005454-5149876:+	-0.2	-3.82	0.000142	Intelligence	
BRCA	cis	1	rs17135597	chr5:112719722	YTHDC2	chr5:112849410-112930979:+	0.14	4.2	2.87E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs17135608	chr5:112742307	YTHDC2	chr5:112849410-112930979:+	0.13	3.87	0.000115	Cerebral amyloid angiopathy	
BRCA	cis	1	rs17135616	chr5:112761680	YTHDC2	chr5:112849410-112930979:+	0.15	4.22	2.65E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs17135630	chr5:112785124	YTHDC2	chr5:112849410-112930979:+	0.14	4.15	3.57E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs17138171	chr11:79062930	NARS2	chr11:78147017-78285909:-	-0.19	-3.92	9.45E-5	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);Bipolar disorder	
BRCA	cis	1	rs17138884	chr5:115425628	COMMD10	chr5:115420727-115628978:+	0.19	4.4	1.2E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs17138917	chr5:115469316	COMMD10	chr5:115420727-115628978:+	0.2	4.36	1.41E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs17139192	chr5:115561710	COMMD10	chr5:115420727-115628978:+	0.24	5.06	4.95E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs17139193	chr5:115562073	COMMD10	chr5:115420727-115628978:+	0.24	5.06	4.95E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs17139224	chr5:115568193	COMMD10	chr5:115420727-115628978:+	0.27	5.14	3.28E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs17139265	chr5:115578810	COMMD10	chr5:115420727-115628978:+	0.22	4.61	4.5E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs17139314	chr5:115607127	COMMD10	chr5:115420727-115628978:+	0.26	4.9	1.09E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs17145713	chr7:72904810	MLXIPL	chr7:73007524-73038870:-	0.3	5.79	9.2E-9	Triglycerides	
BRCA	cis	1	rs17149161	chr7:75978229	UPK3B	chr7:76139745-76157197:+	-0.24	-6.3	4.32E-10	Multiple sclerosis	
BRCA	cis	1	rs1715235	chr7:65488394	CCT6P1	chr7:65216092-65228661:+	0.34	7.28	6.53E-13	Diabetic kidney disease	
BRCA	cis	1	rs1715235	chr7:65488394	LOC493754	chr7:65993446-66057363:-	0.2	3.44	0.000608	Diabetic kidney disease	
BRCA	cis	1	rs17154676	chr5:125912120	ALDH7A1	chr5:125878918-125931082:-	0.22	3.73	0.000203	Osteoporosis	
BRCA	cis	1	rs17161692	chr7:98953863	CYP3A5	chr7:99245818-99332821:-	-0.36	-5.74	1.26E-8	Blood metabolite levels	
BRCA	cis	1	rs17162339	chr1:27252823	GPATCH3	chr1:27216980-27226962:-	-0.22	-4.44	1.01E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs17162339	chr1:27252823	HMGN2	chr1:26798902-26803131:+	-0.22	-3.51	0.000463	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs17162387	chr1:27293356	GPATCH3	chr1:27216980-27226962:-	0.18	3.64	0.000289	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.39	9.01	9.28E-19	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs1717732	chr7:37999138	EPDR1	chr7:37960163-37991539:+	-0.2	-3.49	0.000494	Myopia (pathological)	
BRCA	cis	1	rs1717737	chr7:38013916	EPDR1	chr7:37960163-37991539:+	-0.23	-3.87	0.000116	Myopia (pathological)	
BRCA	cis	1	rs1717741	chr7:38004057	EPDR1	chr7:37960163-37991539:+	-0.22	-3.89	0.000105	Myopia (pathological)	
BRCA	cis	1	rs1717742	chr7:38005001	EPDR1	chr7:37960163-37991539:+	-0.23	-3.79	0.000156	Myopia (pathological)	
BRCA	cis	1	rs1717744	chr7:38009296	EPDR1	chr7:37960163-37991539:+	0.21	3.64	0.000286	Myopia (pathological)	
BRCA	cis	1	rs17177753	chr14:71619724	RGS6	chr14:72399156-73033237:+	0.15	3.56	0.000387	Gestational age at birth in labor-initiated deliveries (child effect);Response to zileuton treatment in asthma (FEV1 change interaction)	
BRCA	cis	1	rs17185211	chr18:67148381	TMX3	chr18:66340927-66382353:-	-0.15	-3.93	9.05E-5	Osteoporosis-related phenotypes	
BRCA	cis	1	rs17185907	chr1:119465793	WARS2	chr1:119573841-119683295:-	0.26	4.79	1.86E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs17185933	chr1:119474772	WARS2	chr1:119573841-119683295:-	0.25	4.81	1.74E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs1719271	chr15:65183801	PIF1	chr15:65107833-65117838:-	0.09	3.81	0.000147	Platelet count	
BRCA	cis	1	rs17194199	chr2:218312376	DIRC3	chr2:218148748-218621316:-	0.19	3.98	7.51E-5	Metabolite levels (MHPG)	
BRCA	cis	1	rs17194225	chr16:83141106	NECAB2	chr16:84002237-84036377:+	-0.21	-3.41	0.000671	Maximal oxygen uptake response	
BRCA	cis	1	rs1720825	chr3:138108083	TXNDC6	chr3:137980279-138048728:-	-0.19	-4.16	3.39E-5	Body mass index	
BRCA	cis	1	rs17218267	chr6:55935111	COL21A1	chr6:55921389-56258892:-	-0.38	-6.93	7.21E-12	Psychosis (atypical)	
BRCA	cis	1	rs17218309	chr6:55935196	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs17218770	chr6:55942956	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs17219063	chr6:56000228	COL21A1	chr6:55921389-56258892:-	-0.34	-6.33	3.66E-10	Psychosis (atypical)	
BRCA	cis	1	rs17219126	chr6:56001681	COL21A1	chr6:55921389-56258892:-	-0.37	-6.77	2.09E-11	Psychosis (atypical)	
BRCA	cis	1	rs17219382	chr6:56009638	COL21A1	chr6:55921389-56258892:-	0.37	7.14	1.71E-12	Psychosis (atypical)	
BRCA	cis	1	rs17223420	chr12:983720	RAD52	chr12:1021255-1099219:-	-0.33	-7.23	9.35E-13	Colorectal cancer	
BRCA	cis	1	rs1723267	chr7:65473314	CCT6P1	chr7:65216092-65228661:+	0.34	7.34	4.13E-13	Diabetic kidney disease	
BRCA	cis	1	rs1723269	chr7:65472786	CCT6P1	chr7:65216092-65228661:+	0.35	7.48	1.56E-13	Diabetic kidney disease	
BRCA	cis	1	rs1723269	chr7:65472786	LOC493754	chr7:65993446-66057363:-	0.2	3.43	0.000635	Diabetic kidney disease	
BRCA	cis	1	rs1723270	chr7:65469830	CCT6P1	chr7:65216092-65228661:+	0.35	7.48	1.59E-13	Diabetic kidney disease	
BRCA	cis	1	rs1723270	chr7:65469830	LOC493754	chr7:65993446-66057363:-	0.21	3.46	0.000556	Diabetic kidney disease	
BRCA	cis	1	rs17246035	chr14:65874130	LOC645431	chr14:65877313-65879335:-	-0.3	-6.34	3.46E-10	Ischemic stroke	
BRCA	cis	1	rs17246042	chr14:65874330	LOC645431	chr14:65877313-65879335:-	-0.29	-6.21	7.63E-10	Ischemic stroke	
BRCA	cis	1	rs1727052	chr6:152947175	VIP	chr6:153071933-153080898:+	0.12	4.04	5.66E-5	Tonometry	
BRCA	cis	1	rs1727054	chr6:152947742	VIP	chr6:153071933-153080898:+	0.12	4.04	5.66E-5	Tonometry	
BRCA	cis	1	rs17280791	chr4:76503379	G3BP2	chr4:76567955-76598667:-	-0.12	-4	6.9E-5	Magnesium levels	
BRCA	cis	1	rs1728327	chr7:23235483	NUPL2	chr7:23221446-23240629:+	-0.25	-3.46	0.000561	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs17284288	chr5:82444816	XRCC4	chr5:82373317-82649577:+	-0.12	-3.4	0.000703	Hypertension	
BRCA	cis	1	rs17290922	chr16:57024317	CX3CL1	chr16:57406414-57418954:+	-0.15	-3.48	0.000515	Schizophrenia	
BRCA	cis	1	rs1729245	chr2:233424891	EIF4E2	chr2:233415357-233448349:+	0.21	4.91	1.05E-6	Height	
BRCA	cis	1	rs1729245	chr2:233424891	TIGD1	chr2:233412779-233415226:-	0.15	3.8	0.000154	Height	
BRCA	cis	1	rs17293608	chr10:1056252	IDI2	chr10:1064847-1071799:-	-0.21	-4.03	5.86E-5	Response to angiotensin II receptor blocker therapy	
BRCA	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.71	-9.74	1.53E-21	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs17311679	chr19:50521331	TBC1D17	chr19:50380829-50392000:+	0.19	3.66	0.000262	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs17317888	chr20:33594959	MMP24	chr20:33814539-33864804:+	-0.24	-4.19	3.0E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs17317888	chr20:33594959	PROCR	chr20:33758727-33765164:+	-0.24	-4.94	9.07E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs17318666	chr19:41940342	B3GNT8	chr19:41931265-41934635:-	0.24	7.14	1.77E-12	Height	
BRCA	cis	1	rs17319967	chr20:33693650	MMP24	chr20:33814539-33864804:+	-0.2	-3.61	0.000326	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs17319967	chr20:33693650	PROCR	chr20:33758727-33765164:+	-0.24	-5.03	5.67E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs173334	chr6:88080223	C6orf163	chr6:88057220-88075180:+	0.17	4.33	1.64E-5	Depressive episodes in bipolar disorder	
BRCA	cis	1	rs17340509	chr1:27274700	GPATCH3	chr1:27216980-27226962:-	0.23	4.17	3.26E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs17341301	chr2:160902420	LY75	chr2:160625141-160761262:-	0.15	5.09	4.23E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs17341301	chr2:160902420	PLA2R1	chr2:160798012-160919121:-	0.17	5.73	1.27E-8	Idiopathic membranous nephropathy	
BRCA	cis	1	rs17356923	chr1:27282676	GPATCH3	chr1:27216980-27226962:-	0.22	3.92	9.59E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs17360994	chr1:27278573	GPATCH3	chr1:27216980-27226962:-	0.23	4.17	3.26E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs17385641	chr7:77362489	PHTF2	chr7:77428109-77586818:+	0.17	4.85	1.4E-6	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs17386555	chr2:242371825	ANO7	chr2:242127924-242164791:+	0.22	3.52	0.000442	Prostate cancer	
BRCA	cis	1	rs17386695	chr2:242379751	ANO7	chr2:242127924-242164791:+	-0.21	-3.58	0.000362	Prostate cancer	
BRCA	cis	1	rs17396823	chr7:128384605	OPN1SW	chr7:128412545-128415844:-	-0.15	-3.76	0.000178	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
BRCA	cis	1	rs17401924	chr1:10384439	PGD	chr1:10459085-10480200:+	0.22	6.28	4.96E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs17401966	chr1:10385471	PGD	chr1:10459085-10480200:+	-0.2	-5.73	1.33E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs17410793	chr1:10391886	PGD	chr1:10459085-10480200:+	0.23	6.49	1.3E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs17411502	chr1:10431158	PGD	chr1:10459085-10480200:+	0.23	6.49	1.29E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs17431934	chr9:100695776	C9orf156	chr9:100666772-100684852:-	-0.17	-4.62	4.26E-6	Quantitative traits	
BRCA	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.94	32.89	2.09E-164	Carotid intima media thickness	
BRCA	cis	1	rs1744369	chr6:152946531	VIP	chr6:153071933-153080898:+	0.12	4.04	5.66E-5	Tonometry	
BRCA	cis	1	rs1744379	chr6:152942844	SYNE1	chr6:152442823-152958534:-	-0.1	-3.91	9.7E-5	Tonometry	
BRCA	cis	1	rs17450853	chr6:56788004	BEND6	chr6:56819773-56892138:+	-0.26	-7.85	1.0E-14	Menarche (age at onset)	
BRCA	cis	1	rs17450853	chr6:56788004	KIAA1586	chr6:56911384-56920021:+	-0.19	-4.24	2.47E-5	Menarche (age at onset)	
BRCA	cis	1	rs17453724	chr2:9764001	YWHAQ	chr2:9724107-9771106:-	0.15	4.09	4.55E-5	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
BRCA	cis	1	rs17453752	chr2:9766171	YWHAQ	chr2:9724107-9771106:-	-0.14	-3.8	0.000156	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
BRCA	cis	1	rs17470624	chr11:16445649	C11orf58	chr11:16760148-16779901:+	0.21	3.62	0.000313	Obesity and osteoporosis	
BRCA	cis	1	rs17471869	chr10:70749869	KIAA1279	chr10:70748493-70776734:+	-0.12	-4.17	3.23E-5	Schizophrenia	
BRCA	cis	1	rs17475665	chr7:128408313	OPN1SW	chr7:128412545-128415844:-	0.16	3.82	0.000143	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
BRCA	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.5	12.48	1.84E-33	Sex hormone-binding globulin levels	
BRCA	cis	1	rs17504106	chr5:160469639	SLU7	chr5:159828649-159846168:-	-0.13	-3.6	0.000333	Post-traumatic stress disorder	
BRCA	cis	1	rs17508864	chr4:39130645	KLHL5	chr4:39046659-39123828:+	-0.15	-4.58	5.23E-6	Uric acid levels	
BRCA	cis	1	rs17510733	chr6:111710918	KIAA1919	chr6:111580482-111590259:+	0.32	4.48	8.12E-6	Psoriasis	
BRCA	cis	1	rs17510761	chr6:111708583	KIAA1919	chr6:111580482-111590259:+	0.31	4.42	1.08E-5	Psoriasis	
BRCA	cis	1	rs17513621	chr2:99246559	UNC50	chr2:99225042-99234975:+	-0.2	-4.07	5.01E-5	Bipolar disorder	
BRCA	cis	1	rs17528859	chr11:59867379	MS4A4A	chr11:60048139-60076444:+	-0.11	-4.44	9.96E-6	Alzheimer's disease (late onset)	
BRCA	cis	1	rs17529983	chr11:59927039	MS4A4A	chr11:60048139-60076444:+	-0.09	-3.79	0.000161	Alzheimer's disease (late onset)	
BRCA	cis	1	rs17538840	chr2:61077817	AHSA2	chr2:61404553-61414058:+	0.13	4.98	7.44E-7	Inflammatory skin disease	
BRCA	cis	1	rs17538840	chr2:61077817	C2orf74	chr2:61372243-61391964:+	-0.28	-6	2.71E-9	Inflammatory skin disease	
BRCA	cis	1	rs175425	chr14:75626131	EIF2B2	chr14:75469612-75476292:+	-0.18	-5.03	5.63E-7	Height	
BRCA	cis	1	rs175425	chr14:75626131	MLH3	chr14:75480467-75518235:-	-0.22	-7.03	3.6E-12	Height	
BRCA	cis	1	rs175426	chr14:75624134	EIF2B2	chr14:75469612-75476292:+	-0.19	-5.37	9.56E-8	Height	
BRCA	cis	1	rs175426	chr14:75624134	MLH3	chr14:75480467-75518235:-	-0.22	-7.05	3.29E-12	Height	
BRCA	cis	1	rs175436	chr14:75608683	EIF2B2	chr14:75469612-75476292:+	-0.19	-5.28	1.58E-7	Height	
BRCA	cis	1	rs175436	chr14:75608683	MLH3	chr14:75480467-75518235:-	-0.23	-7.27	6.78E-13	Height	
BRCA	cis	1	rs175442	chr14:75603564	EIF2B2	chr14:75469612-75476292:+	-0.19	-5.4	8.16E-8	Height	
BRCA	cis	1	rs175442	chr14:75603564	MLH3	chr14:75480467-75518235:-	-0.22	-7.1	2.22E-12	Height	
BRCA	cis	1	rs175443	chr14:75601963	EIF2B2	chr14:75469612-75476292:+	-0.19	-5.34	1.13E-7	Height	
BRCA	cis	1	rs175443	chr14:75601963	MLH3	chr14:75480467-75518235:-	-0.23	-7.37	3.32E-13	Height	
BRCA	cis	1	rs175449	chr14:75590846	EIF2B2	chr14:75469612-75476292:+	-0.18	-5.23	2.09E-7	Height	
BRCA	cis	1	rs175449	chr14:75590846	MLH3	chr14:75480467-75518235:-	-0.22	-6.94	6.9E-12	Height	
BRCA	cis	1	rs17554301	chr11:16402082	C11orf58	chr11:16760148-16779901:+	0.22	3.87	0.000117	Obesity and osteoporosis	
BRCA	cis	1	rs17554911	chr11:16432694	C11orf58	chr11:16760148-16779901:+	0.23	4.07	5.11E-5	Obesity and osteoporosis	
BRCA	cis	1	rs17566701	chr7:66193183	TYW1	chr7:66461817-66704496:+	0.17	4.56	5.68E-6	Aortic root size	
BRCA	cis	1	rs17584578	chr2:86307624	LOC90784	chr2:86247339-86250991:-	0.33	4.44	9.87E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs17584578	chr2:86307624	ST3GAL5	chr2:86066271-86116157:-	-0.3	-4.36	1.41E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.39	-10.42	2.76E-24	Forced vital capacity	
BRCA	cis	1	rs17598927	chr6:26184640	HIST1H3E	chr6:26224427-26226589:+	-0.34	-6.38	2.64E-10	Renal underexcretion gout;Gout	
BRCA	cis	1	rs17604773	chr2:160109363	WDSUB1	chr2:160092305-160143236:-	0.33	4.09	4.61E-5	Sudden cardiac arrest	
BRCA	cis	1	rs1760621	chr1:183156006	LAMC2	chr1:183155174-183214262:+	-0.1	-3.54	0.000413	Hypertriglyceridemia	
BRCA	cis	1	rs1760624	chr1:183158552	LAMC2	chr1:183155174-183214262:+	-0.11	-3.7	0.000226	Hypertriglyceridemia	
BRCA	cis	1	rs17608677	chr2:219936871	FAM134A	chr2:220042939-220050190:+	0.18	3.95	8.2E-5	Height	
BRCA	cis	1	rs17608677	chr2:219936871	GLB1L	chr2:220101505-220110131:-	0.23	4.39	1.27E-5	Height	
BRCA	cis	1	rs17608677	chr2:219936871	RNF25	chr2:219528588-219536781:-	0.14	3.67	0.000252	Height	
BRCA	cis	1	rs17608677	chr2:219936871	USP37	chr2:219314974-219433084:-	0.14	4.09	4.72E-5	Height	
BRCA	cis	1	rs17608677	chr2:219936871	ZNF142	chr2:219502644-219524261:-	0.19	4.17	3.23E-5	Height	
BRCA	cis	1	rs17616316	chr14:103822762	ASPG	chr14:104552048-104579098:+	-0.25	-3.66	0.000268	Red blood cell traits	
BRCA	cis	1	rs17637907	chr17:33891386	SLFN12L	chr17:33801926-33864880:-	0.09	4.9	1.12E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs17645523	chr15:50882645	SPPL2A	chr15:50999739-51057910:-	0.14	5.29	1.5E-7	QT interval	
BRCA	cis	1	rs17649068	chr1:171713893	VAMP4	chr1:171669298-171711214:-	0.24	7.11	2.05E-12	Hippocampal atrophy	
BRCA	cis	1	rs17649250	chr1:171720586	VAMP4	chr1:171669298-171711214:-	0.24	6.75	2.45E-11	Hippocampal atrophy	
BRCA	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.62	-9.07	5.79E-19	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs17661933	chr19:50534520	TBC1D17	chr19:50380829-50392000:+	0.18	3.65	0.000278	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs1766347	chr13:78387963	CLN5	chr13:77566059-77576651:+	0.13	3.58	0.000363	Hair color	
BRCA	cis	1	rs1766347	chr13:78387963	RNF219	chr13:79188421-79234700:-	0.13	3.88	0.000109	Hair color	
BRCA	cis	1	rs17669480	chr10:102066065	PKD2L1	chr10:102047903-102090243:-	0.24	4.42	1.08E-5	Obesity-related traits	
BRCA	cis	1	rs17671250	chr15:40673124	C15orf23	chr15:40674922-40686488:+	-0.28	-8.35	2.18E-16	Heschl's gyrus morphology	
BRCA	cis	1	rs17671250	chr15:40673124	IVD	chr15:40697686-40713512:+	0.16	3.74	0.000193	Heschl's gyrus morphology	
BRCA	cis	1	rs17683841	chr6:55944441	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs17683846	chr6:55945010	COL21A1	chr6:55921389-56258892:-	-0.38	-6.84	1.34E-11	Psychosis (atypical)	
BRCA	cis	1	rs17685143	chr6:56774788	BEND6	chr6:56819773-56892138:+	-0.34	-9.01	9.47E-19	Menarche (age at onset)	
BRCA	cis	1	rs17685143	chr6:56774788	KIAA1586	chr6:56911384-56920021:+	-0.21	-4.24	2.43E-5	Menarche (age at onset)	
BRCA	cis	1	rs1768803	chr1:46546208	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.77	3.9E-30	Body mass index	
BRCA	cis	1	rs1768803	chr1:46546208	CCDC17	chr1:46085717-46089729:-	0.11	3.41	0.000674	Body mass index	
BRCA	cis	1	rs1768803	chr1:46546208	MUTYH	chr1:45794915-45806142:-	0.12	4.77	2.12E-6	Body mass index	
BRCA	cis	1	rs1768816	chr1:46528599	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.71	7.0E-30	Body mass index	
BRCA	cis	1	rs1768816	chr1:46528599	MUTYH	chr1:45794915-45806142:-	0.12	4.73	2.58E-6	Body mass index	
BRCA	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.27	6.89	9.82E-12	Cognitive performance	
BRCA	cis	1	rs17691170	chr3:121357626	SLC15A2	chr3:121613171-121663034:+	-0.14	-4.03	6.0E-5	Cognitive performance	
BRCA	cis	1	rs17692896	chr19:33089431	SLC7A9	chr19:33321421-33360683:-	-0.27	-3.58	0.000364	Major depressive disorder	
BRCA	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.43	14.46	2.02E-43	Height	
BRCA	cis	1	rs17694011	chr3:134213981	CEP63	chr3:134204575-134293852:+	0.15	4.2	2.89E-5	Height	
BRCA	cis	1	rs17697965	chr19:10519410	DOCK6	chr19:11309973-11373157:-	-0.11	-3.52	0.000445	Gastritis;Multiple sclerosis	
BRCA	cis	1	rs17699333	chr19:19831544	ZNF14	chr19:19821281-19843921:-	0.18	4.89	1.15E-6	Toenail selenium levels	
BRCA	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.67	-19.44	2.81E-72	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.68	-20.1	1.83E-76	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.66	-19.87	5.31E-75	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs17717771	chr6:148946841	UST	chr6:149068271-149398125:+	-0.33	-6.24	6.5E-10	Migraine	
BRCA	cis	1	rs17724311	chr7:22876793	TOMM7	chr7:22852254-22862421:-	-0.15	-4.71	2.87E-6	Fibrinogen	
BRCA	cis	1	rs17733640	chr3:38446742	LOC100128640	chr3:38492524-38496311:-	0.13	3.55	0.000407	Electrocardiographic conduction measures	
BRCA	cis	1	rs17733640	chr3:38446742	XYLB	chr3:38388251-38456467:+	0.21	6.05	2.04E-9	Electrocardiographic conduction measures	
BRCA	cis	1	rs17737030	chr18:48775644	ME2	chr18:48405435-48474258:+	-0.2	-4.84	1.46E-6	Immune response to anthrax vaccine	
BRCA	cis	1	rs17737030	chr18:48775644	MEX3C	chr18:48700922-48723690:-	-0.2	-4.53	6.42E-6	Immune response to anthrax vaccine	
BRCA	cis	1	rs17746014	chr10:102315354	SEC31B	chr10:102246403-102289636:-	-0.29	-10.44	2.34E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs17751067	chr6:55944196	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs17751085	chr6:55945212	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs17751143	chr6:55947368	COL21A1	chr6:55921389-56258892:-	-0.38	-7.01	4.22E-12	Psychosis (atypical)	
BRCA	cis	1	rs17752459	chr6:56798755	BEND6	chr6:56819773-56892138:+	-0.34	-9.18	2.21E-19	Menarche (age at onset)	
BRCA	cis	1	rs17752459	chr6:56798755	KIAA1586	chr6:56911384-56920021:+	-0.19	-3.97	7.52E-5	Menarche (age at onset)	
BRCA	cis	1	rs17756240	chr4:57355192	SRP72	chr4:57333762-57369846:+	-0.25	-4.88	1.25E-6	Airflow obstruction	
BRCA	cis	1	rs17761993	chr16:24508299	PALB2	chr16:23614483-23652678:-	-0.12	-3.72	0.000208	Dysphagia	
BRCA	cis	1	rs17779494	chr15:43579223	CATSPER2P1	chr15:44028148-44039292:-	-0.17	-3.6	0.000332	Lung cancer	
BRCA	cis	1	rs17779494	chr15:43579223	STRC	chr15:43891762-43924561:-	-0.17	-4.32	1.73E-5	Lung cancer	
BRCA	cis	1	rs17780080	chr17:30343146	C17orf79	chr17:30178885-30186326:-	-0.18	-3.67	0.00025	Height	
BRCA	cis	1	rs17780086	chr17:30343282	C17orf79	chr17:30178885-30186326:-	-0.18	-3.67	0.00025	Height	
BRCA	cis	1	rs1778508	chr6:28229881	HIST1H4J	chr6:27791903-27792257:+	0.18	3.47	0.000538	Depression	
BRCA	cis	1	rs1778508	chr6:28229881	ZNF187	chr6:28234788-28245978:+	0.15	3.6	0.00033	Depression	
BRCA	cis	1	rs1778508	chr6:28229881	ZNF323	chr6:28292517-28324048:-	-0.2	-3.51	0.000467	Depression	
BRCA	cis	1	rs1778508	chr6:28229881	ZNF389	chr6:28129551-28137375:+	0.19	3.46	0.000561	Depression	
BRCA	cis	1	rs1778508	chr6:28229881	ZSCAN23	chr6:28393287-28411279:-	-0.18	-3.82	0.000139	Depression	
BRCA	cis	1	rs1778511	chr6:28229411	HIST1H4J	chr6:27791903-27792257:+	0.19	3.68	0.000246	Depression	
BRCA	cis	1	rs1778511	chr6:28229411	ZNF187	chr6:28234788-28245978:+	0.15	3.5	0.000477	Depression	
BRCA	cis	1	rs1778511	chr6:28229411	ZNF323	chr6:28292517-28324048:-	-0.2	-3.58	0.000362	Depression	
BRCA	cis	1	rs1778511	chr6:28229411	ZNF389	chr6:28129551-28137375:+	0.2	3.6	0.000329	Depression	
BRCA	cis	1	rs1778511	chr6:28229411	ZSCAN23	chr6:28393287-28411279:-	-0.16	-3.44	0.000614	Depression	
BRCA	cis	1	rs17806990	chr2:218312398	DIRC3	chr2:218148748-218621316:-	0.17	3.58	0.000365	Metabolite levels (MHPG)	
BRCA	cis	1	rs17809330	chr15:65889250	DPP8	chr15:65737999-65810035:-	0.08	3.62	0.000312	Mean corpuscular hemoglobin	
BRCA	cis	1	rs17818151	chr6:55943812	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs17818399	chr2:46826026	ATP6V1E2	chr2:46738988-46769696:-	-0.21	-5.61	2.63E-8	Height	
BRCA	cis	1	rs17818399	chr2:46826026	CRIPT	chr2:46844325-46852880:+	0.21	5.93	4.2E-9	Height	
BRCA	cis	1	rs17818561	chr6:56007398	COL21A1	chr6:55921389-56258892:-	-0.38	-7.02	3.93E-12	Psychosis (atypical)	
BRCA	cis	1	rs17818687	chr6:56010117	COL21A1	chr6:55921389-56258892:-	-0.37	-6.96	5.89E-12	Psychosis (atypical)	
BRCA	cis	1	rs17826724	chr14:66068320	LOC645431	chr14:65877313-65879335:-	-0.26	-5.62	2.39E-8	Ischemic stroke	
BRCA	cis	1	rs17826790	chr14:66103427	LOC645431	chr14:65877313-65879335:-	-0.31	-6.69	3.62E-11	Ischemic stroke	
BRCA	cis	1	rs17826820	chr14:66113837	LOC645431	chr14:65877313-65879335:-	-0.33	-6.95	6.41E-12	Ischemic stroke	
BRCA	cis	1	rs17831161	chr2:160909360	LY75	chr2:160625141-160761262:-	0.14	4.73	2.57E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs17831161	chr2:160909360	PLA2R1	chr2:160798012-160919121:-	0.15	5.01	6.41E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs17831191	chr2:160911332	LY75	chr2:160625141-160761262:-	0.14	4.71	2.78E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs17831191	chr2:160911332	PLA2R1	chr2:160798012-160919121:-	0.15	4.99	6.94E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs17831251	chr2:160914156	LY75	chr2:160625141-160761262:-	0.13	4.59	5.04E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs17831251	chr2:160914156	PLA2R1	chr2:160798012-160919121:-	0.14	4.86	1.34E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs1783521	chr11:64106291	C11orf20	chr11:64067863-64072238:+	0.13	3.38	0.000759	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
BRCA	cis	1	rs1783521	chr11:64106291	CCDC88B	chr11:64107695-64125005:+	-0.09	-4.6	4.72E-6	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
BRCA	cis	1	rs17839567	chr16:31057945	HSD3B7	chr16:30996519-31000473:+	0.23	7.14	1.76E-12	Response to metformin (IC50)	
BRCA	cis	1	rs17839567	chr16:31057945	MYST1	chr16:31128985-31142713:+	0.2	7.45	1.97E-13	Response to metformin (IC50)	
BRCA	cis	1	rs17839567	chr16:31057945	ORAI3	chr16:30960405-30966258:+	0.1	3.56	0.000386	Response to metformin (IC50)	
BRCA	cis	1	rs17839567	chr16:31057945	SETD1A	chr16:30968615-30995981:+	0.11	3.45	0.000581	Response to metformin (IC50)	
BRCA	cis	1	rs17839567	chr16:31057945	ZNF689	chr16:30614701-30621682:-	0.12	3.62	0.000305	Response to metformin (IC50)	
BRCA	cis	1	rs17860606	chr6:170099561	WDR27	chr6:169857307-170102159:-	-0.12	-3.43	0.000633	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs17878846	chr10:104630412	SFXN2	chr10:104474298-104498946:+	-0.24	-4.32	1.74E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs17878846	chr10:104630412	TMEM180	chr10:104221170-104238858:+	0.21	3.63	0.000298	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs17884832	chr10:96534475	C10orf129	chr10:96953957-96988685:+	0.23	4.12	4.08E-5	Blood metabolite levels	
BRCA	cis	1	rs17885052	chr10:96610082	C10orf129	chr10:96953957-96988685:+	0.25	4.39	1.25E-5	Blood metabolite levels	
BRCA	cis	1	rs17885348	chr10:96534234	C10orf129	chr10:96953957-96988685:+	0.32	5.36	1.03E-7	Blood metabolite levels	
BRCA	cis	1	rs1789892	chr4:100250658	ADH1C	chr4:100257651-100273917:-	-0.19	-5.89	5.23E-9	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789898	chr4:100258336	ADH1C	chr4:100257651-100273917:-	-0.18	-5.96	3.45E-9	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789903	chr4:100262041	ADH1C	chr4:100257651-100273917:-	-0.2	-6.6	6.32E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789903	chr4:100262041	ADH4	chr4:100044835-100065449:-	-0.11	-3.46	0.000571	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789906	chr4:100263219	ADH1C	chr4:100257651-100273917:-	-0.2	-6.38	2.65E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789906	chr4:100263219	ADH4	chr4:100044835-100065449:-	-0.11	-3.42	0.000643	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789911	chr4:100263778	ADH1C	chr4:100257651-100273917:-	-0.2	-6.53	1.02E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789912	chr4:100263942	ADH1C	chr4:100257651-100273917:-	-0.2	-6.43	1.98E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789913	chr4:100265348	ADH1C	chr4:100257651-100273917:-	-0.2	-6.47	1.5E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789917	chr4:100267164	ADH1C	chr4:100257651-100273917:-	-0.2	-6.48	1.38E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789919	chr4:100267719	ADH1C	chr4:100257651-100273917:-	-0.2	-6.48	1.39E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1789924	chr4:100274286	ADH1C	chr4:100257651-100273917:-	-0.21	-6.72	3.03E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs1790947	chr18:67527760	CD226	chr18:67530195-67624232:-	0.11	7.55	9.65E-14	Type 1 diabetes;Type 1 diabetes autoantibodies	
BRCA	cis	1	rs1795379	chr12:75941042	GLIPR1L2	chr12:75784889-75825591:+	-0.25	-7.56	8.69E-14	Polycystic ovary syndrome	
BRCA	cis	1	rs1796220	chr7:66062100	CCT6P1	chr7:65216092-65228661:+	0.31	6.63	5.34E-11	Diabetic kidney disease	
BRCA	cis	1	rs1796220	chr7:66062100	LOC493754	chr7:65993446-66057363:-	0.24	4	6.9E-5	Diabetic kidney disease	
BRCA	cis	1	rs1796228	chr7:66033084	CCT6P1	chr7:65216092-65228661:+	0.31	6.67	4.15E-11	Diabetic kidney disease	
BRCA	cis	1	rs1796228	chr7:66033084	CRCP	chr7:65579805-65619551:+	-0.2	-3.38	0.000742	Diabetic kidney disease	
BRCA	cis	1	rs1796228	chr7:66033084	LOC493754	chr7:65993446-66057363:-	0.24	4.03	5.9E-5	Diabetic kidney disease	
BRCA	cis	1	rs1799865	chr3:46399798	CCR5	chr3:46411633-46417690:+	0.05	3.57	0.000372	Celiac disease	
BRCA	cis	1	rs1799865	chr3:46399798	FYCO1	chr3:45959396-46037307:-	-0.1	-3.54	0.000413	Celiac disease	
BRCA	cis	1	rs1799945	chr6:26091179	HIST1H3E	chr6:26224427-26226589:+	0.22	3.7	0.000227	Systolic blood pressure;Hypertension;Diastolic blood pressure;Iron status biomarkers	
BRCA	cis	1	rs1800615	chr1:15832281	CASP9	chr1:15817324-15851384:-	0.18	5.17	2.85E-7	Glomerular filtration rate (creatinine)	
BRCA	cis	1	rs1800662	chr10:102289078	SEC31B	chr10:102246403-102289636:-	-0.3	-11.09	3.91E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs1801	chr4:103501054	MANBA	chr4:103552644-103682151:-	-0.16	-3.95	8.25E-5	Ulcerative colitis	
BRCA	cis	1	rs1802236	chr12:56679751	COQ10A	chr12:56660642-56664748:+	-0.3	-4.18	3.12E-5	Psoriasis vulgaris	
BRCA	cis	1	rs1802236	chr12:56679751	RPS26	chr12:56435686-56438005:+	-0.29	-3.69	0.000239	Psoriasis vulgaris	
BRCA	cis	1	rs1802236	chr12:56679751	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.9	0.0001	Psoriasis vulgaris	
BRCA	cis	1	rs1807609	chr22:29131129	CCDC117	chr22:29168662-29185282:+	-0.12	-3.51	0.000472	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs1807609	chr22:29131129	CHEK2	chr22:29083731-29137822:-	-0.11	-3.67	0.000252	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs1807609	chr22:29131129	LOC284900	chr22:28315364-28404267:+	-0.13	-3.44	0.000604	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs1808382	chr19:39151034	LGALS7	chr19:39261608-39264157:-	-0.18	-5.69	1.64E-8	Heart rate	
BRCA	cis	1	rs1810563	chr1:12054030	MFN2	chr1:12040238-12073571:+	0.15	4.42	1.07E-5	Platelet count	
BRCA	cis	1	rs1813217	chr11:59872498	MS4A4A	chr11:60048139-60076444:+	-0.11	-4.42	1.11E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs181394970	chr2:86776235	VPS24	chr2:86730554-86948245:-	0.16	3.57	0.000372	Glomerular filtration rate in chronic kidney disease	
BRCA	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.43	14.39	5.01E-43	Height	
BRCA	cis	1	rs1814336	chr3:134200823	CEP63	chr3:134204575-134293852:+	0.16	4.34	1.55E-5	Height	
BRCA	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.43	14.37	5.95E-43	Height	
BRCA	cis	1	rs1814337	chr3:134200682	CEP63	chr3:134204575-134293852:+	0.17	4.51	7.17E-6	Height	
BRCA	cis	1	rs1815338	chr10:91376691	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.75	0.000185	Metabolic traits	
BRCA	cis	1	rs1823061	chr19:37800626	ZFP30	chr19:38123389-38146368:-	-0.12	-3.38	0.000762	Coronary artery calcification	
BRCA	cis	1	rs1823522	chr7:37991450	EPDR1	chr7:37960163-37991539:+	-0.25	-4.33	1.66E-5	Myopia (pathological)	
BRCA	cis	1	rs1823874	chr15:100357435	C15orf51	chr15:100330361-100347132:-	-0.3	-9.54	9.26E-21	IgG glycosylation	
BRCA	cis	1	rs1832181	chr6:134186165	TCF21	chr6:134210259-134219157:+	0.16	4.16	3.39E-5	Coronary heart disease	
BRCA	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.73	18.76	4.3E-68	Type 2 diabetes	
BRCA	cis	1	rs1839622	chr12:7334534	PEX5	chr12:7341759-7371167:+	0.24	6.81	1.65E-11	IgG glycosylation	
BRCA	cis	1	rs1841777	chr3:38484819	LOC100128640	chr3:38492524-38496311:-	0.13	3.45	0.000578	Electrocardiographic conduction measures	
BRCA	cis	1	rs1841777	chr3:38484819	XYLB	chr3:38388251-38456467:+	0.19	5.45	6.33E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs1848048	chr11:18468996	LDHC	chr11:18433853-18472792:+	-0.3	-5.29	1.49E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs1852212	chr3:119279235	CD80	chr3:119243142-119278481:-	0.12	4.27	2.09E-5	Vitiligo	
BRCA	cis	1	rs1852959	chr10:43359636	LOC84856	chr10:42970939-42990784:+	0.18	4.08	4.83E-5	Progressive supranuclear palsy	
BRCA	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.59	-18.65	2.16E-67	Response to antipsychotic treatment	
BRCA	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.56	-17.95	3.91E-63	Response to antipsychotic treatment	
BRCA	cis	1	rs185968827	chr6:56708510	BEND6	chr6:56819773-56892138:+	-0.18	-4.62	4.39E-6	Alzheimer disease and age of onset	
BRCA	cis	1	rs1861243	chr2:39956836	THUMPD2	chr2:39963200-40006416:-	-0.13	-4.03	5.91E-5	Personality dimensions	
BRCA	cis	1	rs1861444	chr2:37464511	CEBPZ	chr2:37428778-37458740:-	0.18	5.98	3.13E-9	Chronic lymphocytic leukemia	
BRCA	cis	1	rs1861637	chr7:117529677	CTTNBP2	chr7:117350708-117513561:-	-0.13	-3.82	0.000142	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.73	18.76	4.3E-68	Type 2 diabetes	
BRCA	cis	1	rs186378	chr7:65582058	CCT6P1	chr7:65216092-65228661:+	0.32	6.8	1.79E-11	Diabetic kidney disease	
BRCA	cis	1	rs186378	chr7:65582058	CRCP	chr7:65579805-65619551:+	-0.21	-3.5	0.000477	Diabetic kidney disease	
BRCA	cis	1	rs186378	chr7:65582058	LOC493754	chr7:65993446-66057363:-	0.23	3.83	0.000133	Diabetic kidney disease	
BRCA	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.41	13.69	2.04E-39	Height	
BRCA	cis	1	rs1863913	chr3:134200205	CEP63	chr3:134204575-134293852:+	0.17	4.69	3.08E-6	Height	
BRCA	cis	1	rs1864410	chr10:43575625	RET	chr10:43572517-43625795:+	0.16	3.81	0.000148	Hirschsprung disease	
BRCA	cis	1	rs1866071	chr12:104310638	HSP90B1	chr12:104324189-104341703:+	-0.13	-3.51	0.000458	Coronary heart disease	
BRCA	cis	1	rs1867486	chr16:86681155	COX4NB	chr16:85812233-85833148:-	0.1	3.38	0.000753	IgG glycosylation	
BRCA	cis	1	rs1867486	chr16:86681155	MAP1LC3B	chr16:87425801-87438379:+	0.12	3.43	0.000635	IgG glycosylation	
BRCA	cis	1	rs1867631	chr1:67046126	TCTEX1D1	chr1:67218140-67244729:+	0.12	3.59	0.000351	Menopause (age at onset)	
BRCA	cis	1	rs1869596	chr1:110624104	ALX3	chr1:110602998-110613322:-	-0.14	-4.06	5.22E-5	Blood metabolite levels	
BRCA	cis	1	rs1872329	chr2:54471823	C2orf73	chr2:54558071-54588714:+	0.17	4.22	2.7E-5	Telomere length	
BRCA	cis	1	rs1872829	chr12:32535100	FGD4	chr12:32638906-32798982:+	-0.33	-10.42	2.92E-24	Response to tocilizumab in rheumatoid arthritis	
BRCA	cis	1	rs1873494	chr7:65649899	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.58	7.53E-11	Diabetic kidney disease	
BRCA	cis	1	rs1873494	chr7:65649899	CRCP	chr7:65579805-65619551:+	0.21	3.48	0.000517	Diabetic kidney disease	
BRCA	cis	1	rs1873494	chr7:65649899	LOC493754	chr7:65993446-66057363:-	-0.23	-3.86	0.000122	Diabetic kidney disease	
BRCA	cis	1	rs1875124	chr12:58196802	B4GALNT1	chr12:58019551-58026985:-	0.12	3.5	0.000491	Multiple sclerosis	
BRCA	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.43	10.53	1.02E-24	Multiple sclerosis	
BRCA	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.36	-10.51	1.19E-24	Multiple sclerosis	
BRCA	cis	1	rs1875124	chr12:58196802	XRCC6BP1	chr12:58335445-58351051:+	-0.19	-5.12	3.66E-7	Multiple sclerosis	
BRCA	cis	1	rs1876219	chr4:17961415	NCAPG	chr4:17812525-17846485:+	0.09	4.31	1.81E-5	Height	
BRCA	cis	1	rs1876673	chr5:115450773	COMMD10	chr5:115420727-115628978:+	0.26	4.97	7.67E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs1876674	chr5:115450969	COMMD10	chr5:115420727-115628978:+	0.2	4.36	1.45E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs1879536	chr8:9768645	TNKS	chr8:9413445-9639855:+	0.17	3.55	0.0004	Obesity (early onset extreme)	
BRCA	cis	1	rs1880023	chr4:8480831	C4orf23	chr4:8440604-8495258:+	0.15	4.03	5.87E-5	Response to antineoplastic agents	
BRCA	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.24	3.75E-37	Height	
BRCA	cis	1	rs1880376	chr3:134270347	CEP63	chr3:134204575-134293852:+	-0.14	-3.74	0.000191	Height	
BRCA	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.24	3.75E-37	Height	
BRCA	cis	1	rs1880377	chr3:134270468	CEP63	chr3:134204575-134293852:+	-0.14	-3.74	0.000191	Height	
BRCA	cis	1	rs1881123	chr7:1084706	ZFAND2A	chr7:1192544-1199855:-	-0.33	-6.43	1.94E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs1882655	chr7:66147057	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.37	2.82E-10	Gout	
BRCA	cis	1	rs1882655	chr7:66147057	CRCP	chr7:65579805-65619551:+	0.21	3.5	0.000482	Gout	
BRCA	cis	1	rs1882655	chr7:66147057	LOC493754	chr7:65993446-66057363:-	-0.23	-3.73	0.000202	Gout	
BRCA	cis	1	rs1884418	chr20:55070076	C20orf43	chr20:55043647-55093942:+	0.14	3.92	9.47E-5	Refractive astigmatism	
BRCA	cis	1	rs1884946	chr6:26545308	BTN2A3	chr6:26422317-26431927:+	0.16	5.45	6.13E-8	Educational attainment	
BRCA	cis	1	rs1884946	chr6:26545308	C6orf41	chr6:26924772-26991752:+	-0.13	-3.79	0.000161	Educational attainment	
BRCA	cis	1	rs1884946	chr6:26545308	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.77	0.000171	Educational attainment	
BRCA	cis	1	rs1884948	chr6:26567988	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.27E-8	Educational attainment	
BRCA	cis	1	rs1884948	chr6:26567988	C6orf41	chr6:26924772-26991752:+	-0.13	-3.94	8.81E-5	Educational attainment	
BRCA	cis	1	rs1884948	chr6:26567988	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.73	0.000201	Educational attainment	
BRCA	cis	1	rs1884949	chr6:26568067	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.27E-8	Educational attainment	
BRCA	cis	1	rs1884949	chr6:26568067	C6orf41	chr6:26924772-26991752:+	-0.13	-3.94	8.81E-5	Educational attainment	
BRCA	cis	1	rs1884949	chr6:26568067	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.73	0.000201	Educational attainment	
BRCA	cis	1	rs1885708	chr14:102960164	ANKRD9	chr14:102973198-102976128:-	0.12	3.51	0.000459	QT interval	
BRCA	cis	1	rs1886644	chr1:85350658	GNG5	chr1:84964007-84972262:-	0.15	4.34	1.53E-5	Glucose homeostasis traits	
BRCA	cis	1	rs1886644	chr1:85350658	RPF1	chr1:84944920-84964032:+	0.14	3.44	0.000605	Glucose homeostasis traits	
BRCA	cis	1	rs1886644	chr1:85350658	SYDE2	chr1:85623357-85666728:-	0.13	3.83	0.000134	Glucose homeostasis traits	
BRCA	cis	1	rs1886682	chr1:92977275	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs1886683	chr1:92976023	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs1888997	chr20:25298988	ABHD12	chr20:25275380-25371477:-	-0.12	-3.46	0.000563	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1888997	chr20:25298988	FAM182A	chr20:26035250-26067552:+	0.22	5.71	1.46E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1888997	chr20:25298988	FAM182B	chr20:25744102-25848786:-	-0.21	-5.53	4.03E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1888997	chr20:25298988	PYGB	chr20:25228706-25278647:+	0.13	3.44	0.000596	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1888998	chr20:25291826	ABHD12	chr20:25275380-25371477:-	-0.12	-3.46	0.000569	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1888998	chr20:25291826	FAM182A	chr20:26035250-26067552:+	0.23	5.98	2.99E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1888998	chr20:25291826	FAM182B	chr20:25744102-25848786:-	-0.22	-5.67	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1888999	chr20:25291848	ABHD12	chr20:25275380-25371477:-	0.12	3.46	0.000557	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1888999	chr20:25291848	FAM182A	chr20:26035250-26067552:+	-0.22	-5.77	1.03E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1888999	chr20:25291848	FAM182B	chr20:25744102-25848786:-	0.23	5.84	6.95E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1894292	chr4:74349158	RASSF6	chr4:74438862-74486340:-	-0.14	-4.15	3.53E-5	Prostate cancer	
BRCA	cis	1	rs1897136	chr4:39132862	KLHL5	chr4:39046659-39123828:+	-0.14	-4.47	8.81E-6	Uric acid levels	
BRCA	cis	1	rs1897137	chr4:39133007	KLHL5	chr4:39046659-39123828:+	-0.14	-4.47	8.81E-6	Uric acid levels	
BRCA	cis	1	rs1901197	chr7:37994963	EPDR1	chr7:37960163-37991539:+	-0.24	-4.08	4.88E-5	Myopia (pathological)	
BRCA	cis	1	rs1903330	chr6:56776985	BEND6	chr6:56819773-56892138:+	0.32	8.84	3.9E-18	Menarche (age at onset)	
BRCA	cis	1	rs1903330	chr6:56776985	KIAA1586	chr6:56911384-56920021:+	0.24	4.99	7.18E-7	Menarche (age at onset)	
BRCA	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.78	19.99	9.02E-76	Type 2 diabetes	
BRCA	cis	1	rs1904302	chr10:118868941	KIAA1598	chr10:118644308-118886097:-	0.15	3.62	0.000305	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
BRCA	cis	1	rs1910272	chr9:91559042	C9orf47	chr9:91605778-91611055:+	0.12	3.38	0.000749	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.59	-19.36	7.89E-72	Response to antipsychotic treatment	
BRCA	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.56	-17.8	3.0E-62	Response to antipsychotic treatment	
BRCA	cis	1	rs1914859	chr4:165906141	TRIM61	chr4:165875600-165898818:-	0.25	8.16	9.61E-16	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs1916284	chr3:57394766	DNAH12	chr3:57327727-57530071:-	0.14	3.52	0.000456	Prostate cancer (gene x gene interaction)	
BRCA	cis	1	rs1916326	chr4:8500023	C4orf23	chr4:8440604-8495258:+	0.15	3.89	0.000109	Response to antineoplastic agents	
BRCA	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.68	1.98E-34	Height	
BRCA	cis	1	rs1917130	chr3:134313773	CEP63	chr3:134204575-134293852:+	-0.14	-3.61	0.000318	Height	
BRCA	cis	1	rs1919125	chr2:27801403	KRTCAP3	chr2:27665263-27667163:+	-0.13	-3.96	8.05E-5	Oral cavity cancer	
BRCA	cis	1	rs1919126	chr2:27801418	KRTCAP3	chr2:27665263-27667163:+	-0.13	-3.96	8.05E-5	Oral cavity cancer	
BRCA	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.16	3.26E-23	Obesity-related traits	
BRCA	cis	1	rs1919948	chr7:143762843	OR2A7	chr7:143955790-143974852:-	0.21	4.9	1.1E-6	Obesity-related traits	
BRCA	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.39	-9.65	3.59E-21	Obesity-related traits	
BRCA	cis	1	rs1919949	chr7:143767723	OR2A7	chr7:143955790-143974852:-	0.21	4.85	1.42E-6	Obesity-related traits	
BRCA	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.39	-9.53	1.06E-20	Obesity-related traits	
BRCA	cis	1	rs1919950	chr7:143767898	OR2A7	chr7:143955790-143974852:-	0.21	4.97	7.84E-7	Obesity-related traits	
BRCA	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.4	-9.66	3.27E-21	Obesity-related traits	
BRCA	cis	1	rs1919951	chr7:143768891	OR2A7	chr7:143955790-143974852:-	0.24	5.49	4.97E-8	Obesity-related traits	
BRCA	cis	1	rs1920638	chr3:160345169	TRIM59	chr3:160153292-160167626:-	0.13	4.03	5.88E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs1920650	chr3:160335588	TRIM59	chr3:160153292-160167626:-	0.12	3.81	0.000145	Primary biliary cirrhosis	
BRCA	cis	1	rs1920735	chr12:91458219	KERA	chr12:91444273-91452131:-	0.21	4.87	1.32E-6	Diabetic kidney disease	
BRCA	cis	1	rs1925148	chr6:56095672	COL21A1	chr6:55921389-56258892:-	0.69	21.75	4.14E-87	Pulse pressure	
BRCA	cis	1	rs1925152	chr6:56102709	COL21A1	chr6:55921389-56258892:-	0.66	20.05	4.08E-76	Pulse pressure	
BRCA	cis	1	rs1925169	chr6:55996576	COL21A1	chr6:55921389-56258892:-	-0.37	-6.91	8.47E-12	Psychosis (atypical)	
BRCA	cis	1	rs1925173	chr6:55999939	COL21A1	chr6:55921389-56258892:-	-0.37	-6.78	1.99E-11	Psychosis (atypical)	
BRCA	cis	1	rs1926712	chr10:96477854	HELLS	chr10:96305543-96361855:+	0.12	3.42	0.000648	Migraine	
BRCA	cis	1	rs1927512	chr13:27416731	WASF3	chr13:27131840-27263080:+	-0.13	-3.44	0.000599	Asthma (toluene diisocyanate-induced)	
BRCA	cis	1	rs1933182	chr1:109999838	AMIGO1	chr1:110049447-110052336:-	-0.12	-3.47	0.000544	Chronic kidney disease	
BRCA	cis	1	rs1933182	chr1:109999838	SYPL2	chr1:110009100-110024763:+	-0.26	-8.43	1.15E-16	Chronic kidney disease	
BRCA	cis	1	rs1935	chr10:64927823	NRBF2	chr10:64893007-64914785:+	-0.16	-5.8	8.62E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs1936365	chr6:28268452	ZNF187	chr6:28234788-28245978:+	0.14	3.41	0.000664	Depression	
BRCA	cis	1	rs1936365	chr6:28268452	ZNF323	chr6:28292517-28324048:-	-0.2	-3.63	0.000298	Depression	
BRCA	cis	1	rs1936365	chr6:28268452	ZSCAN23	chr6:28393287-28411279:-	-0.16	-3.48	0.000519	Depression	
BRCA	cis	1	rs1939748	chr11:62911079	B3GAT3	chr11:62382769-62389449:-	-0.12	-3.8	0.000153	Conotruncal heart defects	
BRCA	cis	1	rs1939748	chr11:62911079	BSCL2	chr11:62457747-62477046:-	-0.14	-3.66	0.000262	Conotruncal heart defects	
BRCA	cis	1	rs1939748	chr11:62911079	HNRNPUL2	chr11:62457747-62494821:-	-0.19	-4.22	2.64E-5	Conotruncal heart defects	
BRCA	cis	1	rs1939748	chr11:62911079	MTA2	chr11:62360675-62369303:-	-0.14	-3.82	0.00014	Conotruncal heart defects	
BRCA	cis	1	rs1939748	chr11:62911079	POLR2G	chr11:62529011-62534185:+	-0.15	-3.87	0.000116	Conotruncal heart defects	
BRCA	cis	1	rs1939748	chr11:62911079	TAF6L	chr11:62538875-62554811:+	-0.14	-4.25	2.34E-5	Conotruncal heart defects	
BRCA	cis	1	rs1939748	chr11:62911079	TMEM179B	chr11:62554874-62557871:+	-0.18	-4.51	7.19E-6	Conotruncal heart defects	
BRCA	cis	1	rs1939748	chr11:62911079	TTC9C	chr11:62495584-62506105:+	-0.17	-3.72	0.000208	Conotruncal heart defects	
BRCA	cis	1	rs1939748	chr11:62911079	ZBTB3	chr11:62518437-62521656:-	-0.16	-3.61	0.000318	Conotruncal heart defects	
BRCA	cis	1	rs1939749	chr11:62910849	B3GAT3	chr11:62382769-62389449:-	-0.12	-3.79	0.000162	Conotruncal heart defects	
BRCA	cis	1	rs1939749	chr11:62910849	BSCL2	chr11:62457747-62477046:-	-0.14	-3.56	0.000385	Conotruncal heart defects	
BRCA	cis	1	rs1939749	chr11:62910849	HNRNPUL2	chr11:62457747-62494821:-	-0.19	-4.26	2.23E-5	Conotruncal heart defects	
BRCA	cis	1	rs1939749	chr11:62910849	MTA2	chr11:62360675-62369303:-	-0.14	-3.79	0.000159	Conotruncal heart defects	
BRCA	cis	1	rs1939749	chr11:62910849	POLR2G	chr11:62529011-62534185:+	-0.15	-3.91	9.79E-5	Conotruncal heart defects	
BRCA	cis	1	rs1939749	chr11:62910849	TAF6L	chr11:62538875-62554811:+	-0.14	-4.28	2.08E-5	Conotruncal heart defects	
BRCA	cis	1	rs1939749	chr11:62910849	TMEM179B	chr11:62554874-62557871:+	-0.18	-4.53	6.5E-6	Conotruncal heart defects	
BRCA	cis	1	rs1939749	chr11:62910849	TTC9C	chr11:62495584-62506105:+	-0.17	-3.77	0.000171	Conotruncal heart defects	
BRCA	cis	1	rs1939749	chr11:62910849	ZBTB3	chr11:62518437-62521656:-	-0.16	-3.6	0.000327	Conotruncal heart defects	
BRCA	cis	1	rs1941746	chr11:65502413	SPDYC	chr11:64937707-64940687:+	-0.14	-3.59	0.000349	Atopic dermatitis	
BRCA	cis	1	rs1947861	chr6:49482687	CENPQ	chr6:49431096-49460820:+	-0.2	-6.6	6.3E-11	Brain structure	
BRCA	cis	1	rs1949733	chr4:8503359	C4orf23	chr4:8440604-8495258:+	0.15	3.99	6.98E-5	Response to antineoplastic agents	
BRCA	cis	1	rs1950500	chr14:24830850	ADCY4	chr14:24787571-24804277:-	-0.09	-4.35	1.47E-5	Height	
BRCA	cis	1	rs1953099	chr1:111290542	ATP5F1	chr1:111991462-112004523:+	-0.21	-3.64	0.00029	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs1953099	chr1:111290542	HBXIP	chr1:110943879-110950546:-	-0.18	-3.81	0.000144	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs1953099	chr1:111290542	RAP1A	chr1:112085055-112256100:+	-0.18	-3.51	0.000468	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.37	-10.25	1.39E-23	Rheumatoid arthritis	
BRCA	cis	1	rs1953126	chr9:123640500	TRAF1	chr9:123664672-123691479:-	0.11	5.04	5.6E-7	Rheumatoid arthritis	
BRCA	cis	1	rs1953417	chr14:65878909	LOC645431	chr14:65877313-65879335:-	-0.31	-6.51	1.12E-10	Ischemic stroke	
BRCA	cis	1	rs1957977	chr14:50090603	RPL36AL	chr14:50085407-50087349:-	0.17	5.42	7.27E-8	Carotid intima media thickness	
BRCA	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.59	-18.5	1.68E-66	Response to antipsychotic treatment	
BRCA	cis	1	rs1964555	chr17:16763555	NCRNA00188	chr17:16342301-16373962:+	0.15	3.92	9.25E-5	Response to platinum-based chemotherapy (cisplatin)	
BRCA	cis	1	rs1964692	chr7:65454183	CCT6P1	chr7:65216092-65228661:+	0.34	7.45	1.99E-13	Diabetic kidney disease	
BRCA	cis	1	rs1964692	chr7:65454183	LOC493754	chr7:65993446-66057363:-	0.2	3.38	0.000752	Diabetic kidney disease	
BRCA	cis	1	rs1964692	chr7:65454183	ZNF117	chr7:64434830-64467121:-	-0.27	-4.91	1.04E-6	Diabetic kidney disease	
BRCA	cis	1	rs1966423	chr2:202216661	ALS2CR12	chr2:202153148-202222101:-	-0.19	-4.97	7.93E-7	Basal cell carcinoma	
BRCA	cis	1	rs1966839	chr7:50627101	FIGNL1	chr7:50511834-50518088:-	-0.12	-4.27	2.14E-5	Malaria	
BRCA	cis	1	rs1971762	chr12:54058238	ATP5G2	chr12:54058945-54070512:-	0.09	3.44	0.000607	Height	
BRCA	cis	1	rs1972669	chr2:27767107	KRTCAP3	chr2:27665263-27667163:+	-0.13	-3.92	9.3E-5	Oral cavity cancer	
BRCA	cis	1	rs1974624	chr4:17650281	MED28	chr4:17616273-17629791:+	0.14	3.57	0.000372	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs1975174	chr19:22515251	ZNF98	chr19:22573899-22605148:-	0.15	4.16	3.51E-5	Telomere length	
BRCA	cis	1	rs1979214	chr2:70137498	ANXA4	chr2:69969127-70053594:+	-0.14	-4.05	5.56E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs1979755	chr2:42708405	COX7A2L	chr2:42577647-42596150:-	-0.16	-4.99	7.1E-7	Body mass index	
BRCA	cis	1	rs1979823	chr7:65704613	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.39	2.44E-10	Diabetic kidney disease	
BRCA	cis	1	rs1979823	chr7:65704613	CRCP	chr7:65579805-65619551:+	0.21	3.54	0.000416	Diabetic kidney disease	
BRCA	cis	1	rs1979823	chr7:65704613	LOC493754	chr7:65993446-66057363:-	-0.22	-3.62	0.000304	Diabetic kidney disease	
BRCA	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.87	-19.37	7.21E-72	Schizophrenia	
BRCA	cis	1	rs1982009	chr4:39124873	KLHL5	chr4:39046659-39123828:+	-0.15	-4.58	5.2E-6	Uric acid levels	
BRCA	cis	1	rs1982861	chr3:49577665	AMT	chr3:49454212-49460012:-	0.13	4.49	7.91E-6	Menarche (age at onset)	
BRCA	cis	1	rs1982861	chr3:49577665	CCDC36	chr3:49235861-49295537:+	0.1	3.9	0.000103	Menarche (age at onset)	
BRCA	cis	1	rs1982861	chr3:49577665	GMPPB	chr3:49758932-49761384:-	-0.12	-3.7	0.000223	Menarche (age at onset)	
BRCA	cis	1	rs1982861	chr3:49577665	NCKIPSD	chr3:48711280-48723334:-	0.14	3.64	0.000284	Menarche (age at onset)	
BRCA	cis	1	rs1982861	chr3:49577665	P4HTM	chr3:49027341-49044579:+	0.09	4.01	6.49E-5	Menarche (age at onset)	
BRCA	cis	1	rs1982861	chr3:49577665	WDR6	chr3:49044637-49053386:+	-0.14	-4.23	2.53E-5	Menarche (age at onset)	
BRCA	cis	1	rs1982963	chr14:52509101	NID2	chr14:52471521-52535946:-	0.07	3.4	0.000689	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs1984450	chr19:53013799	ZNF578	chr19:52956829-53020130:+	0.21	3.45	0.000584	Longitudinal alcohol consumption	
BRCA	cis	1	rs1986112	chr15:63540572	RAB8B	chr15:63481728-63559971:+	0.1	4.29	1.95E-5	Schizophrenia	
BRCA	cis	1	rs1986557	chr4:283118	ZNF718	chr4:53272-156488:+	0.29	6.77	2.08E-11	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs1986631	chr9:73092460	KLF9	chr9:72999515-73029573:-	0.13	3.98	7.22E-5	Migraine with aura	
BRCA	cis	1	rs1986987	chr1:146869283	CHD1L	chr1:146714291-146767441:+	-0.16	-3.67	0.000254	Protein quantitative trait loci	
BRCA	cis	1	rs198806	chr6:26133616	BTN3A2	chr6:26365398-26378546:+	0.16	5.32	1.25E-7	Schizophrenia	
BRCA	cis	1	rs198806	chr6:26133616	HIST1H1T	chr6:26107641-26108364:-	-0.18	-5.04	5.41E-7	Schizophrenia	
BRCA	cis	1	rs198806	chr6:26133616	HIST1H3E	chr6:26224427-26226589:+	-0.16	-4.05	5.56E-5	Schizophrenia	
BRCA	cis	1	rs198806	chr6:26133616	HIST1H4E	chr6:26204873-26205248:+	-0.13	-3.4	0.000692	Schizophrenia	
BRCA	cis	1	rs198811	chr6:26128446	BTN3A2	chr6:26365398-26378546:+	-0.15	-5.23	2.04E-7	Schizophrenia	
BRCA	cis	1	rs198811	chr6:26128446	HIST1H1T	chr6:26107641-26108364:-	0.19	5.41	7.62E-8	Schizophrenia	
BRCA	cis	1	rs198811	chr6:26128446	HIST1H3E	chr6:26224427-26226589:+	0.17	4.53	6.46E-6	Schizophrenia	
BRCA	cis	1	rs198811	chr6:26128446	HIST1H4E	chr6:26204873-26205248:+	0.13	3.39	0.000728	Schizophrenia	
BRCA	cis	1	rs199348	chr7:23293098	GPNMB	chr7:23286316-23314728:+	-0.13	-5.02	6.15E-7	Parkinson's disease	
BRCA	cis	1	rs199357	chr7:23288309	GPNMB	chr7:23286316-23314728:+	0.12	4.62	4.36E-6	Parkinson's disease	
BRCA	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.52	14.29	1.55E-42	Diastolic blood pressure	
BRCA	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.56	-17.8	3.0E-62	Response to antipsychotic treatment	
BRCA	cis	1	rs1997243	chr7:1083777	ZFAND2A	chr7:1192544-1199855:-	-0.33	-6.45	1.72E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs1998035	chr14:66126230	LOC645431	chr14:65877313-65879335:-	-0.3	-6.26	5.67E-10	Ischemic stroke	
BRCA	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.59	-19	1.56E-69	Response to antipsychotic treatment	
BRCA	cis	1	rs2003284	chr10:102202338	SEC31B	chr10:102246403-102289636:-	-0.28	-10.4	3.33E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2003301	chr7:66147656	CRCP	chr7:65579805-65619551:+	0.13	3.41	0.000668	Aortic root size	
BRCA	cis	1	rs2003301	chr7:66147656	TYW1	chr7:66461817-66704496:+	-0.15	-3.98	7.51E-5	Aortic root size	
BRCA	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.37	-9.74	1.58E-21	Forced vital capacity	
BRCA	cis	1	rs2007981	chr19:18567555	LRRC25	chr19:18501955-18508421:-	-0.15	-7.14	1.72E-12	Breast cancer	
BRCA	cis	1	rs2011013	chr15:84625766	LOC388152	chr15:84867600-84898920:-	0.19	5.18	2.64E-7	Sitting height ratio	
BRCA	cis	1	rs2011064	chr15:50957625	SPPL2A	chr15:50999739-51057910:-	0.14	4.92	9.9E-7	QT interval	
BRCA	cis	1	rs2013561	chr19:19826177	ZNF14	chr19:19821281-19843921:-	0.18	4.78	1.97E-6	Toenail selenium levels	
BRCA	cis	1	rs2015246	chr11:62196312	C11orf10	chr11:61556603-61560085:-	-0.11	-3.77	0.000175	Chronic obstructive pulmonary disease-related biomarkers	
BRCA	cis	1	rs2016161	chr20:23621174	CST1	chr20:23728191-23731574:-	-0.19	-4.15	3.64E-5	Chronic kidney disease	
BRCA	cis	1	rs2017962	chr19:22208751	ZNF257	chr19:22235266-22273901:+	0.19	4.03	5.89E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs2019144	chr3:119280688	CD80	chr3:119243142-119278481:-	0.12	4.23	2.57E-5	Vitiligo	
BRCA	cis	1	rs2025023	chr20:55801267	RBM38	chr20:55966463-55984384:+	-0.12	-3.74	0.000192	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
BRCA	cis	1	rs2027003	chr20:25350498	ABHD12	chr20:25275380-25371477:-	-0.13	-3.72	0.000213	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2027003	chr20:25350498	FAM182A	chr20:26035250-26067552:+	0.23	6.12	1.34E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2027003	chr20:25350498	FAM182B	chr20:25744102-25848786:-	-0.23	-5.77	1.05E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2027004	chr20:25350618	ABHD12	chr20:25275380-25371477:-	-0.13	-3.72	0.000213	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2027004	chr20:25350618	FAM182A	chr20:26035250-26067552:+	0.23	6.12	1.34E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2027004	chr20:25350618	FAM182B	chr20:25744102-25848786:-	-0.23	-5.77	1.05E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2027763	chr11:73035799	P2RY6	chr11:72975570-73009656:+	0.13	3.54	0.00041	Pulmonary function (interaction)	
BRCA	cis	1	rs2028062	chr11:61745953	BEST1	chr11:61717356-61731939:+	-0.16	-4.33	1.66E-5	Phospholipid levels (plasma)	
BRCA	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.49	-12.82	4.3E-35	Type 2 diabetes	
BRCA	cis	1	rs2029975	chr14:52506070	NID2	chr14:52471521-52535946:-	0.08	3.56	0.000384	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs2031494	chr1:92965969	EVI5	chr1:92974255-93257961:-	-0.16	-4.38	1.28E-5	Cholesterol, total	
BRCA	cis	1	rs2036402	chr5:156464242	TIMD4	chr5:156346293-156390266:-	-0.18	-4.55	5.95E-6	Hypertriglyceridemia	
BRCA	cis	1	rs2041837	chr2:37468564	CEBPZ	chr2:37428778-37458740:-	-0.19	-6.07	1.8E-9	Chronic lymphocytic leukemia	
BRCA	cis	1	rs2041840	chr2:37467264	CEBPZ	chr2:37428778-37458740:-	-0.17	-5.16	2.89E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs204247	chr6:13722523	RANBP9	chr6:13621731-13711796:-	-0.11	-3.63	0.000296	Breast cancer	
BRCA	cis	1	rs2042947	chr19:12693103	ZNF490	chr19:12686920-12721623:-	0.12	3.48	0.000527	Bipolar disorder	
BRCA	cis	1	rs2045554	chr3:48494542	ATRIP	chr3:48488141-48507708:+	-0.09	-3.38	0.000742	Longevity	
BRCA	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.26	9.87	4.99E-22	Longevity	
BRCA	cis	1	rs204915	chr5:50026928	PARP8	chr5:49961733-50138169:+	-0.13	-3.61	0.000316	Myopia (pathological)	
BRCA	cis	1	rs2050265	chr1:11879699	CLCN6	chr1:11866207-11907674:+	0.17	4.83	1.59E-6	QRS complex (12-leadsum)	
BRCA	cis	1	rs2051090	chr13:36454193	SOHLH2	chr13:36742347-36871992:-	0.15	3.97	7.7E-5	Non-alcoholic fatty liver disease	
BRCA	cis	1	rs2054394	chr4:103268763	SLC39A8	chr4:103172198-103266655:-	0.3	4.75	2.29E-6	Erythrocyte cadmium concentration in never smokers	
BRCA	cis	1	rs2054407	chr4:54527112	LNX1	chr4:54326439-54518682:-	0.13	3.6	0.00033	Beard thickness	
BRCA	cis	1	rs2055127	chr1:235598973	TBCE	chr1:235530728-235612280:+	-0.14	-4.96	8.14E-7	Adiposity	
BRCA	cis	1	rs2055619	chr5:176415964	MXD3	chr5:176732501-176739292:-	-0.09	-4.26	2.25E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs2055619	chr5:176415964	PRELID1	chr5:176730835-176733949:+	-0.09	-3.54	0.000421	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs2055682	chr7:66260289	TYW1	chr7:66461817-66704496:+	0.16	4.3	1.87E-5	Aortic root size	
BRCA	cis	1	rs2056544	chr15:76826003	SCAPER	chr15:76640529-77197744:-	-0.16	-5.55	3.59E-8	Blood metabolite levels	
BRCA	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.4	13.22	4.49E-37	Height	
BRCA	cis	1	rs2056603	chr3:134312749	CEP63	chr3:134204575-134293852:+	0.14	3.74	0.000194	Height	
BRCA	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.39	12.59	5.21E-34	Height	
BRCA	cis	1	rs2056604	chr3:134312648	CEP63	chr3:134204575-134293852:+	0.14	3.81	0.000146	Height	
BRCA	cis	1	rs2056938	chr20:44022672	SYS1	chr20:43991701-44004724:+	0.18	4.63	4.17E-6	Psoriasis	
BRCA	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.47	-10.13	4.3E-23	Subcutaneous adipose tissue	
BRCA	cis	1	rs2058350	chr12:3913427	PARP11	chr12:3918027-3982608:-	-0.16	-4.14	3.76E-5	Cognitive performance	
BRCA	cis	1	rs2058805	chr12:109998591	MMAB	chr12:109991523-110011358:-	-0.13	-3.82	0.000139	HDL cholesterol	
BRCA	cis	1	rs2058805	chr12:109998591	MYO1H	chr12:109826524-109886176:+	0.26	7.75	2.11E-14	HDL cholesterol	
BRCA	cis	1	rs2059776	chr5:178539400	ZNF354C	chr5:178487607-178507689:+	0.11	3.57	0.000376	Height	
BRCA	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.3	7.79	1.53E-14	Pancreatic cancer	
BRCA	cis	1	rs2061973	chr6:49487125	CENPQ	chr6:49431096-49460820:+	0.18	6.05	2.01E-9	Brain structure	
BRCA	cis	1	rs2062340	chr2:54480245	C2orf73	chr2:54558071-54588714:+	0.17	4.12	4.16E-5	Telomere length	
BRCA	cis	1	rs2066587	chr13:50685954	EBPL	chr13:50234811-50265623:-	-0.15	-4	6.74E-5	Height	
BRCA	cis	1	rs2069269	chr7:123406406	HYAL4	chr7:123485223-123517529:+	0.3	4.26	2.27E-5	Platelet count	
BRCA	cis	1	rs2069502	chr12:58144665	B4GALNT1	chr12:58019551-58026985:-	-0.13	-3.77	0.000175	Multiple sclerosis	
BRCA	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.41	-9.94	2.48E-22	Multiple sclerosis	
BRCA	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.34	9.69	2.43E-21	Multiple sclerosis	
BRCA	cis	1	rs2069502	chr12:58144665	XRCC6BP1	chr12:58335445-58351051:+	0.17	4.65	3.66E-6	Multiple sclerosis	
BRCA	cis	1	rs2069837	chr7:22768027	STK31	chr7:23749838-23944365:+	0.25	3.79	0.000156	Longevity	
BRCA	cis	1	rs2069940	chr20:33759272	PROCR	chr20:33758727-33765164:+	-0.26	-4.97	7.66E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.25	-6.4	2.28E-10	Cognitive performance	
BRCA	cis	1	rs2070180	chr3:121351338	SLC15A2	chr3:121613171-121663034:+	0.14	4.03	5.95E-5	Cognitive performance	
BRCA	cis	1	rs2070488	chr3:38442490	XYLB	chr3:38388251-38456467:+	-0.18	-5.41	7.78E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs2070970	chr11:59861983	MS4A4A	chr11:60048139-60076444:+	-0.11	-4.56	5.6E-6	Alzheimer's disease (late onset)	
BRCA	cis	1	rs2072052	chr12:58146719	B4GALNT1	chr12:58019551-58026985:-	0.14	3.88	0.00011	Multiple sclerosis	
BRCA	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.41	9.83	7.17E-22	Multiple sclerosis	
BRCA	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.36	-10.25	1.37E-23	Multiple sclerosis	
BRCA	cis	1	rs2072052	chr12:58146719	XRCC6BP1	chr12:58335445-58351051:+	-0.19	-5.19	2.55E-7	Multiple sclerosis	
BRCA	cis	1	rs2072435	chr7:75959188	UPK3B	chr7:76139745-76157197:+	-0.24	-6.33	3.65E-10	Multiple sclerosis	
BRCA	cis	1	rs2072798	chr22:39148483	LOC646851	chr22:38974125-39052634:-	0.15	4.29	1.98E-5	Resting heart rate	
BRCA	cis	1	rs2073294	chr14:66082493	LOC645431	chr14:65877313-65879335:-	-0.32	-6.71	3.21E-11	Ischemic stroke	
BRCA	cis	1	rs2074771	chr2:242350944	SEPT2	chr2:242254723-242293439:+	0.37	6.88	1.02E-11	Chronic lymphocytic leukemia	
BRCA	cis	1	rs2076028	chr22:39150450	LOC646851	chr22:38974125-39052634:-	0.13	3.88	0.000109	Resting heart rate	
BRCA	cis	1	rs2076474	chr6:56007082	COL21A1	chr6:55921389-56258892:-	-0.38	-7.02	3.93E-12	Psychosis (atypical)	
BRCA	cis	1	rs2077224	chr11:62197427	C11orf10	chr11:61556603-61560085:-	-0.1	-3.48	0.000527	Chronic obstructive pulmonary disease-related biomarkers	
BRCA	cis	1	rs2077393	chr6:25607365	SCGN	chr6:25652429-25702006:+	0.2	5.58	3.11E-8	Uric acid levels	
BRCA	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.82	-27.9	4.56E-129	Homocysteine levels	
BRCA	cis	1	rs2077808	chr1:45988115	MMACHC	chr1:45965856-45976737:+	-0.15	-4.31	1.79E-5	Homocysteine levels	
BRCA	cis	1	rs2078089	chr19:22209753	ZNF257	chr19:22235266-22273901:+	0.19	4.02	6.13E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs2080303	chr2:202165206	ALS2CR12	chr2:202153148-202222101:-	-0.25	-6	2.76E-9	Basal cell carcinoma	
BRCA	cis	1	rs2080303	chr2:202165206	PPIL3	chr2:201735680-201753999:-	-0.2	-5.16	2.96E-7	Basal cell carcinoma	
BRCA	cis	1	rs2081302	chr2:23945355	C2orf84	chr2:24397531-24414566:+	-0.16	-4.03	5.96E-5	Obesity-related traits	
BRCA	cis	1	rs2081302	chr2:23945355	LOC375190	chr2:24299728-24397519:+	0.14	4.19	2.98E-5	Obesity-related traits	
BRCA	cis	1	rs2085683	chr4:18007435	NCAPG	chr4:17812525-17846485:+	0.08	3.52	0.000451	Height	
BRCA	cis	1	rs2089162	chr15:78739763	CHRNA5	chr15:78857906-78886458:+	-0.17	-4.9	1.13E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2089222	chr12:117002658	NCRNA00173	chr12:116971227-116974317:+	0.2	3.62	0.000307	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs2092990	chr20:3346338	ITPA	chr20:3190056-3204504:+	-0.12	-3.65	0.000277	IFN-related cytopenia	
BRCA	cis	1	rs2093433	chr10:96638896	C10orf129	chr10:96953957-96988685:+	0.33	5.55	3.59E-8	Blood metabolite levels	
BRCA	cis	1	rs2096464	chr21:34686049	IFNAR1	chr21:34696734-34732126:+	-0.13	-3.4	0.000697	Narcolepsy	
BRCA	cis	1	rs2098297	chr14:75619118	EIF2B2	chr14:75469612-75476292:+	-0.21	-5.82	7.87E-9	Height	
BRCA	cis	1	rs2098297	chr14:75619118	MLH3	chr14:75480467-75518235:-	-0.22	-6.79	1.86E-11	Height	
BRCA	cis	1	rs2104521	chr6:51656499	TRAM2	chr6:52362202-52441862:-	0.09	3.52	0.000456	Weight loss (gastric bypass surgery)	
BRCA	cis	1	rs2105092	chr6:134184972	TCF21	chr6:134210259-134219157:+	0.15	4	6.64E-5	Coronary heart disease	
BRCA	cis	1	rs2106346	chr9:135784169	C9orf98	chr9:135600965-135754198:-	0.11	3.94	8.8E-5	Psoriasis	
BRCA	cis	1	rs2108622	chr19:15990431	CHERP	chr19:16628700-16653263:-	0.14	3.89	0.000106	Acenocoumarol maintenance dosage;Vitamin E levels;Circulating phylloquinone levels;Metabolite levels;Response to Vitamin E supplementation;Warfarin maintenance dose	
BRCA	cis	1	rs2110309	chr7:110953303	IMMP2L	chr7:110303110-111202538:-	0.16	4.35	1.46E-5	Schizophrenia	
BRCA	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.77	19.32	1.45E-71	Type 2 diabetes	
BRCA	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.8	20.38	2.95E-78	Type 2 diabetes	
BRCA	cis	1	rs2113422	chr2:23939007	C2orf84	chr2:24397531-24414566:+	-0.13	-3.64	0.000284	Obesity-related traits	
BRCA	cis	1	rs2113422	chr2:23939007	LOC375190	chr2:24299728-24397519:+	0.17	5.13	3.51E-7	Obesity-related traits	
BRCA	cis	1	rs2113423	chr2:23942287	C2orf84	chr2:24397531-24414566:+	-0.13	-3.55	0.000397	Obesity-related traits	
BRCA	cis	1	rs2113423	chr2:23942287	LOC375190	chr2:24299728-24397519:+	0.17	5.15	3.04E-7	Obesity-related traits	
BRCA	cis	1	rs2114585	chr2:231039341	SP110	chr2:231033645-231084827:-	0.21	4.05	5.42E-5	Obesity-related traits	
BRCA	cis	1	rs2118404	chr2:25377329	POMC	chr2:25383722-25391559:-	0.16	5.15	3.08E-7	Body mass index	
BRCA	cis	1	rs2118521	chr2:86204379	POLR1A	chr2:86253453-86333278:-	-0.19	-3.53	0.000434	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs2120107	chr15:76869789	SCAPER	chr15:76640529-77197744:-	-0.15	-5.56	3.45E-8	Blood metabolite levels	
BRCA	cis	1	rs2120991	chr12:54270228	LOC400043	chr12:54519855-54526619:+	-0.13	-3.38	0.000755	Biliary atresia	
BRCA	cis	1	rs2121285	chr2:215656168	BARD1	chr2:215593275-215674428:-	0.12	4.4	1.21E-5	Neuroblastoma	
BRCA	cis	1	rs2122660	chr12:62777348	FAM19A2	chr12:62102043-62653925:-	0.17	3.73	0.000201	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs2125211	chr4:103559876	MANBA	chr4:103552644-103682151:-	-0.15	-3.85	0.000125	Primary biliary cirrhosis	
BRCA	cis	1	rs2125654	chr4:18025368	NCAPG	chr4:17812525-17846485:+	0.08	3.54	0.000415	Height	
BRCA	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.45	-17.42	5.26E-60	Kawasaki disease	
BRCA	cis	1	rs2140270	chr3:49439440	AMT	chr3:49454212-49460012:-	-0.14	-4.73	2.59E-6	Menarche (age at onset)	
BRCA	cis	1	rs2140270	chr3:49439440	CCDC36	chr3:49235861-49295537:+	-0.1	-3.92	9.6E-5	Menarche (age at onset)	
BRCA	cis	1	rs2140270	chr3:49439440	NCKIPSD	chr3:48711280-48723334:-	-0.15	-3.92	9.61E-5	Menarche (age at onset)	
BRCA	cis	1	rs2140270	chr3:49439440	P4HTM	chr3:49027341-49044579:+	-0.1	-4.28	2.06E-5	Menarche (age at onset)	
BRCA	cis	1	rs2140270	chr3:49439440	WDR6	chr3:49044637-49053386:+	0.13	3.86	0.000122	Menarche (age at onset)	
BRCA	cis	1	rs2140337	chr4:8502112	C4orf23	chr4:8440604-8495258:+	-0.15	-4	6.74E-5	Response to antineoplastic agents	
BRCA	cis	1	rs2141668	chr3:160336032	TRIM59	chr3:160153292-160167626:-	0.14	4.22	2.62E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs2141924	chr7:66186246	CCT6P1	chr7:65216092-65228661:+	0.31	6.58	7.56E-11	Gout	
BRCA	cis	1	rs2141924	chr7:66186246	CRCP	chr7:65579805-65619551:+	-0.21	-3.43	0.000617	Gout	
BRCA	cis	1	rs2141924	chr7:66186246	LOC493754	chr7:65993446-66057363:-	0.25	4.05	5.56E-5	Gout	
BRCA	cis	1	rs2142991	chr10:43341105	LOC84856	chr10:42970939-42990784:+	-0.16	-3.74	0.000193	Progressive supranuclear palsy	
BRCA	cis	1	rs2143062	chr6:27353852	ZNF391	chr6:27356524-27369227:+	0.16	4.21	2.75E-5	Glomerular filtration rate (creatinine)	
BRCA	cis	1	rs2143346	chr6:26198449	HIST1H3E	chr6:26224427-26226589:+	-0.35	-6.98	5.34E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs2143347	chr6:26198494	HIST1H3E	chr6:26224427-26226589:+	0.36	7.1	2.26E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs2145173	chr6:117230339	FAM162B	chr6:117073360-117086886:-	-0.11	-3.91	9.98E-5	Prostate cancer	
BRCA	cis	1	rs2145173	chr6:117230339	FAM26F	chr6:116782556-116784933:+	-0.09	-3.87	0.000115	Prostate cancer	
BRCA	cis	1	rs2147712	chr14:50091684	RPL36AL	chr14:50085407-50087349:-	0.17	5.28	1.55E-7	Carotid intima media thickness	
BRCA	cis	1	rs2149423	chr13:36772381	SOHLH2	chr13:36742347-36871992:-	0.19	5.09	4.28E-7	Glucose homeostasis traits	
BRCA	cis	1	rs2152375	chr14:65915778	LOC645431	chr14:65877313-65879335:-	-0.3	-5.95	3.6E-9	Ischemic stroke	
BRCA	cis	1	rs2152916	chr10:97392265	ENTPD1	chr10:97471536-97637022:+	0.17	5.86	6.13E-9	Blood metabolite levels	
BRCA	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.25	-7.86	9.42E-15	Eye color traits	
BRCA	cis	1	rs2155233	chr11:57041992	PRG2	chr11:57151267-57191532:-	-0.2	-3.63	0.000302	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs2156257	chr6:163100710	PACRG	chr6:163148164-163736523:+	0.26	4.57	5.5E-6	Body mass index	
BRCA	cis	1	rs2157710	chr22:23457486	RTDR1	chr22:23401594-23484241:-	-0.18	-4.88	1.2E-6	Bone mineral density	
BRCA	cis	1	rs2159584	chr4:17620568	MED28	chr4:17616273-17629791:+	0.15	3.85	0.000126	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs2160215	chr14:81461472	TSHR	chr14:81421869-81612646:+	-0.13	-3.85	0.000127	Graves' disease	
BRCA	cis	1	rs2160392	chr2:37527393	CEBPZ	chr2:37428778-37458740:-	-0.17	-5.29	1.52E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs2160393	chr2:37516950	CEBPZ	chr2:37428778-37458740:-	-0.17	-5.14	3.23E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs2160395	chr2:37479862	CEBPZ	chr2:37428778-37458740:-	-0.17	-5.29	1.48E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs2162478	chr2:231038640	SP110	chr2:231033645-231084827:-	0.21	4.03	6.01E-5	Obesity-related traits	
BRCA	cis	1	rs2163272	chr4:39114410	KLHL5	chr4:39046659-39123828:+	-0.16	-4.89	1.16E-6	Uric acid levels	
BRCA	cis	1	rs2163273	chr4:39114455	KLHL5	chr4:39046659-39123828:+	-0.16	-4.9	1.1E-6	Uric acid levels	
BRCA	cis	1	rs216345	chr9:33799370	NUDT2	chr9:34329504-34343695:+	-0.21	-6.03	2.24E-9	Bipolar disorder	
BRCA	cis	1	rs2163846	chr19:22505844	ZNF98	chr19:22573899-22605148:-	0.14	3.94	8.84E-5	Telomere length	
BRCA	cis	1	rs2165525	chr11:59906792	MS4A4A	chr11:60048139-60076444:+	-0.1	-4.19	2.98E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.59	-19.32	1.46E-71	Response to antipsychotic treatment	
BRCA	cis	1	rs2167287	chr12:62782467	FAM19A2	chr12:62102043-62653925:-	0.17	3.9	0.000101	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs2168154	chr3:190987963	UTS2D	chr3:190984945-191048325:-	-0.21	-6.24	6.25E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.27	6.42	2.02E-10	Body mass index	
BRCA	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.25	-6.08	1.67E-9	Body mass index	
BRCA	cis	1	rs2172252	chr3:49678307	AMT	chr3:49454212-49460012:-	0.11	3.46	0.00056	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs217297	chr6:84380923	SNAP91	chr6:84262607-84419127:-	0.11	3.4	0.000705	Schizophrenia	
BRCA	cis	1	rs217309	chr6:84365449	SNAP91	chr6:84262607-84419127:-	-0.11	-3.42	0.000641	Schizophrenia	
BRCA	cis	1	rs217326	chr6:84349538	SNAP91	chr6:84262607-84419127:-	-0.13	-3.74	0.000197	Schizophrenia	
BRCA	cis	1	rs217328	chr6:84347714	SNAP91	chr6:84262607-84419127:-	-0.14	-4.14	3.7E-5	Schizophrenia	
BRCA	cis	1	rs217333	chr6:84343891	SNAP91	chr6:84262607-84419127:-	-0.14	-4.11	4.2E-5	Schizophrenia	
BRCA	cis	1	rs217335	chr6:84342142	SNAP91	chr6:84262607-84419127:-	-0.11	-3.41	0.000667	Schizophrenia	
BRCA	cis	1	rs2174608	chr15:50871993	SPPL2A	chr15:50999739-51057910:-	0.14	5.29	1.52E-7	QT interval	
BRCA	cis	1	rs2175366	chr19:22128279	ZNF257	chr19:22235266-22273901:+	0.19	4.11	4.2E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs2175416	chr2:160904021	LY75	chr2:160625141-160761262:-	0.14	4.85	1.39E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs2175416	chr2:160904021	PLA2R1	chr2:160798012-160919121:-	0.15	5.16	2.99E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs2176862	chr3:46650993	TDGF1	chr3:46619180-46623950:+	-0.35	-4.67	3.44E-6	Plasma amyloid beta peptide concentrations (ABx-42)	
BRCA	cis	1	rs2177268	chr3:49439725	AMT	chr3:49454212-49460012:-	-0.14	-4.73	2.59E-6	Menarche (age at onset)	
BRCA	cis	1	rs2177268	chr3:49439725	CCDC36	chr3:49235861-49295537:+	-0.1	-3.92	9.6E-5	Menarche (age at onset)	
BRCA	cis	1	rs2177268	chr3:49439725	NCKIPSD	chr3:48711280-48723334:-	-0.15	-3.92	9.61E-5	Menarche (age at onset)	
BRCA	cis	1	rs2177268	chr3:49439725	P4HTM	chr3:49027341-49044579:+	-0.1	-4.28	2.06E-5	Menarche (age at onset)	
BRCA	cis	1	rs2177268	chr3:49439725	WDR6	chr3:49044637-49053386:+	0.13	3.86	0.000122	Menarche (age at onset)	
BRCA	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.19	6.77E-37	Height	
BRCA	cis	1	rs2177601	chr3:134245434	CEP63	chr3:134204575-134293852:+	-0.14	-3.72	0.000212	Height	
BRCA	cis	1	rs2177703	chr7:65391717	CCT6P1	chr7:65216092-65228661:+	0.33	7.26	7.5E-13	Diabetic kidney disease	
BRCA	cis	1	rs2177703	chr7:65391717	LOC493754	chr7:65993446-66057363:-	0.21	3.56	0.000384	Diabetic kidney disease	
BRCA	cis	1	rs2177703	chr7:65391717	ZNF117	chr7:64434830-64467121:-	-0.27	-4.94	9.17E-7	Diabetic kidney disease	
BRCA	cis	1	rs2178451	chr3:160335836	TRIM59	chr3:160153292-160167626:-	0.14	4.22	2.62E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs2179699	chr6:159386594	RSPH3	chr6:159398268-159421198:-	0.22	4.01	6.55E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs2184000	chr20:25395878	FAM182A	chr20:26035250-26067552:+	0.22	5.75	1.17E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2184000	chr20:25395878	FAM182B	chr20:25744102-25848786:-	-0.24	-6.18	8.96E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2185717	chr10:43343875	LOC84856	chr10:42970939-42990784:+	0.17	3.9	0.000102	Progressive supranuclear palsy	
BRCA	cis	1	rs218698	chr17:6594700	TP53	chr17:7565097-7590863:-	0.28	3.81	0.000148	Blood metabolite levels	
BRCA	cis	1	rs2188654	chr7:118179073	ANKRD7	chr7:117864712-117882782:+	0.13	3.4	0.000703	Response to platinum-based chemotherapy in non-small-cell lung cancer	
BRCA	cis	1	rs2202019	chr1:76299181	ACADM	chr1:76190043-76229353:+	-0.21	-3.9	0.000104	Attention function in attention deficit hyperactive disorder	
BRCA	cis	1	rs2208331	chr6:26507319	BTN2A3	chr6:26422317-26431927:+	0.16	5.45	6.19E-8	Educational attainment	
BRCA	cis	1	rs2208331	chr6:26507319	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.4	0.000701	Educational attainment	
BRCA	cis	1	rs2209042	chr6:134188439	TCF21	chr6:134210259-134219157:+	0.16	4.16	3.39E-5	Coronary heart disease	
BRCA	cis	1	rs2219078	chr2:108875198	SULT1C2	chr2:108905095-108926370:+	0.29	6.73	2.68E-11	Blood pressure	
BRCA	cis	1	rs2224380	chr6:26553943	BTN2A3	chr6:26422317-26431927:+	0.16	5.39	8.52E-8	Educational attainment	
BRCA	cis	1	rs2224380	chr6:26553943	C6orf41	chr6:26924772-26991752:+	-0.13	-3.91	9.64E-5	Educational attainment	
BRCA	cis	1	rs2227564	chr10:75673101	BMS1P4	chr10:75458909-75490272:-	-0.12	-3.59	0.000351	Inflammatory bowel disease	
BRCA	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.34	11.41	1.62E-28	Homocysteine levels	
BRCA	cis	1	rs2229384	chr6:49425521	MUT	chr6:49398994-49431031:-	-0.14	-4.19	2.98E-5	Homocysteine levels	
BRCA	cis	1	rs2229687	chr1:10473196	PGD	chr1:10459085-10480200:+	0.22	6.31	4.01E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs2229774	chr12:53605545	RARG	chr12:53604354-53626036:-	-0.25	-3.47	0.000549	Anthracycline-induced cardiotoxicity in childhood cancer	
BRCA	cis	1	rs2231626	chr20:44002665	SYS1	chr20:43991701-44004724:+	0.17	4.34	1.57E-5	Psoriasis	
BRCA	cis	1	rs2231940	chr19:41944237	ATP5SL	chr19:41937224-41945810:-	-0.13	-3.46	0.000556	Height	
BRCA	cis	1	rs2231940	chr19:41944237	B3GNT8	chr19:41931265-41934635:-	0.24	7.04	3.53E-12	Height	
BRCA	cis	1	rs2233551	chr11:76814471	PRKRIR	chr11:76061004-76091880:-	0.19	3.38	0.000758	Cognitive performance	
BRCA	cis	1	rs2235230	chr22:39124467	APOBEC3C	chr22:39410265-39414823:+	0.1	3.64	0.000286	Resting heart rate	
BRCA	cis	1	rs2235230	chr22:39124467	JOSD1	chr22:39081549-39096459:-	0.14	4.1	4.51E-5	Resting heart rate	
BRCA	cis	1	rs2236087	chr20:3255905	ITPA	chr20:3190056-3204504:+	-0.12	-3.61	0.000322	IFN-related cytopenia	
BRCA	cis	1	rs2236089	chr20:3257194	ITPA	chr20:3190056-3204504:+	-0.12	-3.44	0.000611	IFN-related cytopenia	
BRCA	cis	1	rs2236092	chr20:3258188	ITPA	chr20:3190056-3204504:+	-0.13	-3.64	0.000281	IFN-related cytopenia	
BRCA	cis	1	rs2236098	chr20:3267133	ITPA	chr20:3190056-3204504:+	-0.12	-3.59	0.000343	IFN-related cytopenia	
BRCA	cis	1	rs2236104	chr20:3277602	ITPA	chr20:3190056-3204504:+	-0.13	-3.9	0.000101	IFN-related cytopenia	
BRCA	cis	1	rs2236106	chr20:3278410	ITPA	chr20:3190056-3204504:+	-0.12	-3.5	0.00049	IFN-related cytopenia	
BRCA	cis	1	rs2236107	chr20:3285821	ITPA	chr20:3190056-3204504:+	-0.12	-3.44	0.000599	IFN-related cytopenia	
BRCA	cis	1	rs2236108	chr20:3286331	ITPA	chr20:3190056-3204504:+	-0.12	-3.46	0.000565	IFN-related cytopenia	
BRCA	cis	1	rs2236117	chr20:3302021	ITPA	chr20:3190056-3204504:+	-0.12	-3.44	0.000606	IFN-related cytopenia	
BRCA	cis	1	rs2236118	chr20:3302058	ITPA	chr20:3190056-3204504:+	-0.15	-4.34	1.58E-5	IFN-related cytopenia	
BRCA	cis	1	rs2236122	chr20:3305240	ITPA	chr20:3190056-3204504:+	-0.13	-3.86	0.000121	IFN-related cytopenia	
BRCA	cis	1	rs2236123	chr20:3305305	ITPA	chr20:3190056-3204504:+	0.16	4.57	5.39E-6	IFN-related cytopenia	
BRCA	cis	1	rs2236246	chr14:104379206	TDRD9	chr14:104394817-104519002:+	-0.39	-10.07	7.86E-23	Bipolar disorder	
BRCA	cis	1	rs2236247	chr14:104378087	TDRD9	chr14:104394817-104519002:+	0.35	9.46	1.94E-20	Bipolar disorder	
BRCA	cis	1	rs2240539	chr2:242035544	MTERFD2	chr2:242034545-242041747:-	0.26	4.1	4.42E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
BRCA	cis	1	rs2240705	chr10:118467334	C10orf82	chr10:118423208-118429775:-	-0.13	-3.75	0.000185	Age at smoking initiation in chronic obstructive pulmonary disease	
BRCA	cis	1	rs2240706	chr10:118466297	C10orf82	chr10:118423208-118429775:-	-0.13	-3.79	0.000161	Age at smoking initiation in chronic obstructive pulmonary disease	
BRCA	cis	1	rs2241106	chr1:156218910	BGLAP	chr1:156182784-156213112:+	0.18	4.47	8.47E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2241106	chr1:156218910	C1orf85	chr1:156259882-156265449:-	-0.12	-3.47	0.000541	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2241435	chr2:86360916	LOC90784	chr2:86247339-86250991:-	-0.29	-3.82	0.00014	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs2241435	chr2:86360916	ST3GAL5	chr2:86066271-86116157:-	0.26	3.73	0.000202	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs2241706	chr19:41912807	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.28	6.43E-13	Height	
BRCA	cis	1	rs2241708	chr19:41912270	B3GNT8	chr19:41931265-41934635:-	-0.21	-6.54	9.35E-11	Height	
BRCA	cis	1	rs2241709	chr19:41912250	B3GNT8	chr19:41931265-41934635:-	-0.21	-6.51	1.14E-10	Height	
BRCA	cis	1	rs2241710	chr19:41912092	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.28	6.41E-13	Height	
BRCA	cis	1	rs2241711	chr19:41911980	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.39	3.04E-13	Height	
BRCA	cis	1	rs2241878	chr2:234183718	SAG	chr2:234216309-234255701:+	0.13	4.18	3.09E-5	Crohn's disease	
BRCA	cis	1	rs2241879	chr2:234183468	SAG	chr2:234216309-234255701:+	0.13	4.09	4.65E-5	Crohn's disease	
BRCA	cis	1	rs2241880	chr2:234183368	SAG	chr2:234216309-234255701:+	0.13	4.11	4.28E-5	Crohn's disease	
BRCA	cis	1	rs2242050	chr10:102059329	PKD2L1	chr10:102047903-102090243:-	0.23	4.58	5.18E-6	Obesity-related traits	
BRCA	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.28	10.57	6.67E-25	Longevity	
BRCA	cis	1	rs2242330	chr4:68447249	STAP1	chr4:68424446-68473053:+	-0.18	-6.38	2.56E-10	Parkinson's disease	
BRCA	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.19	4.82	1.66E-6	Longevity	
BRCA	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.19	4.82	1.66E-6	Longevity	
BRCA	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.19	4.82	1.66E-6	Longevity	
BRCA	cis	1	rs224329	chr20:34019579	CPNE1	chr20:34213968-34262539:-	-0.23	-6.19	8.39E-10	Height	
BRCA	cis	1	rs224329	chr20:34019579	MMP24	chr20:33814539-33864804:+	-0.15	-4.32	1.73E-5	Height	
BRCA	cis	1	rs224329	chr20:34019579	UQCC	chr20:33890383-33999833:-	-0.32	-9.77	1.15E-21	Height	
BRCA	cis	1	rs2243480	chr7:65599196	CCT6P1	chr7:65216092-65228661:+	0.33	6.78	2.0E-11	Diabetic kidney disease	
BRCA	cis	1	rs2243480	chr7:65599196	LOC493754	chr7:65993446-66057363:-	0.26	4.19	2.97E-5	Diabetic kidney disease	
BRCA	cis	1	rs2245717	chr20:43995880	SYS1	chr20:43991701-44004724:+	0.17	4.58	5.18E-6	Psoriasis	
BRCA	cis	1	rs2246565	chr10:42897648	LOC84856	chr10:42970939-42990784:+	-0.18	-4.67	3.41E-6	Helix rolling	
BRCA	cis	1	rs2246833	chr10:91005854	LIPA	chr10:90973328-91174382:-	0.19	6.44	1.85E-10	Fibrinogen levels	
BRCA	cis	1	rs2246942	chr10:91004886	LIPA	chr10:90973328-91174382:-	0.19	6.37	2.88E-10	Fibrinogen levels	
BRCA	cis	1	rs2247037	chr20:44031295	SYS1	chr20:43991701-44004724:+	0.17	4.52	6.99E-6	Psoriasis	
BRCA	cis	1	rs2248061	chr2:208495059	FAM119A	chr2:208446079-208490065:-	0.17	4.24	2.47E-5	Opioid sensitivity	
BRCA	cis	1	rs2248062	chr2:208495051	FAM119A	chr2:208446079-208490065:-	0.17	4.24	2.47E-5	Opioid sensitivity	
BRCA	cis	1	rs2248393	chr20:33926103	CPNE1	chr20:34213968-34262539:-	-0.24	-6.37	2.83E-10	Height	
BRCA	cis	1	rs2248393	chr20:33926103	MMP24	chr20:33814539-33864804:+	-0.16	-4.49	7.94E-6	Height	
BRCA	cis	1	rs2248393	chr20:33926103	UQCC	chr20:33890383-33999833:-	-0.3	-9.16	2.6E-19	Height	
BRCA	cis	1	rs2248637	chr20:43997240	SYS1	chr20:43991701-44004724:+	-0.17	-4.48	8.11E-6	Psoriasis	
BRCA	cis	1	rs2250006	chr6:153006401	SYNE1	chr6:152442823-152958534:-	0.09	3.69	0.000234	Tonometry	
BRCA	cis	1	rs2250006	chr6:153006401	VIP	chr6:153071933-153080898:+	-0.13	-4.29	1.91E-5	Tonometry	
BRCA	cis	1	rs2250514	chr6:153010920	VIP	chr6:153071933-153080898:+	-0.13	-4.3	1.86E-5	Tonometry	
BRCA	cis	1	rs2250632	chr6:153011126	SYNE1	chr6:152442823-152958534:-	0.08	3.48	0.000512	Tonometry	
BRCA	cis	1	rs2250632	chr6:153011126	VIP	chr6:153071933-153080898:+	-0.14	-4.58	5.14E-6	Tonometry	
BRCA	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.29	-9.87	4.84E-22	Homocysteine levels	
BRCA	cis	1	rs2251115	chr6:49446509	MUT	chr6:49398994-49431031:-	0.18	5.59	2.81E-8	Homocysteine levels	
BRCA	cis	1	rs225243	chr17:33947212	SLFN12L	chr17:33801926-33864880:-	-0.09	-4.79	1.91E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs2252502	chr7:158738634	WDR60	chr7:158649269-158738882:+	0.22	6.38	2.58E-10	Height	
BRCA	cis	1	rs225251	chr17:33951228	SLFN12L	chr17:33801926-33864880:-	-0.08	-4.61	4.48E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs225304	chr17:33921857	SLFN12L	chr17:33801926-33864880:-	-0.09	-4.94	8.85E-7	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs2253105	chr20:44011301	SYS1	chr20:43991701-44004724:+	0.16	4.27	2.1E-5	Psoriasis	
BRCA	cis	1	rs2254230	chr9:131905177	SH3GLB2	chr9:131770314-131790579:-	0.11	3.78	0.000165	Blood metabolite ratios	
BRCA	cis	1	rs2255070	chr6:26501777	BTN2A3	chr6:26422317-26431927:+	0.16	5.45	6.3E-8	Educational attainment	
BRCA	cis	1	rs2255070	chr6:26501777	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.41	0.000681	Educational attainment	
BRCA	cis	1	rs2256686	chr20:44017331	SYS1	chr20:43991701-44004724:+	0.18	4.66	3.55E-6	Psoriasis	
BRCA	cis	1	rs2257420	chr20:25275890	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.41E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257420	chr20:25275890	FAM182B	chr20:25744102-25848786:-	0.23	5.92	4.32E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257432	chr20:25271086	FAM182A	chr20:26035250-26067552:+	-0.21	-5.63	2.29E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257432	chr20:25271086	FAM182B	chr20:25744102-25848786:-	0.22	5.84	6.93E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257432	chr20:25271086	PYGB	chr20:25228706-25278647:+	-0.13	-3.46	0.000566	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257496	chr20:25279315	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.39E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257496	chr20:25279315	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.93E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257790	chr7:65600450	CCT6P1	chr7:65216092-65228661:+	0.31	6.56	8.61E-11	Diabetic kidney disease	
BRCA	cis	1	rs2257790	chr7:65600450	LOC493754	chr7:65993446-66057363:-	0.24	4.05	5.46E-5	Diabetic kidney disease	
BRCA	cis	1	rs2257808	chr20:25266450	FAM182A	chr20:26035250-26067552:+	-0.21	-5.57	3.3E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257808	chr20:25266450	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.84E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257808	chr20:25266450	PYGB	chr20:25228706-25278647:+	-0.13	-3.44	0.000602	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257809	chr20:25266476	FAM182A	chr20:26035250-26067552:+	-0.21	-5.57	3.3E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257809	chr20:25266476	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.84E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257809	chr20:25266476	PYGB	chr20:25228706-25278647:+	-0.13	-3.44	0.000602	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257982	chr20:25269630	FAM182A	chr20:26035250-26067552:+	-0.21	-5.62	2.41E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257982	chr20:25269630	FAM182B	chr20:25744102-25848786:-	0.22	5.85	6.71E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257982	chr20:25269630	PYGB	chr20:25228706-25278647:+	-0.13	-3.46	0.000566	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257985	chr20:25269743	FAM182A	chr20:26035250-26067552:+	-0.21	-5.62	2.41E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257985	chr20:25269743	FAM182B	chr20:25744102-25848786:-	0.22	5.85	6.71E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257985	chr20:25269743	PYGB	chr20:25228706-25278647:+	-0.13	-3.46	0.000566	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257988	chr20:25270003	FAM182A	chr20:26035250-26067552:+	-0.21	-5.62	2.41E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257988	chr20:25270003	FAM182B	chr20:25744102-25848786:-	0.22	5.85	6.71E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257988	chr20:25270003	PYGB	chr20:25228706-25278647:+	-0.13	-3.46	0.000566	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257991	chr20:25270339	FAM182A	chr20:26035250-26067552:+	0.21	5.65	2.05E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257991	chr20:25270339	FAM182B	chr20:25744102-25848786:-	-0.22	-5.82	7.94E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2257991	chr20:25270339	PYGB	chr20:25228706-25278647:+	0.13	3.44	0.000597	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258066	chr20:25271326	FAM182A	chr20:26035250-26067552:+	-0.21	-5.63	2.29E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258066	chr20:25271326	FAM182B	chr20:25744102-25848786:-	0.22	5.84	6.93E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258066	chr20:25271326	PYGB	chr20:25228706-25278647:+	-0.13	-3.46	0.000566	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258135	chr20:25272323	FAM182A	chr20:26035250-26067552:+	-0.21	-5.63	2.29E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258135	chr20:25272323	FAM182B	chr20:25744102-25848786:-	0.22	5.84	6.93E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258135	chr20:25272323	PYGB	chr20:25228706-25278647:+	-0.13	-3.46	0.000566	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258201	chr20:25272490	FAM182A	chr20:26035250-26067552:+	-0.21	-5.49	5.14E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258201	chr20:25272490	FAM182B	chr20:25744102-25848786:-	0.23	5.92	4.21E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258201	chr20:25272490	PYGB	chr20:25228706-25278647:+	-0.13	-3.45	0.000573	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258563	chr20:25273435	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.16E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258563	chr20:25273435	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.9E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258617	chr20:25274318	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.36E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258617	chr20:25274318	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.82E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258719	chr20:25275843	FAM182A	chr20:26035250-26067552:+	-0.23	-6.06	1.91E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258719	chr20:25275843	FAM182B	chr20:25744102-25848786:-	0.23	5.98	3.05E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258719	chr20:25275843	PYGB	chr20:25228706-25278647:+	-0.13	-3.38	0.000744	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258769	chr20:25276680	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.28E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258769	chr20:25276680	FAM182B	chr20:25744102-25848786:-	0.23	5.93	4.07E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258879	chr20:25279213	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.39E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258879	chr20:25279213	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.93E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258884	chr20:25279539	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.39E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2258884	chr20:25279539	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.93E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2259837	chr20:25280205	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.39E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2259837	chr20:25280205	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.93E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2259873	chr20:25280781	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.39E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2259873	chr20:25280781	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.93E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2259926	chr20:25281733	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.27E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2259926	chr20:25281733	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.95E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2259928	chr20:25281834	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.27E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2259928	chr20:25281834	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.95E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2259956	chr20:25282433	FAM182A	chr20:26035250-26067552:+	-0.2	-5.4	8.27E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2259956	chr20:25282433	FAM182B	chr20:25744102-25848786:-	0.23	5.94	3.95E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2263759	chr20:44011502	SYS1	chr20:43991701-44004724:+	0.15	4.02	6.19E-5	Psoriasis	
BRCA	cis	1	rs2263764	chr20:44025815	SYS1	chr20:43991701-44004724:+	0.18	4.63	4.14E-6	Psoriasis	
BRCA	cis	1	rs2263768	chr20:44031241	SYS1	chr20:43991701-44004724:+	0.17	4.52	6.99E-6	Psoriasis	
BRCA	cis	1	rs2267002	chr22:23456702	RTDR1	chr22:23401594-23484241:-	-0.15	-4.17	3.24E-5	Bone mineral density	
BRCA	cis	1	rs2267003	chr22:23457098	RTDR1	chr22:23401594-23484241:-	-0.16	-4.41	1.12E-5	Bone mineral density	
BRCA	cis	1	rs2267138	chr22:29793641	ASCC2	chr22:30184603-30234254:-	-0.2	-4.67	3.37E-6	Myopia (pathological)	
BRCA	cis	1	rs2267138	chr22:29793641	MTMR3	chr22:30279158-30426855:+	-0.17	-4.13	3.87E-5	Myopia (pathological)	
BRCA	cis	1	rs2267138	chr22:29793641	RHBDD3	chr22:29655844-29663914:-	-0.2	-5.22	2.1E-7	Myopia (pathological)	
BRCA	cis	1	rs2267138	chr22:29793641	TBC1D10A	chr22:30687980-30722894:-	-0.14	-3.5	0.000477	Myopia (pathological)	
BRCA	cis	1	rs2267138	chr22:29793641	THOC5	chr22:29904157-29949736:-	-0.17	-3.99	7.01E-5	Myopia (pathological)	
BRCA	cis	1	rs2267138	chr22:29793641	UQCR10	chr22:30163358-30166402:+	-0.18	-4.69	3.03E-6	Myopia (pathological)	
BRCA	cis	1	rs2268753	chr3:38500189	XYLB	chr3:38388251-38456467:+	0.19	5.49	4.92E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs2268757	chr3:38505853	XYLB	chr3:38388251-38456467:+	0.18	5.41	7.85E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs2268758	chr3:38514049	XYLB	chr3:38388251-38456467:+	0.18	5.32	1.24E-7	Electrocardiographic conduction measures	
BRCA	cis	1	rs2268957	chr14:66113233	LOC645431	chr14:65877313-65879335:-	0.32	6.95	6.36E-12	Ischemic stroke	
BRCA	cis	1	rs2268958	chr14:66128238	LOC645431	chr14:65877313-65879335:-	-0.3	-5.79	9.28E-9	Ischemic stroke	
BRCA	cis	1	rs2269186	chr14:104379912	TDRD9	chr14:104394817-104519002:+	0.41	10.31	7.72E-24	Bipolar disorder	
BRCA	cis	1	rs2269558	chr16:682250	PIGQ	chr16:617032-634108:+	-0.11	-5.09	4.28E-7	Height	
BRCA	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.3	8.72	1.08E-17	Height	
BRCA	cis	1	rs2270291	chr1:156244992	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2270291	chr1:156244992	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2271115	chr1:21295864	SH2D5	chr1:21046225-21059330:-	0.13	3.5	0.000488	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs227163	chr1:7961206	UTS2	chr1:7903144-7973294:-	-0.14	-4.55	6.11E-6	Rheumatoid arthritis	
BRCA	cis	1	rs2272565	chr11:244414	PSMD13	chr11:236808-252984:+	-0.16	-4.48	8.22E-6	Menarche (age at onset)	
BRCA	cis	1	rs2272695	chr4:103555803	MANBA	chr4:103552644-103682151:-	0.21	5.47	5.51E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs2272696	chr4:103555821	MANBA	chr4:103552644-103682151:-	0.21	5.47	5.51E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs2272697	chr4:103555992	MANBA	chr4:103552644-103682151:-	0.21	5.47	5.53E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs2273602	chr6:117730592	ROS1	chr6:117609530-117747018:-	-0.15	-4.9	1.13E-6	Lung cancer	
BRCA	cis	1	rs2273694	chr10:102256496	SEC31B	chr10:102246403-102289636:-	-0.28	-10.41	3.01E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2273695	chr10:102259568	SEC31B	chr10:102246403-102289636:-	-0.29	-11.29	5.18E-28	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2273832	chr1:156233143	BGLAP	chr1:156182784-156213112:+	0.19	4.88	1.25E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2273833	chr1:156233189	BGLAP	chr1:156182784-156213112:+	0.19	4.87	1.3E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2273833	chr1:156233189	C1orf85	chr1:156259882-156265449:-	-0.12	-3.52	0.000443	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2273833	chr1:156233189	CCT3	chr1:156278752-156308195:-	-0.11	-3.49	0.00051	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.22	5.49	4.99E-8	Longevity	
BRCA	cis	1	rs2274459	chr6:33762242	IP6K3	chr6:33689443-33714762:-	0.28	4.88	1.22E-6	Obesity (extreme)	
BRCA	cis	1	rs2274465	chr1:44121557	C1orf84	chr1:43855556-43878462:+	0.14	3.57	0.000377	Hypertension risk in short sleep duration	
BRCA	cis	1	rs2275424	chr1:10356562	PGD	chr1:10459085-10480200:+	0.21	5.96	3.43E-9	Hepatocellular carcinoma	
BRCA	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.73	5.39E-30	Body mass index	
BRCA	cis	1	rs2275426	chr1:46487552	CCDC17	chr1:46085717-46089729:-	0.11	3.51	0.000472	Body mass index	
BRCA	cis	1	rs2275426	chr1:46487552	MUTYH	chr1:45794915-45806142:-	0.12	4.89	1.17E-6	Body mass index	
BRCA	cis	1	rs2276161	chr2:135470735	TMEM163	chr2:135213331-135525334:-	-0.23	-4.77	2.09E-6	Gut microbiome composition (winter)	
BRCA	cis	1	rs2276540	chr3:38512507	XYLB	chr3:38388251-38456467:+	0.18	5.39	8.72E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.26	-6.29	4.65E-10	Body mass index	
BRCA	cis	1	rs2276834	chr3:52325759	SPCS1	chr3:52739857-52742195:+	0.12	3.8	0.000153	Electroencephalogram traits	
BRCA	cis	1	rs2277717	chr18:44702718	KATNAL2	chr18:44497557-44628613:+	0.14	3.73	0.000204	Educational attainment	
BRCA	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.57	-12.27	1.81E-32	Cholesterol, total	
BRCA	cis	1	rs2277862	chr20:34152782	ERGIC3	chr20:34129778-34145404:+	-0.19	-4.09	4.62E-5	Cholesterol, total	
BRCA	cis	1	rs2277869	chr12:1016910	RAD52	chr12:1021255-1099219:-	-0.32	-7.07	2.8E-12	Colorectal cancer	
BRCA	cis	1	rs2277870	chr1:156246792	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2277870	chr1:156246792	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2277871	chr1:156246742	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2277871	chr1:156246742	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2277912	chr2:207634236	MDH1B	chr2:207598943-207630050:-	-0.22	-4.81	1.74E-6	Height	
BRCA	cis	1	rs2278086	chr2:86281905	LOC90784	chr2:86247339-86250991:-	-0.45	-5.49	4.91E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs2278161	chr18:72176083	CNDP2	chr18:72163597-72188356:+	0.22	4.56	5.69E-6	Refractive error	
BRCA	cis	1	rs2278162	chr18:72175814	CNDP2	chr18:72163597-72188356:+	0.22	4.57	5.48E-6	Refractive error	
BRCA	cis	1	rs2278238	chr19:18576484	LRRC25	chr19:18501955-18508421:-	-0.15	-7.08	2.56E-12	Breast cancer	
BRCA	cis	1	rs2278842	chr10:102056745	PKD2L1	chr10:102047903-102090243:-	0.24	4.32	1.68E-5	Obesity-related traits	
BRCA	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.29	-10.87	3.49E-26	Longevity	
BRCA	cis	1	rs2279144	chr19:39201781	LGALS7	chr19:39261608-39264157:-	-0.19	-5.88	5.33E-9	Heart rate	
BRCA	cis	1	rs2279581	chr15:40300092	SPINT1	chr15:41136246-41149852:+	-0.18	-3.41	0.000685	Response to haloperidol in psychosis	
BRCA	cis	1	rs2279581	chr15:40300092	SRP14	chr15:40327891-40331389:-	-0.25	-5.63	2.32E-8	Response to haloperidol in psychosis	
BRCA	cis	1	rs2280017	chr16:15151361	RRN3	chr16:15153881-15188158:-	0.13	4.29	1.93E-5	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid);Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
BRCA	cis	1	rs2280018	chr16:15150833	RRN3	chr16:15153881-15188158:-	-0.13	-4.07	5.05E-5	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid);Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
BRCA	cis	1	rs2281006	chr1:171110869	FMO2	chr1:171154388-171181822:+	-0.11	-3.56	0.000384	Blood metabolite levels	
BRCA	cis	1	rs2281006	chr1:171110869	FMO3	chr1:171060018-171086957:+	-0.27	-6.32	3.8E-10	Blood metabolite levels	
BRCA	cis	1	rs2281223	chr20:48484241	CSE1L	chr20:47662838-47713484:+	0.09	3.38	0.000741	Gut microbiota (beta diversity)	
BRCA	cis	1	rs2281503	chr20:3263636	ITPA	chr20:3190056-3204504:+	-0.12	-3.6	0.000334	IFN-related cytopenia	
BRCA	cis	1	rs2281597	chr1:34359858	CSMD2	chr1:33979609-34631443:-	0.14	4.4	1.18E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2281808	chr20:1610551	SIRPG	chr20:1609798-1638425:-	0.05	3.43	0.000616	Type 1 diabetes	
BRCA	cis	1	rs2285087	chr4:3088211	GRK4	chr4:2965343-3042474:+	-0.17	-3.95	8.38E-5	Parental longevity (mother's age at death)	
BRCA	cis	1	rs228591	chr11:108097333	ATM	chr11:108093559-108239826:+	-0.08	-3.58	0.000362	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
BRCA	cis	1	rs2285946	chr7:21583329	DNAH11	chr7:21582833-21941455:+	-0.23	-6.53	1.02E-10	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
BRCA	cis	1	rs2285947	chr7:21584088	DNAH11	chr7:21582833-21941455:+	0.23	6.55	9.1E-11	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
BRCA	cis	1	rs2285949	chr7:21584243	DNAH11	chr7:21582833-21941455:+	-0.23	-6.44	1.82E-10	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
BRCA	cis	1	rs2285950	chr7:21584432	DNAH11	chr7:21582833-21941455:+	0.21	6.04	2.12E-9	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
BRCA	cis	1	rs2286498	chr7:22857504	TOMM7	chr7:22852254-22862421:-	0.16	5.21	2.26E-7	Fibrinogen	
BRCA	cis	1	rs2286499	chr7:22857477	TOMM7	chr7:22852254-22862421:-	-0.17	-5.5	4.67E-8	Fibrinogen	
BRCA	cis	1	rs2286501	chr7:22856785	TOMM7	chr7:22852254-22862421:-	-0.16	-5.19	2.53E-7	Fibrinogen	
BRCA	cis	1	rs2286503	chr7:22856606	TOMM7	chr7:22852254-22862421:-	-0.16	-5.14	3.25E-7	Fibrinogen	
BRCA	cis	1	rs2286684	chr7:66129830	CRCP	chr7:65579805-65619551:+	0.13	3.38	0.000758	Aortic root size	
BRCA	cis	1	rs2286684	chr7:66129830	TYW1	chr7:66461817-66704496:+	-0.15	-4.02	6.33E-5	Aortic root size	
BRCA	cis	1	rs2287754	chr19:49496494	RPS11	chr19:49999634-50002944:+	-0.15	-3.59	0.000345	Follicule stimulating hormone	
BRCA	cis	1	rs2288073	chr2:24413298	LOC375190	chr2:24299728-24397519:+	0.23	6.35	3.21E-10	Venous thromboembolism (SNP x SNP interaction)	
BRCA	cis	1	rs2288871	chr19:41917868	B3GNT8	chr19:41931265-41934635:-	-0.22	-6.71	3.18E-11	Height	
BRCA	cis	1	rs2289130	chr18:44626630	HDHD2	chr18:44633782-44676871:-	0.3	5.17	2.85E-7	Sitting height ratio	
BRCA	cis	1	rs2289131	chr18:44602864	HDHD2	chr18:44633782-44676871:-	0.3	5.13	3.48E-7	Sitting height ratio	
BRCA	cis	1	rs2289132	chr18:44602292	HDHD2	chr18:44633782-44676871:-	0.3	5.13	3.48E-7	Sitting height ratio	
BRCA	cis	1	rs2289472	chr2:234182240	SAG	chr2:234216309-234255701:+	0.13	4.09	4.7E-5	Crohn's disease	
BRCA	cis	1	rs2289474	chr2:234181848	SAG	chr2:234216309-234255701:+	0.13	4.09	4.7E-5	Crohn's disease	
BRCA	cis	1	rs2290409	chr4:1067249	KIAA1530	chr4:1341104-1381836:+	-0.11	-3.84	0.000131	Recombination rate (males)	
BRCA	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.26	-10.06	8.03E-23	Longevity	
BRCA	cis	1	rs2290850	chr11:47807774	MADD	chr11:47290927-47351582:+	0.15	4.68	3.28E-6	Subjective well-being	
BRCA	cis	1	rs2290850	chr11:47807774	MYBPC3	chr11:47352958-47374253:-	-0.13	-3.92	9.54E-5	Subjective well-being	
BRCA	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.71	-21	3.29E-82	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs2291361	chr12:56717805	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.29E-5	Psoriasis vulgaris	
BRCA	cis	1	rs2291361	chr12:56717805	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.000187	Psoriasis vulgaris	
BRCA	cis	1	rs2291361	chr12:56717805	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000365	Psoriasis vulgaris	
BRCA	cis	1	rs2291542	chr3:49751585	CCDC36	chr3:49235861-49295537:+	0.09	3.39	0.000733	Resting heart rate	
BRCA	cis	1	rs2291542	chr3:49751585	DALRD3	chr3:49052435-49058467:-	0.15	4.92	1.0E-6	Resting heart rate	
BRCA	cis	1	rs2291542	chr3:49751585	P4HTM	chr3:49027341-49044579:+	0.1	4.67	3.34E-6	Resting heart rate	
BRCA	cis	1	rs2291738	chr12:56815281	GDF11	chr12:56137064-56150911:+	0.12	3.71	0.000215	Axial length	
BRCA	cis	1	rs2291738	chr12:56815281	TIMELESS	chr12:56810157-56843200:-	-0.09	-4.25	2.3E-5	Axial length	
BRCA	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.59	17.69	1.29E-61	Cognitive function	
BRCA	cis	1	rs2292255	chr5:176334195	MXD3	chr5:176732501-176739292:-	-0.09	-4.3	1.89E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs2292255	chr5:176334195	PRELID1	chr5:176730835-176733949:+	-0.1	-3.63	0.000295	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs2292256	chr5:176333126	MXD3	chr5:176732501-176739292:-	-0.09	-4.4	1.19E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs2292256	chr5:176333126	PRELID1	chr5:176730835-176733949:+	-0.1	-3.62	0.000305	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs2293289	chr6:161551439	MAP3K4	chr6:161412822-161538416:+	0.2	3.79	0.00016	Lipoprotein (a) - cholesterol levels	
BRCA	cis	1	rs2294873	chr1:37961613	SNIP1	chr1:38002145-38019903:-	-0.17	-3.45	0.000591	Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs229540	chr22:37591290	C1QTNF6	chr22:37576206-37594341:-	-0.09	-3.93	8.88E-5	Type 1 diabetes	
BRCA	cis	1	rs2295700	chr20:33591627	MMP24	chr20:33814539-33864804:+	-0.22	-3.88	0.00011	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs2295700	chr20:33591627	PROCR	chr20:33758727-33765164:+	-0.24	-4.91	1.06E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs2295770	chr10:102239829	SEC31B	chr10:102246403-102289636:-	-0.28	-10.24	1.5E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2295772	chr10:102265183	SEC31B	chr10:102246403-102289636:-	-0.31	-11.69	8.92E-30	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2295773	chr10:102265815	SEC31B	chr10:102246403-102289636:-	-0.31	-11.68	9.09E-30	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2295774	chr10:102265847	SEC31B	chr10:102246403-102289636:-	-0.3	-10.58	6.02E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2295776	chr10:102295629	SEC31B	chr10:102246403-102289636:-	-0.3	-11.18	1.69E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2295779	chr10:102296061	SEC31B	chr10:102246403-102289636:-	-0.29	-11.12	2.89E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2295780	chr10:102305965	SEC31B	chr10:102246403-102289636:-	-0.28	-9.64	3.84E-21	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2296375	chr1:156309372	BGLAP	chr1:156182784-156213112:+	0.19	4.98	7.4E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2296375	chr1:156309372	CCT3	chr1:156278752-156308195:-	-0.12	-3.87	0.000114	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs2296691	chr10:97370989	ENTPD1	chr10:97471536-97637022:+	0.17	5.85	6.47E-9	Blood metabolite levels	
BRCA	cis	1	rs2296749	chr6:33763127	IP6K3	chr6:33689443-33714762:-	0.28	4.94	9.04E-7	Obesity (extreme)	
BRCA	cis	1	rs2297112	chr9:131900180	SH3GLB2	chr9:131770314-131790579:-	-0.11	-4.12	4.0E-5	Blood metabolite ratios	
BRCA	cis	1	rs2297496	chr20:25295787	FAM182A	chr20:26035250-26067552:+	0.2	5.39	8.78E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2297496	chr20:25295787	FAM182B	chr20:25744102-25848786:-	-0.23	-5.92	4.39E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2297496	chr20:25295787	PYGB	chr20:25228706-25278647:+	0.13	3.38	0.000753	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2297497	chr20:25297909	FAM182A	chr20:26035250-26067552:+	0.2	5.33	1.21E-7	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2297497	chr20:25297909	FAM182B	chr20:25744102-25848786:-	-0.23	-6.09	1.55E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2298074	chr10:102247526	SEC31B	chr10:102246403-102289636:-	-0.29	-10.18	2.68E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2298075	chr10:102247408	SEC31B	chr10:102246403-102289636:-	-0.29	-10.51	1.16E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2298755	chr4:100261038	ADH1C	chr4:100257651-100273917:-	0.2	6.31	4.04E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs2298948	chr2:75926565	C2orf3	chr2:75889834-75938111:-	-0.16	-4.45	9.44E-6	Hippocampal atrophy	
BRCA	cis	1	rs2300206	chr20:32589808	EIF2S2	chr20:32676117-32700085:-	0.11	3.44	0.00061	Cancer;Cancer (pleiotropy)	
BRCA	cis	1	rs2300601	chr14:75639571	EIF2B2	chr14:75469612-75476292:+	0.22	6.21	7.46E-10	Height	
BRCA	cis	1	rs2300601	chr14:75639571	MLH3	chr14:75480467-75518235:-	0.25	7.81	1.33E-14	Height	
BRCA	cis	1	rs2300871	chr14:66147694	LOC645431	chr14:65877313-65879335:-	0.27	5.8	8.48E-9	Ischemic stroke	
BRCA	cis	1	rs2300872	chr14:66147761	LOC645431	chr14:65877313-65879335:-	-0.29	-5.55	3.69E-8	Ischemic stroke	
BRCA	cis	1	rs2301229	chr1:110136678	AMIGO1	chr1:110049447-110052336:-	0.17	4.09	4.73E-5	Major depressive disorder	
BRCA	cis	1	rs2301229	chr1:110136678	SYPL2	chr1:110009100-110024763:+	-0.15	-3.85	0.000126	Major depressive disorder	
BRCA	cis	1	rs2301713	chr5:131951996	SLC22A5	chr5:131705401-131731302:+	-0.1	-3.4	0.000702	Asthma (childhood onset)	
BRCA	cis	1	rs2301889	chr7:98931105	CYP3A5	chr7:99245818-99332821:-	0.41	6.19	8.31E-10	Blood metabolite levels	
BRCA	cis	1	rs2302045	chr2:242021216	MTERFD2	chr2:242034545-242041747:-	0.23	3.7	0.000227	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
BRCA	cis	1	rs2302052	chr2:242063448	MTERFD2	chr2:242034545-242041747:-	0.24	3.55	0.000404	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
BRCA	cis	1	rs2302139	chr14:74362935	LIN52	chr14:74551656-74667117:+	0.27	6.02	2.43E-9	Morning vs. evening chronotype	
BRCA	cis	1	rs2303049	chr19:49494812	DHDH	chr19:49436939-49448226:+	-0.21	-3.41	0.000679	Follicule stimulating hormone	
BRCA	cis	1	rs2303339	chr2:86346180	LOC90784	chr2:86247339-86250991:-	0.34	4.2	2.94E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs2303339	chr2:86346180	ST3GAL5	chr2:86066271-86116157:-	-0.3	-4.07	4.94E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs2303340	chr2:86333193	LOC90784	chr2:86247339-86250991:-	-0.26	-3.47	0.000541	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs2303340	chr2:86333193	ST3GAL5	chr2:86066271-86116157:-	0.29	4.14	3.79E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs2303695	chr19:18562624	LRRC25	chr19:18501955-18508421:-	-0.15	-7.18	1.29E-12	Breast cancer	
BRCA	cis	1	rs2303759	chr19:49869051	CCDC155	chr19:49891506-49921246:+	-0.28	-7.01	4.08E-12	Multiple sclerosis	
BRCA	cis	1	rs2303759	chr19:49869051	CD37	chr19:49838428-49843859:+	-0.06	-3.95	8.49E-5	Multiple sclerosis	
BRCA	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.44	-11.07	4.76E-27	Multiple sclerosis	
BRCA	cis	1	rs2303790	chr16:57017292	ARL2BP	chr16:57279038-57287545:+	-0.37	-4.97	7.82E-7	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	BBS2	chr16:56518259-56554008:-	-0.34	-4.34	1.56E-5	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	CIAPIN1	chr16:57462087-57481369:-	-0.32	-4.99	6.97E-7	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	COQ9	chr16:57481402-57495178:+	-0.44	-6.48	1.38E-10	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	FAM192A	chr16:57186382-57219976:-	-0.4	-5.41	7.92E-8	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	GPR56	chr16:57653650-57698944:+	-0.33	-4.62	4.36E-6	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	HERPUD1	chr16:56965748-56977793:+	-0.28	-3.85	0.000123	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	KATNB1	chr16:57769660-57791162:+	-0.29	-4.53	6.48E-6	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	NUDT21	chr16:56463049-56485261:-	-0.31	-4.52	7.0E-6	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	NUP93	chr16:56764017-56878676:+	-0.29	-4.88	1.21E-6	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	OGFOD1	chr16:56485424-56511406:+	-0.28	-3.65	0.000278	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	POLR2C	chr16:57496551-57505921:+	-0.34	-4.73	2.51E-6	Exudative age-related macular degeneration	
BRCA	cis	1	rs2303790	chr16:57017292	RSPRY1	chr16:57220241-57272940:+	-0.28	-4.89	1.18E-6	Exudative age-related macular degeneration	
BRCA	cis	1	rs2304242	chr19:41944616	B3GNT8	chr19:41931265-41934635:-	0.24	7.07	2.8E-12	Height	
BRCA	cis	1	rs2305983	chr11:47858755	MADD	chr11:47290927-47351582:+	-0.14	-4.07	5.03E-5	Intraocular pressure	
BRCA	cis	1	rs2306693	chr12:56680531	COQ10A	chr12:56660642-56664748:+	-0.3	-4.18	3.12E-5	Psoriasis vulgaris	
BRCA	cis	1	rs2306693	chr12:56680531	RPS26	chr12:56435686-56438005:+	-0.29	-3.69	0.000239	Psoriasis vulgaris	
BRCA	cis	1	rs2306693	chr12:56680531	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.9	0.0001	Psoriasis vulgaris	
BRCA	cis	1	rs2306694	chr12:56680636	COQ10A	chr12:56660642-56664748:+	0.3	4.21	2.75E-5	Psoriasis vulgaris	
BRCA	cis	1	rs2306694	chr12:56680636	RPS26	chr12:56435686-56438005:+	0.27	3.54	0.00042	Psoriasis vulgaris	
BRCA	cis	1	rs2306694	chr12:56680636	SLC39A5	chr12:56623820-56631627:+	0.26	3.79	0.000158	Psoriasis vulgaris	
BRCA	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.55	11.52	4.81E-29	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.59	13.08	2.31E-36	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs2307021	chr3:49765483	CCDC36	chr3:49235861-49295537:+	0.09	3.65	0.000271	Resting heart rate	
BRCA	cis	1	rs2307021	chr3:49765483	DALRD3	chr3:49052435-49058467:-	0.14	4.59	4.86E-6	Resting heart rate	
BRCA	cis	1	rs2307021	chr3:49765483	P4HTM	chr3:49027341-49044579:+	0.09	3.78	0.000163	Resting heart rate	
BRCA	cis	1	rs2310997	chr3:48678011	CCDC36	chr3:49235861-49295537:+	-0.15	-3.54	0.000421	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs2310997	chr3:48678011	WDR6	chr3:49044637-49053386:+	0.26	4.94	9.21E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs2312462	chr3:49601255	AMT	chr3:49454212-49460012:-	0.15	5.39	8.87E-8	Menarche (age at onset)	
BRCA	cis	1	rs2312462	chr3:49601255	CCDC36	chr3:49235861-49295537:+	0.11	4.24	2.4E-5	Menarche (age at onset)	
BRCA	cis	1	rs2312462	chr3:49601255	NCKIPSD	chr3:48711280-48723334:-	0.19	4.85	1.42E-6	Menarche (age at onset)	
BRCA	cis	1	rs2312462	chr3:49601255	P4HTM	chr3:49027341-49044579:+	0.12	5.05	5.2E-7	Menarche (age at onset)	
BRCA	cis	1	rs2315281	chr19:19480099	CILP2	chr19:19649074-19657466:+	-0.1	-3.75	0.00019	Schizophrenia	
BRCA	cis	1	rs2315281	chr19:19480099	HAPLN4	chr19:19366453-19384074:-	-0.21	-6.83	1.43E-11	Schizophrenia	
BRCA	cis	1	rs2316803	chr9:91551990	C9orf47	chr9:91605778-91611055:+	0.13	3.75	0.000186	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs2316804	chr9:91551898	C9orf47	chr9:91605778-91611055:+	0.13	3.7	0.000229	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.6	-18.25	5.77E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs2329340	chr7:50620229	FIGNL1	chr7:50511834-50518088:-	-0.13	-4.6	4.84E-6	Malaria	
BRCA	cis	1	rs2329341	chr7:50620275	FIGNL1	chr7:50511834-50518088:-	-0.13	-4.6	4.84E-6	Malaria	
BRCA	cis	1	rs2329342	chr7:50624971	FIGNL1	chr7:50511834-50518088:-	0.13	4.32	1.68E-5	Malaria	
BRCA	cis	1	rs2336723	chr3:53106047	RFT1	chr3:53122503-53164470:-	-0.29	-7.65	4.61E-14	Height	
BRCA	cis	1	rs2340952	chr8:39823239	ADAM9	chr8:38854505-38962777:+	0.11	3.42	0.000661	Blood metabolite levels	
BRCA	cis	1	rs2340952	chr8:39823239	TM2D2	chr8:38846328-38854041:-	0.15	3.93	8.91E-5	Blood metabolite levels	
BRCA	cis	1	rs2349075	chr2:202223566	ALS2CR12	chr2:202153148-202222101:-	-0.2	-5.05	5.11E-7	Basal cell carcinoma	
BRCA	cis	1	rs2349075	chr2:202223566	PPIL3	chr2:201735680-201753999:-	-0.16	-4.2	2.89E-5	Basal cell carcinoma	
BRCA	cis	1	rs2349775	chr7:8718080	NXPH1	chr7:8473585-8792592:+	0.15	4.07	4.96E-5	Neuroticism	
BRCA	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.5	-13.11	1.55E-36	Type 2 diabetes	
BRCA	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.5	-13.1	1.73E-36	Type 2 diabetes	
BRCA	cis	1	rs2354427	chr11:28049623	METT5D1	chr11:28129798-28355054:+	-0.11	-3.41	0.000676	Bipolar disorder	
BRCA	cis	1	rs2354550	chr6:107141943	ATG5	chr6:106632354-106773695:-	0.16	4.41	1.12E-5	Daytime sleep phenotypes	
BRCA	cis	1	rs2354550	chr6:107141943	C6orf203	chr6:107349407-107372544:+	0.12	3.57	0.000374	Daytime sleep phenotypes	
BRCA	cis	1	rs2354550	chr6:107141943	RTN4IP1	chr6:107018905-107078366:-	0.15	4.28	2.08E-5	Daytime sleep phenotypes	
BRCA	cis	1	rs2356501	chr6:118942371	C6orf204	chr6:118786239-119031238:-	-0.11	-3.57	0.00038	Renal cell carcinoma	
BRCA	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.77	-25.8	1.87E-114	Homocysteine levels	
BRCA	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.71	-23.23	6.35E-97	Homocysteine levels	
BRCA	cis	1	rs2359155	chr19:21671869	ZNF493	chr19:21579921-21610294:+	-0.13	-4.23	2.52E-5	Pain	
BRCA	cis	1	rs2359821	chr19:22208314	ZNF257	chr19:22235266-22273901:+	0.19	4.03	5.89E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.25	-9.42	2.81E-20	Longevity	
BRCA	cis	1	rs2362452	chr3:48418214	ATRIP	chr3:48488141-48507708:+	-0.11	-3.8	0.000154	Longevity	
BRCA	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.24	9.04	7.49E-19	Longevity	
BRCA	cis	1	rs2363286	chr7:1091625	ZFAND2A	chr7:1192544-1199855:-	-0.31	-6.16	1.04E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.65	-12.43	3.06E-33	Plasma clusterin levels	
BRCA	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.42	13.71	1.66E-39	Height	
BRCA	cis	1	rs2370578	chr3:134199612	CEP63	chr3:134204575-134293852:+	0.17	4.49	7.89E-6	Height	
BRCA	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.43	14.46	2.02E-43	Height	
BRCA	cis	1	rs2370641	chr3:134222161	CEP63	chr3:134204575-134293852:+	0.15	4.2	2.89E-5	Height	
BRCA	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.43	14.44	2.78E-43	Height	
BRCA	cis	1	rs2370642	chr3:134222136	CEP63	chr3:134204575-134293852:+	0.15	4.04	5.82E-5	Height	
BRCA	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.43	-10.63	3.73E-25	Obesity-related traits	
BRCA	cis	1	rs2371244	chr7:143757611	OR2A7	chr7:143955790-143974852:-	0.19	4.58	5.27E-6	Obesity-related traits	
BRCA	cis	1	rs2371244	chr7:143757611	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.56	0.000388	Obesity-related traits	
BRCA	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.42	-10.17	2.87E-23	Obesity-related traits	
BRCA	cis	1	rs2371247	chr7:143764179	OR2A7	chr7:143955790-143974852:-	0.21	4.83	1.55E-6	Obesity-related traits	
BRCA	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.16	3.26E-23	Obesity-related traits	
BRCA	cis	1	rs2371248	chr7:143764189	OR2A7	chr7:143955790-143974852:-	0.21	4.9	1.1E-6	Obesity-related traits	
BRCA	cis	1	rs2371454	chr12:56647243	COQ10A	chr12:56660642-56664748:+	0.29	3.97	7.51E-5	Psoriasis vulgaris	
BRCA	cis	1	rs2371454	chr12:56647243	RPS26	chr12:56435686-56438005:+	0.31	4	6.89E-5	Psoriasis vulgaris	
BRCA	cis	1	rs2371454	chr12:56647243	SLC39A5	chr12:56623820-56631627:+	0.25	3.57	0.000367	Psoriasis vulgaris	
BRCA	cis	1	rs2373000	chr2:37592628	CEBPZ	chr2:37428778-37458740:-	-0.14	-4.46	8.89E-6	Schizophrenia	
BRCA	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.4	-13.04	3.4E-36	Height	
BRCA	cis	1	rs2373865	chr3:134291556	CEP63	chr3:134204575-134293852:+	-0.14	-3.68	0.000243	Height	
BRCA	cis	1	rs2381284	chr4:39119596	KLHL5	chr4:39046659-39123828:+	-0.15	-4.82	1.65E-6	Uric acid levels	
BRCA	cis	1	rs2381285	chr4:39114395	KLHL5	chr4:39046659-39123828:+	-0.16	-4.91	1.06E-6	Uric acid levels	
BRCA	cis	1	rs2382817	chr2:219151218	GPBAR1	chr2:219125738-219128582:+	-0.1	-3.47	0.000549	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs2382817	chr2:219151218	TMBIM1	chr2:219138917-219157280:-	0.13	3.88	0.000111	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs2384654	chr2:27847364	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.18	3.14E-5	Oral cavity cancer	
BRCA	cis	1	rs2386240	chr5:82443011	XRCC4	chr5:82373317-82649577:+	-0.12	-3.54	0.000411	Hypertension	
BRCA	cis	1	rs2387880	chr20:25377787	FAM182A	chr20:26035250-26067552:+	0.21	5.58	2.97E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2387880	chr20:25377787	FAM182B	chr20:25744102-25848786:-	-0.25	-6.42	2.01E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2387881	chr20:25378172	ABHD12	chr20:25275380-25371477:-	-0.12	-3.52	0.000457	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2387881	chr20:25378172	FAM182A	chr20:26035250-26067552:+	0.2	5.27	1.65E-7	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2387881	chr20:25378172	FAM182B	chr20:25744102-25848786:-	-0.23	-5.93	3.98E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2387884	chr20:25379069	ABHD12	chr20:25275380-25371477:-	-0.11	-3.4	0.000704	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2387884	chr20:25379069	FAM182A	chr20:26035250-26067552:+	0.21	5.7	1.59E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2387884	chr20:25379069	FAM182B	chr20:25744102-25848786:-	-0.24	-6.3	4.41E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2391159	chr1:92971951	EVI5	chr1:92974255-93257961:-	-0.17	-4.52	6.84E-6	Cholesterol, total	
BRCA	cis	1	rs2391160	chr1:92992797	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs2393593	chr6:26285683	BTN3A2	chr6:26365398-26378546:+	0.19	6.02	2.43E-9	Educational attainment	
BRCA	cis	1	rs2393670	chr6:26535541	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.59E-8	Educational attainment	
BRCA	cis	1	rs2393670	chr6:26535541	C6orf41	chr6:26924772-26991752:+	-0.12	-3.7	0.000227	Educational attainment	
BRCA	cis	1	rs2393670	chr6:26535541	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.5	0.000488	Educational attainment	
BRCA	cis	1	rs2393969	chr10:65140440	NRBF2	chr10:64893007-64914785:+	-0.12	-4.53	6.49E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2394724	chr10:72121606	LRRC20	chr10:72058729-72142382:-	0.4	4.79	1.89E-6	Brain connectivity	
BRCA	cis	1	rs2395400	chr6:33770076	C6orf125	chr6:33662057-33679504:-	0.11	3.52	0.000446	Body mass index	
BRCA	cis	1	rs2395400	chr6:33770076	LEMD2	chr6:33738991-33756906:-	0.17	5.44	6.52E-8	Body mass index	
BRCA	cis	1	rs2401173	chr15:84576970	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.73	2.5E-6	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs2401173	chr15:84576970	LOC388152	chr15:84867600-84898920:-	-0.13	-4.06	5.21E-5	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs2402267	chr7:117497811	CTTNBP2	chr7:117350708-117513561:-	-0.13	-3.73	0.000203	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs2403083	chr8:86108149	LRRCC1	chr8:86019377-86058312:+	0.16	4.55	5.99E-6	Plasma amyloid beta peptide concentrations (ABx-40)	
BRCA	cis	1	rs2404602	chr15:77030792	SCAPER	chr15:76640529-77197744:-	-0.2	-7.19	1.22E-12	Blood metabolite levels	
BRCA	cis	1	rs2404740	chr15:76852143	SCAPER	chr15:76640529-77197744:-	-0.17	-5.87	5.66E-9	Blood metabolite levels	
BRCA	cis	1	rs2404741	chr15:76851735	SCAPER	chr15:76640529-77197744:-	-0.17	-5.87	5.66E-9	Blood metabolite levels	
BRCA	cis	1	rs2404958	chr5:50063035	PARP8	chr5:49961733-50138169:+	0.13	3.82	0.000143	Myopia (pathological)	
BRCA	cis	1	rs2414060	chr15:50873262	SPPL2A	chr15:50999739-51057910:-	0.14	5.16	2.98E-7	QT interval	
BRCA	cis	1	rs2417577	chr9:100701446	C9orf156	chr9:100666772-100684852:-	-0.16	-4.42	1.11E-5	Quantitative traits	
BRCA	cis	1	rs2419952	chr19:13801341	MRI1	chr19:13875337-13885095:+	-0.16	-4.06	5.35E-5	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs2420170	chr7:65656053	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.39	2.49E-10	Diabetic kidney disease	
BRCA	cis	1	rs2420170	chr7:65656053	CRCP	chr7:65579805-65619551:+	0.21	3.61	0.000322	Diabetic kidney disease	
BRCA	cis	1	rs2420170	chr7:65656053	LOC493754	chr7:65993446-66057363:-	-0.22	-3.65	0.000279	Diabetic kidney disease	
BRCA	cis	1	rs2420171	chr7:65637760	CCT6P1	chr7:65216092-65228661:+	-0.29	-6.27	5.18E-10	Diabetic kidney disease	
BRCA	cis	1	rs2420171	chr7:65637760	CRCP	chr7:65579805-65619551:+	0.22	3.66	0.00027	Diabetic kidney disease	
BRCA	cis	1	rs2420171	chr7:65637760	LOC493754	chr7:65993446-66057363:-	-0.22	-3.7	0.000229	Diabetic kidney disease	
BRCA	cis	1	rs2420824	chr7:66131116	TYW1	chr7:66461817-66704496:+	-0.16	-4.39	1.23E-5	Aortic root size	
BRCA	cis	1	rs2421143	chr10:124737546	PSTK	chr10:124739556-124749906:+	0.13	3.69	0.000237	Migraine without aura	
BRCA	cis	1	rs2421144	chr10:124733066	PSTK	chr10:124739556-124749906:+	0.13	3.71	0.000216	Migraine without aura	
BRCA	cis	1	rs2421145	chr10:124730565	PSTK	chr10:124739556-124749906:+	0.14	3.75	0.000186	Migraine without aura	
BRCA	cis	1	rs2421146	chr10:124730505	C10orf88	chr10:124690419-124713919:-	0.13	3.41	0.000667	Migraine without aura	
BRCA	cis	1	rs2421332	chr2:61876965	C2orf74	chr2:61372243-61391964:+	-0.2	-4.56	5.76E-6	Homeostasis model assessment of beta-cell function (interaction)	
BRCA	cis	1	rs242271	chr6:88082029	C6orf163	chr6:88057220-88075180:+	0.17	4.33	1.66E-5	Depressive episodes in bipolar disorder	
BRCA	cis	1	rs242271	chr6:88082029	C6orf164	chr6:88032306-88109459:+	-0.19	-4.87	1.27E-6	Depressive episodes in bipolar disorder	
BRCA	cis	1	rs2424700	chr20:25266513	FAM182A	chr20:26035250-26067552:+	-0.21	-5.61	2.55E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424700	chr20:25266513	FAM182B	chr20:25744102-25848786:-	0.23	5.92	4.32E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424700	chr20:25266513	PYGB	chr20:25228706-25278647:+	-0.13	-3.47	0.000544	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424704	chr20:25273929	FAM182A	chr20:26035250-26067552:+	-0.21	-5.47	5.65E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424704	chr20:25273929	FAM182B	chr20:25744102-25848786:-	0.24	6.27	5.2E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424704	chr20:25273929	PYGB	chr20:25228706-25278647:+	-0.14	-3.66	0.000269	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424710	chr20:25283886	FAM182A	chr20:26035250-26067552:+	-0.22	-5.66	1.97E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424710	chr20:25283886	FAM182B	chr20:25744102-25848786:-	0.22	5.61	2.58E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424712	chr20:25416942	FAM182A	chr20:26035250-26067552:+	-0.23	-6.12	1.29E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424712	chr20:25416942	FAM182B	chr20:25744102-25848786:-	0.24	6.18	9.0E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424712	chr20:25416942	PYGB	chr20:25228706-25278647:+	-0.13	-3.52	0.000446	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424713	chr20:25418482	FAM182A	chr20:26035250-26067552:+	-0.26	-6.74	2.67E-11	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424713	chr20:25418482	FAM182B	chr20:25744102-25848786:-	0.22	5.52	4.27E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424716	chr20:25423538	FAM182A	chr20:26035250-26067552:+	-0.23	-6.2	7.93E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2424716	chr20:25423538	FAM182B	chr20:25744102-25848786:-	0.22	5.78	9.83E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2425027	chr20:33849390	CPNE1	chr20:34213968-34262539:-	-0.22	-4.14	3.76E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425027	chr20:33849390	MMP24	chr20:33814539-33864804:+	-0.18	-3.71	0.000214	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425031	chr20:33855284	CPNE1	chr20:34213968-34262539:-	-0.19	-3.76	0.000182	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425031	chr20:33855284	MMP24	chr20:33814539-33864804:+	-0.18	-3.75	0.000186	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425032	chr20:33855454	CPNE1	chr20:34213968-34262539:-	-0.21	-4.04	5.79E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425032	chr20:33855454	MMP24	chr20:33814539-33864804:+	-0.21	-4.26	2.27E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425032	chr20:33855454	UQCC	chr20:33890383-33999833:-	-0.17	-3.53	0.000434	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425034	chr20:33855814	CPNE1	chr20:34213968-34262539:-	-0.21	-4	6.88E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425034	chr20:33855814	MMP24	chr20:33814539-33864804:+	-0.21	-4.2	2.88E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425034	chr20:33855814	UQCC	chr20:33890383-33999833:-	-0.17	-3.53	0.000428	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425036	chr20:33855981	CPNE1	chr20:34213968-34262539:-	-0.2	-3.78	0.000163	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425036	chr20:33855981	MMP24	chr20:33814539-33864804:+	-0.21	-4.31	1.8E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425036	chr20:33855981	UQCC	chr20:33890383-33999833:-	-0.16	-3.46	0.000571	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425037	chr20:33856429	CPNE1	chr20:34213968-34262539:-	0.2	3.78	0.000168	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425037	chr20:33856429	MMP24	chr20:33814539-33864804:+	0.21	4.23	2.57E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425037	chr20:33856429	UQCC	chr20:33890383-33999833:-	0.16	3.44	0.000603	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425040	chr20:33858878	MMP24	chr20:33814539-33864804:+	-0.22	-4.41	1.14E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425041	chr20:33859013	CPNE1	chr20:34213968-34262539:-	-0.21	-3.83	0.000134	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425041	chr20:33859013	MMP24	chr20:33814539-33864804:+	-0.21	-4.1	4.46E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs2425065	chr20:33926268	CPNE1	chr20:34213968-34262539:-	-0.24	-6.45	1.66E-10	Height	
BRCA	cis	1	rs2425065	chr20:33926268	MMP24	chr20:33814539-33864804:+	-0.16	-4.67	3.4E-6	Height	
BRCA	cis	1	rs2425065	chr20:33926268	UQCC	chr20:33890383-33999833:-	-0.32	-9.85	5.48E-22	Height	
BRCA	cis	1	rs2425066	chr20:33927006	CPNE1	chr20:34213968-34262539:-	-0.24	-6.49	1.34E-10	Height	
BRCA	cis	1	rs2425066	chr20:33927006	MMP24	chr20:33814539-33864804:+	-0.17	-4.78	2.0E-6	Height	
BRCA	cis	1	rs2425066	chr20:33927006	UQCC	chr20:33890383-33999833:-	-0.33	-10.02	1.17E-22	Height	
BRCA	cis	1	rs2425697	chr20:44025175	SYS1	chr20:43991701-44004724:+	0.18	4.66	3.52E-6	Psoriasis	
BRCA	cis	1	rs2426701	chr20:55804505	RBM38	chr20:55966463-55984384:+	-0.11	-3.47	0.000548	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
BRCA	cis	1	rs2429024	chr10:70740573	KIAA1279	chr10:70748493-70776734:+	-0.11	-3.79	0.000158	Schizophrenia	
BRCA	cis	1	rs2429030	chr10:70751673	KIAA1279	chr10:70748493-70776734:+	-0.12	-4.19	2.98E-5	Schizophrenia	
BRCA	cis	1	rs2429031	chr10:70755877	KIAA1279	chr10:70748493-70776734:+	-0.12	-4.11	4.17E-5	Schizophrenia	
BRCA	cis	1	rs2430494	chr2:37463620	CEBPZ	chr2:37428778-37458740:-	-0.18	-5.28	1.58E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.77	20.55	2.59E-79	Type 2 diabetes	
BRCA	cis	1	rs2435356	chr10:43583150	RET	chr10:43572517-43625795:+	-0.15	-3.51	0.000459	Hirschsprung disease	
BRCA	cis	1	rs2435357	chr10:43582056	RET	chr10:43572517-43625795:+	0.16	3.82	0.000142	Hirschsprung disease	
BRCA	cis	1	rs2435362	chr10:43578779	RET	chr10:43572517-43625795:+	0.16	3.86	0.00012	Hirschsprung disease	
BRCA	cis	1	rs2439209	chr4:46274771	GABRA2	chr4:46251581-46392421:-	-0.14	-3.99	7.08E-5	Epilepsy	
BRCA	cis	1	rs244291	chr17:53231137	STXBP4	chr17:53046126-53241449:+	-0.12	-4.16	3.51E-5	Menarche (age at onset)	
BRCA	cis	1	rs244293	chr17:53230722	COX11	chr17:53029259-53046064:-	-0.12	-3.46	0.000567	Menarche (age at onset)	
BRCA	cis	1	rs244293	chr17:53230722	STXBP4	chr17:53046126-53241449:+	-0.13	-4.41	1.14E-5	Menarche (age at onset)	
BRCA	cis	1	rs244299	chr17:53240266	COX11	chr17:53029259-53046064:-	0.12	3.45	0.000586	Menarche (age at onset)	
BRCA	cis	1	rs244299	chr17:53240266	STXBP4	chr17:53046126-53241449:+	0.13	4.56	5.68E-6	Menarche (age at onset)	
BRCA	cis	1	rs2447097	chr17:2278064	KIAA0664	chr17:2592680-2614927:-	-0.1	-3.71	0.000221	Autism spectrum disorder	
BRCA	cis	1	rs2447097	chr17:2278064	SMG6	chr17:1963133-2207069:-	-0.12	-3.6	0.00033	Autism spectrum disorder	
BRCA	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.33	10.86	3.87E-26	Homocysteine levels	
BRCA	cis	1	rs2448704	chr6:49453672	MUT	chr6:49398994-49431031:-	-0.15	-4.64	3.85E-6	Homocysteine levels	
BRCA	cis	1	rs2448707	chr6:49446951	CENPQ	chr6:49431096-49460820:+	0.24	7.8	1.52E-14	Folate pathway vitamin levels	
BRCA	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.32	-10.15	3.75E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs2460422	chr7:65601505	CCT6P1	chr7:65216092-65228661:+	0.33	6.99	4.83E-12	Diabetic kidney disease	
BRCA	cis	1	rs2460422	chr7:65601505	LOC493754	chr7:65993446-66057363:-	0.24	3.97	7.79E-5	Diabetic kidney disease	
BRCA	cis	1	rs2462569	chr7:65474846	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.77	2.07E-11	Diabetic kidney disease	
BRCA	cis	1	rs2462569	chr7:65474846	CRCP	chr7:65579805-65619551:+	0.19	3.41	0.000684	Diabetic kidney disease	
BRCA	cis	1	rs2463796	chr5:50025690	PARP8	chr5:49961733-50138169:+	-0.13	-3.59	0.000346	Myopia (pathological)	
BRCA	cis	1	rs2463797	chr5:50044622	PARP8	chr5:49961733-50138169:+	-0.14	-3.86	0.000119	Myopia (pathological)	
BRCA	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.5	-18.38	8.74E-66	Ankylosing spondylitis	
BRCA	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.4	10.87	3.73E-26	Ankylosing spondylitis	
BRCA	cis	1	rs2465120	chr7:65620974	CCT6P1	chr7:65216092-65228661:+	0.29	6.17	9.76E-10	Diabetic kidney disease	
BRCA	cis	1	rs2465120	chr7:65620974	CRCP	chr7:65579805-65619551:+	-0.23	-3.81	0.000148	Diabetic kidney disease	
BRCA	cis	1	rs2465120	chr7:65620974	LOC493754	chr7:65993446-66057363:-	0.21	3.47	0.000546	Diabetic kidney disease	
BRCA	cis	1	rs2473119	chr10:43339038	LOC84856	chr10:42970939-42990784:+	-0.16	-3.77	0.000171	Progressive supranuclear palsy	
BRCA	cis	1	rs2474777	chr20:25272633	ABHD12	chr20:25275380-25371477:-	0.14	4.21	2.73E-5	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2474777	chr20:25272633	FAM182A	chr20:26035250-26067552:+	-0.18	-4.77	2.1E-6	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2474777	chr20:25272633	FAM182B	chr20:25744102-25848786:-	0.23	6.08	1.64E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482911	chr20:25395528	ABHD12	chr20:25275380-25371477:-	-0.13	-3.79	0.000161	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482911	chr20:25395528	FAM182A	chr20:26035250-26067552:+	0.23	5.99	2.88E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482911	chr20:25395528	FAM182B	chr20:25744102-25848786:-	-0.21	-5.45	6.3E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482919	chr20:25299756	ABHD12	chr20:25275380-25371477:-	-0.12	-3.54	0.000414	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482919	chr20:25299756	FAM182A	chr20:26035250-26067552:+	0.23	5.97	3.23E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482919	chr20:25299756	FAM182B	chr20:25744102-25848786:-	-0.22	-5.73	1.28E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482927	chr20:25327151	ABHD12	chr20:25275380-25371477:-	-0.12	-3.51	0.000467	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482927	chr20:25327151	FAM182A	chr20:26035250-26067552:+	0.23	6.02	2.4E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482927	chr20:25327151	FAM182B	chr20:25744102-25848786:-	-0.22	-5.72	1.4E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482928	chr20:25331530	ABHD12	chr20:25275380-25371477:-	-0.11	-3.38	0.000748	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482928	chr20:25331530	FAM182A	chr20:26035250-26067552:+	0.22	5.79	9.31E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482928	chr20:25331530	FAM182B	chr20:25744102-25848786:-	-0.21	-5.48	5.33E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482928	chr20:25331530	PYGB	chr20:25228706-25278647:+	0.13	3.39	0.000728	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482930	chr20:25334115	ABHD12	chr20:25275380-25371477:-	-0.11	-3.41	0.00067	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482930	chr20:25334115	FAM182A	chr20:26035250-26067552:+	0.22	5.83	7.4E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482930	chr20:25334115	FAM182B	chr20:25744102-25848786:-	-0.21	-5.45	6.23E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482930	chr20:25334115	PYGB	chr20:25228706-25278647:+	0.13	3.39	0.000716	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482931	chr20:25334445	ABHD12	chr20:25275380-25371477:-	-0.12	-3.61	0.000326	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482931	chr20:25334445	FAM182A	chr20:26035250-26067552:+	0.24	6.12	1.32E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482931	chr20:25334445	FAM182B	chr20:25744102-25848786:-	-0.22	-5.61	2.56E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482937	chr20:25340786	ABHD12	chr20:25275380-25371477:-	-0.11	-3.41	0.000683	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482937	chr20:25340786	FAM182A	chr20:26035250-26067552:+	0.22	5.83	7.34E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482937	chr20:25340786	FAM182B	chr20:25744102-25848786:-	-0.21	-5.45	6.28E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482937	chr20:25340786	PYGB	chr20:25228706-25278647:+	0.13	3.4	0.00071	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482940	chr20:25349830	ABHD12	chr20:25275380-25371477:-	-0.12	-3.58	0.000355	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482940	chr20:25349830	FAM182A	chr20:26035250-26067552:+	0.24	6.16	1.06E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482940	chr20:25349830	FAM182B	chr20:25744102-25848786:-	-0.22	-5.65	2.05E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482941	chr20:25361216	ABHD12	chr20:25275380-25371477:-	-0.12	-3.71	0.000221	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482941	chr20:25361216	FAM182A	chr20:26035250-26067552:+	0.23	6.13	1.27E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482941	chr20:25361216	FAM182B	chr20:25744102-25848786:-	-0.23	-5.77	1.03E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482943	chr20:25380593	ABHD12	chr20:25275380-25371477:-	-0.13	-3.94	8.82E-5	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482943	chr20:25380593	FAM182A	chr20:26035250-26067552:+	0.24	6.15	1.06E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2482943	chr20:25380593	FAM182B	chr20:25744102-25848786:-	-0.22	-5.54	3.72E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2486447	chr1:46545724	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.76	4.14E-30	Body mass index	
BRCA	cis	1	rs2486447	chr1:46545724	CCDC17	chr1:46085717-46089729:-	0.11	3.4	0.000706	Body mass index	
BRCA	cis	1	rs2486447	chr1:46545724	MUTYH	chr1:45794915-45806142:-	0.12	4.75	2.33E-6	Body mass index	
BRCA	cis	1	rs2487701	chr10:70746267	KIAA1279	chr10:70748493-70776734:+	-0.12	-3.87	0.000115	Schizophrenia	
BRCA	cis	1	rs2487702	chr10:70750148	KIAA1279	chr10:70748493-70776734:+	-0.12	-4.09	4.57E-5	Schizophrenia	
BRCA	cis	1	rs2487706	chr10:70764444	KIAA1279	chr10:70748493-70776734:+	-0.12	-3.98	7.48E-5	Schizophrenia	
BRCA	cis	1	rs2487707	chr10:70765092	KIAA1279	chr10:70748493-70776734:+	-0.12	-3.98	7.32E-5	Schizophrenia	
BRCA	cis	1	rs2487708	chr10:70767402	KIAA1279	chr10:70748493-70776734:+	-0.12	-4.19	2.97E-5	Schizophrenia	
BRCA	cis	1	rs2489034	chr10:102319192	SEC31B	chr10:102246403-102289636:-	-0.28	-10.22	1.79E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489035	chr10:102319395	SEC31B	chr10:102246403-102289636:-	-0.27	-9.78	1.1E-21	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489036	chr10:102319581	SEC31B	chr10:102246403-102289636:-	-0.28	-10.22	1.79E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489037	chr10:102319918	SEC31B	chr10:102246403-102289636:-	0.27	9.58	6.73E-21	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489039	chr10:102328036	SEC31B	chr10:102246403-102289636:-	-0.27	-10.02	1.16E-22	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489040	chr10:102331298	SEC31B	chr10:102246403-102289636:-	-0.27	-9.86	5.41E-22	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489043	chr10:102334327	SEC31B	chr10:102246403-102289636:-	-0.29	-10.83	5.33E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489045	chr10:102344754	SEC31B	chr10:102246403-102289636:-	-0.29	-10.06	8.26E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489046	chr10:102346282	SEC31B	chr10:102246403-102289636:-	-0.28	-10.76	1.07E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489047	chr10:102347028	SEC31B	chr10:102246403-102289636:-	-0.27	-10.17	3.0E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489048	chr10:102348497	SEC31B	chr10:102246403-102289636:-	-0.27	-9.61	4.92E-21	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489049	chr10:102350732	SEC31B	chr10:102246403-102289636:-	-0.28	-10.31	8.12E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489050	chr10:102350898	SEC31B	chr10:102246403-102289636:-	-0.27	-9.31	7.06E-20	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489051	chr10:102351785	SEC31B	chr10:102246403-102289636:-	0.26	9.28	8.82E-20	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489053	chr10:102353341	SEC31B	chr10:102246403-102289636:-	-0.25	-9.5	1.32E-20	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2489715	chr10:42917476	LOC84856	chr10:42970939-42990784:+	-0.2	-5.3	1.42E-7	Helix rolling	
BRCA	cis	1	rs2490261	chr1:207477469	C4BPA	chr1:207277511-207318308:+	0.12	3.5	0.000481	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs2491023	chr10:70754071	KIAA1279	chr10:70748493-70776734:+	-0.13	-4.22	2.71E-5	Schizophrenia	
BRCA	cis	1	rs2492859	chr6:34645266	UHRF1BP1	chr6:34759794-34853117:+	0.16	4.39	1.27E-5	Pubertal anthropometrics	
BRCA	cis	1	rs2495734	chr10:102338686	SEC31B	chr10:102246403-102289636:-	-0.26	-9.33	5.75E-20	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495736	chr10:102338410	SEC31B	chr10:102246403-102289636:-	-0.28	-9.69	2.42E-21	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495737	chr10:102338344	SEC31B	chr10:102246403-102289636:-	-0.27	-9.56	7.64E-21	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495739	chr10:102335507	SEC31B	chr10:102246403-102289636:-	-0.26	-9.37	4.31E-20	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495741	chr10:102331795	SEC31B	chr10:102246403-102289636:-	-0.27	-10.07	7.28E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495742	chr10:102331364	SEC31B	chr10:102246403-102289636:-	-0.3	-10.37	4.48E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495743	chr10:102329739	SEC31B	chr10:102246403-102289636:-	-0.28	-9.88	4.21E-22	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495745	chr10:102329075	SEC31B	chr10:102246403-102289636:-	-0.26	-9.57	7.25E-21	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495747	chr10:102328247	SEC31B	chr10:102246403-102289636:-	-0.26	-9.64	3.66E-21	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495750	chr10:102327708	SEC31B	chr10:102246403-102289636:-	-0.27	-9.5	1.29E-20	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495751	chr10:102327260	SEC31B	chr10:102246403-102289636:-	-0.27	-9.99	1.65E-22	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495752	chr10:102326115	SEC31B	chr10:102246403-102289636:-	-0.29	-10.68	2.31E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495753	chr10:102325640	SEC31B	chr10:102246403-102289636:-	-0.28	-9.45	2.16E-20	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495754	chr10:102324812	SEC31B	chr10:102246403-102289636:-	-0.29	-10.65	2.98E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495755	chr10:102324649	SEC31B	chr10:102246403-102289636:-	-0.29	-10	1.47E-22	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495758	chr10:102321900	SEC31B	chr10:102246403-102289636:-	-0.29	-10.02	1.21E-22	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495759	chr10:102320363	SEC31B	chr10:102246403-102289636:-	-0.29	-9.07	5.42E-19	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2495760	chr10:102318771	SEC31B	chr10:102246403-102289636:-	-0.29	-9.61	4.99E-21	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs2498471	chr6:49484433	CENPQ	chr6:49431096-49460820:+	0.19	6.23	6.73E-10	Brain structure	
BRCA	cis	1	rs2500404	chr20:25359758	ABHD12	chr20:25275380-25371477:-	-0.12	-3.71	0.000221	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500404	chr20:25359758	FAM182A	chr20:26035250-26067552:+	0.23	6.13	1.27E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500404	chr20:25359758	FAM182B	chr20:25744102-25848786:-	-0.23	-5.77	1.03E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500405	chr20:25360826	ABHD12	chr20:25275380-25371477:-	-0.12	-3.71	0.000221	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500405	chr20:25360826	FAM182A	chr20:26035250-26067552:+	0.23	6.13	1.27E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500405	chr20:25360826	FAM182B	chr20:25744102-25848786:-	-0.23	-5.77	1.03E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500418	chr20:25382268	ABHD12	chr20:25275380-25371477:-	-0.13	-3.9	0.000102	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500418	chr20:25382268	FAM182A	chr20:26035250-26067552:+	0.23	6.11	1.43E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500418	chr20:25382268	FAM182B	chr20:25744102-25848786:-	-0.22	-5.6	2.79E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500424	chr20:25391969	ABHD12	chr20:25275380-25371477:-	-0.14	-4.01	6.63E-5	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500424	chr20:25391969	FAM182A	chr20:26035250-26067552:+	0.24	6.18	8.87E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500424	chr20:25391969	FAM182B	chr20:25744102-25848786:-	-0.22	-5.59	2.83E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500432	chr20:25290512	ABHD12	chr20:25275380-25371477:-	0.12	3.55	0.000402	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500432	chr20:25290512	FAM182A	chr20:26035250-26067552:+	-0.22	-5.81	8.25E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500432	chr20:25290512	FAM182B	chr20:25744102-25848786:-	0.21	5.54	3.78E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500432	chr20:25290512	PYGB	chr20:25228706-25278647:+	-0.13	-3.59	0.000349	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500436	chr20:25406366	ABHD12	chr20:25275380-25371477:-	-0.11	-3.38	0.00075	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500436	chr20:25406366	FAM182A	chr20:26035250-26067552:+	0.23	6.19	8.66E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500436	chr20:25406366	FAM182B	chr20:25744102-25848786:-	-0.2	-5.28	1.6E-7	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500436	chr20:25406366	PYGB	chr20:25228706-25278647:+	0.13	3.37	0.000772	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500443	chr20:25331442	FAM182A	chr20:26035250-26067552:+	0.22	5.74	1.23E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500443	chr20:25331442	FAM182B	chr20:25744102-25848786:-	-0.21	-5.49	5.14E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500443	chr20:25331442	PYGB	chr20:25228706-25278647:+	0.13	3.41	0.000681	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500446	chr20:25339664	ABHD12	chr20:25275380-25371477:-	-0.11	-3.41	0.00068	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500446	chr20:25339664	FAM182A	chr20:26035250-26067552:+	0.22	5.84	7.09E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500446	chr20:25339664	FAM182B	chr20:25744102-25848786:-	-0.21	-5.45	6.34E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500446	chr20:25339664	PYGB	chr20:25228706-25278647:+	0.13	3.4	0.000704	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500448	chr20:25404027	ABHD12	chr20:25275380-25371477:-	-0.12	-3.67	0.000256	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500448	chr20:25404027	FAM182A	chr20:26035250-26067552:+	0.25	6.49	1.35E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2500448	chr20:25404027	FAM182B	chr20:25744102-25848786:-	-0.21	-5.46	6.01E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2501276	chr1:22373624	HSPC157	chr1:22351707-22357713:+	0.21	3.39	0.000715	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs2501962	chr6:49453636	CENPQ	chr6:49431096-49460820:+	0.25	8.13	1.15E-15	Folate pathway vitamin levels	
BRCA	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.32	-10.24	1.56E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs2501963	chr6:49454281	CENPQ	chr6:49431096-49460820:+	0.24	7.81	1.39E-14	Folate pathway vitamin levels	
BRCA	cis	1	rs2501963	chr6:49454281	MUT	chr6:49398994-49431031:-	-0.33	-10.32	7.57E-24	Folate pathway vitamin levels	
BRCA	cis	1	rs2502757	chr9:136586954	DBH	chr9:136501485-136524466:+	-0.15	-4.33	1.66E-5	Asthma	
BRCA	cis	1	rs2502757	chr9:136586954	SARDH	chr9:136528686-136605077:-	-0.44	-11.92	7.93E-31	Asthma	
BRCA	cis	1	rs2505841	chr10:42886786	LOC84856	chr10:42970939-42990784:+	-0.2	-5.05	5.18E-7	Helix rolling	
BRCA	cis	1	rs2505842	chr10:42887560	LOC84856	chr10:42970939-42990784:+	-0.28	-6.6	6.44E-11	Helix rolling	
BRCA	cis	1	rs2505859	chr10:42905911	LOC84856	chr10:42970939-42990784:+	-0.19	-4.92	1.0E-6	Helix rolling	
BRCA	cis	1	rs2505998	chr10:43570925	RET	chr10:43572517-43625795:+	0.16	3.83	0.000135	Hirschsprung disease	
BRCA	cis	1	rs2506006	chr10:43581501	RET	chr10:43572517-43625795:+	0.15	3.59	0.000352	Hirschsprung disease	
BRCA	cis	1	rs2510340	chr18:21142438	NPC1	chr18:21108363-21166581:-	0.15	4.55	6.09E-6	Body mass index	
BRCA	cis	1	rs2519974	chr16:22889186	PLK1	chr16:23690201-23701688:+	-0.06	-3.62	0.000305	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	
BRCA	cis	1	rs2524005	chr6:29899677	HCG4	chr6:29758809-29760850:-	-0.37	-8	3.12E-15	Bipolar disorder and schizophrenia	
BRCA	cis	1	rs2524005	chr6:29899677	HCG4P6	chr6:29867168-29911213:-	0.24	4.48	8.36E-6	Bipolar disorder and schizophrenia	
BRCA	cis	1	rs2524005	chr6:29899677	HLA-A	chr6:29910331-29913653:+	-0.12	-3.4	0.000708	Bipolar disorder and schizophrenia	
BRCA	cis	1	rs2524005	chr6:29899677	HLA-G	chr6:29794756-29977731:+	-0.2	-4.49	7.93E-6	Bipolar disorder and schizophrenia	
BRCA	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.56	12.76	8.28E-35	Bipolar disorder and schizophrenia	
BRCA	cis	1	rs2527199	chr7:158737113	WDR60	chr7:158649269-158738882:+	0.23	6.53	1.03E-10	Height	
BRCA	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.78	19.71	5.23E-74	Type 2 diabetes	
BRCA	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.78	20.69	3.15E-80	Type 2 diabetes	
BRCA	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.78	20.14	1.1E-76	Type 2 diabetes	
BRCA	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.76	19.54	6.28E-73	Type 2 diabetes	
BRCA	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.76	19.45	2.42E-72	Type 2 diabetes	
BRCA	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	0.81	20.58	1.67E-79	Type 2 diabetes	
BRCA	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.79	-20.26	1.77E-77	Type 2 diabetes	
BRCA	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.77	20.69	2.95E-80	Type 2 diabetes	
BRCA	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.76	19.59	2.9E-73	Type 2 diabetes	
BRCA	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.77	20.62	8.61E-80	Type 2 diabetes	
BRCA	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.77	20.66	4.9E-80	Type 2 diabetes	
BRCA	cis	1	rs2533288	chr7:66056711	CCT6P1	chr7:65216092-65228661:+	0.31	6.58	7.2E-11	Diabetic kidney disease	
BRCA	cis	1	rs2533288	chr7:66056711	LOC493754	chr7:65993446-66057363:-	0.23	3.92	9.52E-5	Diabetic kidney disease	
BRCA	cis	1	rs253664	chr3:138113353	TXNDC6	chr3:137980279-138048728:-	-0.19	-4.15	3.57E-5	Body mass index	
BRCA	cis	1	rs2540227	chr2:39957578	THUMPD2	chr2:39963200-40006416:-	0.12	3.81	0.000149	Personality dimensions	
BRCA	cis	1	rs2540977	chr2:37462228	CEBPZ	chr2:37428778-37458740:-	-0.17	-5.28	1.59E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs2541161	chr9:131884802	SH3GLB2	chr9:131770314-131790579:-	0.13	4.96	8.2E-7	Blood metabolite ratios	
BRCA	cis	1	rs2541164	chr9:131876908	SH3GLB2	chr9:131770314-131790579:-	-0.1	-3.58	0.00036	Blood metabolite ratios	
BRCA	cis	1	rs25422	chr6:118807847	C6orf204	chr6:118786239-119031238:-	0.11	3.44	0.000601	Renal cell carcinoma	
BRCA	cis	1	rs2544424	chr4:106718316	ARHGEF38	chr4:106473777-106552836:+	-0.15	-3.61	0.000324	Lung function (FEV1)	
BRCA	cis	1	rs2544426	chr4:106717797	ARHGEF38	chr4:106473777-106552836:+	-0.15	-3.46	0.000557	Lung function (FEV1)	
BRCA	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.77	19.72	4.39E-74	Type 2 diabetes	
BRCA	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.77	19.7	6.26E-74	Type 2 diabetes	
BRCA	cis	1	rs2551936	chr2:208497027	FAM119A	chr2:208446079-208490065:-	0.16	4.12	4.04E-5	Opioid sensitivity	
BRCA	cis	1	rs2551938	chr2:208496390	FAM119A	chr2:208446079-208490065:-	0.17	4.38	1.31E-5	Opioid sensitivity	
BRCA	cis	1	rs2551941	chr2:208492143	FAM119A	chr2:208446079-208490065:-	0.19	4.67	3.47E-6	Opioid sensitivity	
BRCA	cis	1	rs2553470	chr4:106713673	ARHGEF38	chr4:106473777-106552836:+	0.16	3.51	0.00046	Lung function (FEV1)	
BRCA	cis	1	rs2562126	chr16:56972713	ARL2BP	chr16:57279038-57287545:+	-0.16	-3.7	0.00023	Metabolic syndrome	
BRCA	cis	1	rs2562456	chr19:21666210	ZNF493	chr19:21579921-21610294:+	0.11	3.8	0.000156	Pain	
BRCA	cis	1	rs2562784	chr15:84286492	GOLGA6L5	chr15:85047738-85060078:-	0.13	4.05	5.51E-5	Height	
BRCA	cis	1	rs2562784	chr15:84286492	LOC388152	chr15:84867600-84898920:-	0.12	3.49	0.00051	Height	
BRCA	cis	1	rs2564956	chr3:53070462	ITIH4	chr3:52847007-52866554:-	-0.11	-3.75	0.000184	Ulcerative colitis	
BRCA	cis	1	rs2564973	chr1:207480104	C4BPA	chr1:207277511-207318308:+	0.14	3.86	0.000121	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs2569754	chr19:41936734	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.13	1.8E-12	Height	
BRCA	cis	1	rs2573346	chr10:81918041	PLAC9	chr10:81892258-81904784:+	0.06	3.4	0.000711	Sarcoidosis	
BRCA	cis	1	rs2581800	chr3:53109352	RFT1	chr3:53122503-53164470:-	-0.29	-7.67	3.83E-14	Height	
BRCA	cis	1	rs2581817	chr3:53071797	ITIH4	chr3:52847007-52866554:-	-0.1	-3.64	0.000286	Ulcerative colitis	
BRCA	cis	1	rs2583471	chr11:59861814	MS4A4A	chr11:60048139-60076444:+	-0.11	-4.56	5.6E-6	Alzheimer's disease (late onset)	
BRCA	cis	1	rs2585417	chr20:52843799	DOK5	chr20:53092257-53267709:+	0.12	4.29	1.97E-5	Obesity-related traits	
BRCA	cis	1	rs2594708	chr5:50024668	PARP8	chr5:49961733-50138169:+	-0.13	-3.59	0.000346	Myopia (pathological)	
BRCA	cis	1	rs2595500	chr11:6963165	ZNF215	chr11:6947654-7005861:+	0.31	6.73	2.7E-11	Response to cytadine analogues (cytosine arabinoside)	
BRCA	cis	1	rs2595501	chr11:6955340	ZNF215	chr11:6947654-7005861:+	-0.31	-6.66	4.27E-11	Response to cytadine analogues (cytosine arabinoside)	
BRCA	cis	1	rs2598086	chr7:38003642	EPDR1	chr7:37960163-37991539:+	-0.23	-3.9	0.000102	Myopia (pathological)	
BRCA	cis	1	rs2598093	chr7:37995998	EPDR1	chr7:37960163-37991539:+	-0.24	-4.09	4.66E-5	Myopia (pathological)	
BRCA	cis	1	rs2610739	chr6:89253649	ORC3L	chr6:88299843-88377166:+	-0.15	-3.43	0.000633	IgG glycosylation	
BRCA	cis	1	rs261360	chr20:5037774	C20orf30	chr20:5049130-5093733:-	-0.18	-5.35	1.09E-7	Hair morphology	
BRCA	cis	1	rs2617170	chr12:10560957	KLRC1	chr12:10594863-10606984:-	0.18	6.46	1.56E-10	Behcet's disease	
BRCA	cis	1	rs2617170	chr12:10560957	KLRC2	chr12:10579193-10588592:-	-0.18	-5.1	3.94E-7	Behcet's disease	
BRCA	cis	1	rs262147	chr7:158745142	WDR60	chr7:158649269-158738882:+	-0.29	-5.47	5.5E-8	Hippocampal volume	
BRCA	cis	1	rs2628314	chr17:53235182	STXBP4	chr17:53046126-53241449:+	-0.12	-4.19	3.03E-5	Menarche (age at onset)	
BRCA	cis	1	rs2629540	chr10:126426148	METTL10	chr10:126447406-126480439:-	0.25	4.99	7.2E-7	Cocaine dependence	
BRCA	cis	1	rs2631740	chr4:8484106	C4orf23	chr4:8440604-8495258:+	0.15	3.95	8.34E-5	Response to antineoplastic agents	
BRCA	cis	1	rs2631745	chr4:8490530	C4orf23	chr4:8440604-8495258:+	0.16	4.1	4.47E-5	Response to antineoplastic agents	
BRCA	cis	1	rs2631758	chr4:8495304	C4orf23	chr4:8440604-8495258:+	0.15	4.01	6.45E-5	Response to antineoplastic agents	
BRCA	cis	1	rs2635043	chr18:44679769	KATNAL2	chr18:44497557-44628613:+	0.14	3.76	0.000182	Educational attainment	
BRCA	cis	1	rs2635045	chr18:44668417	KATNAL2	chr18:44497557-44628613:+	0.14	3.93	9.17E-5	Educational attainment	
BRCA	cis	1	rs2635049	chr18:44687303	KATNAL2	chr18:44497557-44628613:+	-0.14	-3.93	9.19E-5	Educational attainment	
BRCA	cis	1	rs2638090	chr11:6955142	ZNF215	chr11:6947654-7005861:+	-0.32	-6.72	3.02E-11	Response to cytadine analogues (cytosine arabinoside)	
BRCA	cis	1	rs2638092	chr11:6961746	ZNF215	chr11:6947654-7005861:+	-0.32	-6.82	1.56E-11	Response to cytadine analogues (cytosine arabinoside)	
BRCA	cis	1	rs2642660	chr5:156152920	HAVCR2	chr5:156512843-156536138:-	-0.07	-3.44	0.000609	Airway responsiveness in chronic obstructive pulmonary disease	
BRCA	cis	1	rs2645424	chr8:11684463	FDFT1	chr8:11653082-11696817:+	-0.14	-3.39	0.000732	Non-alcoholic fatty liver disease histology (lobular);Non-alcoholic fatty liver disease histology (other)	
BRCA	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.5	-18.2	1.13E-64	Ankylosing spondylitis	
BRCA	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.4	10.87	3.66E-26	Ankylosing spondylitis	
BRCA	cis	1	rs2657345	chr7:158744169	WDR60	chr7:158649269-158738882:+	0.23	6.48	1.4E-10	Height	
BRCA	cis	1	rs2657365	chr7:158722753	WDR60	chr7:158649269-158738882:+	0.2	5.82	7.61E-9	Height	
BRCA	cis	1	rs2659889	chr7:66217112	CRCP	chr7:65579805-65619551:+	-0.13	-3.55	0.000406	Aortic root size	
BRCA	cis	1	rs2659889	chr7:66217112	LOC493754	chr7:65993446-66057363:-	-0.13	-3.42	0.000649	Aortic root size	
BRCA	cis	1	rs2659889	chr7:66217112	TYW1	chr7:66461817-66704496:+	0.14	3.84	0.000132	Aortic root size	
BRCA	cis	1	rs2659903	chr7:66180931	CCT6P1	chr7:65216092-65228661:+	0.31	6.56	8.57E-11	Gout	
BRCA	cis	1	rs2659903	chr7:66180931	LOC493754	chr7:65993446-66057363:-	0.24	3.92	9.39E-5	Gout	
BRCA	cis	1	rs2659906	chr7:66165310	CRCP	chr7:65579805-65619551:+	-0.13	-3.44	0.000613	Aortic root size	
BRCA	cis	1	rs2659906	chr7:66165310	TYW1	chr7:66461817-66704496:+	0.15	3.91	9.73E-5	Aortic root size	
BRCA	cis	1	rs2659909	chr7:66160279	TYW1	chr7:66461817-66704496:+	0.16	4.31	1.79E-5	Aortic root size	
BRCA	cis	1	rs2659911	chr7:66158420	CCT6P1	chr7:65216092-65228661:+	0.31	6.55	9.18E-11	Gout	
BRCA	cis	1	rs2659911	chr7:66158420	LOC493754	chr7:65993446-66057363:-	0.23	3.88	0.000109	Gout	
BRCA	cis	1	rs2659912	chr7:66157999	CRCP	chr7:65579805-65619551:+	-0.13	-3.49	0.000494	Aortic root size	
BRCA	cis	1	rs2659912	chr7:66157999	TYW1	chr7:66461817-66704496:+	0.14	3.87	0.000115	Aortic root size	
BRCA	cis	1	rs2659913	chr7:66157336	CCT6P1	chr7:65216092-65228661:+	0.31	6.55	9.18E-11	Gout	
BRCA	cis	1	rs2659913	chr7:66157336	LOC493754	chr7:65993446-66057363:-	0.23	3.88	0.000109	Gout	
BRCA	cis	1	rs2659915	chr7:66153101	TYW1	chr7:66461817-66704496:+	0.17	4.47	8.65E-6	Aortic root size	
BRCA	cis	1	rs2661357	chr1:207483938	C4BPA	chr1:207277511-207318308:+	0.15	4.34	1.59E-5	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs2667011	chr2:160867059	LY75	chr2:160625141-160761262:-	-0.2	-5.67	1.84E-8	Bilirubin levels	
BRCA	cis	1	rs2675680	chr10:75658864	BMS1P4	chr10:75458909-75490272:-	0.12	4.07	5.09E-5	Inflammatory bowel disease	
BRCA	cis	1	rs267952	chr5:10743135	MARCH6	chr5:10353828-10435491:+	-0.19	-3.37	0.00077	Metabolite levels (Pyroglutamine)	
BRCA	cis	1	rs2684818	chr18:44712965	KATNAL2	chr18:44497557-44628613:+	0.13	3.47	0.000546	Educational attainment	
BRCA	cis	1	rs2684825	chr18:44666415	KATNAL2	chr18:44497557-44628613:+	0.14	3.76	0.000181	Educational attainment	
BRCA	cis	1	rs2684826	chr18:44679147	KATNAL2	chr18:44497557-44628613:+	0.13	3.54	0.000412	Educational attainment	
BRCA	cis	1	rs2687826	chr8:133925027	TG	chr8:133879205-134147141:+	-0.17	-4.14	3.67E-5	Vitiligo	
BRCA	cis	1	rs2688223	chr4:8471398	C4orf23	chr4:8440604-8495258:+	-0.15	-3.93	9.1E-5	Response to antineoplastic agents	
BRCA	cis	1	rs2688233	chr4:8491885	C4orf23	chr4:8440604-8495258:+	-0.15	-4.07	5.0E-5	Response to antineoplastic agents	
BRCA	cis	1	rs2688608	chr10:75658349	BMS1P4	chr10:75458909-75490272:-	0.12	4.07	5.09E-5	Inflammatory bowel disease	
BRCA	cis	1	rs2688610	chr10:75654931	BMS1P4	chr10:75458909-75490272:-	-0.11	-3.72	0.000211	Inflammatory bowel disease	
BRCA	cis	1	rs2707828	chr7:66171377	CCT6P1	chr7:65216092-65228661:+	0.31	6.55	9.18E-11	Gout	
BRCA	cis	1	rs2707828	chr7:66171377	LOC493754	chr7:65993446-66057363:-	0.23	3.88	0.000109	Gout	
BRCA	cis	1	rs2707830	chr7:66167645	CCT6P1	chr7:65216092-65228661:+	0.31	6.55	9.18E-11	Gout	
BRCA	cis	1	rs2707830	chr7:66167645	LOC493754	chr7:65993446-66057363:-	0.23	3.88	0.000109	Gout	
BRCA	cis	1	rs2707831	chr7:66062511	CCT6P1	chr7:65216092-65228661:+	0.31	6.63	5.34E-11	Diabetic kidney disease	
BRCA	cis	1	rs2707831	chr7:66062511	LOC493754	chr7:65993446-66057363:-	0.24	4	6.9E-5	Diabetic kidney disease	
BRCA	cis	1	rs2707832	chr7:66136549	CCT6P1	chr7:65216092-65228661:+	0.31	6.75	2.39E-11	Gout	
BRCA	cis	1	rs2707832	chr7:66136549	LOC493754	chr7:65993446-66057363:-	0.26	4.36	1.43E-5	Gout	
BRCA	cis	1	rs2707836	chr7:66160435	CRCP	chr7:65579805-65619551:+	-0.13	-3.51	0.000475	Aortic root size	
BRCA	cis	1	rs2707836	chr7:66160435	TYW1	chr7:66461817-66704496:+	0.14	3.87	0.000114	Aortic root size	
BRCA	cis	1	rs2707838	chr7:66159201	CCT6P1	chr7:65216092-65228661:+	0.31	6.55	9.18E-11	Gout	
BRCA	cis	1	rs2707838	chr7:66159201	LOC493754	chr7:65993446-66057363:-	0.23	3.88	0.000109	Gout	
BRCA	cis	1	rs2707840	chr7:66158015	CCT6P1	chr7:65216092-65228661:+	0.31	6.53	1.01E-10	Gout	
BRCA	cis	1	rs2707840	chr7:66158015	LOC493754	chr7:65993446-66057363:-	0.24	3.92	9.45E-5	Gout	
BRCA	cis	1	rs2707844	chr7:66059509	CCT6P1	chr7:65216092-65228661:+	0.31	6.63	5.34E-11	Diabetic kidney disease	
BRCA	cis	1	rs2707844	chr7:66059509	LOC493754	chr7:65993446-66057363:-	0.24	4	6.9E-5	Diabetic kidney disease	
BRCA	cis	1	rs2707845	chr7:66198798	CRCP	chr7:65579805-65619551:+	-0.14	-3.69	0.000239	Aortic root size	
BRCA	cis	1	rs2707845	chr7:66198798	TYW1	chr7:66461817-66704496:+	0.14	3.72	0.000208	Aortic root size	
BRCA	cis	1	rs2707850	chr7:66203870	CRCP	chr7:65579805-65619551:+	-0.14	-3.69	0.000239	Aortic root size	
BRCA	cis	1	rs2707850	chr7:66203870	TYW1	chr7:66461817-66704496:+	0.14	3.72	0.000208	Aortic root size	
BRCA	cis	1	rs2707854	chr7:66212597	CRCP	chr7:65579805-65619551:+	-0.14	-3.69	0.000239	Aortic root size	
BRCA	cis	1	rs2707854	chr7:66212597	TYW1	chr7:66461817-66704496:+	0.14	3.72	0.000208	Aortic root size	
BRCA	cis	1	rs2707856	chr7:66211010	CRCP	chr7:65579805-65619551:+	-0.15	-3.98	7.32E-5	Aortic root size	
BRCA	cis	1	rs2707856	chr7:66211010	LOC493754	chr7:65993446-66057363:-	-0.13	-3.38	0.000756	Aortic root size	
BRCA	cis	1	rs2707856	chr7:66211010	TYW1	chr7:66461817-66704496:+	0.13	3.5	0.000483	Aortic root size	
BRCA	cis	1	rs2709379	chr2:208496182	FAM119A	chr2:208446079-208490065:-	0.17	4.4	1.21E-5	Opioid sensitivity	
BRCA	cis	1	rs2709380	chr2:208496410	FAM119A	chr2:208446079-208490065:-	0.17	4.38	1.31E-5	Opioid sensitivity	
BRCA	cis	1	rs2709382	chr2:208496715	FAM119A	chr2:208446079-208490065:-	0.16	4.11	4.29E-5	Opioid sensitivity	
BRCA	cis	1	rs2709383	chr2:208496742	FAM119A	chr2:208446079-208490065:-	0.17	4.15	3.66E-5	Opioid sensitivity	
BRCA	cis	1	rs2709384	chr2:208496943	FAM119A	chr2:208446079-208490065:-	0.16	4.13	3.96E-5	Opioid sensitivity	
BRCA	cis	1	rs2709386	chr2:208497034	FAM119A	chr2:208446079-208490065:-	0.16	4.12	4.04E-5	Opioid sensitivity	
BRCA	cis	1	rs2709390	chr2:208506371	FAM119A	chr2:208446079-208490065:-	0.15	3.66	0.000268	Opioid sensitivity	
BRCA	cis	1	rs2709394	chr2:208491975	FAM119A	chr2:208446079-208490065:-	0.19	4.74	2.39E-6	Opioid sensitivity	
BRCA	cis	1	rs2709397	chr2:208492569	FAM119A	chr2:208446079-208490065:-	0.18	4.55	5.86E-6	Opioid sensitivity	
BRCA	cis	1	rs2709409	chr2:208511233	FAM119A	chr2:208446079-208490065:-	0.15	3.69	0.000232	Opioid sensitivity	
BRCA	cis	1	rs2714470	chr2:37486527	CEBPZ	chr2:37428778-37458740:-	-0.17	-5.22	2.2E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs271621	chr19:18631332	LRRC25	chr19:18501955-18508421:-	-0.13	-6.36	2.98E-10	Breast cancer	
BRCA	cis	1	rs271623	chr19:18628947	LRRC25	chr19:18501955-18508421:-	-0.14	-6.56	8.16E-11	Breast cancer	
BRCA	cis	1	rs271623	chr19:18628947	SSBP4	chr19:18530221-18545371:+	-0.1	-3.52	0.000445	Breast cancer	
BRCA	cis	1	rs2722278	chr7:37990917	EPDR1	chr7:37960163-37991539:+	-0.25	-4.39	1.26E-5	Myopia (pathological)	
BRCA	cis	1	rs2722279	chr7:37991129	EPDR1	chr7:37960163-37991539:+	-0.24	-4.15	3.56E-5	Myopia (pathological)	
BRCA	cis	1	rs2722287	chr7:37996018	EPDR1	chr7:37960163-37991539:+	-0.24	-4.09	4.66E-5	Myopia (pathological)	
BRCA	cis	1	rs2730241	chr7:158723014	WDR60	chr7:158649269-158738882:+	0.2	5.52	4.29E-8	Height	
BRCA	cis	1	rs2730245	chr7:158724789	WDR60	chr7:158649269-158738882:+	0.22	6.17	9.48E-10	Height	
BRCA	cis	1	rs273635	chr19:51718867	CD33	chr19:51728335-51747115:+	0.11	4.31	1.79E-5	Alzheimer's disease	
BRCA	cis	1	rs2736371	chr8:11105529	TDH	chr8:11197146-11225961:+	0.15	3.84	0.000128	Retinal vascular caliber	
BRCA	cis	1	rs2740	chr16:15132108	C16orf63	chr16:15959577-15982447:-	0.13	3.57	0.000375	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs2741432	chr20:43989514	SYS1	chr20:43991701-44004724:+	0.16	4.29	1.91E-5	Psoriasis	
BRCA	cis	1	rs2741435	chr20:43988198	SYS1	chr20:43991701-44004724:+	0.17	4.38	1.3E-5	Psoriasis	
BRCA	cis	1	rs2741611	chr20:44020809	SYS1	chr20:43991701-44004724:+	0.18	4.63	4.17E-6	Psoriasis	
BRCA	cis	1	rs2741612	chr20:44019972	SYS1	chr20:43991701-44004724:+	0.18	4.63	4.17E-6	Psoriasis	
BRCA	cis	1	rs2741639	chr20:44008432	SYS1	chr20:43991701-44004724:+	0.16	4.23	2.5E-5	Psoriasis	
BRCA	cis	1	rs2741640	chr20:44008408	SYS1	chr20:43991701-44004724:+	0.16	4.21	2.81E-5	Psoriasis	
BRCA	cis	1	rs2743237	chr20:44026618	SYS1	chr20:43991701-44004724:+	0.16	4.24	2.41E-5	Psoriasis	
BRCA	cis	1	rs2743402	chr20:43985204	SYS1	chr20:43991701-44004724:+	0.16	4.29	1.91E-5	Psoriasis	
BRCA	cis	1	rs2743414	chr20:43991566	SYS1	chr20:43991701-44004724:+	0.17	4.55	5.95E-6	Psoriasis	
BRCA	cis	1	rs2743419	chr20:43992645	SYS1	chr20:43991701-44004724:+	0.18	4.78	2.04E-6	Psoriasis	
BRCA	cis	1	rs2743423	chr20:43993539	SYS1	chr20:43991701-44004724:+	0.18	4.79	1.86E-6	Psoriasis	
BRCA	cis	1	rs2743424	chr20:43993934	SYS1	chr20:43991701-44004724:+	0.17	4.57	5.43E-6	Psoriasis	
BRCA	cis	1	rs2743439	chr20:43999636	SYS1	chr20:43991701-44004724:+	0.18	4.63	4.03E-6	Psoriasis	
BRCA	cis	1	rs2744090	chr10:43339614	LOC84856	chr10:42970939-42990784:+	-0.16	-3.78	0.000163	Progressive supranuclear palsy	
BRCA	cis	1	rs2744092	chr10:43339343	LOC84856	chr10:42970939-42990784:+	-0.16	-3.78	0.000163	Progressive supranuclear palsy	
BRCA	cis	1	rs2744947	chr6:34657809	UHRF1BP1	chr6:34759794-34853117:+	0.16	4.39	1.27E-5	Pubertal anthropometrics	
BRCA	cis	1	rs2744954	chr6:34621470	UHRF1BP1	chr6:34759794-34853117:+	0.17	4.43	1.02E-5	Pubertal anthropometrics	
BRCA	cis	1	rs2744955	chr6:34618958	UHRF1BP1	chr6:34759794-34853117:+	0.16	4.38	1.29E-5	Pubertal anthropometrics	
BRCA	cis	1	rs2744956	chr6:34618937	UHRF1BP1	chr6:34759794-34853117:+	0.17	4.39	1.25E-5	Pubertal anthropometrics	
BRCA	cis	1	rs2744972	chr6:34659054	UHRF1BP1	chr6:34759794-34853117:+	0.16	4.31	1.8E-5	Pubertal anthropometrics	
BRCA	cis	1	rs2749876	chr14:52504397	NID2	chr14:52471521-52535946:-	0.08	3.71	0.000216	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.5	-18.32	2.21E-65	Ankylosing spondylitis	
BRCA	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.4	10.73	1.42E-25	Ankylosing spondylitis	
BRCA	cis	1	rs2758322	chr6:160075188	PNLDC1	chr6:160221301-160241735:+	0.17	3.93	9.14E-5	Age-related macular degeneration (GA)	
BRCA	cis	1	rs2758322	chr6:160075188	WTAP	chr6:160148129-160177349:+	0.15	3.79	0.000158	Age-related macular degeneration (GA)	
BRCA	cis	1	rs2758776	chr6:153006317	SYNE1	chr6:152442823-152958534:-	0.09	3.69	0.000234	Tonometry	
BRCA	cis	1	rs2758776	chr6:153006317	VIP	chr6:153071933-153080898:+	-0.13	-4.29	1.91E-5	Tonometry	
BRCA	cis	1	rs2758777	chr6:153007467	SYNE1	chr6:152442823-152958534:-	0.09	3.6	0.000337	Tonometry	
BRCA	cis	1	rs2758777	chr6:153007467	VIP	chr6:153071933-153080898:+	-0.13	-4.27	2.17E-5	Tonometry	
BRCA	cis	1	rs2758779	chr6:153008022	SYNE1	chr6:152442823-152958534:-	0.08	3.54	0.00042	Tonometry	
BRCA	cis	1	rs2758779	chr6:153008022	VIP	chr6:153071933-153080898:+	-0.13	-4.2	2.91E-5	Tonometry	
BRCA	cis	1	rs2758780	chr6:153008108	SYNE1	chr6:152442823-152958534:-	0.08	3.54	0.00042	Tonometry	
BRCA	cis	1	rs2758780	chr6:153008108	VIP	chr6:153071933-153080898:+	-0.13	-4.2	2.91E-5	Tonometry	
BRCA	cis	1	rs2758782	chr6:153010341	SYNE1	chr6:152442823-152958534:-	0.09	3.56	0.000394	Tonometry	
BRCA	cis	1	rs2758782	chr6:153010341	VIP	chr6:153071933-153080898:+	-0.13	-4.22	2.68E-5	Tonometry	
BRCA	cis	1	rs2758784	chr6:153010489	SYNE1	chr6:152442823-152958534:-	0.09	3.56	0.000394	Tonometry	
BRCA	cis	1	rs2758784	chr6:153010489	VIP	chr6:153071933-153080898:+	-0.13	-4.22	2.68E-5	Tonometry	
BRCA	cis	1	rs2758785	chr6:153010878	SYNE1	chr6:152442823-152958534:-	0.09	3.68	0.000248	Tonometry	
BRCA	cis	1	rs2758785	chr6:153010878	VIP	chr6:153071933-153080898:+	-0.14	-4.41	1.11E-5	Tonometry	
BRCA	cis	1	rs2758812	chr6:152965908	SYNE1	chr6:152442823-152958534:-	-0.08	-3.37	0.000772	Tonometry	
BRCA	cis	1	rs2758812	chr6:152965908	VIP	chr6:153071933-153080898:+	0.13	4.34	1.59E-5	Tonometry	
BRCA	cis	1	rs2758816	chr6:152968338	VIP	chr6:153071933-153080898:+	0.13	4.27	2.16E-5	Tonometry	
BRCA	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.49	17.99	2.02E-63	Ankylosing spondylitis	
BRCA	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.39	-10.65	3.18E-25	Ankylosing spondylitis	
BRCA	cis	1	rs2779180	chr19:4841151	LRG1	chr19:4537228-4540036:-	0.12	3.81	0.000148	Depression in response to interferon-based therapy in chronic hepatitis C	
BRCA	cis	1	rs2779180	chr19:4841151	PLIN3	chr19:4838346-4867780:-	0.12	3.8	0.000154	Depression in response to interferon-based therapy in chronic hepatitis C	
BRCA	cis	1	rs2782840	chr1:207484183	C4BPA	chr1:207277511-207318308:+	0.13	3.77	0.000172	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs2782842	chr1:207483576	C4BPA	chr1:207277511-207318308:+	0.14	3.88	0.000113	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs2782846	chr1:207473840	C4BPA	chr1:207277511-207318308:+	0.14	3.83	0.000136	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs2786113	chr1:197304081	CFHR3	chr1:196743930-196762872:+	-0.13	-3.53	0.000433	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs2789679	chr10:81907884	PLAC9	chr10:81892258-81904784:+	0.06	3.6	0.000328	Sarcoidosis	
BRCA	cis	1	rs27934	chr5:50118959	PARP8	chr5:49961733-50138169:+	0.12	3.43	0.000627	Myopia (pathological)	
BRCA	cis	1	rs2795496	chr10:43337842	LOC84856	chr10:42970939-42990784:+	-0.16	-3.67	0.000252	Progressive supranuclear palsy	
BRCA	cis	1	rs2795497	chr10:43339475	LOC84856	chr10:42970939-42990784:+	-0.16	-3.78	0.000163	Progressive supranuclear palsy	
BRCA	cis	1	rs2795502	chr10:43340662	LOC84856	chr10:42970939-42990784:+	-0.16	-3.74	0.000193	Progressive supranuclear palsy	
BRCA	cis	1	rs2795503	chr10:43347224	LOC84856	chr10:42970939-42990784:+	-0.16	-3.82	0.000143	Progressive supranuclear palsy	
BRCA	cis	1	rs2795508	chr10:43353555	LOC84856	chr10:42970939-42990784:+	0.17	4.09	4.73E-5	Progressive supranuclear palsy	
BRCA	cis	1	rs27964	chr5:50152467	PARP8	chr5:49961733-50138169:+	0.14	3.81	0.000146	Myopia (pathological)	
BRCA	cis	1	rs2796575	chr10:43374911	LOC84856	chr10:42970939-42990784:+	0.17	4.01	6.37E-5	Progressive supranuclear palsy	
BRCA	cis	1	rs2799077	chr6:28234597	HIST1H4J	chr6:27791903-27792257:+	-0.18	-3.58	0.000353	Depression	
BRCA	cis	1	rs2799077	chr6:28234597	ZNF187	chr6:28234788-28245978:+	-0.14	-3.38	0.000741	Depression	
BRCA	cis	1	rs2799077	chr6:28234597	ZNF323	chr6:28292517-28324048:-	0.2	3.62	0.000303	Depression	
BRCA	cis	1	rs2799077	chr6:28234597	ZNF389	chr6:28129551-28137375:+	-0.21	-3.76	0.000178	Depression	
BRCA	cis	1	rs2799077	chr6:28234597	ZSCAN23	chr6:28393287-28411279:-	0.17	3.47	0.000536	Depression	
BRCA	cis	1	rs2799079	chr6:28235176	HIST1H4J	chr6:27791903-27792257:+	-0.17	-3.45	0.000579	Depression	
BRCA	cis	1	rs2799079	chr6:28235176	ZKSCAN3	chr6:28317691-28334523:+	-0.15	-3.41	0.00067	Depression	
BRCA	cis	1	rs2799079	chr6:28235176	ZNF187	chr6:28234788-28245978:+	-0.16	-4.04	5.74E-5	Depression	
BRCA	cis	1	rs2799079	chr6:28235176	ZNF389	chr6:28129551-28137375:+	-0.22	-4.09	4.58E-5	Depression	
BRCA	cis	1	rs2800623	chr6:153003720	VIP	chr6:153071933-153080898:+	-0.14	-4.39	1.23E-5	Tonometry	
BRCA	cis	1	rs2800625	chr6:153006016	SYNE1	chr6:152442823-152958534:-	0.09	3.63	0.000294	Tonometry	
BRCA	cis	1	rs2800625	chr6:153006016	VIP	chr6:153071933-153080898:+	-0.14	-4.32	1.69E-5	Tonometry	
BRCA	cis	1	rs2800626	chr6:153006340	SYNE1	chr6:152442823-152958534:-	0.09	3.69	0.000234	Tonometry	
BRCA	cis	1	rs2800626	chr6:153006340	VIP	chr6:153071933-153080898:+	-0.13	-4.29	1.91E-5	Tonometry	
BRCA	cis	1	rs2800630	chr6:153008261	SYNE1	chr6:152442823-152958534:-	0.09	3.68	0.000248	Tonometry	
BRCA	cis	1	rs2800630	chr6:153008261	VIP	chr6:153071933-153080898:+	-0.14	-4.45	9.4E-6	Tonometry	
BRCA	cis	1	rs2800631	chr6:153008631	SYNE1	chr6:152442823-152958534:-	0.08	3.51	0.000467	Tonometry	
BRCA	cis	1	rs2800631	chr6:153008631	VIP	chr6:153071933-153080898:+	-0.13	-4.17	3.26E-5	Tonometry	
BRCA	cis	1	rs2800632	chr6:153008632	SYNE1	chr6:152442823-152958534:-	0.08	3.51	0.000467	Tonometry	
BRCA	cis	1	rs2800632	chr6:153008632	VIP	chr6:153071933-153080898:+	-0.13	-4.17	3.26E-5	Tonometry	
BRCA	cis	1	rs2800633	chr6:153010308	SYNE1	chr6:152442823-152958534:-	0.09	3.56	0.000394	Tonometry	
BRCA	cis	1	rs2800633	chr6:153010308	VIP	chr6:153071933-153080898:+	-0.13	-4.22	2.68E-5	Tonometry	
BRCA	cis	1	rs2800634	chr6:153010414	VIP	chr6:153071933-153080898:+	-0.13	-4.26	2.25E-5	Tonometry	
BRCA	cis	1	rs2801020	chr10:42957330	LOC84856	chr10:42970939-42990784:+	0.21	5.49	5.03E-8	Helix rolling	
BRCA	cis	1	rs2802235	chr1:207471799	C4BPA	chr1:207277511-207318308:+	0.12	3.46	0.000567	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs2811396	chr3:127987356	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.53	0.000436	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811518	chr3:128013645	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.53	0.000434	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811519	chr3:128012876	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.53	0.000434	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811522	chr3:128011423	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.56	0.000391	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811523	chr3:128011397	RUVBL1	chr3:127783627-127872757:-	0.15	3.72	0.000211	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811525	chr3:127999430	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.41	0.000666	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811527	chr3:127994604	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.5	0.000492	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811534	chr3:127991108	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.53	0.000428	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811537	chr3:127987924	RUVBL1	chr3:127783627-127872757:-	0.14	3.5	0.000491	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811538	chr3:127986631	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.44	0.000606	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811539	chr3:127986473	RUVBL1	chr3:127783627-127872757:-	0.16	3.85	0.000124	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811540	chr3:127985569	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.44	0.000606	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811541	chr3:127984794	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.44	0.000606	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811542	chr3:127983800	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.44	0.000606	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811543	chr3:127983796	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.44	0.000606	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811544	chr3:127983495	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.44	0.000606	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2811545	chr3:127983148	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.46	0.000562	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.59	-19.49	1.36E-72	Response to antipsychotic treatment	
BRCA	cis	1	rs2814993	chr6:34618893	UHRF1BP1	chr6:34759794-34853117:+	-0.16	-4.28	2.01E-5	Pubertal anthropometrics	
BRCA	cis	1	rs2814994	chr6:34620153	UHRF1BP1	chr6:34759794-34853117:+	0.16	4.27	2.13E-5	Pubertal anthropometrics	
BRCA	cis	1	rs2814996	chr6:34621314	UHRF1BP1	chr6:34759794-34853117:+	0.17	4.44	9.86E-6	Pubertal anthropometrics	
BRCA	cis	1	rs2815005	chr6:34638847	UHRF1BP1	chr6:34759794-34853117:+	0.16	4.31	1.75E-5	Pubertal anthropometrics	
BRCA	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.6	-19.71	5.36E-74	Response to antipsychotic treatment	
BRCA	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.59	-19.22	5.93E-71	Response to antipsychotic treatment	
BRCA	cis	1	rs2821131	chr1:197302402	CFHR3	chr1:196743930-196762872:+	0.15	3.88	0.00011	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs282544	chr5:50026465	PARP8	chr5:49961733-50138169:+	-0.13	-3.61	0.000323	Myopia (pathological)	
BRCA	cis	1	rs282556	chr5:50032285	PARP8	chr5:49961733-50138169:+	-0.14	-4	6.69E-5	Myopia (pathological)	
BRCA	cis	1	rs282802	chr15:80072820	MTHFS	chr15:80137320-80189370:-	0.18	5.02	6.08E-7	Disease-free survival in breast cancer	
BRCA	cis	1	rs282804	chr15:80071108	MTHFS	chr15:80137320-80189370:-	-0.17	-4.7	2.89E-6	Disease-free survival in breast cancer	
BRCA	cis	1	rs2832183	chr21:30482150	N6AMT1	chr21:30244513-30257693:-	-0.12	-3.48	0.00053	Dental caries	
BRCA	cis	1	rs2832183	chr21:30482150	NCRNA00189	chr21:30565801-30660525:+	0.18	5.36	1.02E-7	Dental caries	
BRCA	cis	1	rs2832184	chr21:30483265	N6AMT1	chr21:30244513-30257693:-	-0.12	-3.4	0.00069	Dental caries	
BRCA	cis	1	rs2832184	chr21:30483265	NCRNA00189	chr21:30565801-30660525:+	0.18	5.38	9.21E-8	Dental caries	
BRCA	cis	1	rs2832185	chr21:30483761	NCRNA00189	chr21:30565801-30660525:+	0.18	5.4	8.36E-8	Dental caries	
BRCA	cis	1	rs2832189	chr21:30487414	NCRNA00189	chr21:30565801-30660525:+	0.18	5.36	1.01E-7	Dental caries	
BRCA	cis	1	rs2832190	chr21:30488226	NCRNA00189	chr21:30565801-30660525:+	0.17	5.27	1.63E-7	Dental caries	
BRCA	cis	1	rs2832191	chr21:30489300	NCRNA00189	chr21:30565801-30660525:+	0.17	4.95	8.69E-7	Dental caries	
BRCA	cis	1	rs2833888	chr21:33927560	TCP10L	chr21:33947152-33957845:-	-0.29	-5.84	7.1E-9	Gastritis	
BRCA	cis	1	rs2833889	chr21:33927768	TCP10L	chr21:33947152-33957845:-	0.28	6	2.76E-9	Gastritis	
BRCA	cis	1	rs2833890	chr21:33927886	TCP10L	chr21:33947152-33957845:-	0.28	6.07	1.75E-9	Gastritis	
BRCA	cis	1	rs2834187	chr21:34687410	IFNAR1	chr21:34696734-34732126:+	0.13	3.42	0.00066	Narcolepsy	
BRCA	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.25	-7.82	1.25E-14	Eye color traits	
BRCA	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.25	-7.86	9.42E-15	Eye color traits	
BRCA	cis	1	rs28360661	chr21:40681972	HMGN1	chr21:40714247-40721270:-	-0.19	-4.88	1.25E-6	Cognitive function	
BRCA	cis	1	rs28360661	chr21:40681972	PSMG1	chr21:40547390-40555440:-	-0.19	-6.5	1.26E-10	Cognitive function	
BRCA	cis	1	rs2836974	chr21:40663181	HMGN1	chr21:40714247-40721270:-	0.18	4.86	1.32E-6	Cognitive function	
BRCA	cis	1	rs2836974	chr21:40663181	PSMG1	chr21:40547390-40555440:-	0.21	7.46	1.83E-13	Cognitive function	
BRCA	cis	1	rs28371412	chr4:68415525	STAP1	chr4:68424446-68473053:+	-0.18	-5.93	4.04E-9	Parkinson's disease	
BRCA	cis	1	rs28371583	chr1:207494679	C4BPA	chr1:207277511-207318308:+	0.13	3.64	0.000291	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs28371597	chr1:207496896	C4BPA	chr1:207277511-207318308:+	0.14	3.75	0.000187	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs28371614	chr1:207505274	C4BPA	chr1:207277511-207318308:+	0.13	3.64	0.000289	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs28371676	chr10:96702363	C10orf129	chr10:96953957-96988685:+	0.32	5.48	5.32E-8	Blood metabolite levels	
BRCA	cis	1	rs28372828	chr1:156253031	BGLAP	chr1:156182784-156213112:+	0.2	5.36	1.02E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs28385906	chr12:122599361	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.49E-6	Urate levels	
BRCA	cis	1	rs28391259	chr4:107014012	TBCK	chr4:106967233-107237861:-	0.26	7.82	1.26E-14	Airflow obstruction	
BRCA	cis	1	rs2839181	chr21:47685939	C21orf56	chr21:47581063-47604373:-	-0.2	-5.48	5.36E-8	Testicular germ cell tumor	
BRCA	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.41	-12.53	1.1E-33	Testicular germ cell tumor	
BRCA	cis	1	rs2839181	chr21:47685939	MCM3APAS	chr21:47649158-47671743:+	0.11	3.83	0.000138	Testicular germ cell tumor	
BRCA	cis	1	rs2839181	chr21:47685939	MCM3AP	chr21:47655048-47705236:-	0.13	3.64	0.000288	Testicular germ cell tumor	
BRCA	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.45	-13.77	8.31E-40	Testicular germ cell tumor	
BRCA	cis	1	rs2839186	chr21:47690068	MCM3APAS	chr21:47649158-47671743:+	0.12	3.98	7.46E-5	Testicular germ cell tumor	
BRCA	cis	1	rs2839186	chr21:47690068	MCM3AP	chr21:47655048-47705236:-	0.16	4.53	6.58E-6	Testicular germ cell tumor	
BRCA	cis	1	rs2839337	chr21:47987167	C21orf56	chr21:47581063-47604373:-	0.16	3.97	7.56E-5	Lymphocyte counts	
BRCA	cis	1	rs2839434	chr21:43418905	C21orf121	chr21:43442113-43445060:+	0.26	6.45	1.71E-10	Hand grip strength	
BRCA	cis	1	rs28399511	chr10:96580140	C10orf129	chr10:96953957-96988685:+	0.33	5.42	7.32E-8	Blood metabolite levels	
BRCA	cis	1	rs2840044	chr17:33892068	SLFN12L	chr17:33801926-33864880:-	0.09	4.92	9.92E-7	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs28406132	chr8:96030377	C8orf38	chr8:95908040-96088396:+	-0.15	-3.53	0.000439	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.24	3.75E-37	Height	
BRCA	cis	1	rs28409322	chr3:134252385	CEP63	chr3:134204575-134293852:+	-0.14	-3.74	0.000191	Height	
BRCA	cis	1	rs28414202	chr12:122590563	LRRC43	chr12:122652266-122688017:+	-0.17	-4.69	3.06E-6	Urate levels	
BRCA	cis	1	rs28416696	chr2:54484326	C2orf73	chr2:54558071-54588714:+	0.17	4.26	2.19E-5	Telomere length	
BRCA	cis	1	rs2842992	chr6:160071159	PNLDC1	chr6:160221301-160241735:+	0.16	3.83	0.000137	Age-related macular degeneration (GA)	
BRCA	cis	1	rs2842992	chr6:160071159	WTAP	chr6:160148129-160177349:+	0.14	3.61	0.000326	Age-related macular degeneration (GA)	
BRCA	cis	1	rs28430881	chr12:122602899	LRRC43	chr12:122652266-122688017:+	-0.17	-4.8	1.82E-6	Urate levels	
BRCA	cis	1	rs28433617	chr4:122664138	EXOSC9	chr4:122722472-122738175:+	0.13	4.19	3.0E-5	Type 2 diabetes	
BRCA	cis	1	rs28447380	chr3:156964553	LEKR1	chr3:156544076-156763918:+	-0.24	-3.48	0.000522	Smoking cessation in chronic obstructive pulmonary disease;Diabetic retinopathy	
BRCA	cis	1	rs28450064	chr12:122598941	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.49E-6	Urate levels	
BRCA	cis	1	rs28464252	chr12:122599856	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.49E-6	Urate levels	
BRCA	cis	1	rs284648	chr19:41926790	B3GNT8	chr19:41931265-41934635:-	-0.25	-7.62	5.76E-14	Height	
BRCA	cis	1	rs284649	chr19:41926838	B3GNT8	chr19:41931265-41934635:-	-0.25	-7.62	5.76E-14	Height	
BRCA	cis	1	rs284650	chr19:41927129	B3GNT8	chr19:41931265-41934635:-	-0.25	-7.6	6.49E-14	Height	
BRCA	cis	1	rs284651	chr19:41928336	B3GNT8	chr19:41931265-41934635:-	-0.25	-7.38	3.14E-13	Height	
BRCA	cis	1	rs284652	chr19:41928652	B3GNT8	chr19:41931265-41934635:-	-0.25	-7.56	8.65E-14	Height	
BRCA	cis	1	rs284654	chr19:41928724	B3GNT8	chr19:41931265-41934635:-	-0.23	-6.92	7.8E-12	Height	
BRCA	cis	1	rs28465556	chr4:39121189	KLHL5	chr4:39046659-39123828:+	-0.15	-4.71	2.77E-6	Uric acid levels	
BRCA	cis	1	rs284655	chr19:41928765	B3GNT8	chr19:41931265-41934635:-	-0.25	-7.59	7.01E-14	Height	
BRCA	cis	1	rs284656	chr19:41929251	B3GNT8	chr19:41931265-41934635:-	-0.25	-7.55	9.45E-14	Height	
BRCA	cis	1	rs284657	chr19:41929915	B3GNT8	chr19:41931265-41934635:-	-0.23	-6.92	7.85E-12	Height	
BRCA	cis	1	rs284658	chr19:41929988	B3GNT8	chr19:41931265-41934635:-	-0.22	-6.68	3.75E-11	Height	
BRCA	cis	1	rs284663	chr19:41932612	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.18	1.28E-12	Height	
BRCA	cis	1	rs28469723	chr20:33700717	MMP24	chr20:33814539-33864804:+	-0.2	-3.64	0.000288	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs28469723	chr20:33700717	PROCR	chr20:33758727-33765164:+	-0.26	-5.6	2.68E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs2847655	chr11:59865671	MS4A4A	chr11:60048139-60076444:+	-0.11	-4.52	6.79E-6	Alzheimer's disease (late onset)	
BRCA	cis	1	rs2847666	chr11:59859576	MS4A4A	chr11:60048139-60076444:+	-0.11	-4.53	6.44E-6	Alzheimer's disease (late onset)	
BRCA	cis	1	rs2847667	chr11:59859609	MS4A4A	chr11:60048139-60076444:+	-0.11	-4.56	5.74E-6	Alzheimer's disease (late onset)	
BRCA	cis	1	rs2847668	chr11:59862261	MS4A4A	chr11:60048139-60076444:+	-0.11	-4.56	5.6E-6	Alzheimer's disease (late onset)	
BRCA	cis	1	rs28477467	chr8:96032905	C8orf38	chr8:95908040-96088396:+	-0.15	-3.57	0.000375	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs28478366	chr12:122606662	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.49E-6	Urate levels	
BRCA	cis	1	rs28478717	chr12:122602939	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.56E-6	Urate levels	
BRCA	cis	1	rs28496357	chr8:96030511	C8orf38	chr8:95908040-96088396:+	-0.15	-3.57	0.00038	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs2851300	chr4:100279824	ADH1C	chr4:100257651-100273917:-	-0.21	-6.72	3.03E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs28522614	chr10:102323141	SEC31B	chr10:102246403-102289636:-	-0.28	-9.99	1.57E-22	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs28529535	chr12:122600803	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.55E-6	Urate levels	
BRCA	cis	1	rs28532673	chr4:122664323	EXOSC9	chr4:122722472-122738175:+	-0.12	-3.98	7.42E-5	Type 2 diabetes	
BRCA	cis	1	rs28548845	chr12:122594249	LRRC43	chr12:122652266-122688017:+	-0.17	-4.72	2.73E-6	Urate levels	
BRCA	cis	1	rs2855017	chr11:59866309	MS4A4A	chr11:60048139-60076444:+	-0.11	-4.43	1.06E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs28558133	chr6:26531433	BTN2A3	chr6:26422317-26431927:+	0.17	5.59	2.9E-8	Educational attainment	
BRCA	cis	1	rs28558133	chr6:26531433	C6orf41	chr6:26924772-26991752:+	-0.12	-3.73	0.000201	Educational attainment	
BRCA	cis	1	rs28558133	chr6:26531433	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.45	0.000572	Educational attainment	
BRCA	cis	1	rs28564902	chr4:56479491	SRD5A3	chr4:56212409-56237866:+	-0.17	-4.33	1.67E-5	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs28567450	chr6:34747409	UHRF1BP1	chr6:34759794-34853117:+	0.16	4.34	1.54E-5	Pubertal anthropometrics	
BRCA	cis	1	rs28569273	chr12:122593042	LRRC43	chr12:122652266-122688017:+	-0.17	-4.76	2.17E-6	Urate levels	
BRCA	cis	1	rs2856	chr20:25433536	FAM182A	chr20:26035250-26067552:+	-0.24	-6.29	4.64E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2856	chr20:25433536	FAM182B	chr20:25744102-25848786:-	0.24	6.43	1.9E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs2856	chr20:25433536	PYGB	chr20:25228706-25278647:+	-0.13	-3.61	0.000323	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs28572537	chr19:18552208	LRRC25	chr19:18501955-18508421:-	-0.14	-6.76	2.28E-11	Breast cancer	
BRCA	cis	1	rs2857891	chr11:6962957	ZNF215	chr11:6947654-7005861:+	-0.32	-6.87	1.12E-11	Response to cytadine analogues (cytosine arabinoside)	
BRCA	cis	1	rs28599680	chr16:29860685	LOC440356	chr16:29875004-29879374:+	-0.28	-5.71	1.5E-8	Multiple sclerosis	
BRCA	cis	1	rs2859998	chr8:59324162	UBXN2B	chr8:59323823-59364059:+	-0.12	-4.13	3.87E-5	Narcolepsy with cataplexy	
BRCA	cis	1	rs2860223	chr8:134668677	PHF20L1	chr8:133787604-133861050:+	-0.09	-3.43	0.000619	Schizophrenia (negative symptoms)	
BRCA	cis	1	rs28605425	chr12:122596148	LRRC43	chr12:122652266-122688017:+	-0.17	-4.69	3.08E-6	Urate levels	
BRCA	cis	1	rs28607301	chr4:39138080	KLHL5	chr4:39046659-39123828:+	-0.14	-4.33	1.64E-5	Uric acid levels	
BRCA	cis	1	rs2860838	chr10:96453039	HELLS	chr10:96305543-96361855:+	0.12	3.43	0.000615	Migraine	
BRCA	cis	1	rs28616734	chr8:96021443	C8orf38	chr8:95908040-96088396:+	-0.15	-3.55	0.000406	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs28618203	chr4:122663935	EXOSC9	chr4:122722472-122738175:+	0.13	4.09	4.63E-5	Type 2 diabetes	
BRCA	cis	1	rs28620427	chr4:1086247	CRIPAK	chr4:1385340-1389782:+	0.11	3.5	0.000478	Recombination rate (males)	
BRCA	cis	1	rs28620427	chr4:1086247	KIAA1530	chr4:1341104-1381836:+	0.11	3.73	0.000201	Recombination rate (males)	
BRCA	cis	1	rs28626850	chr12:122600968	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.55E-6	Urate levels	
BRCA	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.37	9.7	2.25E-21	Forced vital capacity	
BRCA	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.36	9.51	1.19E-20	Forced vital capacity	
BRCA	cis	1	rs2862985	chr10:102062809	PKD2L1	chr10:102047903-102090243:-	0.24	4.33	1.66E-5	Obesity-related traits	
BRCA	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.37	-9.74	1.58E-21	Forced vital capacity	
BRCA	cis	1	rs28639626	chr12:122599042	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.6E-6	Urate levels	
BRCA	cis	1	rs28640980	chr4:122664284	EXOSC9	chr4:122722472-122738175:+	0.13	4.16	3.48E-5	Type 2 diabetes	
BRCA	cis	1	rs28649184	chr12:122599259	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.56E-6	Urate levels	
BRCA	cis	1	rs2866406	chr4:103554019	MANBA	chr4:103552644-103682151:-	0.2	5.3	1.4E-7	Primary biliary cirrhosis	
BRCA	cis	1	rs2866407	chr4:103554108	MANBA	chr4:103552644-103682151:-	0.21	5.44	6.78E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs2866408	chr4:103554113	MANBA	chr4:103552644-103682151:-	0.21	5.44	6.78E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs2866409	chr4:103554261	MANBA	chr4:103552644-103682151:-	0.21	5.35	1.09E-7	Primary biliary cirrhosis	
BRCA	cis	1	rs2866413	chr4:103557077	MANBA	chr4:103552644-103682151:-	0.21	5.46	5.82E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs2866414	chr4:103557219	MANBA	chr4:103552644-103682151:-	0.21	5.46	5.82E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs28672333	chr7:142826798	TMEM139	chr7:142982044-142985140:+	-0.21	-3.45	0.000572	Dermatomyositis	
BRCA	cis	1	rs2867898	chr20:37690952	DHX35	chr20:37591000-37668363:+	-0.15	-4.13	3.96E-5	Dialysis-related mortality	
BRCA	cis	1	rs28679372	chr16:67882932	LRRC36	chr16:67360747-67419108:+	-0.27	-3.96	7.95E-5	Crohn's disease	
BRCA	cis	1	rs28683528	chr12:123845351	CDK2AP1	chr12:123745542-123756687:-	-0.21	-6.71	3.26E-11	Educational attainment;Height;Head circumference (infant)	
BRCA	cis	1	rs2869548	chr15:78922638	AGPHD1	chr15:78799906-78829714:+	-0.18	-3.92	9.56E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2869548	chr15:78922638	CHRNA5	chr15:78857906-78886458:+	-0.17	-4.86	1.36E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.52	14.29	1.55E-42	Diastolic blood pressure	
BRCA	cis	1	rs28737311	chr12:122601289	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.56E-6	Urate levels	
BRCA	cis	1	rs28739522	chr12:122599834	LRRC43	chr12:122652266-122688017:+	-0.17	-4.73	2.49E-6	Urate levels	
BRCA	cis	1	rs2876629	chr6:55981048	COL21A1	chr6:55921389-56258892:-	-0.37	-6.87	1.08E-11	Psychosis (atypical)	
BRCA	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.27	-10.18	2.77E-23	Longevity	
BRCA	cis	1	rs28836882	chr6:55998918	COL21A1	chr6:55921389-56258892:-	-0.36	-6.49	1.33E-10	Psychosis (atypical)	
BRCA	cis	1	rs28854485	chr3:101628537	LOC152225	chr3:101659703-101716770:+	-0.16	-3.77	0.000171	Psoriasis vulgaris;Psoriasis	
BRCA	cis	1	rs2885510	chr3:48418226	ATRIP	chr3:48488141-48507708:+	-0.1	-3.46	0.000557	Longevity	
BRCA	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.25	9.59	6.14E-21	Longevity	
BRCA	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.44	14.45	2.31E-43	Height	
BRCA	cis	1	rs2887797	chr3:134202506	CEP63	chr3:134204575-134293852:+	0.16	4.37	1.36E-5	Height	
BRCA	cis	1	rs28897193	chr4:107005529	TBCK	chr4:106967233-107237861:-	0.23	7.2	1.14E-12	Airflow obstruction	
BRCA	cis	1	rs2889873	chr20:33646841	MMP24	chr20:33814539-33864804:+	-0.23	-3.98	7.33E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs2889873	chr20:33646841	PROCR	chr20:33758727-33765164:+	-0.24	-4.92	9.79E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs2890659	chr4:39127021	KLHL5	chr4:39046659-39123828:+	-0.15	-4.64	3.99E-6	Uric acid levels	
BRCA	cis	1	rs2896954	chr15:76851692	SCAPER	chr15:76640529-77197744:-	-0.18	-6.29	4.57E-10	Blood metabolite levels	
BRCA	cis	1	rs2901354	chr10:124733038	PSTK	chr10:124739556-124749906:+	0.17	4.7	2.98E-6	Migraine without aura	
BRCA	cis	1	rs2901355	chr10:124731766	PSTK	chr10:124739556-124749906:+	0.13	3.49	0.000506	Migraine without aura	
BRCA	cis	1	rs2903283	chr4:103557753	MANBA	chr4:103552644-103682151:-	0.21	5.46	5.82E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs2904804	chr10:5009759	ASB13	chr10:5680820-5708558:-	0.1	3.42	0.000656	Economic and political preferences (immigration/crime)	
BRCA	cis	1	rs2905425	chr19:19475717	CILP2	chr19:19649074-19657466:+	-0.1	-3.49	0.000496	Schizophrenia	
BRCA	cis	1	rs2905425	chr19:19475717	HAPLN4	chr19:19366453-19384074:-	-0.22	-7.24	8.68E-13	Schizophrenia	
BRCA	cis	1	rs2916068	chr19:19516433	CILP2	chr19:19649074-19657466:+	0.1	3.55	0.000403	Schizophrenia	
BRCA	cis	1	rs2916068	chr19:19516433	HAPLN4	chr19:19366453-19384074:-	0.22	7.19	1.26E-12	Schizophrenia	
BRCA	cis	1	rs292194	chr5:36941767	C5orf33	chr5:36192695-36242258:-	0.12	3.42	0.000641	Height	
BRCA	cis	1	rs2922809	chr8:6350464	AGPAT5	chr8:6565878-6619019:+	0.22	3.48	0.000531	Cytomegalovirus antibody response	
BRCA	cis	1	rs2922809	chr8:6350464	MCPH1	chr8:6264121-6506025:+	0.3	4.76	2.23E-6	Cytomegalovirus antibody response	
BRCA	cis	1	rs2932538	chr1:113216543	ST7L	chr1:113066142-113162405:-	-0.4	-9.28	9.11E-20	Systolic blood pressure;Hypertension;Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs2938670	chr15:78740688	CHRNA5	chr15:78857906-78886458:+	-0.13	-4.19	2.96E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1 in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2940927	chr5:42422389	CCDC152	chr5:42756920-42802539:+	-0.12	-3.85	0.000128	Systemic lupus erythematosus	
BRCA	cis	1	rs2940927	chr5:42422389	OXCT1	chr5:41730168-41870791:-	-0.13	-3.62	0.000312	Systemic lupus erythematosus	
BRCA	cis	1	rs2940927	chr5:42422389	SEPP1	chr5:42799983-42825998:-	-0.11	-3.4	0.000702	Systemic lupus erythematosus	
BRCA	cis	1	rs2940940	chr5:42397230	CCDC152	chr5:42756920-42802539:+	-0.11	-3.55	0.000409	Systemic lupus erythematosus	
BRCA	cis	1	rs2940940	chr5:42397230	OXCT1	chr5:41730168-41870791:-	-0.14	-3.79	0.000159	Systemic lupus erythematosus	
BRCA	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.39	9.82	7.3E-22	Obesity-related traits	
BRCA	cis	1	rs2951308	chr7:143767149	OR2A7	chr7:143955790-143974852:-	-0.2	-4.76	2.23E-6	Obesity-related traits	
BRCA	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.42	-10.18	2.82E-23	Obesity-related traits	
BRCA	cis	1	rs2951353	chr7:143761116	OR2A7	chr7:143955790-143974852:-	0.21	4.84	1.5E-6	Obesity-related traits	
BRCA	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.16	3.26E-23	Obesity-related traits	
BRCA	cis	1	rs2951354	chr7:143761001	OR2A7	chr7:143955790-143974852:-	0.21	4.9	1.1E-6	Obesity-related traits	
BRCA	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.43	-10.41	2.96E-24	Obesity-related traits	
BRCA	cis	1	rs2951360	chr7:143757349	OR2A7	chr7:143955790-143974852:-	0.21	4.87	1.27E-6	Obesity-related traits	
BRCA	cis	1	rs2951360	chr7:143757349	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.46	0.000565	Obesity-related traits	
BRCA	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.27	1.14E-23	Obesity-related traits	
BRCA	cis	1	rs2951363	chr7:143754724	OR2A7	chr7:143955790-143974852:-	0.19	4.59	4.99E-6	Obesity-related traits	
BRCA	cis	1	rs2951363	chr7:143754724	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.52	0.000448	Obesity-related traits	
BRCA	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.23	1.75E-23	Obesity-related traits	
BRCA	cis	1	rs2951364	chr7:143754483	OR2A7	chr7:143955790-143974852:-	0.19	4.59	5.04E-6	Obesity-related traits	
BRCA	cis	1	rs2951364	chr7:143754483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.13	-3.42	0.000661	Obesity-related traits	
BRCA	cis	1	rs2951368	chr7:143752821	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.17	3.09E-23	Obesity-related traits	
BRCA	cis	1	rs2951368	chr7:143752821	OR2A7	chr7:143955790-143974852:-	0.19	4.59	4.89E-6	Obesity-related traits	
BRCA	cis	1	rs2951368	chr7:143752821	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.48	0.000531	Obesity-related traits	
BRCA	cis	1	rs2951369	chr7:143752638	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.21	2.09E-23	Obesity-related traits	
BRCA	cis	1	rs2951369	chr7:143752638	OR2A7	chr7:143955790-143974852:-	0.19	4.58	5.22E-6	Obesity-related traits	
BRCA	cis	1	rs2951369	chr7:143752638	OR2A9P	chr7:143991573-143997832:+;chr7	-0.13	-3.41	0.000681	Obesity-related traits	
BRCA	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.23	1.75E-23	Obesity-related traits	
BRCA	cis	1	rs2951372	chr7:143749503	OR2A7	chr7:143955790-143974852:-	0.19	4.46	9.15E-6	Obesity-related traits	
BRCA	cis	1	rs2951372	chr7:143749503	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.49	0.000506	Obesity-related traits	
BRCA	cis	1	rs2952768	chr2:208494234	FAM119A	chr2:208446079-208490065:-	0.18	4.56	5.58E-6	Opioid sensitivity	
BRCA	cis	1	rs2952770	chr2:208496923	FAM119A	chr2:208446079-208490065:-	0.16	4.13	3.96E-5	Opioid sensitivity	
BRCA	cis	1	rs2953176	chr2:241520754	CAPN10	chr2:241526145-241557122:+	-0.11	-3.58	0.000357	Bipolar disorder	
BRCA	cis	1	rs2955095	chr3:127977665	RUVBL1	chr3:127783627-127872757:-	0.15	3.73	0.000201	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2955097	chr3:127978505	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.42	0.000656	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2955099	chr3:127979654	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.46	0.000562	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2955100	chr3:127993325	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.4	0.000706	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2955101	chr3:128009612	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.38	0.000746	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2961102	chr7:65424658	CCT6P1	chr7:65216092-65228661:+	0.35	7.7	3.02E-14	Diabetic kidney disease	
BRCA	cis	1	rs2961102	chr7:65424658	LOC493754	chr7:65993446-66057363:-	0.21	3.53	0.000438	Diabetic kidney disease	
BRCA	cis	1	rs2961102	chr7:65424658	ZNF117	chr7:64434830-64467121:-	-0.27	-4.95	8.53E-7	Diabetic kidney disease	
BRCA	cis	1	rs2961115	chr7:143753371	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.17	2.93E-23	Obesity-related traits	
BRCA	cis	1	rs2961115	chr7:143753371	OR2A7	chr7:143955790-143974852:-	0.19	4.59	4.97E-6	Obesity-related traits	
BRCA	cis	1	rs2961115	chr7:143753371	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.52	0.000453	Obesity-related traits	
BRCA	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.42	-10.14	3.94E-23	Obesity-related traits	
BRCA	cis	1	rs2961117	chr7:143755253	OR2A7	chr7:143955790-143974852:-	0.2	4.67	3.43E-6	Obesity-related traits	
BRCA	cis	1	rs2961117	chr7:143755253	OR2A9P	chr7:143991573-143997832:+;chr7	-0.15	-3.59	0.000341	Obesity-related traits	
BRCA	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.42	-10.52	1.07E-24	Obesity-related traits	
BRCA	cis	1	rs2961118	chr7:143755443	OR2A7	chr7:143955790-143974852:-	0.2	4.78	2.04E-6	Obesity-related traits	
BRCA	cis	1	rs2961118	chr7:143755443	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.42	0.000654	Obesity-related traits	
BRCA	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.42	-10.46	1.98E-24	Obesity-related traits	
BRCA	cis	1	rs2961119	chr7:143755852	OR2A7	chr7:143955790-143974852:-	0.2	4.78	2.05E-6	Obesity-related traits	
BRCA	cis	1	rs2961119	chr7:143755852	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.42	0.00064	Obesity-related traits	
BRCA	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.42	-10.36	5.2E-24	Obesity-related traits	
BRCA	cis	1	rs2961120	chr7:143756585	OR2A7	chr7:143955790-143974852:-	0.22	4.99	7.15E-7	Obesity-related traits	
BRCA	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.16	3.26E-23	Obesity-related traits	
BRCA	cis	1	rs2961125	chr7:143761770	OR2A7	chr7:143955790-143974852:-	0.21	4.9	1.1E-6	Obesity-related traits	
BRCA	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.16	3.26E-23	Obesity-related traits	
BRCA	cis	1	rs2961126	chr7:143762736	OR2A7	chr7:143955790-143974852:-	0.21	4.9	1.1E-6	Obesity-related traits	
BRCA	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.16	3.26E-23	Obesity-related traits	
BRCA	cis	1	rs2961128	chr7:143763483	OR2A7	chr7:143955790-143974852:-	0.21	4.9	1.1E-6	Obesity-related traits	
BRCA	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.39	-9.51	1.23E-20	Obesity-related traits	
BRCA	cis	1	rs2961132	chr7:143768128	OR2A7	chr7:143955790-143974852:-	0.21	4.98	7.49E-7	Obesity-related traits	
BRCA	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10.27	1.18E-23	Obesity-related traits	
BRCA	cis	1	rs2961134	chr7:143771062	OR2A7	chr7:143955790-143974852:-	0.21	4.96	8.37E-7	Obesity-related traits	
BRCA	cis	1	rs2961134	chr7:143771062	OR2A9P	chr7:143991573-143997832:+;chr7	-0.15	-3.68	0.000243	Obesity-related traits	
BRCA	cis	1	rs2961144	chr7:143747870	ARHGEF35	chr7:143883677-143892736:-	0.4	10.13	4.23E-23	Obesity-related traits	
BRCA	cis	1	rs2961144	chr7:143747870	OR2A7	chr7:143955790-143974852:-	-0.19	-4.57	5.36E-6	Obesity-related traits	
BRCA	cis	1	rs2961144	chr7:143747870	OR2A9P	chr7:143991573-143997832:+;chr7	0.13	3.45	0.000591	Obesity-related traits	
BRCA	cis	1	rs2962283	chr5:41232698	C7	chr5:40909599-40983039:+	-0.11	-4.55	5.86E-6	Response to fenofibrate (adiponectin levels)	
BRCA	cis	1	rs2962284	chr5:41224610	C7	chr5:40909599-40983039:+	0.11	4.61	4.5E-6	Response to fenofibrate (adiponectin levels)	
BRCA	cis	1	rs2962285	chr5:41224540	C7	chr5:40909599-40983039:+	-0.1	-4.48	8.41E-6	Response to fenofibrate (adiponectin levels)	
BRCA	cis	1	rs2962288	chr5:41223861	C7	chr5:40909599-40983039:+	-0.11	-4.63	4.11E-6	Response to fenofibrate (adiponectin levels)	
BRCA	cis	1	rs2965188	chr19:19522557	CILP2	chr19:19649074-19657466:+	0.1	3.76	0.000178	Schizophrenia	
BRCA	cis	1	rs2965188	chr19:19522557	HAPLN4	chr19:19366453-19384074:-	0.21	6.81	1.66E-11	Schizophrenia	
BRCA	cis	1	rs2965198	chr19:19473030	CILP2	chr19:19649074-19657466:+	-0.12	-4.1	4.5E-5	Schizophrenia	
BRCA	cis	1	rs2965198	chr19:19473030	HAPLN4	chr19:19366453-19384074:-	-0.22	-6.98	5.01E-12	Schizophrenia	
BRCA	cis	1	rs2965198	chr19:19473030	KIAA0892	chr19:19431630-19469562:+	0.12	3.41	0.000666	Schizophrenia	
BRCA	cis	1	rs2972396	chr5:42407985	CCDC152	chr5:42756920-42802539:+	-0.12	-3.88	0.000109	Systemic lupus erythematosus	
BRCA	cis	1	rs2972396	chr5:42407985	OXCT1	chr5:41730168-41870791:-	-0.13	-3.59	0.000339	Systemic lupus erythematosus	
BRCA	cis	1	rs2975734	chr8:10090097	TNKS	chr8:9413445-9639855:+	0.1	3.38	0.000759	Chronotype;Morning vs. evening chronotype	
BRCA	cis	1	rs2975754	chr2:241522634	CAPN10	chr2:241526145-241557122:+	-0.11	-3.77	0.000172	Bipolar disorder	
BRCA	cis	1	rs2985697	chr14:50092902	RPL36AL	chr14:50085407-50087349:-	0.17	5.46	6.08E-8	Carotid intima media thickness	
BRCA	cis	1	rs2992257	chr10:26734587	APBB1IP	chr10:26727266-26856730:+	-0.07	-3.49	0.000503	Response to angiotensin II receptor blocker therapy	
BRCA	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.81	-27.47	4.5E-126	Homocysteine levels	
BRCA	cis	1	rs2993259	chr1:46001550	MMACHC	chr1:45965856-45976737:+	-0.14	-4.06	5.19E-5	Homocysteine levels	
BRCA	cis	1	rs2996635	chr6:153011163	VIP	chr6:153071933-153080898:+	-0.14	-4.37	1.34E-5	Tonometry	
BRCA	cis	1	rs2999061	chr3:127993623	RUVBL1	chr3:127783627-127872757:-	0.14	3.51	0.000467	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2999062	chr3:127993606	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.4	0.000693	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2999065	chr3:127981438	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.46	0.000562	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2999066	chr3:127980286	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.46	0.000562	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2999067	chr3:127978531	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.49	0.000495	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs2999068	chr3:127977978	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.46	0.000562	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs3002702	chr20:25268920	FAM182A	chr20:26035250-26067552:+	-0.21	-5.64	2.18E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs3002702	chr20:25268920	FAM182B	chr20:25744102-25848786:-	0.23	5.92	4.38E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs3002702	chr20:25268920	PYGB	chr20:25228706-25278647:+	-0.13	-3.48	0.000522	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs3003214	chr1:244605036	C1orf101	chr1:244617679-244803660:+	0.14	4.36	1.42E-5	Dementia and core Alzheimer's disease neuropathologic changes	
BRCA	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.5	-18.24	6.31E-65	Ankylosing spondylitis	
BRCA	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.4	10.61	4.33E-25	Ankylosing spondylitis	
BRCA	cis	1	rs3019587	chr11:68569642	C11orf24	chr11:68028805-68039469:-	0.31	4.77	2.06E-6	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	CHKA	chr11:67820328-67888858:-	0.27	3.75	0.000185	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	CPT1A	chr11:68522091-68609399:-	0.33	4.81	1.69E-6	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	IGHMBP2	chr11:68671319-68708069:+	0.48	7.12	1.99E-12	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	LOC645332	chr11:67559240-67572807:-	0.29	4.03	6.0E-5	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	MRPL21	chr11:68658747-68671303:-	0.43	6.48	1.43E-10	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	MTL5	chr11:68474910-68518988:-	0.35	5.86	6.3E-9	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	NDUFS8	chr11:67798094-67804114:+	0.26	5.17	2.79E-7	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	ORAOV1	chr11:69471368-69490165:-	0.3	4.24	2.39E-5	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	SAPS3	chr11:68228186-68382799:+	0.39	5.75	1.18E-8	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	SUV420H1	chr11:67923507-67981068:-	0.32	4.93	9.42E-7	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	TCIRG1	chr11:67806483-67818365:+	0.21	3.87	0.000115	Obesity-related traits	
BRCA	cis	1	rs3019587	chr11:68569642	TPCN2	chr11:68816350-68929907:+	0.39	5.32	1.26E-7	Obesity-related traits	
BRCA	cis	1	rs302714	chr1:8486131	RERE	chr1:8412466-8877699:-	0.12	3.55	0.000408	Optic cup area;Vertical cup-disc ratio	
BRCA	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.5	-18.44	4.12E-66	Ankylosing spondylitis	
BRCA	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.4	10.77	9.74E-26	Ankylosing spondylitis	
BRCA	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.5	-18.44	4.06E-66	Ankylosing spondylitis	
BRCA	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.41	10.86	3.85E-26	Ankylosing spondylitis	
BRCA	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.5	-18.44	4.06E-66	Ankylosing spondylitis	
BRCA	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.41	10.86	3.85E-26	Ankylosing spondylitis	
BRCA	cis	1	rs3087243	chr2:204738919	CTLA4	chr2:204732509-204738683:+	0.06	3.61	0.00032	Type 1 diabetes;Rheumatoid arthritis;Type 1 diabetes autoantibodies	
BRCA	cis	1	rs3088162	chr20:23607752	CST1	chr20:23728191-23731574:-	0.19	4.14	3.73E-5	Chronic kidney disease	
BRCA	cis	1	rs3091250	chr3:46306130	TDGF1	chr3:46619180-46623950:+	0.14	3.99	6.98E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs3091312	chr3:46308472	TDGF1	chr3:46619180-46623950:+	0.13	3.6	0.000329	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs3092744	chr20:44025282	SYS1	chr20:43991701-44004724:+	0.16	4.35	1.52E-5	Psoriasis	
BRCA	cis	1	rs3099301	chr6:166524417	SFT2D1	chr6:166733519-166755991:-	-0.14	-4.05	5.55E-5	Asthma	
BRCA	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.76	19.44	2.64E-72	Type 2 diabetes	
BRCA	cis	1	rs310124	chr1:153020275	SPRR1A	chr1:152956557-152958289:+	0.17	4.94	9.21E-7	Inflammatory skin disease	
BRCA	cis	1	rs3101852	chr15:50848370	SPPL2A	chr15:50999739-51057910:-	-0.14	-5.12	3.54E-7	QT interval	
BRCA	cis	1	rs3101853	chr15:50848382	SPPL2A	chr15:50999739-51057910:-	-0.13	-4.88	1.21E-6	QT interval	
BRCA	cis	1	rs3101855	chr15:50859874	SPPL2A	chr15:50999739-51057910:-	0.14	5.15	3.11E-7	QT interval	
BRCA	cis	1	rs3103067	chr4:8511223	C4orf23	chr4:8440604-8495258:+	-0.15	-3.95	8.43E-5	Response to antineoplastic agents	
BRCA	cis	1	rs3103071	chr4:8508579	C4orf23	chr4:8440604-8495258:+	0.16	4.29	1.94E-5	Response to antineoplastic agents	
BRCA	cis	1	rs3103072	chr4:8508431	C4orf23	chr4:8440604-8495258:+	0.17	4.35	1.48E-5	Response to antineoplastic agents	
BRCA	cis	1	rs3105591	chr15:50869042	SPPL2A	chr15:50999739-51057910:-	0.15	5.34	1.15E-7	QT interval	
BRCA	cis	1	rs3105593	chr15:50845018	SPPL2A	chr15:50999739-51057910:-	0.12	4.4	1.17E-5	QT interval	
BRCA	cis	1	rs3109878	chr15:50836243	SPPL2A	chr15:50999739-51057910:-	0.12	4.34	1.54E-5	QT interval	
BRCA	cis	1	rs3109888	chr15:50860694	SPPL2A	chr15:50999739-51057910:-	0.14	5.02	6.03E-7	QT interval	
BRCA	cis	1	rs3109892	chr15:50877011	SPPL2A	chr15:50999739-51057910:-	0.14	5.31	1.34E-7	QT interval	
BRCA	cis	1	rs3109894	chr15:50878574	SPPL2A	chr15:50999739-51057910:-	0.12	4.38	1.3E-5	QT interval	
BRCA	cis	1	rs3109895	chr15:50880560	SPPL2A	chr15:50999739-51057910:-	0.14	5.21	2.32E-7	QT interval	
BRCA	cis	1	rs3110496	chr17:27917771	ABHD15	chr17:27888311-27894048:-	-0.14	-4.05	5.58E-5	Height	
BRCA	cis	1	rs3118632	chr9:131901284	SH3GLB2	chr9:131770314-131790579:-	0.11	4.08	4.8E-5	Blood metabolite ratios	
BRCA	cis	1	rs3121278	chr10:43375646	LOC84856	chr10:42970939-42990784:+	0.16	3.93	9.07E-5	Progressive supranuclear palsy	
BRCA	cis	1	rs3121279	chr10:43378449	LOC84856	chr10:42970939-42990784:+	0.15	3.72	0.000213	Progressive supranuclear palsy	
BRCA	cis	1	rs3121323	chr10:43377166	LOC84856	chr10:42970939-42990784:+	-0.15	-3.63	0.000298	Progressive supranuclear palsy	
BRCA	cis	1	rs3124510	chr9:131899690	SH3GLB2	chr9:131770314-131790579:-	0.1	3.82	0.000144	Blood metabolite ratios	
BRCA	cis	1	rs3124511	chr9:131901458	SH3GLB2	chr9:131770314-131790579:-	0.09	3.44	0.000612	Blood metabolite ratios	
BRCA	cis	1	rs3124513	chr9:131904593	SH3GLB2	chr9:131770314-131790579:-	0.11	4.15	3.64E-5	Blood metabolite ratios	
BRCA	cis	1	rs3124514	chr9:131904608	SH3GLB2	chr9:131770314-131790579:-	0.11	4.15	3.64E-5	Blood metabolite ratios	
BRCA	cis	1	rs3131577	chr15:50863516	SPPL2A	chr15:50999739-51057910:-	0.14	5.08	4.57E-7	QT interval	
BRCA	cis	1	rs3135071	chr4:2406321	WHSC1	chr4:1873123-1983933:+	-0.15	-3.56	0.000384	Influenza A (H1N1) severity	
BRCA	cis	1	rs313798	chr7:65493031	CCT6P1	chr7:65216092-65228661:+	0.34	7.39	3.03E-13	Diabetic kidney disease	
BRCA	cis	1	rs313798	chr7:65493031	LOC493754	chr7:65993446-66057363:-	0.21	3.51	0.000462	Diabetic kidney disease	
BRCA	cis	1	rs313799	chr7:65494330	CCT6P1	chr7:65216092-65228661:+	0.31	6.75	2.49E-11	Diabetic kidney disease	
BRCA	cis	1	rs313799	chr7:65494330	LOC493754	chr7:65993446-66057363:-	0.2	3.4	0.000703	Diabetic kidney disease	
BRCA	cis	1	rs313802	chr7:65516373	CCT6P1	chr7:65216092-65228661:+	0.32	6.74	2.51E-11	Diabetic kidney disease	
BRCA	cis	1	rs313802	chr7:65516373	LOC493754	chr7:65993446-66057363:-	0.21	3.44	0.00061	Diabetic kidney disease	
BRCA	cis	1	rs313803	chr7:65514731	CCT6P1	chr7:65216092-65228661:+	0.32	6.77	2.06E-11	Diabetic kidney disease	
BRCA	cis	1	rs313803	chr7:65514731	LOC493754	chr7:65993446-66057363:-	0.21	3.48	0.000526	Diabetic kidney disease	
BRCA	cis	1	rs313807	chr7:65499481	CCT6P1	chr7:65216092-65228661:+	0.31	6.75	2.49E-11	Diabetic kidney disease	
BRCA	cis	1	rs313809	chr7:65499983	CCT6P1	chr7:65216092-65228661:+	0.34	7.38	3.07E-13	Diabetic kidney disease	
BRCA	cis	1	rs313809	chr7:65499983	LOC493754	chr7:65993446-66057363:-	0.21	3.47	0.000541	Diabetic kidney disease	
BRCA	cis	1	rs313813	chr7:65503500	CCT6P1	chr7:65216092-65228661:+	0.32	6.74	2.52E-11	Diabetic kidney disease	
BRCA	cis	1	rs313813	chr7:65503500	CRCP	chr7:65579805-65619551:+	-0.22	-3.7	0.00023	Diabetic kidney disease	
BRCA	cis	1	rs313814	chr7:65503293	CCT6P1	chr7:65216092-65228661:+	0.34	7.16	1.54E-12	Diabetic kidney disease	
BRCA	cis	1	rs313814	chr7:65503293	LOC493754	chr7:65993446-66057363:-	0.23	3.73	0.000205	Diabetic kidney disease	
BRCA	cis	1	rs313820	chr7:65574466	CCT6P1	chr7:65216092-65228661:+	0.32	6.74	2.53E-11	Diabetic kidney disease	
BRCA	cis	1	rs313820	chr7:65574466	CRCP	chr7:65579805-65619551:+	-0.21	-3.51	0.000465	Diabetic kidney disease	
BRCA	cis	1	rs313820	chr7:65574466	LOC493754	chr7:65993446-66057363:-	0.23	3.76	0.000178	Diabetic kidney disease	
BRCA	cis	1	rs313824	chr7:65581207	CCT6P1	chr7:65216092-65228661:+	0.32	6.8	1.79E-11	Diabetic kidney disease	
BRCA	cis	1	rs313824	chr7:65581207	CRCP	chr7:65579805-65619551:+	-0.21	-3.5	0.000477	Diabetic kidney disease	
BRCA	cis	1	rs313824	chr7:65581207	LOC493754	chr7:65993446-66057363:-	0.23	3.83	0.000133	Diabetic kidney disease	
BRCA	cis	1	rs313831	chr7:65551226	CCT6P1	chr7:65216092-65228661:+	0.34	7.05	3.2E-12	Diabetic kidney disease	
BRCA	cis	1	rs313831	chr7:65551226	LOC493754	chr7:65993446-66057363:-	0.26	4.11	4.18E-5	Diabetic kidney disease	
BRCA	cis	1	rs313832	chr7:65550891	CCT6P1	chr7:65216092-65228661:+	0.34	7.05	3.21E-12	Diabetic kidney disease	
BRCA	cis	1	rs313832	chr7:65550891	LOC493754	chr7:65993446-66057363:-	0.26	4.15	3.62E-5	Diabetic kidney disease	
BRCA	cis	1	rs316009	chr6:160675764	TCP1	chr6:160199531-160210735:-	-0.18	-3.49	0.000509	Blood metabolite ratios	
BRCA	cis	1	rs316009	chr6:160675764	WTAP	chr6:160148129-160177349:+	-0.2	-3.4	0.00069	Blood metabolite ratios	
BRCA	cis	1	rs316304	chr7:65616894	CCT6P1	chr7:65216092-65228661:+	0.3	6.45	1.73E-10	Diabetic kidney disease	
BRCA	cis	1	rs316304	chr7:65616894	CRCP	chr7:65579805-65619551:+	-0.21	-3.51	0.00046	Diabetic kidney disease	
BRCA	cis	1	rs316304	chr7:65616894	LOC493754	chr7:65993446-66057363:-	0.21	3.59	0.00034	Diabetic kidney disease	
BRCA	cis	1	rs316307	chr7:65570171	CCT6P1	chr7:65216092-65228661:+	0.32	6.74	2.61E-11	Diabetic kidney disease	
BRCA	cis	1	rs316307	chr7:65570171	LOC493754	chr7:65993446-66057363:-	0.22	3.66	0.000267	Diabetic kidney disease	
BRCA	cis	1	rs316312	chr7:65596491	CCT6P1	chr7:65216092-65228661:+	0.33	6.97	5.42E-12	Diabetic kidney disease	
BRCA	cis	1	rs316312	chr7:65596491	LOC493754	chr7:65993446-66057363:-	0.25	4.11	4.33E-5	Diabetic kidney disease	
BRCA	cis	1	rs316313	chr7:65593548	CCT6P1	chr7:65216092-65228661:+	0.33	6.97	5.42E-12	Diabetic kidney disease	
BRCA	cis	1	rs316313	chr7:65593548	LOC493754	chr7:65993446-66057363:-	0.25	4.11	4.33E-5	Diabetic kidney disease	
BRCA	cis	1	rs316317	chr7:65613637	CCT6P1	chr7:65216092-65228661:+	0.3	6.45	1.73E-10	Diabetic kidney disease	
BRCA	cis	1	rs316317	chr7:65613637	CRCP	chr7:65579805-65619551:+	-0.21	-3.51	0.00046	Diabetic kidney disease	
BRCA	cis	1	rs316317	chr7:65613637	LOC493754	chr7:65993446-66057363:-	0.21	3.59	0.00034	Diabetic kidney disease	
BRCA	cis	1	rs316318	chr7:65612904	CCT6P1	chr7:65216092-65228661:+	0.3	6.45	1.73E-10	Diabetic kidney disease	
BRCA	cis	1	rs316318	chr7:65612904	CRCP	chr7:65579805-65619551:+	-0.21	-3.51	0.00046	Diabetic kidney disease	
BRCA	cis	1	rs316318	chr7:65612904	LOC493754	chr7:65993446-66057363:-	0.21	3.59	0.00034	Diabetic kidney disease	
BRCA	cis	1	rs316321	chr7:65611613	CCT6P1	chr7:65216092-65228661:+	0.3	6.45	1.73E-10	Diabetic kidney disease	
BRCA	cis	1	rs316321	chr7:65611613	CRCP	chr7:65579805-65619551:+	-0.21	-3.51	0.00046	Diabetic kidney disease	
BRCA	cis	1	rs316321	chr7:65611613	LOC493754	chr7:65993446-66057363:-	0.21	3.59	0.00034	Diabetic kidney disease	
BRCA	cis	1	rs316322	chr7:65611233	CCT6P1	chr7:65216092-65228661:+	0.32	6.94	7.01E-12	Diabetic kidney disease	
BRCA	cis	1	rs316322	chr7:65611233	LOC493754	chr7:65993446-66057363:-	0.24	4.06	5.31E-5	Diabetic kidney disease	
BRCA	cis	1	rs316325	chr7:65609518	CCT6P1	chr7:65216092-65228661:+	0.32	6.87	1.05E-11	Diabetic kidney disease	
BRCA	cis	1	rs316325	chr7:65609518	LOC493754	chr7:65993446-66057363:-	0.24	4.07	5.1E-5	Diabetic kidney disease	
BRCA	cis	1	rs316326	chr7:65609453	CCT6P1	chr7:65216092-65228661:+	0.32	6.87	1.05E-11	Diabetic kidney disease	
BRCA	cis	1	rs316326	chr7:65609453	LOC493754	chr7:65993446-66057363:-	0.24	4.07	5.1E-5	Diabetic kidney disease	
BRCA	cis	1	rs316327	chr7:65609201	CCT6P1	chr7:65216092-65228661:+	-0.32	-7.07	2.79E-12	Diabetic kidney disease	
BRCA	cis	1	rs316327	chr7:65609201	LOC493754	chr7:65993446-66057363:-	-0.25	-4.37	1.34E-5	Diabetic kidney disease	
BRCA	cis	1	rs316329	chr7:65608416	CCT6P1	chr7:65216092-65228661:+	0.31	6.74	2.54E-11	Diabetic kidney disease	
BRCA	cis	1	rs316329	chr7:65608416	LOC493754	chr7:65993446-66057363:-	0.25	4.3	1.84E-5	Diabetic kidney disease	
BRCA	cis	1	rs316330	chr7:65605372	CCT6P1	chr7:65216092-65228661:+	0.32	6.96	5.88E-12	Diabetic kidney disease	
BRCA	cis	1	rs316330	chr7:65605372	LOC493754	chr7:65993446-66057363:-	0.25	4.23	2.49E-5	Diabetic kidney disease	
BRCA	cis	1	rs316331	chr7:65604622	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.76	2.34E-11	Diabetic kidney disease	
BRCA	cis	1	rs316331	chr7:65604622	LOC493754	chr7:65993446-66057363:-	-0.26	-4.5	7.64E-6	Diabetic kidney disease	
BRCA	cis	1	rs316332	chr7:65604299	CCT6P1	chr7:65216092-65228661:+	0.29	6.31	4.06E-10	Diabetic kidney disease	
BRCA	cis	1	rs316332	chr7:65604299	CRCP	chr7:65579805-65619551:+	-0.2	-3.42	0.000639	Diabetic kidney disease	
BRCA	cis	1	rs316332	chr7:65604299	LOC493754	chr7:65993446-66057363:-	0.24	4.08	4.91E-5	Diabetic kidney disease	
BRCA	cis	1	rs316334	chr7:65602126	CCT6P1	chr7:65216092-65228661:+	0.33	6.99	4.83E-12	Diabetic kidney disease	
BRCA	cis	1	rs316334	chr7:65602126	LOC493754	chr7:65993446-66057363:-	0.24	3.97	7.79E-5	Diabetic kidney disease	
BRCA	cis	1	rs3183928	chr9:100684719	C9orf156	chr9:100666772-100684852:-	-0.17	-4.7	2.89E-6	Quantitative traits	
BRCA	cis	1	rs3194585	chr4:103553090	MANBA	chr4:103552644-103682151:-	0.21	5.37	9.79E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs319690	chr3:47927484	CSPG5	chr3:47603729-47621730:-	0.15	3.73	0.000202	Blood pressure	
BRCA	cis	1	rs319690	chr3:47927484	ZNF589	chr3:48282596-48329113:+	0.13	4.09	4.57E-5	Blood pressure	
BRCA	cis	1	rs3213861	chr19:41919944	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.31	5.21E-13	Height	
BRCA	cis	1	rs3213984	chr12:62785537	FAM19A2	chr12:62102043-62653925:-	0.17	3.66	0.000269	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.28	-10.46	1.84E-24	Longevity	
BRCA	cis	1	rs321622	chr4:48024380	CNGA1	chr4:47937996-48018610:-	0.23	7.76	1.94E-14	Renal underexcretion gout;Gout	
BRCA	cis	1	rs321622	chr4:48024380	NIPAL1	chr4:48018791-48039078:+	0.11	3.62	0.000307	Renal underexcretion gout;Gout	
BRCA	cis	1	rs32396	chr5:50106439	PARP8	chr5:49961733-50138169:+	0.12	3.44	0.000597	Myopia (pathological)	
BRCA	cis	1	rs3310	chr20:3237232	ITPA	chr20:3190056-3204504:+	-0.13	-3.78	0.000165	IFN-related cytopenia	
BRCA	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.78	19.75	2.86E-74	Type 2 diabetes	
BRCA	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.78	20.79	7.54E-81	Type 2 diabetes	
BRCA	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.77	19.62	2.0E-73	Type 2 diabetes	
BRCA	cis	1	rs336585	chr3:161081670	C3orf57	chr3:161062581-161089871:-	0.13	3.45	0.000586	Morning vs. evening chronotype	
BRCA	cis	1	rs33794	chr3:45300605	SACM1L	chr3:45730754-45786900:+	0.11	4.17	3.22E-5	Forced expiratory volume in 1 second	
BRCA	cis	1	rs33794	chr3:45300605	ZNF445	chr3:44481262-44561226:-	0.1	3.89	0.000106	Forced expiratory volume in 1 second	
BRCA	cis	1	rs339331	chr6:117210052	FAM162B	chr6:117073360-117086886:-	-0.13	-4.94	9.05E-7	Prostate cancer	
BRCA	cis	1	rs339344	chr6:117217950	FAM162B	chr6:117073360-117086886:-	-0.12	-4.52	6.84E-6	Prostate cancer	
BRCA	cis	1	rs339344	chr6:117217950	FAM26F	chr6:116782556-116784933:+	-0.08	-3.51	0.000469	Prostate cancer	
BRCA	cis	1	rs33988592	chr3:121415610	IQCB1	chr3:121488610-121553926:-	0.28	7.09	2.47E-12	Cognitive performance	
BRCA	cis	1	rs33988592	chr3:121415610	SLC15A2	chr3:121613171-121663034:+	-0.13	-3.81	0.000149	Cognitive performance	
BRCA	cis	1	rs34025766	chr4:17968811	NCAPG	chr4:17812525-17846485:+	0.09	4.4	1.21E-5	Height	
BRCA	cis	1	rs34031374	chr12:82235615	PPFIA2	chr12:81652880-82153109:-	0.13	3.39	0.000713	Resting heart rate	
BRCA	cis	1	rs34034766	chr2:231036768	SP110	chr2:231033645-231084827:-	0.21	3.97	7.67E-5	Obesity-related traits	
BRCA	cis	1	rs34047458	chr3:46253599	CCR5	chr3:46411633-46417690:+	-0.11	-4.37	1.38E-5	Celiac disease	
BRCA	cis	1	rs34052221	chr6:163160803	PACRG	chr6:163148164-163736523:+	0.22	3.84	0.000132	Body mass index	
BRCA	cis	1	rs34055941	chr9:131895076	SH3GLB2	chr9:131770314-131790579:-	-0.12	-4.48	8.4E-6	Blood metabolite ratios	
BRCA	cis	1	rs34066731	chr6:163011047	PACRG	chr6:163148164-163736523:+	0.23	4.37	1.36E-5	Body mass index	
BRCA	cis	1	rs34072732	chr4:106604364	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs34084277	chr19:17387176	ANKLE1	chr19:17392454-17398454:+	0.2	5.92	4.35E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs34084277	chr19:17387176	ANO8	chr19:17434032-17445638:-	0.15	3.84	0.000132	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs34084277	chr19:17387176	OCEL1	chr19:17337055-17340027:+	0.15	4.75	2.27E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs34084277	chr19:17387176	PLVAP	chr19:17462264-17488137:-	-0.09	-3.51	0.000463	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.25	6.63	5.39E-11	Cognitive performance	
BRCA	cis	1	rs34086988	chr3:121352745	SLC15A2	chr3:121613171-121663034:+	-0.14	-4.14	3.81E-5	Cognitive performance	
BRCA	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.69	8.54E-30	Body mass index	
BRCA	cis	1	rs34102169	chr1:46424864	MUTYH	chr1:45794915-45806142:-	0.12	4.79	1.87E-6	Body mass index	
BRCA	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.57	-17.75	6.06E-62	Response to antipsychotic treatment	
BRCA	cis	1	rs34113620	chr4:54996515	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.91	9.99E-5	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs34117728	chr5:156433497	TIMD4	chr5:156346293-156390266:-	-0.17	-4.35	1.51E-5	Hypertriglyceridemia	
BRCA	cis	1	rs34122378	chr2:231040163	SP110	chr2:231033645-231084827:-	0.2	3.78	0.000165	Obesity-related traits	
BRCA	cis	1	rs34123137	chr2:234167881	SAG	chr2:234216309-234255701:+	0.13	3.96	7.91E-5	Crohn's disease	
BRCA	cis	1	rs34127220	chr16:29842891	LOC440356	chr16:29875004-29879374:+	-0.27	-5.52	4.32E-8	Multiple sclerosis	
BRCA	cis	1	rs34128973	chr11:47851376	MADD	chr11:47290927-47351582:+	0.15	4.52	6.99E-6	Subjective well-being	
BRCA	cis	1	rs34128973	chr11:47851376	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.08	4.78E-5	Subjective well-being	
BRCA	cis	1	rs34136756	chr7:65381256	CCT6P1	chr7:65216092-65228661:+	0.34	7.43	2.24E-13	Diabetic kidney disease	
BRCA	cis	1	rs34136756	chr7:65381256	LOC493754	chr7:65993446-66057363:-	0.2	3.38	0.00076	Diabetic kidney disease	
BRCA	cis	1	rs34136756	chr7:65381256	ZNF117	chr7:64434830-64467121:-	-0.27	-5	6.54E-7	Diabetic kidney disease	
BRCA	cis	1	rs34138336	chr6:163144929	PACRG	chr6:163148164-163736523:+	0.24	4.09	4.73E-5	Body mass index	
BRCA	cis	1	rs34139049	chr6:33716784	IP6K3	chr6:33689443-33714762:-	0.24	4.17	3.29E-5	Obesity (extreme)	
BRCA	cis	1	rs34140872	chr11:28335872	METT5D1	chr11:28129798-28355054:+	-0.13	-3.7	0.000224	Bipolar disorder	
BRCA	cis	1	rs34156351	chr4:17983055	NCAPG	chr4:17812525-17846485:+	0.1	4.63	4.09E-6	Height	
BRCA	cis	1	rs34171762	chr19:18559410	LRRC25	chr19:18501955-18508421:-	-0.14	-6.83	1.4E-11	Breast cancer	
BRCA	cis	1	rs34177053	chr6:163007772	PACRG	chr6:163148164-163736523:+	0.2	4.02	6.15E-5	Body mass index	
BRCA	cis	1	rs34180939	chr5:148618964	CDX1	chr5:149546344-149564120:+	-0.12	-3.89	0.000105	Body mass index	
BRCA	cis	1	rs34192067	chr7:65887657	CCT6P1	chr7:65216092-65228661:+	0.31	6.53	1.02E-10	Diabetic kidney disease	
BRCA	cis	1	rs34192067	chr7:65887657	CRCP	chr7:65579805-65619551:+	-0.21	-3.51	0.00046	Diabetic kidney disease	
BRCA	cis	1	rs34192067	chr7:65887657	LOC493754	chr7:65993446-66057363:-	0.22	3.7	0.000228	Diabetic kidney disease	
BRCA	cis	1	rs34192365	chr6:163012382	PACRG	chr6:163148164-163736523:+	0.24	4.54	6.36E-6	Body mass index	
BRCA	cis	1	rs34193460	chr7:65393110	CCT6P1	chr7:65216092-65228661:+	0.35	7.66	4.23E-14	Diabetic kidney disease	
BRCA	cis	1	rs34193460	chr7:65393110	LOC493754	chr7:65993446-66057363:-	0.21	3.46	0.000555	Diabetic kidney disease	
BRCA	cis	1	rs34193460	chr7:65393110	ZNF117	chr7:64434830-64467121:-	-0.28	-5.04	5.51E-7	Diabetic kidney disease	
BRCA	cis	1	rs34198350	chr2:48169382	MSH6	chr2:48010221-48034084:+	-0.18	-4.49	7.85E-6	QT interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs34201939	chr1:27093711	PIGV	chr1:27114455-27124886:+	-0.23	-3.67	0.000252	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs34209421	chr4:18031110	NCAPG	chr4:17812525-17846485:+	0.11	4.46	9.07E-6	Height	
BRCA	cis	1	rs34228197	chr6:163008232	PACRG	chr6:163148164-163736523:+	0.2	4.02	6.15E-5	Body mass index	
BRCA	cis	1	rs34230359	chr5:156449561	TIMD4	chr5:156346293-156390266:-	-0.16	-4.12	4.15E-5	Hypertriglyceridemia	
BRCA	cis	1	rs34252323	chr2:135486302	TMEM163	chr2:135213331-135525334:-	-0.24	-4.94	8.87E-7	Gut microbiome composition (winter)	
BRCA	cis	1	rs34256197	chr19:18606472	LRRC25	chr19:18501955-18508421:-	-0.14	-6.92	7.94E-12	Breast cancer	
BRCA	cis	1	rs34258593	chr3:38464565	LOC100128640	chr3:38492524-38496311:-	0.13	3.49	0.000501	Electrocardiographic conduction measures	
BRCA	cis	1	rs34258593	chr3:38464565	XYLB	chr3:38388251-38456467:+	0.19	5.68	1.69E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.6	-18.93	4.05E-69	Response to antipsychotic treatment	
BRCA	cis	1	rs34292685	chr11:64049021	C11orf20	chr11:64067863-64072238:+	-0.23	-4.57	5.38E-6	Mean platelet volume	
BRCA	cis	1	rs34333482	chr6:116855952	FAM162B	chr6:117073360-117086886:-	0.1	4.01	6.5E-5	Pelvic organ prolapse (moderate/severe)	
BRCA	cis	1	rs34333482	chr6:116855952	FAM26F	chr6:116782556-116784933:+	0.19	9.17	2.4E-19	Pelvic organ prolapse (moderate/severe)	
BRCA	cis	1	rs34339105	chr6:33723457	IP6K3	chr6:33689443-33714762:-	0.24	4.18	3.12E-5	Obesity (extreme)	
BRCA	cis	1	rs34344888	chr14:23387585	HAUS4	chr14:23415438-23426335:-	-0.29	-7.81	1.36E-14	Educational attainment (years of education)	
BRCA	cis	1	rs34344906	chr6:162993378	PACRG	chr6:163148164-163736523:+	0.24	4.43	1.04E-5	Body mass index	
BRCA	cis	1	rs34374560	chr20:23609462	CST1	chr20:23728191-23731574:-	0.22	4.65	3.73E-6	Chronic kidney disease	
BRCA	cis	1	rs34375435	chr2:75914044	C2orf3	chr2:75889834-75938111:-	-0.16	-4.23	2.48E-5	Hippocampal atrophy	
BRCA	cis	1	rs34382476	chr6:111744754	KIAA1919	chr6:111580482-111590259:+	0.32	4.45	9.34E-6	Psoriasis	
BRCA	cis	1	rs34394661	chr3:119279148	CD80	chr3:119243142-119278481:-	0.12	4.23	2.57E-5	Vitiligo	
BRCA	cis	1	rs34396223	chr1:95697828	RWDD3	chr1:95583479-95712773:+	0.24	3.74	0.000193	Stearic acid (18:0) plasma levels	
BRCA	cis	1	rs34398656	chr6:162999612	PACRG	chr6:163148164-163736523:+	0.22	4.26	2.22E-5	Body mass index	
BRCA	cis	1	rs34405766	chr2:135486189	TMEM163	chr2:135213331-135525334:-	-0.24	-4.94	8.87E-7	Gut microbiome composition (winter)	
BRCA	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.26	6.22	7.16E-10	Body mass index	
BRCA	cis	1	rs34434809	chr10:17187634	TRDMT1	chr10:17184983-17243681:-	-0.11	-3.45	0.000591	Homocysteine levels	
BRCA	cis	1	rs34443622	chr6:163208214	PACRG	chr6:163148164-163736523:+	0.22	3.63	0.000302	Body mass index	
BRCA	cis	1	rs34460651	chr6:33731312	IP6K3	chr6:33689443-33714762:-	0.27	4.68	3.17E-6	Obesity (extreme)	
BRCA	cis	1	rs34473788	chr1:27271519	GPATCH3	chr1:27216980-27226962:-	0.2	3.94	8.66E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs3448	chr3:49396751	AMT	chr3:49454212-49460012:-	0.14	4.69	3.12E-6	Menarche (age at onset)	
BRCA	cis	1	rs3448	chr3:49396751	CCDC36	chr3:49235861-49295537:+	0.1	3.93	8.91E-5	Menarche (age at onset)	
BRCA	cis	1	rs3448	chr3:49396751	NCKIPSD	chr3:48711280-48723334:-	0.15	3.89	0.000105	Menarche (age at onset)	
BRCA	cis	1	rs3448	chr3:49396751	P4HTM	chr3:49027341-49044579:+	0.1	4.29	1.96E-5	Menarche (age at onset)	
BRCA	cis	1	rs3448	chr3:49396751	WDR6	chr3:49044637-49053386:+	-0.13	-3.89	0.000109	Menarche (age at onset)	
BRCA	cis	1	rs34514856	chr1:27287560	GPATCH3	chr1:27216980-27226962:-	0.22	3.92	9.59E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs34523729	chr6:134184826	TCF21	chr6:134210259-134219157:+	0.16	4.27	2.12E-5	Coronary heart disease	
BRCA	cis	1	rs34529418	chr7:65403209	CCT6P1	chr7:65216092-65228661:+	0.33	7.28	6.44E-13	Diabetic kidney disease	
BRCA	cis	1	rs34529418	chr7:65403209	LOC493754	chr7:65993446-66057363:-	0.21	3.57	0.000374	Diabetic kidney disease	
BRCA	cis	1	rs34529418	chr7:65403209	ZNF117	chr7:64434830-64467121:-	-0.27	-4.93	9.41E-7	Diabetic kidney disease	
BRCA	cis	1	rs34532657	chr1:113300568	FAM19A3	chr1:113263189-113269854:+	0.2	6.16	1.01E-9	Hyperactive-impulsive symptoms	
BRCA	cis	1	rs34556682	chr1:27186149	GPATCH3	chr1:27216980-27226962:-	0.22	3.88	0.000112	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs34560516	chr7:65404092	CCT6P1	chr7:65216092-65228661:+	0.35	7.59	6.92E-14	Diabetic kidney disease	
BRCA	cis	1	rs34560516	chr7:65404092	LOC493754	chr7:65993446-66057363:-	0.2	3.46	0.000564	Diabetic kidney disease	
BRCA	cis	1	rs34560516	chr7:65404092	ZNF117	chr7:64434830-64467121:-	-0.27	-4.94	8.96E-7	Diabetic kidney disease	
BRCA	cis	1	rs34577383	chr7:65385726	CCT6P1	chr7:65216092-65228661:+	0.33	7.26	7.5E-13	Diabetic kidney disease	
BRCA	cis	1	rs34577383	chr7:65385726	LOC493754	chr7:65993446-66057363:-	0.21	3.56	0.000384	Diabetic kidney disease	
BRCA	cis	1	rs34577383	chr7:65385726	ZNF117	chr7:64434830-64467121:-	-0.27	-4.94	9.17E-7	Diabetic kidney disease	
BRCA	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.59	-18.47	2.49E-66	Response to antipsychotic treatment	
BRCA	cis	1	rs34583567	chr15:67983281	IQCH	chr15:67547188-67794139:+	0.14	4.96	8.29E-7	Motion sickness	
BRCA	cis	1	rs34586537	chr2:70163316	ANXA4	chr2:69969127-70053594:+	0.13	3.6	0.000328	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs34588175	chr4:17967114	NCAPG	chr4:17812525-17846485:+	0.1	4.43	1.05E-5	Height	
BRCA	cis	1	rs34591938	chr6:163087003	PACRG	chr6:163148164-163736523:+	0.26	4.6	4.79E-6	Body mass index	
BRCA	cis	1	rs34594435	chr7:72977249	MLXIPL	chr7:73007524-73038870:-	0.35	6.62	5.76E-11	Triglycerides	
BRCA	cis	1	rs34594856	chr6:163051845	PACRG	chr6:163148164-163736523:+	0.23	4.13	3.86E-5	Body mass index	
BRCA	cis	1	rs34614532	chr16:15132908	C16orf63	chr16:15959577-15982447:-	0.13	3.64	0.00028	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs34619021	chr6:163029767	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.01E-6	Body mass index	
BRCA	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.56	-17.8	3.0E-62	Response to antipsychotic treatment	
BRCA	cis	1	rs34629498	chr19:23060720	ZNF492	chr19:22817126-22850472:+	-0.22	-4.76	2.23E-6	Bronchopulmonary dysplasia	
BRCA	cis	1	rs34637087	chr6:163004064	PACRG	chr6:163148164-163736523:+	0.24	4.45	9.5E-6	Body mass index	
BRCA	cis	1	rs34637256	chr7:65360131	CCT6P1	chr7:65216092-65228661:+	0.32	6.9	9.12E-12	Diabetic kidney disease	
BRCA	cis	1	rs34637256	chr7:65360131	ZNF117	chr7:64434830-64467121:-	-0.27	-5.04	5.6E-7	Diabetic kidney disease	
BRCA	cis	1	rs34645895	chr20:25368373	FAM182A	chr20:26035250-26067552:+	0.21	5.59	2.83E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs34645895	chr20:25368373	FAM182B	chr20:25744102-25848786:-	-0.24	-6.4	2.26E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs34653853	chr6:163114362	PACRG	chr6:163148164-163736523:+	0.23	4.07	4.95E-5	Body mass index	
BRCA	cis	1	rs34667713	chr1:27292678	GPATCH3	chr1:27216980-27226962:-	0.22	3.92	9.55E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs34672838	chr8:15537996	TUSC3	chr8:15397730-15621993:+	0.22	4.89	1.16E-6	Pulmonary function decline	
BRCA	cis	1	rs34683079	chr4:17939302	NCAPG	chr4:17812525-17846485:+	0.09	3.96	7.92E-5	Height	
BRCA	cis	1	rs34697913	chr6:163000187	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.06E-6	Body mass index	
BRCA	cis	1	rs34698933	chr6:11146891	ERVFRDE1	chr6:11102724-11111959:-	0.17	4.43	1.02E-5	Heschl's gyrus morphology	
BRCA	cis	1	rs34700722	chr8:96021876	C8orf38	chr8:95908040-96088396:+	-0.14	-3.43	0.000632	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs34702770	chr7:65344823	CCT6P1	chr7:65216092-65228661:+	0.32	6.9	9.12E-12	Diabetic kidney disease	
BRCA	cis	1	rs34702770	chr7:65344823	ZNF117	chr7:64434830-64467121:-	-0.27	-5.04	5.6E-7	Diabetic kidney disease	
BRCA	cis	1	rs34703416	chr7:65300642	CCT6P1	chr7:65216092-65228661:+	0.31	6.7	3.37E-11	Diabetic kidney disease	
BRCA	cis	1	rs34703416	chr7:65300642	ZNF117	chr7:64434830-64467121:-	-0.27	-4.9	1.09E-6	Diabetic kidney disease	
BRCA	cis	1	rs34714518	chr6:163080778	PACRG	chr6:163148164-163736523:+	0.26	4.58	5.14E-6	Body mass index	
BRCA	cis	1	rs34725898	chr6:163127302	PACRG	chr6:163148164-163736523:+	0.25	4.28	2.05E-5	Body mass index	
BRCA	cis	1	rs34762726	chr3:49689210	AMT	chr3:49454212-49460012:-	0.11	3.5	0.000489	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs34762726	chr3:49689210	GMPPB	chr3:49758932-49761384:-	-0.12	-3.48	0.000514	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs34771104	chr4:39129052	KLHL5	chr4:39046659-39123828:+	-0.15	-4.58	5.28E-6	Uric acid levels	
BRCA	cis	1	rs34773528	chr6:163088796	PACRG	chr6:163148164-163736523:+	0.28	4.82	1.68E-6	Body mass index	
BRCA	cis	1	rs34781030	chr8:65641102	CYP7B1	chr8:65508529-65711348:-	0.12	3.8	0.00015	HIV-1 susceptibility	
BRCA	cis	1	rs34782690	chr8:65706044	CYP7B1	chr8:65508529-65711348:-	0.12	3.81	0.000144	HIV-1 susceptibility	
BRCA	cis	1	rs34785390	chr4:76534481	G3BP2	chr4:76567955-76598667:-	-0.12	-4.18	3.17E-5	Magnesium levels	
BRCA	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.36	-9.58	6.72E-21	Menarche (age at onset)	
BRCA	cis	1	rs34812189	chr6:56806727	KIAA1586	chr6:56911384-56920021:+	-0.21	-4.06	5.33E-5	Menarche (age at onset)	
BRCA	cis	1	rs34815098	chr7:65292254	CCT6P1	chr7:65216092-65228661:+	0.31	6.85	1.21E-11	Diabetic kidney disease	
BRCA	cis	1	rs34815098	chr7:65292254	LOC493754	chr7:65993446-66057363:-	0.2	3.5	0.000484	Diabetic kidney disease	
BRCA	cis	1	rs34815098	chr7:65292254	ZNF117	chr7:64434830-64467121:-	-0.26	-4.85	1.4E-6	Diabetic kidney disease	
BRCA	cis	1	rs34829812	chr10:96466073	HELLS	chr10:96305543-96361855:+	0.12	3.4	0.000687	Migraine	
BRCA	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.59	13.05	3.17E-36	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs34849118	chr2:240919912	NDUFA10	chr2:240900158-240964798:-	0.26	7.01	4.1E-12	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.57	-18.26	4.7E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs34853396	chr12:131519265	FZD10	chr12:130647032-130650284:+	0.14	3.51	0.000459	Longevity	
BRCA	cis	1	rs34865093	chr5:156424767	TIMD4	chr5:156346293-156390266:-	-0.15	-4	6.82E-5	Hypertriglyceridemia	
BRCA	cis	1	rs34869648	chr6:33724059	IP6K3	chr6:33689443-33714762:-	0.25	4.32	1.73E-5	Obesity (extreme)	
BRCA	cis	1	rs34878139	chr12:124446253	DNAH10	chr12:124247042-124420265:+	0.26	6.91	8.5E-12	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs34884883	chr6:33768726	IP6K3	chr6:33689443-33714762:-	0.27	4.8	1.86E-6	Obesity (extreme)	
BRCA	cis	1	rs34889675	chr1:37965851	SNIP1	chr1:38002145-38019903:-	-0.19	-3.75	0.000184	Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs34889971	chr1:27188057	GPATCH3	chr1:27216980-27226962:-	0.23	3.94	8.74E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs34894912	chr12:82228721	PPFIA2	chr12:81652880-82153109:-	0.13	3.38	0.000754	Resting heart rate	
BRCA	cis	1	rs34897231	chr20:23620268	CST1	chr20:23728191-23731574:-	0.24	5.14	3.32E-7	Chronic kidney disease	
BRCA	cis	1	rs34897866	chr2:231036754	SP110	chr2:231033645-231084827:-	0.21	3.97	7.67E-5	Obesity-related traits	
BRCA	cis	1	rs34910028	chr11:47758449	MADD	chr11:47290927-47351582:+	0.15	4.51	7.28E-6	Subjective well-being	
BRCA	cis	1	rs34910028	chr11:47758449	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.29	1.98E-5	Subjective well-being	
BRCA	cis	1	rs34910254	chr6:55963885	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs34918316	chr6:163005386	PACRG	chr6:163148164-163736523:+	0.24	4.43	1.03E-5	Body mass index	
BRCA	cis	1	rs34931503	chr6:163003876	PACRG	chr6:163148164-163736523:+	0.24	4.45	9.5E-6	Body mass index	
BRCA	cis	1	rs34933526	chr7:65383199	CCT6P1	chr7:65216092-65228661:+	0.34	7.43	2.18E-13	Diabetic kidney disease	
BRCA	cis	1	rs34933526	chr7:65383199	LOC493754	chr7:65993446-66057363:-	0.2	3.39	0.000714	Diabetic kidney disease	
BRCA	cis	1	rs34933526	chr7:65383199	ZNF117	chr7:64434830-64467121:-	-0.27	-5.04	5.54E-7	Diabetic kidney disease	
BRCA	cis	1	rs34934312	chr4:17950172	NCAPG	chr4:17812525-17846485:+	0.09	4.05	5.59E-5	Height	
BRCA	cis	1	rs34947476	chr2:135486150	TMEM163	chr2:135213331-135525334:-	-0.24	-4.85	1.43E-6	Gut microbiome composition (winter)	
BRCA	cis	1	rs34953792	chr20:55086281	C20orf43	chr20:55043647-55093942:+	0.17	4.68	3.17E-6	Refractive astigmatism	
BRCA	cis	1	rs34964872	chr14:104448435	TDRD9	chr14:104394817-104519002:+	0.43	10.81	6.6E-26	Bipolar disorder	
BRCA	cis	1	rs34970380	chr7:65431493	CCT6P1	chr7:65216092-65228661:+	0.35	7.59	6.94E-14	Diabetic kidney disease	
BRCA	cis	1	rs34970380	chr7:65431493	LOC493754	chr7:65993446-66057363:-	0.21	3.52	0.000447	Diabetic kidney disease	
BRCA	cis	1	rs34970380	chr7:65431493	ZNF117	chr7:64434830-64467121:-	-0.26	-4.83	1.54E-6	Diabetic kidney disease	
BRCA	cis	1	rs34974633	chr12:122503444	LRRC43	chr12:122652266-122688017:+	-0.16	-4.41	1.14E-5	Urate levels	
BRCA	cis	1	rs34974928	chr7:65364006	CCT6P1	chr7:65216092-65228661:+	0.31	6.88	1.01E-11	Diabetic kidney disease	
BRCA	cis	1	rs34974928	chr7:65364006	LOC493754	chr7:65993446-66057363:-	0.21	3.51	0.000474	Diabetic kidney disease	
BRCA	cis	1	rs34974928	chr7:65364006	ZNF117	chr7:64434830-64467121:-	-0.27	-4.9	1.11E-6	Diabetic kidney disease	
BRCA	cis	1	rs34976021	chr1:27298564	GPATCH3	chr1:27216980-27226962:-	0.18	3.61	0.000322	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs34983295	chr20:55079380	C20orf43	chr20:55043647-55093942:+	0.17	4.68	3.19E-6	Refractive astigmatism	
BRCA	cis	1	rs35000415	chr7:128585616	IRF5	chr7:128577769-128590086:+	0.17	3.49	0.000507	Systemic lupus erythematosus	
BRCA	cis	1	rs35008770	chr3:160334317	TRIM59	chr3:160153292-160167626:-	0.14	4.21	2.77E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs35017019	chr6:162982581	PACRG	chr6:163148164-163736523:+	0.25	4.59	4.89E-6	Body mass index	
BRCA	cis	1	rs35021342	chr1:27086227	PIGV	chr1:27114455-27124886:+	-0.23	-3.67	0.000253	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs35044651	chr6:163004142	PACRG	chr6:163148164-163736523:+	0.24	4.45	9.5E-6	Body mass index	
BRCA	cis	1	rs35046236	chr7:65408613	CCT6P1	chr7:65216092-65228661:+	0.34	7.49	1.42E-13	Diabetic kidney disease	
BRCA	cis	1	rs35046236	chr7:65408613	LOC493754	chr7:65993446-66057363:-	0.2	3.46	0.00056	Diabetic kidney disease	
BRCA	cis	1	rs35046236	chr7:65408613	ZNF117	chr7:64434830-64467121:-	-0.27	-4.95	8.45E-7	Diabetic kidney disease	
BRCA	cis	1	rs35058610	chr7:65390925	CCT6P1	chr7:65216092-65228661:+	0.34	7.4	2.66E-13	Diabetic kidney disease	
BRCA	cis	1	rs35058610	chr7:65390925	LOC493754	chr7:65993446-66057363:-	0.2	3.38	0.000754	Diabetic kidney disease	
BRCA	cis	1	rs35058610	chr7:65390925	ZNF117	chr7:64434830-64467121:-	-0.27	-5.04	5.33E-7	Diabetic kidney disease	
BRCA	cis	1	rs35059412	chr4:54996252	FIP1L1	chr4:54243820-54326102:+	-0.16	-3.72	0.000209	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.39	-10.4	3.34E-24	Forced vital capacity	
BRCA	cis	1	rs35068485	chr11:466032	RNH1	chr11:494512-507273:-	-0.2	-4.85	1.44E-6	Body mass index	
BRCA	cis	1	rs35081654	chr4:18017938	NCAPG	chr4:17812525-17846485:+	0.08	3.6	0.000332	Height	
BRCA	cis	1	rs35092540	chr6:163090778	PACRG	chr6:163148164-163736523:+	0.27	4.79	1.88E-6	Body mass index	
BRCA	cis	1	rs35106985	chr10:102307542	SEC31B	chr10:102246403-102289636:-	-0.29	-10.64	3.27E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs35108146	chr1:27248440	GPATCH3	chr1:27216980-27226962:-	0.22	3.99	6.94E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs35116118	chr4:39128913	KLHL5	chr4:39046659-39123828:+	-0.16	-4.8	1.85E-6	Uric acid levels	
BRCA	cis	1	rs35126854	chr6:163012443	PACRG	chr6:163148164-163736523:+	0.21	4.07	5.07E-5	Body mass index	
BRCA	cis	1	rs35151650	chr6:111757727	KIAA1919	chr6:111580482-111590259:+	0.32	4.51	7.31E-6	Psoriasis	
BRCA	cis	1	rs35160687	chr2:86472114	LOC90784	chr2:86247339-86250991:-	0.23	5.89	5.11E-9	Night sleep phenotypes	
BRCA	cis	1	rs35160687	chr2:86472114	ST3GAL5	chr2:86066271-86116157:-	0.13	3.68	0.000244	Night sleep phenotypes	
BRCA	cis	1	rs35162264	chr15:31200683	MTMR15	chr15:31196055-31235307:+	0.15	3.65	0.000276	Hypertriglyceridemia	
BRCA	cis	1	rs35172334	chr10:96497169	HELLS	chr10:96305543-96361855:+	0.12	3.43	0.000635	Migraine	
BRCA	cis	1	rs35174175	chr3:53041509	NT5DC2	chr3:52558386-52569093:-	-0.21	-4.33	1.61E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs35174175	chr3:53041509	RFT1	chr3:53122503-53164470:-	0.27	3.78	0.000167	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs35174175	chr3:53041509	TMEM110	chr3:52867139-52931547:-	0.27	4.15	3.63E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs35196908	chr8:65665988	CYP7B1	chr8:65508529-65711348:-	0.11	3.45	0.000584	HIV-1 susceptibility	
BRCA	cis	1	rs35198526	chr6:148941726	UST	chr6:149068271-149398125:+	0.36	6.49	1.34E-10	Migraine	
BRCA	cis	1	rs35202312	chr6:56788937	BEND6	chr6:56819773-56892138:+	-0.31	-8.79	6.03E-18	Menarche (age at onset)	
BRCA	cis	1	rs35202312	chr6:56788937	KIAA1586	chr6:56911384-56920021:+	-0.21	-4.32	1.7E-5	Menarche (age at onset)	
BRCA	cis	1	rs35208445	chr6:111756147	KIAA1919	chr6:111580482-111590259:+	0.32	4.51	7.31E-6	Psoriasis	
BRCA	cis	1	rs35210497	chr4:17985374	NCAPG	chr4:17812525-17846485:+	0.1	4.6	4.68E-6	Height	
BRCA	cis	1	rs35224452	chr4:122664677	EXOSC9	chr4:122722472-122738175:+	0.13	4.24	2.44E-5	Type 2 diabetes	
BRCA	cis	1	rs35248830	chr6:111756750	KIAA1919	chr6:111580482-111590259:+	0.32	4.51	7.31E-6	Psoriasis	
BRCA	cis	1	rs3525	chr1:110136846	AMIGO1	chr1:110049447-110052336:-	0.17	4.09	4.73E-5	Major depressive disorder	
BRCA	cis	1	rs3525	chr1:110136846	SYPL2	chr1:110009100-110024763:+	-0.15	-3.85	0.000126	Major depressive disorder	
BRCA	cis	1	rs35274562	chr6:33716831	IP6K3	chr6:33689443-33714762:-	0.24	4.17	3.29E-5	Obesity (extreme)	
BRCA	cis	1	rs35283677	chr7:65359233	CCT6P1	chr7:65216092-65228661:+	0.33	7.02	3.88E-12	Diabetic kidney disease	
BRCA	cis	1	rs35283677	chr7:65359233	LOC493754	chr7:65993446-66057363:-	0.2	3.38	0.00075	Diabetic kidney disease	
BRCA	cis	1	rs35283677	chr7:65359233	ZNF117	chr7:64434830-64467121:-	-0.27	-4.92	9.85E-7	Diabetic kidney disease	
BRCA	cis	1	rs35317957	chr4:17986863	NCAPG	chr4:17812525-17846485:+	0.1	4.6	4.68E-6	Height	
BRCA	cis	1	rs35328846	chr8:65660350	CYP7B1	chr8:65508529-65711348:-	0.12	3.8	0.000152	HIV-1 susceptibility	
BRCA	cis	1	rs35332070	chr19:23034266	ZNF492	chr19:22817126-22850472:+	-0.19	-4.25	2.35E-5	Bronchopulmonary dysplasia	
BRCA	cis	1	rs353464	chr5:176403023	MXD3	chr5:176732501-176739292:-	-0.09	-4.17	3.27E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs353464	chr5:176403023	PRELID1	chr5:176730835-176733949:+	-0.09	-3.48	0.000516	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs353467	chr5:176445698	MXD3	chr5:176732501-176739292:-	-0.09	-4.21	2.78E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs353468	chr5:176445494	MXD3	chr5:176732501-176739292:-	-0.09	-4.21	2.78E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs353478	chr5:176370988	MXD3	chr5:176732501-176739292:-	-0.08	-3.83	0.000135	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs35348660	chr4:17988635	NCAPG	chr4:17812525-17846485:+	0.1	4.7	2.94E-6	Height	
BRCA	cis	1	rs353490	chr5:176433063	MXD3	chr5:176732501-176739292:-	-0.09	-4.19	3.05E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs353490	chr5:176433063	PRELID1	chr5:176730835-176733949:+	-0.09	-3.56	0.000389	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs353493	chr5:176432585	MXD3	chr5:176732501-176739292:-	-0.09	-4.25	2.35E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs353493	chr5:176432585	PRELID1	chr5:176730835-176733949:+	-0.09	-3.52	0.000446	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs35383933	chr6:163002869	PACRG	chr6:163148164-163736523:+	0.25	4.62	4.38E-6	Body mass index	
BRCA	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.59	-19.35	9.57E-72	Response to antipsychotic treatment	
BRCA	cis	1	rs35391607	chr7:65360829	CCT6P1	chr7:65216092-65228661:+	0.31	6.88	1.01E-11	Diabetic kidney disease	
BRCA	cis	1	rs35391607	chr7:65360829	LOC493754	chr7:65993446-66057363:-	0.21	3.51	0.000474	Diabetic kidney disease	
BRCA	cis	1	rs35391607	chr7:65360829	ZNF117	chr7:64434830-64467121:-	-0.27	-4.9	1.11E-6	Diabetic kidney disease	
BRCA	cis	1	rs35393217	chr1:44101648	C1orf84	chr1:43855556-43878462:+	-0.15	-3.63	0.000293	Hypertension risk in short sleep duration	
BRCA	cis	1	rs35395156	chr15:67962763	IQCH	chr15:67547188-67794139:+	0.14	5	6.73E-7	Motion sickness	
BRCA	cis	1	rs35396113	chr7:65495461	CCT6P1	chr7:65216092-65228661:+	0.34	7.3	5.79E-13	Diabetic kidney disease	
BRCA	cis	1	rs35396113	chr7:65495461	LOC493754	chr7:65993446-66057363:-	0.21	3.52	0.000456	Diabetic kidney disease	
BRCA	cis	1	rs354033	chr7:149289464	C7orf29	chr7:150026938-150029808:+	-0.15	-3.59	0.000342	Multiple sclerosis	
BRCA	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.6	-18.93	4.05E-69	Response to antipsychotic treatment	
BRCA	cis	1	rs35421653	chr7:65363429	CCT6P1	chr7:65216092-65228661:+	0.33	7.02	3.88E-12	Diabetic kidney disease	
BRCA	cis	1	rs35421653	chr7:65363429	LOC493754	chr7:65993446-66057363:-	0.2	3.38	0.00075	Diabetic kidney disease	
BRCA	cis	1	rs35421653	chr7:65363429	ZNF117	chr7:64434830-64467121:-	-0.27	-4.92	9.85E-7	Diabetic kidney disease	
BRCA	cis	1	rs35424047	chr6:163029715	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.01E-6	Body mass index	
BRCA	cis	1	rs35429781	chr3:46253607	CCR5	chr3:46411633-46417690:+	-0.11	-4.37	1.38E-5	Celiac disease	
BRCA	cis	1	rs35432774	chr7:65393019	CCT6P1	chr7:65216092-65228661:+	0.32	7.1	2.35E-12	Diabetic kidney disease	
BRCA	cis	1	rs35432774	chr7:65393019	LOC493754	chr7:65993446-66057363:-	0.21	3.6	0.000334	Diabetic kidney disease	
BRCA	cis	1	rs35432774	chr7:65393019	ZNF117	chr7:64434830-64467121:-	-0.27	-5.09	4.32E-7	Diabetic kidney disease	
BRCA	cis	1	rs35437629	chr4:39133332	KLHL5	chr4:39046659-39123828:+	-0.14	-4.51	7.25E-6	Uric acid levels	
BRCA	cis	1	rs35445446	chr6:33716745	IP6K3	chr6:33689443-33714762:-	0.25	4.36	1.41E-5	Obesity (extreme)	
BRCA	cis	1	rs35449999	chr6:163023465	PACRG	chr6:163148164-163736523:+	0.25	4.56	5.67E-6	Body mass index	
BRCA	cis	1	rs354511	chr8:15534444	TUSC3	chr8:15397730-15621993:+	0.17	4.4	1.18E-5	Pulmonary function decline	
BRCA	cis	1	rs35454259	chr6:27254475	BTN3A2	chr6:26365398-26378546:+	-0.32	-8.29	3.32E-16	Schizophrenia	
BRCA	cis	1	rs35468353	chr16:31056433	HSD3B7	chr16:30996519-31000473:+	0.23	7.19	1.23E-12	Response to metformin (IC50)	
BRCA	cis	1	rs35468353	chr16:31056433	MYST1	chr16:31128985-31142713:+	0.2	7.38	3.17E-13	Response to metformin (IC50)	
BRCA	cis	1	rs35468353	chr16:31056433	ORAI3	chr16:30960405-30966258:+	0.1	3.54	0.000419	Response to metformin (IC50)	
BRCA	cis	1	rs35468353	chr16:31056433	SETD1A	chr16:30968615-30995981:+	0.11	3.46	0.000567	Response to metformin (IC50)	
BRCA	cis	1	rs35468353	chr16:31056433	ZNF689	chr16:30614701-30621682:-	0.11	3.52	0.000442	Response to metformin (IC50)	
BRCA	cis	1	rs35477332	chr5:42420637	CCDC152	chr5:42756920-42802539:+	-0.12	-3.88	0.000109	Systemic lupus erythematosus	
BRCA	cis	1	rs35477332	chr5:42420637	OXCT1	chr5:41730168-41870791:-	-0.12	-3.48	0.000512	Systemic lupus erythematosus	
BRCA	cis	1	rs35477332	chr5:42420637	SEPP1	chr5:42799983-42825998:-	-0.11	-3.38	0.000751	Systemic lupus erythematosus	
BRCA	cis	1	rs35488434	chr20:23620401	CST1	chr20:23728191-23731574:-	0.24	5.14	3.32E-7	Chronic kidney disease	
BRCA	cis	1	rs35511042	chr4:55009261	FIP1L1	chr4:54243820-54326102:+	-0.17	-3.77	0.000171	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs35527216	chr6:56791278	BEND6	chr6:56819773-56892138:+	-0.28	-7.82	1.22E-14	Menarche (age at onset)	
BRCA	cis	1	rs35527216	chr6:56791278	KIAA1586	chr6:56911384-56920021:+	-0.18	-3.87	0.000117	Menarche (age at onset)	
BRCA	cis	1	rs35542501	chr7:65431215	CCT6P1	chr7:65216092-65228661:+	0.33	7.38	3.11E-13	Diabetic kidney disease	
BRCA	cis	1	rs35542501	chr7:65431215	LOC493754	chr7:65993446-66057363:-	0.21	3.58	0.000356	Diabetic kidney disease	
BRCA	cis	1	rs35542501	chr7:65431215	ZNF117	chr7:64434830-64467121:-	-0.26	-4.85	1.39E-6	Diabetic kidney disease	
BRCA	cis	1	rs35565383	chr4:17984874	NCAPG	chr4:17812525-17846485:+	0.1	4.6	4.68E-6	Height	
BRCA	cis	1	rs35573827	chr2:64394433	C2orf86	chr2:63348537-63815851:-	-0.12	-3.68	0.000241	Neuroticism	
BRCA	cis	1	rs35573827	chr2:64394433	CEP68	chr2:65283495-65314141:+	-0.1	-3.47	0.000535	Neuroticism	
BRCA	cis	1	rs35574015	chr16:15146061	C16orf63	chr16:15959577-15982447:-	0.13	3.62	0.000305	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs35575481	chr6:163007746	PACRG	chr6:163148164-163736523:+	0.24	4.49	7.94E-6	Body mass index	
BRCA	cis	1	rs35587956	chr4:17944743	NCAPG	chr4:17812525-17846485:+	0.11	4.37	1.37E-5	Height	
BRCA	cis	1	rs35593189	chr11:18468378	LDHC	chr11:18433853-18472792:+	-0.29	-5.24	1.98E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs356203	chr4:90666041	MMRN1	chr4:90816003-90875778:+	-0.08	-3.43	0.000631	Parkinson's disease	
BRCA	cis	1	rs356219	chr4:90637601	MMRN1	chr4:90816003-90875778:+	-0.08	-3.48	0.000513	Parkinson's disease	
BRCA	cis	1	rs356220	chr4:90641340	MMRN1	chr4:90816003-90875778:+	-0.09	-3.66	0.000262	Parkinson's disease	
BRCA	cis	1	rs35624992	chr11:47615798	ACP2	chr11:47260854-47270457:-	0.14	3.47	0.00055	Subjective well-being	
BRCA	cis	1	rs35624992	chr11:47615798	MADD	chr11:47290927-47351582:+	0.14	4.4	1.2E-5	Subjective well-being	
BRCA	cis	1	rs35624992	chr11:47615798	MYBPC3	chr11:47352958-47374253:-	-0.15	-4.39	1.23E-5	Subjective well-being	
BRCA	cis	1	rs35632377	chr5:156436252	TIMD4	chr5:156346293-156390266:-	-0.16	-4.16	3.39E-5	Hypertriglyceridemia	
BRCA	cis	1	rs35646598	chr6:33717416	IP6K3	chr6:33689443-33714762:-	0.24	4.17	3.24E-5	Obesity (extreme)	
BRCA	cis	1	rs35659126	chr7:72988069	MLXIPL	chr7:73007524-73038870:-	0.35	6.78	1.98E-11	Triglycerides	
BRCA	cis	1	rs35682316	chr7:29181260	CPVL	chr7:29035249-29234892:-	-0.17	-5.04	5.51E-7	Diabetes related insulin traits	
BRCA	cis	1	rs35703976	chr2:135486350	TMEM163	chr2:135213331-135525334:-	-0.24	-4.94	8.87E-7	Gut microbiome composition (winter)	
BRCA	cis	1	rs35708663	chr6:148946347	UST	chr6:149068271-149398125:+	0.32	5.88	5.54E-9	Migraine	
BRCA	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.19	6.77E-37	Height	
BRCA	cis	1	rs35718987	chr3:134272783	CEP63	chr3:134204575-134293852:+	-0.14	-3.72	0.000212	Height	
BRCA	cis	1	rs35721478	chr6:33725129	IP6K3	chr6:33689443-33714762:-	0.26	4.43	1.06E-5	Obesity (extreme)	
BRCA	cis	1	rs35723993	chr6:163008197	PACRG	chr6:163148164-163736523:+	0.23	4.37	1.36E-5	Body mass index	
BRCA	cis	1	rs35734267	chr2:70281190	FAM136A	chr2:70523109-70529220:-	-0.11	-3.62	0.000307	Obesity-related traits	
BRCA	cis	1	rs35735127	chr7:65300423	CCT6P1	chr7:65216092-65228661:+	0.31	6.85	1.21E-11	Diabetic kidney disease	
BRCA	cis	1	rs35735127	chr7:65300423	LOC493754	chr7:65993446-66057363:-	0.2	3.5	0.000484	Diabetic kidney disease	
BRCA	cis	1	rs35735127	chr7:65300423	ZNF117	chr7:64434830-64467121:-	-0.26	-4.85	1.4E-6	Diabetic kidney disease	
BRCA	cis	1	rs35737577	chr3:53002557	NT5DC2	chr3:52558386-52569093:-	-0.18	-3.94	8.73E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs35737577	chr3:53002557	RFT1	chr3:53122503-53164470:-	0.25	3.78	0.000163	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs35737577	chr3:53002557	TMEM110	chr3:52867139-52931547:-	0.24	3.97	7.75E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.59	-19.35	9.57E-72	Response to antipsychotic treatment	
BRCA	cis	1	rs35764187	chr12:122505652	LRRC43	chr12:122652266-122688017:+	-0.16	-4.29	1.95E-5	Urate levels	
BRCA	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.58	-18.31	2.49E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs35808787	chr4:106681179	INTS12	chr4:106603787-106629881:-	-0.31	-3.85	0.000125	Post bronchodilator FEV1	
BRCA	cis	1	rs35818596	chr6:163001874	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.06E-6	Body mass index	
BRCA	cis	1	rs35820085	chr7:65442758	CCT6P1	chr7:65216092-65228661:+	0.35	7.53	1.08E-13	Diabetic kidney disease	
BRCA	cis	1	rs35820085	chr7:65442758	LOC493754	chr7:65993446-66057363:-	0.2	3.39	0.000718	Diabetic kidney disease	
BRCA	cis	1	rs35820085	chr7:65442758	ZNF117	chr7:64434830-64467121:-	-0.28	-5.01	6.41E-7	Diabetic kidney disease	
BRCA	cis	1	rs35820211	chr6:163046252	PACRG	chr6:163148164-163736523:+	0.23	4.1	4.51E-5	Body mass index	
BRCA	cis	1	rs35825738	chr7:65318027	CCT6P1	chr7:65216092-65228661:+	0.31	6.85	1.21E-11	Diabetic kidney disease	
BRCA	cis	1	rs35825738	chr7:65318027	LOC493754	chr7:65993446-66057363:-	0.2	3.5	0.000484	Diabetic kidney disease	
BRCA	cis	1	rs35825738	chr7:65318027	ZNF117	chr7:64434830-64467121:-	-0.26	-4.85	1.4E-6	Diabetic kidney disease	
BRCA	cis	1	rs35835884	chr10:127708468	UROS	chr10:127477148-127511837:-	-0.17	-4.93	9.41E-7	Visceral fat	
BRCA	cis	1	rs35837142	chr1:10322358	PGD	chr1:10459085-10480200:+	0.2	5.65	2.08E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs35849389	chr3:53005235	NT5DC2	chr3:52558386-52569093:-	-0.18	-3.94	8.73E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs35849389	chr3:53005235	RFT1	chr3:53122503-53164470:-	0.25	3.78	0.000163	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs35849389	chr3:53005235	TMEM110	chr3:52867139-52931547:-	0.24	3.97	7.75E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs35856111	chr6:111773468	KIAA1919	chr6:111580482-111590259:+	0.32	4.53	6.66E-6	Psoriasis	
BRCA	cis	1	rs35865480	chr1:8603777	RERE	chr1:8412466-8877699:-	0.1	3.43	0.000629	Vitiligo	
BRCA	cis	1	rs35868174	chr5:156425303	TIMD4	chr5:156346293-156390266:-	-0.15	-3.99	7.13E-5	Hypertriglyceridemia	
BRCA	cis	1	rs35889327	chr10:29802957	LOC387647	chr10:29698483-29776785:+	0.14	3.76	0.000177	Platelet thrombus formation	
BRCA	cis	1	rs35890695	chr9:98931655	C9orf130	chr9:98568372-98638259:-	0.15	3.53	0.000439	Glomerular filtration rate in chronic kidney disease	
BRCA	cis	1	rs35898083	chr11:484469	RNH1	chr11:494512-507273:-	-0.18	-4.35	1.48E-5	Body mass index	
BRCA	cis	1	rs35901586	chr4:122664757	EXOSC9	chr4:122722472-122738175:+	0.13	4.27	2.1E-5	Type 2 diabetes	
BRCA	cis	1	rs35902101	chr11:47795169	MADD	chr11:47290927-47351582:+	0.15	4.51	7.28E-6	Subjective well-being	
BRCA	cis	1	rs35902101	chr11:47795169	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.29	1.98E-5	Subjective well-being	
BRCA	cis	1	rs35911566	chr6:162994154	PACRG	chr6:163148164-163736523:+	0.24	4.43	1.04E-5	Body mass index	
BRCA	cis	1	rs35962879	chr1:27283456	GPATCH3	chr1:27216980-27226962:-	0.19	3.85	0.000128	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs35969145	chr1:27259392	GPATCH3	chr1:27216980-27226962:-	0.23	4.17	3.35E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs35974852	chr6:117229958	FAM162B	chr6:117073360-117086886:-	-0.1	-3.72	0.00021	Prostate cancer	
BRCA	cis	1	rs35974852	chr6:117229958	FAM26F	chr6:116782556-116784933:+	-0.08	-3.67	0.00025	Prostate cancer	
BRCA	cis	1	rs35977534	chr5:176335231	MXD3	chr5:176732501-176739292:-	-0.09	-4.42	1.09E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs35977534	chr5:176335231	PRELID1	chr5:176730835-176733949:+	-0.1	-3.67	0.000257	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs35988617	chr3:121432902	IQCB1	chr3:121488610-121553926:-	0.28	7.13	1.87E-12	Cognitive performance	
BRCA	cis	1	rs35988617	chr3:121432902	SLC15A2	chr3:121613171-121663034:+	-0.13	-3.83	0.000137	Cognitive performance	
BRCA	cis	1	rs36004835	chr15:67951542	IQCH	chr15:67547188-67794139:+	0.14	4.96	8.08E-7	Motion sickness	
BRCA	cis	1	rs36006749	chr3:38443312	XYLB	chr3:38388251-38456467:+	0.19	5.66	1.91E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs36006965	chr19:19830051	ZNF14	chr19:19821281-19843921:-	0.18	4.78	1.97E-6	Toenail selenium levels	
BRCA	cis	1	rs36007635	chr6:163009335	PACRG	chr6:163148164-163736523:+	0.23	4.37	1.36E-5	Body mass index	
BRCA	cis	1	rs36033484	chr7:65390558	CCT6P1	chr7:65216092-65228661:+	0.35	7.57	8.34E-14	Diabetic kidney disease	
BRCA	cis	1	rs36033484	chr7:65390558	LOC493754	chr7:65993446-66057363:-	0.21	3.47	0.000546	Diabetic kidney disease	
BRCA	cis	1	rs36033484	chr7:65390558	ZNF117	chr7:64434830-64467121:-	-0.27	-4.92	9.79E-7	Diabetic kidney disease	
BRCA	cis	1	rs36035949	chr6:109736614	SMPD2	chr6:109761931-109765121:+	0.22	6.78	1.95E-11	Height	
BRCA	cis	1	rs36042757	chr6:163004744	PACRG	chr6:163148164-163736523:+	0.21	4.09	4.61E-5	Body mass index	
BRCA	cis	1	rs360559	chr6:49659871	CRISP3	chr6:49695092-49712056:-	0.14	3.63	0.000291	Bone mineral density (hip) and age at menarche	
BRCA	cis	1	rs360560	chr6:49659634	CRISP3	chr6:49695092-49712056:-	0.14	3.63	0.000291	Bone mineral density (hip) and age at menarche	
BRCA	cis	1	rs360564	chr6:49658090	CRISP3	chr6:49695092-49712056:-	0.14	3.73	0.000204	Bone mineral density (hip) and age at menarche	
BRCA	cis	1	rs360565	chr6:49657805	CRISP3	chr6:49695092-49712056:-	0.14	3.7	0.000225	Bone mineral density (hip) and age at menarche	
BRCA	cis	1	rs36068983	chr7:65408991	CCT6P1	chr7:65216092-65228661:+	0.34	7.49	1.42E-13	Diabetic kidney disease	
BRCA	cis	1	rs36068983	chr7:65408991	LOC493754	chr7:65993446-66057363:-	0.2	3.46	0.00056	Diabetic kidney disease	
BRCA	cis	1	rs36068983	chr7:65408991	ZNF117	chr7:64434830-64467121:-	-0.27	-4.95	8.45E-7	Diabetic kidney disease	
BRCA	cis	1	rs36090629	chr4:39138815	KLHL5	chr4:39046659-39123828:+	-0.14	-4.33	1.63E-5	Uric acid levels	
BRCA	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.58	-18.34	1.51E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs36107456	chr6:162997399	PACRG	chr6:163148164-163736523:+	0.22	4.27	2.14E-5	Body mass index	
BRCA	cis	1	rs36113695	chr6:163004733	PACRG	chr6:163148164-163736523:+	0.24	4.45	9.5E-6	Body mass index	
BRCA	cis	1	rs36122085	chr6:33765255	IP6K3	chr6:33689443-33714762:-	0.29	5.01	6.38E-7	Obesity (extreme)	
BRCA	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.68	-20.31	8.36E-78	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs365132	chr5:176378574	MXD3	chr5:176732501-176739292:-	-0.09	-4.04	5.69E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs368512	chr6:13718126	RANBP9	chr6:13621731-13711796:-	-0.11	-3.48	0.000516	Breast cancer	
BRCA	cis	1	rs371729	chr6:13719129	RANBP9	chr6:13621731-13711796:-	-0.11	-3.63	0.000295	Breast cancer	
BRCA	cis	1	rs371883	chr5:122263970	SNX24	chr5:122181160-122344901:+	0.15	3.47	0.000535	Migraine	
BRCA	cis	1	rs372883	chr21:30717737	NCRNA00189	chr21:30565801-30660525:+	-0.13	-3.89	0.000107	Pancreatic cancer	
BRCA	cis	1	rs3729931	chr3:12626516	MKRN2	chr3:12598594-12625208:+	-0.15	-3.87	0.000114	Cardiac hypertrophy	
BRCA	cis	1	rs3730658	chr18:51794699	POLI	chr18:51795849-51824602:+	0.14	4.4	1.19E-5	Psoriasis	
BRCA	cis	1	rs3730682	chr18:51797332	POLI	chr18:51795849-51824602:+	0.13	4.18	3.18E-5	Psoriasis	
BRCA	cis	1	rs3730688	chr18:51797948	POLI	chr18:51795849-51824602:+	0.13	4.24	2.42E-5	Psoriasis	
BRCA	cis	1	rs3730721	chr18:51802928	POLI	chr18:51795849-51824602:+	0.13	4.22	2.71E-5	Psoriasis	
BRCA	cis	1	rs3730729	chr18:51804702	POLI	chr18:51795849-51824602:+	-0.14	-4.42	1.08E-5	Psoriasis	
BRCA	cis	1	rs3730758	chr18:51812048	POLI	chr18:51795849-51824602:+	0.13	4.14	3.7E-5	Psoriasis	
BRCA	cis	1	rs3730764	chr18:51812814	POLI	chr18:51795849-51824602:+	0.12	3.96	7.96E-5	Psoriasis	
BRCA	cis	1	rs3730767	chr18:51813363	POLI	chr18:51795849-51824602:+	0.13	4.2	2.9E-5	Psoriasis	
BRCA	cis	1	rs3730787	chr18:51815443	POLI	chr18:51795849-51824602:+	0.12	3.99	7.03E-5	Psoriasis	
BRCA	cis	1	rs3730814	chr18:51818901	POLI	chr18:51795849-51824602:+	0.13	4.26	2.19E-5	Psoriasis	
BRCA	cis	1	rs3730818	chr18:51819101	POLI	chr18:51795849-51824602:+	0.13	4.18	3.1E-5	Psoriasis	
BRCA	cis	1	rs3731714	chr2:202060820	PPIL3	chr2:201735680-201753999:-	0.32	7.76	1.92E-14	Trans fatty acid levels	
BRCA	cis	1	rs3732408	chr3:121421179	IQCB1	chr3:121488610-121553926:-	0.27	7.08	2.54E-12	Cognitive performance	
BRCA	cis	1	rs3732408	chr3:121421179	SLC15A2	chr3:121613171-121663034:+	-0.13	-3.86	0.00012	Cognitive performance	
BRCA	cis	1	rs3733202	chr4:103556861	MANBA	chr4:103552644-103682151:-	0.22	5.75	1.19E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs3733274	chr4:39122577	KLHL5	chr4:39046659-39123828:+	-0.15	-4.65	3.69E-6	Uric acid levels	
BRCA	cis	1	rs3733276	chr4:39116911	KLHL5	chr4:39046659-39123828:+	-0.16	-4.99	7.02E-7	Uric acid levels	
BRCA	cis	1	rs3733277	chr4:39117103	KLHL5	chr4:39046659-39123828:+	-0.16	-4.99	7.02E-7	Uric acid levels	
BRCA	cis	1	rs3733278	chr4:39117235	KLHL5	chr4:39046659-39123828:+	-0.16	-4.99	7.02E-7	Uric acid levels	
BRCA	cis	1	rs3733279	chr4:39117245	KLHL5	chr4:39046659-39123828:+	-0.16	-4.99	7.02E-7	Uric acid levels	
BRCA	cis	1	rs3734266	chr6:34823187	UHRF1BP1	chr6:34759794-34853117:+	0.14	3.51	0.000474	Systemic lupus erythematosus	
BRCA	cis	1	rs3734530	chr6:26195408	HIST1H3E	chr6:26224427-26226589:+	0.35	6.74	2.58E-11	Renal underexcretion gout;Gout	
BRCA	cis	1	rs3736582	chr10:124742895	PSTK	chr10:124739556-124749906:+	0.13	3.66	0.000264	Migraine without aura	
BRCA	cis	1	rs3736583	chr10:124742792	PSTK	chr10:124739556-124749906:+	0.13	3.66	0.000264	Migraine without aura	
BRCA	cis	1	rs3736584	chr10:124742683	PSTK	chr10:124739556-124749906:+	0.13	3.66	0.000264	Migraine without aura	
BRCA	cis	1	rs3736585	chr10:124742586	PSTK	chr10:124739556-124749906:+	0.13	3.72	0.000213	Migraine without aura	
BRCA	cis	1	rs3736781	chr6:26505362	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.58E-8	Educational attainment	
BRCA	cis	1	rs3736781	chr6:26505362	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.42	0.000651	Educational attainment	
BRCA	cis	1	rs3736782	chr6:26505403	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.58E-8	Educational attainment	
BRCA	cis	1	rs3736782	chr6:26505403	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.42	0.000651	Educational attainment	
BRCA	cis	1	rs3739034	chr2:135483381	TMEM163	chr2:135213331-135525334:-	0.24	5.2	2.43E-7	Gut microbiome composition (winter)	
BRCA	cis	1	rs3739036	chr2:135483534	TMEM163	chr2:135213331-135525334:-	0.25	5.46	6.05E-8	Gut microbiome composition (winter)	
BRCA	cis	1	rs3739843	chr9:131882961	SH3GLB2	chr9:131770314-131790579:-	-0.13	-4.8	1.83E-6	Blood metabolite ratios	
BRCA	cis	1	rs3739847	chr9:131911574	SH3GLB2	chr9:131770314-131790579:-	0.1	3.67	0.000257	Blood metabolite ratios	
BRCA	cis	1	rs3740367	chr10:96495266	C10orf129	chr10:96953957-96988685:+	0.29	4.98	7.41E-7	Blood metabolite levels	
BRCA	cis	1	rs3740711	chr11:18379839	GTF2H1	chr11:18343816-18388590:+	0.31	8.38	1.68E-16	Pancreatic cancer	
BRCA	cis	1	rs3740713	chr11:18451096	LDHC	chr11:18433853-18472792:+	-0.28	-4.59	4.87E-6	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.34	-12.56	8.04E-34	IgG glycosylation	
BRCA	cis	1	rs3742536	chr14:52507429	NID2	chr14:52471521-52535946:-	-0.08	-3.72	0.000209	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs3742704	chr14:88477882	GPR65	chr14:88471496-88478414:+	-0.12	-4.84	1.48E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs3742778	chr14:75538217	EIF2B2	chr14:75469612-75476292:+	-0.18	-5.16	2.95E-7	Height	
BRCA	cis	1	rs3742778	chr14:75538217	MLH3	chr14:75480467-75518235:-	-0.21	-6.61	6.19E-11	Height	
BRCA	cis	1	rs3745859	chr19:39196745	LGALS7	chr19:39261608-39264157:-	-0.18	-5.82	7.97E-9	Heart rate	
BRCA	cis	1	rs3745859	chr19:39196745	ZNF607	chr19:38187276-38210691:-	0.12	3.41	0.00068	Heart rate	
BRCA	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.48	13.76	8.43E-40	Schizophrenia	
BRCA	cis	1	rs3746722	chr20:1610939	SIRPG	chr20:1609798-1638425:-	0.06	3.48	0.000523	Type 1 diabetes	
BRCA	cis	1	rs3747113	chr22:24717518	POM121L9P	chr22:24647589-24661490:+	0.25	7.16	1.45E-12	Gut microbiome composition (summer)	
BRCA	cis	1	rs3747174	chr22:39069181	DDX17	chr22:38879445-38903665:-	-0.1	-3.39	0.000733	Resting heart rate	
BRCA	cis	1	rs3747174	chr22:39069181	JOSD1	chr22:39081549-39096459:-	-0.12	-4.06	5.24E-5	Resting heart rate	
BRCA	cis	1	rs3747174	chr22:39069181	TOMM22	chr22:39077954-39080763:+	-0.1	-3.45	0.000581	Resting heart rate	
BRCA	cis	1	rs3748578	chr1:10420918	PGD	chr1:10459085-10480200:+	-0.2	-5.8	8.51E-9	Hepatocellular carcinoma	
BRCA	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.58	12.99	6.52E-36	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs3748682	chr1:38279987	FHL3	chr1:38462444-38471234:-	0.08	3.47	0.000542	Hypothyroidism	
BRCA	cis	1	rs3749237	chr3:49770032	CCDC36	chr3:49235861-49295537:+	0.09	3.73	0.000199	Resting heart rate	
BRCA	cis	1	rs3749237	chr3:49770032	DALRD3	chr3:49052435-49058467:-	0.11	3.8	0.000154	Resting heart rate	
BRCA	cis	1	rs3749237	chr3:49770032	P4HTM	chr3:49027341-49044579:+	0.08	3.81	0.000149	Resting heart rate	
BRCA	cis	1	rs3749237	chr3:49770032	RBM6	chr3:49977592-50137484:+	-0.1	-3.38	0.000749	Resting heart rate	
BRCA	cis	1	rs3750626	chr10:102266316	SEC31B	chr10:102246403-102289636:-	-0.31	-11.68	9.09E-30	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3750627	chr10:102275642	SEC31B	chr10:102246403-102289636:-	-0.29	-10.95	1.64E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3750629	chr10:102275727	SEC31B	chr10:102246403-102289636:-	-0.3	-11.25	7.78E-28	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3750630	chr10:102275780	SEC31B	chr10:102246403-102289636:-	-0.29	-11.02	8.42E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3750633	chr10:102308214	SEC31B	chr10:102246403-102289636:-	-0.28	-9.93	2.78E-22	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3750719	chr10:102248950	SEC31B	chr10:102246403-102289636:-	-0.29	-10.25	1.35E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3750720	chr10:102248884	SEC31B	chr10:102246403-102289636:-	-0.28	-10.08	6.81E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3751237	chr12:27963507	LOC100133893	chr12:27915599-27924209:-	0.36	7.61	5.94E-14	Type 2 diabetes	
BRCA	cis	1	rs3752749	chr4:1737262	FAM53A	chr4:1641609-1685854:-	-0.2	-5.28	1.52E-7	Urinary bladder cancer;Bladder cancer	
BRCA	cis	1	rs3753037	chr1:10355834	PGD	chr1:10459085-10480200:+	0.2	5.68	1.75E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs3753242	chr1:2069681	SLC35E2	chr1:1590990-1677431:-	0.24	4.5	7.7E-6	Response to antipsychotic treatment in schizophrenia (reasoning)	
BRCA	cis	1	rs3754210	chr1:150954261	HORMAD1	chr1:150670542-150693352:-	-0.18	-4.33	1.66E-5	Congenital left-sided heart lesions	
BRCA	cis	1	rs3754439	chr1:110615094	ALX3	chr1:110602998-110613322:-	-0.14	-4.25	2.28E-5	Blood metabolite levels	
BRCA	cis	1	rs3754440	chr1:110613674	ALX3	chr1:110602998-110613322:-	-0.14	-4.22	2.7E-5	Blood metabolite levels	
BRCA	cis	1	rs3756766	chr5:137673167	CDC25C	chr5:137620959-137674044:-	-0.09	-3.47	0.000548	Schizophrenia	
BRCA	cis	1	rs3757135	chr6:26200707	HIST1H3E	chr6:26224427-26226589:+	0.35	6.96	5.76E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs3758086	chr8:23714992	STC1	chr8:23699434-23712320:-	0.18	4.65	3.72E-6	Glomerular filtration rate (creatinine)	
BRCA	cis	1	rs3758253	chr9:100700654	C9orf156	chr9:100666772-100684852:-	-0.16	-4.4	1.19E-5	Quantitative traits	
BRCA	cis	1	rs3758254	chr9:100701001	C9orf156	chr9:100666772-100684852:-	-0.16	-4.42	1.11E-5	Quantitative traits	
BRCA	cis	1	rs3758581	chr10:96602623	C10orf129	chr10:96953957-96988685:+	0.34	5.52	4.15E-8	Blood metabolite levels	
BRCA	cis	1	rs3759745	chr14:74962670	PTGR2	chr14:74318534-74352166:+	-0.14	-3.48	0.000527	Advanced glycation end-product levels	
BRCA	cis	1	rs3760982	chr19:44286513	ZNF155	chr19:44488355-44502477:+	-0.14	-3.86	0.000123	Breast cancer	
BRCA	cis	1	rs3760982	chr19:44286513	ZNF404	chr19:44376516-44384288:-	-0.22	-6.12	1.31E-9	Breast cancer	
BRCA	cis	1	rs3760983	chr19:44286660	ZNF155	chr19:44488355-44502477:+	0.14	3.78	0.000167	Breast cancer	
BRCA	cis	1	rs3760983	chr19:44286660	ZNF404	chr19:44376516-44384288:-	0.22	6.1	1.52E-9	Breast cancer	
BRCA	cis	1	rs3761117	chr20:25388070	FAM182A	chr20:26035250-26067552:+	0.21	5.69	1.62E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs3761117	chr20:25388070	FAM182B	chr20:25744102-25848786:-	-0.23	-6.13	1.25E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.23	12.37	6.23E-33	Type 1 diabetes autoantibodies	
BRCA	cis	1	rs3762567	chr2:207630338	MDH1B	chr2:207598943-207630050:-	-0.21	-4.66	3.63E-6	Height	
BRCA	cis	1	rs3763695	chr10:102269206	SEC31B	chr10:102246403-102289636:-	-0.31	-11.67	1.01E-29	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3763947	chr11:22835069	SVIP	chr11:22843600-22851382:-	-0.17	-3.5	0.000482	Dialysis-related mortality	
BRCA	cis	1	rs3768486	chr1:110123971	AMIGO1	chr1:110049447-110052336:-	0.17	3.96	7.83E-5	Major depressive disorder	
BRCA	cis	1	rs3768486	chr1:110123971	SYPL2	chr1:110009100-110024763:+	-0.15	-3.85	0.000126	Major depressive disorder	
BRCA	cis	1	rs3768707	chr2:215645135	BARD1	chr2:215593275-215674428:-	-0.12	-4.61	4.59E-6	Neuroblastoma	
BRCA	cis	1	rs3769693	chr2:99259346	UNC50	chr2:99225042-99234975:+	-0.22	-4.51	7.07E-6	Bipolar disorder	
BRCA	cis	1	rs3769694	chr2:99259239	UNC50	chr2:99225042-99234975:+	-0.22	-4.37	1.34E-5	Bipolar disorder	
BRCA	cis	1	rs3769696	chr2:99258927	UNC50	chr2:99225042-99234975:+	-0.23	-4.75	2.27E-6	Bipolar disorder	
BRCA	cis	1	rs3769697	chr2:99242580	UNC50	chr2:99225042-99234975:+	-0.2	-4.25	2.3E-5	Bipolar disorder	
BRCA	cis	1	rs3770066	chr2:86392350	LOC90784	chr2:86247339-86250991:-	-0.31	-4.23	2.54E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs3770066	chr2:86392350	ST3GAL5	chr2:86066271-86116157:-	0.31	4.55	6.03E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs3770089	chr2:86263815	MRPL35	chr2:86426556-86440476:+	0.29	3.41	0.000666	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs3770089	chr2:86263815	POLR1A	chr2:86253453-86333278:-	-0.25	-3.92	9.23E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs3770752	chr2:37576136	CEBPZ	chr2:37428778-37458740:-	0.23	7.1	2.22E-12	Schizophrenia	
BRCA	cis	1	rs3771531	chr2:70164034	ANXA4	chr2:69969127-70053594:+	-0.14	-3.93	8.98E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs3771564	chr2:242355701	ANO7	chr2:242127924-242164791:+	0.23	3.81	0.000149	Prostate cancer	
BRCA	cis	1	rs3771570	chr2:242382864	ANO7	chr2:242127924-242164791:+	0.22	3.66	0.000263	Prostate cancer	
BRCA	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.26	6.66	4.33E-11	Cognitive performance	
BRCA	cis	1	rs3772128	chr3:121345094	SLC15A2	chr3:121613171-121663034:+	-0.14	-4	6.77E-5	Cognitive performance	
BRCA	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.26	6.68	3.96E-11	Cognitive performance	
BRCA	cis	1	rs3772130	chr3:121344140	SLC15A2	chr3:121613171-121663034:+	-0.14	-4.07	5.08E-5	Cognitive performance	
BRCA	cis	1	rs3773621	chr3:150996434	P2RY14	chr3:150929905-150996230:-	-0.08	-3.71	0.000214	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
BRCA	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.52	14.28	1.87E-42	Diastolic blood pressure	
BRCA	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.29	-10.88	3.3E-26	Longevity	
BRCA	cis	1	rs3774957	chr4:103509025	MANBA	chr4:103552644-103682151:-	0.17	4.13	3.84E-5	Ulcerative colitis	
BRCA	cis	1	rs3775870	chr4:68446421	STAP1	chr4:68424446-68473053:+	-0.18	-6.19	8.41E-10	Parkinson's disease	
BRCA	cis	1	rs3778483	chr6:46627100	CYP39A1	chr6:46517445-46620523:-	-0.11	-3.6	0.000331	QRS complex (Sokolow-Lyon)	
BRCA	cis	1	rs3778483	chr6:46627100	SLC25A27	chr6:46620679-46645925:+	-0.14	-5.08	4.52E-7	QRS complex (Sokolow-Lyon)	
BRCA	cis	1	rs3778909	chr7:66255646	CRCP	chr7:65579805-65619551:+	-0.13	-3.53	0.000439	Aortic root size	
BRCA	cis	1	rs3778909	chr7:66255646	TYW1	chr7:66461817-66704496:+	0.14	3.69	0.000235	Aortic root size	
BRCA	cis	1	rs3780849	chr10:29804245	LOC387647	chr10:29698483-29776785:+	0.14	3.77	0.000171	Platelet thrombus formation	
BRCA	cis	1	rs3781001	chr10:127706028	UROS	chr10:127477148-127511837:-	-0.17	-4.91	1.07E-6	Visceral fat	
BRCA	cis	1	rs3782130	chr12:58161898	B4GALNT1	chr12:58019551-58026985:-	0.13	3.91	9.92E-5	Multiple sclerosis	
BRCA	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.41	10.18	2.79E-23	Multiple sclerosis	
BRCA	cis	1	rs3782130	chr12:58161898	SLC26A10	chr12:58013693-58019933:+	0.12	3.38	0.000764	Multiple sclerosis	
BRCA	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.33	-9.74	1.52E-21	Multiple sclerosis	
BRCA	cis	1	rs3782130	chr12:58161898	XRCC6BP1	chr12:58335445-58351051:+	-0.17	-4.77	2.09E-6	Multiple sclerosis	
BRCA	cis	1	rs3782707	chr12:107185187	C12orf23	chr12:107349544-107367811:+	-0.15	-3.73	0.000198	Social autistic-like traits	
BRCA	cis	1	rs3782707	chr12:107185187	MTERFD3	chr12:107371069-107380929:-	-0.15	-4.16	3.42E-5	Social autistic-like traits	
BRCA	cis	1	rs3782894	chr12:110026024	MYO1H	chr12:109826524-109886176:+	0.27	8.34	2.33E-16	HDL cholesterol	
BRCA	cis	1	rs3786835	chr19:39155880	LGALS7	chr19:39261608-39264157:-	-0.19	-5.92	4.38E-9	Heart rate	
BRCA	cis	1	rs3786845	chr19:39195083	LGALS7	chr19:39261608-39264157:-	-0.19	-5.84	6.93E-9	Heart rate	
BRCA	cis	1	rs3786845	chr19:39195083	ZNF607	chr19:38187276-38210691:-	0.13	3.52	0.000454	Heart rate	
BRCA	cis	1	rs3786848	chr19:39207329	LGALS4	chr19:39292312-39303740:-	-0.11	-3.49	0.000502	Heart rate	
BRCA	cis	1	rs3786848	chr19:39207329	LGALS7	chr19:39261608-39264157:-	-0.2	-6.32	3.85E-10	Heart rate	
BRCA	cis	1	rs3786851	chr19:39215333	LGALS4	chr19:39292312-39303740:-	-0.11	-3.47	0.000545	Heart rate	
BRCA	cis	1	rs3786851	chr19:39215333	LGALS7	chr19:39261608-39264157:-	-0.2	-6.23	6.78E-10	Heart rate	
BRCA	cis	1	rs3787395	chr20:55078573	C20orf43	chr20:55043647-55093942:+	-0.17	-4.76	2.22E-6	Refractive astigmatism	
BRCA	cis	1	rs3787498	chr20:23616781	CST1	chr20:23728191-23731574:-	0.23	4.92	1.02E-6	Chronic kidney disease	
BRCA	cis	1	rs3787499	chr20:23616807	CST1	chr20:23728191-23731574:-	0.23	4.86	1.32E-6	Chronic kidney disease	
BRCA	cis	1	rs3789967	chr12:124447339	DNAH10	chr12:124247042-124420265:+	0.26	6.82	1.48E-11	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs3790012	chr13:36773489	SOHLH2	chr13:36742347-36871992:-	0.19	5.08	4.47E-7	Glucose homeostasis traits	
BRCA	cis	1	rs3791185	chr1:107600869	PRMT6	chr1:107599267-107601907:+	0.2	3.79	0.00016	AIDS	
BRCA	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.68	-20.47	8.78E-79	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.68	-20.54	2.93E-79	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.7	-20.58	1.53E-79	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.68	-20.41	1.89E-78	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs379161	chr6:13717387	RANBP9	chr6:13621731-13711796:-	-0.11	-3.65	0.000272	Breast cancer	
BRCA	cis	1	rs3792112	chr2:234176609	SAG	chr2:234216309-234255701:+	0.13	4.05	5.53E-5	Crohn's disease	
BRCA	cis	1	rs3792527	chr3:38493212	XYLB	chr3:38388251-38456467:+	0.19	5.45	6.36E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs3793080	chr6:33767803	IP6K3	chr6:33689443-33714762:-	-0.2	-3.77	0.000173	Obesity (extreme)	
BRCA	cis	1	rs3793706	chr10:102269085	SEC31B	chr10:102246403-102289636:-	0.29	11	1.0E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3793771	chr10:102222957	SEC31B	chr10:102246403-102289636:-	-0.28	-10.58	6.18E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3793772	chr10:102222825	SEC31B	chr10:102246403-102289636:-	-0.28	-10.51	1.21E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs3795649	chr1:161931562	ATF6	chr1:161736084-161932960:+	-0.08	-3.38	0.000763	Parkinson's disease (age of onset)	
BRCA	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.57	-12.65	2.78E-34	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs3796093	chr2:242039198	MTERFD2	chr2:242034545-242041747:-	0.25	3.78	0.000167	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
BRCA	cis	1	rs3796104	chr2:160117045	WDSUB1	chr2:160092305-160143236:-	0.32	3.86	0.00012	Sudden cardiac arrest	
BRCA	cis	1	rs3796509	chr4:39110186	KLHL5	chr4:39046659-39123828:+	-0.16	-4.82	1.68E-6	Uric acid levels	
BRCA	cis	1	rs3796511	chr4:39122206	KLHL5	chr4:39046659-39123828:+	-0.15	-4.65	3.69E-6	Uric acid levels	
BRCA	cis	1	rs3796619	chr4:1095281	KIAA1530	chr4:1341104-1381836:+	0.11	3.74	0.000193	Recombination rate (males)	
BRCA	cis	1	rs3796689	chr4:185649866	CASP3	chr4:185548852-185570629:-	0.12	3.54	0.000424	Kawasaki disease	
BRCA	cis	1	rs3796689	chr4:185649866	CCDC111	chr4:185570767-185616112:+	0.13	3.66	0.000265	Kawasaki disease	
BRCA	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.42	-16.2	5.97E-53	Kawasaki disease	
BRCA	cis	1	rs3798390	chr6:117726553	ROS1	chr6:117609530-117747018:-	-0.15	-5.02	5.98E-7	Lung cancer	
BRCA	cis	1	rs3798393	chr6:117731968	ROS1	chr6:117609530-117747018:-	-0.15	-4.9	1.09E-6	Lung cancer	
BRCA	cis	1	rs3798394	chr6:117732362	ROS1	chr6:117609530-117747018:-	-0.14	-4.78	2.01E-6	Lung cancer	
BRCA	cis	1	rs3798867	chr6:84331841	SNAP91	chr6:84262607-84419127:-	0.12	3.62	0.00031	Schizophrenia	
BRCA	cis	1	rs3800457	chr6:34663598	UHRF1BP1	chr6:34759794-34853117:+	-0.16	-4.45	9.45E-6	Pubertal anthropometrics	
BRCA	cis	1	rs3800812	chr7:66223461	CRCP	chr7:65579805-65619551:+	-0.13	-3.54	0.00041	Aortic root size	
BRCA	cis	1	rs3800812	chr7:66223461	LOC493754	chr7:65993446-66057363:-	-0.13	-3.42	0.000661	Aortic root size	
BRCA	cis	1	rs3800812	chr7:66223461	TYW1	chr7:66461817-66704496:+	0.14	3.76	0.000178	Aortic root size	
BRCA	cis	1	rs3802681	chr10:104114328	PITX3	chr10:103989946-104001231:-	-0.12	-3.43	0.000637	QT interval	
BRCA	cis	1	rs3803106	chr12:62670895	FAM19A2	chr12:62102043-62653925:-	0.17	3.78	0.000168	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs3803575	chr16:15138447	C16orf63	chr16:15959577-15982447:-	0.14	3.97	7.7E-5	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs3804105	chr6:25612683	SCGN	chr6:25652429-25702006:+	0.19	5.21	2.23E-7	Uric acid levels	
BRCA	cis	1	rs3804106	chr6:25608374	HIST1H2BC	chr6:26114633-26124154:-	0.13	3.4	0.000695	Uric acid levels	
BRCA	cis	1	rs3804106	chr6:25608374	SCGN	chr6:25652429-25702006:+	0.2	5.51	4.57E-8	Uric acid levels	
BRCA	cis	1	rs3804108	chr6:25608215	HIST1H2BC	chr6:26114633-26124154:-	0.13	3.4	0.000695	Uric acid levels	
BRCA	cis	1	rs3804108	chr6:25608215	SCGN	chr6:25652429-25702006:+	0.2	5.51	4.57E-8	Uric acid levels	
BRCA	cis	1	rs3804109	chr6:25608009	HIST1H2BC	chr6:26114633-26124154:-	0.13	3.4	0.000695	Uric acid levels	
BRCA	cis	1	rs3804109	chr6:25608009	SCGN	chr6:25652429-25702006:+	0.2	5.51	4.57E-8	Uric acid levels	
BRCA	cis	1	rs3804118	chr6:25592651	HIST1H2BC	chr6:26114633-26124154:-	0.14	3.43	0.00063	Uric acid levels	
BRCA	cis	1	rs3804118	chr6:25592651	SCGN	chr6:25652429-25702006:+	0.22	5.9	4.99E-9	Uric acid levels	
BRCA	cis	1	rs3804508	chr6:52289961	EFHC1	chr6:52284994-52387892:+	0.16	4.19	3.03E-5	Atopic march	
BRCA	cis	1	rs3805383	chr4:56475338	SRD5A3	chr4:56212409-56237866:+	-0.16	-4.14	3.69E-5	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs3805389	chr4:56482750	SRD5A3	chr4:56212409-56237866:+	-0.17	-4.25	2.28E-5	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs3806107	chr6:33767413	IP6K3	chr6:33689443-33714762:-	0.23	4.22	2.62E-5	Obesity (extreme)	
BRCA	cis	1	rs3806407	chr1:156251742	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs3806407	chr1:156251742	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs3806408	chr1:156252137	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs3806408	chr1:156252137	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs3806409	chr1:156252291	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs3806409	chr1:156252291	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs3806988	chr6:49431569	CENPQ	chr6:49431096-49460820:+	-0.22	-7.33	4.46E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.34	10.68	2.35E-25	Folate pathway vitamin levels	
BRCA	cis	1	rs3808894	chr9:100686129	C9orf156	chr9:100666772-100684852:-	-0.17	-4.66	3.53E-6	Quantitative traits	
BRCA	cis	1	rs3809060	chr11:32458807	WIT1	chr11:32457285-32468261:+	-0.14	-3.69	0.000232	Inguinal hernia	
BRCA	cis	1	rs3809117	chr12:122630285	LRRC43	chr12:122652266-122688017:+	-0.18	-5.08	4.55E-7	Urate levels	
BRCA	cis	1	rs3809868	chr17:45750596	C17orf57	chr17:45401142-45518675:+	-0.29	-10.04	9.9E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs3809868	chr17:45750596	TBKBP1	chr17:45772630-45789427:+	0.14	4.26	2.19E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs3810174	chr19:41904165	B3GNT8	chr19:41931265-41934635:-	-0.23	-7.17	1.35E-12	Height	
BRCA	cis	1	rs3810175	chr19:41904396	B3GNT8	chr19:41931265-41934635:-	0.24	7.21	1.05E-12	Height	
BRCA	cis	1	rs3810176	chr19:49496786	RPS11	chr19:49999634-50002944:+	0.15	3.77	0.000171	Follicule stimulating hormone	
BRCA	cis	1	rs3811053	chr2:113830926	RABL2A	chr2:114384817-114400974:+	0.15	3.4	0.000687	Stroke	
BRCA	cis	1	rs3814184	chr10:69966251	PBLD	chr10:70042417-70092684:-	0.21	4.21	2.72E-5	Optic nerve measurement (disc area)	
BRCA	cis	1	rs3815292	chr2:242032762	MTERFD2	chr2:242034545-242041747:-	0.25	3.74	0.00019	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
BRCA	cis	1	rs3815475	chr2:160114315	WDSUB1	chr2:160092305-160143236:-	0.28	3.41	0.000668	Sudden cardiac arrest	
BRCA	cis	1	rs3815824	chr16:29852860	LOC440356	chr16:29875004-29879374:+	-0.28	-5.75	1.17E-8	Multiple sclerosis	
BRCA	cis	1	rs3816037	chr19:41918009	B3GNT8	chr19:41931265-41934635:-	-0.22	-6.71	3.11E-11	Height	
BRCA	cis	1	rs3816587	chr4:25417244	ZCCHC4	chr4:25314396-25372003:+	-0.11	-3.46	0.000568	Rheumatoid arthritis	
BRCA	cis	1	rs3816804	chr12:56680745	RPS26	chr12:56435686-56438005:+	0.28	4.29	1.93E-5	Height	
BRCA	cis	1	rs3818187	chr14:52509788	NID2	chr14:52471521-52535946:-	-0.08	-3.76	0.000178	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs3818233	chr6:101086372	ASCC3	chr6:100956609-101329224:-	-0.11	-4.38	1.29E-5	Menarche (age at onset)	
BRCA	cis	1	rs3818361	chr1:207784968	FAIM3	chr1:207076633-207096592:-	0.13	3.41	0.000674	Alzheimer's disease (late onset)	
BRCA	cis	1	rs3823114	chr6:49431720	CENPQ	chr6:49431096-49460820:+	-0.24	-8.01	2.95E-15	Folate pathway vitamin levels	
BRCA	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.33	10.42	2.92E-24	Folate pathway vitamin levels	
BRCA	cis	1	rs3824496	chr9:100684645	C9orf156	chr9:100666772-100684852:-	-0.17	-4.66	3.53E-6	Quantitative traits	
BRCA	cis	1	rs3824754	chr10:104614350	SFXN2	chr10:104474298-104498946:+	-0.25	-4.63	4.1E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs3824754	chr10:104614350	TMEM180	chr10:104221170-104238858:+	0.23	4.14	3.73E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs3824755	chr10:104595849	SFXN2	chr10:104474298-104498946:+	-0.2	-4.05	5.6E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.42	10.2	2.24E-23	Multiple sclerosis	
BRCA	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.36	-10.34	6.23E-24	Multiple sclerosis	
BRCA	cis	1	rs3825079	chr12:58203354	XRCC6BP1	chr12:58335445-58351051:+	-0.19	-5.3	1.43E-7	Multiple sclerosis	
BRCA	cis	1	rs3826656	chr19:51726613	CD33	chr19:51728335-51747115:+	-0.1	-4.18	3.16E-5	Alzheimer's disease	
BRCA	cis	1	rs3827066	chr20:44586023	PLTP	chr20:44527397-44540786:-	0.21	4.98	7.35E-7	Abdominal aortic aneurysm	
BRCA	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.47	-8.47	7.94E-17	Abdominal aortic aneurysm	
BRCA	cis	1	rs3827107	chr20:55070539	C20orf43	chr20:55043647-55093942:+	0.14	3.9	0.000102	Refractive astigmatism	
BRCA	cis	1	rs3827142	chr20:23617007	CST1	chr20:23728191-23731574:-	0.23	4.86	1.32E-6	Chronic kidney disease	
BRCA	cis	1	rs3827143	chr20:23619617	CST1	chr20:23728191-23731574:-	0.24	5.14	3.32E-7	Chronic kidney disease	
BRCA	cis	1	rs3827316	chr22:23468538	RTDR1	chr22:23401594-23484241:-	-0.17	-4.56	5.62E-6	Bone mineral density	
BRCA	cis	1	rs3827357	chr22:39079413	DDX17	chr22:38879445-38903665:-	-0.1	-3.47	0.000548	Resting heart rate	
BRCA	cis	1	rs3827357	chr22:39079413	JOSD1	chr22:39081549-39096459:-	-0.13	-4.28	2.02E-5	Resting heart rate	
BRCA	cis	1	rs3827357	chr22:39079413	TOMM22	chr22:39077954-39080763:+	-0.11	-3.75	0.000184	Resting heart rate	
BRCA	cis	1	rs3827500	chr6:25607908	HIST1H2BC	chr6:26114633-26124154:-	0.13	3.4	0.000695	Uric acid levels	
BRCA	cis	1	rs3827500	chr6:25607908	SCGN	chr6:25652429-25702006:+	0.2	5.51	4.57E-8	Uric acid levels	
BRCA	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.7	-20.54	2.88E-79	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs3828309	chr2:234180410	SAG	chr2:234216309-234255701:+	-0.13	-3.99	7.12E-5	Crohn's disease	
BRCA	cis	1	rs3829218	chr11:58331309	CNTF	chr11:58390146-58393203:+	0.18	3.72	0.000211	Lymphoma	
BRCA	cis	1	rs3829640	chr18:72174980	CNDP2	chr18:72163597-72188356:+	0.21	4.46	9.13E-6	Refractive error	
BRCA	cis	1	rs383402	chr7:65586653	CCT6P1	chr7:65216092-65228661:+	-0.28	-6.02	2.43E-9	Diabetic kidney disease	
BRCA	cis	1	rs383402	chr7:65586653	CRCP	chr7:65579805-65619551:+	0.24	4.05	5.39E-5	Diabetic kidney disease	
BRCA	cis	1	rs383402	chr7:65586653	LOC493754	chr7:65993446-66057363:-	-0.2	-3.38	0.000742	Diabetic kidney disease	
BRCA	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.44	14.67	1.67E-44	Height	
BRCA	cis	1	rs3846055	chr3:134203973	CEP63	chr3:134204575-134293852:+	0.16	4.27	2.17E-5	Height	
BRCA	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.43	14.46	2.02E-43	Height	
BRCA	cis	1	rs3846056	chr3:134227292	CEP63	chr3:134204575-134293852:+	0.15	4.2	2.89E-5	Height	
BRCA	cis	1	rs3846721	chr5:112754567	YTHDC2	chr5:112849410-112930979:+	-0.13	-3.89	0.000108	Cerebral amyloid angiopathy	
BRCA	cis	1	rs3846772	chr6:87237249	C6orf162	chr6:88032306-88052043:+	-0.15	-4.1	4.51E-5	Gut microbiome composition (winter)	
BRCA	cis	1	rs3846926	chr6:56092186	COL21A1	chr6:55921389-56258892:-	0.69	22.03	6.31E-89	Pulse pressure	
BRCA	cis	1	rs3847687	chr12:131525053	EP400	chr12:132434508-132565004:+	-0.11	-3.51	0.000471	Longevity	
BRCA	cis	1	rs3847688	chr12:131525310	FZD10	chr12:130647032-130650284:+	0.16	4.12	4.17E-5	Longevity	
BRCA	cis	1	rs3848129	chr15:50892064	SPPL2A	chr15:50999739-51057910:-	0.15	5.42	7.4E-8	QT interval	
BRCA	cis	1	rs3857043	chr4:89882590	SPP1	chr4:88896802-88904562:+	0.1	3.39	0.00073	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs3857610	chr6:56012458	COL21A1	chr6:55921389-56258892:-	-0.38	-7.06	2.95E-12	Psychosis (atypical)	
BRCA	cis	1	rs3857688	chr7:66127806	CRCP	chr7:65579805-65619551:+	0.13	3.38	0.000758	Aortic root size	
BRCA	cis	1	rs3857688	chr7:66127806	TYW1	chr7:66461817-66704496:+	-0.15	-4.02	6.33E-5	Aortic root size	
BRCA	cis	1	rs3858526	chr11:5959757	OR56A3	chr11:5968577-5969522:+	0.12	3.68	0.000247	DNA methylation (variation)	
BRCA	cis	1	rs3858526	chr11:5959757	UBQLNL	chr11:5535624-5537956:-	0.16	3.73	0.0002	DNA methylation (variation)	
BRCA	cis	1	rs3858527	chr11:5959848	OR56A3	chr11:5968577-5969522:+	0.11	3.66	0.000268	DNA methylation (variation)	
BRCA	cis	1	rs3858527	chr11:5959848	UBQLNL	chr11:5535624-5537956:-	0.16	3.72	0.000209	DNA methylation (variation)	
BRCA	cis	1	rs3862008	chr10:96619002	C10orf129	chr10:96953957-96988685:+	0.27	4.73	2.59E-6	Blood metabolite levels	
BRCA	cis	1	rs3862009	chr10:96619025	C10orf129	chr10:96953957-96988685:+	0.35	5.74	1.26E-8	Blood metabolite levels	
BRCA	cis	1	rs3864639	chr7:76738591	POMZP3	chr7:76239304-76256620:-	0.24	5.25	1.83E-7	Obesity-related traits	
BRCA	cis	1	rs3866330	chr3:49582994	AMT	chr3:49454212-49460012:-	0.14	4.68	3.29E-6	Menarche (age at onset)	
BRCA	cis	1	rs3866330	chr3:49582994	CCDC36	chr3:49235861-49295537:+	0.11	4	6.76E-5	Menarche (age at onset)	
BRCA	cis	1	rs3866330	chr3:49582994	GMPPB	chr3:49758932-49761384:-	-0.12	-3.49	0.000505	Menarche (age at onset)	
BRCA	cis	1	rs3866330	chr3:49582994	NCKIPSD	chr3:48711280-48723334:-	0.15	3.92	9.34E-5	Menarche (age at onset)	
BRCA	cis	1	rs3866330	chr3:49582994	P4HTM	chr3:49027341-49044579:+	0.09	3.91	9.81E-5	Menarche (age at onset)	
BRCA	cis	1	rs3866330	chr3:49582994	WDR6	chr3:49044637-49053386:+	-0.15	-4.52	6.77E-6	Menarche (age at onset)	
BRCA	cis	1	rs3870339	chr3:49536863	AMT	chr3:49454212-49460012:-	0.14	4.76	2.18E-6	Menarche (age at onset)	
BRCA	cis	1	rs3870339	chr3:49536863	CCDC36	chr3:49235861-49295537:+	0.1	3.94	8.84E-5	Menarche (age at onset)	
BRCA	cis	1	rs3870339	chr3:49536863	GMPPB	chr3:49758932-49761384:-	-0.12	-3.58	0.000353	Menarche (age at onset)	
BRCA	cis	1	rs3870339	chr3:49536863	NCKIPSD	chr3:48711280-48723334:-	0.16	4.01	6.48E-5	Menarche (age at onset)	
BRCA	cis	1	rs3870339	chr3:49536863	P4HTM	chr3:49027341-49044579:+	0.09	3.78	0.000168	Menarche (age at onset)	
BRCA	cis	1	rs3870339	chr3:49536863	WDR6	chr3:49044637-49053386:+	-0.15	-4.61	4.6E-6	Menarche (age at onset)	
BRCA	cis	1	rs3870341	chr3:49584745	AMT	chr3:49454212-49460012:-	0.14	4.67	3.47E-6	Menarche (age at onset)	
BRCA	cis	1	rs3870341	chr3:49584745	CCDC36	chr3:49235861-49295537:+	0.1	3.98	7.43E-5	Menarche (age at onset)	
BRCA	cis	1	rs3870341	chr3:49584745	GMPPB	chr3:49758932-49761384:-	-0.11	-3.41	0.000664	Menarche (age at onset)	
BRCA	cis	1	rs3870341	chr3:49584745	NCKIPSD	chr3:48711280-48723334:-	0.16	3.94	8.65E-5	Menarche (age at onset)	
BRCA	cis	1	rs3870341	chr3:49584745	P4HTM	chr3:49027341-49044579:+	0.09	3.91	9.91E-5	Menarche (age at onset)	
BRCA	cis	1	rs3870341	chr3:49584745	WDR6	chr3:49044637-49053386:+	-0.15	-4.57	5.53E-6	Menarche (age at onset)	
BRCA	cis	1	rs387676	chr7:65598220	CCT6P1	chr7:65216092-65228661:+	0.33	6.99	4.88E-12	Diabetic kidney disease	
BRCA	cis	1	rs387676	chr7:65598220	LOC493754	chr7:65993446-66057363:-	0.25	4.1	4.42E-5	Diabetic kidney disease	
BRCA	cis	1	rs3885839	chr7:65290403	CCT6P1	chr7:65216092-65228661:+	0.33	7.01	4.34E-12	Diabetic kidney disease	
BRCA	cis	1	rs3885839	chr7:65290403	LOC493754	chr7:65993446-66057363:-	0.2	3.38	0.000756	Diabetic kidney disease	
BRCA	cis	1	rs3885839	chr7:65290403	ZNF117	chr7:64434830-64467121:-	-0.27	-4.91	1.07E-6	Diabetic kidney disease	
BRCA	cis	1	rs3892630	chr19:33181484	NUDT19	chr19:33182867-33204701:+	0.24	5.38	9.25E-8	Red blood cell traits	
BRCA	cis	1	rs3892761	chr12:54070445	ATP5G2	chr12:54058945-54070512:-	0.09	3.41	0.000665	Height	
BRCA	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.24	-5.76	1.11E-8	Crohn's disease	
BRCA	cis	1	rs3905330	chr3:49550774	AMT	chr3:49454212-49460012:-	0.13	4.5	7.7E-6	Menarche (age at onset)	
BRCA	cis	1	rs3905330	chr3:49550774	CCDC36	chr3:49235861-49295537:+	0.1	3.75	0.000187	Menarche (age at onset)	
BRCA	cis	1	rs3905330	chr3:49550774	GMPPB	chr3:49758932-49761384:-	-0.13	-3.78	0.000168	Menarche (age at onset)	
BRCA	cis	1	rs3905330	chr3:49550774	NCKIPSD	chr3:48711280-48723334:-	0.15	3.91	9.93E-5	Menarche (age at onset)	
BRCA	cis	1	rs3905330	chr3:49550774	P4HTM	chr3:49027341-49044579:+	0.09	3.74	0.000197	Menarche (age at onset)	
BRCA	cis	1	rs3905330	chr3:49550774	WDR6	chr3:49044637-49053386:+	-0.15	-4.61	4.54E-6	Menarche (age at onset)	
BRCA	cis	1	rs3915165	chr3:119279351	CD80	chr3:119243142-119278481:-	0.12	4.27	2.09E-5	Vitiligo	
BRCA	cis	1	rs3915166	chr3:119279281	CD80	chr3:119243142-119278481:-	0.12	4.27	2.09E-5	Vitiligo	
BRCA	cis	1	rs3920455	chr12:91452184	KERA	chr12:91444273-91452131:-	-0.18	-4.43	1.02E-5	Diabetic kidney disease	
BRCA	cis	1	rs3923093	chr2:204798020	CD28	chr2:204571198-204602556:+	-0.09	-3.59	0.000349	Celiac disease	
BRCA	cis	1	rs3931020	chr1:75235317	CRYZ	chr1:75171175-75199092:-	-0.38	-10.3	8.88E-24	Resistin levels	
BRCA	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.41	13.73	1.2E-39	Height	
BRCA	cis	1	rs3932818	chr3:134206069	CEP63	chr3:134204575-134293852:+	0.16	4.47	8.53E-6	Height	
BRCA	cis	1	rs3933453	chr4:17636319	MED28	chr4:17616273-17629791:+	0.13	3.51	0.000463	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs3936203	chr2:241834654	C2orf54	chr2:241825466-241835573:-	-0.27	-7.64	4.68E-14	Urinary metabolites	
BRCA	cis	1	rs3950155	chr6:55936254	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.4E-12	Psychosis (atypical)	
BRCA	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.51	-13.16	9.12E-37	Type 2 diabetes	
BRCA	cis	1	rs396508	chr16:20682354	ACSM1	chr16:20634559-20709066:-	-0.45	-15.81	9.26E-51	Schizophrenia	
BRCA	cis	1	rs397119	chr20:25440187	FAM182A	chr20:26035250-26067552:+	-0.22	-5.95	3.74E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs397119	chr20:25440187	FAM182B	chr20:25744102-25848786:-	0.23	6.04	2.12E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs3976455	chr16:29861447	LOC440356	chr16:29875004-29879374:+	-0.28	-6.02	2.42E-9	Multiple sclerosis	
BRCA	cis	1	rs3979179	chr1:16306846	CLCNKA	chr1:16345370-16360544:+	0.21	5.44	6.65E-8	Dilated cardiomyopathy	
BRCA	cis	1	rs398036	chr20:25439850	FAM182A	chr20:26035250-26067552:+	-0.22	-5.95	3.74E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs398036	chr20:25439850	FAM182B	chr20:25744102-25848786:-	0.23	6.04	2.12E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs3981351	chr10:115515120	CASP7	chr10:115438935-115490662:+	0.27	7.22	9.88E-13	Obesity-related traits	
BRCA	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.47	-15.78	1.41E-50	Inflammatory skin disease	
BRCA	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.44	11.29	5.49E-28	Inflammatory skin disease	
BRCA	cis	1	rs3999544	chr6:26285867	BTN3A2	chr6:26365398-26378546:+	0.2	6.06	1.86E-9	Educational attainment	
BRCA	cis	1	rs400063	chr6:167386592	GPR31	chr6:167570361-167571319:-	-0.1	-3.38	0.000762	Crohn's disease	
BRCA	cis	1	rs400063	chr6:167386592	RNASET2	chr6:167343008-167412795:-	-0.14	-4.53	6.67E-6	Crohn's disease	
BRCA	cis	1	rs400736	chr1:8078309	PARK7	chr1:8021714-8045341:+	0.1	3.66	0.000263	Response to antidepressants and depression	
BRCA	cis	1	rs401166	chr20:25446308	FAM182A	chr20:26035250-26067552:+	-0.22	-5.79	9.42E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs401166	chr20:25446308	FAM182B	chr20:25744102-25848786:-	0.23	6.1	1.45E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs401166	chr20:25446308	PYGB	chr20:25228706-25278647:+	-0.13	-3.6	0.000334	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4013	chr4:103552813	MANBA	chr4:103552644-103682151:-	0.21	5.38	8.99E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs402418	chr7:65509469	CCT6P1	chr7:65216092-65228661:+	0.32	6.81	1.6E-11	Diabetic kidney disease	
BRCA	cis	1	rs402418	chr7:65509469	LOC493754	chr7:65993446-66057363:-	0.22	3.57	0.00038	Diabetic kidney disease	
BRCA	cis	1	rs40246	chr8:90765172	RIPK2	chr8:90769975-90803291:+	0.15	5.94	3.85E-9	Leprosy	
BRCA	cis	1	rs402511	chr5:176434440	MXD3	chr5:176732501-176739292:-	-0.09	-4.25	2.35E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs402511	chr5:176434440	PRELID1	chr5:176730835-176733949:+	-0.09	-3.53	0.000435	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs4037	chr10:97365820	ENTPD1	chr10:97471536-97637022:+	0.16	5.67	1.82E-8	Blood metabolite levels	
BRCA	cis	1	rs404394	chr20:25447896	FAM182A	chr20:26035250-26067552:+	-0.22	-5.75	1.17E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs404394	chr20:25447896	FAM182B	chr20:25744102-25848786:-	0.23	6.12	1.34E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs404394	chr20:25447896	PYGB	chr20:25228706-25278647:+	-0.13	-3.53	0.000426	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs40544	chr8:90781095	RIPK2	chr8:90769975-90803291:+	0.14	5.62	2.46E-8	Leprosy	
BRCA	cis	1	rs4057984	chr4:17957200	NCAPG	chr4:17812525-17846485:+	0.09	4.28	2.0E-5	Height	
BRCA	cis	1	rs4073846	chr1:46462881	CCDC163P	chr1:45960581-45965646:-	0.39	11.61	1.89E-29	Body mass index	
BRCA	cis	1	rs4073846	chr1:46462881	CCDC17	chr1:46085717-46089729:-	-0.11	-3.63	0.000296	Body mass index	
BRCA	cis	1	rs4073846	chr1:46462881	MUTYH	chr1:45794915-45806142:-	-0.13	-4.91	1.06E-6	Body mass index	
BRCA	cis	1	rs4076006	chr1:46438076	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.75	4.73E-30	Body mass index	
BRCA	cis	1	rs4076006	chr1:46438076	CCDC17	chr1:46085717-46089729:-	0.11	3.38	0.000746	Body mass index	
BRCA	cis	1	rs4076006	chr1:46438076	MUTYH	chr1:45794915-45806142:-	0.13	5.02	6.01E-7	Body mass index	
BRCA	cis	1	rs4078160	chr10:52565940	ASAH2B	chr10:52499696-52514567:+	-0.35	-7.37	3.39E-13	Urate levels in lean individuals	
BRCA	cis	1	rs408087	chr6:167398952	RNASET2	chr6:167343008-167412795:-	-0.13	-4.35	1.51E-5	Crohn's disease	
BRCA	cis	1	rs408918	chr6:167399282	RNASET2	chr6:167343008-167412795:-	-0.13	-4.03	5.95E-5	Crohn's disease	
BRCA	cis	1	rs410128	chr7:65603173	CCT6P1	chr7:65216092-65228661:+	0.32	6.43	1.94E-10	Diabetic kidney disease	
BRCA	cis	1	rs410128	chr7:65603173	CRCP	chr7:65579805-65619551:+	-0.22	-3.59	0.000348	Diabetic kidney disease	
BRCA	cis	1	rs4118325	chr1:107577832	PRMT6	chr1:107599267-107601907:+	0.21	4.36	1.43E-5	AIDS	
BRCA	cis	1	rs41266807	chr6:26199822	HIST1H3E	chr6:26224427-26226589:+	0.35	7.03	3.64E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs41271391	chr3:119278457	CD80	chr3:119243142-119278481:-	0.12	4.04	5.82E-5	Vitiligo	
BRCA	cis	1	rs41271393	chr3:119278693	CD80	chr3:119243142-119278481:-	0.12	4.17	3.28E-5	Vitiligo	
BRCA	cis	1	rs41271844	chr6:55988932	COL21A1	chr6:55921389-56258892:-	-0.38	-6.99	4.75E-12	Psychosis (atypical)	
BRCA	cis	1	rs41274152	chr7:128399231	OPN1SW	chr7:128412545-128415844:-	0.17	4.09	4.66E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
BRCA	cis	1	rs41275472	chr1:11876300	CLCN6	chr1:11866207-11907674:+	0.17	4.8	1.85E-6	QRS complex (12-leadsum)	
BRCA	cis	1	rs4130590	chr9:130107964	RPL12	chr9:130209955-130213684:-	-0.09	-3.5	0.00048	Bipolar disorder	
BRCA	cis	1	rs4130590	chr9:130107964	ZNF79	chr9:130186653-130207650:+	0.16	4.4	1.19E-5	Bipolar disorder	
BRCA	cis	1	rs41307935	chr1:27181067	GPATCH3	chr1:27216980-27226962:-	0.22	3.84	0.000133	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs4132601	chr7:50470604	FIGNL1	chr7:50511834-50518088:-	-0.11	-3.54	0.00041	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs4134342	chr8:65700156	CYP7B1	chr8:65508529-65711348:-	0.12	3.81	0.000144	HIV-1 susceptibility	
BRCA	cis	1	rs41343448	chr8:20271413	ATP6V1B2	chr8:20054704-20079205:+	0.19	4.09	4.7E-5	Preeclampsia	
BRCA	cis	1	rs41343448	chr8:20271413	INTS10	chr8:19674918-19709584:+	0.27	4.99	6.88E-7	Preeclampsia	
BRCA	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.9	9.16E-31	Body mass index	
BRCA	cis	1	rs4134386	chr1:46395089	MUTYH	chr1:45794915-45806142:-	0.13	4.93	9.66E-7	Body mass index	
BRCA	cis	1	rs4134504	chr2:102982223	IL18R1	chr2:102927962-103015215:+	0.12	3.46	0.000565	Serum protein levels (sST2)	
BRCA	cis	1	rs41363748	chr12:56696056	COQ10A	chr12:56660642-56664748:+	0.23	3.56	0.000393	Psoriasis vulgaris	
BRCA	cis	1	rs41363748	chr12:56696056	RPS26	chr12:56435686-56438005:+	0.24	3.51	0.000464	Psoriasis vulgaris	
BRCA	cis	1	rs41363748	chr12:56696056	SLC39A5	chr12:56623820-56631627:+	0.21	3.43	0.000626	Psoriasis vulgaris	
BRCA	cis	1	rs41392645	chr12:56696742	COQ10A	chr12:56660642-56664748:+	-0.28	-4.01	6.39E-5	Psoriasis vulgaris	
BRCA	cis	1	rs41392645	chr12:56696742	RPS26	chr12:56435686-56438005:+	-0.3	-3.87	0.000116	Psoriasis vulgaris	
BRCA	cis	1	rs41392645	chr12:56696742	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.71	0.00022	Psoriasis vulgaris	
BRCA	cis	1	rs4140574	chr6:56099424	COL21A1	chr6:55921389-56258892:-	0.67	21	3.4E-82	Pulse pressure	
BRCA	cis	1	rs4140575	chr6:56099222	COL21A1	chr6:55921389-56258892:-	0.69	21.72	6.34E-87	Pulse pressure	
BRCA	cis	1	rs41423244	chr12:56693520	COQ10A	chr12:56660642-56664748:+	0.31	4.22	2.71E-5	Psoriasis vulgaris	
BRCA	cis	1	rs41423244	chr12:56693520	RPS26	chr12:56435686-56438005:+	0.29	3.64	0.000289	Psoriasis vulgaris	
BRCA	cis	1	rs41423244	chr12:56693520	SLC39A5	chr12:56623820-56631627:+	0.25	3.69	0.000236	Psoriasis vulgaris	
BRCA	cis	1	rs4144081	chr2:70155482	ANXA4	chr2:69969127-70053594:+	-0.13	-3.74	0.000193	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs4144937	chr6:46628516	CYP39A1	chr6:46517445-46620523:-	-0.11	-3.59	0.000349	QRS complex (Sokolow-Lyon)	
BRCA	cis	1	rs4144937	chr6:46628516	SLC25A27	chr6:46620679-46645925:+	-0.14	-5.05	5.25E-7	QRS complex (Sokolow-Lyon)	
BRCA	cis	1	rs4145008	chr7:65647511	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.38	2.6E-10	Diabetic kidney disease	
BRCA	cis	1	rs4145008	chr7:65647511	CRCP	chr7:65579805-65619551:+	0.21	3.58	0.000354	Diabetic kidney disease	
BRCA	cis	1	rs4145008	chr7:65647511	LOC493754	chr7:65993446-66057363:-	-0.22	-3.78	0.000167	Diabetic kidney disease	
BRCA	cis	1	rs41455648	chr4:119718030	METTL14	chr4:119606574-119632075:+	-0.19	-3.39	0.000721	Cannabis dependence	
BRCA	cis	1	rs4147024	chr3:38456664	LOC100128640	chr3:38492524-38496311:-	0.13	3.48	0.000528	Electrocardiographic conduction measures	
BRCA	cis	1	rs4147024	chr3:38456664	XYLB	chr3:38388251-38456467:+	0.21	6.06	1.9E-9	Electrocardiographic conduction measures	
BRCA	cis	1	rs4147025	chr3:38456531	LOC100128640	chr3:38492524-38496311:-	0.13	3.53	0.000431	Electrocardiographic conduction measures	
BRCA	cis	1	rs4147025	chr3:38456531	XYLB	chr3:38388251-38456467:+	0.21	6.11	1.37E-9	Electrocardiographic conduction measures	
BRCA	cis	1	rs4149468	chr7:65825690	CCT6P1	chr7:65216092-65228661:+	0.31	6.69	3.59E-11	Diabetic kidney disease	
BRCA	cis	1	rs4149468	chr7:65825690	CRCP	chr7:65579805-65619551:+	-0.2	-3.44	0.000615	Diabetic kidney disease	
BRCA	cis	1	rs4149468	chr7:65825690	LOC493754	chr7:65993446-66057363:-	0.24	4.03	6.06E-5	Diabetic kidney disease	
BRCA	cis	1	rs4149547	chr2:240933308	NDUFA10	chr2:240900158-240964798:-	0.28	7.44	2.04E-13	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs4149551	chr2:240921463	NDUFA10	chr2:240900158-240964798:-	0.26	6.85	1.21E-11	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs4149556	chr2:240915307	NDUFA10	chr2:240900158-240964798:-	0.25	6.52	1.11E-10	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs4149556	chr2:240915307	PP14571	chr2:241388732-241396117:-	-0.13	-3.49	0.000497	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs4150550	chr11:18350898	GTF2H1	chr11:18343816-18388590:+	0.3	8.18	8.08E-16	Pancreatic cancer	
BRCA	cis	1	rs4150562	chr11:18354995	GTF2H1	chr11:18343816-18388590:+	0.31	8.32	2.6E-16	Pancreatic cancer	
BRCA	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.3	7.79	1.59E-14	Pancreatic cancer	
BRCA	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.3	8.12	1.23E-15	Pancreatic cancer	
BRCA	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.3	8.08	1.79E-15	Pancreatic cancer	
BRCA	cis	1	rs4150579	chr11:18357180	GTF2H1	chr11:18343816-18388590:+	-0.31	-8.41	1.31E-16	Pancreatic cancer	
BRCA	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.29	7.7	2.99E-14	Pancreatic cancer	
BRCA	cis	1	rs4150612	chr11:18364358	GTF2H1	chr11:18343816-18388590:+	0.3	8.04	2.43E-15	Pancreatic cancer	
BRCA	cis	1	rs4150615	chr11:18365028	GTF2H1	chr11:18343816-18388590:+	-0.29	-7.83	1.13E-14	Pancreatic cancer	
BRCA	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.31	8.21	6.09E-16	Pancreatic cancer	
BRCA	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.3	8.21	6.52E-16	Pancreatic cancer	
BRCA	cis	1	rs4150650	chr11:18374279	GTF2H1	chr11:18343816-18388590:+	0.31	8.41	1.32E-16	Pancreatic cancer	
BRCA	cis	1	rs4150651	chr11:18374425	GTF2H1	chr11:18343816-18388590:+	0.3	8.18	7.95E-16	Pancreatic cancer	
BRCA	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.3	-8.07	1.85E-15	Pancreatic cancer	
BRCA	cis	1	rs4150661	chr11:18379629	GTF2H1	chr11:18343816-18388590:+	0.31	8.27	3.81E-16	Pancreatic cancer	
BRCA	cis	1	rs4150673	chr11:18383449	GTF2H1	chr11:18343816-18388590:+	0.31	8.33	2.44E-16	Pancreatic cancer	
BRCA	cis	1	rs416131	chr6:167406544	RNASET2	chr6:167343008-167412795:-	0.15	4.8	1.86E-6	Crohn's disease	
BRCA	cis	1	rs418720	chr6:13718399	RANBP9	chr6:13621731-13711796:-	-0.11	-3.55	0.000395	Breast cancer	
BRCA	cis	1	rs419603	chr7:65597341	CCT6P1	chr7:65216092-65228661:+	0.33	6.97	5.42E-12	Diabetic kidney disease	
BRCA	cis	1	rs419603	chr7:65597341	LOC493754	chr7:65993446-66057363:-	0.25	4.11	4.33E-5	Diabetic kidney disease	
BRCA	cis	1	rs420259	chr16:23634026	COG7	chr16:23399816-23464503:-	-0.12	-3.99	7.17E-5	Bipolar disorder	
BRCA	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.27	-7.58	7.71E-14	Bipolar disorder	
BRCA	cis	1	rs422164	chr7:65586605	CCT6P1	chr7:65216092-65228661:+	0.33	6.99	4.96E-12	Diabetic kidney disease	
BRCA	cis	1	rs422164	chr7:65586605	LOC493754	chr7:65993446-66057363:-	0.24	4.01	6.49E-5	Diabetic kidney disease	
BRCA	cis	1	rs422424	chr20:25445446	FAM182A	chr20:26035250-26067552:+	-0.22	-5.79	9.42E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs422424	chr20:25445446	FAM182B	chr20:25744102-25848786:-	0.23	6.1	1.45E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs422424	chr20:25445446	PYGB	chr20:25228706-25278647:+	-0.13	-3.6	0.000334	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs422562	chr6:167406318	RNASET2	chr6:167343008-167412795:-	-0.14	-4.33	1.67E-5	Crohn's disease	
BRCA	cis	1	rs422844	chr20:25445591	FAM182A	chr20:26035250-26067552:+	-0.22	-5.79	9.42E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs422844	chr20:25445591	FAM182B	chr20:25744102-25848786:-	0.23	6.1	1.45E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs422844	chr20:25445591	PYGB	chr20:25228706-25278647:+	-0.13	-3.6	0.000334	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.37	9.59	5.72E-21	Forced vital capacity	
BRCA	cis	1	rs4241407	chr3:49600319	AMT	chr3:49454212-49460012:-	0.14	5	6.55E-7	Menarche (age at onset)	
BRCA	cis	1	rs4241407	chr3:49600319	CCDC36	chr3:49235861-49295537:+	0.1	3.93	8.99E-5	Menarche (age at onset)	
BRCA	cis	1	rs4241407	chr3:49600319	NCKIPSD	chr3:48711280-48723334:-	0.16	4.17	3.35E-5	Menarche (age at onset)	
BRCA	cis	1	rs4241407	chr3:49600319	P4HTM	chr3:49027341-49044579:+	0.1	4.27	2.11E-5	Menarche (age at onset)	
BRCA	cis	1	rs4241407	chr3:49600319	WDR6	chr3:49044637-49053386:+	-0.14	-4.15	3.57E-5	Menarche (age at onset)	
BRCA	cis	1	rs4244338	chr10:102272802	SEC31B	chr10:102246403-102289636:-	-0.3	-11.23	1.02E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4244350	chr10:104008751	C10orf32	chr10:104613967-104624718:+	0.11	4.06	5.22E-5	QT interval	
BRCA	cis	1	rs4244350	chr10:104008751	PITX3	chr10:103989946-104001231:-	0.12	3.57	0.000371	QT interval	
BRCA	cis	1	rs4244351	chr10:104008870	C10orf32	chr10:104613967-104624718:+	0.11	3.93	8.95E-5	QT interval	
BRCA	cis	1	rs4244351	chr10:104008870	PITX3	chr10:103989946-104001231:-	0.12	3.44	0.0006	QT interval	
BRCA	cis	1	rs42490	chr8:90778513	RIPK2	chr8:90769975-90803291:+	0.15	5.7	1.52E-8	Leprosy	
BRCA	cis	1	rs4256922	chr10:52568616	ASAH2B	chr10:52499696-52514567:+	-0.35	-7.4	2.68E-13	Urate levels in lean individuals	
BRCA	cis	1	rs4260737	chr6:163137746	PACRG	chr6:163148164-163736523:+	0.25	4.25	2.37E-5	Body mass index	
BRCA	cis	1	rs4261185	chr10:29803931	LOC387647	chr10:29698483-29776785:+	0.14	3.76	0.000177	Platelet thrombus formation	
BRCA	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.41	-11.23	9.96E-28	Plasma amyloid beta peptide concentrations (ABx-40)	
BRCA	cis	1	rs42648	chr7:89977760	GTPBP10	chr7:89969690-90016650:+	0.17	4.69	3.11E-6	Homocysteine levels	
BRCA	cis	1	rs42649	chr7:89977789	GTPBP10	chr7:89969690-90016650:+	0.17	4.81	1.7E-6	Homocysteine levels	
BRCA	cis	1	rs42656	chr7:89981636	GTPBP10	chr7:89969690-90016650:+	0.17	4.8	1.8E-6	Homocysteine levels	
BRCA	cis	1	rs42658	chr7:89981915	GTPBP10	chr7:89969690-90016650:+	0.16	4.53	6.5E-6	Homocysteine levels	
BRCA	cis	1	rs42658	chr7:89981915	STEAP1	chr7:89783689-89794140:+	-0.13	-3.51	0.000464	Homocysteine levels	
BRCA	cis	1	rs4267943	chr6:49439805	CENPQ	chr6:49431096-49460820:+	0.26	8.34	2.29E-16	Folate pathway vitamin levels	
BRCA	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.29	-8.85	3.6E-18	Folate pathway vitamin levels	
BRCA	cis	1	rs427044	chr7:65508545	CCT6P1	chr7:65216092-65228661:+	0.33	7	4.65E-12	Diabetic kidney disease	
BRCA	cis	1	rs427044	chr7:65508545	LOC493754	chr7:65993446-66057363:-	0.22	3.6	0.000335	Diabetic kidney disease	
BRCA	cis	1	rs4272382	chr8:8433488	ERI1	chr8:8860314-8890849:+	-0.37	-6.78	1.94E-11	Response to cytidine analogues (gemcitabine)	
BRCA	cis	1	rs4272382	chr8:8433488	PPP1R3B	chr8:8993774-9009084:-	-0.2	-3.72	0.000209	Response to cytidine analogues (gemcitabine)	
BRCA	cis	1	rs4272382	chr8:8433488	TNKS	chr8:9413445-9639855:+	-0.28	-5.88	5.45E-9	Response to cytidine analogues (gemcitabine)	
BRCA	cis	1	rs4279493	chr7:66226620	CRCP	chr7:65579805-65619551:+	-0.13	-3.54	0.00041	Aortic root size	
BRCA	cis	1	rs4279493	chr7:66226620	LOC493754	chr7:65993446-66057363:-	-0.13	-3.42	0.000661	Aortic root size	
BRCA	cis	1	rs4279493	chr7:66226620	TYW1	chr7:66461817-66704496:+	0.14	3.76	0.000178	Aortic root size	
BRCA	cis	1	rs4280164	chr14:24771285	ADCY4	chr14:24787571-24804277:-	0.12	4.78	2.03E-6	Parent of origin effect on language impairment (paternal)	
BRCA	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.2	-5.04	5.54E-7	Longevity	
BRCA	cis	1	rs4283605	chr3:49678651	AMT	chr3:49454212-49460012:-	0.11	3.53	0.000428	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs4283605	chr3:49678651	GMPPB	chr3:49758932-49761384:-	-0.12	-3.4	0.000709	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs428445	chr20:55036547	C20orf43	chr20:55043647-55093942:+	-0.15	-4.15	3.65E-5	Refractive astigmatism	
BRCA	cis	1	rs4293565	chr2:241834770	C2orf54	chr2:241825466-241835573:-	0.25	6.71	3.24E-11	Urinary metabolites	
BRCA	cis	1	rs4295483	chr6:55965456	COL21A1	chr6:55921389-56258892:-	-0.36	-6.71	3.25E-11	Psychosis (atypical)	
BRCA	cis	1	rs4295484	chr6:55965646	COL21A1	chr6:55921389-56258892:-	-0.37	-6.82	1.48E-11	Psychosis (atypical)	
BRCA	cis	1	rs4297570	chr13:36755179	SOHLH2	chr13:36742347-36871992:-	-0.18	-4.95	8.8E-7	Glucose homeostasis traits	
BRCA	cis	1	rs4307563	chr1:16313788	CLCNKA	chr1:16345370-16360544:+	-0.22	-5.47	5.66E-8	Dilated cardiomyopathy	
BRCA	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.42	13.98	6.92E-41	Height	
BRCA	cis	1	rs4309773	chr3:134277301	CEP63	chr3:134204575-134293852:+	0.15	4	6.88E-5	Height	
BRCA	cis	1	rs4310508	chr10:65138573	NRBF2	chr10:64893007-64914785:+	-0.15	-5.56	3.36E-8	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs431076	chr7:65600320	CCT6P1	chr7:65216092-65228661:+	0.33	6.99	4.83E-12	Diabetic kidney disease	
BRCA	cis	1	rs431076	chr7:65600320	LOC493754	chr7:65993446-66057363:-	0.24	3.97	7.79E-5	Diabetic kidney disease	
BRCA	cis	1	rs4311055	chr2:241821017	C2orf54	chr2:241825466-241835573:-	0.26	7.49	1.47E-13	Urinary metabolites	
BRCA	cis	1	rs431264	chr8:90777510	RIPK2	chr8:90769975-90803291:+	0.15	5.71	1.5E-8	Leprosy	
BRCA	cis	1	rs431318	chr7:65511597	CCT6P1	chr7:65216092-65228661:+	0.32	6.8	1.69E-11	Diabetic kidney disease	
BRCA	cis	1	rs431318	chr7:65511597	LOC493754	chr7:65993446-66057363:-	0.22	3.56	0.000382	Diabetic kidney disease	
BRCA	cis	1	rs431328	chr19:22222236	ZNF257	chr19:22235266-22273901:+	0.18	4.17	3.3E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs43134	chr8:90787960	RIPK2	chr8:90769975-90803291:+	-0.13	-5.07	4.62E-7	Leprosy	
BRCA	cis	1	rs4314214	chr3:46328069	TDGF1	chr3:46619180-46623950:+	0.14	4.01	6.41E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs4315635	chr22:49571530	ALG12	chr22:50296856-50312106:-	0.14	4.01	6.46E-5	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	
BRCA	cis	1	rs4315635	chr22:49571530	BRD1	chr22:50166938-50221180:-	0.15	4.17	3.25E-5	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	
BRCA	cis	1	rs4315635	chr22:49571530	ZBED4	chr22:50247497-50283726:+	0.11	3.72	0.000214	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	
BRCA	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.77	19.65	1.29E-73	Type 2 diabetes	
BRCA	cis	1	rs4323442	chr8:96022986	C8orf38	chr8:95908040-96088396:+	-0.14	-3.43	0.000632	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.36	-9.94	2.45E-22	Rheumatoid arthritis	
BRCA	cis	1	rs4323544	chr9:123647377	TRAF1	chr9:123664672-123691479:-	0.11	4.98	7.4E-7	Rheumatoid arthritis	
BRCA	cis	1	rs4330287	chr3:119288848	CD80	chr3:119243142-119278481:-	0.13	4.39	1.24E-5	Vitiligo	
BRCA	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.39	12.59	5.21E-34	Height	
BRCA	cis	1	rs4334685	chr3:134304335	CEP63	chr3:134204575-134293852:+	0.14	3.81	0.000146	Height	
BRCA	cis	1	rs4336432	chr6:55946490	COL21A1	chr6:55921389-56258892:-	-0.38	-7.07	2.85E-12	Psychosis (atypical)	
BRCA	cis	1	rs4344931	chr2:241818527	C2orf54	chr2:241825466-241835573:-	0.26	7.43	2.23E-13	Urinary metabolites	
BRCA	cis	1	rs4346503	chr3:138107597	TXNDC6	chr3:137980279-138048728:-	-0.19	-4.16	3.39E-5	Body mass index	
BRCA	cis	1	rs4351285	chr6:159384673	RSPH3	chr6:159398268-159421198:-	0.21	3.8	0.000153	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs4351668	chr1:8535818	RERE	chr1:8412466-8877699:-	0.1	3.47	0.000543	Vitiligo	
BRCA	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.29	7.5	1.35E-13	Pancreatic cancer	
BRCA	cis	1	rs4356975	chr4:69972463	UGT2B7	chr4:69962193-69978704:+	-0.14	-4.25	2.29E-5	Obesity-related traits	
BRCA	cis	1	rs4358532	chr5:42379957	CCDC152	chr5:42756920-42802539:+	-0.12	-3.87	0.000118	Systemic lupus erythematosus	
BRCA	cis	1	rs4358532	chr5:42379957	OXCT1	chr5:41730168-41870791:-	-0.14	-3.89	0.000108	Systemic lupus erythematosus	
BRCA	cis	1	rs4358532	chr5:42379957	SEPP1	chr5:42799983-42825998:-	-0.12	-3.54	0.000412	Systemic lupus erythematosus	
BRCA	cis	1	rs436039	chr19:22214873	ZNF257	chr19:22235266-22273901:+	0.19	4.04	5.72E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs4363385	chr1:152989321	SPRR1A	chr1:152956557-152958289:+	0.15	4.38	1.32E-5	Inflammatory skin disease	
BRCA	cis	1	rs4363822	chr15:67992583	IQCH	chr15:67547188-67794139:+	0.14	4.89	1.17E-6	Motion sickness	
BRCA	cis	1	rs4366490	chr11:62912854	B3GAT3	chr11:62382769-62389449:-	-0.11	-3.73	0.000199	Conotruncal heart defects	
BRCA	cis	1	rs4366490	chr11:62912854	BSCL2	chr11:62457747-62477046:-	-0.14	-3.57	0.000378	Conotruncal heart defects	
BRCA	cis	1	rs4366490	chr11:62912854	HNRNPUL2	chr11:62457747-62494821:-	-0.18	-4.18	3.19E-5	Conotruncal heart defects	
BRCA	cis	1	rs4366490	chr11:62912854	MTA2	chr11:62360675-62369303:-	-0.14	-3.73	0.000203	Conotruncal heart defects	
BRCA	cis	1	rs4366490	chr11:62912854	POLR2G	chr11:62529011-62534185:+	-0.15	-3.83	0.000137	Conotruncal heart defects	
BRCA	cis	1	rs4366490	chr11:62912854	TAF6L	chr11:62538875-62554811:+	-0.14	-4.17	3.25E-5	Conotruncal heart defects	
BRCA	cis	1	rs4366490	chr11:62912854	TMEM179B	chr11:62554874-62557871:+	-0.18	-4.47	8.66E-6	Conotruncal heart defects	
BRCA	cis	1	rs4366490	chr11:62912854	TTC9C	chr11:62495584-62506105:+	-0.16	-3.62	0.000308	Conotruncal heart defects	
BRCA	cis	1	rs4366490	chr11:62912854	ZBTB3	chr11:62518437-62521656:-	-0.16	-3.56	0.000388	Conotruncal heart defects	
BRCA	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.41	13.5	1.92E-38	Height	
BRCA	cis	1	rs4367113	chr3:134287975	CEP63	chr3:134204575-134293852:+	0.14	3.65	0.00027	Height	
BRCA	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.4	-12.84	3.54E-35	Height	
BRCA	cis	1	rs4368544	chr3:134300014	CEP63	chr3:134204575-134293852:+	-0.13	-3.58	0.00036	Height	
BRCA	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.25	-6.13	1.21E-9	Body mass index	
BRCA	cis	1	rs4373160	chr4:106648641	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs4374383	chr2:112770770	TMEM87B	chr2:112812800-112876895:+	-0.11	-3.99	7.11E-5	Hepatitis C induced liver fibrosis	
BRCA	cis	1	rs4374747	chr5:156426239	TIMD4	chr5:156346293-156390266:-	-0.14	-3.84	0.000133	Hypertriglyceridemia	
BRCA	cis	1	rs4375281	chr1:92987575	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs4375701	chr17:45712218	C17orf57	chr17:45401142-45518675:+	0.29	9.93	2.7E-22	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs4375701	chr17:45712218	TBKBP1	chr17:45772630-45789427:+	-0.15	-4.7	2.89E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs4376778	chr1:46288846	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.84	1.72E-30	Body mass index	
BRCA	cis	1	rs4376778	chr1:46288846	CCDC17	chr1:46085717-46089729:-	0.11	3.45	0.000583	Body mass index	
BRCA	cis	1	rs4376778	chr1:46288846	MUTYH	chr1:45794915-45806142:-	0.12	4.92	1.02E-6	Body mass index	
BRCA	cis	1	rs437889	chr7:65509234	CCT6P1	chr7:65216092-65228661:+	0.32	6.8	1.71E-11	Diabetic kidney disease	
BRCA	cis	1	rs437889	chr7:65509234	LOC493754	chr7:65993446-66057363:-	0.22	3.55	0.000395	Diabetic kidney disease	
BRCA	cis	1	rs4379723	chr10:64963449	NRBF2	chr10:64893007-64914785:+	-0.16	-5.89	5.31E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4383562	chr3:46320633	TDGF1	chr3:46619180-46623950:+	0.14	3.91	9.8E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs4388288	chr6:55948205	COL21A1	chr6:55921389-56258892:-	-0.38	-7.01	4.22E-12	Psychosis (atypical)	
BRCA	cis	1	rs4393318	chr11:62912785	B3GAT3	chr11:62382769-62389449:-	0.12	4.03	5.86E-5	Conotruncal heart defects	
BRCA	cis	1	rs4393318	chr11:62912785	BSCL2	chr11:62457747-62477046:-	0.16	3.98	7.32E-5	Conotruncal heart defects	
BRCA	cis	1	rs4393318	chr11:62912785	HNRNPUL2	chr11:62457747-62494821:-	0.19	4.4	1.19E-5	Conotruncal heart defects	
BRCA	cis	1	rs4393318	chr11:62912785	INTS5	chr11:62414322-62420774:-	0.15	3.61	0.000319	Conotruncal heart defects	
BRCA	cis	1	rs4393318	chr11:62912785	MTA2	chr11:62360675-62369303:-	0.16	4.13	3.84E-5	Conotruncal heart defects	
BRCA	cis	1	rs4393318	chr11:62912785	POLR2G	chr11:62529011-62534185:+	0.16	4.18	3.19E-5	Conotruncal heart defects	
BRCA	cis	1	rs4393318	chr11:62912785	TAF6L	chr11:62538875-62554811:+	0.15	4.58	5.14E-6	Conotruncal heart defects	
BRCA	cis	1	rs4393318	chr11:62912785	TMEM179B	chr11:62554874-62557871:+	0.2	4.95	8.46E-7	Conotruncal heart defects	
BRCA	cis	1	rs4393318	chr11:62912785	TMEM223	chr11:62557787-62559486:-	0.13	3.47	0.000545	Conotruncal heart defects	
BRCA	cis	1	rs4393318	chr11:62912785	TTC9C	chr11:62495584-62506105:+	0.18	4.05	5.48E-5	Conotruncal heart defects	
BRCA	cis	1	rs4393318	chr11:62912785	ZBTB3	chr11:62518437-62521656:-	0.18	4.03	6.04E-5	Conotruncal heart defects	
BRCA	cis	1	rs439553	chr6:167391212	RNASET2	chr6:167343008-167412795:-	-0.15	-4.8	1.78E-6	Crohn's disease	
BRCA	cis	1	rs4398671	chr5:115557842	COMMD10	chr5:115420727-115628978:+	0.24	5.06	4.95E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs4399232	chr10:64999490	NRBF2	chr10:64893007-64914785:+	-0.16	-5.88	5.62E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4400684	chr10:65012687	NRBF2	chr10:64893007-64914785:+	-0.16	-5.78	9.94E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.24	5.2	2.36E-7	Breast cancer (estrogen-receptor negative);Breast cancer	
BRCA	cis	1	rs4407429	chr3:119288897	CD80	chr3:119243142-119278481:-	-0.13	-4.45	9.44E-6	Vitiligo	
BRCA	cis	1	rs4409766	chr10:104616663	SFXN2	chr10:104474298-104498946:+	-0.2	-4.07	5.03E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs441125	chr6:13716592	RANBP9	chr6:13621731-13711796:-	-0.11	-3.49	0.000496	Breast cancer	
BRCA	cis	1	rs4413512	chr5:73077349	ANKRA2	chr5:72848163-72861498:-	0.08	3.45	0.000578	Venous thromboembolism (SNP x SNP interaction)	
BRCA	cis	1	rs4413512	chr5:73077349	FCHO2	chr5:72251808-72386348:+	0.08	3.53	0.000432	Venous thromboembolism (SNP x SNP interaction)	
BRCA	cis	1	rs4413512	chr5:73077349	GFM2	chr5:74017031-74063042:-	0.11	3.69	0.000237	Venous thromboembolism (SNP x SNP interaction)	
BRCA	cis	1	rs4413512	chr5:73077349	UTP15	chr5:72861598-72877794:+	0.14	4.89	1.18E-6	Venous thromboembolism (SNP x SNP interaction)	
BRCA	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.42	13.73	1.26E-39	Height	
BRCA	cis	1	rs4417907	chr3:134291363	CEP63	chr3:134204575-134293852:+	0.13	3.58	0.000356	Height	
BRCA	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.65	2.97E-34	Height	
BRCA	cis	1	rs4423809	chr3:134300107	CEP63	chr3:134204575-134293852:+	-0.14	-3.6	0.000338	Height	
BRCA	cis	1	rs4452748	chr7:50625056	FIGNL1	chr7:50511834-50518088:-	0.12	4.18	3.16E-5	Malaria	
BRCA	cis	1	rs4460230	chr6:159369990	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs4465830	chr20:44585420	SLC12A5	chr20:44650329-44688789:+	0.22	3.94	8.78E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
BRCA	cis	1	rs4469291	chr6:49440614	CENPQ	chr6:49431096-49460820:+	-0.24	-7.79	1.54E-14	Folate pathway vitamin levels	
BRCA	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.32	10.13	4.46E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs4473887	chr6:159369470	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs447722	chr20:25443510	FAM182A	chr20:26035250-26067552:+	-0.22	-5.79	9.42E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs447722	chr20:25443510	FAM182B	chr20:25744102-25848786:-	0.23	6.1	1.45E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs447722	chr20:25443510	PYGB	chr20:25228706-25278647:+	-0.13	-3.6	0.000334	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4480156	chr8:65685148	CYP7B1	chr8:65508529-65711348:-	0.12	3.87	0.000115	HIV-1 susceptibility	
BRCA	cis	1	rs448396	chr20:25440269	FAM182A	chr20:26035250-26067552:+	-0.22	-5.83	7.17E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs448396	chr20:25440269	FAM182B	chr20:25744102-25848786:-	0.23	6.09	1.6E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs448396	chr20:25440269	PYGB	chr20:25228706-25278647:+	-0.13	-3.55	0.000405	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4489133	chr6:163137793	PACRG	chr6:163148164-163736523:+	0.25	4.25	2.33E-5	Body mass index	
BRCA	cis	1	rs4489999	chr16:50014914	TMEM188	chr16:50059189-50070998:+	0.23	5.22	2.2E-7	Electroencephalogram traits	
BRCA	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.27	-10.11	5.4E-23	Longevity	
BRCA	cis	1	rs4490669	chr6:56789465	BEND6	chr6:56819773-56892138:+	-0.26	-7.8	1.48E-14	Menarche (age at onset)	
BRCA	cis	1	rs4490669	chr6:56789465	KIAA1586	chr6:56911384-56920021:+	-0.19	-4.25	2.34E-5	Menarche (age at onset)	
BRCA	cis	1	rs4493873	chr8:92075643	LRRC69	chr8:92114847-92231464:+	-0.17	-4.33	1.65E-5	Migraine - clinic-based	
BRCA	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.67	-20.4	2.17E-78	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.42	13.71	1.66E-39	Height	
BRCA	cis	1	rs4498009	chr3:134198008	CEP63	chr3:134204575-134293852:+	0.17	4.49	7.89E-6	Height	
BRCA	cis	1	rs4500751	chr16:15140211	C16orf63	chr16:15959577-15982447:-	0.15	4.1	4.45E-5	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs4502963	chr6:159369462	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs4509157	chr6:111835078	KIAA1919	chr6:111580482-111590259:+	0.28	4.46	9.01E-6	Psoriasis	
BRCA	cis	1	rs451396	chr7:65484074	CCT6P1	chr7:65216092-65228661:+	0.34	7.28	6.53E-13	Diabetic kidney disease	
BRCA	cis	1	rs451396	chr7:65484074	LOC493754	chr7:65993446-66057363:-	0.2	3.44	0.000608	Diabetic kidney disease	
BRCA	cis	1	rs4515105	chr3:190987891	UTS2D	chr3:190984945-191048325:-	-0.21	-6.17	9.44E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs4525554	chr17:30312819	C17orf79	chr17:30178885-30186326:-	-0.16	-3.43	0.00062	Height	
BRCA	cis	1	rs4525561	chr18:51835955	POLI	chr18:51795849-51824602:+	0.14	4.46	9.14E-6	Psoriasis	
BRCA	cis	1	rs453329	chr20:25440593	FAM182A	chr20:26035250-26067552:+	-0.23	-6.15	1.08E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs453329	chr20:25440593	FAM182B	chr20:25744102-25848786:-	0.24	6.13	1.2E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs453329	chr20:25440593	PYGB	chr20:25228706-25278647:+	-0.13	-3.55	0.000406	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.4	-13.04	3.45E-36	Height	
BRCA	cis	1	rs4535272	chr3:134299916	CEP63	chr3:134204575-134293852:+	-0.14	-3.76	0.000177	Height	
BRCA	cis	1	rs454441	chr8:90763070	RIPK2	chr8:90769975-90803291:+	0.16	5.97	3.22E-9	Leprosy	
BRCA	cis	1	rs4544908	chr6:55946166	COL21A1	chr6:55921389-56258892:-	-0.38	-7.07	2.85E-12	Psychosis (atypical)	
BRCA	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.56	3.29E-29	Body mass index	
BRCA	cis	1	rs4545281	chr1:46360054	CCDC17	chr1:46085717-46089729:-	0.11	3.4	0.000691	Body mass index	
BRCA	cis	1	rs4545281	chr1:46360054	MUTYH	chr1:45794915-45806142:-	0.12	4.9	1.13E-6	Body mass index	
BRCA	cis	1	rs4547797	chr4:103557192	MANBA	chr4:103552644-103682151:-	0.21	5.46	5.82E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs4548056	chr7:65298873	CCT6P1	chr7:65216092-65228661:+	0.32	6.85	1.25E-11	Diabetic kidney disease	
BRCA	cis	1	rs4548056	chr7:65298873	LOC493754	chr7:65993446-66057363:-	0.21	3.48	0.000528	Diabetic kidney disease	
BRCA	cis	1	rs4548056	chr7:65298873	ZNF117	chr7:64434830-64467121:-	-0.26	-4.81	1.7E-6	Diabetic kidney disease	
BRCA	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.25	-6.16	1.0E-9	Body mass index	
BRCA	cis	1	rs4553849	chr2:1855567	MYT1L	chr2:1792887-2335045:-	0.32	5.21	2.24E-7	Gut microbiota (functional units)	
BRCA	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.27	7.58	7.25E-14	Hematology traits	
BRCA	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.4	-13.04	3.4E-36	Height	
BRCA	cis	1	rs4572812	chr3:134291177	CEP63	chr3:134204575-134293852:+	-0.14	-3.68	0.000243	Height	
BRCA	cis	1	rs4578563	chr14:51159585	NIN	chr14:51186482-51297839:-	-0.12	-3.41	0.000663	Plasma amyloid beta peptide concentrations (ABx-40)	
BRCA	cis	1	rs4578563	chr14:51159585	SAV1	chr14:51100360-51135023:-	-0.13	-3.62	0.000304	Plasma amyloid beta peptide concentrations (ABx-40)	
BRCA	cis	1	rs4579121	chr4:103558169	MANBA	chr4:103552644-103682151:-	0.21	5.46	5.82E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.41	8.54	4.56E-17	Crohn's disease	
BRCA	cis	1	rs4580915	chr6:111760764	KIAA1919	chr6:111580482-111590259:+	0.32	4.51	7.31E-6	Psoriasis	
BRCA	cis	1	rs458291	chr7:65520479	CCT6P1	chr7:65216092-65228661:+	0.32	6.74	2.51E-11	Diabetic kidney disease	
BRCA	cis	1	rs458291	chr7:65520479	LOC493754	chr7:65993446-66057363:-	0.21	3.44	0.00061	Diabetic kidney disease	
BRCA	cis	1	rs4586937	chr4:103556462	MANBA	chr4:103552644-103682151:-	-0.21	-5.5	4.78E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs459048	chr6:111689632	KIAA1919	chr6:111580482-111590259:+	0.32	4.52	6.96E-6	Psoriasis	
BRCA	cis	1	rs459055	chr5:156151046	HAVCR2	chr5:156512843-156536138:-	-0.08	-3.45	0.000582	Airway responsiveness in chronic obstructive pulmonary disease	
BRCA	cis	1	rs4591730	chr5:82447802	XRCC4	chr5:82373317-82649577:+	-0.12	-3.56	0.000382	Hypertension	
BRCA	cis	1	rs459498	chr21:42795027	MX1	chr21:42792520-42831140:+	-0.14	-4.11	4.18E-5	IgG glycosylation	
BRCA	cis	1	rs4595427	chr10:65012944	NRBF2	chr10:64893007-64914785:+	-0.16	-5.78	9.94E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs459697	chr3:161093420	C3orf57	chr3:161062581-161089871:-	0.13	3.42	0.000658	Morning vs. evening chronotype	
BRCA	cis	1	rs459888	chr6:111651156	KIAA1919	chr6:111580482-111590259:+	-0.27	-4.09	4.71E-5	Psoriasis	
BRCA	cis	1	rs4604805	chr10:102261409	SEC31B	chr10:102246403-102289636:-	-0.3	-11.18	1.6E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4609941	chr18:44645491	HDHD2	chr18:44633782-44676871:-	0.3	5.16	3.01E-7	Sitting height ratio	
BRCA	cis	1	rs4615179	chr4:38465471	KLF3	chr4:38665790-38703128:+	0.13	3.43	0.000631	Obesity-related traits	
BRCA	cis	1	rs4615179	chr4:38465471	WDR19	chr4:39184024-39287429:+	0.11	3.54	0.000424	Obesity-related traits	
BRCA	cis	1	rs4627050	chr11:18822037	PTPN5	chr11:18749478-18813389:-	-0.2	-5.45	6.19E-8	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
BRCA	cis	1	rs462853	chr7:65558167	CCT6P1	chr7:65216092-65228661:+	0.31	6.65	4.57E-11	Diabetic kidney disease	
BRCA	cis	1	rs462853	chr7:65558167	LOC493754	chr7:65993446-66057363:-	0.23	3.85	0.000123	Diabetic kidney disease	
BRCA	cis	1	rs4629607	chr5:44857467	MRPS30	chr5:44809027-44815614:+	-0.17	-4.82	1.65E-6	Schizophrenia	
BRCA	cis	1	rs4631576	chr9:100705210	C9orf156	chr9:100666772-100684852:-	-0.14	-3.88	0.000112	Quantitative traits	
BRCA	cis	1	rs4633	chr22:19950235	COMT	chr22:19929263-19957496:+	-0.14	-4.52	6.88E-6	Blood metabolite levels	
BRCA	cis	1	rs4634357	chr5:45089926	MRPS30	chr5:44809027-44815614:+	0.14	3.42	0.000655	Age at first birth	
BRCA	cis	1	rs463543	chr6:111667552	KIAA1919	chr6:111580482-111590259:+	0.32	4.52	6.74E-6	Psoriasis	
BRCA	cis	1	rs4638245	chr10:96500563	C10orf129	chr10:96953957-96988685:+	0.33	5.5	4.85E-8	Blood metabolite levels	
BRCA	cis	1	rs4638651	chr18:51829870	POLI	chr18:51795849-51824602:+	0.13	4.29	1.94E-5	Psoriasis	
BRCA	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.25	-6.24	6.34E-10	Body mass index	
BRCA	cis	1	rs4642247	chr4:17957158	NCAPG	chr4:17812525-17846485:+	0.09	4.24	2.43E-5	Height	
BRCA	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.41	10.34	6.07E-24	Multiple sclerosis	
BRCA	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.32	-9.56	7.5E-21	Multiple sclerosis	
BRCA	cis	1	rs4646536	chr12:58157988	XRCC6BP1	chr12:58335445-58351051:+	-0.16	-4.54	6.27E-6	Multiple sclerosis	
BRCA	cis	1	rs4646622	chr15:58257199	ALDH1A2	chr15:58245628-58571462:-	0.09	3.44	0.000602	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	
BRCA	cis	1	rs4646638	chr15:58248783	ALDH1A2	chr15:58245628-58571462:-	-0.09	-3.56	0.000393	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	
BRCA	cis	1	rs4646640	chr15:58247563	ALDH1A2	chr15:58245628-58571462:-	-0.1	-3.57	0.000374	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	
BRCA	cis	1	rs4647277	chr3:37058509	LRRFIP2	chr3:37094117-37217851:-	0.17	4.73	2.5E-6	Cerebrospinal P-tau181p levels	
BRCA	cis	1	rs464783	chr21:42796480	MX1	chr21:42792520-42831140:+	0.13	3.95	8.48E-5	IgG glycosylation	
BRCA	cis	1	rs4647934	chr4:1016279	FGFRL1	chr4:1004940-1020685:+	-0.19	-3.59	0.00034	Bone mineral density	
BRCA	cis	1	rs464895	chr7:65527106	CCT6P1	chr7:65216092-65228661:+	0.35	7.03	3.77E-12	Diabetic kidney disease	
BRCA	cis	1	rs464895	chr7:65527106	LOC493754	chr7:65993446-66057363:-	0.24	3.72	0.000206	Diabetic kidney disease	
BRCA	cis	1	rs465359	chr7:65558164	CCT6P1	chr7:65216092-65228661:+	0.31	6.65	4.57E-11	Diabetic kidney disease	
BRCA	cis	1	rs465359	chr7:65558164	LOC493754	chr7:65993446-66057363:-	0.23	3.85	0.000123	Diabetic kidney disease	
BRCA	cis	1	rs4654863	chr1:20902244	CDA	chr1:20915444-20945398:+	-0.18	-4.88	1.2E-6	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs4654863	chr1:20902244	FAM43B	chr1:20878932-20881512:+	0.15	4.85	1.43E-6	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs4654896	chr1:21356930	HP1BP3	chr1:21069171-21113799:-	0.11	3.47	0.000542	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs4654896	chr1:21356930	SH2D5	chr1:21046225-21059330:-	0.13	3.59	0.000344	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs4654899	chr1:21410231	HP1BP3	chr1:21069171-21113799:-	0.11	3.68	0.000241	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs4656958	chr1:160856964	CD244	chr1:160799951-160832645:-	-0.14	-6.1	1.49E-9	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs4657039	chr1:161462728	FCGR2C	chr1:161551129-161570031:+	-0.11	-3.89	0.000104	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
BRCA	cis	1	rs465969	chr6:111655530	C6orf225	chr6:112408674-112423992:+	-0.18	-3.54	0.00042	Psoriasis	
BRCA	cis	1	rs465969	chr6:111655530	DDO	chr6:110713384-110736753:-	-0.18	-3.38	0.000757	Psoriasis	
BRCA	cis	1	rs4660117	chr1:236031533	GNG4	chr1:235710987-235814054:-	0.18	4.64	3.96E-6	Systemic lupus erythematosus	
BRCA	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.81	27.59	6.37E-127	Homocysteine levels	
BRCA	cis	1	rs4660306	chr1:45978675	MMACHC	chr1:45965856-45976737:+	0.14	3.92	9.38E-5	Homocysteine levels	
BRCA	cis	1	rs4660317	chr1:46326226	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.71	7.32E-30	Body mass index	
BRCA	cis	1	rs4660317	chr1:46326226	CCDC17	chr1:46085717-46089729:-	0.11	3.54	0.000424	Body mass index	
BRCA	cis	1	rs4660317	chr1:46326226	MUTYH	chr1:45794915-45806142:-	0.13	5.11	3.87E-7	Body mass index	
BRCA	cis	1	rs4660319	chr1:46341623	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.71	7.32E-30	Body mass index	
BRCA	cis	1	rs4660319	chr1:46341623	CCDC17	chr1:46085717-46089729:-	0.11	3.54	0.000424	Body mass index	
BRCA	cis	1	rs4660319	chr1:46341623	MUTYH	chr1:45794915-45806142:-	0.13	5.11	3.87E-7	Body mass index	
BRCA	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.97	4.36E-31	Body mass index	
BRCA	cis	1	rs4660321	chr1:46366760	MUTYH	chr1:45794915-45806142:-	0.12	4.91	1.08E-6	Body mass index	
BRCA	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.71	-22.99	2.58E-95	Homocysteine levels	
BRCA	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.95	5.64E-31	Body mass index	
BRCA	cis	1	rs4660898	chr1:46402171	MUTYH	chr1:45794915-45806142:-	0.13	4.9	1.13E-6	Body mass index	
BRCA	cis	1	rs4660910	chr1:46548402	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.77	3.8E-30	Body mass index	
BRCA	cis	1	rs4660910	chr1:46548402	CCDC17	chr1:46085717-46089729:-	0.11	3.41	0.000673	Body mass index	
BRCA	cis	1	rs4660910	chr1:46548402	MUTYH	chr1:45794915-45806142:-	0.12	4.77	2.12E-6	Body mass index	
BRCA	cis	1	rs4665238	chr2:23942446	C2orf84	chr2:24397531-24414566:+	-0.13	-3.53	0.000428	Obesity-related traits	
BRCA	cis	1	rs4665238	chr2:23942446	LOC375190	chr2:24299728-24397519:+	0.16	5.05	5.17E-7	Obesity-related traits	
BRCA	cis	1	rs4665381	chr2:27757150	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.05	5.48E-5	Oral cavity cancer	
BRCA	cis	1	rs4665768	chr2:25372229	POMC	chr2:25383722-25391559:-	0.15	4.97	7.95E-7	Body mass index	
BRCA	cis	1	rs4666007	chr2:27856495	KRTCAP3	chr2:27665263-27667163:+	-0.12	-3.84	0.00013	Oral cavity cancer	
BRCA	cis	1	rs4666009	chr2:27857992	KRTCAP3	chr2:27665263-27667163:+	-0.13	-3.99	7.07E-5	Oral cavity cancer	
BRCA	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.25	-6.15	1.09E-9	Body mass index	
BRCA	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.26	-6.33	3.66E-10	Body mass index	
BRCA	cis	1	rs466983	chr7:65520496	CCT6P1	chr7:65216092-65228661:+	0.33	6.84	1.34E-11	Diabetic kidney disease	
BRCA	cis	1	rs466983	chr7:65520496	LOC493754	chr7:65993446-66057363:-	0.21	3.44	0.000615	Diabetic kidney disease	
BRCA	cis	1	rs4671400	chr2:61472632	AHSA2	chr2:61404553-61414058:+	-0.23	-6.53	1.03E-10	3-hydroxypropylmercapturic acid levels in smokers	
BRCA	cis	1	rs4671400	chr2:61472632	C2orf74	chr2:61372243-61391964:+	0.41	6.24	6.23E-10	3-hydroxypropylmercapturic acid levels in smokers	
BRCA	cis	1	rs4671458	chr2:63374063	C2orf86	chr2:63348537-63815851:-	-0.2	-4.83	1.57E-6	Subjective well-being	
BRCA	cis	1	rs4671459	chr2:63392872	C2orf86	chr2:63348537-63815851:-	-0.19	-4.61	4.42E-6	Subjective well-being	
BRCA	cis	1	rs4671460	chr2:63397203	C2orf86	chr2:63348537-63815851:-	-0.2	-4.84	1.53E-6	Subjective well-being	
BRCA	cis	1	rs4671461	chr2:63406800	C2orf86	chr2:63348537-63815851:-	-0.2	-4.89	1.17E-6	Subjective well-being	
BRCA	cis	1	rs4671552	chr2:64393955	C2orf86	chr2:63348537-63815851:-	-0.12	-3.66	0.000262	Neuroticism	
BRCA	cis	1	rs4671552	chr2:64393955	CEP68	chr2:65283495-65314141:+	-0.1	-3.45	0.000573	Neuroticism	
BRCA	cis	1	rs4674284	chr2:219161241	GPBAR1	chr2:219125738-219128582:+	0.12	4.18	3.22E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs4674284	chr2:219161241	TMBIM1	chr2:219138917-219157280:-	-0.13	-3.93	9.02E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs4674	chr19:41930396	B3GNT8	chr19:41931265-41934635:-	-0.25	-7.58	7.65E-14	Height	
BRCA	cis	1	rs4675374	chr2:204802578	CD28	chr2:204571198-204602556:+	0.09	3.59	0.000348	Celiac disease	
BRCA	cis	1	rs4675860	chr2:241840417	C2orf54	chr2:241825466-241835573:-	0.27	7.35	3.83E-13	Urinary metabolites	
BRCA	cis	1	rs4675863	chr2:241830763	C2orf54	chr2:241825466-241835573:-	0.27	7.45	1.89E-13	Urinary metabolites	
BRCA	cis	1	rs4675868	chr2:241828542	C2orf54	chr2:241825466-241835573:-	0.26	7.41	2.62E-13	Urinary metabolites	
BRCA	cis	1	rs4675874	chr2:241819796	C2orf54	chr2:241825466-241835573:-	-0.25	-6.83	1.39E-11	Urinary metabolites	
BRCA	cis	1	rs4678851	chr3:36190651	STAC	chr3:36422097-36589496:+	0.11	4.3	1.86E-5	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	
BRCA	cis	1	rs4679903	chr3:160328568	TRIM59	chr3:160153292-160167626:-	-0.14	-4.13	3.88E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs4679904	chr3:160340896	TRIM59	chr3:160153292-160167626:-	0.13	3.98	7.49E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs4679906	chr3:160351187	TRIM59	chr3:160153292-160167626:-	0.13	3.78	0.000167	Primary biliary cirrhosis	
BRCA	cis	1	rs4679907	chr3:160351401	TRIM59	chr3:160153292-160167626:-	-0.14	-4.39	1.22E-5	Primary biliary cirrhosis	
BRCA	cis	1	rs4680356	chr3:151051100	P2RY14	chr3:150929905-150996230:-	-0.08	-3.41	0.000674	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
BRCA	cis	1	rs4682751	chr3:42528065	C3orf39	chr3:43120729-43147565:-	0.16	3.54	0.000422	Magnesium levels	
BRCA	cis	1	rs4683200	chr3:46333235	TDGF1	chr3:46619180-46623950:+	0.15	4.21	2.79E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs4683208	chr3:46336899	TDGF1	chr3:46619180-46623950:+	0.16	4.36	1.4E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs4683948	chr3:101650188	LOC152225	chr3:101659703-101716770:+	-0.16	-3.82	0.00014	Psoriasis vulgaris;Psoriasis	
BRCA	cis	1	rs4683950	chr3:101653958	LOC152225	chr3:101659703-101716770:+	-0.17	-4.21	2.74E-5	Psoriasis vulgaris;Psoriasis	
BRCA	cis	1	rs4684520	chr3:6255713	GRM7	chr3:6902802-7783218:+	0.15	3.82	0.000144	Response to tocilizumab in rheumatoid arthritis	
BRCA	cis	1	rs4684521	chr3:6255788	GRM7	chr3:6902802-7783218:+	0.15	3.84	0.00013	Response to tocilizumab in rheumatoid arthritis	
BRCA	cis	1	rs4687697	chr3:53090490	ITIH4	chr3:52847007-52866554:-	0.12	3.98	7.35E-5	Ulcerative colitis	
BRCA	cis	1	rs4687721	chr3:51598254	HEMK1	chr3:50606583-50622419:+	0.14	3.93	8.96E-5	Melanoma	
BRCA	cis	1	rs4687721	chr3:51598254	VPRBP	chr3:51433298-51534001:-	0.15	3.97	7.57E-5	Melanoma	
BRCA	cis	1	rs4690071	chr4:3086753	GRK4	chr4:2965343-3042474:+	-0.17	-4.04	5.64E-5	Parental longevity (mother's age at death)	
BRCA	cis	1	rs4691139	chr4:165908721	TRIM61	chr4:165875600-165898818:-	0.24	7.58	7.72E-14	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs4693089	chr4:84373622	MRPS18C	chr4:84377118-84389352:+	-0.2	-5.97	3.22E-9	Menopause (age at onset)	
BRCA	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.5	-18.38	8.63E-66	Ankylosing spondylitis	
BRCA	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.4	10.69	2.09E-25	Ankylosing spondylitis	
BRCA	cis	1	rs4698635	chr4:17630242	MED28	chr4:17616273-17629791:+	0.14	3.67	0.000251	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs4698641	chr4:17642630	MED28	chr4:17616273-17629791:+	0.14	3.61	0.00032	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs4699052	chr4:104137790	MANBA	chr4:103552644-103682151:-	0.17	4.55	6.09E-6	Testicular germ cell tumor	
BRCA	cis	1	rs4699055	chr4:104154500	MANBA	chr4:103552644-103682151:-	0.17	4.51	7.05E-6	Testicular germ cell tumor	
BRCA	cis	1	rs470119	chr22:50966914	SCO2	chr22:50961999-50964034:-	0.19	7.25	8.03E-13	Mean corpuscular hemoglobin	
BRCA	cis	1	rs470360	chr11:65500530	SPDYC	chr11:64937707-64940687:+	-0.14	-3.59	0.000349	Atopic dermatitis	
BRCA	cis	1	rs4704727	chr5:156380067	TIMD4	chr5:156346293-156390266:-	-0.26	-8.28	3.61E-16	Triglycerides;Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs4704729	chr5:156424516	TIMD4	chr5:156346293-156390266:-	-0.15	-3.94	8.84E-5	Hypertriglyceridemia	
BRCA	cis	1	rs4705814	chr5:112696916	YTHDC2	chr5:112849410-112930979:+	0.14	4.09	4.56E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs4705817	chr5:112724016	YTHDC2	chr5:112849410-112930979:+	0.14	4.22	2.64E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs4705818	chr5:112754926	YTHDC2	chr5:112849410-112930979:+	0.14	3.97	7.57E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs4705819	chr5:112754941	YTHDC2	chr5:112849410-112930979:+	0.14	3.97	7.57E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.59	-19.28	2.68E-71	Response to antipsychotic treatment	
BRCA	cis	1	rs4706789	chr6:80178365	IRAK1BP1	chr6:79577189-79656157:+	0.24	3.48	0.000519	Hoarding	
BRCA	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.58	-19.26	3.31E-71	Response to antipsychotic treatment	
BRCA	cis	1	rs4709251	chr6:159380322	RSPH3	chr6:159398268-159421198:-	0.2	3.61	0.000325	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs4709254	chr6:159408597	RSPH3	chr6:159398268-159421198:-	0.23	4.13	3.93E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs4709256	chr6:159409058	RSPH3	chr6:159398268-159421198:-	0.24	4.31	1.81E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs4709258	chr6:159412010	RSPH3	chr6:159398268-159421198:-	0.23	4.13	3.93E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs4709259	chr6:159419584	RSPH3	chr6:159398268-159421198:-	0.26	4.57	5.49E-6	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs4711346	chr6:33730996	C6orf125	chr6:33662057-33679504:-	0.13	4.39	1.25E-5	Body mass index	
BRCA	cis	1	rs4711346	chr6:33730996	LEMD2	chr6:33738991-33756906:-	0.18	5.7	1.57E-8	Body mass index	
BRCA	cis	1	rs4711935	chr6:49647822	CRISP3	chr6:49695092-49712056:-	0.14	3.65	0.000278	Bone mineral density (hip) and age at menarche	
BRCA	cis	1	rs4712120	chr6:56092916	COL21A1	chr6:55921389-56258892:-	0.67	20.39	2.61E-78	Pulse pressure	
BRCA	cis	1	rs4713006	chr6:26519872	BTN2A3	chr6:26422317-26431927:+	0.16	5.45	6.42E-8	Educational attainment	
BRCA	cis	1	rs4713006	chr6:26519872	C6orf41	chr6:26924772-26991752:+	-0.12	-3.53	0.000427	Educational attainment	
BRCA	cis	1	rs4713006	chr6:26519872	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.47	0.000534	Educational attainment	
BRCA	cis	1	rs4713008	chr6:26538268	BTN2A3	chr6:26422317-26431927:+	0.16	5.48	5.38E-8	Educational attainment	
BRCA	cis	1	rs4713008	chr6:26538268	C6orf41	chr6:26924772-26991752:+	-0.12	-3.75	0.00019	Educational attainment	
BRCA	cis	1	rs4713008	chr6:26538268	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.72	0.000207	Educational attainment	
BRCA	cis	1	rs4713858	chr6:35402785	C6orf106	chr6:34555066-34664625:-	-0.16	-3.56	0.00039	Height	
BRCA	cis	1	rs4713858	chr6:35402785	SNRPC	chr6:34725312-34741571:+	-0.12	-3.8	0.000153	Height	
BRCA	cis	1	rs4715129	chr6:49415043	CENPQ	chr6:49431096-49460820:+	-0.22	-7.3	5.71E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.33	10.23	1.69E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs4715130	chr6:49416825	CENPQ	chr6:49431096-49460820:+	-0.24	-7.51	1.25E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.32	9.73	1.76E-21	Folate pathway vitamin levels	
BRCA	cis	1	rs4715134	chr6:49488287	CENPQ	chr6:49431096-49460820:+	0.19	6.17	9.46E-10	Brain structure	
BRCA	cis	1	rs4715590	chr6:56060017	COL21A1	chr6:55921389-56258892:-	0.69	21.63	2.6E-86	Pulse pressure	
BRCA	cis	1	rs4717310	chr7:66161007	CRCP	chr7:65579805-65619551:+	-0.13	-3.51	0.000465	Aortic root size	
BRCA	cis	1	rs4717310	chr7:66161007	TYW1	chr7:66461817-66704496:+	0.15	3.97	7.59E-5	Aortic root size	
BRCA	cis	1	rs4717319	chr7:66242593	CRCP	chr7:65579805-65619551:+	-0.14	-3.75	0.000183	Aortic root size	
BRCA	cis	1	rs4717319	chr7:66242593	LOC493754	chr7:65993446-66057363:-	-0.13	-3.42	0.00065	Aortic root size	
BRCA	cis	1	rs4717319	chr7:66242593	TYW1	chr7:66461817-66704496:+	0.14	3.69	0.000236	Aortic root size	
BRCA	cis	1	rs4718269	chr7:65200778	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.81	1.61E-11	Diabetic kidney disease	
BRCA	cis	1	rs4718269	chr7:65200778	ZNF117	chr7:64434830-64467121:-	0.27	4.99	7.05E-7	Diabetic kidney disease	
BRCA	cis	1	rs4718270	chr7:65202407	CCT6P1	chr7:65216092-65228661:+	0.34	7.36	3.55E-13	Diabetic kidney disease	
BRCA	cis	1	rs4718270	chr7:65202407	LOC493754	chr7:65993446-66057363:-	0.2	3.39	0.000733	Diabetic kidney disease	
BRCA	cis	1	rs4718270	chr7:65202407	ZNF117	chr7:64434830-64467121:-	-0.26	-4.81	1.7E-6	Diabetic kidney disease	
BRCA	cis	1	rs4718309	chr7:65627764	CCT6P1	chr7:65216092-65228661:+	-0.29	-6.17	9.76E-10	Diabetic kidney disease	
BRCA	cis	1	rs4718309	chr7:65627764	CRCP	chr7:65579805-65619551:+	0.23	3.81	0.000148	Diabetic kidney disease	
BRCA	cis	1	rs4718309	chr7:65627764	LOC493754	chr7:65993446-66057363:-	-0.21	-3.47	0.000546	Diabetic kidney disease	
BRCA	cis	1	rs4718315	chr7:65648541	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.38	2.57E-10	Diabetic kidney disease	
BRCA	cis	1	rs4718315	chr7:65648541	CRCP	chr7:65579805-65619551:+	0.21	3.59	0.000351	Diabetic kidney disease	
BRCA	cis	1	rs4718315	chr7:65648541	LOC493754	chr7:65993446-66057363:-	-0.22	-3.79	0.000157	Diabetic kidney disease	
BRCA	cis	1	rs4718316	chr7:65648731	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.38	2.57E-10	Diabetic kidney disease	
BRCA	cis	1	rs4718316	chr7:65648731	CRCP	chr7:65579805-65619551:+	0.21	3.59	0.000351	Diabetic kidney disease	
BRCA	cis	1	rs4718316	chr7:65648731	LOC493754	chr7:65993446-66057363:-	-0.22	-3.79	0.000157	Diabetic kidney disease	
BRCA	cis	1	rs4718317	chr7:65648901	CCT6P1	chr7:65216092-65228661:+	-0.27	-6.08	1.69E-9	Diabetic kidney disease	
BRCA	cis	1	rs4718317	chr7:65648901	CRCP	chr7:65579805-65619551:+	0.25	4.34	1.58E-5	Diabetic kidney disease	
BRCA	cis	1	rs4718333	chr7:65772758	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.66	4.5E-11	Diabetic kidney disease	
BRCA	cis	1	rs4718333	chr7:65772758	CRCP	chr7:65579805-65619551:+	0.21	3.51	0.000465	Diabetic kidney disease	
BRCA	cis	1	rs4718333	chr7:65772758	LOC493754	chr7:65993446-66057363:-	-0.22	-3.71	0.00022	Diabetic kidney disease	
BRCA	cis	1	rs4718334	chr7:65789454	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.43	1.93E-10	Diabetic kidney disease	
BRCA	cis	1	rs4718334	chr7:65789454	CRCP	chr7:65579805-65619551:+	0.22	3.74	0.000196	Diabetic kidney disease	
BRCA	cis	1	rs4718334	chr7:65789454	LOC493754	chr7:65993446-66057363:-	-0.21	-3.56	0.000383	Diabetic kidney disease	
BRCA	cis	1	rs472265	chr19:39580737	ZFP36	chr19:39897487-39900045:+	0.12	3.46	0.000568	Type 2 diabetes	
BRCA	cis	1	rs4723719	chr7:38002679	EPDR1	chr7:37960163-37991539:+	-0.23	-3.93	8.95E-5	Myopia (pathological)	
BRCA	cis	1	rs4725372	chr7:150536172	TMEM176A	chr7:150497854-150502208:+	-0.16	-3.65	0.000275	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs4725372	chr7:150536172	TMEM176B	chr7:150488378-150498448:-	-0.16	-3.88	0.000112	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.42	-10.45	2.13E-24	Obesity-related traits	
BRCA	cis	1	rs4726669	chr7:143758191	OR2A7	chr7:143955790-143974852:-	0.2	4.71	2.86E-6	Obesity-related traits	
BRCA	cis	1	rs4726669	chr7:143758191	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.47	0.000539	Obesity-related traits	
BRCA	cis	1	rs4727443	chr7:99593346	AZGP1	chr7:99564352-99573687:-	-0.12	-3.63	0.000296	Interstitial lung disease	
BRCA	cis	1	rs4727443	chr7:99593346	CYP3A5	chr7:99245818-99332821:-	-0.18	-4.57	5.52E-6	Interstitial lung disease	
BRCA	cis	1	rs4727443	chr7:99593346	TRIM4	chr7:99488037-99517154:-	-0.22	-6.39	2.43E-10	Interstitial lung disease	
BRCA	cis	1	rs4727845	chr7:116914651	MET	chr7:116312459-116438439:+	-0.09	-3.39	0.000732	Dupuytren's disease	
BRCA	cis	1	rs4727976	chr7:123422357	HYAL4	chr7:123485223-123517529:+	0.28	4.09	4.62E-5	Platelet count	
BRCA	cis	1	rs4727979	chr7:123429697	HYAL4	chr7:123485223-123517529:+	0.25	3.65	0.000278	Platelet count	
BRCA	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.28	10.55	8.19E-25	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs4731120	chr7:123411223	HYAL4	chr7:123485223-123517529:+	0.29	4.11	4.29E-5	Platelet count	
BRCA	cis	1	rs4732038	chr7:134250322	AKR1B15	chr7:134233849-134264300:+	-0.11	-3.54	0.000424	Longevity	
BRCA	cis	1	rs4737199	chr8:65641907	CYP7B1	chr8:65508529-65711348:-	0.12	3.8	0.00015	HIV-1 susceptibility	
BRCA	cis	1	rs4737680	chr8:65675055	CYP7B1	chr8:65508529-65711348:-	0.12	3.84	0.00013	HIV-1 susceptibility	
BRCA	cis	1	rs4737681	chr8:65684304	CYP7B1	chr8:65508529-65711348:-	-0.11	-3.53	0.000433	HIV-1 susceptibility	
BRCA	cis	1	rs4743130	chr9:100546040	NCBP1	chr9:100395705-100436027:+	-0.13	-3.96	7.9E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs4743130	chr9:100546040	TSTD2	chr9:100362364-100395962:-	-0.11	-4	6.69E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs4743131	chr9:100554907	NCBP1	chr9:100395705-100436027:+	-0.11	-3.43	0.000636	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs4743131	chr9:100554907	TSTD2	chr9:100362364-100395962:-	-0.1	-3.55	0.000404	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs4746091	chr10:73407537	C10orf54	chr10:73507316-73533337:-	0.07	3.51	0.000472	Selective IgA deficiency	
BRCA	cis	1	rs4746994	chr10:64905324	NRBF2	chr10:64893007-64914785:+	0.14	3.42	0.00065	Arthritis (juvenile idiopathic)	
BRCA	cis	1	rs4747016	chr10:72124664	LRRC20	chr10:72058729-72142382:-	0.4	4.96	8.35E-7	Brain connectivity	
BRCA	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.26	-10.39	3.9E-24	Response to temozolomide	
BRCA	cis	1	rs4752028	chr10:118834991	KIAA1598	chr10:118644308-118886097:-	-0.18	-4.57	5.55E-6	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
BRCA	cis	1	rs4752797	chr11:47874364	ACP2	chr11:47260854-47270457:-	0.13	3.39	0.00073	Subjective well-being	
BRCA	cis	1	rs4752797	chr11:47874364	MADD	chr11:47290927-47351582:+	0.12	3.68	0.000244	Subjective well-being	
BRCA	cis	1	rs4752797	chr11:47874364	MYBPC3	chr11:47352958-47374253:-	-0.13	-3.99	6.99E-5	Subjective well-being	
BRCA	cis	1	rs4752856	chr11:47648042	ACP2	chr11:47260854-47270457:-	0.15	3.72	0.000206	Subjective well-being	
BRCA	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.11	-3.47	0.000551	Subjective well-being	
BRCA	cis	1	rs4752856	chr11:47648042	MADD	chr11:47290927-47351582:+	0.15	4.79	1.89E-6	Subjective well-being	
BRCA	cis	1	rs4752856	chr11:47648042	MYBPC3	chr11:47352958-47374253:-	-0.15	-4.42	1.06E-5	Subjective well-being	
BRCA	cis	1	rs4752857	chr11:47655752	ACP2	chr11:47260854-47270457:-	0.14	3.53	0.00043	Subjective well-being	
BRCA	cis	1	rs4752857	chr11:47655752	MADD	chr11:47290927-47351582:+	0.14	4.35	1.51E-5	Subjective well-being	
BRCA	cis	1	rs4752857	chr11:47655752	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.21	2.8E-5	Subjective well-being	
BRCA	cis	1	rs4752873	chr11:47857520	MADD	chr11:47290927-47351582:+	0.15	4.51	7.06E-6	Subjective well-being	
BRCA	cis	1	rs4752873	chr11:47857520	MYBPC3	chr11:47352958-47374253:-	-0.13	-3.93	8.98E-5	Subjective well-being	
BRCA	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.36	-9.31	6.83E-20	Forced vital capacity	
BRCA	cis	1	rs4756846	chr11:16403511	C11orf58	chr11:16760148-16779901:+	-0.21	-3.66	0.00026	Obesity and osteoporosis	
BRCA	cis	1	rs4758685	chr12:122626842	LRRC43	chr12:122652266-122688017:+	0.16	4.6	4.83E-6	Urate levels	
BRCA	cis	1	rs4758686	chr12:122623000	LRRC43	chr12:122652266-122688017:+	0.15	4.32	1.72E-5	Urate levels	
BRCA	cis	1	rs4758687	chr12:122616286	LRRC43	chr12:122652266-122688017:+	0.16	4.52	6.8E-6	Urate levels	
BRCA	cis	1	rs4758690	chr12:122610909	LRRC43	chr12:122652266-122688017:+	-0.16	-4.6	4.75E-6	Urate levels	
BRCA	cis	1	rs4758691	chr12:122610019	LRRC43	chr12:122652266-122688017:+	-0.16	-4.6	4.75E-6	Urate levels	
BRCA	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.59	-16.99	1.83E-57	Cognitive function	
BRCA	cis	1	rs4759318	chr12:54420098	FLJ12825	chr12:54452038-54516018:+	0.16	4.13	3.91E-5	Bone mineral density	
BRCA	cis	1	rs4759318	chr12:54420098	SMUG1	chr12:54573783-54582757:-	-0.12	-3.8	0.000151	Bone mineral density	
BRCA	cis	1	rs4759787	chr12:131290180	STX2	chr12:131274149-131323811:-	-0.23	-3.72	0.00021	Plasma plasminogen activator levels	
BRCA	cis	1	rs4761470	chr12:94683204	PLXNC1	chr12:94542499-94699224:+	0.08	3.61	0.000326	Estradiol plasma levels (breast cancer)	
BRCA	cis	1	rs4763049	chr12:63431918	PPM1H	chr12:63037763-63328915:-	-0.14	-3.64	0.000283	Obesity-related traits	
BRCA	cis	1	rs4763555	chr12:10721456	KLRA1	chr12:10741078-10752434:-	0.15	4.69	3.02E-6	Cognitive function	
BRCA	cis	1	rs4763879	chr12:9910164	CLEC2D	chr12:9822309-9852039:+	-0.12	-4.21	2.82E-5	Type 1 diabetes	
BRCA	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.33	-13.13	1.29E-36	Type 1 diabetes	
BRCA	cis	1	rs4765305	chr12:124430612	DNAH10	chr12:124247042-124420265:+	0.25	6.55	8.77E-11	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs4768	chr3:49758764	CCDC36	chr3:49235861-49295537:+	0.1	3.86	0.000122	Resting heart rate	
BRCA	cis	1	rs4768	chr3:49758764	DALRD3	chr3:49052435-49058467:-	0.13	4.45	9.64E-6	Resting heart rate	
BRCA	cis	1	rs4768	chr3:49758764	P4HTM	chr3:49027341-49044579:+	0.08	3.77	0.000174	Resting heart rate	
BRCA	cis	1	rs4769671	chr13:29621461	POMP	chr13:29233241-29253091:+	0.3	4.74	2.47E-6	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
BRCA	cis	1	rs4770509	chr13:24438643	PCOTH	chr13:24463028-24466241:+	-0.29	-3.59	0.000344	3-hydroxypropylmercapturic acid levels in smokers	
BRCA	cis	1	rs4775893	chr15:50898695	SPPL2A	chr15:50999739-51057910:-	0.15	5.47	5.48E-8	QT interval	
BRCA	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.25	9.77	1.21E-21	Response to temozolomide	
BRCA	cis	1	rs4779797	chr15:31208425	MTMR10	chr15:31231144-31283807:-	-0.12	-3.53	0.000441	Hypertriglyceridemia	
BRCA	cis	1	rs4779797	chr15:31208425	MTMR15	chr15:31196055-31235307:+	-0.15	-3.74	0.000193	Hypertriglyceridemia	
BRCA	cis	1	rs4784227	chr16:52599188	TOX3	chr16:52471918-52581714:-	-0.28	-7.34	4.13E-13	Breast cancer (estrogen-receptor negative);Breast cancer	
BRCA	cis	1	rs4787480	chr16:29857316	LOC440356	chr16:29875004-29879374:+	-0.28	-5.71	1.49E-8	Multiple sclerosis	
BRCA	cis	1	rs4787491	chr16:30015337	MAPK3	chr16:30125427-30134630:-	-0.11	-3.41	0.000677	Body mass index	
BRCA	cis	1	rs4788187	chr16:29845685	LOC440356	chr16:29875004-29879374:+	0.27	5.88	5.44E-9	Multiple sclerosis	
BRCA	cis	1	rs4788196	chr16:29967434	ALDOA	chr16:30064472-30081734:+	0.11	3.83	0.000136	Pubertal anthropometrics	
BRCA	cis	1	rs4788196	chr16:29967434	BOLA2	chr16:29454226-29466285:-;chr16	-0.1	-3.94	8.81E-5	Pubertal anthropometrics	
BRCA	cis	1	rs4788196	chr16:29967434	FAM57B	chr16:30035749-30042186:-	0.12	4.09	4.7E-5	Pubertal anthropometrics	
BRCA	cis	1	rs4788196	chr16:29967434	LOC440356	chr16:29875004-29879374:+	-0.16	-4.55	5.92E-6	Pubertal anthropometrics	
BRCA	cis	1	rs4788196	chr16:29967434	LOC613037	chr16:30234351-30257122:-	0.13	3.38	0.000755	Pubertal anthropometrics	
BRCA	cis	1	rs4788196	chr16:29967434	MAPK3	chr16:30125427-30134630:-	-0.11	-3.63	0.000301	Pubertal anthropometrics	
BRCA	cis	1	rs479343	chr6:111690904	KIAA1919	chr6:111580482-111590259:+	0.32	4.52	6.96E-6	Psoriasis	
BRCA	cis	1	rs4794016	chr17:45725931	C17orf57	chr17:45401142-45518675:+	-0.3	-10.27	1.21E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs4794016	chr17:45725931	TBKBP1	chr17:45772630-45789427:+	0.14	4.25	2.29E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs4794048	chr17:45763073	C17orf57	chr17:45401142-45518675:+	0.29	10.21	1.96E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs4794048	chr17:45763073	TBKBP1	chr17:45772630-45789427:+	-0.14	-4.2	2.88E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs479879	chr10:105945985	C10orf79	chr10:105889647-105992120:-	0.15	5.12	3.57E-7	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs479994	chr1:183161729	LAMC2	chr1:183155174-183214262:+	-0.1	-3.62	0.000307	Hypertriglyceridemia	
BRCA	cis	1	rs480132	chr1:183161779	LAMC2	chr1:183155174-183214262:+	-0.1	-3.62	0.000307	Hypertriglyceridemia	
BRCA	cis	1	rs4802200	chr19:44289518	LYPD5	chr19:44300080-44324808:-	-0.15	-4.31	1.8E-5	Breast cancer	
BRCA	cis	1	rs4802200	chr19:44289518	ZNF155	chr19:44488355-44502477:+	-0.14	-3.72	0.000212	Breast cancer	
BRCA	cis	1	rs4802200	chr19:44289518	ZNF404	chr19:44376516-44384288:-	-0.21	-5.67	1.79E-8	Breast cancer	
BRCA	cis	1	rs4803200	chr19:39583012	ZFP36	chr19:39897487-39900045:+	0.12	3.46	0.000554	Type 2 diabetes	
BRCA	cis	1	rs4803463	chr19:41911040	B3GNT8	chr19:41931265-41934635:-	-0.23	-7.17	1.35E-12	Height	
BRCA	cis	1	rs4803465	chr19:41918158	B3GNT8	chr19:41931265-41934635:-	0.22	6.94	6.7E-12	Height	
BRCA	cis	1	rs4803468	chr19:41922352	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.34	4.36E-13	Height	
BRCA	cis	1	rs4803469	chr19:41922775	B3GNT8	chr19:41931265-41934635:-	-0.24	-7.34	4.36E-13	Height	
BRCA	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.47	13.4	6.05E-38	Schizophrenia	
BRCA	cis	1	rs4803658	chr19:44290013	LYPD5	chr19:44300080-44324808:-	-0.13	-3.74	0.000194	Breast cancer	
BRCA	cis	1	rs4803658	chr19:44290013	ZNF155	chr19:44488355-44502477:+	-0.15	-4	6.8E-5	Breast cancer	
BRCA	cis	1	rs4803658	chr19:44290013	ZNF404	chr19:44376516-44384288:-	-0.22	-5.96	3.45E-9	Breast cancer	
BRCA	cis	1	rs4805834	chr19:33453659	SLC7A9	chr19:33321421-33360683:-	-0.36	-6.88	1.05E-11	Creatinine levels	
BRCA	cis	1	rs4808133	chr19:18608518	LRRC25	chr19:18501955-18508421:-	-0.14	-6.75	2.37E-11	Breast cancer	
BRCA	cis	1	rs4808134	chr19:18608579	LRRC25	chr19:18501955-18508421:-	-0.14	-6.75	2.37E-11	Breast cancer	
BRCA	cis	1	rs4808136	chr19:18618867	LRRC25	chr19:18501955-18508421:-	0.13	6.65	4.69E-11	Breast cancer	
BRCA	cis	1	rs4808200	chr19:19554803	HAPLN4	chr19:19366453-19384074:-	0.2	6.62	5.71E-11	Schizophrenia	
BRCA	cis	1	rs4808801	chr19:18571141	LRRC25	chr19:18501955-18508421:-	-0.15	-7.44	2.0E-13	Breast cancer	
BRCA	cis	1	rs4810486	chr20:44766403	CD40	chr20:44746906-44758384:+	-0.11	-3.61	0.000324	Kawasaki disease	
BRCA	cis	1	rs4810988	chr20:48465969	CSE1L	chr20:47662838-47713484:+	0.09	3.38	0.000753	Gut microbiota (beta diversity)	
BRCA	cis	1	rs4810988	chr20:48465969	SNAI1	chr20:48599527-48605418:+	-0.1	-3.46	0.000572	Gut microbiota (beta diversity)	
BRCA	cis	1	rs4812048	chr20:57587771	TH1L	chr20:57556311-57570186:+	-0.2	-4.31	1.82E-5	Mean platelet volume	
BRCA	cis	1	rs4813001	chr20:44762857	CD40	chr20:44746906-44758384:+	-0.1	-3.43	0.000616	Kawasaki disease	
BRCA	cis	1	rs4813002	chr20:44763187	CD40	chr20:44746906-44758384:+	-0.11	-3.64	0.000285	Kawasaki disease	
BRCA	cis	1	rs481311	chr4:46254382	GABRA2	chr4:46251581-46392421:-	-0.13	-3.79	0.000161	Epilepsy	
BRCA	cis	1	rs4813562	chr20:25352588	FAM182A	chr20:26035250-26067552:+	0.21	5.59	2.88E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4813562	chr20:25352588	FAM182B	chr20:25744102-25848786:-	-0.24	-6.4	2.27E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4813563	chr20:25365340	ABHD12	chr20:25275380-25371477:-	-0.11	-3.43	0.000616	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4813563	chr20:25365340	FAM182A	chr20:26035250-26067552:+	0.21	5.69	1.67E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4813563	chr20:25365340	FAM182B	chr20:25744102-25848786:-	-0.23	-6.03	2.2E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4813566	chr20:25386465	FAM182A	chr20:26035250-26067552:+	0.21	5.66	1.94E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4813566	chr20:25386465	FAM182B	chr20:25744102-25848786:-	-0.24	-6.27	5.22E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815404	chr20:25301845	FAM182A	chr20:26035250-26067552:+	0.21	5.64	2.14E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815404	chr20:25301845	FAM182B	chr20:25744102-25848786:-	-0.23	-5.91	4.62E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815405	chr20:25317492	FAM182A	chr20:26035250-26067552:+	0.21	5.48	5.45E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815405	chr20:25317492	FAM182B	chr20:25744102-25848786:-	-0.23	-5.94	3.88E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815405	chr20:25317492	PYGB	chr20:25228706-25278647:+	0.13	3.44	0.000602	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815406	chr20:25341316	FAM182A	chr20:26035250-26067552:+	0.22	5.71	1.5E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815406	chr20:25341316	FAM182B	chr20:25744102-25848786:-	-0.24	-6.28	4.89E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815406	chr20:25341316	PYGB	chr20:25228706-25278647:+	0.13	3.51	0.000474	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815407	chr20:25341478	FAM182A	chr20:26035250-26067552:+	0.22	5.74	1.22E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815407	chr20:25341478	FAM182B	chr20:25744102-25848786:-	-0.22	-5.84	6.81E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815408	chr20:25346678	FAM182A	chr20:26035250-26067552:+	0.22	5.78	1.01E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815408	chr20:25346678	FAM182B	chr20:25744102-25848786:-	-0.23	-5.9	4.81E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815409	chr20:25346697	FAM182A	chr20:26035250-26067552:+	0.22	5.74	1.24E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815409	chr20:25346697	FAM182B	chr20:25744102-25848786:-	-0.24	-6.34	3.29E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815409	chr20:25346697	PYGB	chr20:25228706-25278647:+	0.13	3.56	0.000387	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815411	chr20:25350223	FAM182A	chr20:26035250-26067552:+	0.21	5.58	3.05E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815411	chr20:25350223	FAM182B	chr20:25744102-25848786:-	-0.23	-6.13	1.22E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815411	chr20:25350223	PYGB	chr20:25228706-25278647:+	0.13	3.45	0.000574	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815412	chr20:25350325	FAM182A	chr20:26035250-26067552:+	-0.2	-5.41	7.63E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815412	chr20:25350325	FAM182B	chr20:25744102-25848786:-	0.25	6.51	1.12E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815417	chr20:25379526	ABHD12	chr20:25275380-25371477:-	-0.13	-3.92	9.43E-5	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815417	chr20:25379526	FAM182A	chr20:26035250-26067552:+	0.21	5.7	1.53E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815417	chr20:25379526	FAM182B	chr20:25744102-25848786:-	-0.25	-6.65	4.54E-11	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815418	chr20:25382211	FAM182A	chr20:26035250-26067552:+	0.21	5.62	2.41E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815418	chr20:25382211	FAM182B	chr20:25744102-25848786:-	-0.24	-6.2	8.21E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815420	chr20:25383979	FAM182A	chr20:26035250-26067552:+	0.22	5.75	1.18E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815420	chr20:25383979	FAM182B	chr20:25744102-25848786:-	-0.24	-6.32	3.93E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815421	chr20:25386509	FAM182A	chr20:26035250-26067552:+	0.21	5.66	1.94E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815421	chr20:25386509	FAM182B	chr20:25744102-25848786:-	-0.24	-6.27	5.22E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815424	chr20:25390284	ABHD12	chr20:25275380-25371477:-	-0.12	-3.73	0.000204	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815424	chr20:25390284	FAM182A	chr20:26035250-26067552:+	0.22	5.81	8.19E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815424	chr20:25390284	FAM182B	chr20:25744102-25848786:-	-0.22	-5.85	6.72E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815426	chr20:25405186	FAM182A	chr20:26035250-26067552:+	0.22	5.93	4.1E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815426	chr20:25405186	FAM182B	chr20:25744102-25848786:-	-0.23	-6.01	2.5E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4815426	chr20:25405186	PYGB	chr20:25228706-25278647:+	0.13	3.39	0.000727	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs4820539	chr22:23477970	RTDR1	chr22:23401594-23484241:-	0.14	3.71	0.000215	Bone mineral density	
BRCA	cis	1	rs4821812	chr22:39075235	DDX17	chr22:38879445-38903665:-	-0.1	-3.47	0.000541	Resting heart rate	
BRCA	cis	1	rs4821812	chr22:39075235	JOSD1	chr22:39081549-39096459:-	-0.13	-4.23	2.59E-5	Resting heart rate	
BRCA	cis	1	rs4821812	chr22:39075235	TOMM22	chr22:39077954-39080763:+	-0.11	-3.63	0.000296	Resting heart rate	
BRCA	cis	1	rs4822357	chr22:23473231	RTDR1	chr22:23401594-23484241:-	-0.19	-4.97	7.96E-7	Bone mineral density	
BRCA	cis	1	rs4822358	chr22:23474795	RTDR1	chr22:23401594-23484241:-	-0.17	-4.71	2.77E-6	Bone mineral density	
BRCA	cis	1	rs4822360	chr22:23482460	RTDR1	chr22:23401594-23484241:-	-0.15	-4.08	4.85E-5	Bone mineral density	
BRCA	cis	1	rs4822361	chr22:23482718	RTDR1	chr22:23401594-23484241:-	0.17	4.58	5.27E-6	Bone mineral density	
BRCA	cis	1	rs4822362	chr22:23482744	RTDR1	chr22:23401594-23484241:-	-0.16	-4.33	1.65E-5	Bone mineral density	
BRCA	cis	1	rs483783	chr1:183162152	LAMC2	chr1:183155174-183214262:+	-0.1	-3.73	0.000204	Hypertriglyceridemia	
BRCA	cis	1	rs4838890	chr1:110616679	ALX3	chr1:110602998-110613322:-	-0.13	-4.05	5.55E-5	Blood metabolite levels	
BRCA	cis	1	rs4839103	chr1:110620701	ALX3	chr1:110602998-110613322:-	-0.13	-3.91	9.65E-5	Blood metabolite levels	
BRCA	cis	1	rs4842838	chr15:84582124	GOLGA6L5	chr15:85047738-85060078:-	0.14	4.52	6.76E-6	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs4842838	chr15:84582124	LOC388152	chr15:84867600-84898920:-	0.12	3.72	0.00021	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs4842924	chr15:84587607	GOLGA6L5	chr15:85047738-85060078:-	0.14	4.83	1.55E-6	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs4842924	chr15:84587607	LOC388152	chr15:84867600-84898920:-	0.12	3.79	0.000162	Waist circumference adjusted for body mass index;Waist circumference	
BRCA	cis	1	rs4844588	chr1:207429668	C4BPA	chr1:207277511-207318308:+	0.15	4.34	1.58E-5	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs4844590	chr1:207496129	C4BPA	chr1:207277511-207318308:+	0.13	3.77	0.000169	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs4845934	chr1:10468946	PGD	chr1:10459085-10480200:+	0.21	5.96	3.38E-9	Hepatocellular carcinoma	
BRCA	cis	1	rs4846208	chr1:10313839	PGD	chr1:10459085-10480200:+	0.2	5.52	4.32E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs4846210	chr1:10322153	PGD	chr1:10459085-10480200:+	0.2	5.52	4.32E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs4847181	chr1:93028792	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	9.0E-7	Cholesterol, total	
BRCA	cis	1	rs4852375	chr2:70125988	ANXA4	chr2:69969127-70053594:+	-0.15	-4.23	2.55E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs4852375	chr2:70125988	FAM136A	chr2:70523109-70529220:-	-0.09	-3.5	0.000489	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs4853634	chr2:190779231	ORMDL1	chr2:190634994-190649097:-	0.25	4.19	3.02E-5	Subcutaneous adipose tissue	
BRCA	cis	1	rs4854058	chr2:240923677	NDUFA10	chr2:240900158-240964798:-	0.29	7.47	1.63E-13	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.25	9.77	1.21E-21	Response to temozolomide	
BRCA	cis	1	rs4858793	chr3:48415007	ATRIP	chr3:48488141-48507708:+	-0.11	-3.76	0.000179	Longevity	
BRCA	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.26	9.49	1.44E-20	Longevity	
BRCA	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.26	9.61	4.89E-21	Longevity	
BRCA	cis	1	rs4858888	chr3:47405305	C3orf75	chr3:47537131-47555199:-	0.11	3.68	0.000242	Colorectal cancer	
BRCA	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.19	4.88	1.23E-6	Longevity	
BRCA	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.2	-4.92	9.94E-7	Longevity	
BRCA	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.21	-5.29	1.5E-7	Longevity	
BRCA	cis	1	rs4864809	chr4:54511913	LNX1	chr4:54326439-54518682:-	0.13	3.55	0.000409	Beard thickness	
BRCA	cis	1	rs4869313	chr5:96223880	ERAP1	chr5:96096515-96149837:-	0.19	6.47	1.47E-10	Pediatric autoimmune diseases	
BRCA	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1	-43.8	1.25E-240	Pediatric autoimmune diseases	
BRCA	cis	1	rs4871	chr6:26545632	BTN2A3	chr6:26422317-26431927:+	0.16	5.44	6.67E-8	Educational attainment	
BRCA	cis	1	rs4871	chr6:26545632	C6orf41	chr6:26924772-26991752:+	-0.13	-3.8	0.000151	Educational attainment	
BRCA	cis	1	rs4871	chr6:26545632	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.78	0.000163	Educational attainment	
BRCA	cis	1	rs4879628	chr9:32888520	APTX	chr9:32972609-33025110:-	0.16	3.38	0.00075	Amyotrophic lateral sclerosis	
BRCA	cis	1	rs4879628	chr9:32888520	B4GALT1	chr9:33110639-33167356:-	0.19	3.74	0.000191	Amyotrophic lateral sclerosis	
BRCA	cis	1	rs4879628	chr9:32888520	NFX1	chr9:33290510-33371154:+	0.21	4.2	2.92E-5	Amyotrophic lateral sclerosis	
BRCA	cis	1	rs4879628	chr9:32888520	SMU1	chr9:33041850-33076714:-	0.21	3.96	8.16E-5	Amyotrophic lateral sclerosis	
BRCA	cis	1	rs4879628	chr9:32888520	UBE2R2	chr9:33817182-33920399:+	0.2	3.57	0.000368	Amyotrophic lateral sclerosis	
BRCA	cis	1	rs487965	chr4:46232957	GABRA2	chr4:46251581-46392421:-	-0.13	-3.59	0.00034	Epilepsy	
BRCA	cis	1	rs4879670	chr9:33205408	NFX1	chr9:33290510-33371154:+	-0.13	-3.64	0.000286	Diabetic kidney disease	
BRCA	cis	1	rs4879672	chr9:33206383	NFX1	chr9:33290510-33371154:+	-0.14	-3.86	0.000122	Diabetic kidney disease	
BRCA	cis	1	rs4886615	chr15:75131661	MPI	chr15:75182410-75190565:+	0.2	5.37	9.45E-8	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
BRCA	cis	1	rs4886615	chr15:75131661	ULK3	chr15:75128459-75135552:-	-0.17	-5.02	6.2E-7	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
BRCA	cis	1	rs4886818	chr15:76880939	SCAPER	chr15:76640529-77197744:-	-0.19	-6.86	1.18E-11	Blood metabolite levels	
BRCA	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.22	-9.12	3.76E-19	Testicular germ cell tumor	
BRCA	cis	1	rs4889609	chr16:31026427	HSD3B7	chr16:30996519-31000473:+	0.24	7.44	2.05E-13	Response to metformin (IC50)	
BRCA	cis	1	rs4889609	chr16:31026427	MYST1	chr16:31128985-31142713:+	0.19	7.15	1.64E-12	Response to metformin (IC50)	
BRCA	cis	1	rs4889609	chr16:31026427	ORAI3	chr16:30960405-30966258:+	0.1	3.47	0.000533	Response to metformin (IC50)	
BRCA	cis	1	rs489266	chr4:46214525	GABRA2	chr4:46251581-46392421:-	-0.13	-3.58	0.000354	Epilepsy	
BRCA	cis	1	rs4899514	chr14:74940170	TMEM90A	chr14:74872596-74892805:-	0.18	3.93	9.1E-5	Advanced glycation end-product levels	
BRCA	cis	1	rs490049	chr13:33564863	BRCA2	chr13:32889617-32973809:+	0.25	5.51	4.49E-8	Diabetic kidney disease	
BRCA	cis	1	rs490049	chr13:33564863	CG030	chr13:33078645-33083532:-	0.28	4.88	1.22E-6	Diabetic kidney disease	
BRCA	cis	1	rs490049	chr13:33564863	N4BP2L2	chr13:33006930-33112936:-	0.4	6.47	1.47E-10	Diabetic kidney disease	
BRCA	cis	1	rs490049	chr13:33564863	PDS5B	chr13:33160592-33352155:+	0.36	6.33	3.69E-10	Diabetic kidney disease	
BRCA	cis	1	rs490049	chr13:33564863	RFC3	chr13:34392206-34540694:+	0.32	5.81	8.34E-9	Diabetic kidney disease	
BRCA	cis	1	rs490049	chr13:33564863	STARD13	chr13:33677273-34250932:-	0.25	4.32	1.68E-5	Diabetic kidney disease	
BRCA	cis	1	rs490102	chr4:46273584	GABRA2	chr4:46251581-46392421:-	-0.14	-4.02	6.2E-5	Epilepsy	
BRCA	cis	1	rs4901186	chr14:52509484	NID2	chr14:52471521-52535946:-	0.08	3.72	0.000211	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs4902364	chr14:65602006	CHURC1	chr14:65381140-65411309:+	0.12	3.49	0.000509	Obesity-related traits	
BRCA	cis	1	rs4903232	chr14:74963288	PTGR2	chr14:74318534-74352166:+	-0.14	-3.53	0.000438	Advanced glycation end-product levels	
BRCA	cis	1	rs4903233	chr14:74963994	PTGR2	chr14:74318534-74352166:+	-0.15	-3.93	9.16E-5	Advanced glycation end-product levels	
BRCA	cis	1	rs4903961	chr14:81462649	TSHR	chr14:81421869-81612646:+	-0.13	-3.89	0.000107	Graves' disease	
BRCA	cis	1	rs4906205	chr14:102932447	ANKRD9	chr14:102973198-102976128:-	0.13	3.89	0.000107	QT interval	
BRCA	cis	1	rs491098	chr13:113769346	F10	chr13:113777113-113803841:+	-0.15	-4.3	1.89E-5	End-stage coagulation	
BRCA	cis	1	rs491098	chr13:113769346	F7	chr13:113760105-113774994:+	0.17	3.9	0.000104	End-stage coagulation	
BRCA	cis	1	rs4911178	chr20:33952620	CPNE1	chr20:34213968-34262539:-	0.24	6.47	1.49E-10	Height	
BRCA	cis	1	rs4911178	chr20:33952620	ERGIC3	chr20:34129778-34145404:+	0.12	3.47	0.000549	Height	
BRCA	cis	1	rs4911178	chr20:33952620	MMP24	chr20:33814539-33864804:+	0.16	4.73	2.49E-6	Height	
BRCA	cis	1	rs4911178	chr20:33952620	UQCC	chr20:33890383-33999833:-	0.32	9.82	7.62E-22	Height	
BRCA	cis	1	rs4911180	chr20:33972948	CPNE1	chr20:34213968-34262539:-	0.23	6.22	7.31E-10	Height	
BRCA	cis	1	rs4911180	chr20:33972948	MMP24	chr20:33814539-33864804:+	0.15	4.25	2.3E-5	Height	
BRCA	cis	1	rs4911180	chr20:33972948	UQCC	chr20:33890383-33999833:-	0.31	9.45	2.08E-20	Height	
BRCA	cis	1	rs4911491	chr20:33947285	CPNE1	chr20:34213968-34262539:-	0.25	6.64	4.94E-11	Height	
BRCA	cis	1	rs4911491	chr20:33947285	MMP24	chr20:33814539-33864804:+	0.16	4.7	2.99E-6	Height	
BRCA	cis	1	rs4911491	chr20:33947285	UQCC	chr20:33890383-33999833:-	0.32	9.91	3.33E-22	Height	
BRCA	cis	1	rs4911492	chr20:33951799	CPNE1	chr20:34213968-34262539:-	0.25	6.74	2.53E-11	Height	
BRCA	cis	1	rs4911492	chr20:33951799	ERGIC3	chr20:34129778-34145404:+	0.12	3.42	0.00066	Height	
BRCA	cis	1	rs4911492	chr20:33951799	MMP24	chr20:33814539-33864804:+	0.17	4.76	2.19E-6	Height	
BRCA	cis	1	rs4911492	chr20:33951799	UQCC	chr20:33890383-33999833:-	0.33	10.02	1.15E-22	Height	
BRCA	cis	1	rs4911494	chr20:33971914	CPNE1	chr20:34213968-34262539:-	0.24	6.4	2.26E-10	Height	
BRCA	cis	1	rs4911494	chr20:33971914	MMP24	chr20:33814539-33864804:+	0.16	4.48	8.14E-6	Height	
BRCA	cis	1	rs4911494	chr20:33971914	UQCC	chr20:33890383-33999833:-	0.31	9.54	9.0E-21	Height	
BRCA	cis	1	rs4911496	chr20:33972053	CPNE1	chr20:34213968-34262539:-	-0.22	-5.98	2.96E-9	Height	
BRCA	cis	1	rs4911496	chr20:33972053	MMP24	chr20:33814539-33864804:+	-0.12	-3.56	0.000385	Height	
BRCA	cis	1	rs4911496	chr20:33972053	UQCC	chr20:33890383-33999833:-	-0.29	-8.71	1.11E-17	Height	
BRCA	cis	1	rs4917385	chr10:105003721	C10orf32	chr10:104613967-104624718:+	-0.15	-4.8	1.83E-6	Systemic lupus erythematosus	
BRCA	cis	1	rs4917901	chr10:102201773	SEC31B	chr10:102246403-102289636:-	-0.28	-10.4	3.33E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4919464	chr10:102221195	SEC31B	chr10:102246403-102289636:-	-0.27	-10.22	1.86E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4919465	chr10:102221703	SEC31B	chr10:102246403-102289636:-	-0.27	-10.22	1.86E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4919466	chr10:102241213	SEC31B	chr10:102246403-102289636:-	-0.29	-10.77	9.37E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4919468	chr10:102288343	SEC31B	chr10:102246403-102289636:-	-0.3	-10.4	3.27E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4919469	chr10:102298855	SEC31B	chr10:102246403-102289636:-	-0.3	-11.17	1.71E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4919470	chr10:102298920	SEC31B	chr10:102246403-102289636:-	-0.3	-10.43	2.55E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4919471	chr10:102299239	SEC31B	chr10:102246403-102289636:-	-0.29	-10.68	2.24E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4919472	chr10:102315864	SEC31B	chr10:102246403-102289636:-	-0.29	-10.45	2.18E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs4919690	chr10:104616500	AS3MT	chr10:104613967-104661653:+	0.22	5.34	1.16E-7	Arsenic metabolism	
BRCA	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.36	12.08	1.44E-31	Arsenic metabolism	
BRCA	cis	1	rs4921163	chr5:158545438	TTC1	chr5:159436180-159492549:+	0.16	4.04	5.67E-5	Gut microbiome composition (winter)	
BRCA	cis	1	rs4925540	chr1:247214878	ZNF670	chr1:247200087-247242069:-	-0.25	-7.03	3.68E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs4930726	chr12:124428331	DNAH10	chr12:124247042-124420265:+	0.26	6.73	2.85E-11	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.49	-12.84	3.45E-35	Type 2 diabetes	
BRCA	cis	1	rs493459	chr4:46251032	GABRA2	chr4:46251581-46392421:-	-0.13	-3.86	0.000119	Epilepsy	
BRCA	cis	1	rs4939311	chr11:59877967	MS4A4A	chr11:60048139-60076444:+	-0.1	-4.36	1.4E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs4939312	chr11:59900106	MS4A4A	chr11:60048139-60076444:+	0.1	4.39	1.26E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs4939312	chr11:59900106	PRPF19	chr11:60658021-60674061:-	0.14	3.61	0.00032	Alzheimer's disease (late onset)	
BRCA	cis	1	rs4939314	chr11:59900575	MS4A4A	chr11:60048139-60076444:+	-0.1	-4.1	4.47E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs494003	chr11:65542298	CTSW	chr11:65647284-65651212:+	-0.16	-5.87	5.74E-9	Systemic lupus erythematosus	
BRCA	cis	1	rs494003	chr11:65542298	SNX32	chr11:65601410-65621170:+	0.19	4.78	1.99E-6	Systemic lupus erythematosus	
BRCA	cis	1	rs4941822	chr13:36453613	SOHLH2	chr13:36742347-36871992:-	0.15	4.04	5.71E-5	Non-alcoholic fatty liver disease	
BRCA	cis	1	rs4942486	chr13:32953388	N4BP2L1	chr13:32974861-33002315:-	0.1	3.9	0.000102	LDL cholesterol	
BRCA	cis	1	rs4942487	chr13:46709389	COG3	chr13:46039071-46110759:+	-0.3	-6.55	8.69E-11	Non-alcoholic fatty liver disease histology (other)	
BRCA	cis	1	rs4942487	chr13:46709389	ESD	chr13:47345392-47371367:-	-0.19	-4.08	4.79E-5	Non-alcoholic fatty liver disease histology (other)	
BRCA	cis	1	rs4942487	chr13:46709389	TPT1	chr13:45911304-45915297:-	-0.2	-5.01	6.34E-7	Non-alcoholic fatty liver disease histology (other)	
BRCA	cis	1	rs4942487	chr13:46709389	ZC3H13	chr13:46529805-46626894:-	-0.26	-6.5	1.24E-10	Non-alcoholic fatty liver disease histology (other)	
BRCA	cis	1	rs4947015	chr6:110052515	PPIL6	chr6:109711419-109761990:-	-0.37	-5.64	2.23E-8	Hematological parameters	
BRCA	cis	1	rs494735	chr1:66767167	PDE4B	chr1:66258193-66840261:+	0.12	3.45	0.000574	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs4947534	chr7:56079094	GBAS	chr7:56032296-56067871:+	-0.18	-4.19	3.06E-5	Blood metabolite levels;Amino acid levels	
BRCA	cis	1	rs4947534	chr7:56079094	PSPH	chr7:56078746-56184090:-	-0.16	-3.63	0.000298	Blood metabolite levels;Amino acid levels	
BRCA	cis	1	rs4948102	chr7:56097265	GBAS	chr7:56032296-56067871:+	-0.18	-4.11	4.33E-5	Plasma homocysteine levels (post-methionine load test)	
BRCA	cis	1	rs4948102	chr7:56097265	PSPH	chr7:56078746-56184090:-	-0.15	-3.54	0.000423	Plasma homocysteine levels (post-methionine load test)	
BRCA	cis	1	rs4950429	chr1:146871957	CHD1L	chr1:146714291-146767441:+	-0.16	-3.64	0.000289	Protein quantitative trait loci	
BRCA	cis	1	rs4953925	chr2:135471290	TMEM163	chr2:135213331-135525334:-	-0.25	-5.4	8.2E-8	Gut microbiome composition (winter)	
BRCA	cis	1	rs495477	chr1:66767128	PDE4B	chr1:66258193-66840261:+	0.13	3.53	0.000431	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.38	12.53	1.09E-33	Height	
BRCA	cis	1	rs4955485	chr3:134295843	CEP63	chr3:134204575-134293852:+	0.14	3.87	0.000115	Height	
BRCA	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.41	13.7	1.72E-39	Height	
BRCA	cis	1	rs4955555	chr3:134286427	CEP63	chr3:134204575-134293852:+	0.14	3.79	0.000161	Height	
BRCA	cis	1	rs495572	chr6:13717932	RANBP9	chr6:13621731-13711796:-	-0.11	-3.61	0.000326	Breast cancer	
BRCA	cis	1	rs495633	chr6:13717913	RANBP9	chr6:13621731-13711796:-	-0.11	-3.48	0.000516	Breast cancer	
BRCA	cis	1	rs495818	chr4:46247898	GABRA2	chr4:46251581-46392421:-	-0.14	-3.95	8.28E-5	Epilepsy	
BRCA	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.35	8.08	1.71E-15	Crohn's disease	
BRCA	cis	1	rs4965872	chr15:102004002	ASB7	chr15:101142755-101191902:+	-0.14	-3.61	0.000319	Diabetic kidney disease	
BRCA	cis	1	rs4970696	chr1:92968853	EVI5	chr1:92974255-93257961:-	-0.16	-4.23	2.55E-5	Cholesterol, total	
BRCA	cis	1	rs4970698	chr1:92972933	EVI5	chr1:92974255-93257961:-	-0.17	-4.69	3.16E-6	Cholesterol, total	
BRCA	cis	1	rs4970705	chr1:92971828	EVI5	chr1:92974255-93257961:-	0.19	5.17	2.76E-7	Cholesterol, total	
BRCA	cis	1	rs4970708	chr1:92986514	EVI5	chr1:92974255-93257961:-	-0.18	-4.81	1.75E-6	Cholesterol, total	
BRCA	cis	1	rs4970709	chr1:92988592	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs4970710	chr1:92988717	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs4970712	chr1:92993547	EVI5	chr1:92974255-93257961:-	0.15	4.38	1.29E-5	Cholesterol, total	
BRCA	cis	1	rs4970948	chr1:151291243	PIP5K1A	chr1:151171021-151222006:+	-0.11	-4.06	5.26E-5	Gut microbiota (functional units)	
BRCA	cis	1	rs4971316	chr1:247210903	ZNF670	chr1:247200087-247242069:-	-0.25	-6.94	6.89E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs4971319	chr1:247211565	ZNF670	chr1:247200087-247242069:-	-0.25	-6.94	6.89E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs4974105	chr3:51369574	GRM2	chr3:51741081-51752623:+	-0.18	-3.44	0.000597	Melanoma	
BRCA	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.41	13.75	1.03E-39	Height	
BRCA	cis	1	rs4974483	chr3:134219001	CEP63	chr3:134204575-134293852:+	0.16	4.31	1.79E-5	Height	
BRCA	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.42	13.77	7.75E-40	Height	
BRCA	cis	1	rs4974484	chr3:134219019	CEP63	chr3:134204575-134293852:+	0.16	4.2	2.95E-5	Height	
BRCA	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.43	14.44	2.78E-43	Height	
BRCA	cis	1	rs4974493	chr3:134219993	CEP63	chr3:134204575-134293852:+	0.15	4.04	5.82E-5	Height	
BRCA	cis	1	rs4974601	chr4:1095410	KIAA1530	chr4:1341104-1381836:+	0.11	3.81	0.000147	Recombination rate (males)	
BRCA	cis	1	rs4974931	chr4:39110516	KLHL5	chr4:39046659-39123828:+	-0.16	-4.84	1.5E-6	Uric acid levels	
BRCA	cis	1	rs4974997	chr4:39110771	KLHL5	chr4:39046659-39123828:+	-0.16	-5.02	6.08E-7	Uric acid levels	
BRCA	cis	1	rs4974998	chr4:39110749	KLHL5	chr4:39046659-39123828:+	-0.16	-4.89	1.14E-6	Uric acid levels	
BRCA	cis	1	rs4980171	chr10:124743200	PSTK	chr10:124739556-124749906:+	0.13	3.66	0.000261	Migraine without aura	
BRCA	cis	1	rs4980239	chr10:124741184	PSTK	chr10:124739556-124749906:+	0.13	3.66	0.000264	Migraine without aura	
BRCA	cis	1	rs4985124	chr16:15125441	C16orf63	chr16:15959577-15982447:-	0.13	3.63	0.000292	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs4985154	chr16:15131642	C16orf63	chr16:15959577-15982447:-	0.13	3.54	0.00042	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs4986894	chr10:96522365	HELLS	chr10:96305543-96361855:+	0.12	3.39	0.000727	Migraine	
BRCA	cis	1	rs4990365	chr6:159375553	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs499425	chr11:64105929	CCDC88B	chr11:64107695-64125005:+	0.09	4.6	4.72E-6	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
BRCA	cis	1	rs4996257	chr2:219162836	TMBIM1	chr2:219138917-219157280:-	0.16	4.9	1.13E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs500059	chr11:83283859	CCDC90B	chr11:82972506-82997414:-	-0.14	-3.85	0.000126	Subcortical brain region volumes	
BRCA	cis	1	rs500571	chr11:83305542	CCDC90B	chr11:82972506-82997414:-	0.2	5.25	1.85E-7	Subcortical brain region volumes	
BRCA	cis	1	rs5008080	chr14:92644632	NDUFB1	chr14:92582470-92588153:-	-0.1	-3.52	0.000452	Dialysis-related mortality	
BRCA	cis	1	rs5008830	chr3:122030462	CSTA	chr3:122044011-122060813:+	-0.2	-4.07	5.14E-5	Serum parathyroid hormone levels	
BRCA	cis	1	rs5022636	chr1:151295061	PIP5K1A	chr1:151171021-151222006:+	-0.11	-3.96	7.97E-5	Gut microbiota (functional units)	
BRCA	cis	1	rs5024798	chr13:24440203	PCOTH	chr13:24463028-24466241:+	-0.29	-3.6	0.000339	3-hydroxypropylmercapturic acid levels in smokers	
BRCA	cis	1	rs5026472	chr4:103554773	MANBA	chr4:103552644-103682151:-	0.21	5.55	3.58E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs5026473	chr4:103554793	MANBA	chr4:103552644-103682151:-	0.21	5.57	3.25E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs5026476	chr4:103554910	MANBA	chr4:103552644-103682151:-	0.21	5.47	5.53E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs5030707	chr20:23618656	CST1	chr20:23728191-23731574:-	0.24	5.11	3.74E-7	Chronic kidney disease	
BRCA	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.25	9.72	1.89E-21	Response to temozolomide	
BRCA	cis	1	rs505564	chr11:83277912	CCDC90B	chr11:82972506-82997414:-	0.14	3.99	6.92E-5	Subcortical brain region volumes	
BRCA	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.25	9.61	5.15E-21	Response to temozolomide	
BRCA	cis	1	rs506644	chr4:46239450	GABRA2	chr4:46251581-46392421:-	-0.14	-3.96	8.13E-5	Epilepsy	
BRCA	cis	1	rs507646	chr4:46239579	GABRA2	chr4:46251581-46392421:-	-0.13	-3.63	0.000297	Epilepsy	
BRCA	cis	1	rs507788	chr4:46257458	GABRA2	chr4:46251581-46392421:-	-0.14	-4.02	6.19E-5	Epilepsy	
BRCA	cis	1	rs508970	chr11:60906450	CD5	chr11:60869930-60895321:+	-0.07	-4.27	2.1E-5	Rheumatoid arthritis	
BRCA	cis	1	rs508970	chr11:60906450	PGA3	chr11:60970984-60993916:+	0.17	4.82	1.62E-6	Rheumatoid arthritis	
BRCA	cis	1	rs509548	chr12:123181855	GPR109A	chr12:123185840-123187904:-	-0.15	-3.43	0.000618	Adiponectin levels	
BRCA	cis	1	rs510642	chr1:183162776	LAMC2	chr1:183155174-183214262:+	-0.11	-3.77	0.000173	Hypertriglyceridemia	
BRCA	cis	1	rs512140	chr6:84230653	PRSS35	chr6:84222274-84235419:+	-0.13	-3.86	0.00012	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs512140	chr6:84230653	SNAP91	chr6:84262607-84419127:-	0.13	3.48	0.00052	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs515910	chr10:105966404	C10orf79	chr10:105889647-105992120:-	0.13	4.59	5.02E-6	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs517134	chr4:46279117	GABRA2	chr4:46251581-46392421:-	-0.15	-4.32	1.68E-5	Epilepsy	
BRCA	cis	1	rs517350	chr4:46244124	GABRA2	chr4:46251581-46392421:-	-0.14	-4.1	4.52E-5	Epilepsy	
BRCA	cis	1	rs519113	chr19:45376284	PVRL2	chr19:45349393-45392485:+	0.13	3.72	0.000212	HDL cholesterol;Alzheimer's disease (late onset)	
BRCA	cis	1	rs519113	chr19:45376284	TOMM40	chr19:45394477-45406935:+	0.1	3.9	0.000104	HDL cholesterol;Alzheimer's disease (late onset)	
BRCA	cis	1	rs519270	chr4:46274451	GABRA2	chr4:46251581-46392421:-	-0.12	-3.42	0.000655	Epilepsy	
BRCA	cis	1	rs525630	chr4:46268570	GABRA2	chr4:46251581-46392421:-	-0.13	-3.72	0.00021	Epilepsy	
BRCA	cis	1	rs525862	chr4:46249047	GABRA2	chr4:46251581-46392421:-	-0.13	-3.66	0.000261	Epilepsy	
BRCA	cis	1	rs526805	chr4:46263391	GABRA2	chr4:46251581-46392421:-	-0.13	-3.72	0.00021	Epilepsy	
BRCA	cis	1	rs527154	chr10:105943683	C10orf79	chr10:105889647-105992120:-	0.15	5.21	2.28E-7	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs530329	chr4:46281119	GABRA2	chr4:46251581-46392421:-	-0.15	-4.3	1.82E-5	Epilepsy	
BRCA	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.26	10.07	7.46E-23	Response to temozolomide	
BRCA	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.25	-9.87	4.59E-22	Response to temozolomide	
BRCA	cis	1	rs531676	chr10:99637578	CRTAC1	chr10:99624758-99790585:-	0.21	6.51	1.17E-10	Metabolic syndrome	
BRCA	cis	1	rs532011	chr4:46243447	GABRA2	chr4:46251581-46392421:-	-0.13	-3.68	0.000244	Epilepsy	
BRCA	cis	1	rs535066	chr4:46240287	GABRA2	chr4:46251581-46392421:-	-0.14	-3.97	7.66E-5	Epilepsy	
BRCA	cis	1	rs537134	chr4:46271268	GABRA2	chr4:46251581-46392421:-	0.13	3.67	0.000254	Epilepsy	
BRCA	cis	1	rs538773	chr4:46264839	GABRA2	chr4:46251581-46392421:-	-0.14	-4.03	5.86E-5	Epilepsy	
BRCA	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.25	9.56	7.66E-21	Response to temozolomide	
BRCA	cis	1	rs541126	chr12:120972396	POP5	chr12:121016849-121019201:-	0.16	3.77	0.000173	Type 1 diabetes nephropathy	
BRCA	cis	1	rs541418	chr4:46253216	GABRA2	chr4:46251581-46392421:-	-0.14	-4.01	6.56E-5	Epilepsy	
BRCA	cis	1	rs542432	chr4:46246540	GABRA2	chr4:46251581-46392421:-	-0.14	-4.11	4.21E-5	Epilepsy	
BRCA	cis	1	rs543351	chr4:46246425	GABRA2	chr4:46251581-46392421:-	-0.13	-3.68	0.000242	Epilepsy	
BRCA	cis	1	rs543725	chr11:57483039	MED19	chr11:57471182-57479673:-	-0.15	-3.9	0.000103	Schizophrenia	
BRCA	cis	1	rs544352	chr1:183157546	LAMC2	chr1:183155174-183214262:+	-0.1	-3.69	0.000233	Hypertriglyceridemia	
BRCA	cis	1	rs544368	chr11:124537995	C11orf61	chr11:124636394-124670299:-	0.16	3.69	0.000236	Bipolar disorder	
BRCA	cis	1	rs546183	chr1:183157753	LAMC2	chr1:183155174-183214262:+	-0.1	-3.69	0.000233	Hypertriglyceridemia	
BRCA	cis	1	rs546784	chr1:66762466	PDE4B	chr1:66258193-66840261:+	0.13	3.57	0.000378	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs547843	chr15:26424047	UBE3A	chr15:25582397-25684128:-	0.14	4.39	1.22E-5	Smoking behavior	
BRCA	cis	1	rs547905	chr1:183157924	LAMC2	chr1:183155174-183214262:+	-0.11	-3.82	0.000143	Hypertriglyceridemia	
BRCA	cis	1	rs548260	chr4:46268484	GABRA2	chr4:46251581-46392421:-	-0.14	-4.02	6.27E-5	Epilepsy	
BRCA	cis	1	rs549944	chr1:34424462	C1orf212	chr1:35319124-35325392:-	0.15	4.4	1.19E-5	Depressive symptoms (SSRI exposure interaction)	
BRCA	cis	1	rs549944	chr1:34424462	ZSCAN20	chr1:33938232-33961993:+	0.13	4.25	2.36E-5	Depressive symptoms (SSRI exposure interaction)	
BRCA	cis	1	rs551569	chr1:183158293	LAMC2	chr1:183155174-183214262:+	-0.11	-3.7	0.000226	Hypertriglyceridemia	
BRCA	cis	1	rs551905	chr4:46278365	GABRA2	chr4:46251581-46392421:-	-0.14	-4.02	6.3E-5	Epilepsy	
BRCA	cis	1	rs554112	chr4:46262776	GABRA2	chr4:46251581-46392421:-	-0.13	-3.7	0.000226	Epilepsy	
BRCA	cis	1	rs556199	chr11:83276006	CCDC90B	chr11:82972506-82997414:-	0.14	4.04	5.64E-5	Subcortical brain region volumes	
BRCA	cis	1	rs556292	chr10:105961957	C10orf79	chr10:105889647-105992120:-	0.13	4.52	6.75E-6	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs55634485	chr2:242268994	ANO7	chr2:242127924-242164791:+	0.21	3.38	0.000762	Prostate cancer	
BRCA	cis	1	rs55638602	chr1:207428942	C4BPA	chr1:207277511-207318308:+	0.15	4.34	1.59E-5	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs55650602	chr8:65688677	CYP7B1	chr8:65508529-65711348:-	0.12	3.81	0.000144	HIV-1 susceptibility	
BRCA	cis	1	rs55666439	chr1:44111212	C1orf84	chr1:43855556-43878462:+	-0.14	-3.4	0.000701	Hypertension risk in short sleep duration	
BRCA	cis	1	rs55670848	chr1:171697497	VAMP4	chr1:171669298-171711214:-	0.19	5.51	4.54E-8	Hippocampal atrophy	
BRCA	cis	1	rs55697388	chr6:118891544	C6orf204	chr6:118786239-119031238:-	-0.11	-3.41	0.000673	Renal cell carcinoma	
BRCA	cis	1	rs55727637	chr16:15145252	C16orf63	chr16:15959577-15982447:-	0.15	3.97	7.54E-5	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs55734215	chr20:33585437	MMP24	chr20:33814539-33864804:+	-0.22	-3.87	0.000115	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs55734215	chr20:33585437	PROCR	chr20:33758727-33765164:+	-0.24	-4.92	9.97E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs55737216	chr9:100695901	C9orf156	chr9:100666772-100684852:-	-0.17	-4.67	3.33E-6	Quantitative traits	
BRCA	cis	1	rs55738731	chr3:119290358	CD80	chr3:119243142-119278481:-	0.13	4.48	8.38E-6	Vitiligo	
BRCA	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.67	-20.27	1.62E-77	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs557675	chr11:65566719	CTSW	chr11:65647284-65651212:+	-0.1	-4.41	1.16E-5	Urate levels	
BRCA	cis	1	rs55775340	chr6:33751784	LEMD2	chr6:33738991-33756906:-	0.18	5.72	1.37E-8	Body mass index	
BRCA	cis	1	rs55786720	chr6:56783647	BEND6	chr6:56819773-56892138:+	-0.32	-8.93	1.79E-18	Menarche (age at onset)	
BRCA	cis	1	rs55786720	chr6:56783647	KIAA1586	chr6:56911384-56920021:+	-0.21	-4.44	9.99E-6	Menarche (age at onset)	
BRCA	cis	1	rs55791720	chr12:1066834	RAD52	chr12:1021255-1099219:-	0.16	4.85	1.39E-6	Lung cancer	
BRCA	cis	1	rs55805503	chr10:96534043	C10orf129	chr10:96953957-96988685:+	0.23	4.12	4.08E-5	Blood metabolite levels	
BRCA	cis	1	rs55820833	chr11:16400359	C11orf58	chr11:16760148-16779901:+	0.22	3.87	0.000117	Obesity and osteoporosis	
BRCA	cis	1	rs55822577	chr6:163069710	PACRG	chr6:163148164-163736523:+	0.23	3.88	0.000109	Body mass index	
BRCA	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.25	6.12	1.35E-9	Body mass index	
BRCA	cis	1	rs55838400	chr3:122032293	CSTA	chr3:122044011-122060813:+	-0.18	-3.73	0.000202	Serum parathyroid hormone levels	
BRCA	cis	1	rs55847558	chr11:59903793	MS4A4A	chr11:60048139-60076444:+	-0.09	-3.98	7.24E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs55847707	chr6:163003414	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.06E-6	Body mass index	
BRCA	cis	1	rs55848839	chr3:119290454	CD80	chr3:119243142-119278481:-	0.13	4.48	8.38E-6	Vitiligo	
BRCA	cis	1	rs55857306	chr1:11895795	CLCN6	chr1:11866207-11907674:+	0.24	6.1	1.49E-9	QRS complex (12-leadsum)	
BRCA	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.23	-8.89	2.51E-18	Response to temozolomide	
BRCA	cis	1	rs55895244	chr7:65387678	CCT6P1	chr7:65216092-65228661:+	0.33	7.26	7.5E-13	Diabetic kidney disease	
BRCA	cis	1	rs55895244	chr7:65387678	LOC493754	chr7:65993446-66057363:-	0.21	3.56	0.000384	Diabetic kidney disease	
BRCA	cis	1	rs55895244	chr7:65387678	ZNF117	chr7:64434830-64467121:-	-0.27	-4.94	9.17E-7	Diabetic kidney disease	
BRCA	cis	1	rs55905547	chr20:57589995	TH1L	chr20:57556311-57570186:+	-0.21	-4.4	1.17E-5	Mean platelet volume	
BRCA	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.41	13.7	1.72E-39	Height	
BRCA	cis	1	rs55913793	chr3:134285968	CEP63	chr3:134204575-134293852:+	0.14	3.79	0.000161	Height	
BRCA	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.64	8.74	9.02E-18	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs55914901	chr19:50528346	TBC1D17	chr19:50380829-50392000:+	-0.21	-4.03	6.08E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs55934348	chr2:99246885	UNC50	chr2:99225042-99234975:+	-0.19	-3.76	0.000178	Bipolar disorder	
BRCA	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.69	-20.44	1.29E-78	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs55938551	chr2:242033593	MTERFD2	chr2:242034545-242041747:-	0.28	4.5	7.5E-6	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
BRCA	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.69	-20.41	2.12E-78	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs559476	chr1:183160704	LAMC2	chr1:183155174-183214262:+	-0.1	-3.68	0.000247	Hypertriglyceridemia	
BRCA	cis	1	rs559555	chr2:31810974	NLRC4	chr2:32449518-32490801:-	0.11	4.76	2.19E-6	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs55962025	chr4:3112109	GRK4	chr4:2965343-3042474:+	-0.17	-4.05	5.58E-5	Parental longevity (mother's age at death)	
BRCA	cis	1	rs55979739	chr16:31049155	HSD3B7	chr16:30996519-31000473:+	0.2	6.1	1.5E-9	Response to metformin (IC50)	
BRCA	cis	1	rs55979739	chr16:31049155	MYST1	chr16:31128985-31142713:+	0.19	7	4.46E-12	Response to metformin (IC50)	
BRCA	cis	1	rs55979739	chr16:31049155	ZNF689	chr16:30614701-30621682:-	0.12	3.88	0.000113	Response to metformin (IC50)	
BRCA	cis	1	rs55986560	chr19:41939835	B3GNT8	chr19:41931265-41934635:-	0.2	5.94	3.78E-9	Height	
BRCA	cis	1	rs559972	chr17:27814496	TP53I13	chr17:27895739-27900174:+	0.09	3.43	0.000616	Mean platelet volume	
BRCA	cis	1	rs56016656	chr7:65383481	CCT6P1	chr7:65216092-65228661:+	0.35	7.57	8.34E-14	Diabetic kidney disease	
BRCA	cis	1	rs56016656	chr7:65383481	LOC493754	chr7:65993446-66057363:-	0.21	3.47	0.000546	Diabetic kidney disease	
BRCA	cis	1	rs56016656	chr7:65383481	ZNF117	chr7:64434830-64467121:-	-0.27	-4.92	9.79E-7	Diabetic kidney disease	
BRCA	cis	1	rs56028644	chr19:17388790	ANKLE1	chr19:17392454-17398454:+	0.21	5.98	3.04E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs56028644	chr19:17388790	ANO8	chr19:17434032-17445638:-	0.14	3.44	0.000605	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs56028644	chr19:17388790	OCEL1	chr19:17337055-17340027:+	0.15	4.63	4.06E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs56030154	chr11:16400608	C11orf58	chr11:16760148-16779901:+	0.22	3.87	0.000117	Obesity and osteoporosis	
BRCA	cis	1	rs56030203	chr6:56783857	BEND6	chr6:56819773-56892138:+	-0.32	-8.97	1.34E-18	Menarche (age at onset)	
BRCA	cis	1	rs56030203	chr6:56783857	KIAA1586	chr6:56911384-56920021:+	-0.21	-4.46	8.87E-6	Menarche (age at onset)	
BRCA	cis	1	rs56040780	chr16:28861881	EIF3C	chr16:28722782-28747052:+;chr16	0.17	4.8	1.77E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
BRCA	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.28	7.21	1.07E-12	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
BRCA	cis	1	rs56040780	chr16:28861881	SULT1A1	chr16:28616918-28634866:-	-0.14	-4.2	2.83E-5	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
BRCA	cis	1	rs56077333	chr15:78899003	AGPHD1	chr15:78799906-78829714:+	-0.16	-3.73	0.000202	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs56077333	chr15:78899003	CHRNA5	chr15:78857906-78886458:+	-0.2	-6.03	2.2E-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs56101873	chr1:119474790	WARS2	chr1:119573841-119683295:-	0.26	4.81	1.75E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs56104203	chr2:86336256	LOC90784	chr2:86247339-86250991:-	-0.27	-3.51	0.000465	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs56104203	chr2:86336256	ST3GAL5	chr2:86066271-86116157:-	0.32	4.45	9.43E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs56105592	chr2:17779641	GEN1	chr2:17935162-17966632:+	0.14	3.46	0.000557	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs56113315	chr19:39184166	LGALS7	chr19:39261608-39264157:-	-0.18	-5.69	1.67E-8	Heart rate	
BRCA	cis	1	rs56119980	chr4:39141010	KLHL5	chr4:39046659-39123828:+	-0.14	-4.22	2.68E-5	Uric acid levels	
BRCA	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.52	14.31	1.35E-42	Diastolic blood pressure	
BRCA	cis	1	rs56124423	chr3:119278163	CD80	chr3:119243142-119278481:-	0.12	4.15	3.63E-5	Vitiligo	
BRCA	cis	1	rs56127630	chr3:49438036	AMT	chr3:49454212-49460012:-	-0.14	-4.69	3.04E-6	Menarche (age at onset)	
BRCA	cis	1	rs56127630	chr3:49438036	CCDC36	chr3:49235861-49295537:+	-0.11	-3.98	7.44E-5	Menarche (age at onset)	
BRCA	cis	1	rs56127630	chr3:49438036	NCKIPSD	chr3:48711280-48723334:-	-0.16	-3.97	7.55E-5	Menarche (age at onset)	
BRCA	cis	1	rs56127630	chr3:49438036	P4HTM	chr3:49027341-49044579:+	-0.1	-4.24	2.44E-5	Menarche (age at onset)	
BRCA	cis	1	rs56127630	chr3:49438036	WDR6	chr3:49044637-49053386:+	0.13	3.87	0.000118	Menarche (age at onset)	
BRCA	cis	1	rs56135341	chr3:119290314	CD80	chr3:119243142-119278481:-	0.13	4.48	8.38E-6	Vitiligo	
BRCA	cis	1	rs56139710	chr1:27269788	GPATCH3	chr1:27216980-27226962:-	0.2	3.94	8.6E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs56153133	chr1:11885647	CLCN6	chr1:11866207-11907674:+	0.23	6.17	9.8E-10	QRS complex (12-leadsum)	
BRCA	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.26	6.53	1.01E-10	Metabolite levels	
BRCA	cis	1	rs56156035	chr2:242205955	ANO7	chr2:242127924-242164791:+	0.22	3.63	0.000295	Prostate cancer	
BRCA	cis	1	rs56157864	chr5:132267859	HSPA4	chr5:132387662-132440708:+	-0.18	-3.62	0.000307	Apolipoprotein A-IV levels	
BRCA	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.52	14.31	1.35E-42	Diastolic blood pressure	
BRCA	cis	1	rs56159542	chr19:19682971	CILP2	chr19:19649074-19657466:+	-0.16	-4.41	1.12E-5	Attention deficit hyperactivity disorder symptom score	
BRCA	cis	1	rs56159542	chr19:19682971	HAPLN4	chr19:19366453-19384074:-	-0.28	-6.82	1.49E-11	Attention deficit hyperactivity disorder symptom score	
BRCA	cis	1	rs56159542	chr19:19682971	YJEFN3	chr19:19639720-19648393:+	0.14	3.68	0.000249	Attention deficit hyperactivity disorder symptom score	
BRCA	cis	1	rs56160723	chr10:91373631	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.76	0.000178	Metabolic traits	
BRCA	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.7	-20.32	7.7E-78	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs561779	chr4:46238778	GABRA2	chr4:46251581-46392421:-	0.13	3.54	0.000412	Epilepsy	
BRCA	cis	1	rs56184857	chr1:119468861	WARS2	chr1:119573841-119683295:-	0.26	4.89	1.15E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs56190030	chr1:11887382	CLCN6	chr1:11866207-11907674:+	0.17	4.95	8.59E-7	QRS complex (12-leadsum)	
BRCA	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.64	15.33	4.4E-48	Diastolic blood pressure	
BRCA	cis	1	rs56222556	chr2:242364119	ANO7	chr2:242127924-242164791:+	0.23	3.74	0.000197	Prostate cancer	
BRCA	cis	1	rs56243714	chr2:207641069	MDH1B	chr2:207598943-207630050:-	-0.22	-4.88	1.23E-6	Height	
BRCA	cis	1	rs56278218	chr15:84626694	LOC388152	chr15:84867600-84898920:-	0.21	5.38	9.35E-8	Sitting height ratio	
BRCA	cis	1	rs56278218	chr15:84626694	WDR73	chr15:85186012-85197524:-	0.16	3.75	0.000185	Sitting height ratio	
BRCA	cis	1	rs56280028	chr9:73088034	KLF9	chr9:72999515-73029573:-	-0.12	-3.75	0.000189	Migraine with aura	
BRCA	cis	1	rs56291018	chr7:65390339	CCT6P1	chr7:65216092-65228661:+	0.35	7.57	8.34E-14	Diabetic kidney disease	
BRCA	cis	1	rs56291018	chr7:65390339	LOC493754	chr7:65993446-66057363:-	0.21	3.47	0.000546	Diabetic kidney disease	
BRCA	cis	1	rs56291018	chr7:65390339	ZNF117	chr7:64434830-64467121:-	-0.27	-4.92	9.79E-7	Diabetic kidney disease	
BRCA	cis	1	rs56297666	chr2:160902023	LY75	chr2:160625141-160761262:-	0.15	4.99	7.16E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs56297666	chr2:160902023	PLA2R1	chr2:160798012-160919121:-	0.16	5.35	1.08E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs563026	chr1:183161037	LAMC2	chr1:183155174-183214262:+	0.11	3.8	0.000155	Hypertriglyceridemia	
BRCA	cis	1	rs56306402	chr20:33937704	CPNE1	chr20:34213968-34262539:-	0.24	6.4	2.38E-10	Height	
BRCA	cis	1	rs56306402	chr20:33937704	ERGIC3	chr20:34129778-34145404:+	0.12	3.44	0.000612	Height	
BRCA	cis	1	rs56306402	chr20:33937704	MMP24	chr20:33814539-33864804:+	0.15	4.31	1.75E-5	Height	
BRCA	cis	1	rs56306402	chr20:33937704	UQCC	chr20:33890383-33999833:-	0.33	9.96	2.11E-22	Height	
BRCA	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.26	6.84	1.36E-11	Cognitive performance	
BRCA	cis	1	rs56314138	chr3:121356656	SLC15A2	chr3:121613171-121663034:+	-0.14	-4.05	5.45E-5	Cognitive performance	
BRCA	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.66	-19.91	2.92E-75	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs56322409	chr10:97395962	ENTPD1	chr10:97471536-97637022:+	0.17	5.86	6.16E-9	Blood metabolite levels	
BRCA	cis	1	rs56326127	chr2:86212201	POLR1A	chr2:86253453-86333278:-	-0.24	-3.88	0.00011	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs563538	chr13:37433721	ALG5	chr13:37523910-37573504:-	0.31	4.78	2.01E-6	Spontaneous preterm birth (preterm birth)	
BRCA	cis	1	rs563538	chr13:37433721	EXOSC8	chr13:37574678-37583749:+	0.31	5.59	2.92E-8	Spontaneous preterm birth (preterm birth)	
BRCA	cis	1	rs563538	chr13:37433721	FAM48A	chr13:37583453-37633850:-	0.25	4.14	3.74E-5	Spontaneous preterm birth (preterm birth)	
BRCA	cis	1	rs56364559	chr7:77480561	PHTF2	chr7:77428109-77586818:+	-0.17	-4.82	1.64E-6	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs56365761	chr19:39148103	LGALS7	chr19:39261608-39264157:-	-0.17	-5.09	4.26E-7	Heart rate	
BRCA	cis	1	rs56373916	chr15:84626741	LOC388152	chr15:84867600-84898920:-	0.18	5.08	4.48E-7	Sitting height ratio	
BRCA	cis	1	rs56383420	chr2:242219281	ANO7	chr2:242127924-242164791:+	0.22	3.68	0.000247	Prostate cancer	
BRCA	cis	1	rs56390833	chr15:78877381	AGPHD1	chr15:78799906-78829714:+	-0.15	-3.43	0.00062	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs56390833	chr15:78877381	CHRNA5	chr15:78857906-78886458:+	-0.2	-5.91	4.53E-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs56400413	chr7:77340821	PHTF2	chr7:77428109-77586818:+	-0.15	-4.38	1.32E-5	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs566625	chr1:183161441	LAMC2	chr1:183155174-183214262:+	-0.1	-3.52	0.00045	Hypertriglyceridemia	
BRCA	cis	1	rs566776	chr4:46241929	GABRA2	chr4:46251581-46392421:-	0.16	4.47	8.57E-6	Epilepsy	
BRCA	cis	1	rs567926	chr4:46241769	GABRA2	chr4:46251581-46392421:-	-0.13	-3.69	0.000234	Epilepsy	
BRCA	cis	1	rs568129	chr6:84229114	PRSS35	chr6:84222274-84235419:+	0.14	4.13	3.98E-5	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs568129	chr6:84229114	SNAP91	chr6:84262607-84419127:-	-0.15	-4	6.86E-5	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs568328	chr10:13081704	CCDC3	chr10:12938625-13141713:-	-0.15	-3.41	0.000683	Coronary artery aneurysm in Kawasaki disease	
BRCA	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.55	-28.2	3.59E-131	Crohn's disease	
BRCA	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.37	10.26	1.34E-23	Crohn's disease	
BRCA	cis	1	rs56884994	chr1:247211057	ZNF670	chr1:247200087-247242069:-	-0.25	-6.93	7.35E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs56901035	chr8:96043188	C8orf38	chr8:95908040-96088396:+	-0.18	-4.47	8.83E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs569856	chr10:105942304	C10orf79	chr10:105889647-105992120:-	0.14	5.11	3.82E-7	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs56985706	chr7:65394562	CCT6P1	chr7:65216092-65228661:+	0.33	7.26	7.5E-13	Diabetic kidney disease	
BRCA	cis	1	rs56985706	chr7:65394562	LOC493754	chr7:65993446-66057363:-	0.21	3.56	0.000384	Diabetic kidney disease	
BRCA	cis	1	rs56985706	chr7:65394562	ZNF117	chr7:64434830-64467121:-	-0.27	-4.94	9.17E-7	Diabetic kidney disease	
BRCA	cis	1	rs569967	chr10:105942337	C10orf79	chr10:105889647-105992120:-	0.14	5.11	3.82E-7	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs57025426	chr10:102205868	SEC31B	chr10:102246403-102289636:-	-0.28	-10.3	9.13E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs57049169	chr18:46565797	DYM	chr18:46570172-46987079:-	0.23	3.86	0.000122	Height	
BRCA	cis	1	rs570524	chr9:15295483	TTC39B	chr9:15171561-15307244:-	-0.17	-3.51	0.000462	Coenzyme Q10 levels;Metabolite levels (lipoprotein measures)	
BRCA	cis	1	rs57057549	chr7:65405738	CCT6P1	chr7:65216092-65228661:+	0.35	7.68	3.51E-14	Diabetic kidney disease	
BRCA	cis	1	rs57057549	chr7:65405738	LOC493754	chr7:65993446-66057363:-	0.2	3.45	0.000573	Diabetic kidney disease	
BRCA	cis	1	rs57057549	chr7:65405738	ZNF117	chr7:64434830-64467121:-	-0.28	-5.06	5.04E-7	Diabetic kidney disease	
BRCA	cis	1	rs571576	chr4:46236233	GABRA2	chr4:46251581-46392421:-	-0.13	-3.59	0.000339	Epilepsy	
BRCA	cis	1	rs571676	chr6:13718872	RANBP9	chr6:13621731-13711796:-	-0.11	-3.58	0.000359	Breast cancer	
BRCA	cis	1	rs57196672	chr2:242235193	ANO7	chr2:242127924-242164791:+	0.21	3.46	0.000569	Prostate cancer	
BRCA	cis	1	rs57201867	chr14:66093872	LOC645431	chr14:65877313-65879335:-	-0.3	-5.99	2.93E-9	Ischemic stroke	
BRCA	cis	1	rs572227	chr4:46251393	GABRA2	chr4:46251581-46392421:-	-0.13	-3.74	0.000193	Epilepsy	
BRCA	cis	1	rs57279772	chr12:56698960	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.29E-5	Psoriasis vulgaris	
BRCA	cis	1	rs57279772	chr12:56698960	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.000187	Psoriasis vulgaris	
BRCA	cis	1	rs57279772	chr12:56698960	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000365	Psoriasis vulgaris	
BRCA	cis	1	rs573400	chr4:46252066	GABRA2	chr4:46251581-46392421:-	0.12	3.57	0.00037	Epilepsy	
BRCA	cis	1	rs574091	chr4:46228078	GABRA2	chr4:46251581-46392421:-	-0.13	-3.61	0.000323	Epilepsy	
BRCA	cis	1	rs5743112	chr2:190708982	ORMDL1	chr2:190634994-190649097:-	0.23	3.86	0.000122	Subcutaneous adipose tissue	
BRCA	cis	1	rs5743117	chr2:190714245	ORMDL1	chr2:190634994-190649097:-	0.22	3.74	0.000191	Subcutaneous adipose tissue	
BRCA	cis	1	rs5743202	chr2:190742666	ORMDL1	chr2:190634994-190649097:-	0.33	4.63	4.08E-6	Subcutaneous adipose tissue	
BRCA	cis	1	rs5743208	chr2:190743048	ORMDL1	chr2:190634994-190649097:-	-0.22	-3.85	0.000125	Subcutaneous adipose tissue	
BRCA	cis	1	rs5745392	chr1:76306809	ACADM	chr1:76190043-76229353:+	-0.21	-3.99	7.18E-5	Attention function in attention deficit hyperactive disorder	
BRCA	cis	1	rs5745568	chr6:33548394	BAK1	chr6:33540324-33548070:-	-0.14	-3.58	0.000359	Platelet count	
BRCA	cis	1	rs5745582	chr6:33546498	BAK1	chr6:33540324-33548070:-	-0.16	-4.46	9.23E-6	Platelet count	
BRCA	cis	1	rs57461652	chr11:118146197	AMICA1	chr11:118064442-118095809:-	0.06	3.97	7.72E-5	Pain	
BRCA	cis	1	rs57461652	chr11:118146197	MPZL3	chr11:118100337-118123011:-	0.09	3.54	0.000416	Pain	
BRCA	cis	1	rs57461652	chr11:118146197	SCN2B	chr11:118033519-118047337:-	0.1	4.66	3.54E-6	Pain	
BRCA	cis	1	rs57463944	chr11:16400535	C11orf58	chr11:16760148-16779901:+	0.22	3.87	0.000117	Obesity and osteoporosis	
BRCA	cis	1	rs5750630	chr22:38985818	JOSD1	chr22:39081549-39096459:-	-0.13	-4.24	2.38E-5	Resting heart rate	
BRCA	cis	1	rs5750659	chr22:39068789	DDX17	chr22:38879445-38903665:-	-0.1	-3.39	0.000733	Resting heart rate	
BRCA	cis	1	rs5750659	chr22:39068789	JOSD1	chr22:39081549-39096459:-	-0.12	-4.06	5.24E-5	Resting heart rate	
BRCA	cis	1	rs5750659	chr22:39068789	TOMM22	chr22:39077954-39080763:+	-0.1	-3.45	0.000581	Resting heart rate	
BRCA	cis	1	rs5750662	chr22:39072472	DDX17	chr22:38879445-38903665:-	-0.1	-3.43	0.000627	Resting heart rate	
BRCA	cis	1	rs5750662	chr22:39072472	JOSD1	chr22:39081549-39096459:-	-0.13	-4.18	3.12E-5	Resting heart rate	
BRCA	cis	1	rs5750662	chr22:39072472	TOMM22	chr22:39077954-39080763:+	-0.11	-3.63	0.000297	Resting heart rate	
BRCA	cis	1	rs5750664	chr22:39072769	DDX17	chr22:38879445-38903665:-	-0.1	-3.43	0.000627	Resting heart rate	
BRCA	cis	1	rs5750664	chr22:39072769	JOSD1	chr22:39081549-39096459:-	-0.13	-4.18	3.12E-5	Resting heart rate	
BRCA	cis	1	rs5750664	chr22:39072769	TOMM22	chr22:39077954-39080763:+	-0.11	-3.63	0.000297	Resting heart rate	
BRCA	cis	1	rs5750668	chr22:39079964	DDX17	chr22:38879445-38903665:-	-0.1	-3.48	0.000512	Resting heart rate	
BRCA	cis	1	rs5750668	chr22:39079964	JOSD1	chr22:39081549-39096459:-	-0.13	-4.3	1.9E-5	Resting heart rate	
BRCA	cis	1	rs5750668	chr22:39079964	TOMM22	chr22:39077954-39080763:+	-0.11	-3.77	0.000171	Resting heart rate	
BRCA	cis	1	rs5750669	chr22:39080638	DDX17	chr22:38879445-38903665:-	-0.11	-3.51	0.000467	Resting heart rate	
BRCA	cis	1	rs5750669	chr22:39080638	JOSD1	chr22:39081549-39096459:-	-0.14	-4.46	9.07E-6	Resting heart rate	
BRCA	cis	1	rs5750669	chr22:39080638	TOMM22	chr22:39077954-39080763:+	-0.11	-3.61	0.000321	Resting heart rate	
BRCA	cis	1	rs5750672	chr22:39104168	APOBEC3C	chr22:39410265-39414823:+	0.09	3.42	0.000656	Resting heart rate	
BRCA	cis	1	rs5750672	chr22:39104168	CBX7	chr22:39526790-39548538:-	0.08	3.53	0.00044	Resting heart rate	
BRCA	cis	1	rs5750672	chr22:39104168	DDX17	chr22:38879445-38903665:-	0.11	3.75	0.000183	Resting heart rate	
BRCA	cis	1	rs5750672	chr22:39104168	GTPBP1	chr22:39101807-39129590:+	0.13	3.69	0.000239	Resting heart rate	
BRCA	cis	1	rs5750672	chr22:39104168	JOSD1	chr22:39081549-39096459:-	0.14	4.6	4.75E-6	Resting heart rate	
BRCA	cis	1	rs5750672	chr22:39104168	TOMM22	chr22:39077954-39080763:+	0.11	3.81	0.000149	Resting heart rate	
BRCA	cis	1	rs5750673	chr22:39110124	DDX17	chr22:38879445-38903665:-	-0.1	-3.45	0.000578	Resting heart rate	
BRCA	cis	1	rs5750673	chr22:39110124	JOSD1	chr22:39081549-39096459:-	-0.13	-4.23	2.52E-5	Resting heart rate	
BRCA	cis	1	rs5750677	chr22:39147715	LOC646851	chr22:38974125-39052634:-	0.14	4.28	2.08E-5	Resting heart rate	
BRCA	cis	1	rs575100	chr4:46228221	GABRA2	chr4:46251581-46392421:-	-0.13	-3.61	0.000319	Epilepsy	
BRCA	cis	1	rs5751589	chr22:23475762	RTDR1	chr22:23401594-23484241:-	0.19	5.13	3.38E-7	Bone mineral density	
BRCA	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.69	-19.97	1.16E-75	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs575474	chr1:183158599	LAMC2	chr1:183155174-183214262:+	-0.11	-3.7	0.000226	Hypertriglyceridemia	
BRCA	cis	1	rs5756813	chr22:38175477	TRIOBP	chr22:38082344-38172562:+	-0.16	-5.47	5.75E-8	Optic cup area;Vertical cup-disc ratio	
BRCA	cis	1	rs5757187	chr22:39021522	DDX17	chr22:38879445-38903665:-	0.11	3.84	0.000131	Resting heart rate	
BRCA	cis	1	rs5757187	chr22:39021522	JOSD1	chr22:39081549-39096459:-	0.13	4.28	2.02E-5	Resting heart rate	
BRCA	cis	1	rs5757187	chr22:39021522	TOMM22	chr22:39077954-39080763:+	0.11	3.71	0.000222	Resting heart rate	
BRCA	cis	1	rs5757193	chr22:39034867	JOSD1	chr22:39081549-39096459:-	0.14	4.19	3.04E-5	Resting heart rate	
BRCA	cis	1	rs5757193	chr22:39034867	NPTXR	chr22:39214458-39240017:-	0.15	3.56	0.000393	Resting heart rate	
BRCA	cis	1	rs5757226	chr22:39070550	DDX17	chr22:38879445-38903665:-	-0.1	-3.39	0.000733	Resting heart rate	
BRCA	cis	1	rs5757226	chr22:39070550	JOSD1	chr22:39081549-39096459:-	-0.12	-4.06	5.24E-5	Resting heart rate	
BRCA	cis	1	rs5757226	chr22:39070550	TOMM22	chr22:39077954-39080763:+	-0.1	-3.45	0.000581	Resting heart rate	
BRCA	cis	1	rs5757231	chr22:39071658	APOBEC3C	chr22:39410265-39414823:+	0.09	3.49	0.000511	Resting heart rate	
BRCA	cis	1	rs5757231	chr22:39071658	DDX17	chr22:38879445-38903665:-	0.11	3.82	0.00014	Resting heart rate	
BRCA	cis	1	rs5757231	chr22:39071658	JOSD1	chr22:39081549-39096459:-	0.14	4.41	1.12E-5	Resting heart rate	
BRCA	cis	1	rs5757231	chr22:39071658	TOMM22	chr22:39077954-39080763:+	0.11	3.76	0.00018	Resting heart rate	
BRCA	cis	1	rs5757232	chr22:39071677	APOBEC3C	chr22:39410265-39414823:+	-0.09	-3.41	0.000666	Resting heart rate	
BRCA	cis	1	rs5757232	chr22:39071677	DDX17	chr22:38879445-38903665:-	-0.1	-3.38	0.000741	Resting heart rate	
BRCA	cis	1	rs5757232	chr22:39071677	JOSD1	chr22:39081549-39096459:-	-0.13	-4.15	3.53E-5	Resting heart rate	
BRCA	cis	1	rs5757232	chr22:39071677	TOMM22	chr22:39077954-39080763:+	-0.1	-3.45	0.000577	Resting heart rate	
BRCA	cis	1	rs57576577	chr16:31036367	HSD3B7	chr16:30996519-31000473:+	0.23	7.22	9.9E-13	Response to metformin (IC50)	
BRCA	cis	1	rs57576577	chr16:31036367	MYST1	chr16:31128985-31142713:+	0.18	6.81	1.68E-11	Response to metformin (IC50)	
BRCA	cis	1	rs5759595	chr22:23471624	RTDR1	chr22:23401594-23484241:-	-0.17	-4.65	3.82E-6	Bone mineral density	
BRCA	cis	1	rs5759596	chr22:23475750	RTDR1	chr22:23401594-23484241:-	-0.17	-4.67	3.34E-6	Bone mineral density	
BRCA	cis	1	rs5759598	chr22:23480962	RTDR1	chr22:23401594-23484241:-	-0.17	-4.51	7.19E-6	Bone mineral density	
BRCA	cis	1	rs5770917	chr22:51017353	CPT1B	chr22:51007291-51017096:-	-0.17	-3.73	0.000198	Narcolepsy	
BRCA	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.25	9.66	3.28E-21	Response to temozolomide	
BRCA	cis	1	rs577544	chr4:46278859	GABRA2	chr4:46251581-46392421:-	-0.15	-4.31	1.8E-5	Epilepsy	
BRCA	cis	1	rs578056	chr11:65514874	CTSW	chr11:65647284-65651212:+	-0.17	-6.34	3.42E-10	Systemic lupus erythematosus	
BRCA	cis	1	rs578056	chr11:65514874	SNX32	chr11:65601410-65621170:+	0.2	4.91	1.04E-6	Systemic lupus erythematosus	
BRCA	cis	1	rs57928699	chr18:44645593	HDHD2	chr18:44633782-44676871:-	0.3	5.16	3.01E-7	Sitting height ratio	
BRCA	cis	1	rs58053556	chr1:10442903	PGD	chr1:10459085-10480200:+	0.24	6.5	1.25E-10	Hepatocellular carcinoma	
BRCA	cis	1	rs58062456	chr7:65394852	CCT6P1	chr7:65216092-65228661:+	0.33	7.26	7.5E-13	Diabetic kidney disease	
BRCA	cis	1	rs58062456	chr7:65394852	LOC493754	chr7:65993446-66057363:-	0.21	3.56	0.000384	Diabetic kidney disease	
BRCA	cis	1	rs58062456	chr7:65394852	ZNF117	chr7:64434830-64467121:-	-0.27	-4.94	9.17E-7	Diabetic kidney disease	
BRCA	cis	1	rs58162302	chr11:118146199	AMICA1	chr11:118064442-118095809:-	0.06	3.97	7.72E-5	Pain	
BRCA	cis	1	rs58162302	chr11:118146199	MPZL3	chr11:118100337-118123011:-	0.09	3.54	0.000416	Pain	
BRCA	cis	1	rs58162302	chr11:118146199	SCN2B	chr11:118033519-118047337:-	0.1	4.66	3.54E-6	Pain	
BRCA	cis	1	rs581686	chr10:105983356	C10orf79	chr10:105889647-105992120:-	0.13	4.73	2.52E-6	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs58288071	chr2:203214739	NOP58	chr2:203130515-203168382:+	0.15	3.49	0.000501	Urate levels	
BRCA	cis	1	rs58335703	chr10:96508000	HELLS	chr10:96305543-96361855:+	0.12	3.42	0.000651	Migraine	
BRCA	cis	1	rs58349349	chr10:96553499	C10orf129	chr10:96953957-96988685:+	0.22	4.09	4.54E-5	Blood metabolite levels	
BRCA	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.18	5	6.68E-7	Schizophrenia (negative symptoms)	
BRCA	cis	1	rs58365138	chr2:86213105	POLR1A	chr2:86253453-86333278:-	-0.24	-3.74	0.000197	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs584309	chr10:105956776	C10orf79	chr10:105889647-105992120:-	0.14	4.83	1.55E-6	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs58453750	chr2:17778329	GEN1	chr2:17935162-17966632:+	0.15	3.5	0.000482	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs58455759	chr1:171674987	VAMP4	chr1:171669298-171711214:-	0.19	5.42	7.32E-8	Hippocampal atrophy	
BRCA	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.68	-20.11	1.71E-76	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs58507982	chr11:118146510	AMICA1	chr11:118064442-118095809:-	0.06	3.97	7.72E-5	Pain	
BRCA	cis	1	rs58507982	chr11:118146510	MPZL3	chr11:118100337-118123011:-	0.09	3.54	0.000416	Pain	
BRCA	cis	1	rs58507982	chr11:118146510	SCN2B	chr11:118033519-118047337:-	0.1	4.66	3.54E-6	Pain	
BRCA	cis	1	rs58515922	chr2:86173037	MRPL35	chr2:86426556-86440476:+	0.31	4.23	2.54E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs58515922	chr2:86173037	POLR1A	chr2:86253453-86333278:-	-0.2	-3.61	0.000322	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs58515922	chr2:86173037	REEP1	chr2:86441122-86564777:-	0.25	3.58	0.000358	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs58515922	chr2:86173037	ST3GAL5	chr2:86066271-86116157:-	0.26	3.43	0.000616	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs58549151	chr1:10314657	PGD	chr1:10459085-10480200:+	0.2	5.52	4.32E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs58613639	chr3:119290964	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs58669269	chr7:65951953	CCT6P1	chr7:65216092-65228661:+	0.32	6.81	1.64E-11	Diabetic kidney disease	
BRCA	cis	1	rs58669269	chr7:65951953	LOC493754	chr7:65993446-66057363:-	0.25	4.22	2.62E-5	Diabetic kidney disease	
BRCA	cis	1	rs58686314	chr2:86123967	POLR1A	chr2:86253453-86333278:-	-0.19	-3.38	0.000754	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs58749629	chr20:44571317	PLTP	chr20:44527397-44540786:-	0.19	4.81	1.76E-6	Abdominal aortic aneurysm	
BRCA	cis	1	rs58749629	chr20:44571317	WFDC3	chr20:44402847-44420547:-	-0.44	-8.3	3.04E-16	Abdominal aortic aneurysm	
BRCA	cis	1	rs58852079	chr12:56706922	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.29E-5	Psoriasis vulgaris	
BRCA	cis	1	rs58852079	chr12:56706922	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.000187	Psoriasis vulgaris	
BRCA	cis	1	rs58852079	chr12:56706922	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000365	Psoriasis vulgaris	
BRCA	cis	1	rs58898686	chr2:86216909	POLR1A	chr2:86253453-86333278:-	-0.28	-4.59	4.96E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs58923657	chr7:50472842	FIGNL1	chr7:50511834-50518088:-	-0.11	-3.43	0.000627	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs58924738	chr3:119290528	CD80	chr3:119243142-119278481:-	0.13	4.48	8.38E-6	Vitiligo	
BRCA	cis	1	rs58994922	chr8:65641267	CYP7B1	chr8:65508529-65711348:-	0.12	3.8	0.00015	HIV-1 susceptibility	
BRCA	cis	1	rs59032271	chr5:148618749	CDX1	chr5:149546344-149564120:+	-0.12	-3.89	0.000105	Body mass index	
BRCA	cis	1	rs59104589	chr2:242237902	ANO7	chr2:242127924-242164791:+	0.17	3.91	9.89E-5	Fibrinogen levels	
BRCA	cis	1	rs59117465	chr14:66052472	LOC645431	chr14:65877313-65879335:-	-0.29	-5.64	2.24E-8	Ischemic stroke	
BRCA	cis	1	rs59123962	chr4:103512451	MANBA	chr4:103552644-103682151:-	0.17	4.16	3.42E-5	Ulcerative colitis	
BRCA	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.3	8.02	2.71E-15	Pancreatic cancer	
BRCA	cis	1	rs591668	chr3:27535931	NEK10	chr3:27152395-27410912:-	0.13	4.46	9.19E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs591784	chr10:105936290	C10orf79	chr10:105889647-105992120:-	0.14	4.92	9.96E-7	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs591992	chr12:121019323	GATC	chr12:120884284-120897761:+	-0.14	-3.61	0.000316	Type 1 diabetes nephropathy	
BRCA	cis	1	rs591992	chr12:121019323	POP5	chr12:121016849-121019201:-	-0.15	-3.73	0.0002	Type 1 diabetes nephropathy	
BRCA	cis	1	rs59204447	chr14:66106727	LOC645431	chr14:65877313-65879335:-	-0.33	-6.87	1.11E-11	Ischemic stroke	
BRCA	cis	1	rs59223102	chr3:119295064	CD80	chr3:119243142-119278481:-	0.12	4.07	4.98E-5	Vitiligo	
BRCA	cis	1	rs59227481	chr12:110007993	KCTD10	chr12:109886460-109915155:-	-0.15	-4.76	2.21E-6	Age-related nuclear cataracts	
BRCA	cis	1	rs59227481	chr12:110007993	MYO1H	chr12:109826524-109886176:+	0.18	5.57	3.17E-8	Age-related nuclear cataracts	
BRCA	cis	1	rs59295315	chr12:56708576	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.29E-5	Psoriasis vulgaris	
BRCA	cis	1	rs59295315	chr12:56708576	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.000187	Psoriasis vulgaris	
BRCA	cis	1	rs59295315	chr12:56708576	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000365	Psoriasis vulgaris	
BRCA	cis	1	rs593151	chr10:105935979	C10orf79	chr10:105889647-105992120:-	0.14	4.91	1.04E-6	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs59363432	chr14:74397545	LIN52	chr14:74551656-74667117:+	0.29	6.47	1.47E-10	Morning vs. evening chronotype	
BRCA	cis	1	rs59374417	chr3:119288414	CD80	chr3:119243142-119278481:-	0.12	4.23	2.55E-5	Vitiligo	
BRCA	cis	1	rs594074	chr6:6552994	LY86	chr6:6588934-6655216:+	0.15	6.25	5.91E-10	Diabetic kidney disease	
BRCA	cis	1	rs59468948	chr1:156288058	BGLAP	chr1:156182784-156213112:+	0.19	5.12	3.57E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs59498179	chr1:146872147	CHD1L	chr1:146714291-146767441:+	-0.16	-3.64	0.000289	Protein quantitative trait loci	
BRCA	cis	1	rs595018	chr11:60592276	TMEM109	chr11:60681371-60690913:+	0.16	3.54	0.000413	Wegener's granulomatosis	
BRCA	cis	1	rs59570296	chr12:62821258	FAM19A2	chr12:62102043-62653925:-	0.17	3.72	0.000213	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs59606579	chr6:25608370	HIST1H2BC	chr6:26114633-26124154:-	0.14	3.43	0.000637	Uric acid levels	
BRCA	cis	1	rs59606579	chr6:25608370	SCGN	chr6:25652429-25702006:+	0.2	5.39	8.45E-8	Uric acid levels	
BRCA	cis	1	rs59626664	chr12:56636975	COQ10A	chr12:56660642-56664748:+	-0.29	-4.09	4.65E-5	Psoriasis vulgaris	
BRCA	cis	1	rs59626664	chr12:56636975	RPS26	chr12:56435686-56438005:+	-0.29	-3.69	0.000233	Psoriasis vulgaris	
BRCA	cis	1	rs59626664	chr12:56636975	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.9	0.000102	Psoriasis vulgaris	
BRCA	cis	1	rs59685862	chr14:66080130	LOC645431	chr14:65877313-65879335:-	-0.32	-6.78	1.96E-11	Ischemic stroke	
BRCA	cis	1	rs59757169	chr5:148618752	CDX1	chr5:149546344-149564120:+	-0.12	-3.89	0.000105	Body mass index	
BRCA	cis	1	rs59762006	chr3:119280625	CD80	chr3:119243142-119278481:-	0.12	4.13	3.99E-5	Vitiligo	
BRCA	cis	1	rs59770215	chr6:159371062	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs59794892	chr7:65415873	CCT6P1	chr7:65216092-65228661:+	0.33	7.32	4.93E-13	Diabetic kidney disease	
BRCA	cis	1	rs59794892	chr7:65415873	LOC493754	chr7:65993446-66057363:-	0.21	3.63	0.0003	Diabetic kidney disease	
BRCA	cis	1	rs59794892	chr7:65415873	ZNF117	chr7:64434830-64467121:-	-0.26	-4.86	1.38E-6	Diabetic kidney disease	
BRCA	cis	1	rs59811639	chr12:56695954	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.29E-5	Psoriasis vulgaris	
BRCA	cis	1	rs59811639	chr12:56695954	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.000187	Psoriasis vulgaris	
BRCA	cis	1	rs59811639	chr12:56695954	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000365	Psoriasis vulgaris	
BRCA	cis	1	rs59828023	chr3:119295156	CD80	chr3:119243142-119278481:-	0.12	4.07	4.98E-5	Vitiligo	
BRCA	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.66	-19.96	1.48E-75	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs59947468	chr2:86289436	LOC90784	chr2:86247339-86250991:-	-0.45	-5.47	5.52E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs59954246	chr5:112691505	YTHDC2	chr5:112849410-112930979:+	0.15	4.33	1.63E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs59989824	chr7:118175322	ANKRD7	chr7:117864712-117882782:+	0.13	3.4	0.000703	Response to platinum-based chemotherapy in non-small-cell lung cancer	
BRCA	cis	1	rs6001191	chr22:39074452	DDX17	chr22:38879445-38903665:-	-0.1	-3.43	0.000627	Resting heart rate	
BRCA	cis	1	rs6001191	chr22:39074452	JOSD1	chr22:39081549-39096459:-	-0.13	-4.18	3.12E-5	Resting heart rate	
BRCA	cis	1	rs6001191	chr22:39074452	TOMM22	chr22:39077954-39080763:+	-0.11	-3.63	0.000297	Resting heart rate	
BRCA	cis	1	rs6001214	chr22:39149155	LOC646851	chr22:38974125-39052634:-	0.15	4.29	1.94E-5	Resting heart rate	
BRCA	cis	1	rs6003518	chr22:23471533	RTDR1	chr22:23401594-23484241:-	-0.17	-4.5	7.64E-6	Bone mineral density	
BRCA	cis	1	rs601019	chr10:105976452	C10orf79	chr10:105889647-105992120:-	-0.12	-4.32	1.68E-5	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs601338	chr19:49206674	FUT2	chr19:49199228-49209190:+	-0.3	-7.45	1.92E-13	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs601338	chr19:49206674	NTN5	chr19:49164666-49176264:-	0.11	3.8	0.000156	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs601338	chr19:49206674	RASIP1	chr19:49223843-49243970:-	0.14	4.75	2.32E-6	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs60144605	chr1:76359699	ACADM	chr1:76190043-76229353:+	-0.21	-4.11	4.23E-5	Attention function in attention deficit hyperactive disorder	
BRCA	cis	1	rs60146975	chr6:159358206	RSPH3	chr6:159398268-159421198:-	0.21	3.75	0.000187	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.69	-20.23	2.82E-77	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs60184524	chr19:44294215	LYPD5	chr19:44300080-44324808:-	-0.13	-3.75	0.000184	Breast cancer	
BRCA	cis	1	rs60184524	chr19:44294215	ZNF155	chr19:44488355-44502477:+	-0.14	-3.91	9.62E-5	Breast cancer	
BRCA	cis	1	rs60184524	chr19:44294215	ZNF404	chr19:44376516-44384288:-	-0.22	-6.02	2.43E-9	Breast cancer	
BRCA	cis	1	rs60184731	chr3:119291720	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs601923	chr5:176417386	MXD3	chr5:176732501-176739292:-	-0.09	-4.31	1.76E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs601923	chr5:176417386	PRELID1	chr5:176730835-176733949:+	-0.09	-3.49	0.000504	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs60228288	chr18:44640412	HDHD2	chr18:44633782-44676871:-	0.3	5.16	3.01E-7	Sitting height ratio	
BRCA	cis	1	rs6028335	chr20:37845477	DHX35	chr20:37591000-37668363:+	-0.18	-3.81	0.000148	Alcohol and nictotine co-dependence	
BRCA	cis	1	rs60326618	chr7:66166358	CCT6P1	chr7:65216092-65228661:+	0.31	6.55	9.18E-11	Gout	
BRCA	cis	1	rs60326618	chr7:66166358	LOC493754	chr7:65993446-66057363:-	0.23	3.88	0.000109	Gout	
BRCA	cis	1	rs60340200	chr1:27287716	GPATCH3	chr1:27216980-27226962:-	0.22	3.92	9.59E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs6036476	chr20:23610308	CST1	chr20:23728191-23731574:-	0.22	4.67	3.45E-6	Chronic kidney disease	
BRCA	cis	1	rs6036478	chr20:23611359	CST1	chr20:23728191-23731574:-	0.22	4.69	3.03E-6	Chronic kidney disease	
BRCA	cis	1	rs6037086	chr20:25306338	ABHD12	chr20:25275380-25371477:-	-0.12	-3.54	0.000418	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037086	chr20:25306338	FAM182A	chr20:26035250-26067552:+	0.23	6.04	2.18E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037086	chr20:25306338	FAM182B	chr20:25744102-25848786:-	-0.22	-5.74	1.2E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037095	chr20:25335687	FAM182A	chr20:26035250-26067552:+	0.22	5.74	1.25E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037095	chr20:25335687	FAM182B	chr20:25744102-25848786:-	-0.22	-5.84	6.73E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037099	chr20:25356876	FAM182A	chr20:26035250-26067552:+	0.21	5.59	2.83E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037099	chr20:25356876	FAM182B	chr20:25744102-25848786:-	-0.24	-6.4	2.26E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037105	chr20:25374199	FAM182A	chr20:26035250-26067552:+	0.21	5.59	2.83E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037105	chr20:25374199	FAM182B	chr20:25744102-25848786:-	-0.24	-6.4	2.26E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037121	chr20:25428311	FAM182A	chr20:26035250-26067552:+	-0.23	-6.12	1.31E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037121	chr20:25428311	FAM182B	chr20:25744102-25848786:-	0.24	6.18	9.04E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037121	chr20:25428311	PYGB	chr20:25228706-25278647:+	-0.13	-3.52	0.000454	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6037526	chr20:3251248	ITPA	chr20:3190056-3204504:+	-0.12	-3.5	0.000488	IFN-related cytopenia	
BRCA	cis	1	rs6037532	chr20:3267911	ITPA	chr20:3190056-3204504:+	-0.12	-3.59	0.000343	IFN-related cytopenia	
BRCA	cis	1	rs6037533	chr20:3268817	ITPA	chr20:3190056-3204504:+	-0.12	-3.57	0.000368	IFN-related cytopenia	
BRCA	cis	1	rs6037535	chr20:3270621	ITPA	chr20:3190056-3204504:+	-0.13	-3.8	0.000154	IFN-related cytopenia	
BRCA	cis	1	rs6037547	chr20:3299228	ITPA	chr20:3190056-3204504:+	-0.13	-3.8	0.000152	IFN-related cytopenia	
BRCA	cis	1	rs6037551	chr20:3306690	ITPA	chr20:3190056-3204504:+	-0.12	-3.44	0.000594	IFN-related cytopenia	
BRCA	cis	1	rs6037560	chr20:3323055	ITPA	chr20:3190056-3204504:+	-0.13	-3.71	0.000214	IFN-related cytopenia	
BRCA	cis	1	rs6037562	chr20:3326141	ITPA	chr20:3190056-3204504:+	-0.13	-3.93	9.02E-5	IFN-related cytopenia	
BRCA	cis	1	rs6037567	chr20:3332160	ITPA	chr20:3190056-3204504:+	-0.13	-3.93	8.98E-5	IFN-related cytopenia	
BRCA	cis	1	rs6037579	chr20:3347980	ITPA	chr20:3190056-3204504:+	-0.13	-3.81	0.000148	IFN-related cytopenia	
BRCA	cis	1	rs6037583	chr20:3360632	ITPA	chr20:3190056-3204504:+	-0.12	-3.53	0.000426	IFN-related cytopenia	
BRCA	cis	1	rs6037590	chr20:3374085	ITPA	chr20:3190056-3204504:+	-0.14	-4.06	5.28E-5	IFN-related cytopenia	
BRCA	cis	1	rs60376560	chr11:18453742	LDHC	chr11:18433853-18472792:+	-0.29	-5.16	3.01E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs60422392	chr18:44621473	HDHD2	chr18:44633782-44676871:-	0.3	5.17	2.85E-7	Sitting height ratio	
BRCA	cis	1	rs60479377	chr2:86283948	LOC90784	chr2:86247339-86250991:-	-0.33	-4.15	3.61E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.7	-20.43	1.48E-78	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs6048956	chr20:23609301	CST1	chr20:23728191-23731574:-	0.22	4.65	3.73E-6	Chronic kidney disease	
BRCA	cis	1	rs6050542	chr20:25318879	FAM182A	chr20:26035250-26067552:+	0.21	5.48	5.45E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050542	chr20:25318879	FAM182B	chr20:25744102-25848786:-	-0.23	-5.94	3.88E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050542	chr20:25318879	PYGB	chr20:25228706-25278647:+	0.13	3.44	0.000602	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050544	chr20:25320228	FAM182A	chr20:26035250-26067552:+	0.21	5.65	2.0E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050544	chr20:25320228	FAM182B	chr20:25744102-25848786:-	-0.22	-5.87	5.83E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050547	chr20:25326012	FAM182A	chr20:26035250-26067552:+	0.2	5.35	1.05E-7	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050547	chr20:25326012	FAM182B	chr20:25744102-25848786:-	-0.23	-6.02	2.46E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050547	chr20:25326012	PYGB	chr20:25228706-25278647:+	0.13	3.41	0.000681	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050555	chr20:25328543	FAM182A	chr20:26035250-26067552:+	0.21	5.34	1.11E-7	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050555	chr20:25328543	FAM182B	chr20:25744102-25848786:-	-0.25	-6.35	3.11E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050555	chr20:25328543	PYGB	chr20:25228706-25278647:+	0.14	3.61	0.000326	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050559	chr20:25329915	FAM182A	chr20:26035250-26067552:+	-0.21	-5.61	2.55E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050559	chr20:25329915	FAM182B	chr20:25744102-25848786:-	0.23	5.92	4.37E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050561	chr20:25334855	FAM182A	chr20:26035250-26067552:+	0.22	5.7	1.52E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050561	chr20:25334855	FAM182B	chr20:25744102-25848786:-	-0.24	-6.28	4.86E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050561	chr20:25334855	PYGB	chr20:25228706-25278647:+	0.13	3.5	0.000477	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050562	chr20:25336186	FAM182A	chr20:26035250-26067552:+	0.22	5.74	1.25E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050562	chr20:25336186	FAM182B	chr20:25744102-25848786:-	-0.22	-5.84	6.73E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050564	chr20:25344231	FAM182A	chr20:26035250-26067552:+	0.22	5.71	1.49E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050564	chr20:25344231	FAM182B	chr20:25744102-25848786:-	-0.24	-6.28	4.94E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050564	chr20:25344231	PYGB	chr20:25228706-25278647:+	0.13	3.51	0.000466	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050565	chr20:25347563	FAM182A	chr20:26035250-26067552:+	0.22	5.93	4.07E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050565	chr20:25347563	FAM182B	chr20:25744102-25848786:-	-0.25	-6.5	1.23E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050565	chr20:25347563	PYGB	chr20:25228706-25278647:+	0.15	3.95	8.21E-5	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050566	chr20:25351071	ABHD12	chr20:25275380-25371477:-	-0.11	-3.44	0.000604	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050566	chr20:25351071	FAM182A	chr20:26035250-26067552:+	0.21	5.68	1.72E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050566	chr20:25351071	FAM182B	chr20:25744102-25848786:-	-0.23	-6.03	2.22E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050573	chr20:25366065	FAM182A	chr20:26035250-26067552:+	-0.22	-5.95	3.57E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050573	chr20:25366065	FAM182B	chr20:25744102-25848786:-	0.25	6.43	1.88E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050573	chr20:25366065	PYGB	chr20:25228706-25278647:+	-0.13	-3.58	0.000361	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050590	chr20:25384994	FAM182A	chr20:26035250-26067552:+	0.21	5.66	1.94E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050590	chr20:25384994	FAM182B	chr20:25744102-25848786:-	-0.24	-6.27	5.22E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050598	chr20:25397257	FAM182A	chr20:26035250-26067552:+	-0.21	-5.56	3.37E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050598	chr20:25397257	FAM182B	chr20:25744102-25848786:-	0.24	6.38	2.59E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050599	chr20:25400240	FAM182A	chr20:26035250-26067552:+	0.22	5.85	6.64E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050599	chr20:25400240	FAM182B	chr20:25744102-25848786:-	-0.23	-6.08	1.69E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050602	chr20:25401203	FAM182A	chr20:26035250-26067552:+	0.22	5.91	4.7E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050602	chr20:25401203	FAM182B	chr20:25744102-25848786:-	-0.23	-6.05	1.97E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050609	chr20:25411751	FAM182A	chr20:26035250-26067552:+	0.23	6.04	2.06E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050609	chr20:25411751	FAM182B	chr20:25744102-25848786:-	-0.24	-6.25	5.94E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050609	chr20:25411751	PYGB	chr20:25228706-25278647:+	0.13	3.38	0.000747	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050617	chr20:25421648	FAM182A	chr20:26035250-26067552:+	-0.23	-6.12	1.31E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050617	chr20:25421648	FAM182B	chr20:25744102-25848786:-	0.24	6.18	9.04E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050617	chr20:25421648	PYGB	chr20:25228706-25278647:+	-0.13	-3.52	0.000454	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050626	chr20:25428261	FAM182A	chr20:26035250-26067552:+	-0.22	-6	2.64E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050626	chr20:25428261	FAM182B	chr20:25744102-25848786:-	0.24	6.25	5.92E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050626	chr20:25428261	PYGB	chr20:25228706-25278647:+	-0.13	-3.5	0.000487	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050629	chr20:25430680	FAM182A	chr20:26035250-26067552:+	-0.23	-6.12	1.31E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050629	chr20:25430680	FAM182B	chr20:25744102-25848786:-	0.24	6.18	9.04E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050629	chr20:25430680	PYGB	chr20:25228706-25278647:+	-0.13	-3.52	0.000454	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050630	chr20:25430745	FAM182A	chr20:26035250-26067552:+	-0.23	-6.12	1.31E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050630	chr20:25430745	FAM182B	chr20:25744102-25848786:-	0.24	6.18	9.04E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050630	chr20:25430745	PYGB	chr20:25228706-25278647:+	-0.13	-3.52	0.000454	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050631	chr20:25431749	FAM182A	chr20:26035250-26067552:+	-0.23	-6.07	1.79E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050631	chr20:25431749	FAM182B	chr20:25744102-25848786:-	0.23	5.9	4.87E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050632	chr20:25432601	FAM182A	chr20:26035250-26067552:+	-0.23	-6.12	1.31E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050632	chr20:25432601	FAM182B	chr20:25744102-25848786:-	0.24	6.18	9.16E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6050632	chr20:25432601	PYGB	chr20:25228706-25278647:+	-0.13	-3.52	0.000446	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.26	-9.94	2.47E-22	Longevity	
BRCA	cis	1	rs6051672	chr20:3224819	ITPA	chr20:3190056-3204504:+	-0.14	-3.9	0.000103	IFN-related cytopenia	
BRCA	cis	1	rs6051702	chr20:3251924	ITPA	chr20:3190056-3204504:+	-0.12	-3.5	0.000488	IFN-related cytopenia	
BRCA	cis	1	rs6051703	chr20:3252347	ITPA	chr20:3190056-3204504:+	-0.13	-3.67	0.000254	IFN-related cytopenia	
BRCA	cis	1	rs6051705	chr20:3253143	ITPA	chr20:3190056-3204504:+	-0.13	-3.67	0.000254	IFN-related cytopenia	
BRCA	cis	1	rs6051708	chr20:3262493	ITPA	chr20:3190056-3204504:+	-0.19	-5.35	1.09E-7	IFN-related cytopenia	
BRCA	cis	1	rs6051709	chr20:3263685	ITPA	chr20:3190056-3204504:+	-0.12	-3.6	0.000334	IFN-related cytopenia	
BRCA	cis	1	rs6051712	chr20:3265029	ITPA	chr20:3190056-3204504:+	-0.12	-3.63	0.000291	IFN-related cytopenia	
BRCA	cis	1	rs6051713	chr20:3265779	ITPA	chr20:3190056-3204504:+	0.12	3.72	0.00021	IFN-related cytopenia	
BRCA	cis	1	rs6051715	chr20:3266548	ITPA	chr20:3190056-3204504:+	-0.12	-3.63	0.000301	IFN-related cytopenia	
BRCA	cis	1	rs6051716	chr20:3267736	ITPA	chr20:3190056-3204504:+	-0.15	-4.21	2.72E-5	IFN-related cytopenia	
BRCA	cis	1	rs6051718	chr20:3270370	ITPA	chr20:3190056-3204504:+	-0.13	-3.85	0.000123	IFN-related cytopenia	
BRCA	cis	1	rs6051722	chr20:3274435	ITPA	chr20:3190056-3204504:+	-0.14	-3.98	7.3E-5	IFN-related cytopenia	
BRCA	cis	1	rs6051723	chr20:3278512	ITPA	chr20:3190056-3204504:+	-0.13	-3.81	0.000146	IFN-related cytopenia	
BRCA	cis	1	rs6051724	chr20:3279338	ITPA	chr20:3190056-3204504:+	-0.12	-3.5	0.00049	IFN-related cytopenia	
BRCA	cis	1	rs6051732	chr20:3294182	ITPA	chr20:3190056-3204504:+	-0.13	-3.64	0.000284	IFN-related cytopenia	
BRCA	cis	1	rs6051736	chr20:3296898	ITPA	chr20:3190056-3204504:+	-0.13	-3.83	0.000137	IFN-related cytopenia	
BRCA	cis	1	rs6051737	chr20:3296992	ITPA	chr20:3190056-3204504:+	-0.12	-3.46	0.000552	IFN-related cytopenia	
BRCA	cis	1	rs6051745	chr20:3307243	ITPA	chr20:3190056-3204504:+	-0.12	-3.63	0.000293	IFN-related cytopenia	
BRCA	cis	1	rs6051751	chr20:3310049	ITPA	chr20:3190056-3204504:+	-0.12	-3.63	0.000293	IFN-related cytopenia	
BRCA	cis	1	rs6051762	chr20:3321590	ITPA	chr20:3190056-3204504:+	-0.14	-3.9	0.000104	IFN-related cytopenia	
BRCA	cis	1	rs6051763	chr20:3321616	ITPA	chr20:3190056-3204504:+	-0.13	-3.67	0.000255	IFN-related cytopenia	
BRCA	cis	1	rs6051764	chr20:3321807	ITPA	chr20:3190056-3204504:+	0.13	3.85	0.000127	IFN-related cytopenia	
BRCA	cis	1	rs6051779	chr20:3333449	ITPA	chr20:3190056-3204504:+	-0.12	-3.65	0.00028	IFN-related cytopenia	
BRCA	cis	1	rs6051790	chr20:3342994	ITPA	chr20:3190056-3204504:+	-0.12	-3.49	0.000503	IFN-related cytopenia	
BRCA	cis	1	rs6051792	chr20:3343519	ITPA	chr20:3190056-3204504:+	-0.12	-3.49	0.000503	IFN-related cytopenia	
BRCA	cis	1	rs6051806	chr20:3350319	ITPA	chr20:3190056-3204504:+	-0.13	-3.82	0.00014	IFN-related cytopenia	
BRCA	cis	1	rs6051807	chr20:3350485	ITPA	chr20:3190056-3204504:+	-0.15	-4.1	4.46E-5	IFN-related cytopenia	
BRCA	cis	1	rs6051808	chr20:3350697	ITPA	chr20:3190056-3204504:+	-0.13	-3.73	0.000201	IFN-related cytopenia	
BRCA	cis	1	rs6051809	chr20:3352551	ITPA	chr20:3190056-3204504:+	-0.12	-3.65	0.000277	IFN-related cytopenia	
BRCA	cis	1	rs6051810	chr20:3355384	ITPA	chr20:3190056-3204504:+	-0.13	-3.71	0.000214	IFN-related cytopenia	
BRCA	cis	1	rs6051827	chr20:3372007	ITPA	chr20:3190056-3204504:+	-0.13	-3.82	0.000141	IFN-related cytopenia	
BRCA	cis	1	rs6051831	chr20:3373712	ITPA	chr20:3190056-3204504:+	0.12	3.5	0.000483	IFN-related cytopenia	
BRCA	cis	1	rs6051838	chr20:3389012	ITPA	chr20:3190056-3204504:+	-0.12	-3.47	0.000541	IFN-related cytopenia	
BRCA	cis	1	rs60554055	chr14:66068285	LOC645431	chr14:65877313-65879335:-	-0.28	-5.89	5.22E-9	Ischemic stroke	
BRCA	cis	1	rs60571765	chr4:76549046	G3BP2	chr4:76567955-76598667:-	-0.13	-4.26	2.22E-5	Magnesium levels	
BRCA	cis	1	rs6058219	chr20:33859244	MMP24	chr20:33814539-33864804:+	-0.19	-3.87	0.000116	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs6058352	chr20:30269179	COX4I2	chr20:30225691-30232800:+	0.17	6.57	7.79E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6058352	chr20:30269179	MYLK2	chr20:30407178-30422500:+	0.31	8.05	2.11E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6058465	chr20:30397691	COX4I2	chr20:30225691-30232800:+	0.17	6.59	6.83E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6058465	chr20:30397691	FRG1B	chr20:29611879-29653908:+	0.15	3.38	0.000747	Subcortical brain region volumes	
BRCA	cis	1	rs6058465	chr20:30397691	MYLK2	chr20:30407178-30422500:+	0.32	8.2	6.68E-16	Subcortical brain region volumes	
BRCA	cis	1	rs6058468	chr20:30406448	COX4I2	chr20:30225691-30232800:+	0.17	6.32	3.75E-10	Subcortical brain region volumes	
BRCA	cis	1	rs6058468	chr20:30406448	MYLK2	chr20:30407178-30422500:+	0.31	8.03	2.53E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6060235	chr20:33691652	MMP24	chr20:33814539-33864804:+	-0.2	-3.61	0.000326	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6060235	chr20:33691652	PROCR	chr20:33758727-33765164:+	-0.24	-5.03	5.67E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6060236	chr20:33692618	MMP24	chr20:33814539-33864804:+	-0.2	-3.52	0.000449	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6060236	chr20:33692618	PROCR	chr20:33758727-33765164:+	-0.23	-4.84	1.5E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6060244	chr20:33699435	PROCR	chr20:33758727-33765164:+	0.26	5.77	1.02E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6060245	chr20:33699625	MMP24	chr20:33814539-33864804:+	-0.2	-3.64	0.000288	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6060245	chr20:33699625	PROCR	chr20:33758727-33765164:+	-0.26	-5.6	2.68E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6060246	chr20:33701107	MMP24	chr20:33814539-33864804:+	-0.21	-3.85	0.000128	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6060246	chr20:33701107	PROCR	chr20:33758727-33765164:+	-0.25	-5.35	1.05E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6060401	chr20:34005214	CPNE1	chr20:34213968-34262539:-	0.23	6.09	1.55E-9	Height	
BRCA	cis	1	rs6060401	chr20:34005214	MMP24	chr20:33814539-33864804:+	0.14	4.06	5.28E-5	Height	
BRCA	cis	1	rs6060401	chr20:34005214	UQCC	chr20:33890383-33999833:-	0.32	9.52	1.11E-20	Height	
BRCA	cis	1	rs6060402	chr20:34005240	CPNE1	chr20:34213968-34262539:-	0.24	6.36	3.05E-10	Height	
BRCA	cis	1	rs6060402	chr20:34005240	MMP24	chr20:33814539-33864804:+	0.15	4.13	3.95E-5	Height	
BRCA	cis	1	rs6060402	chr20:34005240	UQCC	chr20:33890383-33999833:-	0.32	9.62	4.4E-21	Height	
BRCA	cis	1	rs60604866	chr2:242352257	ANO7	chr2:242127924-242164791:+	0.22	3.51	0.00047	Prostate cancer	
BRCA	cis	1	rs6060599	chr20:30257754	COX4I2	chr20:30225691-30232800:+	0.19	7.07	2.84E-12	Subcortical brain region volumes	
BRCA	cis	1	rs6060599	chr20:30257754	MYLK2	chr20:30407178-30422500:+	0.32	8.11	1.38E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6060621	chr20:30261562	COX4I2	chr20:30225691-30232800:+	0.18	6.9	8.66E-12	Subcortical brain region volumes	
BRCA	cis	1	rs6060621	chr20:30261562	MYLK2	chr20:30407178-30422500:+	0.31	7.89	7.53E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6060716	chr20:30274847	COX4I2	chr20:30225691-30232800:+	0.17	6.67	4.1E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6060716	chr20:30274847	MYLK2	chr20:30407178-30422500:+	0.29	7.44	2.09E-13	Subcortical brain region volumes	
BRCA	cis	1	rs6060857	chr20:30300222	COX4I2	chr20:30225691-30232800:+	0.17	6.49	1.33E-10	Subcortical brain region volumes	
BRCA	cis	1	rs6060857	chr20:30300222	MYLK2	chr20:30407178-30422500:+	0.31	8.12	1.3E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6060915	chr20:30330306	COX4I2	chr20:30225691-30232800:+	0.15	5.93	4.17E-9	Subcortical brain region volumes	
BRCA	cis	1	rs6060915	chr20:30330306	MYLK2	chr20:30407178-30422500:+	0.28	7.41	2.59E-13	Subcortical brain region volumes	
BRCA	cis	1	rs6060919	chr20:30331922	COX4I2	chr20:30225691-30232800:+	0.17	6.51	1.18E-10	Subcortical brain region volumes	
BRCA	cis	1	rs6060919	chr20:30331922	MYLK2	chr20:30407178-30422500:+	0.31	8.1	1.49E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6060922	chr20:30333909	COX4I2	chr20:30225691-30232800:+	0.17	6.51	1.18E-10	Subcortical brain region volumes	
BRCA	cis	1	rs6060922	chr20:30333909	MYLK2	chr20:30407178-30422500:+	0.31	8.1	1.49E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6060932	chr20:30350545	COX4I2	chr20:30225691-30232800:+	0.17	6.62	5.76E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6060932	chr20:30350545	MYLK2	chr20:30407178-30422500:+	0.31	8.12	1.27E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6060933	chr20:30351903	COX4I2	chr20:30225691-30232800:+	0.17	6.57	7.86E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6060933	chr20:30351903	MYLK2	chr20:30407178-30422500:+	0.31	8.15	9.95E-16	Subcortical brain region volumes	
BRCA	cis	1	rs6060944	chr20:30372114	COX4I2	chr20:30225691-30232800:+	0.17	6.62	5.76E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6060944	chr20:30372114	MYLK2	chr20:30407178-30422500:+	0.31	8.12	1.27E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6060950	chr20:30378031	COX4I2	chr20:30225691-30232800:+	0.17	6.64	4.91E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6060950	chr20:30378031	MYLK2	chr20:30407178-30422500:+	0.31	8.12	1.29E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6060962	chr20:30397847	COX4I2	chr20:30225691-30232800:+	0.17	6.57	7.92E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6060962	chr20:30397847	FRG1B	chr20:29611879-29653908:+	0.15	3.41	0.000682	Subcortical brain region volumes	
BRCA	cis	1	rs6060962	chr20:30397847	MYLK2	chr20:30407178-30422500:+	0.31	8.17	8.51E-16	Subcortical brain region volumes	
BRCA	cis	1	rs6064401	chr20:55057904	C20orf43	chr20:55043647-55093942:+	0.15	4.15	3.52E-5	Refractive astigmatism	
BRCA	cis	1	rs6064405	chr20:55070946	C20orf43	chr20:55043647-55093942:+	0.15	3.99	7.12E-5	Refractive astigmatism	
BRCA	cis	1	rs60654041	chr20:55077917	C20orf43	chr20:55043647-55093942:+	0.16	4.46	8.9E-6	Refractive astigmatism	
BRCA	cis	1	rs60683927	chr7:65394768	CCT6P1	chr7:65216092-65228661:+	0.33	7.26	7.5E-13	Diabetic kidney disease	
BRCA	cis	1	rs60683927	chr7:65394768	LOC493754	chr7:65993446-66057363:-	0.21	3.56	0.000384	Diabetic kidney disease	
BRCA	cis	1	rs60683927	chr7:65394768	ZNF117	chr7:64434830-64467121:-	-0.27	-4.94	9.17E-7	Diabetic kidney disease	
BRCA	cis	1	rs6069758	chr20:55046735	C20orf43	chr20:55043647-55093942:+	0.14	3.8	0.000153	Refractive astigmatism	
BRCA	cis	1	rs6069763	chr20:55071639	C20orf43	chr20:55043647-55093942:+	-0.15	-4.01	6.41E-5	Refractive astigmatism	
BRCA	cis	1	rs6069766	chr20:55079036	C20orf43	chr20:55043647-55093942:+	0.17	4.69	3.04E-6	Refractive astigmatism	
BRCA	cis	1	rs6069767	chr20:55083478	C20orf43	chr20:55043647-55093942:+	0.13	3.61	0.000321	Refractive astigmatism	
BRCA	cis	1	rs6070692	chr20:57586374	TH1L	chr20:57556311-57570186:+	-0.21	-4.35	1.51E-5	Mean platelet volume	
BRCA	cis	1	rs6070697	chr20:57599402	TH1L	chr20:57556311-57570186:+	-0.18	-4.03	5.88E-5	Mean platelet volume	
BRCA	cis	1	rs60719662	chr6:163006643	PACRG	chr6:163148164-163736523:+	0.2	3.93	8.9E-5	Body mass index	
BRCA	cis	1	rs6073534	chr20:43365504	KCNK15	chr20:43374488-43379666:+	0.12	4.41	1.12E-5	Obesity-related traits	
BRCA	cis	1	rs6073957	chr20:44549476	SLC12A5	chr20:44650329-44688789:+	0.2	3.61	0.000322	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
BRCA	cis	1	rs6073971	chr20:44589970	SLC12A5	chr20:44650329-44688789:+	0.21	3.74	0.000194	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
BRCA	cis	1	rs6073972	chr20:44590298	SLC12A5	chr20:44650329-44688789:+	-0.22	-3.95	8.17E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
BRCA	cis	1	rs6074022	chr20:44740196	CD40	chr20:44746906-44758384:+	0.16	5.7	1.52E-8	Crohn's disease;Inflammatory bowel disease;Multiple sclerosis	
BRCA	cis	1	rs60743860	chr1:10442926	PGD	chr1:10459085-10480200:+	0.24	6.59	6.82E-11	Hepatocellular carcinoma	
BRCA	cis	1	rs6076336	chr20:25319212	FAM182A	chr20:26035250-26067552:+	0.21	5.47	5.51E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6076336	chr20:25319212	FAM182B	chr20:25744102-25848786:-	-0.23	-5.94	3.85E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6076336	chr20:25319212	PYGB	chr20:25228706-25278647:+	0.13	3.44	0.000606	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6076339	chr20:25348712	FAM182A	chr20:26035250-26067552:+	0.23	5.98	3.09E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6076339	chr20:25348712	FAM182B	chr20:25744102-25848786:-	-0.25	-6.44	1.81E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6076345	chr20:25381895	ABHD12	chr20:25275380-25371477:-	-0.11	-3.4	0.000695	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6076345	chr20:25381895	FAM182A	chr20:26035250-26067552:+	0.21	5.69	1.59E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6076345	chr20:25381895	FAM182B	chr20:25744102-25848786:-	-0.24	-6.3	4.35E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs607934	chr6:56290411	PRIM2	chr6:57182422-57513375:+	-0.16	-3.53	0.000436	Daytime sleep phenotypes	
BRCA	cis	1	rs6083804	chr20:25317060	FAM182A	chr20:26035250-26067552:+	0.21	5.48	5.45E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083804	chr20:25317060	FAM182B	chr20:25744102-25848786:-	-0.23	-5.94	3.88E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083804	chr20:25317060	PYGB	chr20:25228706-25278647:+	0.13	3.44	0.000602	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083805	chr20:25317356	FAM182A	chr20:26035250-26067552:+	0.21	5.65	2.04E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083805	chr20:25317356	FAM182B	chr20:25744102-25848786:-	-0.23	-5.92	4.34E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083809	chr20:25329309	FAM182A	chr20:26035250-26067552:+	0.21	5.57	3.24E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083809	chr20:25329309	FAM182B	chr20:25744102-25848786:-	-0.25	-6.42	2.05E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083809	chr20:25329309	PYGB	chr20:25228706-25278647:+	0.13	3.52	0.000444	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083813	chr20:25337671	FAM182A	chr20:26035250-26067552:+	0.22	5.7	1.52E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083813	chr20:25337671	FAM182B	chr20:25744102-25848786:-	-0.24	-6.28	4.86E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083813	chr20:25337671	PYGB	chr20:25228706-25278647:+	0.13	3.5	0.000477	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083825	chr20:25366424	FAM182A	chr20:26035250-26067552:+	0.21	5.59	2.83E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083825	chr20:25366424	FAM182B	chr20:25744102-25848786:-	-0.24	-6.4	2.26E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083828	chr20:25369918	FAM182A	chr20:26035250-26067552:+	0.23	6.04	2.13E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083828	chr20:25369918	FAM182B	chr20:25744102-25848786:-	-0.25	-6.46	1.61E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083844	chr20:25386832	FAM182A	chr20:26035250-26067552:+	0.21	5.58	3.05E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083844	chr20:25386832	FAM182B	chr20:25744102-25848786:-	-0.24	-6.19	8.81E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083856	chr20:25407585	FAM182A	chr20:26035250-26067552:+	0.23	6.19	8.44E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083856	chr20:25407585	FAM182B	chr20:25744102-25848786:-	-0.2	-5.27	1.66E-7	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083856	chr20:25407585	PYGB	chr20:25228706-25278647:+	0.13	3.38	0.000746	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083862	chr20:25411086	ABHD12	chr20:25275380-25371477:-	-0.13	-3.93	9.04E-5	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083862	chr20:25411086	FAM182A	chr20:26035250-26067552:+	0.2	5.42	7.17E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6083862	chr20:25411086	FAM182B	chr20:25744102-25848786:-	-0.2	-5.31	1.34E-7	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs60854219	chr18:44646664	HDHD2	chr18:44633782-44676871:-	0.3	5.17	2.84E-7	Sitting height ratio	
BRCA	cis	1	rs6087698	chr20:33948919	CPNE1	chr20:34213968-34262539:-	0.25	6.65	4.78E-11	Height	
BRCA	cis	1	rs6087698	chr20:33948919	MMP24	chr20:33814539-33864804:+	0.16	4.7	2.94E-6	Height	
BRCA	cis	1	rs6087698	chr20:33948919	UQCC	chr20:33890383-33999833:-	0.32	9.9	3.63E-22	Height	
BRCA	cis	1	rs6087702	chr20:33995945	CPNE1	chr20:34213968-34262539:-	0.24	6.51	1.17E-10	Height	
BRCA	cis	1	rs6087702	chr20:33995945	MMP24	chr20:33814539-33864804:+	0.16	4.56	5.68E-6	Height	
BRCA	cis	1	rs6087702	chr20:33995945	UQCC	chr20:33890383-33999833:-	0.32	9.92	3.13E-22	Height	
BRCA	cis	1	rs6087703	chr20:33996433	CPNE1	chr20:34213968-34262539:-	0.24	6.34	3.48E-10	Height	
BRCA	cis	1	rs6087703	chr20:33996433	ERGIC3	chr20:34129778-34145404:+	0.12	3.38	0.000753	Height	
BRCA	cis	1	rs6087703	chr20:33996433	MMP24	chr20:33814539-33864804:+	0.15	4.19	3.04E-5	Height	
BRCA	cis	1	rs6087703	chr20:33996433	UQCC	chr20:33890383-33999833:-	0.33	9.89	4.05E-22	Height	
BRCA	cis	1	rs6087704	chr20:34001058	CPNE1	chr20:34213968-34262539:-	0.24	6.37	2.85E-10	Height	
BRCA	cis	1	rs6087704	chr20:34001058	ERGIC3	chr20:34129778-34145404:+	0.12	3.38	0.000743	Height	
BRCA	cis	1	rs6087704	chr20:34001058	MMP24	chr20:33814539-33864804:+	0.15	4.32	1.67E-5	Height	
BRCA	cis	1	rs6087704	chr20:34001058	UQCC	chr20:33890383-33999833:-	0.33	9.97	1.94E-22	Height	
BRCA	cis	1	rs6087705	chr20:34001250	CPNE1	chr20:34213968-34262539:-	0.24	6.56	8.22E-11	Height	
BRCA	cis	1	rs6087705	chr20:34001250	MMP24	chr20:33814539-33864804:+	0.16	4.64	3.99E-6	Height	
BRCA	cis	1	rs6087705	chr20:34001250	UQCC	chr20:33890383-33999833:-	0.32	9.93	2.81E-22	Height	
BRCA	cis	1	rs6087771	chr20:30306724	COX4I2	chr20:30225691-30232800:+	0.16	6.18	8.99E-10	Subcortical brain region volumes	
BRCA	cis	1	rs6087771	chr20:30306724	MYLK2	chr20:30407178-30422500:+	0.31	8	3.33E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6087779	chr20:30370566	COX4I2	chr20:30225691-30232800:+	0.17	6.62	5.76E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6087779	chr20:30370566	MYLK2	chr20:30407178-30422500:+	0.31	8.12	1.27E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6087782	chr20:30391580	COX4I2	chr20:30225691-30232800:+	0.18	6.77	2.1E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6087782	chr20:30391580	MYLK2	chr20:30407178-30422500:+	0.31	8.16	9.44E-16	Subcortical brain region volumes	
BRCA	cis	1	rs6087990	chr20:31349908	MAPRE1	chr20:31407699-31438210:+	0.12	3.81	0.00015	Ulcerative colitis	
BRCA	cis	1	rs6088799	chr20:33934301	CPNE1	chr20:34213968-34262539:-	0.24	6.45	1.73E-10	Height	
BRCA	cis	1	rs6088799	chr20:33934301	MMP24	chr20:33814539-33864804:+	0.16	4.66	3.56E-6	Height	
BRCA	cis	1	rs6088799	chr20:33934301	UQCC	chr20:33890383-33999833:-	0.32	9.72	1.82E-21	Height	
BRCA	cis	1	rs6088812	chr20:33974163	CPNE1	chr20:34213968-34262539:-	0.24	6.4	2.26E-10	Height	
BRCA	cis	1	rs6088812	chr20:33974163	MMP24	chr20:33814539-33864804:+	0.16	4.48	8.14E-6	Height	
BRCA	cis	1	rs6088812	chr20:33974163	UQCC	chr20:33890383-33999833:-	0.31	9.54	9.0E-21	Height	
BRCA	cis	1	rs6088813	chr20:33975181	CPNE1	chr20:34213968-34262539:-	0.24	6.4	2.26E-10	Height	
BRCA	cis	1	rs6088813	chr20:33975181	MMP24	chr20:33814539-33864804:+	0.16	4.48	8.14E-6	Height	
BRCA	cis	1	rs6088813	chr20:33975181	UQCC	chr20:33890383-33999833:-	0.31	9.54	9.0E-21	Height	
BRCA	cis	1	rs6088815	chr20:33976474	CPNE1	chr20:34213968-34262539:-	0.23	6.27	5.19E-10	Height	
BRCA	cis	1	rs6088815	chr20:33976474	MMP24	chr20:33814539-33864804:+	0.16	4.53	6.56E-6	Height	
BRCA	cis	1	rs6088815	chr20:33976474	UQCC	chr20:33890383-33999833:-	0.32	9.79	9.94E-22	Height	
BRCA	cis	1	rs6088816	chr20:33982435	CPNE1	chr20:34213968-34262539:-	0.24	6.41	2.22E-10	Height	
BRCA	cis	1	rs6088816	chr20:33982435	MMP24	chr20:33814539-33864804:+	0.16	4.59	5.05E-6	Height	
BRCA	cis	1	rs6088816	chr20:33982435	UQCC	chr20:33890383-33999833:-	0.32	9.79	1.01E-21	Height	
BRCA	cis	1	rs6088820	chr20:33987298	CPNE1	chr20:34213968-34262539:-	0.24	6.5	1.2E-10	Height	
BRCA	cis	1	rs6088820	chr20:33987298	MMP24	chr20:33814539-33864804:+	0.16	4.56	5.61E-6	Height	
BRCA	cis	1	rs6088820	chr20:33987298	UQCC	chr20:33890383-33999833:-	0.32	9.91	3.18E-22	Height	
BRCA	cis	1	rs6088821	chr20:33987576	CPNE1	chr20:34213968-34262539:-	0.24	6.33	3.59E-10	Height	
BRCA	cis	1	rs6088821	chr20:33987576	MMP24	chr20:33814539-33864804:+	0.15	4.18	3.09E-5	Height	
BRCA	cis	1	rs6088821	chr20:33987576	UQCC	chr20:33890383-33999833:-	0.33	9.89	4.11E-22	Height	
BRCA	cis	1	rs6088823	chr20:33994265	CPNE1	chr20:34213968-34262539:-	0.24	6.34	3.48E-10	Height	
BRCA	cis	1	rs6088823	chr20:33994265	ERGIC3	chr20:34129778-34145404:+	0.12	3.38	0.000753	Height	
BRCA	cis	1	rs6088823	chr20:33994265	MMP24	chr20:33814539-33864804:+	0.15	4.19	3.04E-5	Height	
BRCA	cis	1	rs6088823	chr20:33994265	UQCC	chr20:33890383-33999833:-	0.33	9.89	4.05E-22	Height	
BRCA	cis	1	rs6088825	chr20:33995972	CPNE1	chr20:34213968-34262539:-	0.24	6.38	2.63E-10	Height	
BRCA	cis	1	rs6088825	chr20:33995972	MMP24	chr20:33814539-33864804:+	0.16	4.55	5.87E-6	Height	
BRCA	cis	1	rs6088825	chr20:33995972	UQCC	chr20:33890383-33999833:-	0.32	9.86	5.42E-22	Height	
BRCA	cis	1	rs60929805	chr1:95646386	RWDD3	chr1:95583479-95712773:+	0.23	3.65	0.000277	Stearic acid (18:0) plasma levels	
BRCA	cis	1	rs60942639	chr14:66107636	LOC645431	chr14:65877313-65879335:-	-0.3	-5.91	4.73E-9	Ischemic stroke	
BRCA	cis	1	rs60982898	chr6:49385806	CENPQ	chr6:49431096-49460820:+	-0.23	-7.33	4.56E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.32	10.11	5.39E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs6099171	chr20:55071253	C20orf43	chr20:55043647-55093942:+	0.14	3.87	0.000116	Refractive astigmatism	
BRCA	cis	1	rs6099184	chr20:55097478	C20orf43	chr20:55043647-55093942:+	0.16	4.34	1.55E-5	Refractive astigmatism	
BRCA	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.38	-9.92	2.93E-22	Forced vital capacity	
BRCA	cis	1	rs6107033	chr20:25363591	FAM182A	chr20:26035250-26067552:+	0.22	5.82	7.65E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6107033	chr20:25363591	FAM182B	chr20:25744102-25848786:-	-0.24	-6.4	2.38E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6107045	chr20:25441936	FAM182A	chr20:26035250-26067552:+	-0.23	-6.1	1.44E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6107045	chr20:25441936	FAM182B	chr20:25744102-25848786:-	0.22	5.62	2.4E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6107045	chr20:25441936	PYGB	chr20:25228706-25278647:+	-0.14	-3.75	0.000186	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6107046	chr20:25442049	FAM182A	chr20:26035250-26067552:+	-0.23	-6.1	1.44E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6107046	chr20:25442049	FAM182B	chr20:25744102-25848786:-	0.22	5.62	2.4E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6107046	chr20:25442049	PYGB	chr20:25228706-25278647:+	-0.14	-3.75	0.000186	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6107047	chr20:25442097	FAM182A	chr20:26035250-26067552:+	-0.23	-6.1	1.44E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6107047	chr20:25442097	FAM182B	chr20:25744102-25848786:-	0.22	5.62	2.4E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6107047	chr20:25442097	PYGB	chr20:25228706-25278647:+	-0.14	-3.75	0.000186	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.7	8.0E-30	Body mass index	
BRCA	cis	1	rs61102033	chr1:46382441	CCDC17	chr1:46085717-46089729:-	0.11	3.49	0.000495	Body mass index	
BRCA	cis	1	rs61102033	chr1:46382441	MUTYH	chr1:45794915-45806142:-	0.13	5.06	4.84E-7	Body mass index	
BRCA	cis	1	rs6114206	chr20:23611789	CST1	chr20:23728191-23731574:-	0.22	4.68	3.22E-6	Chronic kidney disease	
BRCA	cis	1	rs6114208	chr20:23621734	CST1	chr20:23728191-23731574:-	0.23	4.86	1.36E-6	Chronic kidney disease	
BRCA	cis	1	rs6114209	chr20:23622266	CST1	chr20:23728191-23731574:-	0.23	4.85	1.42E-6	Chronic kidney disease	
BRCA	cis	1	rs6115140	chr20:25285507	ABHD12	chr20:25275380-25371477:-	0.11	3.4	0.000699	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115140	chr20:25285507	FAM182A	chr20:26035250-26067552:+	-0.22	-5.7	1.54E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115140	chr20:25285507	FAM182B	chr20:25744102-25848786:-	0.22	5.55	3.53E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115146	chr20:25304507	FAM182A	chr20:26035250-26067552:+	0.21	5.54	3.9E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115146	chr20:25304507	FAM182B	chr20:25744102-25848786:-	-0.23	-5.97	3.32E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115146	chr20:25304507	PYGB	chr20:25228706-25278647:+	0.13	3.4	0.000708	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115153	chr20:25325567	FAM182A	chr20:26035250-26067552:+	0.21	5.62	2.44E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115153	chr20:25325567	FAM182B	chr20:25744102-25848786:-	-0.24	-6.33	3.72E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115153	chr20:25325567	PYGB	chr20:25228706-25278647:+	0.13	3.59	0.000345	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115159	chr20:25350944	FAM182A	chr20:26035250-26067552:+	0.21	5.59	2.88E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115159	chr20:25350944	FAM182B	chr20:25744102-25848786:-	-0.24	-6.4	2.27E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115168	chr20:25372891	FAM182A	chr20:26035250-26067552:+	0.21	5.56	3.45E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115168	chr20:25372891	FAM182B	chr20:25744102-25848786:-	-0.24	-6.34	3.37E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115168	chr20:25372891	PYGB	chr20:25228706-25278647:+	0.13	3.38	0.000763	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115182	chr20:25410259	FAM182A	chr20:26035250-26067552:+	0.22	5.99	2.88E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115182	chr20:25410259	FAM182B	chr20:25744102-25848786:-	-0.23	-6.11	1.43E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115191	chr20:25440478	FAM182A	chr20:26035250-26067552:+	-0.23	-6.1	1.44E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115191	chr20:25440478	FAM182B	chr20:25744102-25848786:-	0.22	5.62	2.4E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6115191	chr20:25440478	PYGB	chr20:25228706-25278647:+	-0.14	-3.75	0.000186	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs61153799	chr10:96547356	C10orf129	chr10:96953957-96988685:+	0.23	4.12	4.08E-5	Blood metabolite levels	
BRCA	cis	1	rs6119650	chr20:30258480	COX4I2	chr20:30225691-30232800:+	0.19	7.09	2.47E-12	Subcortical brain region volumes	
BRCA	cis	1	rs6119650	chr20:30258480	MYLK2	chr20:30407178-30422500:+	0.29	7.39	3.03E-13	Subcortical brain region volumes	
BRCA	cis	1	rs6119652	chr20:30259445	COX4I2	chr20:30225691-30232800:+	0.18	6.92	7.73E-12	Subcortical brain region volumes	
BRCA	cis	1	rs6119652	chr20:30259445	MYLK2	chr20:30407178-30422500:+	0.31	7.93	5.46E-15	Subcortical brain region volumes	
BRCA	cis	1	rs61200368	chr6:55943942	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs6120849	chr20:33730387	EDEM2	chr20:33703160-33865928:-	-0.14	-3.4	0.00071	Protein C levels	
BRCA	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.53	-10.86	3.86E-26	Triglycerides	
BRCA	cis	1	rs6120974	chr20:34126827	ERGIC3	chr20:34129778-34145404:+	-0.17	-3.67	0.000257	Triglycerides	
BRCA	cis	1	rs6121038	chr20:30254773	COX4I2	chr20:30225691-30232800:+	0.18	6.91	8.28E-12	Subcortical brain region volumes	
BRCA	cis	1	rs6121038	chr20:30254773	MYLK2	chr20:30407178-30422500:+	0.3	7.88	7.95E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6121172	chr20:30296095	COX4I2	chr20:30225691-30232800:+	0.17	6.45	1.69E-10	Subcortical brain region volumes	
BRCA	cis	1	rs6121172	chr20:30296095	MYLK2	chr20:30407178-30422500:+	0.31	8.14	1.08E-15	Subcortical brain region volumes	
BRCA	cis	1	rs6121243	chr20:30415094	COX4I2	chr20:30225691-30232800:+	0.17	6.63	5.49E-11	Subcortical brain region volumes	
BRCA	cis	1	rs6121243	chr20:30415094	FRG1B	chr20:29611879-29653908:+	0.16	3.55	0.000399	Subcortical brain region volumes	
BRCA	cis	1	rs6121243	chr20:30415094	MYLK2	chr20:30407178-30422500:+	0.31	8.1	1.54E-15	Subcortical brain region volumes	
BRCA	cis	1	rs61230354	chr1:146869891	CHD1L	chr1:146714291-146767441:+	-0.16	-3.67	0.000254	Protein quantitative trait loci	
BRCA	cis	1	rs61236373	chr11:28212720	METT5D1	chr11:28129798-28355054:+	-0.12	-3.41	0.000666	Bipolar disorder	
BRCA	cis	1	rs61247217	chr2:68425454	PNO1	chr2:68385005-68403089:+	0.11	3.41	0.000665	Height	
BRCA	cis	1	rs6127978	chr20:55819173	RBM38	chr20:55966463-55984384:+	-0.16	-4.59	5.0E-6	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
BRCA	cis	1	rs61316646	chr18:44610670	HDHD2	chr18:44633782-44676871:-	0.3	5.14	3.24E-7	Sitting height ratio	
BRCA	cis	1	rs6132835	chr20:25434667	FAM182A	chr20:26035250-26067552:+	-0.22	-5.79	9.42E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6132835	chr20:25434667	FAM182B	chr20:25744102-25848786:-	0.23	6.1	1.45E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6132835	chr20:25434667	PYGB	chr20:25228706-25278647:+	-0.13	-3.6	0.000334	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6133036	chr20:3349682	ITPA	chr20:3190056-3204504:+	-0.12	-3.65	0.000277	IFN-related cytopenia	
BRCA	cis	1	rs6138572	chr20:25435934	FAM182A	chr20:26035250-26067552:+	-0.25	-6.43	1.94E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6138572	chr20:25435934	FAM182B	chr20:25744102-25848786:-	0.23	5.8	8.49E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6138572	chr20:25435934	PYGB	chr20:25228706-25278647:+	-0.13	-3.37	0.000765	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6138575	chr20:25438952	FAM182A	chr20:26035250-26067552:+	-0.25	-6.43	1.94E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6138575	chr20:25438952	FAM182B	chr20:25744102-25848786:-	0.23	5.8	8.49E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6138575	chr20:25438952	PYGB	chr20:25228706-25278647:+	-0.13	-3.37	0.000765	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6139030	chr20:3187733	ITPA	chr20:3190056-3204504:+	-0.16	-3.57	0.000379	Response to hepatitis C treatment	
BRCA	cis	1	rs6139030	chr20:3187733	MAVS	chr20:3827449-3856761:+	-0.2	-3.39	0.000734	Response to hepatitis C treatment	
BRCA	cis	1	rs6139064	chr20:3277050	ITPA	chr20:3190056-3204504:+	-0.12	-3.52	0.000445	IFN-related cytopenia	
BRCA	cis	1	rs6139068	chr20:3284393	ITPA	chr20:3190056-3204504:+	-0.13	-3.79	0.000158	IFN-related cytopenia	
BRCA	cis	1	rs6139088	chr20:3329063	ITPA	chr20:3190056-3204504:+	-0.13	-3.93	9.02E-5	IFN-related cytopenia	
BRCA	cis	1	rs6139103	chr20:3361140	ITPA	chr20:3190056-3204504:+	-0.13	-3.86	0.00012	IFN-related cytopenia	
BRCA	cis	1	rs61394483	chr6:33751945	C6orf125	chr6:33662057-33679504:-	0.11	3.6	0.000337	Body mass index	
BRCA	cis	1	rs61394483	chr6:33751945	LEMD2	chr6:33738991-33756906:-	0.18	5.7	1.54E-8	Body mass index	
BRCA	cis	1	rs6141546	chr20:33949282	CPNE1	chr20:34213968-34262539:-	0.25	6.65	4.78E-11	Height	
BRCA	cis	1	rs6141546	chr20:33949282	MMP24	chr20:33814539-33864804:+	0.16	4.7	2.94E-6	Height	
BRCA	cis	1	rs6141546	chr20:33949282	UQCC	chr20:33890383-33999833:-	0.32	9.9	3.63E-22	Height	
BRCA	cis	1	rs6141548	chr20:33971085	CPNE1	chr20:34213968-34262539:-	0.24	6.39	2.43E-10	Height	
BRCA	cis	1	rs6141548	chr20:33971085	MMP24	chr20:33814539-33864804:+	0.16	4.47	8.76E-6	Height	
BRCA	cis	1	rs6141548	chr20:33971085	UQCC	chr20:33890383-33999833:-	0.31	9.54	9.19E-21	Height	
BRCA	cis	1	rs6141549	chr20:33974051	CPNE1	chr20:34213968-34262539:-	0.24	6.4	2.26E-10	Height	
BRCA	cis	1	rs6141549	chr20:33974051	MMP24	chr20:33814539-33864804:+	0.16	4.48	8.14E-6	Height	
BRCA	cis	1	rs6141549	chr20:33974051	UQCC	chr20:33890383-33999833:-	0.31	9.54	9.0E-21	Height	
BRCA	cis	1	rs614226	chr12:120974510	POP5	chr12:121016849-121019201:-	0.16	3.77	0.000169	Type 1 diabetes nephropathy	
BRCA	cis	1	rs6142358	chr20:33960308	CPNE1	chr20:34213968-34262539:-	-0.23	-6.23	6.65E-10	Height	
BRCA	cis	1	rs6142358	chr20:33960308	MMP24	chr20:33814539-33864804:+	-0.16	-4.48	8.3E-6	Height	
BRCA	cis	1	rs6142358	chr20:33960308	UQCC	chr20:33890383-33999833:-	-0.32	-9.72	1.8E-21	Height	
BRCA	cis	1	rs6142359	chr20:33960450	CPNE1	chr20:34213968-34262539:-	0.24	6.59	6.98E-11	Height	
BRCA	cis	1	rs6142359	chr20:33960450	MMP24	chr20:33814539-33864804:+	0.17	4.82	1.68E-6	Height	
BRCA	cis	1	rs6142359	chr20:33960450	UQCC	chr20:33890383-33999833:-	0.32	9.85	5.57E-22	Height	
BRCA	cis	1	rs6142360	chr20:33960486	CPNE1	chr20:34213968-34262539:-	0.25	6.47	1.51E-10	Height	
BRCA	cis	1	rs6142360	chr20:33960486	MMP24	chr20:33814539-33864804:+	0.13	3.72	0.000212	Height	
BRCA	cis	1	rs6142360	chr20:33960486	UQCC	chr20:33890383-33999833:-	0.33	9.71	2.07E-21	Height	
BRCA	cis	1	rs6142369	chr20:33973315	CPNE1	chr20:34213968-34262539:-	0.23	6.14	1.14E-9	Height	
BRCA	cis	1	rs6142369	chr20:33973315	MMP24	chr20:33814539-33864804:+	0.15	4.12	4.1E-5	Height	
BRCA	cis	1	rs6142369	chr20:33973315	UQCC	chr20:33890383-33999833:-	0.32	9.7	2.28E-21	Height	
BRCA	cis	1	rs6142370	chr20:33973378	CPNE1	chr20:34213968-34262539:-	0.24	6.4	2.26E-10	Height	
BRCA	cis	1	rs6142370	chr20:33973378	MMP24	chr20:33814539-33864804:+	0.16	4.48	8.14E-6	Height	
BRCA	cis	1	rs6142370	chr20:33973378	UQCC	chr20:33890383-33999833:-	0.31	9.54	9.0E-21	Height	
BRCA	cis	1	rs6142373	chr20:33983314	CPNE1	chr20:34213968-34262539:-	0.24	6.54	9.69E-11	Height	
BRCA	cis	1	rs6142373	chr20:33983314	MMP24	chr20:33814539-33864804:+	0.16	4.6	4.72E-6	Height	
BRCA	cis	1	rs6142373	chr20:33983314	UQCC	chr20:33890383-33999833:-	0.32	9.85	5.89E-22	Height	
BRCA	cis	1	rs6142374	chr20:33985568	CPNE1	chr20:34213968-34262539:-	0.24	6.36	2.94E-10	Height	
BRCA	cis	1	rs6142374	chr20:33985568	ERGIC3	chr20:34129778-34145404:+	0.12	3.42	0.000651	Height	
BRCA	cis	1	rs6142374	chr20:33985568	MMP24	chr20:33814539-33864804:+	0.15	4.22	2.65E-5	Height	
BRCA	cis	1	rs6142374	chr20:33985568	UQCC	chr20:33890383-33999833:-	0.33	9.82	7.47E-22	Height	
BRCA	cis	1	rs6142376	chr20:33992761	CPNE1	chr20:34213968-34262539:-	0.24	6.38	2.68E-10	Height	
BRCA	cis	1	rs6142376	chr20:33992761	MMP24	chr20:33814539-33864804:+	0.16	4.56	5.81E-6	Height	
BRCA	cis	1	rs6142376	chr20:33992761	UQCC	chr20:33890383-33999833:-	0.32	9.85	5.49E-22	Height	
BRCA	cis	1	rs6142379	chr20:33999267	CPNE1	chr20:34213968-34262539:-	0.24	6.34	3.42E-10	Height	
BRCA	cis	1	rs6142379	chr20:33999267	ERGIC3	chr20:34129778-34145404:+	0.12	3.37	0.000773	Height	
BRCA	cis	1	rs6142379	chr20:33999267	MMP24	chr20:33814539-33864804:+	0.15	4.26	2.21E-5	Height	
BRCA	cis	1	rs6142379	chr20:33999267	UQCC	chr20:33890383-33999833:-	0.33	9.95	2.26E-22	Height	
BRCA	cis	1	rs61457762	chr1:27284157	GPATCH3	chr1:27216980-27226962:-	0.19	3.85	0.000128	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs615199	chr6:117113653	FAM162B	chr6:117073360-117086886:-	0.18	6.4	2.29E-10	C-reactive protein levels	
BRCA	cis	1	rs61524473	chr15:45646283	GATM	chr15:45653324-45670980:-	-0.25	-5.96	3.47E-9	Metabolite levels (small molecules and protein measures)	
BRCA	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.4	9.28	8.81E-20	Metabolite levels (small molecules and protein measures)	
BRCA	cis	1	rs616147	chr3:39534481	RPSA	chr3:39448204-39454030:+	0.2	5.97	3.19E-9	Corticobasal degeneration;Progressive supranuclear palsy	
BRCA	cis	1	rs61634114	chr19:17387254	ANKLE1	chr19:17392454-17398454:+	0.21	5.84	7.07E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs61634114	chr19:17387254	ANO8	chr19:17434032-17445638:-	0.15	3.69	0.000234	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs61634114	chr19:17387254	OCEL1	chr19:17337055-17340027:+	0.17	5.09	4.28E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs61634114	chr19:17387254	PLVAP	chr19:17462264-17488137:-	-0.09	-3.37	0.000773	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs61662306	chr6:33746697	C6orf125	chr6:33662057-33679504:-	0.11	3.56	0.000385	Body mass index	
BRCA	cis	1	rs61662306	chr6:33746697	LEMD2	chr6:33738991-33756906:-	0.18	5.49	5.0E-8	Body mass index	
BRCA	cis	1	rs61692996	chr3:119280368	CD80	chr3:119243142-119278481:-	0.12	4.27	2.09E-5	Vitiligo	
BRCA	cis	1	rs617219	chr5:78429594	BHMT	chr5:78407604-78428112:+	-0.15	-4.56	5.78E-6	Betaine levels in individuals undergoing cardiac evaluation	
BRCA	cis	1	rs61783200	chr1:46297403	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.84	1.72E-30	Body mass index	
BRCA	cis	1	rs61783200	chr1:46297403	CCDC17	chr1:46085717-46089729:-	0.11	3.45	0.000592	Body mass index	
BRCA	cis	1	rs61783200	chr1:46297403	MUTYH	chr1:45794915-45806142:-	0.12	4.91	1.05E-6	Body mass index	
BRCA	cis	1	rs61783220	chr1:46335312	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.71	7.32E-30	Body mass index	
BRCA	cis	1	rs61783220	chr1:46335312	CCDC17	chr1:46085717-46089729:-	0.11	3.54	0.000424	Body mass index	
BRCA	cis	1	rs61783220	chr1:46335312	MUTYH	chr1:45794915-45806142:-	0.13	5.11	3.87E-7	Body mass index	
BRCA	cis	1	rs61806199	chr1:119450102	WARS2	chr1:119573841-119683295:-	0.25	4.62	4.23E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs61806202	chr1:119465457	WARS2	chr1:119573841-119683295:-	0.26	4.79	1.86E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs61806205	chr1:119482315	WARS2	chr1:119573841-119683295:-	0.24	4.51	7.14E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs61806231	chr1:119496482	WARS2	chr1:119573841-119683295:-	0.26	4.81	1.75E-6	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.55	11.63	1.57E-29	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs61822697	chr1:207485164	C4BPA	chr1:207277511-207318308:+	0.14	3.76	0.000179	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs61852630	chr1:247210193	ZNF670	chr1:247200087-247242069:-	-0.25	-6.94	6.89E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs61871790	chr10:97391223	ENTPD1	chr10:97471536-97637022:+	0.17	5.77	1.02E-8	Blood metabolite levels	
BRCA	cis	1	rs61871792	chr10:97397586	ENTPD1	chr10:97471536-97637022:+	0.17	5.86	6.12E-9	Blood metabolite levels	
BRCA	cis	1	rs61871793	chr10:97407738	ENTPD1	chr10:97471536-97637022:+	0.16	5.4	8.4E-8	Blood metabolite levels	
BRCA	cis	1	rs61876326	chr11:467368	RNH1	chr11:494512-507273:-	-0.2	-4.85	1.44E-6	Body mass index	
BRCA	cis	1	rs61876335	chr11:488878	RNH1	chr11:494512-507273:-	-0.16	-4.06	5.29E-5	Body mass index	
BRCA	cis	1	rs61879300	chr11:22117880	ANO5	chr11:22214722-22304913:+	0.29	6.13	1.21E-9	Parkinson's disease	
BRCA	cis	1	rs61886892	chr11:18738575	LDHC	chr11:18433853-18472792:+	-0.17	-3.66	0.000269	Diabetic kidney disease	
BRCA	cis	1	rs61888887	chr11:57099051	PRG2	chr11:57151267-57191532:-	-0.22	-3.97	7.7E-5	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs61890486	chr11:27321035	LGR4	chr11:27387510-27494334:-	0.15	4.22	2.64E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs61900636	chr11:74359591	P4HA3	chr11:73958550-74022699:-	0.11	3.38	0.000759	Response to metformin (IC50)	
BRCA	cis	1	rs61901691	chr11:59902799	MS4A4A	chr11:60048139-60076444:+	-0.1	-4.14	3.67E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs61935678	chr12:102029254	CHPT1	chr12:102091417-102123424:+	-0.22	-3.42	0.000644	Lung function (FEV1)	
BRCA	cis	1	rs61952922	chr12:122520575	LRRC43	chr12:122652266-122688017:+	-0.16	-4.55	6.06E-6	Urate levels	
BRCA	cis	1	rs62096463	chr18:44628928	HDHD2	chr18:44633782-44676871:-	0.3	5.17	2.85E-7	Sitting height ratio	
BRCA	cis	1	rs62096464	chr18:44629207	HDHD2	chr18:44633782-44676871:-	0.3	5.17	2.85E-7	Sitting height ratio	
BRCA	cis	1	rs62096466	chr18:44636171	HDHD2	chr18:44633782-44676871:-	0.3	5.16	3.01E-7	Sitting height ratio	
BRCA	cis	1	rs62096469	chr18:44638298	HDHD2	chr18:44633782-44676871:-	0.3	5.16	3.01E-7	Sitting height ratio	
BRCA	cis	1	rs62096470	chr18:44641466	HDHD2	chr18:44633782-44676871:-	0.3	5.16	3.01E-7	Sitting height ratio	
BRCA	cis	1	rs62096471	chr18:44643814	HDHD2	chr18:44633782-44676871:-	0.3	5.16	3.01E-7	Sitting height ratio	
BRCA	cis	1	rs62096474	chr18:44647504	HDHD2	chr18:44633782-44676871:-	0.3	5.22	2.18E-7	Sitting height ratio	
BRCA	cis	1	rs62096476	chr18:44658621	HDHD2	chr18:44633782-44676871:-	0.29	5.1	4.09E-7	Sitting height ratio	
BRCA	cis	1	rs62096478	chr18:44662409	HDHD2	chr18:44633782-44676871:-	0.29	5.1	4.09E-7	Sitting height ratio	
BRCA	cis	1	rs62111121	chr19:13804408	MRI1	chr19:13875337-13885095:+	-0.17	-4.32	1.7E-5	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.71	-20.86	2.61E-81	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.71	-20.8	6.53E-81	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.69	-20.41	2.12E-78	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.7	-20.35	4.65E-78	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs62120832	chr19:23064264	ZNF492	chr19:22817126-22850472:+	-0.21	-4.59	5.04E-6	Bronchopulmonary dysplasia	
BRCA	cis	1	rs62121818	chr19:39167760	LGALS7	chr19:39261608-39264157:-	-0.18	-5.57	3.14E-8	Heart rate	
BRCA	cis	1	rs62132092	chr2:17770893	GEN1	chr2:17935162-17966632:+	0.17	3.63	0.000302	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132093	chr2:17771207	GEN1	chr2:17935162-17966632:+	0.17	3.55	0.000407	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132127	chr2:17778708	GEN1	chr2:17935162-17966632:+	0.15	3.5	0.000482	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132133	chr2:17780483	GEN1	chr2:17935162-17966632:+	0.16	3.43	0.000627	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132135	chr2:17783190	GEN1	chr2:17935162-17966632:+	0.16	3.51	0.000475	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132137	chr2:17784194	GEN1	chr2:17935162-17966632:+	0.16	3.51	0.000475	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132138	chr2:17784781	GEN1	chr2:17935162-17966632:+	0.16	3.51	0.000475	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132139	chr2:17785987	GEN1	chr2:17935162-17966632:+	0.16	3.5	0.000482	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132140	chr2:17786559	GEN1	chr2:17935162-17966632:+	0.16	3.5	0.000482	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132141	chr2:17786758	GEN1	chr2:17935162-17966632:+	0.16	3.5	0.000482	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132142	chr2:17788469	GEN1	chr2:17935162-17966632:+	0.16	3.5	0.000482	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132143	chr2:17788743	GEN1	chr2:17935162-17966632:+	0.16	3.5	0.000482	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132144	chr2:17788790	GEN1	chr2:17935162-17966632:+	0.16	3.5	0.000482	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132145	chr2:17789253	GEN1	chr2:17935162-17966632:+	0.17	3.56	0.000392	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132146	chr2:17790133	GEN1	chr2:17935162-17966632:+	0.17	3.56	0.000392	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132147	chr2:17790876	GEN1	chr2:17935162-17966632:+	0.16	3.48	0.000512	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132148	chr2:17791048	GEN1	chr2:17935162-17966632:+	0.16	3.48	0.000512	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132150	chr2:17792359	GEN1	chr2:17935162-17966632:+	0.16	3.55	0.000399	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132151	chr2:17792698	GEN1	chr2:17935162-17966632:+	0.16	3.53	0.00044	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62132152	chr2:17794404	GEN1	chr2:17935162-17966632:+	0.16	3.53	0.00044	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133576	chr2:17795297	GEN1	chr2:17935162-17966632:+	0.16	3.53	0.00044	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133577	chr2:17798777	GEN1	chr2:17935162-17966632:+	0.16	3.53	0.00044	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133578	chr2:17799575	GEN1	chr2:17935162-17966632:+	0.16	3.53	0.00044	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133579	chr2:17800196	GEN1	chr2:17935162-17966632:+	0.16	3.53	0.00044	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133583	chr2:17805779	GEN1	chr2:17935162-17966632:+	0.17	3.59	0.000344	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133584	chr2:17805944	GEN1	chr2:17935162-17966632:+	0.17	3.59	0.000344	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133586	chr2:17806579	GEN1	chr2:17935162-17966632:+	0.17	3.59	0.000344	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133587	chr2:17806654	GEN1	chr2:17935162-17966632:+	0.17	3.59	0.000344	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133588	chr2:17807469	GEN1	chr2:17935162-17966632:+	0.17	3.59	0.000344	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133589	chr2:17807626	GEN1	chr2:17935162-17966632:+	0.17	3.59	0.000344	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62133590	chr2:17811126	GEN1	chr2:17935162-17966632:+	0.16	3.47	0.00054	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs62136864	chr2:46829124	ATP6V1E2	chr2:46738988-46769696:-	-0.22	-5.85	6.65E-9	Height	
BRCA	cis	1	rs62136864	chr2:46829124	CRIPT	chr2:46844325-46852880:+	0.22	6.07	1.74E-9	Height	
BRCA	cis	1	rs62139200	chr2:54475507	C2orf73	chr2:54558071-54588714:+	0.14	3.41	0.000669	Telomere length	
BRCA	cis	1	rs62139251	chr2:54478605	C2orf73	chr2:54558071-54588714:+	0.17	4	6.63E-5	Telomere length	
BRCA	cis	1	rs62139254	chr2:54480336	C2orf73	chr2:54558071-54588714:+	0.17	4.13	3.87E-5	Telomere length	
BRCA	cis	1	rs62151174	chr2:70363968	FAM136A	chr2:70523109-70529220:-	-0.11	-3.61	0.000326	Obesity-related traits	
BRCA	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.26	6.67	4.2E-11	Metabolite levels	
BRCA	cis	1	rs62175515	chr2:160909524	LY75	chr2:160625141-160761262:-	0.14	4.73	2.57E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs62175515	chr2:160909524	PLA2R1	chr2:160798012-160919121:-	0.15	5.01	6.41E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs62175517	chr2:160911575	LY75	chr2:160625141-160761262:-	0.14	4.71	2.78E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs62175517	chr2:160911575	PLA2R1	chr2:160798012-160919121:-	0.15	4.99	6.94E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs62180307	chr2:63341015	C2orf86	chr2:63348537-63815851:-	0.21	4.63	4.08E-6	Prostate cancer	
BRCA	cis	1	rs62190367	chr2:242376276	ANO7	chr2:242127924-242164791:+	0.22	3.6	0.000329	Prostate cancer	
BRCA	cis	1	rs62190370	chr2:242384194	ANO7	chr2:242127924-242164791:+	0.23	3.75	0.000186	Prostate cancer	
BRCA	cis	1	rs62193171	chr2:242276523	ANO7	chr2:242127924-242164791:+	0.21	3.38	0.000762	Prostate cancer	
BRCA	cis	1	rs62193175	chr2:242284405	ANO7	chr2:242127924-242164791:+	0.21	3.38	0.000762	Prostate cancer	
BRCA	cis	1	rs62193197	chr2:242294301	ANO7	chr2:242127924-242164791:+	0.21	3.37	0.000768	Prostate cancer	
BRCA	cis	1	rs62193204	chr2:242315443	ANO7	chr2:242127924-242164791:+	0.21	3.38	0.000741	Prostate cancer	
BRCA	cis	1	rs62193207	chr2:242318501	ANO7	chr2:242127924-242164791:+	0.21	3.4	0.000696	Prostate cancer	
BRCA	cis	1	rs62193208	chr2:242322430	ANO7	chr2:242127924-242164791:+	0.21	3.41	0.000669	Prostate cancer	
BRCA	cis	1	rs62193210	chr2:242323616	ANO7	chr2:242127924-242164791:+	0.21	3.41	0.000669	Prostate cancer	
BRCA	cis	1	rs62193256	chr2:242362168	ANO7	chr2:242127924-242164791:+	0.23	3.68	0.000246	Prostate cancer	
BRCA	cis	1	rs62211529	chr20:33959315	CPNE1	chr20:34213968-34262539:-	0.24	6.5	1.24E-10	Height	
BRCA	cis	1	rs62211529	chr20:33959315	ERGIC3	chr20:34129778-34145404:+	0.12	3.41	0.000665	Height	
BRCA	cis	1	rs62211529	chr20:33959315	MMP24	chr20:33814539-33864804:+	0.16	4.48	8.2E-6	Height	
BRCA	cis	1	rs62211529	chr20:33959315	UQCC	chr20:33890383-33999833:-	0.33	10.12	4.68E-23	Height	
BRCA	cis	1	rs62236665	chr22:38059847	LGALS2	chr22:37966254-37976024:-	0.08	3.41	0.000684	Fat distribution (HIV)	
BRCA	cis	1	rs62236667	chr22:38061520	LGALS2	chr22:37966254-37976024:-	0.09	3.78	0.000166	Fat distribution (HIV)	
BRCA	cis	1	rs62236668	chr22:38063870	LGALS2	chr22:37966254-37976024:-	0.09	3.82	0.000142	Fat distribution (HIV)	
BRCA	cis	1	rs62243926	chr3:46319920	TDGF1	chr3:46619180-46623950:+	0.14	3.91	9.8E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs62259933	chr3:49469703	AMT	chr3:49454212-49460012:-	-0.13	-4.39	1.22E-5	Menarche (age at onset)	
BRCA	cis	1	rs62259933	chr3:49469703	CCDC36	chr3:49235861-49295537:+	-0.1	-3.88	0.00011	Menarche (age at onset)	
BRCA	cis	1	rs62259933	chr3:49469703	GMPPB	chr3:49758932-49761384:-	0.13	3.67	0.000253	Menarche (age at onset)	
BRCA	cis	1	rs62259933	chr3:49469703	NCKIPSD	chr3:48711280-48723334:-	-0.14	-3.59	0.000339	Menarche (age at onset)	
BRCA	cis	1	rs62259933	chr3:49469703	P4HTM	chr3:49027341-49044579:+	-0.09	-3.89	0.000108	Menarche (age at onset)	
BRCA	cis	1	rs62259933	chr3:49469703	TREX1	chr3:48501186-48509043:+	0.12	3.77	0.000174	Menarche (age at onset)	
BRCA	cis	1	rs62259933	chr3:49469703	WDR6	chr3:49044637-49053386:+	0.15	4.45	9.43E-6	Menarche (age at onset)	
BRCA	cis	1	rs62259947	chr3:49439924	AMT	chr3:49454212-49460012:-	-0.15	-4.79	1.89E-6	Menarche (age at onset)	
BRCA	cis	1	rs62259947	chr3:49439924	NCKIPSD	chr3:48711280-48723334:-	-0.16	-3.94	8.5E-5	Menarche (age at onset)	
BRCA	cis	1	rs62259947	chr3:49439924	P4HTM	chr3:49027341-49044579:+	-0.11	-4.48	8.22E-6	Menarche (age at onset)	
BRCA	cis	1	rs62259947	chr3:49439924	TREX1	chr3:48501186-48509043:+	0.13	4.14	3.78E-5	Menarche (age at onset)	
BRCA	cis	1	rs62259947	chr3:49439924	WDR6	chr3:49044637-49053386:+	0.15	4.18	3.16E-5	Menarche (age at onset)	
BRCA	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.28	7.05	3.25E-12	Cognitive performance	
BRCA	cis	1	rs62268732	chr3:121370455	SLC15A2	chr3:121613171-121663034:+	-0.14	-3.9	0.000101	Cognitive performance	
BRCA	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.43	14.46	2.02E-43	Height	
BRCA	cis	1	rs62269547	chr3:134214042	CEP63	chr3:134204575-134293852:+	0.15	4.2	2.89E-5	Height	
BRCA	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.7	1.57E-34	Height	
BRCA	cis	1	rs62271513	chr3:134298412	CEP63	chr3:134204575-134293852:+	-0.14	-3.62	0.00031	Height	
BRCA	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.39	-12.69	1.78E-34	Height	
BRCA	cis	1	rs62271514	chr3:134298554	CEP63	chr3:134204575-134293852:+	-0.14	-3.61	0.000316	Height	
BRCA	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.39	12.59	5.21E-34	Height	
BRCA	cis	1	rs62271515	chr3:134300507	CEP63	chr3:134204575-134293852:+	0.14	3.81	0.000146	Height	
BRCA	cis	1	rs62279921	chr3:161065441	C3orf57	chr3:161062581-161089871:-	0.14	3.56	0.00039	Morning vs. evening chronotype	
BRCA	cis	1	rs62310332	chr4:39114559	KLHL5	chr4:39046659-39123828:+	-0.16	-4.91	1.06E-6	Uric acid levels	
BRCA	cis	1	rs62321365	chr4:107013723	TBCK	chr4:106967233-107237861:-	0.25	7.72	2.58E-14	Airflow obstruction	
BRCA	cis	1	rs62322549	chr4:71319058	AMTN	chr4:71384298-71398459:+	0.24	7.27	6.95E-13	Alcoholism (heaviness of drinking)	
BRCA	cis	1	rs62374373	chr5:82433208	XRCC4	chr5:82373317-82649577:+	-0.12	-3.4	0.000709	Hypertension	
BRCA	cis	1	rs62374374	chr5:82440657	XRCC4	chr5:82373317-82649577:+	-0.12	-3.54	0.000411	Hypertension	
BRCA	cis	1	rs62384253	chr5:115563415	COMMD10	chr5:115420727-115628978:+	0.24	4.6	4.77E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs62384469	chr5:115624964	COMMD10	chr5:115420727-115628978:+	0.22	4.7	2.97E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs62384678	chr5:115422688	COMMD10	chr5:115420727-115628978:+	0.23	5.03	5.68E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs62384697	chr5:115438284	COMMD10	chr5:115420727-115628978:+	0.22	4.91	1.06E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs62384714	chr5:115452597	COMMD10	chr5:115420727-115628978:+	0.22	4.41	1.13E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs62385177	chr5:115480480	COMMD10	chr5:115420727-115628978:+	0.23	4.84	1.46E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs62385980	chr5:115592908	COMMD10	chr5:115420727-115628978:+	0.26	4.86	1.32E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs62385993	chr5:115602254	COMMD10	chr5:115420727-115628978:+	0.26	4.92	9.8E-7	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs62401232	chr6:43898345	MRPL14	chr6:44081374-44095191:-	0.13	4.28	2.02E-5	Vascular endothelial growth factor levels	
BRCA	cis	1	rs62401235	chr6:43900192	MRPL14	chr6:44081374-44095191:-	0.13	4.4	1.22E-5	Vascular endothelial growth factor levels	
BRCA	cis	1	rs62402013	chr6:26915000	BTN3A2	chr6:26365398-26378546:+	0.16	4.86	1.36E-6	Schizophrenia	
BRCA	cis	1	rs62402013	chr6:26915000	LOC100270746	chr6:26987146-26988085:-	-0.16	-4.22	2.7E-5	Schizophrenia	
BRCA	cis	1	rs62402013	chr6:26915000	ZNF391	chr6:27356524-27369227:+	-0.12	-3.48	0.000531	Schizophrenia	
BRCA	cis	1	rs62404862	chr6:55943199	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs62404863	chr6:55943202	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs62404865	chr6:55944559	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.57E-12	Psychosis (atypical)	
BRCA	cis	1	rs62404866	chr6:55956146	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs62404867	chr6:55957970	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs62404868	chr6:55958119	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs62404869	chr6:55958205	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs62404893	chr6:55961216	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs62404894	chr6:55961287	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.69E-11	Psychosis (atypical)	
BRCA	cis	1	rs62404895	chr6:55961427	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs62404896	chr6:55962092	COL21A1	chr6:55921389-56258892:-	-0.37	-6.82	1.56E-11	Psychosis (atypical)	
BRCA	cis	1	rs62406152	chr6:55932036	COL21A1	chr6:55921389-56258892:-	-0.38	-7.04	3.55E-12	Psychosis (atypical)	
BRCA	cis	1	rs62406153	chr6:55935232	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs62406155	chr6:55937492	COL21A1	chr6:55921389-56258892:-	-0.37	-6.91	8.37E-12	Psychosis (atypical)	
BRCA	cis	1	rs62406156	chr6:55941887	COL21A1	chr6:55921389-56258892:-	-0.37	-6.91	8.37E-12	Psychosis (atypical)	
BRCA	cis	1	rs62406157	chr6:55941999	COL21A1	chr6:55921389-56258892:-	-0.37	-6.74	2.57E-11	Psychosis (atypical)	
BRCA	cis	1	rs62411452	chr6:55964425	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs62411455	chr6:55968366	COL21A1	chr6:55921389-56258892:-	-0.37	-6.83	1.38E-11	Psychosis (atypical)	
BRCA	cis	1	rs62411456	chr6:55968420	COL21A1	chr6:55921389-56258892:-	-0.36	-6.71	3.25E-11	Psychosis (atypical)	
BRCA	cis	1	rs62411457	chr6:55968487	COL21A1	chr6:55921389-56258892:-	-0.37	-6.8	1.71E-11	Psychosis (atypical)	
BRCA	cis	1	rs62412799	chr6:55977839	COL21A1	chr6:55921389-56258892:-	-0.37	-6.86	1.14E-11	Psychosis (atypical)	
BRCA	cis	1	rs62412803	chr6:55986547	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.99E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412804	chr6:55986975	COL21A1	chr6:55921389-56258892:-	-0.34	-6.04	2.1E-9	Psychosis (atypical)	
BRCA	cis	1	rs62412805	chr6:55986986	COL21A1	chr6:55921389-56258892:-	-0.34	-6.08	1.65E-9	Psychosis (atypical)	
BRCA	cis	1	rs62412806	chr6:55987105	COL21A1	chr6:55921389-56258892:-	-0.38	-6.95	6.22E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412807	chr6:55987693	COL21A1	chr6:55921389-56258892:-	-0.38	-6.92	7.66E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412808	chr6:55987806	COL21A1	chr6:55921389-56258892:-	-0.38	-6.92	7.66E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412809	chr6:55987863	COL21A1	chr6:55921389-56258892:-	-0.38	-6.92	7.66E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412810	chr6:55988047	COL21A1	chr6:55921389-56258892:-	-0.38	-6.92	7.66E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412811	chr6:55988062	COL21A1	chr6:55921389-56258892:-	-0.38	-6.92	7.66E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412813	chr6:55988257	COL21A1	chr6:55921389-56258892:-	-0.38	-6.99	4.77E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412814	chr6:55988296	COL21A1	chr6:55921389-56258892:-	-0.38	-6.99	4.75E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412818	chr6:55989784	COL21A1	chr6:55921389-56258892:-	-0.38	-6.98	5.28E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412819	chr6:55992889	COL21A1	chr6:55921389-56258892:-	-0.38	-6.96	5.96E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412820	chr6:55992934	COL21A1	chr6:55921389-56258892:-	-0.38	-6.98	5.28E-12	Psychosis (atypical)	
BRCA	cis	1	rs62412822	chr6:55993174	COL21A1	chr6:55921389-56258892:-	-0.38	-7.06	2.98E-12	Psychosis (atypical)	
BRCA	cis	1	rs62413465	chr6:55998202	COL21A1	chr6:55921389-56258892:-	-0.37	-6.82	1.48E-11	Psychosis (atypical)	
BRCA	cis	1	rs62413470	chr6:55999537	COL21A1	chr6:55921389-56258892:-	-0.33	-6.37	2.89E-10	Psychosis (atypical)	
BRCA	cis	1	rs62413472	chr6:56000117	COL21A1	chr6:55921389-56258892:-	-0.37	-6.78	1.99E-11	Psychosis (atypical)	
BRCA	cis	1	rs62413473	chr6:56000463	COL21A1	chr6:55921389-56258892:-	-0.37	-6.79	1.83E-11	Psychosis (atypical)	
BRCA	cis	1	rs62413474	chr6:56001074	COL21A1	chr6:55921389-56258892:-	-0.37	-6.76	2.29E-11	Psychosis (atypical)	
BRCA	cis	1	rs62413475	chr6:56001075	COL21A1	chr6:55921389-56258892:-	-0.37	-6.76	2.29E-11	Psychosis (atypical)	
BRCA	cis	1	rs62413476	chr6:56001918	COL21A1	chr6:55921389-56258892:-	-0.36	-6.53	1.03E-10	Psychosis (atypical)	
BRCA	cis	1	rs62413477	chr6:56002434	COL21A1	chr6:55921389-56258892:-	-0.37	-6.77	2.09E-11	Psychosis (atypical)	
BRCA	cis	1	rs62413478	chr6:56002867	COL21A1	chr6:55921389-56258892:-	-0.37	-6.77	2.09E-11	Psychosis (atypical)	
BRCA	cis	1	rs62413479	chr6:56004203	COL21A1	chr6:55921389-56258892:-	-0.37	-6.83	1.43E-11	Psychosis (atypical)	
BRCA	cis	1	rs624159	chr10:105939451	C10orf79	chr10:105889647-105992120:-	0.14	4.97	7.63E-7	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs62421539	chr6:118730559	C6orf204	chr6:118786239-119031238:-	-0.11	-3.6	0.000335	Renal cell carcinoma	
BRCA	cis	1	rs62422220	chr6:118923731	C6orf204	chr6:118786239-119031238:-	-0.11	-3.39	0.000721	Renal cell carcinoma	
BRCA	cis	1	rs62422227	chr6:118957200	C6orf204	chr6:118786239-119031238:-	-0.11	-3.5	0.000486	Renal cell carcinoma	
BRCA	cis	1	rs62422228	chr6:118957276	C6orf204	chr6:118786239-119031238:-	-0.11	-3.48	0.000528	Renal cell carcinoma	
BRCA	cis	1	rs62422229	chr6:118959288	C6orf204	chr6:118786239-119031238:-	-0.11	-3.43	0.000621	Renal cell carcinoma	
BRCA	cis	1	rs62424172	chr6:118777533	C6orf204	chr6:118786239-119031238:-	-0.11	-3.46	0.000565	Renal cell carcinoma	
BRCA	cis	1	rs62445866	chr7:50472324	FIGNL1	chr7:50511834-50518088:-	-0.11	-3.43	0.000627	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs62460739	chr7:77406747	PHTF2	chr7:77428109-77586818:+	-0.18	-5.09	4.18E-7	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs62460740	chr7:77409439	PHTF2	chr7:77428109-77586818:+	-0.18	-5.06	4.82E-7	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs62465144	chr7:72883106	MLXIPL	chr7:73007524-73038870:-	0.3	5.74	1.26E-8	Triglycerides	
BRCA	cis	1	rs62466793	chr7:66191517	CRCP	chr7:65579805-65619551:+	-0.14	-3.69	0.000232	Aortic root size	
BRCA	cis	1	rs62466793	chr7:66191517	TYW1	chr7:66461817-66704496:+	0.14	3.72	0.000206	Aortic root size	
BRCA	cis	1	rs62466794	chr7:66191579	CRCP	chr7:65579805-65619551:+	-0.14	-3.7	0.000226	Aortic root size	
BRCA	cis	1	rs62466794	chr7:66191579	TYW1	chr7:66461817-66704496:+	0.14	3.82	0.000139	Aortic root size	
BRCA	cis	1	rs62479588	chr7:128405521	OPN1SW	chr7:128412545-128415844:-	0.16	3.88	0.000109	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
BRCA	cis	1	rs62502114	chr8:15535598	TUSC3	chr8:15397730-15621993:+	0.23	5.07	4.79E-7	Pulmonary function decline	
BRCA	cis	1	rs62521129	chr8:65680661	CYP7B1	chr8:65508529-65711348:-	0.11	3.61	0.000325	HIV-1 susceptibility	
BRCA	cis	1	rs625917	chr1:183157991	LAMC2	chr1:183155174-183214262:+	-0.1	-3.69	0.000233	Hypertriglyceridemia	
BRCA	cis	1	rs62625008	chr1:95702582	RWDD3	chr1:95583479-95712773:+	0.24	3.7	0.00023	Stearic acid (18:0) plasma levels	
BRCA	cis	1	rs629301	chr1:109818306	PSRC1	chr1:109822179-109825808:-	-0.13	-4.26	2.27E-5	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
BRCA	cis	1	rs633185	chr11:100593538	TMEM133	chr11:100862811-100864665:+	-0.15	-4.27	2.1E-5	Systolic blood pressure;Hypertension;Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs638781	chr1:183157358	LAMC2	chr1:183155174-183214262:+	-0.1	-3.56	0.000389	Hypertriglyceridemia	
BRCA	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.55	-28.21	3.03E-131	Crohn's disease	
BRCA	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.37	10.24	1.6E-23	Crohn's disease	
BRCA	cis	1	rs641862	chr13:110790232	ANKRD10	chr13:111530888-111567416:-	0.49	9.31	6.99E-20	Obesity-related traits	
BRCA	cis	1	rs641862	chr13:110790232	ARHGEF7	chr13:111767624-111958080:+	0.72	12.91	1.51E-35	Obesity-related traits	
BRCA	cis	1	rs641862	chr13:110790232	CARKD	chr13:111267881-111292340:+	0.73	12.35	7.71E-33	Obesity-related traits	
BRCA	cis	1	rs641862	chr13:110790232	CARS2	chr13:111293757-111365950:-	0.57	10.29	1.01E-23	Obesity-related traits	
BRCA	cis	1	rs641862	chr13:110790232	ING1	chr13:111365083-111373420:+	0.56	8.46	9.04E-17	Obesity-related traits	
BRCA	cis	1	rs641862	chr13:110790232	IRS2	chr13:110406186-110438914:-	0.28	4.87	1.25E-6	Obesity-related traits	
BRCA	cis	1	rs641862	chr13:110790232	RAB20	chr13:111175414-111214071:-	0.44	8.52	5.42E-17	Obesity-related traits	
BRCA	cis	1	rs6422512	chr1:93024844	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	9.0E-7	Cholesterol, total	
BRCA	cis	1	rs6426656	chr1:21343245	HP1BP3	chr1:21069171-21113799:-	0.11	3.57	0.000371	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6426656	chr1:21343245	SH2D5	chr1:21046225-21059330:-	0.13	3.56	0.000386	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6426659	chr1:21361302	HP1BP3	chr1:21069171-21113799:-	0.12	3.61	0.00032	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6426659	chr1:21361302	SH2D5	chr1:21046225-21059330:-	0.13	3.42	0.000645	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6426660	chr1:21361640	HP1BP3	chr1:21069171-21113799:-	0.12	3.66	0.00026	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6426660	chr1:21361640	SH2D5	chr1:21046225-21059330:-	0.12	3.37	0.00077	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.37	10.47	1.69E-24	Height	
BRCA	cis	1	rs6429082	chr1:235600129	TBCE	chr1:235530728-235612280:+	0.13	4.72	2.72E-6	Adiposity	
BRCA	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.83	-27.89	4.96E-129	Homocysteine levels	
BRCA	cis	1	rs6429567	chr1:45956700	MMACHC	chr1:45965856-45976737:+	-0.14	-4.05	5.54E-5	Homocysteine levels	
BRCA	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.69	-22.55	2.12E-92	Homocysteine levels	
BRCA	cis	1	rs6429582	chr1:46321843	CCDC163P	chr1:45960581-45965646:-	0.38	11.09	4.0E-27	Body mass index	
BRCA	cis	1	rs6429582	chr1:46321843	CCDC17	chr1:46085717-46089729:-	-0.11	-3.61	0.000321	Body mass index	
BRCA	cis	1	rs6429582	chr1:46321843	MUTYH	chr1:45794915-45806142:-	-0.13	-5.24	1.95E-7	Body mass index	
BRCA	cis	1	rs643025	chr1:197298860	CFHR3	chr1:196743930-196762872:+	-0.14	-3.58	0.000364	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs6430585	chr2:136506927	DARS	chr2:136664254-136743222:-	-0.17	-4.62	4.25E-6	Corneal structure	
BRCA	cis	1	rs6430585	chr2:136506927	LCT	chr2:136545415-136594750:-	0.17	4.52	6.79E-6	Corneal structure	
BRCA	cis	1	rs6431654	chr2:234161769	SAG	chr2:234216309-234255701:+	0.12	3.88	0.000109	Crohn's disease	
BRCA	cis	1	rs6435079	chr2:202200331	ALS2CR12	chr2:202153148-202222101:-	-0.22	-5.58	2.99E-8	Basal cell carcinoma	
BRCA	cis	1	rs6435079	chr2:202200331	PPIL3	chr2:201735680-201753999:-	-0.15	-4.04	5.81E-5	Basal cell carcinoma	
BRCA	cis	1	rs6435081	chr2:202220623	ALS2CR12	chr2:202153148-202222101:-	-0.2	-5.31	1.34E-7	Basal cell carcinoma	
BRCA	cis	1	rs6435081	chr2:202220623	PPIL3	chr2:201735680-201753999:-	-0.16	-4.2	2.94E-5	Basal cell carcinoma	
BRCA	cis	1	rs643531	chr9:15296034	TTC39B	chr9:15171561-15307244:-	-0.16	-3.55	0.000404	Coenzyme Q10 levels;Metabolite levels (lipoprotein measures)	
BRCA	cis	1	rs6438537	chr3:119277846	CD80	chr3:119243142-119278481:-	0.12	4.07	5.08E-5	Vitiligo	
BRCA	cis	1	rs6439124	chr3:128007466	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.41	0.000668	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.42	13.99	6.23E-41	Height	
BRCA	cis	1	rs6439484	chr3:134249899	CEP63	chr3:134204575-134293852:+	0.14	3.92	9.49E-5	Height	
BRCA	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.42	13.99	6.23E-41	Height	
BRCA	cis	1	rs6439487	chr3:134260860	CEP63	chr3:134204575-134293852:+	0.14	3.92	9.49E-5	Height	
BRCA	cis	1	rs6439649	chr3:136371691	PCCB	chr3:135969167-136056737:+	-0.14	-3.8	0.000152	Schizophrenia	
BRCA	cis	1	rs6441961	chr3:46352384	FYCO1	chr3:45959396-46037307:-	0.12	4.1	4.47E-5	Celiac disease	
BRCA	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.26	9.69	2.48E-21	Longevity	
BRCA	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.27	-10.04	9.59E-23	Longevity	
BRCA	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.29	-10.93	2.02E-26	Longevity	
BRCA	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.29	-10.87	3.61E-26	Longevity	
BRCA	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.27	-10.21	2.08E-23	Longevity	
BRCA	cis	1	rs6444530	chr3:190982425	UTS2D	chr3:190984945-191048325:-	-0.21	-6.16	1.0E-9	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs6444531	chr3:190988002	UTS2D	chr3:190984945-191048325:-	-0.22	-6.4	2.39E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs6444533	chr3:190999790	CCDC50	chr3:191046874-191116458:+	0.1	3.5	0.000481	Total ventricular volume (Alzheimer's disease interaction)	
BRCA	cis	1	rs6444534	chr3:190999872	CCDC50	chr3:191046874-191116458:+	0.1	3.5	0.000481	Total ventricular volume (Alzheimer's disease interaction)	
BRCA	cis	1	rs6444535	chr3:190999990	CCDC50	chr3:191046874-191116458:+	0.1	3.5	0.000481	Total ventricular volume (Alzheimer's disease interaction)	
BRCA	cis	1	rs6445358	chr3:52308845	NT5DC2	chr3:52558386-52569093:-	-0.1	-3.58	0.000355	Electroencephalogram traits	
BRCA	cis	1	rs6445622	chr3:51356823	GRM2	chr3:51741081-51752623:+	-0.18	-3.44	0.000598	Melanoma	
BRCA	cis	1	rs6446262	chr3:49401153	AMT	chr3:49454212-49460012:-	0.15	4.79	1.89E-6	Menarche (age at onset)	
BRCA	cis	1	rs6446262	chr3:49401153	NCKIPSD	chr3:48711280-48723334:-	0.16	3.94	8.5E-5	Menarche (age at onset)	
BRCA	cis	1	rs6446262	chr3:49401153	P4HTM	chr3:49027341-49044579:+	0.11	4.48	8.22E-6	Menarche (age at onset)	
BRCA	cis	1	rs6446262	chr3:49401153	TREX1	chr3:48501186-48509043:+	-0.13	-4.14	3.78E-5	Menarche (age at onset)	
BRCA	cis	1	rs6446262	chr3:49401153	WDR6	chr3:49044637-49053386:+	-0.15	-4.18	3.16E-5	Menarche (age at onset)	
BRCA	cis	1	rs6446275	chr3:49466871	AMT	chr3:49454212-49460012:-	-0.13	-4.35	1.47E-5	Menarche (age at onset)	
BRCA	cis	1	rs6446275	chr3:49466871	CCDC36	chr3:49235861-49295537:+	-0.1	-3.91	9.73E-5	Menarche (age at onset)	
BRCA	cis	1	rs6446275	chr3:49466871	GMPPB	chr3:49758932-49761384:-	0.13	3.79	0.000157	Menarche (age at onset)	
BRCA	cis	1	rs6446275	chr3:49466871	NCKIPSD	chr3:48711280-48723334:-	-0.14	-3.49	0.000507	Menarche (age at onset)	
BRCA	cis	1	rs6446275	chr3:49466871	P4HTM	chr3:49027341-49044579:+	-0.09	-3.88	0.000112	Menarche (age at onset)	
BRCA	cis	1	rs6446275	chr3:49466871	TREX1	chr3:48501186-48509043:+	0.12	3.8	0.000152	Menarche (age at onset)	
BRCA	cis	1	rs6446275	chr3:49466871	WDR6	chr3:49044637-49053386:+	0.15	4.55	6.02E-6	Menarche (age at onset)	
BRCA	cis	1	rs6447875	chr4:8503206	C4orf23	chr4:8440604-8495258:+	-0.16	-4.33	1.6E-5	Response to antineoplastic agents	
BRCA	cis	1	rs6449350	chr4:17977535	NCAPG	chr4:17812525-17846485:+	0.09	4.35	1.49E-5	Height	
BRCA	cis	1	rs6449353	chr4:18033488	NCAPG	chr4:17812525-17846485:+	0.09	4.18	3.15E-5	Height	
BRCA	cis	1	rs6450384	chr5:50058684	PARP8	chr5:49961733-50138169:+	0.13	3.85	0.000127	Myopia (pathological)	
BRCA	cis	1	rs6450391	chr5:50064387	PARP8	chr5:49961733-50138169:+	0.13	3.75	0.000187	Myopia (pathological)	
BRCA	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.78	19.86	5.79E-75	Type 2 diabetes	
BRCA	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.72	18.77	3.66E-68	Type 2 diabetes	
BRCA	cis	1	rs6452524	chr5:82433781	XRCC4	chr5:82373317-82649577:+	0.13	3.82	0.000144	Hypertension	
BRCA	cis	1	rs6452526	chr5:82436811	XRCC4	chr5:82373317-82649577:+	-0.12	-3.45	0.000584	Hypertension	
BRCA	cis	1	rs6452527	chr5:82436840	XRCC4	chr5:82373317-82649577:+	-0.12	-3.45	0.000584	Hypertension	
BRCA	cis	1	rs6452531	chr5:82466174	XRCC4	chr5:82373317-82649577:+	-0.12	-3.39	0.000722	Hypertension	
BRCA	cis	1	rs6453279	chr5:76417074	LOC728723	chr5:76382623-76444175:+	-0.14	-3.45	0.000587	Autism	
BRCA	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.59	19.06	6.1E-70	Response to antipsychotic treatment	
BRCA	cis	1	rs645485	chr11:108168863	C11orf65	chr11:108179246-108338258:-	0.15	3.76	0.000181	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
BRCA	cis	1	rs645485	chr11:108168863	CUL5	chr11:107879408-107978484:+	0.11	3.63	0.000299	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
BRCA	cis	1	rs645485	chr11:108168863	EXPH5	chr11:108376159-108464374:-	0.13	3.62	0.00031	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
BRCA	cis	1	rs645491	chr12:123181661	GPR109A	chr12:123185840-123187904:-	-0.15	-3.53	0.000441	Adiponectin levels	
BRCA	cis	1	rs6456733	chr6:26566804	BTN2A3	chr6:26422317-26431927:+	0.16	5.43	7.16E-8	Educational attainment	
BRCA	cis	1	rs6456733	chr6:26566804	C6orf41	chr6:26924772-26991752:+	-0.13	-4.04	5.84E-5	Educational attainment	
BRCA	cis	1	rs6456733	chr6:26566804	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.66	0.000268	Educational attainment	
BRCA	cis	1	rs6456734	chr6:26566965	BTN2A3	chr6:26422317-26431927:+	0.16	5.37	9.66E-8	Educational attainment	
BRCA	cis	1	rs6456734	chr6:26566965	C6orf41	chr6:26924772-26991752:+	-0.13	-3.99	6.99E-5	Educational attainment	
BRCA	cis	1	rs6456734	chr6:26566965	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.64	0.000289	Educational attainment	
BRCA	cis	1	rs6458307	chr6:42731115	PEX6	chr6:42931613-42946981:-	-0.19	-5.26	1.78E-7	Bipolar disorder	
BRCA	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.31	-10.46	2.0E-24	Homocysteine levels	
BRCA	cis	1	rs6458685	chr6:49379536	MUT	chr6:49398994-49431031:-	0.16	4.82	1.6E-6	Homocysteine levels	
BRCA	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.32	-10.6	5.14E-25	Homocysteine levels	
BRCA	cis	1	rs6458688	chr6:49406056	MUT	chr6:49398994-49431031:-	0.15	4.57	5.52E-6	Homocysteine levels	
BRCA	cis	1	rs6458690	chr6:49411619	CENPQ	chr6:49431096-49460820:+	-0.22	-7.21	1.06E-12	Folate pathway vitamin levels	
BRCA	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.33	10.47	1.76E-24	Folate pathway vitamin levels	
BRCA	cis	1	rs6458694	chr6:49445306	CENPQ	chr6:49431096-49460820:+	-0.24	-7.79	1.54E-14	Folate pathway vitamin levels	
BRCA	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.32	10.13	4.46E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs6459657	chr6:170136454	WDR27	chr6:169857307-170102159:-	-0.11	-3.38	0.000756	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs6460260	chr7:65215455	CCT6P1	chr7:65216092-65228661:+	-0.34	-7.41	2.61E-13	Diabetic kidney disease	
BRCA	cis	1	rs6460260	chr7:65215455	ZNF117	chr7:64434830-64467121:-	0.27	5	6.55E-7	Diabetic kidney disease	
BRCA	cis	1	rs6460261	chr7:65215580	CCT6P1	chr7:65216092-65228661:+	-0.34	-7.41	2.61E-13	Diabetic kidney disease	
BRCA	cis	1	rs6460261	chr7:65215580	ZNF117	chr7:64434830-64467121:-	0.27	5	6.55E-7	Diabetic kidney disease	
BRCA	cis	1	rs6460274	chr7:65628484	CCT6P1	chr7:65216092-65228661:+	-0.29	-6.17	9.76E-10	Diabetic kidney disease	
BRCA	cis	1	rs6460274	chr7:65628484	CRCP	chr7:65579805-65619551:+	0.23	3.81	0.000148	Diabetic kidney disease	
BRCA	cis	1	rs6460274	chr7:65628484	LOC493754	chr7:65993446-66057363:-	-0.21	-3.47	0.000546	Diabetic kidney disease	
BRCA	cis	1	rs6464573	chr7:143748098	ARHGEF35	chr7:143883677-143892736:-	0.39	9.56	8.16E-21	Obesity-related traits	
BRCA	cis	1	rs6464573	chr7:143748098	OR2A7	chr7:143955790-143974852:-	-0.21	-4.97	7.74E-7	Obesity-related traits	
BRCA	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.43	-10.19	2.39E-23	Obesity-related traits	
BRCA	cis	1	rs6464574	chr7:143748257	OR2A7	chr7:143955790-143974852:-	0.23	5.09	4.33E-7	Obesity-related traits	
BRCA	cis	1	rs6464574	chr7:143748257	OR2A9P	chr7:143991573-143997832:+;chr7	-0.14	-3.45	0.000588	Obesity-related traits	
BRCA	cis	1	rs6467244	chr7:129049507	ATP6V1F	chr7:128502898-128505902:+	0.16	4.09	4.58E-5	Tuberculosis	
BRCA	cis	1	rs6467244	chr7:129049507	CALU	chr7:128379346-128411530:+	0.11	3.65	0.000274	Tuberculosis	
BRCA	cis	1	rs6467244	chr7:129049507	KLHDC10	chr7:129710349-129773593:+	0.12	3.38	0.000757	Tuberculosis	
BRCA	cis	1	rs6467244	chr7:129049507	METTL2B	chr7:128116783-128142977:+	0.27	5.61	2.64E-8	Tuberculosis	
BRCA	cis	1	rs6467244	chr7:129049507	TNPO3	chr7:128594948-128695198:-	0.17	4.2	2.93E-5	Tuberculosis	
BRCA	cis	1	rs6467244	chr7:129049507	UBE2H	chr7:129472995-129592789:-	0.2	4.77	2.07E-6	Tuberculosis	
BRCA	cis	1	rs646776	chr1:109818530	PSRC1	chr1:109822179-109825808:-	-0.14	-4.6	4.67E-6	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
BRCA	cis	1	rs6472155	chr8:65730207	CYP7B1	chr8:65508529-65711348:-	0.11	3.97	7.57E-5	Retinopathy in non-diabetics	
BRCA	cis	1	rs6477692	chr9:111904758	C9orf5	chr9:111777416-111882225:-	0.15	3.39	0.00073	Information processing speed	
BRCA	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.36	-9.88	4.18E-22	Rheumatoid arthritis	
BRCA	cis	1	rs6478484	chr9:123652380	TRAF1	chr9:123664672-123691479:-	0.11	5.02	6.03E-7	Rheumatoid arthritis	
BRCA	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.36	-10.1	5.57E-23	Rheumatoid arthritis	
BRCA	cis	1	rs6478486	chr9:123655329	TRAF1	chr9:123664672-123691479:-	0.1	4.79	1.87E-6	Rheumatoid arthritis	
BRCA	cis	1	rs6478867	chr9:131903923	SH3GLB2	chr9:131770314-131790579:-	0.13	5.06	4.89E-7	Blood metabolite ratios	
BRCA	cis	1	rs6478867	chr9:131903923	USP20	chr9:132597696-132644107:+	0.09	3.44	0.000603	Blood metabolite ratios	
BRCA	cis	1	rs6480314	chr10:69967447	PBLD	chr10:70042417-70092684:-	-0.18	-3.82	0.000141	Optic nerve measurement (disc area)	
BRCA	cis	1	rs6483501	chr11:96108061	CCDC82	chr11:96085930-96123083:-	-0.12	-3.38	0.00074	Parkinson's disease	
BRCA	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.38	-10.15	3.72E-23	Forced vital capacity	
BRCA	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.4	10.7	1.97E-25	Forced vital capacity	
BRCA	cis	1	rs6485774	chr11:47773226	MADD	chr11:47290927-47351582:+	-0.13	-3.7	0.000228	Intraocular pressure	
BRCA	cis	1	rs6485784	chr11:47832260	MADD	chr11:47290927-47351582:+	-0.12	-3.65	0.000274	Intraocular pressure	
BRCA	cis	1	rs6485788	chr11:47873883	MADD	chr11:47290927-47351582:+	0.12	3.64	0.000282	Intraocular pressure	
BRCA	cis	1	rs6487679	chr12:9371332	LOC642846	chr12:9436253-9466684:+	0.14	4.82	1.62E-6	Non-alcoholic fatty liver disease histology (AST)	
BRCA	cis	1	rs6488051	chr12:32532733	FGD4	chr12:32638906-32798982:+	-0.32	-10.14	4.13E-23	Response to tocilizumab in rheumatoid arthritis	
BRCA	cis	1	rs6489238	chr12:122612635	LRRC43	chr12:122652266-122688017:+	-0.16	-4.51	7.08E-6	Urate levels	
BRCA	cis	1	rs6489242	chr12:122613278	LRRC43	chr12:122652266-122688017:+	-0.16	-4.59	4.91E-6	Urate levels	
BRCA	cis	1	rs6489244	chr12:122613540	LRRC43	chr12:122652266-122688017:+	-0.16	-4.6	4.65E-6	Urate levels	
BRCA	cis	1	rs6490525	chr13:20736216	IFT88	chr13:21141208-21265574:+	0.23	3.42	0.000641	Capecitabine sensitivity	
BRCA	cis	1	rs6490525	chr13:20736216	N6AMT2	chr13:21303073-21348095:-	0.27	3.53	0.000432	Capecitabine sensitivity	
BRCA	cis	1	rs6490525	chr13:20736216	SAP18	chr13:21714653-21723223:+	0.28	3.51	0.000466	Capecitabine sensitivity	
BRCA	cis	1	rs6490525	chr13:20736216	XPO4	chr13:21351469-21476913:-	0.3	4.56	5.83E-6	Capecitabine sensitivity	
BRCA	cis	1	rs6490525	chr13:20736216	ZMYM2	chr13:20532810-20660938:+	0.28	4.2	2.89E-5	Capecitabine sensitivity	
BRCA	cis	1	rs6490604	chr13:21284828	IFT88	chr13:21141208-21265574:+	0.12	3.88	0.000109	Dental caries	
BRCA	cis	1	rs6492925	chr15:40304170	SRP14	chr15:40327891-40331389:-	-0.24	-5.42	7.25E-8	Response to haloperidol in psychosis	
BRCA	cis	1	rs6495206	chr15:76870963	SCAPER	chr15:76640529-77197744:-	-0.18	-6.32	3.88E-10	Blood metabolite levels	
BRCA	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.5	-12.98	7.08E-36	Type 2 diabetes	
BRCA	cis	1	rs6498540	chr16:15130594	C16orf63	chr16:15959577-15982447:-	0.13	3.56	0.000393	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs6498541	chr16:15140657	C16orf63	chr16:15959577-15982447:-	0.14	3.91	9.76E-5	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs6500602	chr16:4497451	C16orf5	chr16:4560679-4588816:-	0.17	4.36	1.43E-5	Schizophrenia	
BRCA	cis	1	rs6508977	chr19:41909346	B3GNT8	chr19:41931265-41934635:-	-0.23	-7.17	1.35E-12	Height	
BRCA	cis	1	rs6515375	chr20:23610841	CST1	chr20:23728191-23731574:-	0.22	4.7	2.97E-6	Chronic kidney disease	
BRCA	cis	1	rs6515651	chr20:25414539	FAM182A	chr20:26035250-26067552:+	0.23	6.21	7.69E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6515651	chr20:25414539	FAM182B	chr20:25744102-25848786:-	-0.22	-5.78	9.75E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs6515773	chr20:3174105	ITPA	chr20:3190056-3204504:+	0.11	3.87	0.000116	Night sleep phenotypes	
BRCA	cis	1	rs6515773	chr20:3174105	ProSAPiP1	chr20:3143273-3154192:-	0.15	3.92	9.3E-5	Night sleep phenotypes	
BRCA	cis	1	rs6516891	chr21:30483070	N6AMT1	chr21:30244513-30257693:-	-0.12	-3.4	0.00069	Dental caries	
BRCA	cis	1	rs6516891	chr21:30483070	NCRNA00189	chr21:30565801-30660525:+	0.18	5.38	9.21E-8	Dental caries	
BRCA	cis	1	rs6519120	chr22:38991393	JOSD1	chr22:39081549-39096459:-	0.13	4.21	2.78E-5	Resting heart rate	
BRCA	cis	1	rs652753	chr1:183156569	LAMC2	chr1:183155174-183214262:+	-0.1	-3.56	0.000389	Hypertriglyceridemia	
BRCA	cis	1	rs6532022	chr4:88773734	SPP1	chr4:88896802-88904562:+	-0.18	-5.8	8.64E-9	Bone mineral density;Bone mineral density (paediatric, total body less head)	
BRCA	cis	1	rs6532023	chr4:88773849	SPP1	chr4:88896802-88904562:+	-0.18	-5.8	8.64E-9	Bone mineral density;Bone mineral density (paediatric, total body less head)	
BRCA	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.2	-5.04	5.43E-7	Longevity	
BRCA	cis	1	rs6533014	chr4:103349740	SLC39A8	chr4:103172198-103266655:-	0.19	4.93	9.66E-7	Homeostasis model assessment of beta-cell function (interaction)	
BRCA	cis	1	rs6533059	chr4:104133376	MANBA	chr4:103552644-103682151:-	0.17	4.59	4.99E-6	Testicular germ cell tumor	
BRCA	cis	1	rs6533060	chr4:104139996	MANBA	chr4:103552644-103682151:-	0.17	4.48	8.22E-6	Testicular germ cell tumor	
BRCA	cis	1	rs6536882	chr4:165900680	TRIM61	chr4:165875600-165898818:-	0.25	7.81	1.37E-14	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs6536883	chr4:165900704	TRIM61	chr4:165875600-165898818:-	0.25	7.81	1.37E-14	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs6537837	chr1:110119732	AMIGO1	chr1:110049447-110052336:-	0.15	3.66	0.000263	Major depressive disorder	
BRCA	cis	1	rs6537837	chr1:110119732	SYPL2	chr1:110009100-110024763:+	-0.15	-3.75	0.000185	Major depressive disorder	
BRCA	cis	1	rs6540896	chr1:207440851	CR2	chr1:207627670-207663238:+	0.1	3.39	0.000719	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs6542527	chr2:120148080	TMEM37	chr2:120189446-120196094:+	0.11	3.44	0.000597	Obesity-related traits	
BRCA	cis	1	rs6544065	chr2:37497417	CEBPZ	chr2:37428778-37458740:-	-0.17	-5.15	3.08E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.2	-9.77	1.15E-21	Tuberculosis	
BRCA	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.45	12.08	1.37E-31	Tuberculosis	
BRCA	cis	1	rs6546377	chr2:68570223	PLEK	chr2:68592322-68624584:+	-0.04	-3.39	0.000712	Metabolite levels	
BRCA	cis	1	rs6546556	chr2:70139001	ANXA4	chr2:69969127-70053594:+	-0.14	-3.95	8.49E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6546556	chr2:70139001	FAM136A	chr2:70523109-70529220:-	-0.09	-3.45	0.000577	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6546558	chr2:70145717	ANXA4	chr2:69969127-70053594:+	-0.15	-4.39	1.26E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6546559	chr2:70145833	ANXA4	chr2:69969127-70053594:+	-0.14	-4.05	5.53E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6547734	chr2:27830990	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.02	6.16E-5	Oral cavity cancer	
BRCA	cis	1	rs6547740	chr2:27854369	KRTCAP3	chr2:27665263-27667163:+	-0.12	-3.89	0.000107	Oral cavity cancer	
BRCA	cis	1	rs6547741	chr2:27855924	KRTCAP3	chr2:27665263-27667163:+	-0.12	-3.84	0.000131	Oral cavity cancer	
BRCA	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.26	-6.39	2.4E-10	Body mass index	
BRCA	cis	1	rs6554106	chr4:54292791	SCFD2	chr4:53739152-54232242:-	0.14	3.5	0.000491	DNA methylation (variation)	
BRCA	cis	1	rs6568967	chr6:117230721	FAM162B	chr6:117073360-117086886:-	-0.11	-3.93	9.06E-5	Prostate cancer	
BRCA	cis	1	rs6568967	chr6:117230721	FAM26F	chr6:116782556-116784933:+	-0.09	-3.92	9.52E-5	Prostate cancer	
BRCA	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.56	-28.45	5.9E-133	Crohn's disease	
BRCA	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.38	10.5	1.33E-24	Crohn's disease	
BRCA	cis	1	rs6577488	chr1:8534529	RERE	chr1:8412466-8877699:-	0.1	3.47	0.000543	Vitiligo	
BRCA	cis	1	rs6577494	chr1:8576925	RERE	chr1:8412466-8877699:-	0.1	3.42	0.000653	Vitiligo	
BRCA	cis	1	rs6577499	chr1:8612104	RERE	chr1:8412466-8877699:-	-0.1	-3.45	0.000587	Vitiligo	
BRCA	cis	1	rs6577502	chr1:8615577	RERE	chr1:8412466-8877699:-	0.1	3.44	0.000599	Vitiligo	
BRCA	cis	1	rs6579211	chr20:33605857	MMP24	chr20:33814539-33864804:+	-0.23	-4.03	6.09E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6579211	chr20:33605857	PROCR	chr20:33758727-33765164:+	-0.25	-4.99	7.12E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs6579234	chr20:33983485	CPNE1	chr20:34213968-34262539:-	0.24	6.54	9.69E-11	Height	
BRCA	cis	1	rs6579234	chr20:33983485	MMP24	chr20:33814539-33864804:+	0.16	4.6	4.72E-6	Height	
BRCA	cis	1	rs6579234	chr20:33983485	UQCC	chr20:33890383-33999833:-	0.32	9.85	5.89E-22	Height	
BRCA	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.55	-11.13	2.78E-27	Cholesterol, total	
BRCA	cis	1	rs6579245	chr20:34125271	ERGIC3	chr20:34129778-34145404:+	-0.18	-3.78	0.000164	Cholesterol, total	
BRCA	cis	1	rs6581155	chr12:58178162	B4GALNT1	chr12:58019551-58026985:-	0.12	3.66	0.000266	Multiple sclerosis	
BRCA	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.41	10.64	3.45E-25	Multiple sclerosis	
BRCA	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.32	-9.89	3.92E-22	Multiple sclerosis	
BRCA	cis	1	rs6581155	chr12:58178162	XRCC6BP1	chr12:58335445-58351051:+	-0.18	-5.28	1.53E-7	Multiple sclerosis	
BRCA	cis	1	rs6583203	chr3:197079586	KIAA0226	chr3:197398259-197476568:-	-0.14	-3.98	7.28E-5	Allergic rhinitis	
BRCA	cis	1	rs6583954	chr10:96534263	HELLS	chr10:96305543-96361855:+	0.12	3.38	0.000751	Migraine	
BRCA	cis	1	rs6584379	chr10:102224490	SEC31B	chr10:102246403-102289636:-	-0.28	-10.28	1.09E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs6584383	chr10:102303065	SEC31B	chr10:102246403-102289636:-	-0.28	-10.41	3.0E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs6586028	chr10:82253984	DYDC1	chr10:82095864-82116511:-	0.16	3.71	0.000216	Post bronchodilator FEV1	
BRCA	cis	1	rs6589576	chr11:116735788	PCSK7	chr11:117075789-117102811:-	0.16	3.56	0.000382	Protein quantitative trait loci	
BRCA	cis	1	rs659307	chr1:183163078	LAMC2	chr1:183155174-183214262:+	-0.11	-3.69	0.000232	Hypertriglyceridemia	
BRCA	cis	1	rs6598060	chr11:243987	PSMD13	chr11:236808-252984:+	-0.17	-4.72	2.62E-6	Menarche (age at onset)	
BRCA	cis	1	rs6598061	chr11:243853	PSMD13	chr11:236808-252984:+	-0.16	-4.58	5.13E-6	Menarche (age at onset)	
BRCA	cis	1	rs6598062	chr11:243712	PSMD13	chr11:236808-252984:+	-0.16	-4.52	6.82E-6	Menarche (age at onset)	
BRCA	cis	1	rs6598063	chr11:243672	PSMD13	chr11:236808-252984:+	-0.16	-4.52	6.82E-6	Menarche (age at onset)	
BRCA	cis	1	rs6598065	chr11:243211	PSMD13	chr11:236808-252984:+	-0.16	-4.42	1.08E-5	Menarche (age at onset)	
BRCA	cis	1	rs6598266	chr15:100299239	C15orf51	chr15:100330361-100347132:-	0.18	4.43	1.06E-5	Major depressive disorder	
BRCA	cis	1	rs6598267	chr15:100299295	C15orf51	chr15:100330361-100347132:-	-0.18	-4.37	1.39E-5	Major depressive disorder	
BRCA	cis	1	rs6598268	chr15:100299300	C15orf51	chr15:100330361-100347132:-	-0.18	-4.35	1.48E-5	Major depressive disorder	
BRCA	cis	1	rs6598271	chr15:100299633	C15orf51	chr15:100330361-100347132:-	-0.18	-4.36	1.41E-5	Major depressive disorder	
BRCA	cis	1	rs6598272	chr15:100299673	C15orf51	chr15:100330361-100347132:-	-0.19	-4.43	1.04E-5	Major depressive disorder	
BRCA	cis	1	rs6598955	chr1:26619649	TRIM63	chr1:26377798-26394121:-	-0.14	-4.1	4.53E-5	Obesity-related traits	
BRCA	cis	1	rs6598955	chr1:26619649	ZNF593	chr1:26496388-26497362:+	0.12	5.02	5.92E-7	Obesity-related traits	
BRCA	cis	1	rs6599639	chr10:124743751	PSTK	chr10:124739556-124749906:+	0.13	3.66	0.000264	Migraine without aura	
BRCA	cis	1	rs6601011	chr5:178507344	ZNF354C	chr5:178487607-178507689:+	-0.11	-3.91	9.85E-5	Height	
BRCA	cis	1	rs6601012	chr5:178507516	ZNF354C	chr5:178487607-178507689:+	-0.12	-3.98	7.34E-5	Height	
BRCA	cis	1	rs6601013	chr5:178507927	ZNF354C	chr5:178487607-178507689:+	-0.11	-3.91	9.83E-5	Height	
BRCA	cis	1	rs6603033	chr15:83335875	FAM154B	chr15:82555152-82577265:+	0.14	4.22	2.62E-5	Schizophrenia	
BRCA	cis	1	rs6603033	chr15:83335875	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.1	3.76	0.000182	Schizophrenia	
BRCA	cis	1	rs6603979	chr1:92979354	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs6603981	chr1:92993807	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs6603982	chr1:92994033	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs6603984	chr1:93011572	EVI5	chr1:92974255-93257961:-	-0.18	-4.81	1.7E-6	Cholesterol, total	
BRCA	cis	1	rs6603985	chr1:93017159	EVI5	chr1:92974255-93257961:-	-0.18	-4.93	9.68E-7	Cholesterol, total	
BRCA	cis	1	rs6603987	chr1:93019313	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	9.0E-7	Cholesterol, total	
BRCA	cis	1	rs6603990	chr1:93030735	EVI5	chr1:92974255-93257961:-	-0.18	-5.03	5.75E-7	Cholesterol, total	
BRCA	cis	1	rs6604026	chr1:93303603	EVI5	chr1:92974255-93257961:-	0.12	3.74	0.000192	Multiple sclerosis	
BRCA	cis	1	rs6604026	chr1:93303603	TMED5	chr1:93617411-93646246:-	0.11	3.41	0.000682	Multiple sclerosis	
BRCA	cis	1	rs660498	chr10:27740959	PTCHD3	chr10:27687117-27703297:-	0.13	3.47	0.000534	Asthma (childhood onset)	
BRCA	cis	1	rs660602	chr1:183162774	LAMC2	chr1:183155174-183214262:+	-0.11	-3.77	0.000173	Hypertriglyceridemia	
BRCA	cis	1	rs66502937	chr5:112781274	YTHDC2	chr5:112849410-112930979:+	0.14	4.15	3.57E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs6651271	chr8:96047621	C8orf38	chr8:95908040-96088396:+	-0.19	-4.31	1.79E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs6651272	chr8:96047933	C8orf38	chr8:95908040-96088396:+	0.2	4.67	3.42E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs66529337	chr6:163005662	PACRG	chr6:163148164-163736523:+	0.21	4.07	5.11E-5	Body mass index	
BRCA	cis	1	rs66530629	chr1:25032168	CLIC4	chr1:25071760-25170815:+	-0.1	-3.68	0.00024	Height	
BRCA	cis	1	rs66534347	chr2:240899346	NDUFA10	chr2:240900158-240964798:-	0.25	6.65	4.61E-11	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs66534429	chr6:163003322	PACRG	chr6:163148164-163736523:+	0.22	4.27	2.17E-5	Body mass index	
BRCA	cis	1	rs6656432	chr1:93029453	EVI5	chr1:92974255-93257961:-	-0.18	-5.04	5.37E-7	Cholesterol, total	
BRCA	cis	1	rs6656992	chr1:46333068	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.71	7.32E-30	Body mass index	
BRCA	cis	1	rs6656992	chr1:46333068	CCDC17	chr1:46085717-46089729:-	0.11	3.54	0.000424	Body mass index	
BRCA	cis	1	rs6656992	chr1:46333068	MUTYH	chr1:45794915-45806142:-	0.13	5.11	3.87E-7	Body mass index	
BRCA	cis	1	rs6656999	chr1:166956807	MAEL	chr1:166958519-166991447:+	-0.15	-3.64	0.000283	Refractive astigmatism	
BRCA	cis	1	rs6657049	chr1:115825531	AMPD1	chr1:115215722-115238176:-	-0.1	-3.47	0.000536	Migraine	
BRCA	cis	1	rs6657809	chr1:93293063	EVI5	chr1:92974255-93257961:-	0.12	4	6.64E-5	Multiple sclerosis	
BRCA	cis	1	rs66583752	chr5:112781645	YTHDC2	chr5:112849410-112930979:+	0.14	4.15	3.57E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs6658718	chr1:207458906	C4BPA	chr1:207277511-207318308:+	0.13	3.81	0.000146	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs6658855	chr1:110123334	AMIGO1	chr1:110049447-110052336:-	0.18	4.79	1.89E-6	Major depressive disorder	
BRCA	cis	1	rs6659152	chr1:21355841	SH2D5	chr1:21046225-21059330:-	0.13	3.7	0.000229	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6659176	chr1:27239920	GPATCH3	chr1:27216980-27226962:-	0.21	3.7	0.000227	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs66594243	chr6:163169024	PACRG	chr6:163148164-163736523:+	0.21	3.65	0.000274	Body mass index	
BRCA	cis	1	rs6661134	chr1:93010908	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	9.0E-7	Cholesterol, total	
BRCA	cis	1	rs6661910	chr1:46290632	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.74	5.37E-30	Body mass index	
BRCA	cis	1	rs6661910	chr1:46290632	CCDC17	chr1:46085717-46089729:-	0.11	3.59	0.000342	Body mass index	
BRCA	cis	1	rs6661910	chr1:46290632	MUTYH	chr1:45794915-45806142:-	0.13	4.94	9.09E-7	Body mass index	
BRCA	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.72	6.14E-30	Body mass index	
BRCA	cis	1	rs6662641	chr1:46571509	MUTYH	chr1:45794915-45806142:-	0.12	4.83	1.56E-6	Body mass index	
BRCA	cis	1	rs66644309	chr5:112708146	YTHDC2	chr5:112849410-112930979:+	0.14	4.09	4.68E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs66646148	chr12:82248520	PPFIA2	chr12:81652880-82153109:-	0.13	3.44	0.000598	Resting heart rate	
BRCA	cis	1	rs6664760	chr1:3648268	KIAA0495	chr1:3652550-3663886:-	0.18	3.4	0.0007	Visceral adipose tissue adjusted for BMI	
BRCA	cis	1	rs66651343	chr15:43558004	STRC	chr15:43891762-43924561:-	0.17	4.16	3.48E-5	Lung cancer	
BRCA	cis	1	rs6665341	chr1:166947018	MAEL	chr1:166958519-166991447:+	-0.15	-3.58	0.000364	Refractive astigmatism	
BRCA	cis	1	rs6665859	chr1:67077555	TCTEX1D1	chr1:67218140-67244729:+	0.12	3.4	0.000709	Menopause (age at onset)	
BRCA	cis	1	rs6665958	chr1:100381815	LRRC39	chr1:100614413-100643800:-	0.33	3.89	0.000106	Carotid intima media thickness	
BRCA	cis	1	rs66670017	chr6:33763563	IP6K3	chr6:33689443-33714762:-	0.28	4.87	1.26E-6	Obesity (extreme)	
BRCA	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.83	-28.03	5.45E-130	Homocysteine levels	
BRCA	cis	1	rs6667191	chr1:45982844	MMACHC	chr1:45965856-45976737:+	-0.15	-4.12	4.0E-5	Homocysteine levels	
BRCA	cis	1	rs6667559	chr1:171653957	VAMP4	chr1:171669298-171711214:-	0.12	3.56	0.00038	Hippocampal atrophy	
BRCA	cis	1	rs6668284	chr1:46354510	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.84	1.73E-30	Body mass index	
BRCA	cis	1	rs6668284	chr1:46354510	CCDC17	chr1:46085717-46089729:-	0.11	3.46	0.000571	Body mass index	
BRCA	cis	1	rs6668284	chr1:46354510	MUTYH	chr1:45794915-45806142:-	0.13	4.96	8.15E-7	Body mass index	
BRCA	cis	1	rs666845	chr11:83277544	CCDC90B	chr11:82972506-82997414:-	0.14	3.98	7.43E-5	Subcortical brain region volumes	
BRCA	cis	1	rs6669102	chr1:21355543	HP1BP3	chr1:21069171-21113799:-	0.11	3.5	0.000485	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6669102	chr1:21355543	SH2D5	chr1:21046225-21059330:-	0.13	3.62	0.000304	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.94	6.25E-31	Body mass index	
BRCA	cis	1	rs6669522	chr1:46397941	MUTYH	chr1:45794915-45806142:-	0.13	4.89	1.18E-6	Body mass index	
BRCA	cis	1	rs66702115	chr11:28181703	METT5D1	chr11:28129798-28355054:+	-0.12	-3.54	0.000411	Bipolar disorder	
BRCA	cis	1	rs6672267	chr1:12054911	MFN2	chr1:12040238-12073571:+	-0.12	-3.53	0.000434	Platelet count	
BRCA	cis	1	rs66728961	chr5:112726620	YTHDC2	chr5:112849410-112930979:+	0.14	4.13	3.88E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs6672898	chr1:46290588	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.84	1.72E-30	Body mass index	
BRCA	cis	1	rs6672898	chr1:46290588	CCDC17	chr1:46085717-46089729:-	0.11	3.45	0.000583	Body mass index	
BRCA	cis	1	rs6672898	chr1:46290588	MUTYH	chr1:45794915-45806142:-	0.12	4.92	1.02E-6	Body mass index	
BRCA	cis	1	rs6673218	chr1:236041062	GNG4	chr1:235710987-235814054:-	0.2	4.65	3.69E-6	Systemic lupus erythematosus	
BRCA	cis	1	rs6673237	chr1:236041129	GNG4	chr1:235710987-235814054:-	-0.18	-4.52	6.99E-6	Systemic lupus erythematosus	
BRCA	cis	1	rs6674970	chr1:151116279	SEMA6C	chr1:151104165-151119104:-	-0.12	-4.27	2.15E-5	Body mass index	
BRCA	cis	1	rs66754062	chr20:23839051	CST2	chr20:23804404-23807312:-	-0.14	-3.38	0.000748	Response to TNF antagonist treatment	
BRCA	cis	1	rs6675726	chr1:46560643	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.69	8.52E-30	Body mass index	
BRCA	cis	1	rs6675726	chr1:46560643	MUTYH	chr1:45794915-45806142:-	0.12	4.86	1.32E-6	Body mass index	
BRCA	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.97	4.36E-31	Body mass index	
BRCA	cis	1	rs6675946	chr1:46371774	MUTYH	chr1:45794915-45806142:-	0.12	4.91	1.08E-6	Body mass index	
BRCA	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.95	5.64E-31	Body mass index	
BRCA	cis	1	rs6677007	chr1:46400590	MUTYH	chr1:45794915-45806142:-	0.13	4.9	1.13E-6	Body mass index	
BRCA	cis	1	rs6678890	chr1:171694566	VAMP4	chr1:171669298-171711214:-	0.19	5.54	3.77E-8	Hippocampal atrophy	
BRCA	cis	1	rs66789102	chr6:163104432	PACRG	chr6:163148164-163736523:+	0.27	4.74	2.39E-6	Body mass index	
BRCA	cis	1	rs6678944	chr1:115824658	AMPD1	chr1:115215722-115238176:-	-0.1	-3.39	0.00072	Migraine	
BRCA	cis	1	rs6679145	chr1:156256000	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs6679145	chr1:156256000	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs6679354	chr1:171668002	VAMP4	chr1:171669298-171711214:-	0.16	4.76	2.2E-6	Hippocampal atrophy	
BRCA	cis	1	rs66797613	chr10:1090469	IDI2	chr10:1064847-1071799:-	-0.17	-3.39	0.000735	Response to angiotensin II receptor blocker therapy	
BRCA	cis	1	rs66797637	chr3:119279658	CD80	chr3:119243142-119278481:-	0.12	4.27	2.09E-5	Vitiligo	
BRCA	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.59	13.05	3.05E-36	Diastolic blood pressure;Blood pressure	
BRCA	cis	1	rs6680380	chr1:46300189	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.83	1.88E-30	Body mass index	
BRCA	cis	1	rs6680380	chr1:46300189	CCDC17	chr1:46085717-46089729:-	0.11	3.46	0.000553	Body mass index	
BRCA	cis	1	rs6680380	chr1:46300189	MUTYH	chr1:45794915-45806142:-	0.13	4.96	8.1E-7	Body mass index	
BRCA	cis	1	rs6681064	chr1:21339644	HP1BP3	chr1:21069171-21113799:-	0.12	3.8	0.000154	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6681064	chr1:21339644	SH2D5	chr1:21046225-21059330:-	0.13	3.53	0.000426	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6682956	chr1:110130264	AMIGO1	chr1:110049447-110052336:-	0.18	4.13	3.86E-5	Major depressive disorder	
BRCA	cis	1	rs6682956	chr1:110130264	SYPL2	chr1:110009100-110024763:+	-0.15	-3.88	0.000112	Major depressive disorder	
BRCA	cis	1	rs6683542	chr1:21369610	HP1BP3	chr1:21069171-21113799:-	0.11	3.55	0.000397	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6683542	chr1:21369610	SH2D5	chr1:21046225-21059330:-	0.12	3.37	0.000771	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6683604	chr1:66765778	PDE4B	chr1:66258193-66840261:+	0.13	3.75	0.000183	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs6684514	chr1:156255456	BGLAP	chr1:156182784-156213112:+	0.2	5.45	6.36E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs6684514	chr1:156255456	C1orf85	chr1:156259882-156265449:-	-0.11	-3.46	0.000552	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs6684571	chr1:107623224	NTNG1	chr1:107682629-108024471:+	0.16	3.58	0.000361	AIDS	
BRCA	cis	1	rs6684571	chr1:107623224	PRMT6	chr1:107599267-107601907:+	0.21	4.29	1.93E-5	AIDS	
BRCA	cis	1	rs6684976	chr1:21367501	HP1BP3	chr1:21069171-21113799:-	0.11	3.55	0.000397	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6684976	chr1:21367501	SH2D5	chr1:21046225-21059330:-	0.12	3.37	0.000771	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6690097	chr1:19323050	IFFO2	chr1:19230774-19282826:-	0.13	3.45	0.000592	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
BRCA	cis	1	rs6690464	chr1:85466369	MCOLN2	chr1:85391267-85462796:-	0.12	3.61	0.000322	Serum sulfate level	
BRCA	cis	1	rs6690583	chr1:85466337	MCOLN2	chr1:85391267-85462796:-	0.12	3.61	0.000325	Serum sulfate level	
BRCA	cis	1	rs6690764	chr1:92976590	EVI5	chr1:92974255-93257961:-	-0.18	-4.94	8.9E-7	Cholesterol, total	
BRCA	cis	1	rs66918189	chr3:119292618	CD80	chr3:119243142-119278481:-	0.12	4.1	4.44E-5	Vitiligo	
BRCA	cis	1	rs6692187	chr1:93035020	EVI5	chr1:92974255-93257961:-	-0.16	-4.4	1.19E-5	Cholesterol, total	
BRCA	cis	1	rs6695809	chr1:46285461	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.95	5.71E-31	Body mass index	
BRCA	cis	1	rs6695809	chr1:46285461	MUTYH	chr1:45794915-45806142:-	0.12	4.88	1.24E-6	Body mass index	
BRCA	cis	1	rs6696239	chr1:227750068	ZNF678	chr1:227751244-227910352:+	0.08	3.47	0.000544	Height	
BRCA	cis	1	rs66965793	chr1:156285814	BGLAP	chr1:156182784-156213112:+	0.19	5.12	3.68E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs6697555	chr1:21287938	HP1BP3	chr1:21069171-21113799:-	0.11	3.53	0.000438	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6697555	chr1:21287938	SH2D5	chr1:21046225-21059330:-	0.13	3.67	0.000257	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6698409	chr1:227768358	ZNF678	chr1:227751244-227910352:+	0.08	3.53	0.000428	Height	
BRCA	cis	1	rs66990486	chr9:100680919	C9orf156	chr9:100666772-100684852:-	-0.17	-4.82	1.68E-6	Quantitative traits	
BRCA	cis	1	rs6699159	chr1:166946072	MAEL	chr1:166958519-166991447:+	-0.15	-3.58	0.000364	Refractive astigmatism	
BRCA	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.35	-9.95	2.37E-22	Height	
BRCA	cis	1	rs6700597	chr1:46284246	CCDC163P	chr1:45960581-45965646:-	-0.41	-12.04	2.25E-31	Body mass index	
BRCA	cis	1	rs6700597	chr1:46284246	CCDC17	chr1:46085717-46089729:-	0.11	3.45	0.000576	Body mass index	
BRCA	cis	1	rs6700597	chr1:46284246	MUTYH	chr1:45794915-45806142:-	0.12	4.79	1.93E-6	Body mass index	
BRCA	cis	1	rs6700718	chr1:21299363	SH2D5	chr1:21046225-21059330:-	-0.13	-3.48	0.000528	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6700866	chr1:10306038	PGD	chr1:10459085-10480200:+	0.18	5.32	1.25E-7	Hepatocellular carcinoma	
BRCA	cis	1	rs6701614	chr1:46309420	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.81	2.33E-30	Body mass index	
BRCA	cis	1	rs6701614	chr1:46309420	CCDC17	chr1:46085717-46089729:-	0.11	3.43	0.000623	Body mass index	
BRCA	cis	1	rs6701614	chr1:46309420	MUTYH	chr1:45794915-45806142:-	0.13	4.95	8.76E-7	Body mass index	
BRCA	cis	1	rs6701713	chr1:207786289	FAIM3	chr1:207076633-207096592:-	0.13	3.4	0.000705	Alzheimer's disease (late onset)	
BRCA	cis	1	rs6702060	chr1:8607024	RERE	chr1:8412466-8877699:-	0.11	3.51	0.000467	Vitiligo	
BRCA	cis	1	rs6702110	chr1:21515906	HP1BP3	chr1:21069171-21113799:-	0.11	3.49	0.000495	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs6702110	chr1:21515906	SH2D5	chr1:21046225-21059330:-	0.13	3.48	0.000514	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs67025553	chr6:163011552	PACRG	chr6:163148164-163736523:+	0.24	4.49	7.94E-6	Body mass index	
BRCA	cis	1	rs67034206	chr1:156270260	BGLAP	chr1:156182784-156213112:+	0.2	5.3	1.44E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs6703857	chr1:207443553	CR2	chr1:207627670-207663238:+	0.11	3.47	0.000537	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs67042566	chr6:163006541	PACRG	chr6:163148164-163736523:+	0.23	4.28	2.0E-5	Body mass index	
BRCA	cis	1	rs67044039	chr12:62673427	FAM19A2	chr12:62102043-62653925:-	0.17	3.65	0.000279	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs67046187	chr6:163068532	PACRG	chr6:163148164-163736523:+	0.26	4.61	4.59E-6	Body mass index	
BRCA	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.27	6.79	1.89E-11	Metabolite levels	
BRCA	cis	1	rs6706610	chr2:27778091	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.03	5.97E-5	Oral cavity cancer	
BRCA	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.24	5.29	1.51E-7	Breast cancer (estrogen-receptor negative);Breast cancer	
BRCA	cis	1	rs6707458	chr2:160914540	LY75	chr2:160625141-160761262:-	0.13	4.56	5.62E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs6707458	chr2:160914540	PLA2R1	chr2:160798012-160919121:-	0.14	4.79	1.93E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.27	-6.77	2.18E-11	Body mass index	
BRCA	cis	1	rs6708328	chr2:24412413	LOC375190	chr2:24299728-24397519:+	-0.22	-5.93	4.2E-9	Venous thromboembolism (SNP x SNP interaction)	
BRCA	cis	1	rs6708331	chr2:70368923	FAM136A	chr2:70523109-70529220:-	-0.1	-3.45	0.000575	Obesity-related traits	
BRCA	cis	1	rs6708373	chr2:234172846	SAG	chr2:234216309-234255701:+	0.13	4.09	4.59E-5	Crohn's disease	
BRCA	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.68	-19.25	4.1E-71	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs6709635	chr2:102850439	IL18R1	chr2:102927962-103015215:+	0.09	3.58	0.000352	Serum protein levels (sST2)	
BRCA	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.27	-6.98	5.15E-12	Metabolite levels	
BRCA	cis	1	rs67108211	chr3:119293529	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.25	-6.09	1.6E-9	Body mass index	
BRCA	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.26	6.68	3.89E-11	Metabolite levels	
BRCA	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.55	-9.04	7.01E-19	Rheumatoid arthritis	
BRCA	cis	1	rs67113817	chr4:17985189	NCAPG	chr4:17812525-17846485:+	0.1	4.59	4.97E-6	Height	
BRCA	cis	1	rs6711941	chr2:202178130	CASP8	chr2:202098166-202152434:+	0.17	3.39	0.000729	Rheumatoid arthritis	
BRCA	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.53	-9.34	5.35E-20	Rheumatoid arthritis	
BRCA	cis	1	rs6712203	chr2:165557318	SLC38A11	chr2:165754812-165812035:-	0.15	4.66	3.58E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
BRCA	cis	1	rs6714736	chr2:202214148	ALS2CR12	chr2:202153148-202222101:-	0.23	5.79	8.99E-9	Basal cell carcinoma	
BRCA	cis	1	rs6714736	chr2:202214148	PPIL3	chr2:201735680-201753999:-	0.17	4.35	1.52E-5	Basal cell carcinoma	
BRCA	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.55	-8.97	1.33E-18	Rheumatoid arthritis	
BRCA	cis	1	rs6716937	chr2:70127229	ANXA4	chr2:69969127-70053594:+	-0.14	-3.95	8.49E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6716937	chr2:70127229	FAM136A	chr2:70523109-70529220:-	-0.09	-3.45	0.000577	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6718083	chr2:25362194	POMC	chr2:25383722-25391559:-	0.16	4.89	1.14E-6	Body mass index	
BRCA	cis	1	rs6718128	chr2:27833752	KRTCAP3	chr2:27665263-27667163:+	0.12	3.57	0.000373	Oral cavity cancer	
BRCA	cis	1	rs6718128	chr2:27833752	PLB1	chr2:28718982-28866613:+	0.1	3.49	0.000495	Oral cavity cancer	
BRCA	cis	1	rs67185025	chr3:119293812	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs6719686	chr2:160908292	LY75	chr2:160625141-160761262:-	0.14	4.76	2.19E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs6719686	chr2:160908292	PLA2R1	chr2:160798012-160919121:-	0.15	5.14	3.33E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs672059	chr1:183162539	LAMC2	chr1:183155174-183214262:+	-0.11	-3.77	0.000173	Hypertriglyceridemia	
BRCA	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.6	-11.71	7.22E-30	Plasma clusterin levels	
BRCA	cis	1	rs672119	chr1:183162506	LAMC2	chr1:183155174-183214262:+	-0.11	-3.77	0.000173	Hypertriglyceridemia	
BRCA	cis	1	rs67212262	chr3:119292344	CD80	chr3:119243142-119278481:-	0.12	3.99	7.2E-5	Vitiligo	
BRCA	cis	1	rs6721891	chr2:70146121	ANXA4	chr2:69969127-70053594:+	-0.14	-3.94	8.69E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6721891	chr2:70146121	FAM136A	chr2:70523109-70529220:-	-0.09	-3.4	0.000697	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.6	-11.59	2.4E-29	Plasma clusterin levels	
BRCA	cis	1	rs6722750	chr2:64381259	C2orf86	chr2:63348537-63815851:-	-0.12	-3.87	0.000114	Neuroticism	
BRCA	cis	1	rs67239267	chr7:143745116	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10	1.42E-22	Obesity-related traits	
BRCA	cis	1	rs67239267	chr7:143745116	OR2A7	chr7:143955790-143974852:-	0.21	4.88	1.2E-6	Obesity-related traits	
BRCA	cis	1	rs6724662	chr2:241831560	C2orf54	chr2:241825466-241835573:-	0.26	7.41	2.65E-13	Urinary metabolites	
BRCA	cis	1	rs6725425	chr2:70150674	ANXA4	chr2:69969127-70053594:+	-0.14	-3.95	8.44E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6725425	chr2:70150674	FAM136A	chr2:70523109-70529220:-	-0.09	-3.43	0.000624	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs67257959	chr19:17158145	HAUS8	chr19:17160573-17186343:-	-0.14	-5.6	2.75E-8	Selective IgA deficiency	
BRCA	cis	1	rs6726519	chr2:64367031	C2orf86	chr2:63348537-63815851:-	-0.15	-3.48	0.000526	Kawasaki disease	
BRCA	cis	1	rs6727897	chr2:69987384	ANXA4	chr2:69969127-70053594:+	-0.12	-3.44	0.000598	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs6729760	chr2:70161032	ANXA4	chr2:69969127-70053594:+	-0.14	-4.11	4.33E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs67303814	chr5:112767285	YTHDC2	chr5:112849410-112930979:+	0.14	4.13	3.86E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs6730503	chr2:37528478	CEBPZ	chr2:37428778-37458740:-	0.16	5	6.86E-7	Chronic lymphocytic leukemia	
BRCA	cis	1	rs6731027	chr2:203202166	NOP58	chr2:203130515-203168382:+	0.15	3.51	0.000461	Urate levels	
BRCA	cis	1	rs6732236	chr2:136501509	DARS	chr2:136664254-136743222:-	0.17	4.23	2.58E-5	Corneal structure	
BRCA	cis	1	rs6732236	chr2:136501509	LCT	chr2:136545415-136594750:-	-0.18	-4.61	4.52E-6	Corneal structure	
BRCA	cis	1	rs673281	chr11:108182069	ATM	chr11:108093559-108239826:+	-0.08	-3.74	0.000198	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
BRCA	cis	1	rs6734238	chr2:113841030	IL1RN	chr2:113856937-113891592:+	-0.2	-5.07	4.68E-7	C-reactive protein levels or total cholesterol levels (pleiotropy);C-reactive protein;White blood cell count;Fibrinogen;C-reactive protein levels;Fibrinogen levels	
BRCA	cis	1	rs6736360	chr2:190748749	ORMDL1	chr2:190634994-190649097:-	0.25	4.14	3.71E-5	Subcutaneous adipose tissue	
BRCA	cis	1	rs6736408	chr2:70137774	ANXA4	chr2:69969127-70053594:+	-0.14	-3.95	8.5E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6736408	chr2:70137774	FAM136A	chr2:70523109-70529220:-	-0.09	-3.45	0.000578	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.24	5.87	5.83E-9	Metabolite levels	
BRCA	cis	1	rs67369952	chr3:119293600	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs6737085	chr2:202221441	ALS2CR12	chr2:202153148-202222101:-	-0.21	-5.36	9.93E-8	Basal cell carcinoma	
BRCA	cis	1	rs6737085	chr2:202221441	PPIL3	chr2:201735680-201753999:-	-0.16	-4.19	2.97E-5	Basal cell carcinoma	
BRCA	cis	1	rs6737921	chr2:27839107	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.09	4.59E-5	Oral cavity cancer	
BRCA	cis	1	rs6738490	chr2:234161583	SAG	chr2:234216309-234255701:+	0.12	3.98	7.36E-5	Crohn's disease	
BRCA	cis	1	rs6738627	chr2:165544450	SLC38A11	chr2:165754812-165812035:-	0.19	5.72	1.35E-8	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
BRCA	cis	1	rs6739780	chr2:70138111	ANXA4	chr2:69969127-70053594:+	-0.14	-3.95	8.5E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6739780	chr2:70138111	FAM136A	chr2:70523109-70529220:-	-0.09	-3.45	0.000578	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6740641	chr2:54482989	C2orf73	chr2:54558071-54588714:+	0.17	4.23	2.57E-5	Telomere length	
BRCA	cis	1	rs67412075	chr19:17385502	ANKLE1	chr19:17392454-17398454:+	0.21	5.95	3.59E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs67412075	chr19:17385502	ANO8	chr19:17434032-17445638:-	0.14	3.47	0.000547	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs67412075	chr19:17385502	OCEL1	chr19:17337055-17340027:+	0.15	4.63	4.02E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs6741449	chr2:70156589	ANXA4	chr2:69969127-70053594:+	-0.13	-3.67	0.000256	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.24	-11.36	2.56E-28	Tuberculosis	
BRCA	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.49	12.88	2.06E-35	Tuberculosis	
BRCA	cis	1	rs674343	chr1:183162052	LAMC2	chr1:183155174-183214262:+	-0.1	-3.62	0.000304	Hypertriglyceridemia	
BRCA	cis	1	rs67487119	chr6:163102657	PACRG	chr6:163148164-163736523:+	0.26	4.6	4.68E-6	Body mass index	
BRCA	cis	1	rs6748734	chr2:241837452	C2orf54	chr2:241825466-241835573:-	0.27	7.43	2.17E-13	Urinary metabolites	
BRCA	cis	1	rs6749052	chr2:27772879	KRTCAP3	chr2:27665263-27667163:+	-0.13	-3.96	7.99E-5	Oral cavity cancer	
BRCA	cis	1	rs6750047	chr2:38276549	FAM82A1	chr2:38152462-38294280:+	-0.13	-3.94	8.83E-5	Cutaneous malignant melanoma	
BRCA	cis	1	rs6750488	chr2:70146125	ANXA4	chr2:69969127-70053594:+	-0.14	-3.94	8.69E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6750488	chr2:70146125	FAM136A	chr2:70523109-70529220:-	-0.09	-3.4	0.000697	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6750943	chr2:27777904	KRTCAP3	chr2:27665263-27667163:+	-0.13	-3.97	7.56E-5	Oral cavity cancer	
BRCA	cis	1	rs6751693	chr2:241837332	C2orf54	chr2:241825466-241835573:-	0.26	6.91	8.09E-12	Urinary metabolites	
BRCA	cis	1	rs6752050	chr2:242228780	ANO7	chr2:242127924-242164791:+	0.21	3.45	0.000581	Prostate cancer	
BRCA	cis	1	rs6752107	chr2:234161448	SAG	chr2:234216309-234255701:+	0.12	3.89	0.000108	Crohn's disease	
BRCA	cis	1	rs6752978	chr2:165552942	SLC38A11	chr2:165754812-165812035:-	0.17	5.12	3.67E-7	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
BRCA	cis	1	rs6753142	chr2:165544071	SLC38A11	chr2:165754812-165812035:-	0.18	5.62	2.39E-8	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
BRCA	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.26	-6.72	2.98E-11	Metabolite levels	
BRCA	cis	1	rs67536397	chr7:65947917	CCT6P1	chr7:65216092-65228661:+	0.32	6.81	1.64E-11	Diabetic kidney disease	
BRCA	cis	1	rs67536397	chr7:65947917	LOC493754	chr7:65993446-66057363:-	0.25	4.22	2.62E-5	Diabetic kidney disease	
BRCA	cis	1	rs6754896	chr2:70138170	ANXA4	chr2:69969127-70053594:+	-0.14	-3.95	8.5E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6754896	chr2:70138170	FAM136A	chr2:70523109-70529220:-	-0.09	-3.45	0.000578	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.22	5.56	3.45E-8	Metabolite levels	
BRCA	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.26	6.73	2.72E-11	Metabolite levels	
BRCA	cis	1	rs6756238	chr2:27841305	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.13	3.95E-5	Oral cavity cancer	
BRCA	cis	1	rs67567111	chr20:23619075	CST1	chr20:23728191-23731574:-	0.24	5.2	2.42E-7	Chronic kidney disease	
BRCA	cis	1	rs6758443	chr2:102848062	IL18R1	chr2:102927962-103015215:+	-0.09	-3.57	0.000369	Serum protein levels (sST2)	
BRCA	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.17	-5.92	4.26E-9	Triptolide cytotoxicity	
BRCA	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.74	-16.91	4.95E-57	Triptolide cytotoxicity	
BRCA	cis	1	rs6759836	chr2:160912802	LY75	chr2:160625141-160761262:-	0.13	4.49	7.81E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs6759836	chr2:160912802	PLA2R1	chr2:160798012-160919121:-	0.14	4.82	1.65E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs6759924	chr2:160912747	LY75	chr2:160625141-160761262:-	0.14	4.64	3.91E-6	Idiopathic membranous nephropathy	
BRCA	cis	1	rs6759924	chr2:160912747	PLA2R1	chr2:160798012-160919121:-	0.15	4.99	7.1E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs6761514	chr2:202227549	ALS2CR12	chr2:202153148-202222101:-	-0.22	-5.91	4.52E-9	Basal cell carcinoma	
BRCA	cis	1	rs6761514	chr2:202227549	PPIL3	chr2:201735680-201753999:-	-0.15	-4.01	6.36E-5	Basal cell carcinoma	
BRCA	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.19	6.77E-37	Height	
BRCA	cis	1	rs6763088	chr3:134254989	CEP63	chr3:134204575-134293852:+	-0.14	-3.72	0.000212	Height	
BRCA	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.25	3.28E-37	Height	
BRCA	cis	1	rs6763093	chr3:134254995	CEP63	chr3:134204575-134293852:+	-0.14	-3.79	0.000158	Height	
BRCA	cis	1	rs67646369	chr6:163003233	PACRG	chr6:163148164-163736523:+	0.25	4.6	4.64E-6	Body mass index	
BRCA	cis	1	rs67652061	chr5:132280347	HSPA4	chr5:132387662-132440708:+	-0.18	-3.62	0.000307	Apolipoprotein A-IV levels	
BRCA	cis	1	rs6765233	chr3:128002850	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.37	0.000772	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.43	14.46	2.11E-43	Height	
BRCA	cis	1	rs6765505	chr3:134208132	CEP63	chr3:134204575-134293852:+	0.16	4.27	2.1E-5	Height	
BRCA	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.43	14.44	2.78E-43	Height	
BRCA	cis	1	rs6766818	chr3:134226159	CEP63	chr3:134204575-134293852:+	0.15	4.04	5.82E-5	Height	
BRCA	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.4	13.02	4.38E-36	Height	
BRCA	cis	1	rs6766897	chr3:134191303	CEP63	chr3:134204575-134293852:+	0.18	4.76	2.26E-6	Height	
BRCA	cis	1	rs6768930	chr3:57779836	ARF4	chr3:57557092-57583215:-	0.12	3.74	0.000196	Obesity-related traits	
BRCA	cis	1	rs67696450	chr10:1090684	IDI2	chr10:1064847-1071799:-	-0.17	-3.39	0.000735	Response to angiotensin II receptor blocker therapy	
BRCA	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.41	13.5	1.92E-38	Height	
BRCA	cis	1	rs6769885	chr3:134286913	CEP63	chr3:134204575-134293852:+	0.14	3.65	0.00027	Height	
BRCA	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.27	-10.1	5.86E-23	Longevity	
BRCA	cis	1	rs6770670	chr3:49686682	AMT	chr3:49454212-49460012:-	0.11	3.53	0.000433	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs6770670	chr3:49686682	GMPPB	chr3:49758932-49761384:-	-0.12	-3.43	0.000628	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs6772046	chr3:38479660	LOC100128640	chr3:38492524-38496311:-	0.12	3.38	0.000742	Electrocardiographic conduction measures	
BRCA	cis	1	rs6772046	chr3:38479660	XYLB	chr3:38388251-38456467:+	0.17	5.16	3.01E-7	Electrocardiographic conduction measures	
BRCA	cis	1	rs67728539	chr7:65378124	CCT6P1	chr7:65216092-65228661:+	0.34	7.32	4.84E-13	Diabetic kidney disease	
BRCA	cis	1	rs67728539	chr7:65378124	LOC493754	chr7:65993446-66057363:-	0.22	3.68	0.000241	Diabetic kidney disease	
BRCA	cis	1	rs67728539	chr7:65378124	ZNF117	chr7:64434830-64467121:-	-0.27	-4.99	6.93E-7	Diabetic kidney disease	
BRCA	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.43	13.94	1.03E-40	Height	
BRCA	cis	1	rs6772896	chr3:134203347	CEP63	chr3:134204575-134293852:+	0.17	4.47	8.77E-6	Height	
BRCA	cis	1	rs6774280	chr3:6255997	GRM7	chr3:6902802-7783218:+	0.16	4.06	5.32E-5	Response to tocilizumab in rheumatoid arthritis	
BRCA	cis	1	rs67764628	chr5:112745067	YTHDC2	chr5:112849410-112930979:+	0.13	3.68	0.000247	Cerebral amyloid angiopathy	
BRCA	cis	1	rs67765368	chr3:119292453	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.29	-10.85	4.51E-26	Longevity	
BRCA	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.38	-12.55	8.61E-34	Height	
BRCA	cis	1	rs6782563	chr3:134295959	CEP63	chr3:134204575-134293852:+	-0.15	-3.94	8.72E-5	Height	
BRCA	cis	1	rs678292	chr10:105957561	C10orf79	chr10:105889647-105992120:-	0.13	4.76	2.18E-6	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs6783003	chr3:49524778	AMT	chr3:49454212-49460012:-	-0.14	-4.62	4.22E-6	Menarche (age at onset)	
BRCA	cis	1	rs6783003	chr3:49524778	CCDC36	chr3:49235861-49295537:+	-0.1	-3.57	0.000372	Menarche (age at onset)	
BRCA	cis	1	rs6783003	chr3:49524778	GMPPB	chr3:49758932-49761384:-	0.13	3.58	0.000355	Menarche (age at onset)	
BRCA	cis	1	rs6783003	chr3:49524778	NCKIPSD	chr3:48711280-48723334:-	-0.15	-3.68	0.000243	Menarche (age at onset)	
BRCA	cis	1	rs6783003	chr3:49524778	P4HTM	chr3:49027341-49044579:+	-0.1	-4.13	3.87E-5	Menarche (age at onset)	
BRCA	cis	1	rs6783003	chr3:49524778	WDR6	chr3:49044637-49053386:+	0.16	4.54	6.21E-6	Menarche (age at onset)	
BRCA	cis	1	rs67840803	chr6:163049048	PACRG	chr6:163148164-163736523:+	0.24	4.27	2.09E-5	Body mass index	
BRCA	cis	1	rs6784322	chr3:48422235	ATRIP	chr3:48488141-48507708:+	0.11	3.8	0.000154	Longevity	
BRCA	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.27	-9.76	1.36E-21	Longevity	
BRCA	cis	1	rs6784421	chr3:156655494	LEKR1	chr3:156544076-156763918:+	0.18	4.78	2.0E-6	Multiple sclerosis (severity)	
BRCA	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.42	-14.23	3.21E-42	Height	
BRCA	cis	1	rs6785027	chr3:134211649	CEP63	chr3:134204575-134293852:+	-0.15	-4.15	3.66E-5	Height	
BRCA	cis	1	rs6785045	chr3:49435243	AMT	chr3:49454212-49460012:-	-0.14	-4.73	2.59E-6	Menarche (age at onset)	
BRCA	cis	1	rs6785045	chr3:49435243	CCDC36	chr3:49235861-49295537:+	-0.1	-3.92	9.6E-5	Menarche (age at onset)	
BRCA	cis	1	rs6785045	chr3:49435243	NCKIPSD	chr3:48711280-48723334:-	-0.15	-3.92	9.61E-5	Menarche (age at onset)	
BRCA	cis	1	rs6785045	chr3:49435243	P4HTM	chr3:49027341-49044579:+	-0.1	-4.28	2.06E-5	Menarche (age at onset)	
BRCA	cis	1	rs6785045	chr3:49435243	WDR6	chr3:49044637-49053386:+	0.13	3.86	0.000122	Menarche (age at onset)	
BRCA	cis	1	rs67853252	chr12:62686523	FAM19A2	chr12:62102043-62653925:-	0.16	3.5	0.00048	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.41	13.78	6.9E-40	Height	
BRCA	cis	1	rs6787371	chr3:134254991	CEP63	chr3:134204575-134293852:+	0.15	4.06	5.23E-5	Height	
BRCA	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.42	13.78	6.64E-40	Height	
BRCA	cis	1	rs6790466	chr3:134197740	CEP63	chr3:134204575-134293852:+	0.17	4.53	6.52E-6	Height	
BRCA	cis	1	rs67927699	chr2:61187415	AHSA2	chr2:61404553-61414058:+	-0.13	-6.18	9.29E-10	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.35	9.05	6.65E-19	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.38	-12.55	8.61E-34	Height	
BRCA	cis	1	rs6793487	chr3:134299426	CEP63	chr3:134204575-134293852:+	-0.15	-3.94	8.72E-5	Height	
BRCA	cis	1	rs6794300	chr3:46346640	FYCO1	chr3:45959396-46037307:-	-0.11	-3.65	0.000274	Celiac disease	
BRCA	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.27	-10.04	9.84E-23	Longevity	
BRCA	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.27	-10.18	2.77E-23	Longevity	
BRCA	cis	1	rs67978911	chr4:17991423	NCAPG	chr4:17812525-17846485:+	0.1	4.54	6.31E-6	Height	
BRCA	cis	1	rs67981189	chr14:71472226	PCNX	chr14:71374122-71582099:+	-0.13	-5.33	1.21E-7	Schizophrenia	
BRCA	cis	1	rs68004962	chr4:54989569	FIP1L1	chr4:54243820-54326102:+	-0.16	-3.62	0.000303	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.41	13.75	1.03E-39	Height	
BRCA	cis	1	rs6800862	chr3:134228628	CEP63	chr3:134204575-134293852:+	0.16	4.31	1.79E-5	Height	
BRCA	cis	1	rs6800	chr1:156262653	BGLAP	chr1:156182784-156213112:+	0.21	5.54	3.71E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs6800	chr1:156262653	C1orf85	chr1:156259882-156265449:-	-0.11	-3.52	0.000457	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
BRCA	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.4	13.43	3.94E-38	Height	
BRCA	cis	1	rs6801596	chr3:134252114	CEP63	chr3:134204575-134293852:+	0.15	3.98	7.5E-5	Height	
BRCA	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.43	14.46	2.02E-43	Height	
BRCA	cis	1	rs6802654	chr3:134217072	CEP63	chr3:134204575-134293852:+	0.15	4.2	2.89E-5	Height	
BRCA	cis	1	rs68045643	chr6:163029709	PACRG	chr6:163148164-163736523:+	0.21	4.05	5.57E-5	Body mass index	
BRCA	cis	1	rs6804655	chr3:49738945	CCDC36	chr3:49235861-49295537:+	0.1	3.76	0.000181	Resting heart rate	
BRCA	cis	1	rs6804655	chr3:49738945	DALRD3	chr3:49052435-49058467:-	0.13	4.41	1.11E-5	Resting heart rate	
BRCA	cis	1	rs6804655	chr3:49738945	P4HTM	chr3:49027341-49044579:+	0.09	3.86	0.000119	Resting heart rate	
BRCA	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.43	14.46	2.02E-43	Height	
BRCA	cis	1	rs6804770	chr3:134230234	CEP63	chr3:134204575-134293852:+	0.15	4.2	2.89E-5	Height	
BRCA	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.27	-10.1	5.48E-23	Longevity	
BRCA	cis	1	rs6805609	chr3:49471522	AMT	chr3:49454212-49460012:-	-0.12	-4.01	6.47E-5	Menarche (age at onset)	
BRCA	cis	1	rs6805609	chr3:49471522	GMPPB	chr3:49758932-49761384:-	0.13	3.84	0.000132	Menarche (age at onset)	
BRCA	cis	1	rs6805609	chr3:49471522	P4HTM	chr3:49027341-49044579:+	-0.09	-3.75	0.000185	Menarche (age at onset)	
BRCA	cis	1	rs6805609	chr3:49471522	TREX1	chr3:48501186-48509043:+	0.12	3.82	0.000138	Menarche (age at onset)	
BRCA	cis	1	rs6805609	chr3:49471522	WDR6	chr3:49044637-49053386:+	0.19	5.43	7.14E-8	Menarche (age at onset)	
BRCA	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.43	-14.37	5.94E-43	Height	
BRCA	cis	1	rs6806417	chr3:134211446	CEP63	chr3:134204575-134293852:+	-0.15	-4.01	6.59E-5	Height	
BRCA	cis	1	rs680668	chr6:84229366	PRSS35	chr6:84222274-84235419:+	0.14	4.16	3.47E-5	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs680668	chr6:84229366	SNAP91	chr6:84262607-84419127:-	-0.15	-3.97	7.51E-5	Bipolar disorder with mood-incongruent psychosis	
BRCA	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.27	-10.09	6.22E-23	Longevity	
BRCA	cis	1	rs6810665	chr4:17984462	NCAPG	chr4:17812525-17846485:+	0.1	4.6	4.68E-6	Height	
BRCA	cis	1	rs6810869	chr4:103558514	MANBA	chr4:103552644-103682151:-	0.21	5.46	5.91E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs6811842	chr4:18009798	NCAPG	chr4:17812525-17846485:+	0.08	3.64	0.000289	Height	
BRCA	cis	1	rs6812540	chr4:39116423	KLHL5	chr4:39046659-39123828:+	-0.16	-4.91	1.06E-6	Uric acid levels	
BRCA	cis	1	rs6813340	chr4:17922866	NCAPG	chr4:17812525-17846485:+	0.09	4.12	4.02E-5	Height	
BRCA	cis	1	rs68141011	chr6:28217797	HIST1H4J	chr6:27791903-27792257:+	-0.19	-3.58	0.000358	Depression	
BRCA	cis	1	rs68141011	chr6:28217797	ZNF389	chr6:28129551-28137375:+	-0.2	-3.48	0.000531	Depression	
BRCA	cis	1	rs68141011	chr6:28217797	ZSCAN23	chr6:28393287-28411279:-	0.17	3.56	0.000387	Depression	
BRCA	cis	1	rs68144677	chr6:163149024	PACRG	chr6:163148164-163736523:+	0.23	4.03	5.99E-5	Body mass index	
BRCA	cis	1	rs6816071	chr4:122665185	EXOSC9	chr4:122722472-122738175:+	0.13	4.37	1.34E-5	Type 2 diabetes	
BRCA	cis	1	rs68168863	chr6:33758238	IP6K3	chr6:33689443-33714762:-	0.27	4.77	2.08E-6	Obesity (extreme)	
BRCA	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.6	-18.27	4.11E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs68180496	chr3:119278915	CD80	chr3:119243142-119278481:-	0.12	4.22	2.63E-5	Vitiligo	
BRCA	cis	1	rs68189316	chr7:65409169	CCT6P1	chr7:65216092-65228661:+	0.34	7.49	1.42E-13	Diabetic kidney disease	
BRCA	cis	1	rs68189316	chr7:65409169	LOC493754	chr7:65993446-66057363:-	0.2	3.46	0.00056	Diabetic kidney disease	
BRCA	cis	1	rs68189316	chr7:65409169	ZNF117	chr7:64434830-64467121:-	-0.27	-4.95	8.45E-7	Diabetic kidney disease	
BRCA	cis	1	rs6821119	chr4:103555233	MANBA	chr4:103552644-103682151:-	0.21	5.48	5.18E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs6821168	chr4:18005019	NCAPG	chr4:17812525-17846485:+	0.08	3.8	0.000154	Height	
BRCA	cis	1	rs6821283	chr4:165901645	TRIM61	chr4:165875600-165898818:-	0.25	7.72	2.58E-14	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs6823347	chr4:106962725	TBCK	chr4:106967233-107237861:-	0.25	7.73	2.55E-14	Airflow obstruction	
BRCA	cis	1	rs6823488	chr4:122664819	EXOSC9	chr4:122722472-122738175:+	0.14	4.47	8.48E-6	Type 2 diabetes	
BRCA	cis	1	rs6824748	chr4:17997066	NCAPG	chr4:17812525-17846485:+	0.08	3.81	0.000146	Height	
BRCA	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.2	-5.06	4.97E-7	Longevity	
BRCA	cis	1	rs6828122	chr4:18006052	NCAPG	chr4:17812525-17846485:+	0.08	3.73	0.000201	Height	
BRCA	cis	1	rs6829234	chr4:39116206	KLHL5	chr4:39046659-39123828:+	-0.16	-4.91	1.06E-6	Uric acid levels	
BRCA	cis	1	rs6829450	chr4:39116341	KLHL5	chr4:39046659-39123828:+	-0.14	-4.43	1.03E-5	Uric acid levels	
BRCA	cis	1	rs6831102	chr4:18018236	NCAPG	chr4:17812525-17846485:+	0.08	3.6	0.000332	Height	
BRCA	cis	1	rs6831256	chr4:3473139	LRPAP1	chr4:3514290-3534224:-	0.1	3.62	0.000313	Triglycerides;Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs6832503	chr4:48028442	CNGA1	chr4:47937996-48018610:-	-0.21	-7.25	8.23E-13	Renal underexcretion gout;Gout	
BRCA	cis	1	rs6832503	chr4:48028442	NIPAL1	chr4:48018791-48039078:+	-0.11	-3.55	0.000404	Renal underexcretion gout;Gout	
BRCA	cis	1	rs683250	chr11:83276168	CCDC90B	chr11:82972506-82997414:-	0.14	3.89	0.000105	Subcortical brain region volumes	
BRCA	cis	1	rs6833988	chr4:10295586	WDR1	chr4:10075964-10118573:-	-0.17	-3.74	0.000192	Schizophrenia (age at onset)	
BRCA	cis	1	rs6835186	chr4:17984316	NCAPG	chr4:17812525-17846485:+	0.1	4.6	4.68E-6	Height	
BRCA	cis	1	rs6837429	chr4:8502374	C4orf23	chr4:8440604-8495258:+	-0.15	-4.1	4.48E-5	Response to antineoplastic agents	
BRCA	cis	1	rs6839064	chr4:103555676	MANBA	chr4:103552644-103682151:-	0.21	5.47	5.51E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs6839954	chr4:17984129	NCAPG	chr4:17812525-17846485:+	0.1	4.6	4.68E-6	Height	
BRCA	cis	1	rs6840334	chr4:17984277	NCAPG	chr4:17812525-17846485:+	0.1	4.6	4.68E-6	Height	
BRCA	cis	1	rs6840868	chr4:17939331	NCAPG	chr4:17812525-17846485:+	0.09	3.96	7.92E-5	Height	
BRCA	cis	1	rs6841898	chr4:24578097	ANAPC4	chr4:25378848-25420119:+	0.25	4.35	1.5E-5	Myopia (pathological)	
BRCA	cis	1	rs6841898	chr4:24578097	DHX15	chr4:24529089-24586184:-	0.26	5.15	3.05E-7	Myopia (pathological)	
BRCA	cis	1	rs6841898	chr4:24578097	SEPSECS	chr4:25121628-25162204:-	0.14	3.5	0.000488	Myopia (pathological)	
BRCA	cis	1	rs6842114	chr4:18008199	NCAPG	chr4:17812525-17846485:+	0.08	3.72	0.00021	Height	
BRCA	cis	1	rs6843330	chr4:17952056	NCAPG	chr4:17812525-17846485:+	0.09	4.05	5.59E-5	Height	
BRCA	cis	1	rs6846232	chr4:122664805	EXOSC9	chr4:122722472-122738175:+	0.13	4.32	1.69E-5	Type 2 diabetes	
BRCA	cis	1	rs6846238	chr4:17629939	MED28	chr4:17616273-17629791:+	0.14	3.71	0.000219	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs6846579	chr4:107011756	TBCK	chr4:106967233-107237861:-	0.25	7.8	1.52E-14	Airflow obstruction	
BRCA	cis	1	rs6849381	chr4:54524848	LNX1	chr4:54326439-54518682:-	0.13	3.69	0.000236	Beard thickness	
BRCA	cis	1	rs6850259	chr4:17949607	NCAPG	chr4:17812525-17846485:+	0.09	4.05	5.59E-5	Height	
BRCA	cis	1	rs6850306	chr4:18006089	NCAPG	chr4:17812525-17846485:+	0.1	4.12	4.11E-5	Height	
BRCA	cis	1	rs6852678	chr4:76542749	G3BP2	chr4:76567955-76598667:-	0.12	4.14	3.81E-5	Magnesium levels	
BRCA	cis	1	rs6853216	chr4:17970655	NCAPG	chr4:17812525-17846485:+	0.1	4.55	5.88E-6	Height	
BRCA	cis	1	rs6855591	chr4:165906723	TRIM61	chr4:165875600-165898818:-	0.25	8.15	9.8E-16	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs686441	chr10:105950233	C10orf79	chr10:105889647-105992120:-	0.13	4.67	3.44E-6	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs6867113	chr5:115543623	TMED7	chr5:114949203-114961870:-	0.09	3.61	0.000319	Metabolite levels  (X-11787)	
BRCA	cis	1	rs6867913	chr5:141445980	PCDH12	chr5:141324531-141338627:-	0.1	3.46	0.00056	Asthma	
BRCA	cis	1	rs6868817	chr5:82438106	XRCC4	chr5:82373317-82649577:+	-0.12	-3.52	0.00045	Hypertension	
BRCA	cis	1	rs6872393	chr5:155854	CCDC127	chr5:204875-218297:-	0.26	3.52	0.000457	Asthma (childhood onset)	
BRCA	cis	1	rs6872393	chr5:155854	LOC25845	chr5:470626-473080:-	0.29	3.77	0.000172	Asthma (childhood onset)	
BRCA	cis	1	rs6872393	chr5:155854	SDHA	chr5:218356-256812:+	0.26	3.47	0.000541	Asthma (childhood onset)	
BRCA	cis	1	rs6874202	chr5:156391628	TIMD4	chr5:156346293-156390266:-	-0.36	-11.93	6.71E-31	Triglycerides;Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs687557	chr10:105989509	C10orf79	chr10:105889647-105992120:-	0.14	4.84	1.52E-6	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.55	27.59	6.2E-127	Crohn's disease	
BRCA	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.39	-10.72	1.55E-25	Crohn's disease	
BRCA	cis	1	rs6879683	chr5:130585846	LYRM7	chr5:130506641-130541119:+	0.31	4.45	9.34E-6	Diisocyanate-induced asthma	
BRCA	cis	1	rs6879800	chr5:112775010	YTHDC2	chr5:112849410-112930979:+	0.13	3.95	8.4E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs6882076	chr5:156390297	TIMD4	chr5:156346293-156390266:-	-0.37	-12.06	1.76E-31	Triglycerides;Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs6882220	chr5:82435534	XRCC4	chr5:82373317-82649577:+	-0.12	-3.55	0.000402	Hypertension	
BRCA	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.77	19.51	9.38E-73	Type 2 diabetes	
BRCA	cis	1	rs6886255	chr5:176718361	MXD3	chr5:176732501-176739292:-	-0.11	-4.6	4.75E-6	Migraine without aura	
BRCA	cis	1	rs6887846	chr5:82436361	XRCC4	chr5:82373317-82649577:+	0.14	3.92	9.45E-5	Hypertension	
BRCA	cis	1	rs6893174	chr5:56265025	MAP3K1	chr5:56110900-56191976:+	-0.25	-3.99	7.03E-5	Breast cancer (early onset)	
BRCA	cis	1	rs690037	chr3:16395668	DPH3	chr3:16298569-16306496:-	0.19	5.29	1.48E-7	Optic nerve measurement (cup-to-disc ratio);Optic nerve measurement (cup area)	
BRCA	cis	1	rs6901250	chr6:117114025	FAM162B	chr6:117073360-117086886:-	-0.18	-6.61	6.17E-11	C-reactive protein levels	
BRCA	cis	1	rs6901317	chr6:106036151	ATG5	chr6:106632354-106773695:-	-0.18	-5.06	4.88E-7	Beard thickness	
BRCA	cis	1	rs6901317	chr6:106036151	HACE1	chr6:105175968-105307794:-	-0.11	-3.63	0.000292	Beard thickness	
BRCA	cis	1	rs6901317	chr6:106036151	PREP	chr6:105725507-105850969:-	-0.14	-3.96	8.09E-5	Beard thickness	
BRCA	cis	1	rs6901575	chr6:28250984	ZNF389	chr6:28129551-28137375:+	-0.19	-3.52	0.000449	Depression	
BRCA	cis	1	rs6901575	chr6:28250984	ZSCAN23	chr6:28393287-28411279:-	0.18	3.69	0.000234	Depression	
BRCA	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.32	-10.56	7.66E-25	Homocysteine levels	
BRCA	cis	1	rs6902429	chr6:49393500	MUT	chr6:49398994-49431031:-	0.15	4.61	4.58E-6	Homocysteine levels	
BRCA	cis	1	rs6903973	chr6:26499942	BTN2A3	chr6:26422317-26431927:+	0.17	5.57	3.27E-8	Educational attainment	
BRCA	cis	1	rs6904601	chr6:170131905	WDR27	chr6:169857307-170102159:-	-0.12	-3.68	0.000247	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs6905391	chr6:28262686	ZNF323	chr6:28292517-28324048:-	0.21	3.7	0.000227	Depression	
BRCA	cis	1	rs6905391	chr6:28262686	ZSCAN23	chr6:28393287-28411279:-	0.18	3.72	0.000208	Depression	
BRCA	cis	1	rs6907629	chr6:167569519	GPR31	chr6:167570361-167571319:-	-0.25	-7.92	6.14E-15	Asthma (childhood onset)	
BRCA	cis	1	rs6908390	chr6:25609756	SCGN	chr6:25652429-25702006:+	-0.19	-5.25	1.82E-7	Uric acid levels	
BRCA	cis	1	rs6910233	chr6:33534726	BAK1	chr6:33540324-33548070:-	0.19	6.39	2.43E-10	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs6910899	chr6:26524339	BTN2A3	chr6:26422317-26431927:+	0.16	5.45	6.42E-8	Educational attainment	
BRCA	cis	1	rs6910899	chr6:26524339	C6orf41	chr6:26924772-26991752:+	-0.12	-3.53	0.000427	Educational attainment	
BRCA	cis	1	rs6910899	chr6:26524339	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.47	0.000536	Educational attainment	
BRCA	cis	1	rs6911965	chr6:24480295	ALDH5A1	chr6:24495197-24537434:+	-0.19	-4.24	2.42E-5	Hematological and biochemical traits	
BRCA	cis	1	rs6911965	chr6:24480295	GPLD1	chr6:24428405-24489850:-	-0.25	-5.51	4.55E-8	Hematological and biochemical traits	
BRCA	cis	1	rs6912959	chr6:170126224	WDR27	chr6:169857307-170102159:-	-0.12	-3.44	0.000605	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.59	-19.35	9.49E-72	Response to antipsychotic treatment	
BRCA	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.33	-11.33	3.39E-28	Homocysteine levels	
BRCA	cis	1	rs6915187	chr6:49423547	MUT	chr6:49398994-49431031:-	0.15	4.54	6.41E-6	Homocysteine levels	
BRCA	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.32	-10.55	8.14E-25	Homocysteine levels	
BRCA	cis	1	rs6916888	chr6:49383804	MUT	chr6:49398994-49431031:-	0.15	4.6	4.76E-6	Homocysteine levels	
BRCA	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.32	-10.66	2.71E-25	Homocysteine levels	
BRCA	cis	1	rs6918347	chr6:49406348	MUT	chr6:49398994-49431031:-	0.15	4.57	5.51E-6	Homocysteine levels	
BRCA	cis	1	rs6918586	chr6:26097384	BTN3A2	chr6:26365398-26378546:+	-0.14	-4.76	2.24E-6	Schizophrenia	
BRCA	cis	1	rs6918586	chr6:26097384	HIST1H1T	chr6:26107641-26108364:-	0.19	5.37	9.76E-8	Schizophrenia	
BRCA	cis	1	rs6918586	chr6:26097384	HIST1H3B	chr6:26031817-26032288:-	0.13	4.04	5.71E-5	Schizophrenia	
BRCA	cis	1	rs6918586	chr6:26097384	HIST1H3E	chr6:26224427-26226589:+	0.13	3.39	0.000721	Schizophrenia	
BRCA	cis	1	rs6921487	chr6:33749293	LEMD2	chr6:33738991-33756906:-	0.15	4.84	1.52E-6	Body mass index	
BRCA	cis	1	rs6922824	chr6:26553815	BTN2A3	chr6:26422317-26431927:+	-0.16	-5.53	4.01E-8	Educational attainment	
BRCA	cis	1	rs6923124	chr6:49419864	CENPQ	chr6:49431096-49460820:+	-0.22	-7.3	5.46E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.33	10.39	3.83E-24	Folate pathway vitamin levels	
BRCA	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.59	19.26	3.6E-71	Response to antipsychotic treatment	
BRCA	cis	1	rs6923339	chr6:170128033	WDR27	chr6:169857307-170102159:-	-0.12	-3.44	0.000605	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs6924002	chr6:117114223	FAM162B	chr6:117073360-117086886:-	0.18	6.45	1.65E-10	C-reactive protein levels	
BRCA	cis	1	rs6924838	chr6:26571756	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.37E-8	Educational attainment	
BRCA	cis	1	rs6924838	chr6:26571756	C6orf41	chr6:26924772-26991752:+	-0.13	-3.94	8.81E-5	Educational attainment	
BRCA	cis	1	rs6924838	chr6:26571756	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.73	0.000201	Educational attainment	
BRCA	cis	1	rs6925703	chr6:26521589	BTN2A3	chr6:26422317-26431927:+	0.16	5.5	4.74E-8	Educational attainment	
BRCA	cis	1	rs6925703	chr6:26521589	C6orf41	chr6:26924772-26991752:+	-0.12	-3.58	0.000364	Educational attainment	
BRCA	cis	1	rs6925703	chr6:26521589	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.49	0.000497	Educational attainment	
BRCA	cis	1	rs6925895	chr6:26572165	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.43E-8	Educational attainment	
BRCA	cis	1	rs6925895	chr6:26572165	C6orf41	chr6:26924772-26991752:+	-0.13	-3.94	8.76E-5	Educational attainment	
BRCA	cis	1	rs6925895	chr6:26572165	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.73	0.0002	Educational attainment	
BRCA	cis	1	rs6926629	chr6:26499903	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.54E-8	Educational attainment	
BRCA	cis	1	rs6926629	chr6:26499903	ZNF322A	chr6:26634612-26659963:-	-0.09	-3.38	0.000761	Educational attainment	
BRCA	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.48	-12.32	1.02E-32	Diabetic kidney disease	
BRCA	cis	1	rs6928546	chr6:46632006	TDRD6	chr6:46655866-46670149:+	0.14	3.39	0.000721	Lipoprotein-associated phospholipase A2 activity and mass	
BRCA	cis	1	rs6930076	chr6:88088654	C6orf163	chr6:88057220-88075180:+	0.16	4.06	5.24E-5	Depressive episodes in bipolar disorder	
BRCA	cis	1	rs6930120	chr6:26555484	BTN2A3	chr6:26422317-26431927:+	0.16	5.39	8.52E-8	Educational attainment	
BRCA	cis	1	rs6930120	chr6:26555484	C6orf41	chr6:26924772-26991752:+	-0.13	-3.91	9.64E-5	Educational attainment	
BRCA	cis	1	rs6930201	chr6:33738749	C6orf125	chr6:33662057-33679504:-	0.1	3.45	0.000577	Body mass index	
BRCA	cis	1	rs6930201	chr6:33738749	LEMD2	chr6:33738991-33756906:-	0.15	5.02	5.98E-7	Body mass index	
BRCA	cis	1	rs6930576	chr6:148704954	SASH1	chr6:148663729-148873184:+	0.13	3.89	0.000108	Type 2 diabetes nephropathy	
BRCA	cis	1	rs6932156	chr6:26571506	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.37E-8	Educational attainment	
BRCA	cis	1	rs6932156	chr6:26571506	C6orf41	chr6:26924772-26991752:+	-0.13	-3.94	8.81E-5	Educational attainment	
BRCA	cis	1	rs6932156	chr6:26571506	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.73	0.000201	Educational attainment	
BRCA	cis	1	rs6932590	chr6:27248931	BTN3A2	chr6:26365398-26378546:+	-0.28	-7.71	2.81E-14	Schizophrenia	
BRCA	cis	1	rs6933174	chr6:33751003	C6orf125	chr6:33662057-33679504:-	0.1	3.42	0.00065	Body mass index	
BRCA	cis	1	rs6933174	chr6:33751003	LEMD2	chr6:33738991-33756906:-	0.18	5.63	2.31E-8	Body mass index	
BRCA	cis	1	rs6933176	chr6:26540178	BTN2A3	chr6:26422317-26431927:+	0.16	5.48	5.37E-8	Educational attainment	
BRCA	cis	1	rs6933176	chr6:26540178	C6orf41	chr6:26924772-26991752:+	-0.12	-3.75	0.00019	Educational attainment	
BRCA	cis	1	rs6933176	chr6:26540178	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.72	0.000208	Educational attainment	
BRCA	cis	1	rs6933568	chr6:33751261	C6orf125	chr6:33662057-33679504:-	0.1	3.4	0.00069	Body mass index	
BRCA	cis	1	rs6933568	chr6:33751261	LEMD2	chr6:33738991-33756906:-	0.18	5.65	2.11E-8	Body mass index	
BRCA	cis	1	rs6933607	chr6:33743997	C6orf125	chr6:33662057-33679504:-	0.11	3.56	0.000385	Body mass index	
BRCA	cis	1	rs6933607	chr6:33743997	LEMD2	chr6:33738991-33756906:-	0.18	5.49	5.0E-8	Body mass index	
BRCA	cis	1	rs693547	chr4:46256557	GABRA2	chr4:46251581-46392421:-	-0.14	-3.85	0.000126	Epilepsy	
BRCA	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.58	-18.34	1.71E-65	Response to antipsychotic treatment	
BRCA	cis	1	rs6936177	chr6:34783717	UHRF1BP1	chr6:34759794-34853117:+	0.14	4.07	5.09E-5	Pubertal anthropometrics	
BRCA	cis	1	rs6938239	chr6:34683635	UHRF1BP1	chr6:34759794-34853117:+	-0.16	-4.27	2.09E-5	Pubertal anthropometrics	
BRCA	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.55	-28.2	3.59E-131	Crohn's disease	
BRCA	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.37	10.26	1.34E-23	Crohn's disease	
BRCA	cis	1	rs6940053	chr6:26562122	BTN2A3	chr6:26422317-26431927:+	0.16	5.34	1.11E-7	Educational attainment	
BRCA	cis	1	rs6940053	chr6:26562122	C6orf41	chr6:26924772-26991752:+	-0.13	-3.95	8.34E-5	Educational attainment	
BRCA	cis	1	rs6940053	chr6:26562122	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.49	0.000507	Educational attainment	
BRCA	cis	1	rs6940188	chr6:26562029	BTN2A3	chr6:26422317-26431927:+	0.16	5.34	1.11E-7	Educational attainment	
BRCA	cis	1	rs6940188	chr6:26562029	C6orf41	chr6:26924772-26991752:+	-0.13	-3.95	8.27E-5	Educational attainment	
BRCA	cis	1	rs6940188	chr6:26562029	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.49	0.000506	Educational attainment	
BRCA	cis	1	rs6940353	chr6:33752550	LEMD2	chr6:33738991-33756906:-	0.18	5.63	2.34E-8	Body mass index	
BRCA	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.57	-17.95	3.85E-63	Response to antipsychotic treatment	
BRCA	cis	1	rs6941766	chr6:170131653	WDR27	chr6:169857307-170102159:-	-0.12	-3.65	0.00027	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs6942332	chr6:170131934	WDR27	chr6:169857307-170102159:-	-0.13	-3.86	0.000121	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs6947895	chr7:49327094	CDC14C	chr7:48964157-48967049:+	0.18	3.39	0.000735	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs6948775	chr7:98945480	CYP3A5	chr7:99245818-99332821:-	0.39	5.86	6.17E-9	Blood metabolite levels	
BRCA	cis	1	rs6949812	chr7:65387101	CCT6P1	chr7:65216092-65228661:+	0.34	7.43	2.18E-13	Diabetic kidney disease	
BRCA	cis	1	rs6949812	chr7:65387101	LOC493754	chr7:65993446-66057363:-	0.2	3.39	0.000714	Diabetic kidney disease	
BRCA	cis	1	rs6949812	chr7:65387101	ZNF117	chr7:64434830-64467121:-	-0.27	-5.04	5.54E-7	Diabetic kidney disease	
BRCA	cis	1	rs6949897	chr7:50621920	FIGNL1	chr7:50511834-50518088:-	-0.13	-4.33	1.61E-5	Malaria	
BRCA	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.55	-28.34	3.58E-132	Crohn's disease	
BRCA	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.37	10.33	6.34E-24	Crohn's disease	
BRCA	cis	1	rs6950776	chr7:116913823	MET	chr7:116312459-116438439:+	-0.09	-3.48	0.000524	Dupuytren's disease	
BRCA	cis	1	rs6952407	chr7:66045512	CCT6P1	chr7:65216092-65228661:+	0.1	3.39	0.000735	Cotinine glucuronidation	
BRCA	cis	1	rs6952407	chr7:66045512	CRCP	chr7:65579805-65619551:+	0.13	3.61	0.000325	Cotinine glucuronidation	
BRCA	cis	1	rs6952407	chr7:66045512	LOC493754	chr7:65993446-66057363:-	0.13	3.46	0.000556	Cotinine glucuronidation	
BRCA	cis	1	rs6952407	chr7:66045512	TYW1	chr7:66461817-66704496:+	-0.13	-3.57	0.000377	Cotinine glucuronidation	
BRCA	cis	1	rs6952809	chr7:2448493	KIAA1908	chr7:1609709-1629259:+	-0.13	-3.45	0.000592	Multiple sclerosis	
BRCA	cis	1	rs6956014	chr7:50473290	FIGNL1	chr7:50511834-50518088:-	-0.11	-3.45	0.00058	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs6958289	chr7:65657111	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.42	2.03E-10	Diabetic kidney disease	
BRCA	cis	1	rs6958289	chr7:65657111	CRCP	chr7:65579805-65619551:+	0.22	3.64	0.000286	Diabetic kidney disease	
BRCA	cis	1	rs6958289	chr7:65657111	LOC493754	chr7:65993446-66057363:-	-0.22	-3.63	0.000299	Diabetic kidney disease	
BRCA	cis	1	rs6958420	chr7:65751171	CCT6P1	chr7:65216092-65228661:+	-0.29	-6.23	6.55E-10	Diabetic kidney disease	
BRCA	cis	1	rs6958420	chr7:65751171	CRCP	chr7:65579805-65619551:+	0.22	3.79	0.000157	Diabetic kidney disease	
BRCA	cis	1	rs6958420	chr7:65751171	LOC493754	chr7:65993446-66057363:-	-0.21	-3.57	0.000377	Diabetic kidney disease	
BRCA	cis	1	rs6958520	chr7:66151453	CRCP	chr7:65579805-65619551:+	-0.13	-3.4	0.000689	Aortic root size	
BRCA	cis	1	rs6958520	chr7:66151453	TYW1	chr7:66461817-66704496:+	0.15	3.9	0.000104	Aortic root size	
BRCA	cis	1	rs6959002	chr7:65650496	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.58	7.53E-11	Diabetic kidney disease	
BRCA	cis	1	rs6959002	chr7:65650496	CRCP	chr7:65579805-65619551:+	0.21	3.48	0.000517	Diabetic kidney disease	
BRCA	cis	1	rs6959002	chr7:65650496	LOC493754	chr7:65993446-66057363:-	-0.23	-3.86	0.000122	Diabetic kidney disease	
BRCA	cis	1	rs6959670	chr7:110909169	IMMP2L	chr7:110303110-111202538:-	0.16	4.34	1.55E-5	Schizophrenia	
BRCA	cis	1	rs6964245	chr7:65718717	CCT6P1	chr7:65216092-65228661:+	-0.29	-6.38	2.57E-10	Diabetic kidney disease	
BRCA	cis	1	rs6964245	chr7:65718717	CRCP	chr7:65579805-65619551:+	0.21	3.66	0.000261	Diabetic kidney disease	
BRCA	cis	1	rs6964245	chr7:65718717	LOC493754	chr7:65993446-66057363:-	-0.23	-3.99	7.15E-5	Diabetic kidney disease	
BRCA	cis	1	rs6964530	chr7:65718851	CCT6P1	chr7:65216092-65228661:+	-0.29	-6.35	3.17E-10	Diabetic kidney disease	
BRCA	cis	1	rs6964530	chr7:65718851	CRCP	chr7:65579805-65619551:+	0.22	3.71	0.000222	Diabetic kidney disease	
BRCA	cis	1	rs6964530	chr7:65718851	LOC493754	chr7:65993446-66057363:-	-0.23	-3.9	0.000103	Diabetic kidney disease	
BRCA	cis	1	rs6964969	chr7:50473251	FIGNL1	chr7:50511834-50518088:-	0.12	3.81	0.00015	Acute lymphoblastic leukemia (childhood)	
BRCA	cis	1	rs6965685	chr7:158726462	WDR60	chr7:158649269-158738882:+	-0.22	-6.3	4.46E-10	Height	
BRCA	cis	1	rs6966322	chr7:65646754	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.38	2.6E-10	Diabetic kidney disease	
BRCA	cis	1	rs6966322	chr7:65646754	CRCP	chr7:65579805-65619551:+	0.21	3.58	0.000354	Diabetic kidney disease	
BRCA	cis	1	rs6966322	chr7:65646754	LOC493754	chr7:65993446-66057363:-	-0.22	-3.78	0.000167	Diabetic kidney disease	
BRCA	cis	1	rs6970243	chr7:65388490	CCT6P1	chr7:65216092-65228661:+	0.34	7.43	2.18E-13	Diabetic kidney disease	
BRCA	cis	1	rs6970243	chr7:65388490	LOC493754	chr7:65993446-66057363:-	0.2	3.39	0.000714	Diabetic kidney disease	
BRCA	cis	1	rs6970243	chr7:65388490	ZNF117	chr7:64434830-64467121:-	-0.27	-5.04	5.54E-7	Diabetic kidney disease	
BRCA	cis	1	rs6970597	chr7:21583519	DNAH11	chr7:21582833-21941455:+	-0.23	-6.48	1.39E-10	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
BRCA	cis	1	rs6970985	chr7:21583597	DNAH11	chr7:21582833-21941455:+	-0.23	-6.54	9.66E-11	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
BRCA	cis	1	rs6974373	chr7:99590893	AZGP1	chr7:99564352-99573687:-	-0.13	-3.77	0.000173	Interstitial lung disease	
BRCA	cis	1	rs6974373	chr7:99590893	CYP3A5	chr7:99245818-99332821:-	-0.19	-4.72	2.66E-6	Interstitial lung disease	
BRCA	cis	1	rs6974373	chr7:99590893	TRIM4	chr7:99488037-99517154:-	-0.23	-6.43	1.89E-10	Interstitial lung disease	
BRCA	cis	1	rs6974723	chr7:65637939	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.38	2.6E-10	Diabetic kidney disease	
BRCA	cis	1	rs6974723	chr7:65637939	CRCP	chr7:65579805-65619551:+	0.21	3.58	0.000354	Diabetic kidney disease	
BRCA	cis	1	rs6974723	chr7:65637939	LOC493754	chr7:65993446-66057363:-	-0.22	-3.78	0.000167	Diabetic kidney disease	
BRCA	cis	1	rs6975195	chr7:66124774	CRCP	chr7:65579805-65619551:+	0.13	3.47	0.000545	Aortic root size	
BRCA	cis	1	rs6975195	chr7:66124774	TYW1	chr7:66461817-66704496:+	-0.15	-3.94	8.63E-5	Aortic root size	
BRCA	cis	1	rs6976053	chr7:100512119	GIGYF1	chr7:100277130-100286870:-	0.08	3.75	0.000187	Plasminogen activator inhibitor type 1 levels (PAI-1)	
BRCA	cis	1	rs6976053	chr7:100512119	UFSP1	chr7:100486346-100487339:-	-0.17	-5.56	3.44E-8	Plasminogen activator inhibitor type 1 levels (PAI-1)	
BRCA	cis	1	rs6976930	chr7:72885810	MLXIPL	chr7:73007524-73038870:-	0.3	5.92	4.21E-9	Triglycerides	
BRCA	cis	1	rs6977955	chr7:28156887	JAZF1	chr7:27870196-28220437:-	-0.15	-5.15	3.08E-7	Rheumatoid arthritis	
BRCA	cis	1	rs6979857	chr7:123435541	HYAL4	chr7:123485223-123517529:+	0.21	3.44	0.000594	Platelet count	
BRCA	cis	1	rs6984009	chr8:96289091	C8orf37	chr8:96258235-96281437:-	0.28	5.55	3.61E-8	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
BRCA	cis	1	rs698500	chr15:83237769	FAM154B	chr15:82555152-82577265:+	-0.12	-3.53	0.000436	Schizophrenia	
BRCA	cis	1	rs698	chr4:100260789	ADH1C	chr4:100257651-100273917:-	-0.2	-6.38	2.58E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs6999	chr20:55093901	C20orf43	chr20:55043647-55093942:+	0.16	4.57	5.35E-6	Refractive astigmatism	
BRCA	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.86	30.97	9.97E-151	Bone mineral density	
BRCA	cis	1	rs7014273	chr8:67358694	C8orf46	chr8:67405491-67430757:+	-0.17	-4.17	3.33E-5	Blood metabolite levels	
BRCA	cis	1	rs7014578	chr8:92077568	LRRC69	chr8:92114847-92231464:+	-0.16	-4.1	4.49E-5	Migraine - clinic-based	
BRCA	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.86	30.83	9.29E-150	Bone mineral density	
BRCA	cis	1	rs7018	chr20:25278261	FAM182A	chr20:26035250-26067552:+	-0.21	-5.57	3.18E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7018	chr20:25278261	FAM182B	chr20:25744102-25848786:-	0.23	5.92	4.4E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7019938	chr9:91564344	C9orf47	chr9:91605778-91611055:+	0.12	3.47	0.000548	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs7019	chr20:25278278	ABHD12	chr20:25275380-25371477:-	0.11	3.39	0.000737	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7019	chr20:25278278	FAM182A	chr20:26035250-26067552:+	-0.22	-5.7	1.53E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7019	chr20:25278278	FAM182B	chr20:25744102-25848786:-	0.21	5.55	3.6E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7019	chr20:25278278	PYGB	chr20:25228706-25278647:+	-0.13	-3.38	0.000758	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7020528	chr9:91564761	C9orf47	chr9:91605778-91611055:+	0.12	3.41	0.000673	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs7020689	chr9:22972985	CDKN2BAS	chr9:21994790-22121091:+	-0.22	-3.7	0.000228	Cannabis use (initiation)	
BRCA	cis	1	rs7020708	chr9:131885131	SH3GLB2	chr9:131770314-131790579:-	-0.13	-4.74	2.4E-6	Blood metabolite ratios	
BRCA	cis	1	rs7020976	chr9:100547972	NCBP1	chr9:100395705-100436027:+	-0.12	-3.72	0.000207	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7020976	chr9:100547972	TSTD2	chr9:100362364-100395962:-	-0.1	-3.78	0.000168	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7020	chr20:25278600	ABHD12	chr20:25275380-25371477:-	0.11	3.42	0.000649	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7020	chr20:25278600	FAM182A	chr20:26035250-26067552:+	-0.21	-5.56	3.32E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7020	chr20:25278600	FAM182B	chr20:25744102-25848786:-	0.23	6.12	1.29E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7021449	chr9:131899312	SH3GLB2	chr9:131770314-131790579:-	-0.11	-4.01	6.47E-5	Blood metabolite ratios	
BRCA	cis	1	rs7021576	chr9:100540541	NCBP1	chr9:100395705-100436027:+	-0.14	-4.16	3.37E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7021576	chr9:100540541	TSTD2	chr9:100362364-100395962:-	-0.11	-4.09	4.71E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7021651	chr9:91548799	C9orf47	chr9:91605778-91611055:+	0.14	3.99	7.16E-5	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs7021651	chr9:91548799	S1PR3	chr9:91606362-91619924:+	0.12	3.44	0.000596	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.28	-7.87	8.85E-15	Hematology traits	
BRCA	cis	1	rs7023900	chr9:131891152	SH3GLB2	chr9:131770314-131790579:-	-0.13	-4.69	3.15E-6	Blood metabolite ratios	
BRCA	cis	1	rs7024847	chr9:91565755	C9orf47	chr9:91605778-91611055:+	0.13	3.75	0.000189	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs7027030	chr9:100550455	NCBP1	chr9:100395705-100436027:+	-0.12	-3.71	0.000217	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7027030	chr9:100550455	TSTD2	chr9:100362364-100395962:-	-0.1	-3.67	0.00025	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7028197	chr9:91555066	C9orf47	chr9:91605778-91611055:+	0.13	3.72	0.000209	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs7028661	chr9:100538470	CORO2A	chr9:100883258-100954956:-	-0.13	-3.7	0.000222	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7028661	chr9:100538470	NCBP1	chr9:100395705-100436027:+	-0.15	-4.55	5.86E-6	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7028661	chr9:100538470	TSTD2	chr9:100362364-100395962:-	-0.13	-4.6	4.73E-6	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7028661	chr9:100538470	XPA	chr9:100437192-100459691:-	-0.11	-3.4	0.000695	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7030241	chr9:100550375	NCBP1	chr9:100395705-100436027:+	-0.12	-3.63	0.0003	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7030241	chr9:100550375	TSTD2	chr9:100362364-100395962:-	-0.1	-3.72	0.000213	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7030256	chr9:100535203	NCBP1	chr9:100395705-100436027:+	-0.14	-4.22	2.66E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7030256	chr9:100535203	TSTD2	chr9:100362364-100395962:-	-0.11	-4.06	5.22E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7030280	chr9:100535267	NCBP1	chr9:100395705-100436027:+	-0.12	-3.57	0.000369	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7030887	chr9:100688511	C9orf156	chr9:100666772-100684852:-	-0.17	-4.62	4.27E-6	Quantitative traits	
BRCA	cis	1	rs7030907	chr9:100688577	C9orf156	chr9:100666772-100684852:-	-0.17	-4.62	4.27E-6	Quantitative traits	
BRCA	cis	1	rs7032019	chr9:100548144	NCBP1	chr9:100395705-100436027:+	-0.12	-3.72	0.000207	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7032019	chr9:100548144	TSTD2	chr9:100362364-100395962:-	-0.1	-3.78	0.000168	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7032526	chr9:91564276	C9orf47	chr9:91605778-91611055:+	0.12	3.47	0.000548	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs7032662	chr9:91564355	C9orf47	chr9:91605778-91611055:+	0.12	3.45	0.000585	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs7036114	chr9:131893406	SH3GLB2	chr9:131770314-131790579:-	-0.12	-4.64	3.93E-6	Blood metabolite ratios	
BRCA	cis	1	rs7036236	chr9:131899299	SH3GLB2	chr9:131770314-131790579:-	-0.11	-4.2	2.84E-5	Blood metabolite ratios	
BRCA	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.37	-10.12	4.79E-23	Rheumatoid arthritis	
BRCA	cis	1	rs7037140	chr9:123656327	TRAF1	chr9:123664672-123691479:-	0.1	4.83	1.59E-6	Rheumatoid arthritis	
BRCA	cis	1	rs7037163	chr9:131894340	GPR107	chr9:132815985-132902448:+	-0.12	-3.4	0.000704	Blood metabolite ratios	
BRCA	cis	1	rs7037163	chr9:131894340	SH3GLB2	chr9:131770314-131790579:-	-0.11	-3.92	9.39E-5	Blood metabolite ratios	
BRCA	cis	1	rs7037603	chr9:91565874	C9orf47	chr9:91605778-91611055:+	0.13	3.68	0.000242	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs703842	chr12:58162739	B4GALNT1	chr12:58019551-58026985:-	-0.12	-3.57	0.000374	Multiple sclerosis	
BRCA	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.4	-10.34	5.96E-24	Multiple sclerosis	
BRCA	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.32	9.85	5.79E-22	Multiple sclerosis	
BRCA	cis	1	rs703842	chr12:58162739	XRCC6BP1	chr12:58335445-58351051:+	0.17	5.04	5.4E-7	Multiple sclerosis	
BRCA	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.28	-7.87	8.85E-15	Hematology traits	
BRCA	cis	1	rs7038956	chr9:91553712	C9orf47	chr9:91605778-91611055:+	0.13	3.72	0.000209	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs7044951	chr9:91564637	C9orf47	chr9:91605778-91611055:+	0.13	3.62	0.000306	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs7045138	chr9:100591463	TSTD2	chr9:100362364-100395962:-	-0.09	-3.4	0.000686	Thyroid hormone levels	
BRCA	cis	1	rs7045881	chr9:26935996	IFT74	chr9:26947037-27062923:+	0.2	4.03	6.04E-5	Schizophrenia	
BRCA	cis	1	rs7045881	chr9:26935996	LRRC19	chr9:26993143-27005691:-	-0.67	-11.95	5.7E-31	Schizophrenia	
BRCA	cis	1	rs7047321	chr9:91555547	C9orf47	chr9:91605778-91611055:+	0.14	3.83	0.000133	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.65	17.67	1.68E-61	Cognitive function	
BRCA	cis	1	rs7068921	chr10:124733526	PSTK	chr10:124739556-124749906:+	0.13	3.7	0.000227	Migraine without aura	
BRCA	cis	1	rs7070296	chr10:65070438	NRBF2	chr10:64893007-64914785:+	-0.17	-6.13	1.21E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7070776	chr10:102264672	SEC31B	chr10:102246403-102289636:-	-0.3	-11.26	6.95E-28	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7071271	chr10:102264824	SEC31B	chr10:102246403-102289636:-	-0.31	-11.62	1.78E-29	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.67	21.22	1.16E-83	Metabolite levels	
BRCA	cis	1	rs7072634	chr10:17240918	TRDMT1	chr10:17184983-17243681:-	-0.1	-3.38	0.000762	Homocysteine levels	
BRCA	cis	1	rs7073586	chr10:102307671	SEC31B	chr10:102246403-102289636:-	-0.28	-10.33	6.55E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7073746	chr10:64904071	NRBF2	chr10:64893007-64914785:+	-0.17	-6.09	1.55E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7077836	chr10:132751498	PPP2R2D	chr10:133747960-133770051:+	0.17	3.58	0.000358	Insulin-related traits	
BRCA	cis	1	rs7078160	chr10:118827560	KIAA1598	chr10:118644308-118886097:-	0.15	3.59	0.000345	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
BRCA	cis	1	rs7078799	chr10:102301447	SEC31B	chr10:102246403-102289636:-	-0.3	-10.96	1.43E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7079075	chr10:118369513	PNLIPRP2	chr10:118380465-118404654:+	0.27	4.64	3.92E-6	Loneliness;Loneliness (multivariate analysis)	
BRCA	cis	1	rs7079136	chr10:102292709	SEC31B	chr10:102246403-102289636:-	-0.3	-11.09	3.91E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7079756	chr10:102302105	SEC31B	chr10:102246403-102289636:-	-0.29	-10.65	3.19E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7080055	chr10:104008280	PITX3	chr10:103989946-104001231:-	0.11	3.41	0.000679	QT interval	
BRCA	cis	1	rs7080356	chr10:102266735	SEC31B	chr10:102246403-102289636:-	-0.3	-11.14	2.39E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7084810	chr10:102297546	SEC31B	chr10:102246403-102289636:-	-0.29	-10.85	4.47E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7084921	chr10:101813802	CWF19L1	chr10:101992055-102027437:-	0.13	3.53	0.00043	Bone mineral density	
BRCA	cis	1	rs7085439	chr10:102210100	SEC31B	chr10:102246403-102289636:-	-0.28	-10.31	7.69E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7088512	chr10:102303498	SEC31B	chr10:102246403-102289636:-	-0.28	-10.5	1.3E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7088827	chr10:102303865	SEC31B	chr10:102246403-102289636:-	-0.29	-10.71	1.74E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7089349	chr10:96407352	HELLS	chr10:96305543-96361855:+	0.13	3.61	0.000324	Migraine	
BRCA	cis	1	rs7090431	chr10:102261753	SEC31B	chr10:102246403-102289636:-	-0.3	-11.16	1.94E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7091404	chr10:124745458	PSTK	chr10:124739556-124749906:+	0.13	3.66	0.000264	Migraine without aura	
BRCA	cis	1	rs7095889	chr10:124744265	PSTK	chr10:124739556-124749906:+	0.13	3.5	0.000479	Migraine without aura	
BRCA	cis	1	rs7095944	chr10:126302936	METTL10	chr10:126447406-126480439:-	-0.18	-4.76	2.19E-6	Asthma	
BRCA	cis	1	rs709607	chr7:65449541	CCT6P1	chr7:65216092-65228661:+	-0.27	-5.98	3.08E-9	Diabetic kidney disease	
BRCA	cis	1	rs709607	chr7:65449541	ZNF117	chr7:64434830-64467121:-	0.23	4.16	3.42E-5	Diabetic kidney disease	
BRCA	cis	1	rs7096678	chr10:96069208	NOC3L	chr10:96092989-96122683:-	0.12	3.89	0.000108	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs7096692	chr10:17180828	TRDMT1	chr10:17184983-17243681:-	-0.1	-3.46	0.000555	Homocysteine levels	
BRCA	cis	1	rs7097656	chr10:82250831	DYDC1	chr10:82095864-82116511:-	0.17	3.8	0.00015	Post bronchodilator FEV1	
BRCA	cis	1	rs7098825	chr10:104628234	SFXN2	chr10:104474298-104498946:+	-0.22	-4.16	3.5E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs7098825	chr10:104628234	TMEM180	chr10:104221170-104238858:+	0.19	3.47	0.000537	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs7099913	chr10:102314777	SEC31B	chr10:102246403-102289636:-	-0.28	-10.17	3.1E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7099965	chr10:102301165	SEC31B	chr10:102246403-102289636:-	-0.3	-10.96	1.39E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7099	chr20:43997646	SYS1	chr20:43991701-44004724:+	-0.18	-4.94	8.93E-7	Psoriasis	
BRCA	cis	1	rs7100163	chr10:17181177	TRDMT1	chr10:17184983-17243681:-	-0.11	-3.56	0.00039	Homocysteine levels	
BRCA	cis	1	rs7100386	chr10:102301417	SEC31B	chr10:102246403-102289636:-	-0.3	-10.96	1.43E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7100697	chr10:124745323	PSTK	chr10:124739556-124749906:+	0.13	3.66	0.000264	Migraine without aura	
BRCA	cis	1	rs7100783	chr10:96464293	HELLS	chr10:96305543-96361855:+	0.12	3.38	0.000747	Migraine	
BRCA	cis	1	rs7102106	chr11:28343953	METT5D1	chr11:28129798-28355054:+	-0.12	-3.48	0.000517	Bipolar disorder	
BRCA	cis	1	rs7105282	chr11:47805614	MADD	chr11:47290927-47351582:+	0.15	4.5	7.6E-6	Subjective well-being	
BRCA	cis	1	rs7105282	chr11:47805614	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.24	2.41E-5	Subjective well-being	
BRCA	cis	1	rs7107356	chr11:47676170	MYBPC3	chr11:47352958-47374253:-	0.11	3.42	0.000657	Neuroticism	
BRCA	cis	1	rs7107790	chr11:27324730	LGR4	chr11:27387510-27494334:-	0.14	4.15	3.57E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs710865	chr1:19568972	KIAA0090	chr1:19544585-19578046:-	-0.18	-5.58	3.05E-8	Brain structure	
BRCA	cis	1	rs710866	chr1:19568722	KIAA0090	chr1:19544585-19578046:-	-0.17	-5.35	1.06E-7	Brain structure	
BRCA	cis	1	rs7109698	chr11:46673344	DDB2	chr11:47236493-47260769:+	-0.15	-3.74	0.000197	Schizophrenia	
BRCA	cis	1	rs7110026	chr11:27337526	LGR4	chr11:27387510-27494334:-	0.15	4.22	2.66E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.49	-12.82	4.3E-35	Type 2 diabetes	
BRCA	cis	1	rs7112860	chr11:28151609	METT5D1	chr11:28129798-28355054:+	-0.12	-3.38	0.00076	Bipolar disorder	
BRCA	cis	1	rs7112925	chr11:66826160	ACTN3	chr11:66313866-66330797:+	-0.15	-4.03	6.0E-5	Height	
BRCA	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.38	-9.92	2.93E-22	Forced vital capacity	
BRCA	cis	1	rs711737	chr3:27543655	NEK10	chr3:27152395-27410912:-	-0.1	-3.74	0.000196	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs7118648	chr11:96108428	CCDC82	chr11:96085930-96123083:-	-0.13	-3.6	0.000334	Parkinson's disease	
BRCA	cis	1	rs7119590	chr11:131239804	SNX19	chr11:130745767-130786382:-	-0.23	-3.79	0.000158	Aggressiveness in attention deficit hyperactivity disorder	
BRCA	cis	1	rs7119817	chr11:112455924	IL18	chr11:112013976-112034840:-	0.11	4.2	2.92E-5	Response to antipsychotic treatment	
BRCA	cis	1	rs7119931	chr11:27327385	LGR4	chr11:27387510-27494334:-	0.14	4.15	3.57E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs7119	chr15:77777632	LINGO1	chr15:77905369-77988475:-	0.13	3.7	0.000224	Type 2 diabetes	
BRCA	cis	1	rs712022	chr11:22843155	SVIP	chr11:22843600-22851382:-	-0.24	-6.58	7.35E-11	Dialysis-related mortality	
BRCA	cis	1	rs7120333	chr11:47817441	MADD	chr11:47290927-47351582:+	0.14	4.41	1.14E-5	Subjective well-being	
BRCA	cis	1	rs7120333	chr11:47817441	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.13	3.95E-5	Subjective well-being	
BRCA	cis	1	rs7124974	chr11:59906972	MS4A4A	chr11:60048139-60076444:+	-0.1	-4.16	3.42E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs7125827	chr11:112398446	CRYAB	chr11:111779350-111782473:-	0.09	3.7	0.000226	Response to antipsychotic treatment	
BRCA	cis	1	rs7125827	chr11:112398446	IL18	chr11:112013976-112034840:-	0.1	3.56	0.000385	Response to antipsychotic treatment	
BRCA	cis	1	rs7126396	chr11:22130513	ANO5	chr11:22214722-22304913:+	0.18	3.94	8.71E-5	Parkinson's disease	
BRCA	cis	1	rs712704	chr7:127258208	GCC1	chr7:127220683-127225654:-	-0.16	-3.51	0.000461	Type 2 diabetes	
BRCA	cis	1	rs7128029	chr11:244141	PSMD13	chr11:236808-252984:+	-0.16	-4.58	5.13E-6	Menarche (age at onset)	
BRCA	cis	1	rs7128044	chr11:244115	PSMD13	chr11:236808-252984:+	-0.16	-4.58	5.13E-6	Menarche (age at onset)	
BRCA	cis	1	rs7129491	chr11:57095082	PRG2	chr11:57151267-57191532:-	-0.2	-3.65	0.00027	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs7129556	chr11:77300048	AQP11	chr11:77300436-77320691:+	-0.18	-4.46	9.22E-6	Weight loss (gastric bypass surgery)	
BRCA	cis	1	rs7131696	chr12:121459344	GATC	chr12:120884284-120897761:+	-0.14	-3.42	0.000659	Type 2 diabetes	
BRCA	cis	1	rs7131696	chr12:121459344	HNF1A	chr12:121416549-121440312:+	-0.18	-3.59	0.000341	Type 2 diabetes	
BRCA	cis	1	rs713219	chr9:131900920	SH3GLB2	chr9:131770314-131790579:-	-0.1	-3.96	8.16E-5	Blood metabolite ratios	
BRCA	cis	1	rs7132434	chr12:26472562	BHLHE41	chr12:26272961-26278003:-	-0.13	-3.76	0.000178	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs7132434	chr12:26472562	SSPN	chr12:26348269-26405853:+	-0.11	-3.57	0.000375	Waist-hip ratio;Renal cell carcinoma	
BRCA	cis	1	rs71334202	chr20:23618652	CST1	chr20:23728191-23731574:-	0.23	4.9	1.08E-6	Chronic kidney disease	
BRCA	cis	1	rs7133819	chr12:54262756	LOC400043	chr12:54519855-54526619:+	-0.13	-3.44	0.000612	Biliary atresia	
BRCA	cis	1	rs7134594	chr12:110000193	MMAB	chr12:109991523-110011358:-	-0.12	-3.79	0.000161	HDL cholesterol	
BRCA	cis	1	rs7134594	chr12:110000193	MYO1H	chr12:109826524-109886176:+	0.27	8.03	2.62E-15	HDL cholesterol	
BRCA	cis	1	rs713835	chr22:38064650	LGALS2	chr22:37966254-37976024:-	0.09	3.82	0.000141	Fat distribution (HIV)	
BRCA	cis	1	rs7138803	chr12:50247468	C12orf62	chr12:50505900-50514234:+	-0.1	-3.48	0.000516	Menarche (age at onset);Body mass index;Childhood body mass index;Obesity;Weight;Waist circumference	
BRCA	cis	1	rs713909	chr22:39532420	APOBEC3H	chr22:39493290-39500070:+	-0.12	-5.52	4.34E-8	Multiple myeloma	
BRCA	cis	1	rs71430278	chr2:218312448	DIRC3	chr2:218148748-218621316:-	0.19	3.94	8.61E-5	Metabolite levels (MHPG)	
BRCA	cis	1	rs7143682	chr14:104413455	TDRD9	chr14:104394817-104519002:+	0.43	10.77	9.08E-26	Bipolar disorder	
BRCA	cis	1	rs7146689	chr14:93100024	NDUFB1	chr14:92582470-92588153:-	0.13	3.74	0.00019	Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.37	11.78	3.27E-30	Common traits (Other)	
BRCA	cis	1	rs71550519	chr6:56780272	BEND6	chr6:56819773-56892138:+	-0.34	-9.13	3.37E-19	Menarche (age at onset)	
BRCA	cis	1	rs71550519	chr6:56780272	KIAA1586	chr6:56911384-56920021:+	-0.18	-3.69	0.000233	Menarche (age at onset)	
BRCA	cis	1	rs7156105	chr14:75541954	EIF2B2	chr14:75469612-75476292:+	0.19	5.31	1.33E-7	Height	
BRCA	cis	1	rs7156105	chr14:75541954	MLH3	chr14:75480467-75518235:-	0.21	6.48	1.37E-10	Height	
BRCA	cis	1	rs71564866	chr6:56771207	BEND6	chr6:56819773-56892138:+	-0.34	-9.01	9.47E-19	Menarche (age at onset)	
BRCA	cis	1	rs71564866	chr6:56771207	KIAA1586	chr6:56911384-56920021:+	-0.21	-4.24	2.43E-5	Menarche (age at onset)	
BRCA	cis	1	rs71564868	chr6:56798441	BEND6	chr6:56819773-56892138:+	-0.35	-9.55	8.65E-21	Menarche (age at onset)	
BRCA	cis	1	rs71564868	chr6:56798441	KIAA1586	chr6:56911384-56920021:+	-0.18	-3.66	0.000262	Menarche (age at onset)	
BRCA	cis	1	rs71567659	chr6:163001736	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.06E-6	Body mass index	
BRCA	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.4	-12.99	6.59E-36	Common traits (Other)	
BRCA	cis	1	rs71617204	chr3:53042951	NT5DC2	chr3:52558386-52569093:-	-0.2	-4.23	2.56E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs71617204	chr3:53042951	RFT1	chr3:53122503-53164470:-	0.27	3.83	0.000134	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs71617204	chr3:53042951	TMEM110	chr3:52867139-52931547:-	0.27	4.18	3.22E-5	Immune reponse to smallpox (secreted IL-2)	
BRCA	cis	1	rs7165247	chr15:58251786	ADAM10	chr15:58888510-59042177:-	0.08	3.39	0.000716	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	
BRCA	cis	1	rs7165247	chr15:58251786	ALDH1A2	chr15:58245628-58571462:-	-0.09	-3.46	0.000567	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	
BRCA	cis	1	rs7166595	chr15:73094204	ADPGK	chr15:73043710-73076667:-	0.12	3.42	0.000646	Body mass index	
BRCA	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	0.38	10.43	2.53E-24	Heschl's gyrus morphology	
BRCA	cis	1	rs7166991	chr15:40671957	C15orf57	chr15:40823540-40857252:-	0.17	3.65	0.000271	Heschl's gyrus morphology	
BRCA	cis	1	rs7166991	chr15:40671957	IVD	chr15:40697686-40713512:+	-0.18	-4.02	6.19E-5	Heschl's gyrus morphology	
BRCA	cis	1	rs7166991	chr15:40671957	MRPL42P5	chr15:40823540-40846104:-	0.21	3.44	0.000604	Heschl's gyrus morphology	
BRCA	cis	1	rs7169064	chr15:31210862	MTMR10	chr15:31231144-31283807:-	0.13	3.51	0.000461	Hypertriglyceridemia	
BRCA	cis	1	rs7169064	chr15:31210862	MTMR15	chr15:31196055-31235307:+	0.16	3.73	0.000206	Hypertriglyceridemia	
BRCA	cis	1	rs7170930	chr15:66580853	DIS3L	chr15:66585633-66626235:+	0.21	3.89	0.000106	Response to cytadine analogues (cytosine arabinoside)	
BRCA	cis	1	rs7170930	chr15:66580853	TIPIN	chr15:66629008-66649054:-	-0.21	-3.82	0.000141	Response to cytadine analogues (cytosine arabinoside)	
BRCA	cis	1	rs7172118	chr15:78862453	AGPHD1	chr15:78799906-78829714:+	-0.15	-3.4	0.000694	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs7172118	chr15:78862453	CHRNA5	chr15:78857906-78886458:+	-0.2	-5.91	4.47E-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs717238	chr10:96441300	HELLS	chr10:96305543-96361855:+	0.12	3.52	0.000451	Migraine	
BRCA	cis	1	rs7173833	chr15:75369618	SCAMP5	chr15:75287901-75313836:+	0.23	5.84	6.98E-9	Blood trace element (Zn levels)	
BRCA	cis	1	rs7174	chr12:121017171	GATC	chr12:120884284-120897761:+	-0.14	-3.61	0.000323	Type 1 diabetes nephropathy	
BRCA	cis	1	rs7174	chr12:121017171	POP5	chr12:121016849-121019201:-	-0.15	-3.71	0.000215	Type 1 diabetes nephropathy	
BRCA	cis	1	rs7175720	chr15:75348962	SCAMP5	chr15:75287901-75313836:+	-0.27	-6.62	5.77E-11	Blood trace element (Zn levels)	
BRCA	cis	1	rs7178375	chr15:31215935	MTMR10	chr15:31231144-31283807:-	0.13	3.64	0.000287	Hypertriglyceridemia	
BRCA	cis	1	rs7178375	chr15:31215935	MTMR15	chr15:31196055-31235307:+	0.15	3.61	0.000324	Hypertriglyceridemia	
BRCA	cis	1	rs7178533	chr15:31215976	MTMR10	chr15:31231144-31283807:-	0.14	3.86	0.000121	Hypertriglyceridemia	
BRCA	cis	1	rs7178533	chr15:31215976	MTMR15	chr15:31196055-31235307:+	0.17	3.99	7.09E-5	Hypertriglyceridemia	
BRCA	cis	1	rs7186084	chr16:68816260	CENPT	chr16:67862064-67881361:-	0.08	3.42	0.000644	Colorectal cancer	
BRCA	cis	1	rs7186084	chr16:68816260	CIRH1A	chr16:69166499-69202936:+	0.13	4.27	2.13E-5	Colorectal cancer	
BRCA	cis	1	rs7186084	chr16:68816260	CYB5B	chr16:69458498-69500167:+	0.12	3.5	0.000488	Colorectal cancer	
BRCA	cis	1	rs7186084	chr16:68816260	DDX28	chr16:68055174-68057959:-	0.12	3.74	0.000191	Colorectal cancer	
BRCA	cis	1	rs7186084	chr16:68816260	EDC4	chr16:67906999-67920270:+	0.15	4.79	1.89E-6	Colorectal cancer	
BRCA	cis	1	rs7186084	chr16:68816260	LCAT	chr16:67973787-67978015:-	0.09	4.06	5.23E-5	Colorectal cancer	
BRCA	cis	1	rs7186084	chr16:68816260	NFATC3	chr16:68118654-68260837:+	0.13	4.04	5.67E-5	Colorectal cancer	
BRCA	cis	1	rs7186084	chr16:68816260	NOB1	chr16:69775775-69788829:-	0.11	3.46	0.000569	Colorectal cancer	
BRCA	cis	1	rs7186084	chr16:68816260	PRMT7	chr16:68344945-68391162:+	0.13	4.13	3.94E-5	Colorectal cancer	
BRCA	cis	1	rs7186084	chr16:68816260	VPS4A	chr16:69345287-69358945:+	0.12	4.53	6.49E-6	Colorectal cancer	
BRCA	cis	1	rs7186084	chr16:68816260	WWP2	chr16:69796274-69975643:+	0.14	3.9	0.000103	Colorectal cancer	
BRCA	cis	1	rs7187423	chr16:54090495	AKTIP	chr16:53525193-53537170:-	0.22	4.17	3.34E-5	Allergic rhinitis	
BRCA	cis	1	rs7187423	chr16:54090495	FTO	chr16:53737875-54148378:+	0.18	3.4	0.000708	Allergic rhinitis	
BRCA	cis	1	rs7187423	chr16:54090495	RBL2	chr16:53468351-53525559:+	0.14	3.42	0.000655	Allergic rhinitis	
BRCA	cis	1	rs7187423	chr16:54090495	RPGRIP1L	chr16:53633823-53737771:-	0.22	4.78	1.96E-6	Allergic rhinitis	
BRCA	cis	1	rs718834	chr9:114844799	KIAA0368	chr9:114122973-114247025:-	-0.15	-4.04	5.74E-5	Amyotrophic lateral sclerosis	
BRCA	cis	1	rs7189550	chr16:29911260	ALDOA	chr16:30064472-30081734:+	-0.11	-3.7	0.000227	Response to taxane treatment (placlitaxel)	
BRCA	cis	1	rs7189550	chr16:29911260	FAM57B	chr16:30035749-30042186:-	-0.1	-3.43	0.000627	Response to taxane treatment (placlitaxel)	
BRCA	cis	1	rs7189550	chr16:29911260	LOC440356	chr16:29875004-29879374:+	0.22	6.11	1.41E-9	Response to taxane treatment (placlitaxel)	
BRCA	cis	1	rs7189550	chr16:29911260	TBX6	chr16:30097117-30103208:-	-0.15	-4.52	6.8E-6	Response to taxane treatment (placlitaxel)	
BRCA	cis	1	rs7189750	chr16:29911416	ALDOA	chr16:30064472-30081734:+	0.11	3.79	0.000157	Response to taxane treatment (placlitaxel)	
BRCA	cis	1	rs7189750	chr16:29911416	LOC440356	chr16:29875004-29879374:+	-0.23	-6.25	5.9E-10	Response to taxane treatment (placlitaxel)	
BRCA	cis	1	rs7189750	chr16:29911416	TBX6	chr16:30097117-30103208:-	0.15	4.33	1.65E-5	Response to taxane treatment (placlitaxel)	
BRCA	cis	1	rs719394	chr6:52290988	EFHC1	chr6:52284994-52387892:+	0.16	4.19	3.03E-5	Atopic march	
BRCA	cis	1	rs719909	chr10:91345696	FLJ37201	chr10:91451057-91457685:-	-0.19	-4.24	2.41E-5	Metabolic traits	
BRCA	cis	1	rs7201519	chr16:29859977	LOC440356	chr16:29875004-29879374:+	-0.29	-5.93	4.03E-9	Multiple sclerosis	
BRCA	cis	1	rs720475	chr7:144074929	OR2A7	chr7:143955790-143974852:-	-0.41	-9.39	3.44E-20	Breast cancer	
BRCA	cis	1	rs7205409	chr16:642610	PIGQ	chr16:617032-634108:+	-0.09	-4.36	1.43E-5	Height	
BRCA	cis	1	rs7205409	chr16:642610	WFIKKN1	chr16:679239-684116:+	0.27	8.03	2.63E-15	Height	
BRCA	cis	1	rs7210738	chr17:45757598	C17orf57	chr17:45401142-45518675:+	-0.29	-10.04	9.74E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs7210738	chr17:45757598	TBKBP1	chr17:45772630-45789427:+	0.14	4.26	2.2E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs7212704	chr17:33898897	SLFN12L	chr17:33801926-33864880:-	0.08	4.78	2.0E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs7221109	chr17:38770286	SMARCE1	chr17:38783976-38804103:-	-0.14	-3.68	0.000242	Type 1 diabetes	
BRCA	cis	1	rs722782	chr8:516479	ERICH1	chr8:564749-681226:-	0.2	3.79	0.00016	Age-related macular degeneration (GA)	
BRCA	cis	1	rs722782	chr8:516479	FBXO25	chr8:356808-419873:+	0.27	5.02	6.1E-7	Age-related macular degeneration (GA)	
BRCA	cis	1	rs722782	chr8:516479	RPL23AP53	chr8:158347-182318:-	0.2	4.02	6.18E-5	Age-related macular degeneration (GA)	
BRCA	cis	1	rs722782	chr8:516479	ZNF596	chr8:182200-197332:+	0.19	3.83	0.000136	Age-related macular degeneration (GA)	
BRCA	cis	1	rs7228051	chr18:71788898	FBXO15	chr18:71740588-71815100:-	0.17	5.22	2.13E-7	Venous thromboembolism (SNP x SNP interaction)	
BRCA	cis	1	rs7238284	chr18:48373876	MRO	chr18:48321491-48351754:-	0.3	7.18	1.29E-12	Entorhinal cortical thickness	
BRCA	cis	1	rs7243921	chr18:77695237	PQLC1	chr18:77662420-77711653:-	-0.09	-3.5	0.000476	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
BRCA	cis	1	rs7246967	chr19:23056346	ZNF492	chr19:22817126-22850472:+	-0.21	-4.51	7.05E-6	Bronchopulmonary dysplasia	
BRCA	cis	1	rs7247513	chr19:12691185	ZNF490	chr19:12686920-12721623:-	0.13	3.58	0.000357	Bipolar disorder	
BRCA	cis	1	rs7250307	chr19:13800709	MRI1	chr19:13875337-13885095:+	-0.15	-3.76	0.000181	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs7250627	chr19:13803217	MRI1	chr19:13875337-13885095:+	-0.14	-3.69	0.000238	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs7251653	chr19:18608283	LRRC25	chr19:18501955-18508421:-	-0.14	-6.93	7.2E-12	Breast cancer	
BRCA	cis	1	rs7252707	chr19:18612257	LRRC25	chr19:18501955-18508421:-	-0.14	-7.14	1.78E-12	Breast cancer	
BRCA	cis	1	rs7252848	chr19:18612351	LRRC25	chr19:18501955-18508421:-	-0.13	-6.55	9.09E-11	Breast cancer	
BRCA	cis	1	rs725309	chr3:48418708	ATRIP	chr3:48488141-48507708:+	-0.1	-3.46	0.000556	Longevity	
BRCA	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.25	9.59	5.94E-21	Longevity	
BRCA	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.26	9.81	7.9E-22	Longevity	
BRCA	cis	1	rs7253917	chr19:10522176	DOCK6	chr19:11309973-11373157:-	0.11	3.44	0.0006	Gastritis;Multiple sclerosis	
BRCA	cis	1	rs7255436	chr19:8433196	ANGPTL4	chr19:8429011-8439257:+	0.14	4.38	1.31E-5	HDL cholesterol	
BRCA	cis	1	rs7255436	chr19:8433196	KIAA1543	chr19:7660788-7683194:+	0.1	3.38	0.000744	HDL cholesterol	
BRCA	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.47	13.58	7.38E-39	Schizophrenia	
BRCA	cis	1	rs7257127	chr19:23056699	ZNF492	chr19:22817126-22850472:+	-0.23	-5.3	1.39E-7	Bronchopulmonary dysplasia	
BRCA	cis	1	rs7258177	chr19:13803170	CC2D1A	chr19:14016956-14041693:+	-0.1	-3.42	0.000656	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs7258177	chr19:13803170	DCAF15	chr19:14063319-14072254:+	-0.1	-3.63	0.000297	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs7258177	chr19:13803170	MRI1	chr19:13875337-13885095:+	-0.15	-3.98	7.27E-5	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs7258465	chr19:18533642	LRRC25	chr19:18501955-18508421:-	-0.14	-6.65	4.66E-11	Breast cancer	
BRCA	cis	1	rs7258465	chr19:18533642	SSBP4	chr19:18530221-18545371:+	-0.1	-3.49	0.000512	Breast cancer	
BRCA	cis	1	rs725859	chr7:123424583	HYAL4	chr7:123485223-123517529:+	-0.28	-4.18	3.13E-5	Platelet count	
BRCA	cis	1	rs725860	chr7:123424709	HYAL4	chr7:123485223-123517529:+	0.28	4.09	4.62E-5	Platelet count	
BRCA	cis	1	rs725908	chr20:33968067	CPNE1	chr20:34213968-34262539:-	0.24	6.24	6.41E-10	Height	
BRCA	cis	1	rs725908	chr20:33968067	MMP24	chr20:33814539-33864804:+	0.12	3.45	0.000577	Height	
BRCA	cis	1	rs725908	chr20:33968067	UQCC	chr20:33890383-33999833:-	0.32	9.51	1.18E-20	Height	
BRCA	cis	1	rs7259376	chr19:22507705	ZNF98	chr19:22573899-22605148:-	-0.14	-3.72	0.00021	Telomere length	
BRCA	cis	1	rs7263203	chr20:33773375	PROCR	chr20:33758727-33765164:+	-0.24	-4.8	1.84E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7263253	chr20:33649376	MMP24	chr20:33814539-33864804:+	-0.23	-3.98	7.33E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7263253	chr20:33649376	PROCR	chr20:33758727-33765164:+	-0.24	-4.92	9.79E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7265317	chr20:33768523	PROCR	chr20:33758727-33765164:+	-0.23	-4.55	5.95E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7265697	chr20:55070664	C20orf43	chr20:55043647-55093942:+	0.15	4.08	4.74E-5	Refractive astigmatism	
BRCA	cis	1	rs72671805	chr4:106603014	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs72671808	chr4:106605720	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs72671809	chr4:106611537	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs72671811	chr4:106615603	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs72671815	chr4:106618219	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs72671824	chr4:106623223	INTS12	chr4:106603787-106629881:-	-0.28	-3.49	0.000502	Post bronchodilator FEV1	
BRCA	cis	1	rs72671828	chr4:106624800	INTS12	chr4:106603787-106629881:-	-0.28	-3.49	0.000502	Post bronchodilator FEV1	
BRCA	cis	1	rs72671835	chr4:106631356	INTS12	chr4:106603787-106629881:-	-0.3	-3.66	0.000265	Post bronchodilator FEV1	
BRCA	cis	1	rs72671836	chr4:106633045	INTS12	chr4:106603787-106629881:-	-0.3	-3.65	0.000271	Post bronchodilator FEV1	
BRCA	cis	1	rs72671837	chr4:106635902	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs72671840	chr4:106638697	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs72671849	chr4:106643818	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs72671853	chr4:106646886	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs72671854	chr4:106647023	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs72671856	chr4:106647366	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs72671869	chr4:106658658	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs72671871	chr4:106660324	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs72671874	chr4:106661970	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs72671878	chr4:106662692	INTS12	chr4:106603787-106629881:-	-0.29	-3.61	0.000319	Post bronchodilator FEV1	
BRCA	cis	1	rs72671880	chr4:106664424	INTS12	chr4:106603787-106629881:-	-0.3	-3.73	0.000201	Post bronchodilator FEV1	
BRCA	cis	1	rs72671885	chr4:106668546	INTS12	chr4:106603787-106629881:-	-0.3	-3.68	0.000242	Post bronchodilator FEV1	
BRCA	cis	1	rs72671886	chr4:106670589	INTS12	chr4:106603787-106629881:-	-0.3	-3.73	0.000204	Post bronchodilator FEV1	
BRCA	cis	1	rs72671892	chr4:106680363	INTS12	chr4:106603787-106629881:-	-0.31	-3.85	0.000125	Post bronchodilator FEV1	
BRCA	cis	1	rs72671895	chr4:106685633	INTS12	chr4:106603787-106629881:-	-0.31	-3.82	0.00014	Post bronchodilator FEV1	
BRCA	cis	1	rs72671896	chr4:106685825	INTS12	chr4:106603787-106629881:-	-0.31	-3.82	0.00014	Post bronchodilator FEV1	
BRCA	cis	1	rs72673803	chr4:106696756	INTS12	chr4:106603787-106629881:-	-0.31	-3.85	0.000125	Post bronchodilator FEV1	
BRCA	cis	1	rs72673811	chr4:106707297	INTS12	chr4:106603787-106629881:-	-0.3	-3.69	0.000237	Post bronchodilator FEV1	
BRCA	cis	1	rs72673812	chr4:106710454	INTS12	chr4:106603787-106629881:-	-0.31	-3.94	8.57E-5	Post bronchodilator FEV1	
BRCA	cis	1	rs72673817	chr4:106713490	INTS12	chr4:106603787-106629881:-	-0.31	-3.91	9.72E-5	Post bronchodilator FEV1	
BRCA	cis	1	rs72673824	chr4:106724464	INTS12	chr4:106603787-106629881:-	-0.28	-3.54	0.000425	Post bronchodilator FEV1	
BRCA	cis	1	rs72673828	chr4:106730342	INTS12	chr4:106603787-106629881:-	-0.3	-3.61	0.000322	Post bronchodilator FEV1	
BRCA	cis	1	rs72677306	chr4:106997678	TBCK	chr4:106967233-107237861:-	0.25	7.68	3.47E-14	Airflow obstruction	
BRCA	cis	1	rs72678650	chr4:122666000	EXOSC9	chr4:122722472-122738175:+	0.14	4.5	7.59E-6	Type 2 diabetes	
BRCA	cis	1	rs7267979	chr20:25298087	FAM182A	chr20:26035250-26067552:+	-0.2	-5.44	6.56E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7267979	chr20:25298087	FAM182B	chr20:25744102-25848786:-	0.23	5.91	4.48E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7268053	chr20:25328286	FAM182A	chr20:26035250-26067552:+	0.21	5.57	3.24E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7268053	chr20:25328286	FAM182B	chr20:25744102-25848786:-	-0.25	-6.42	2.05E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7268053	chr20:25328286	PYGB	chr20:25228706-25278647:+	0.13	3.52	0.000444	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7268447	chr20:33649593	MMP24	chr20:33814539-33864804:+	-0.22	-3.85	0.000127	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7268447	chr20:33649593	PROCR	chr20:33758727-33765164:+	-0.25	-5.04	5.35E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs72694750	chr1:146868586	CHD1L	chr1:146714291-146767441:+	-0.16	-3.67	0.000254	Protein quantitative trait loci	
BRCA	cis	1	rs72696952	chr1:152172694	FLG	chr1:152274651-152297679:-	0.45	10.58	5.94E-25	Atopic dermatitis	
BRCA	cis	1	rs72696952	chr1:152172694	HRNR	chr1:152184558-152196669:-	-0.18	-3.8	0.000155	Atopic dermatitis	
BRCA	cis	1	rs7270354	chr20:44607661	PLTP	chr20:44527397-44540786:-	0.16	4.06	5.16E-5	Abdominal aortic aneurysm	
BRCA	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.42	-7.97	4.17E-15	Abdominal aortic aneurysm	
BRCA	cis	1	rs7271729	chr20:33610992	MMP24	chr20:33814539-33864804:+	-0.22	-3.87	0.000116	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7271729	chr20:33610992	PROCR	chr20:33758727-33765164:+	-0.25	-5.08	4.48E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs72774845	chr16:15147954	C16orf63	chr16:15959577-15982447:-	0.14	3.82	0.000139	Metabolic traits;Glycerophospholipid levels	
BRCA	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.25	6.09	1.58E-9	Body mass index	
BRCA	cis	1	rs72792179	chr5:112785815	YTHDC2	chr5:112849410-112930979:+	0.14	4.08	4.74E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs72813408	chr2:63363242	C2orf86	chr2:63348537-63815851:-	-0.19	-4.61	4.45E-6	Subjective well-being	
BRCA	cis	1	rs72813411	chr2:63364225	C2orf86	chr2:63348537-63815851:-	-0.2	-4.77	2.09E-6	Subjective well-being	
BRCA	cis	1	rs72813412	chr2:63365500	C2orf86	chr2:63348537-63815851:-	-0.21	-5.07	4.76E-7	Subjective well-being	
BRCA	cis	1	rs72813418	chr2:63385242	C2orf86	chr2:63348537-63815851:-	-0.19	-4.59	4.92E-6	Subjective well-being	
BRCA	cis	1	rs72818709	chr10:91371446	FLJ37201	chr10:91451057-91457685:-	-0.19	-4.05	5.44E-5	Metabolic traits	
BRCA	cis	1	rs72821791	chr10:63454108	C10orf107	chr10:63422719-63526089:+	-0.17	-3.7	0.000227	Blood pressure	
BRCA	cis	1	rs72825704	chr2:99239164	UNC50	chr2:99225042-99234975:+	-0.21	-4.42	1.1E-5	Bipolar disorder	
BRCA	cis	1	rs72825710	chr2:99239497	UNC50	chr2:99225042-99234975:+	-0.21	-4.42	1.1E-5	Bipolar disorder	
BRCA	cis	1	rs72825718	chr2:99247152	UNC50	chr2:99225042-99234975:+	-0.22	-4.46	9.14E-6	Bipolar disorder	
BRCA	cis	1	rs72825719	chr2:99247465	UNC50	chr2:99225042-99234975:+	-0.22	-4.43	1.03E-5	Bipolar disorder	
BRCA	cis	1	rs72825720	chr2:99247508	UNC50	chr2:99225042-99234975:+	-0.2	-3.88	0.000112	Bipolar disorder	
BRCA	cis	1	rs72825725	chr2:99251259	UNC50	chr2:99225042-99234975:+	-0.23	-4.77	2.13E-6	Bipolar disorder	
BRCA	cis	1	rs72825727	chr2:99252750	UNC50	chr2:99225042-99234975:+	-0.23	-4.78	1.95E-6	Bipolar disorder	
BRCA	cis	1	rs72825732	chr2:99259778	UNC50	chr2:99225042-99234975:+	-0.23	-4.78	1.98E-6	Bipolar disorder	
BRCA	cis	1	rs72825746	chr17:30364610	C17orf79	chr17:30178885-30186326:-	-0.19	-3.92	9.34E-5	Height	
BRCA	cis	1	rs72829170	chr10:64940289	NRBF2	chr10:64893007-64914785:+	0.13	3.38	0.000753	Arthritis (juvenile idiopathic)	
BRCA	cis	1	rs72840063	chr2:85550396	CAPG	chr2:85621871-85641170:-	-0.12	-3.57	0.000368	Ear protrusion	
BRCA	cis	1	rs72840063	chr2:85550396	SH2D6	chr2:85646054-85664150:+	-0.15	-3.83	0.000136	Ear protrusion	
BRCA	cis	1	rs72840063	chr2:85550396	TGOLN2	chr2:85545147-85555374:-	-0.21	-7.3	5.64E-13	Ear protrusion	
BRCA	cis	1	rs72843784	chr6:26498758	BTN3A2	chr6:26365398-26378546:+	-0.85	-13.55	1.03E-38	Schizophrenia	
BRCA	cis	1	rs72845397	chr11:6950903	ZNF215	chr11:6947654-7005861:+	-0.31	-6.68	3.79E-11	Response to cytadine analogues (cytosine arabinoside)	
BRCA	cis	1	rs72871370	chr11:16440171	C11orf58	chr11:16760148-16779901:+	0.21	3.68	0.000242	Obesity and osteoporosis	
BRCA	cis	1	rs72871390	chr11:16462626	C11orf58	chr11:16760148-16779901:+	0.21	3.64	0.000286	Obesity and osteoporosis	
BRCA	cis	1	rs72871402	chr11:16472994	C11orf58	chr11:16760148-16779901:+	0.21	3.64	0.000286	Obesity and osteoporosis	
BRCA	cis	1	rs72871849	chr11:17654386	PIK3C2A	chr11:17099277-17229530:-	0.12	3.59	0.00034	Night sleep phenotypes	
BRCA	cis	1	rs72873303	chr11:16473612	C11orf58	chr11:16760148-16779901:+	0.21	3.64	0.000286	Obesity and osteoporosis	
BRCA	cis	1	rs7291867	chr22:38062112	LGALS2	chr22:37966254-37976024:-	0.09	3.59	0.000346	Fat distribution (HIV)	
BRCA	cis	1	rs72922733	chr11:65520746	CTSW	chr11:65647284-65651212:+	-0.21	-7.23	9.29E-13	Systemic lupus erythematosus	
BRCA	cis	1	rs72922733	chr11:65520746	SNX32	chr11:65601410-65621170:+	0.23	5.34	1.12E-7	Systemic lupus erythematosus	
BRCA	cis	1	rs72934537	chr2:203969504	ALS2CR8	chr2:203776978-203851060:+	-0.13	-3.76	0.00018	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72934545	chr2:203975958	ALS2CR8	chr2:203776978-203851060:+	-0.13	-3.62	0.000309	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72934554	chr2:203987806	ALS2CR8	chr2:203776978-203851060:+	-0.13	-3.62	0.000309	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72934563	chr2:203995405	ALS2CR8	chr2:203776978-203851060:+	-0.13	-3.62	0.000303	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72934573	chr2:204005072	ALS2CR8	chr2:203776978-203851060:+	-0.13	-3.61	0.000323	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72934714	chr2:203711581	ALS2CR8	chr2:203776978-203851060:+	-0.12	-3.41	0.000664	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72934715	chr2:203713280	ALS2CR8	chr2:203776978-203851060:+	-0.12	-3.41	0.000664	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.55	-9.04	7.01E-19	Rheumatoid arthritis	
BRCA	cis	1	rs72936304	chr2:204036357	ALS2CR8	chr2:203776978-203851060:+	-0.14	-3.83	0.000138	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72936309	chr2:204040296	ALS2CR8	chr2:203776978-203851060:+	-0.14	-3.83	0.000138	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72936323	chr2:204050474	ALS2CR8	chr2:203776978-203851060:+	-0.14	-3.78	0.000163	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72936326	chr2:204054141	ALS2CR8	chr2:203776978-203851060:+	-0.13	-3.61	0.000324	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72936332	chr2:204056678	ALS2CR8	chr2:203776978-203851060:+	-0.13	-3.61	0.000324	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72936348	chr2:204064839	ALS2CR8	chr2:203776978-203851060:+	-0.13	-3.61	0.000324	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs72936353	chr2:204070956	ALS2CR8	chr2:203776978-203851060:+	-0.14	-3.75	0.000187	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
BRCA	cis	1	rs729376	chr6:33704823	IP6K3	chr6:33689443-33714762:-	0.24	4.26	2.21E-5	Obesity (extreme)	
BRCA	cis	1	rs7295013	chr12:62689163	FAM19A2	chr12:62102043-62653925:-	0.16	3.54	0.000421	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs72952761	chr6:118866758	C6orf204	chr6:118786239-119031238:-	-0.11	-3.53	0.000437	Renal cell carcinoma	
BRCA	cis	1	rs72957112	chr2:207695453	MDH1B	chr2:207598943-207630050:-	-0.22	-4.97	7.91E-7	Height	
BRCA	cis	1	rs72969531	chr6:118729974	C6orf204	chr6:118786239-119031238:-	-0.11	-3.6	0.000335	Renal cell carcinoma	
BRCA	cis	1	rs7298108	chr12:9376168	LOC642846	chr12:9436253-9466684:+	-0.16	-5.45	6.12E-8	Non-alcoholic fatty liver disease histology (AST)	
BRCA	cis	1	rs7298827	chr12:62659710	FAM19A2	chr12:62102043-62653925:-	0.17	3.78	0.000162	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs73002111	chr2:242277833	ANO7	chr2:242127924-242164791:+	0.21	3.38	0.000762	Prostate cancer	
BRCA	cis	1	rs73004354	chr2:242356239	ANO7	chr2:242127924-242164791:+	0.23	3.72	0.000209	Prostate cancer	
BRCA	cis	1	rs73004382	chr2:242382192	ANO7	chr2:242127924-242164791:+	0.23	3.75	0.000186	Prostate cancer	
BRCA	cis	1	rs73008453	chr6:163013384	PACRG	chr6:163148164-163736523:+	0.24	4.47	8.7E-6	Body mass index	
BRCA	cis	1	rs7300928	chr12:62685401	FAM19A2	chr12:62102043-62653925:-	0.16	3.57	0.000377	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs73016459	chr6:163066323	PACRG	chr6:163148164-163736523:+	0.26	4.61	4.57E-6	Body mass index	
BRCA	cis	1	rs73018016	chr19:9997361	OLFM2	chr19:9964395-10047070:-	-0.17	-5.01	6.5E-7	Menarche (age at onset)	
BRCA	cis	1	rs73018141	chr2:242221570	ANO7	chr2:242127924-242164791:+	0.23	3.75	0.000188	Prostate cancer	
BRCA	cis	1	rs730287	chr10:91376346	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.74	0.000194	Metabolic traits	
BRCA	cis	1	rs73035012	chr6:162997279	PACRG	chr6:163148164-163736523:+	0.25	4.6	4.73E-6	Body mass index	
BRCA	cis	1	rs73035021	chr6:163000716	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.06E-6	Body mass index	
BRCA	cis	1	rs73035023	chr6:163000927	PACRG	chr6:163148164-163736523:+	0.25	4.71	2.85E-6	Body mass index	
BRCA	cis	1	rs73035025	chr6:163000988	PACRG	chr6:163148164-163736523:+	0.25	4.59	5.06E-6	Body mass index	
BRCA	cis	1	rs73070422	chr4:1016645	FGFRL1	chr4:1004940-1020685:+	-0.2	-3.7	0.000223	Bone mineral density	
BRCA	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.27	-10.18	2.77E-23	Longevity	
BRCA	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.52	14.36	7.34E-43	Diastolic blood pressure	
BRCA	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.52	14.36	7.34E-43	Diastolic blood pressure	
BRCA	cis	1	rs73088137	chr3:49448423	AMT	chr3:49454212-49460012:-	-0.15	-4.78	1.98E-6	Menarche (age at onset)	
BRCA	cis	1	rs73088137	chr3:49448423	NCKIPSD	chr3:48711280-48723334:-	-0.16	-3.96	7.93E-5	Menarche (age at onset)	
BRCA	cis	1	rs73088137	chr3:49448423	P4HTM	chr3:49027341-49044579:+	-0.11	-4.47	8.55E-6	Menarche (age at onset)	
BRCA	cis	1	rs73088137	chr3:49448423	TREX1	chr3:48501186-48509043:+	0.13	4.13	3.86E-5	Menarche (age at onset)	
BRCA	cis	1	rs73088137	chr3:49448423	WDR6	chr3:49044637-49053386:+	0.15	4.18	3.21E-5	Menarche (age at onset)	
BRCA	cis	1	rs7309209	chr12:62767728	FAM19A2	chr12:62102043-62653925:-	0.18	3.93	9.14E-5	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs73098845	chr4:17940718	NCAPG	chr4:17812525-17846485:+	0.09	4.04	5.62E-5	Height	
BRCA	cis	1	rs73098848	chr4:17941027	NCAPG	chr4:17812525-17846485:+	0.08	3.94	8.82E-5	Height	
BRCA	cis	1	rs7309927	chr12:1000185	RAD52	chr12:1021255-1099219:-	-0.31	-6.61	6.23E-11	Colorectal cancer	
BRCA	cis	1	rs73100947	chr4:18021307	NCAPG	chr4:17812525-17846485:+	0.08	3.6	0.000332	Height	
BRCA	cis	1	rs73116394	chr2:242367915	SEPT2	chr2:242254723-242293439:+	0.38	7.13	1.91E-12	Chronic lymphocytic leukemia	
BRCA	cis	1	rs73116396	chr2:242368693	SEPT2	chr2:242254723-242293439:+	0.38	7.13	1.91E-12	Chronic lymphocytic leukemia	
BRCA	cis	1	rs7312210	chr12:122629864	LRRC43	chr12:122652266-122688017:+	0.18	4.98	7.25E-7	Urate levels	
BRCA	cis	1	rs7313402	chr12:108602970	ISCU	chr12:108956294-108963158:+	-0.1	-3.52	0.000447	Temperament (bipolar disorder)	
BRCA	cis	1	rs73136889	chr12:62794598	FAM19A2	chr12:62102043-62653925:-	0.17	3.75	0.000185	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs73140069	chr7:75986790	UPK3B	chr7:76139745-76157197:+	-0.24	-6.3	4.43E-10	Multiple sclerosis	
BRCA	cis	1	rs73142121	chr7:65311206	CCT6P1	chr7:65216092-65228661:+	0.32	6.9	9.12E-12	Diabetic kidney disease	
BRCA	cis	1	rs73142121	chr7:65311206	ZNF117	chr7:64434830-64467121:-	-0.27	-5.04	5.6E-7	Diabetic kidney disease	
BRCA	cis	1	rs73142122	chr7:65311298	CCT6P1	chr7:65216092-65228661:+	0.33	7.02	3.88E-12	Diabetic kidney disease	
BRCA	cis	1	rs73142122	chr7:65311298	LOC493754	chr7:65993446-66057363:-	0.2	3.38	0.00075	Diabetic kidney disease	
BRCA	cis	1	rs73142122	chr7:65311298	ZNF117	chr7:64434830-64467121:-	-0.27	-4.92	9.85E-7	Diabetic kidney disease	
BRCA	cis	1	rs73142162	chr7:65374296	CCT6P1	chr7:65216092-65228661:+	0.34	7.27	7.05E-13	Diabetic kidney disease	
BRCA	cis	1	rs73142162	chr7:65374296	LOC493754	chr7:65993446-66057363:-	0.2	3.4	0.000699	Diabetic kidney disease	
BRCA	cis	1	rs73142162	chr7:65374296	ZNF117	chr7:64434830-64467121:-	-0.28	-4.98	7.41E-7	Diabetic kidney disease	
BRCA	cis	1	rs73142166	chr7:65375832	CCT6P1	chr7:65216092-65228661:+	0.34	7.32	4.92E-13	Diabetic kidney disease	
BRCA	cis	1	rs73142166	chr7:65375832	LOC493754	chr7:65993446-66057363:-	0.2	3.42	0.000642	Diabetic kidney disease	
BRCA	cis	1	rs73142166	chr7:65375832	ZNF117	chr7:64434830-64467121:-	-0.28	-4.98	7.23E-7	Diabetic kidney disease	
BRCA	cis	1	rs73150014	chr7:65450919	CCT6P1	chr7:65216092-65228661:+	0.35	7.55	9.65E-14	Diabetic kidney disease	
BRCA	cis	1	rs73150014	chr7:65450919	LOC493754	chr7:65993446-66057363:-	0.21	3.55	0.000401	Diabetic kidney disease	
BRCA	cis	1	rs73150014	chr7:65450919	ZNF117	chr7:64434830-64467121:-	-0.26	-4.67	3.34E-6	Diabetic kidney disease	
BRCA	cis	1	rs73165541	chr7:150538980	TMEM176B	chr7:150488378-150498448:-	-0.15	-3.48	0.000524	Blood metabolite levels;Blood metabolite ratios	
BRCA	cis	1	rs73186030	chr3:122013465	CSTA	chr3:122044011-122060813:+	-0.23	-4.4	1.2E-5	Serum parathyroid hormone levels	
BRCA	cis	1	rs73186044	chr3:122028476	CSTA	chr3:122044011-122060813:+	-0.19	-3.86	0.000122	Serum parathyroid hormone levels	
BRCA	cis	1	rs73189896	chr3:119292570	CD80	chr3:119243142-119278481:-	0.12	3.9	0.000102	Vitiligo	
BRCA	cis	1	rs73189897	chr3:119292683	CD80	chr3:119243142-119278481:-	0.12	4	6.88E-5	Vitiligo	
BRCA	cis	1	rs731945	chr19:18567039	LRRC25	chr19:18501955-18508421:-	0.1	4.41	1.16E-5	Self-reported allergy	
BRCA	cis	1	rs73198787	chr3:126787210	CHST13	chr3:126243176-126262133:+	0.15	3.47	0.000535	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs732172	chr16:31050033	HSD3B7	chr16:30996519-31000473:+	0.2	6.1	1.5E-9	Response to metformin (IC50)	
BRCA	cis	1	rs732172	chr16:31050033	MYST1	chr16:31128985-31142713:+	0.19	7	4.46E-12	Response to metformin (IC50)	
BRCA	cis	1	rs732172	chr16:31050033	ZNF689	chr16:30614701-30621682:-	0.12	3.88	0.000113	Response to metformin (IC50)	
BRCA	cis	1	rs732173	chr16:31050023	HSD3B7	chr16:30996519-31000473:+	0.2	6.09	1.59E-9	Response to metformin (IC50)	
BRCA	cis	1	rs732173	chr16:31050023	MYST1	chr16:31128985-31142713:+	0.18	6.67	4.19E-11	Response to metformin (IC50)	
BRCA	cis	1	rs732173	chr16:31050023	PRSS53	chr16:31094747-31106276:-	-0.09	-3.41	0.000674	Response to metformin (IC50)	
BRCA	cis	1	rs732173	chr16:31050023	ZNF689	chr16:30614701-30621682:-	0.13	3.93	8.9E-5	Response to metformin (IC50)	
BRCA	cis	1	rs73217796	chr12:122611600	LRRC43	chr12:122652266-122688017:+	-0.16	-4.51	7.13E-6	Urate levels	
BRCA	cis	1	rs73224414	chr4:10297679	WDR1	chr4:10075964-10118573:-	-0.16	-3.47	0.000542	Schizophrenia (age at onset)	
BRCA	cis	1	rs7323755	chr13:45900267	GTF2F2	chr13:45694631-45858237:+	0.28	3.86	0.00012	Myopia (pathological)	
BRCA	cis	1	rs73242910	chr6:170114670	WDR27	chr6:169857307-170102159:-	-0.12	-3.56	0.000394	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs73242927	chr6:170129573	WDR27	chr6:169857307-170102159:-	-0.12	-3.46	0.000552	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs7324410	chr13:24437465	PCOTH	chr13:24463028-24466241:+	-0.29	-3.59	0.000344	3-hydroxypropylmercapturic acid levels in smokers	
BRCA	cis	1	rs7324557	chr13:24296862	PCOTH	chr13:24463028-24466241:+	0.21	5.66	1.99E-8	Visceral adipose tissue adjusted for BMI	
BRCA	cis	1	rs73268512	chr14:66088905	LOC645431	chr14:65877313-65879335:-	-0.29	-6.2	8.06E-10	Ischemic stroke	
BRCA	cis	1	rs73268521	chr14:66093243	LOC645431	chr14:65877313-65879335:-	-0.32	-6.73	2.68E-11	Ischemic stroke	
BRCA	cis	1	rs73276444	chr8:96039247	C8orf38	chr8:95908040-96088396:+	-0.18	-4.39	1.26E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs73286169	chr14:66078448	LOC645431	chr14:65877313-65879335:-	-0.32	-6.71	3.16E-11	Ischemic stroke	
BRCA	cis	1	rs73286173	chr14:66079540	LOC645431	chr14:65877313-65879335:-	-0.29	-6.2	8.06E-10	Ischemic stroke	
BRCA	cis	1	rs73301712	chr14:59898245	C14orf149	chr14:59939406-59951126:-	-0.33	-5.76	1.1E-8	Schizophrenia	
BRCA	cis	1	rs73301712	chr14:59898245	JKAMP	chr14:59951161-59972080:+	0.21	4.39	1.24E-5	Schizophrenia	
BRCA	cis	1	rs73301725	chr14:59902159	C14orf149	chr14:59939406-59951126:-	-0.33	-5.7	1.52E-8	Schizophrenia	
BRCA	cis	1	rs73301725	chr14:59902159	JKAMP	chr14:59951161-59972080:+	0.22	4.5	7.38E-6	Schizophrenia	
BRCA	cis	1	rs733115	chr10:96619086	C10orf129	chr10:96953957-96988685:+	0.25	4.39	1.25E-5	Blood metabolite levels	
BRCA	cis	1	rs73318135	chr20:23618571	CST1	chr20:23728191-23731574:-	0.23	4.92	1.03E-6	Chronic kidney disease	
BRCA	cis	1	rs73321563	chr12:62756049	FAM19A2	chr12:62102043-62653925:-	0.18	3.86	0.000119	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs7332189	chr13:36755610	SOHLH2	chr13:36742347-36871992:-	-0.18	-4.99	6.94E-7	Glucose homeostasis traits	
BRCA	cis	1	rs733283	chr10:103996576	C10orf32	chr10:104613967-104624718:+	-0.09	-3.38	0.000764	QT interval	
BRCA	cis	1	rs7332932	chr13:36755636	SOHLH2	chr13:36742347-36871992:-	-0.18	-4.99	6.94E-7	Glucose homeostasis traits	
BRCA	cis	1	rs733318	chr2:190724141	ORMDL1	chr2:190634994-190649097:-	0.22	3.65	0.000274	Subcutaneous adipose tissue	
BRCA	cis	1	rs73344830	chr10:103816828	BTRC	chr10:103113825-103317068:+	0.12	4.23	2.56E-5	Educational attainment (years of education)	
BRCA	cis	1	rs73348070	chr5:127893533	FBN2	chr5:127593602-127873916:-	0.28	5.2	2.33E-7	Multiple system atrophy	
BRCA	cis	1	rs73395547	chr7:98922746	CYP3A5	chr7:99245818-99332821:-	0.39	5.99	2.85E-9	Blood metabolite levels	
BRCA	cis	1	rs73395557	chr7:98934424	CYP3A5	chr7:99245818-99332821:-	0.39	5.89	5.3E-9	Blood metabolite levels	
BRCA	cis	1	rs7340989	chr4:107148720	TBCK	chr4:106967233-107237861:-	0.23	7.19	1.25E-12	Airflow obstruction	
BRCA	cis	1	rs73412140	chr6:33757014	C6orf125	chr6:33662057-33679504:-	0.11	3.41	0.000677	Body mass index	
BRCA	cis	1	rs73412140	chr6:33757014	LEMD2	chr6:33738991-33756906:-	0.18	5.56	3.41E-8	Body mass index	
BRCA	cis	1	rs7342306	chr12:6291093	VWF	chr12:6058040-6233836:-	-0.07	-3.41	0.000664	Platelet count	
BRCA	cis	1	rs7343481	chr20:25300113	FAM182A	chr20:26035250-26067552:+	0.21	5.49	4.93E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7343481	chr20:25300113	FAM182B	chr20:25744102-25848786:-	-0.23	-5.91	4.55E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7343481	chr20:25300113	PYGB	chr20:25228706-25278647:+	0.13	3.42	0.00066	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs73436668	chr11:18443093	LDHC	chr11:18433853-18472792:+	-0.29	-5.21	2.32E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs73440614	chr11:18466700	LDHC	chr11:18433853-18472792:+	-0.3	-5.29	1.51E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs73440615	chr11:18467283	LDHC	chr11:18433853-18472792:+	-0.23	-4.2	2.93E-5	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs73440625	chr11:18470800	LDHC	chr11:18433853-18472792:+	-0.3	-5.29	1.49E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs73452567	chr7:142816043	TMEM139	chr7:142982044-142985140:+	-0.22	-3.51	0.000459	Dermatomyositis	
BRCA	cis	1	rs734559	chr18:72179579	CNDP2	chr18:72163597-72188356:+	0.22	4.52	6.93E-6	Refractive error	
BRCA	cis	1	rs734559	chr18:72179579	FAM69C	chr18:72102964-72124503:-	0.16	3.43	0.000626	Refractive error	
BRCA	cis	1	rs73470506	chr11:57008246	PRG2	chr11:57151267-57191532:-	-0.22	-3.69	0.000237	Low high density lipoprotein cholesterol levels	
BRCA	cis	1	rs734801	chr20:23612791	CST1	chr20:23728191-23731574:-	0.22	4.78	1.98E-6	Chronic kidney disease	
BRCA	cis	1	rs73509026	chr19:12059467	ZNF763	chr19:12035900-12091196:+	-0.39	-6.28	4.85E-10	Multiple sclerosis	
BRCA	cis	1	rs735403	chr4:103553543	MANBA	chr4:103552644-103682151:-	-0.21	-5.5	4.86E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs735404	chr4:103553665	MANBA	chr4:103552644-103682151:-	0.2	5.24	1.92E-7	Primary biliary cirrhosis	
BRCA	cis	1	rs735405	chr4:103553916	MANBA	chr4:103552644-103682151:-	0.21	5.45	6.38E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs7355073	chr1:110129740	AMIGO1	chr1:110049447-110052336:-	0.19	4.84	1.48E-6	Major depressive disorder	
BRCA	cis	1	rs7355157	chr1:110129835	AMIGO1	chr1:110049447-110052336:-	0.17	4.07	5.01E-5	Major depressive disorder	
BRCA	cis	1	rs7355157	chr1:110129835	SYPL2	chr1:110009100-110024763:+	-0.15	-3.7	0.000224	Major depressive disorder	
BRCA	cis	1	rs735531	chr20:33947730	CPNE1	chr20:34213968-34262539:-	0.24	6.48	1.42E-10	Height	
BRCA	cis	1	rs735531	chr20:33947730	ERGIC3	chr20:34129778-34145404:+	0.12	3.46	0.000568	Height	
BRCA	cis	1	rs735531	chr20:33947730	MMP24	chr20:33814539-33864804:+	0.15	4.35	1.49E-5	Height	
BRCA	cis	1	rs735531	chr20:33947730	UQCC	chr20:33890383-33999833:-	0.33	10.03	1.08E-22	Height	
BRCA	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.42	13.92	1.29E-40	Height	
BRCA	cis	1	rs7356093	chr3:134238753	CEP63	chr3:134204575-134293852:+	0.13	3.64	0.000283	Height	
BRCA	cis	1	rs7356947	chr6:118767920	C6orf204	chr6:118786239-119031238:-	-0.11	-3.6	0.000334	Renal cell carcinoma	
BRCA	cis	1	rs73606110	chr20:1759957	EBF4	chr20:2673524-2740753:+	0.17	3.44	0.000607	Non-obstructive azoospermia	
BRCA	cis	1	rs736344	chr12:110001195	MMAB	chr12:109991523-110011358:-	-0.12	-3.78	0.000163	HDL cholesterol	
BRCA	cis	1	rs736344	chr12:110001195	MYO1H	chr12:109826524-109886176:+	0.27	8.03	2.57E-15	HDL cholesterol	
BRCA	cis	1	rs737008	chr16:11374866	C16orf75	chr16:11343506-11445617:+	0.22	7.42	2.47E-13	Obesity-related traits	
BRCA	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.41	13.77	7.68E-40	Height	
BRCA	cis	1	rs7371896	chr3:134249769	CEP63	chr3:134204575-134293852:+	0.15	3.99	7.02E-5	Height	
BRCA	cis	1	rs7371	chr1:110135308	AMIGO1	chr1:110049447-110052336:-	0.18	4.09	4.55E-5	Major depressive disorder	
BRCA	cis	1	rs7371	chr1:110135308	SYPL2	chr1:110009100-110024763:+	-0.15	-3.71	0.000214	Major depressive disorder	
BRCA	cis	1	rs7372094	chr3:46346271	FYCO1	chr3:45959396-46037307:-	-0.1	-3.54	0.00041	Celiac disease	
BRCA	cis	1	rs73725075	chr7:142823479	TMEM139	chr7:142982044-142985140:+	-0.21	-3.49	0.000506	Dermatomyositis	
BRCA	cis	1	rs7373805	chr3:38455439	LOC100128640	chr3:38492524-38496311:-	0.13	3.5	0.000485	Electrocardiographic conduction measures	
BRCA	cis	1	rs7373805	chr3:38455439	XYLB	chr3:38388251-38456467:+	0.21	6.11	1.37E-9	Electrocardiographic conduction measures	
BRCA	cis	1	rs7373816	chr3:38490443	XYLB	chr3:38388251-38456467:+	0.18	5.41	7.79E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs7373998	chr3:128008223	RUVBL1	chr3:127783627-127872757:-	-0.14	-3.41	0.000668	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.42	13.99	6.23E-41	Height	
BRCA	cis	1	rs7374158	chr3:134270156	CEP63	chr3:134204575-134293852:+	0.14	3.92	9.49E-5	Height	
BRCA	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.42	13.92	1.29E-40	Height	
BRCA	cis	1	rs7374325	chr3:134275601	CEP63	chr3:134204575-134293852:+	0.13	3.64	0.000283	Height	
BRCA	cis	1	rs7374654	chr3:46345787	FYCO1	chr3:45959396-46037307:-	-0.11	-3.57	0.000367	Celiac disease	
BRCA	cis	1	rs7374952	chr3:128001367	RUVBL1	chr3:127783627-127872757:-	0.14	3.45	0.000593	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs7383628	chr6:25607876	HIST1H2BC	chr6:26114633-26124154:-	0.13	3.4	0.000695	Uric acid levels	
BRCA	cis	1	rs7383628	chr6:25607876	SCGN	chr6:25652429-25702006:+	0.2	5.51	4.57E-8	Uric acid levels	
BRCA	cis	1	rs73844281	chr4:122664688	EXOSC9	chr4:122722472-122738175:+	0.13	4.14	3.72E-5	Type 2 diabetes	
BRCA	cis	1	rs738722	chr22:29130012	CCDC117	chr22:29168662-29185282:+	0.12	3.44	0.000611	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs738722	chr22:29130012	CHEK2	chr22:29083731-29137822:-	0.11	3.59	0.000344	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs738722	chr22:29130012	HSCB	chr22:29138043-29153488:+	0.13	3.75	0.000185	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs738722	chr22:29130012	LOC284900	chr22:28315364-28404267:+	0.13	3.53	0.000439	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs738722	chr22:29130012	XBP1	chr22:29190549-29196560:-	0.09	3.51	0.000467	Esophageal cancer and gastric cancer	
BRCA	cis	1	rs739139	chr22:38067011	LGALS2	chr22:37966254-37976024:-	0.09	3.82	0.000141	Fat distribution (HIV)	
BRCA	cis	1	rs739310	chr22:27051299	HPS4	chr22:26847447-26879820:-	-0.16	-3.99	7.06E-5	Obesity-related traits	
BRCA	cis	1	rs739310	chr22:27051299	TFIP11	chr22:26887894-26908437:-	-0.18	-4.36	1.44E-5	Obesity-related traits	
BRCA	cis	1	rs73943909	chr2:86143378	POLR1A	chr2:86253453-86333278:-	-0.23	-3.88	0.000111	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs73945530	chr2:86099368	POLR1A	chr2:86253453-86333278:-	-0.22	-3.78	0.000164	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs73945535	chr2:86124873	POLR1A	chr2:86253453-86333278:-	-0.21	-3.63	0.000296	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs73947314	chr2:86273116	MRPL35	chr2:86426556-86440476:+	0.29	3.41	0.000666	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs73947314	chr2:86273116	POLR1A	chr2:86253453-86333278:-	-0.25	-3.92	9.23E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs739496	chr12:111887659	C12orf47	chr12:112277573-112280706:-	0.14	4.12	4.07E-5	Platelet count	
BRCA	cis	1	rs73958618	chr2:136500475	DARS	chr2:136664254-136743222:-	0.16	4.18	3.18E-5	Corneal structure	
BRCA	cis	1	rs73958618	chr2:136500475	LCT	chr2:136545415-136594750:-	-0.17	-4.35	1.49E-5	Corneal structure	
BRCA	cis	1	rs74000379	chr2:242034103	MTERFD2	chr2:242034545-242041747:-	0.26	4.1	4.42E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
BRCA	cis	1	rs740122	chr7:28166442	JAZF1	chr7:27870196-28220437:-	0.15	5.07	4.72E-7	Rheumatoid arthritis	
BRCA	cis	1	rs740320	chr11:17658520	PIK3C2A	chr11:17099277-17229530:-	0.13	4.26	2.25E-5	Night sleep phenotypes	
BRCA	cis	1	rs740320	chr11:17658520	RPS13	chr11:17095940-17099220:-	0.13	3.46	0.000564	Night sleep phenotypes	
BRCA	cis	1	rs740320	chr11:17658520	UEVLD	chr11:18553245-18610281:-	0.1	3.58	0.000357	Night sleep phenotypes	
BRCA	cis	1	rs74150870	chr10:96406166	C10orf129	chr10:96953957-96988685:+	0.27	4.91	1.06E-6	Blood metabolite levels	
BRCA	cis	1	rs74152357	chr10:96508039	C10orf129	chr10:96953957-96988685:+	0.23	4.27	2.09E-5	Blood metabolite levels	
BRCA	cis	1	rs74152360	chr10:96512547	C10orf129	chr10:96953957-96988685:+	0.23	4.27	2.09E-5	Blood metabolite levels	
BRCA	cis	1	rs74154119	chr10:96632871	C10orf129	chr10:96953957-96988685:+	0.23	4.27	2.12E-5	Blood metabolite levels	
BRCA	cis	1	rs7419837	chr2:70146625	ANXA4	chr2:69969127-70053594:+	-0.14	-3.95	8.44E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs7419837	chr2:70146625	FAM136A	chr2:70523109-70529220:-	-0.09	-3.43	0.000624	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs74210981	chr10:102287520	SEC31B	chr10:102246403-102289636:-	-0.3	-10.2	2.35E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs742132	chr6:25607571	SCGN	chr6:25652429-25702006:+	0.2	5.49	5.14E-8	Uric acid levels	
BRCA	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.65	-12.53	1.05E-33	Plasma clusterin levels	
BRCA	cis	1	rs742614	chr20:32482632	BPIL1	chr20:31595407-31611514:+	0.12	3.75	0.000186	Stearic acid (18:0) plasma levels	
BRCA	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.19	6.77E-37	Height	
BRCA	cis	1	rs7426847	chr3:134267519	CEP63	chr3:134204575-134293852:+	-0.14	-3.72	0.000212	Height	
BRCA	cis	1	rs7427165	chr3:121364624	IQCB1	chr3:121488610-121553926:-	0.26	6.83	1.47E-11	Cognitive performance	
BRCA	cis	1	rs7427165	chr3:121364624	SLC15A2	chr3:121613171-121663034:+	-0.14	-4.17	3.35E-5	Cognitive performance	
BRCA	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.42	13.92	1.29E-40	Height	
BRCA	cis	1	rs7427492	chr3:134261654	CEP63	chr3:134204575-134293852:+	0.13	3.64	0.000283	Height	
BRCA	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.42	13.99	6.23E-41	Height	
BRCA	cis	1	rs7428326	chr3:134251184	CEP63	chr3:134204575-134293852:+	0.14	3.92	9.49E-5	Height	
BRCA	cis	1	rs7428	chr2:85545490	SH2D6	chr2:85646054-85664150:+	0.15	4.1	4.46E-5	Ear protrusion	
BRCA	cis	1	rs7428	chr2:85545490	TGOLN2	chr2:85545147-85555374:-	0.21	7.58	7.75E-14	Ear protrusion	
BRCA	cis	1	rs74298052	chr6:159405298	RSPH3	chr6:159398268-159421198:-	0.23	4.06	5.18E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs74298057	chr6:159417303	RSPH3	chr6:159398268-159421198:-	0.26	4.55	6.05E-6	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs74298058	chr6:159419953	RSPH3	chr6:159398268-159421198:-	0.26	4.57	5.54E-6	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.41	-13.17	8.07E-37	Height	
BRCA	cis	1	rs7429866	chr3:134236306	CEP63	chr3:134204575-134293852:+	-0.14	-3.69	0.000238	Height	
BRCA	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.42	13.97	7.27E-41	Height	
BRCA	cis	1	rs7432268	chr3:134242051	CEP63	chr3:134204575-134293852:+	0.14	3.67	0.000256	Height	
BRCA	cis	1	rs74328550	chr2:48177343	MSH6	chr2:48010221-48034084:+	-0.18	-4.3	1.89E-5	QT interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.42	13.97	7.41E-41	Height	
BRCA	cis	1	rs7433663	chr3:134235790	CEP63	chr3:134204575-134293852:+	0.14	3.89	0.000106	Height	
BRCA	cis	1	rs7433707	chr3:38443180	LOC100128640	chr3:38492524-38496311:-	0.13	3.46	0.000567	Electrocardiographic conduction measures	
BRCA	cis	1	rs7433707	chr3:38443180	XYLB	chr3:38388251-38456467:+	0.2	5.91	4.6E-9	Electrocardiographic conduction measures	
BRCA	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.39	12.59	5.21E-34	Height	
BRCA	cis	1	rs7433991	chr3:134312292	CEP63	chr3:134204575-134293852:+	0.14	3.81	0.000146	Height	
BRCA	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.21	-5.28	1.53E-7	Longevity	
BRCA	cis	1	rs74363821	chr6:26189524	HIST1H3E	chr6:26224427-26226589:+	0.36	6.94	6.61E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs74366004	chr7:1088630	ZFAND2A	chr7:1192544-1199855:-	-0.34	-6.57	7.96E-11	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs743776	chr22:37551487	CYTH4	chr22:37678495-37711388:+	0.05	3.61	0.000319	Rheumatoid arthritis;Type 1 diabetes autoantibodies	
BRCA	cis	1	rs743777	chr22:37551607	APOL3	chr22:36536372-36562225:-	0.09	3.4	0.00069	Rheumatoid arthritis;Type 1 diabetes autoantibodies	
BRCA	cis	1	rs743777	chr22:37551607	CYTH4	chr22:37678495-37711388:+	-0.05	-3.52	0.000446	Rheumatoid arthritis;Type 1 diabetes autoantibodies	
BRCA	cis	1	rs74398423	chr4:106720966	INTS12	chr4:106603787-106629881:-	-0.28	-3.53	0.000439	Post bronchodilator FEV1	
BRCA	cis	1	rs744051	chr12:56667298	COQ10A	chr12:56660642-56664748:+	0.27	3.87	0.000115	Psoriasis vulgaris	
BRCA	cis	1	rs744051	chr12:56667298	RPS26	chr12:56435686-56438005:+	0.31	4.11	4.25E-5	Psoriasis vulgaris	
BRCA	cis	1	rs744051	chr12:56667298	SLC39A5	chr12:56623820-56631627:+	0.25	3.71	0.000222	Psoriasis vulgaris	
BRCA	cis	1	rs74410979	chr6:159361089	RSPH3	chr6:159398268-159421198:-	0.2	3.65	0.00027	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs7443270	chr5:41234046	C7	chr5:40909599-40983039:+	-0.11	-4.65	3.72E-6	Response to fenofibrate (adiponectin levels)	
BRCA	cis	1	rs74471041	chr3:49542543	AMT	chr3:49454212-49460012:-	-0.13	-4.39	1.25E-5	Menarche (age at onset)	
BRCA	cis	1	rs74471041	chr3:49542543	CCDC36	chr3:49235861-49295537:+	-0.11	-4.06	5.29E-5	Menarche (age at onset)	
BRCA	cis	1	rs74471041	chr3:49542543	GMPPB	chr3:49758932-49761384:-	0.13	3.69	0.000233	Menarche (age at onset)	
BRCA	cis	1	rs74471041	chr3:49542543	NCKIPSD	chr3:48711280-48723334:-	-0.14	-3.54	0.000425	Menarche (age at onset)	
BRCA	cis	1	rs74471041	chr3:49542543	P4HTM	chr3:49027341-49044579:+	-0.09	-3.83	0.000138	Menarche (age at onset)	
BRCA	cis	1	rs74471041	chr3:49542543	WDR6	chr3:49044637-49053386:+	0.14	4.26	2.24E-5	Menarche (age at onset)	
BRCA	cis	1	rs7448915	chr5:112760880	YTHDC2	chr5:112849410-112930979:+	0.15	4.22	2.65E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs7449339	chr5:41227477	C7	chr5:40909599-40983039:+	-0.11	-4.48	8.11E-6	Response to fenofibrate (adiponectin levels)	
BRCA	cis	1	rs744937	chr10:118865472	KIAA1598	chr10:118644308-118886097:-	0.14	3.53	0.00043	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
BRCA	cis	1	rs74496027	chr12:56726340	COQ10A	chr12:56660642-56664748:+	-0.28	-3.94	8.81E-5	Psoriasis vulgaris	
BRCA	cis	1	rs74496027	chr12:56726340	RPS26	chr12:56435686-56438005:+	-0.3	-3.9	0.000101	Psoriasis vulgaris	
BRCA	cis	1	rs74496027	chr12:56726340	SLC39A5	chr12:56623820-56631627:+	-0.26	-3.73	0.000205	Psoriasis vulgaris	
BRCA	cis	1	rs74497593	chr4:106616214	INTS12	chr4:106603787-106629881:-	-0.28	-3.48	0.000517	Post bronchodilator FEV1	
BRCA	cis	1	rs7450492	chr6:55935891	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs74508437	chr10:96514363	C10orf129	chr10:96953957-96988685:+	0.23	4.13	3.95E-5	Blood metabolite levels	
BRCA	cis	1	rs7452753	chr6:101053726	ASCC3	chr6:100956609-101329224:-	0.11	4.12	4.07E-5	Menarche (age at onset)	
BRCA	cis	1	rs7454056	chr6:56003136	COL21A1	chr6:55921389-56258892:-	-0.36	-6.71	3.22E-11	Psychosis (atypical)	
BRCA	cis	1	rs74549782	chr10:96482852	C10orf129	chr10:96953957-96988685:+	0.33	5.44	6.5E-8	Blood metabolite levels	
BRCA	cis	1	rs7456042	chr7:65299778	CCT6P1	chr7:65216092-65228661:+	0.32	6.9	9.12E-12	Diabetic kidney disease	
BRCA	cis	1	rs7456042	chr7:65299778	ZNF117	chr7:64434830-64467121:-	-0.27	-5.04	5.6E-7	Diabetic kidney disease	
BRCA	cis	1	rs74599371	chr20:33561495	MMP24	chr20:33814539-33864804:+	-0.19	-3.49	0.00051	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs74599371	chr20:33561495	PROCR	chr20:33758727-33765164:+	-0.24	-5.05	5.21E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs74619037	chr7:123406593	HYAL4	chr7:123485223-123517529:+	0.29	4.22	2.63E-5	Platelet count	
BRCA	cis	1	rs74626382	chr20:33746668	MMP24	chr20:33814539-33864804:+	-0.21	-3.47	0.000542	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs74626382	chr20:33746668	PROCR	chr20:33758727-33765164:+	-0.25	-4.8	1.85E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs74636383	chr10:96546697	C10orf129	chr10:96953957-96988685:+	0.32	5.36	1.03E-7	Blood metabolite levels	
BRCA	cis	1	rs74650218	chr10:102293830	SEC31B	chr10:102246403-102289636:-	-0.3	-11.12	3.01E-27	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs74652290	chr7:1090109	ZFAND2A	chr7:1192544-1199855:-	-0.3	-6.09	1.55E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs74673257	chr12:56638077	COQ10A	chr12:56660642-56664748:+	-0.29	-4.09	4.65E-5	Psoriasis vulgaris	
BRCA	cis	1	rs74673257	chr12:56638077	RPS26	chr12:56435686-56438005:+	-0.29	-3.69	0.000233	Psoriasis vulgaris	
BRCA	cis	1	rs74673257	chr12:56638077	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.9	0.000102	Psoriasis vulgaris	
BRCA	cis	1	rs747692	chr6:33737436	LEMD2	chr6:33738991-33756906:-	0.15	4.58	5.21E-6	Body mass index	
BRCA	cis	1	rs7477246	chr10:102261538	SEC31B	chr10:102246403-102289636:-	-0.31	-11.68	9.94E-30	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs74785791	chr7:1088494	ZFAND2A	chr7:1192544-1199855:-	-0.34	-6.57	7.96E-11	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs7480168	chr11:27330045	LGR4	chr11:27387510-27494334:-	0.14	4.15	3.57E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs74804603	chr10:96566698	C10orf129	chr10:96953957-96988685:+	0.33	5.4	8.38E-8	Blood metabolite levels	
BRCA	cis	1	rs7480595	chr11:27316623	LGR4	chr11:27387510-27494334:-	0.15	4.22	2.64E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs7482097	chr11:27327167	LGR4	chr11:27387510-27494334:-	0.14	4.15	3.57E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs7482591	chr11:245861	PSMD13	chr11:236808-252984:+	-0.15	-4.24	2.46E-5	Menarche (age at onset)	
BRCA	cis	1	rs7483162	chr11:27316394	LGR4	chr11:27387510-27494334:-	0.15	4.22	2.6E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs748404	chr15:43559231	STRC	chr15:43891762-43924561:-	0.18	4.47	8.74E-6	Lung cancer	
BRCA	cis	1	rs7484733	chr12:122612598	LRRC43	chr12:122652266-122688017:+	-0.16	-4.51	7.08E-6	Urate levels	
BRCA	cis	1	rs7485054	chr12:122611100	LRRC43	chr12:122652266-122688017:+	-0.16	-4.62	4.32E-6	Urate levels	
BRCA	cis	1	rs7485380	chr12:122614999	LRRC43	chr12:122652266-122688017:+	-0.16	-4.29	1.93E-5	Urate levels	
BRCA	cis	1	rs7485421	chr12:122611099	LRRC43	chr12:122652266-122688017:+	-0.16	-4.63	4.2E-6	Urate levels	
BRCA	cis	1	rs7485447	chr12:122611200	LRRC43	chr12:122652266-122688017:+	-0.16	-4.51	7.12E-6	Urate levels	
BRCA	cis	1	rs74858697	chr4:17963076	NCAPG	chr4:17812525-17846485:+	0.11	4.49	8.06E-6	Height	
BRCA	cis	1	rs7486198	chr12:122612350	LRRC43	chr12:122652266-122688017:+	-0.16	-4.51	7.08E-6	Urate levels	
BRCA	cis	1	rs7487625	chr12:66319996	LLPH	chr12:66516850-66563807:-	0.15	3.82	0.000139	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
BRCA	cis	1	rs7488268	chr12:122614909	LRRC43	chr12:122652266-122688017:+	-0.16	-4.5	7.59E-6	Urate levels	
BRCA	cis	1	rs74883200	chr10:96390079	C10orf129	chr10:96953957-96988685:+	0.34	5.4	8.04E-8	Blood metabolite levels	
BRCA	cis	1	rs7488393	chr12:122612325	LRRC43	chr12:122652266-122688017:+	-0.16	-4.43	1.02E-5	Urate levels	
BRCA	cis	1	rs74886295	chr4:55008027	FIP1L1	chr4:54243820-54326102:+	-0.16	-3.42	0.000656	Lupus nephritis in systemic lupus erythematosus	
BRCA	cis	1	rs7488857	chr12:122625212	LRRC43	chr12:122652266-122688017:+	0.17	4.68	3.21E-6	Urate levels	
BRCA	cis	1	rs74900588	chr6:170102180	WDR27	chr6:169857307-170102159:-	-0.12	-3.53	0.000433	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs749050	chr10:97376115	ENTPD1	chr10:97471536-97637022:+	0.16	5.5	4.66E-8	Blood metabolite levels	
BRCA	cis	1	rs74917833	chr4:106643161	INTS12	chr4:106603787-106629881:-	-0.3	-3.63	0.000301	Post bronchodilator FEV1	
BRCA	cis	1	rs74963873	chr4:17970326	NCAPG	chr4:17812525-17846485:+	0.12	4.67	3.48E-6	Height	
BRCA	cis	1	rs74967207	chr10:96468755	C10orf129	chr10:96953957-96988685:+	0.33	5.45	6.33E-8	Blood metabolite levels	
BRCA	cis	1	rs7496954	chr15:83345536	FAM154B	chr15:82555152-82577265:+	0.13	3.68	0.000244	Schizophrenia	
BRCA	cis	1	rs7496954	chr15:83345536	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.09	3.41	0.000674	Schizophrenia	
BRCA	cis	1	rs749745	chr10:96406516	HELLS	chr10:96305543-96361855:+	0.12	3.6	0.000334	Migraine	
BRCA	cis	1	rs74984113	chr4:250522	ZNF718	chr4:53272-156488:+	0.35	7.31	5.15E-13	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs74984740	chr2:17796007	GEN1	chr2:17935162-17966632:+	0.16	3.53	0.00044	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs7499306	chr16:20555474	ACSM1	chr16:20634559-20709066:-	0.36	5.19	2.52E-7	Serum metabolite levels	
BRCA	cis	1	rs7506045	chr18:11987272	AFG3L2	chr18:12329108-12377194:-	0.24	4.71	2.87E-6	Stroke	
BRCA	cis	1	rs7506045	chr18:11987272	CEP76	chr18:12661955-12702703:-	0.22	4.45	9.43E-6	Stroke	
BRCA	cis	1	rs7506045	chr18:11987272	CHMP1B	chr18:11851389-11854447:+	0.21	3.51	0.000471	Stroke	
BRCA	cis	1	rs7506045	chr18:11987272	PSMG2	chr18:12658738-12725737:+	0.19	3.86	0.000121	Stroke	
BRCA	cis	1	rs7506045	chr18:11987272	PTPN2	chr18:12785481-12884334:-	0.21	4.85	1.41E-6	Stroke	
BRCA	cis	1	rs7506045	chr18:11987272	SEH1L	chr18:12947983-12987533:+	0.18	3.86	0.000122	Stroke	
BRCA	cis	1	rs7506045	chr18:11987272	SPIRE1	chr18:12446512-12657912:-	0.24	4.27	2.09E-5	Stroke	
BRCA	cis	1	rs75063298	chr10:102213600	SEC31B	chr10:102246403-102289636:-	-0.28	-10.23	1.66E-23	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs751075	chr3:51377300	GRM2	chr3:51741081-51752623:+	-0.17	-3.39	0.000724	Melanoma	
BRCA	cis	1	rs751095	chr6:33742718	IP6K3	chr6:33689443-33714762:-	0.24	4.19	2.99E-5	Obesity (extreme)	
BRCA	cis	1	rs751096	chr6:33742838	C6orf125	chr6:33662057-33679504:-	-0.11	-3.81	0.000146	Body mass index	
BRCA	cis	1	rs751096	chr6:33742838	LEMD2	chr6:33738991-33756906:-	-0.17	-5.38	9.13E-8	Body mass index	
BRCA	cis	1	rs7511868	chr1:161463331	FCGR2C	chr1:161551129-161570031:+	-0.11	-3.83	0.000134	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
BRCA	cis	1	rs7511962	chr1:247212122	ZNF670	chr1:247200087-247242069:-	-0.25	-6.98	5.09E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs7512150	chr1:247212326	ZNF670	chr1:247200087-247242069:-	-0.25	-6.89	9.23E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs75128809	chr21:43418210	C21orf121	chr21:43442113-43445060:+	0.27	6.54	9.31E-11	Hand grip strength	
BRCA	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.57	3.03E-29	Body mass index	
BRCA	cis	1	rs7515491	chr1:46355079	MUTYH	chr1:45794915-45806142:-	0.13	5.03	5.64E-7	Body mass index	
BRCA	cis	1	rs7515577	chr1:93009438	EVI5	chr1:92974255-93257961:-	-0.19	-5.01	6.49E-7	Cholesterol, total	
BRCA	cis	1	rs75156726	chr4:106677999	INTS12	chr4:106603787-106629881:-	-0.31	-3.82	0.00014	Post bronchodilator FEV1	
BRCA	cis	1	rs75165171	chr20:33651453	MMP24	chr20:33814539-33864804:+	-0.22	-3.85	0.000126	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs75165171	chr20:33651453	PROCR	chr20:33758727-33765164:+	-0.25	-4.97	7.73E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs751728	chr6:33764033	C6orf125	chr6:33662057-33679504:-	-0.11	-3.96	7.94E-5	Crohn's disease	
BRCA	cis	1	rs751728	chr6:33764033	ITPR3	chr6:33589161-33664346:+	-0.11	-3.41	0.000668	Crohn's disease	
BRCA	cis	1	rs751728	chr6:33764033	LEMD2	chr6:33738991-33756906:-	-0.16	-5.88	5.61E-9	Crohn's disease	
BRCA	cis	1	rs7517	chr1:150596411	HORMAD1	chr1:150670542-150693352:-	0.21	4.89	1.19E-6	Congenital left-sided heart lesions	
BRCA	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.65	-12.24	2.42E-32	Plasma clusterin levels	
BRCA	cis	1	rs75183624	chr3:184777207	VPS8	chr3:184529931-184770402:+	-0.21	-3.54	0.00042	Heschl's gyrus morphology	
BRCA	cis	1	rs7518565	chr1:207420343	C4BPA	chr1:207277511-207318308:+	0.16	4.67	3.41E-6	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs7518608	chr1:8557320	RERE	chr1:8412466-8877699:-	0.1	3.38	0.000738	Vitiligo	
BRCA	cis	1	rs7519795	chr1:247212126	ZNF670	chr1:247200087-247242069:-	-0.25	-6.98	5.09E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs7520651	chr1:10329872	PGD	chr1:10459085-10480200:+	0.19	5.41	7.81E-8	Hepatocellular carcinoma	
BRCA	cis	1	rs7520844	chr1:25054223	CLIC4	chr1:25071760-25170815:+	0.11	4.08	4.9E-5	Height	
BRCA	cis	1	rs7520935	chr1:10354271	PGD	chr1:10459085-10480200:+	0.21	5.87	5.75E-9	Hepatocellular carcinoma	
BRCA	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.9	9.15E-31	Body mass index	
BRCA	cis	1	rs7522601	chr1:46419021	MUTYH	chr1:45794915-45806142:-	0.12	4.8	1.8E-6	Body mass index	
BRCA	cis	1	rs7522618	chr1:207417426	C4BPA	chr1:207277511-207318308:+	0.15	4.41	1.12E-5	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.73	23.2	1.01E-96	Homocysteine levels	
BRCA	cis	1	rs7522705	chr1:45992300	MMACHC	chr1:45965856-45976737:+	0.12	3.52	0.000453	Homocysteine levels	
BRCA	cis	1	rs7524495	chr1:46266932	CCDC163P	chr1:45960581-45965646:-	-0.41	-12.1	1.1E-31	Body mass index	
BRCA	cis	1	rs7524495	chr1:46266932	CCDC17	chr1:46085717-46089729:-	0.11	3.47	0.000532	Body mass index	
BRCA	cis	1	rs7524495	chr1:46266932	MUTYH	chr1:45794915-45806142:-	0.12	4.81	1.71E-6	Body mass index	
BRCA	cis	1	rs75254631	chr10:96560911	C10orf129	chr10:96953957-96988685:+	0.32	5.36	1.03E-7	Blood metabolite levels	
BRCA	cis	1	rs75265219	chr12:56640341	COQ10A	chr12:56660642-56664748:+	-0.29	-4.09	4.65E-5	Psoriasis vulgaris	
BRCA	cis	1	rs75265219	chr12:56640341	RPS26	chr12:56435686-56438005:+	-0.29	-3.69	0.000233	Psoriasis vulgaris	
BRCA	cis	1	rs75265219	chr12:56640341	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.9	0.000102	Psoriasis vulgaris	
BRCA	cis	1	rs7527389	chr1:8556545	RERE	chr1:8412466-8877699:-	0.1	3.38	0.00076	Vitiligo	
BRCA	cis	1	rs75280500	chr10:96582914	C10orf129	chr10:96953957-96988685:+	0.33	5.42	7.32E-8	Blood metabolite levels	
BRCA	cis	1	rs75287019	chr20:33721261	PROCR	chr20:33758727-33765164:+	-0.26	-5.24	1.93E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7530167	chr1:10453374	PGD	chr1:10459085-10480200:+	0.22	6.02	2.33E-9	Hepatocellular carcinoma	
BRCA	cis	1	rs75302862	chr7:123417079	HYAL4	chr7:123485223-123517529:+	0.28	4.09	4.62E-5	Platelet count	
BRCA	cis	1	rs753050	chr14:52505375	NID2	chr14:52471521-52535946:-	0.08	3.63	0.000298	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs753051	chr14:52505360	NID2	chr14:52471521-52535946:-	0.08	3.66	0.000264	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.66	-12.69	1.91E-34	Plasma clusterin levels	
BRCA	cis	1	rs7531202	chr1:110616474	ALX3	chr1:110602998-110613322:-	-0.15	-4.43	1.06E-5	Blood metabolite levels	
BRCA	cis	1	rs753129	chr4:56668431	EXOC1	chr4:56719816-56771244:+	0.16	4.03	5.97E-5	Psychosis in Alzheimer's disease	
BRCA	cis	1	rs7532664	chr1:207426943	C4BPA	chr1:207277511-207318308:+	0.15	4.34	1.59E-5	Posterior cortical atrophy and Alzheimer's disease	
BRCA	cis	1	rs7532754	chr1:115824515	AMPD1	chr1:115215722-115238176:-	-0.1	-3.39	0.00072	Migraine	
BRCA	cis	1	rs7533623	chr1:110616475	ALX3	chr1:110602998-110613322:-	-0.15	-4.39	1.22E-5	Blood metabolite levels	
BRCA	cis	1	rs7533688	chr1:166944123	MAEL	chr1:166958519-166991447:+	-0.14	-3.41	0.000673	Refractive astigmatism	
BRCA	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.82	-27.9	4.56E-129	Homocysteine levels	
BRCA	cis	1	rs7534467	chr1:45988691	MMACHC	chr1:45965856-45976737:+	-0.15	-4.31	1.79E-5	Homocysteine levels	
BRCA	cis	1	rs7534624	chr1:22494627	HSPC157	chr1:22351707-22357713:+	0.15	3.95	8.29E-5	Obesity-related traits	
BRCA	cis	1	rs7535475	chr1:161463587	FCGR2C	chr1:161551129-161570031:+	0.11	3.92	9.41E-5	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
BRCA	cis	1	rs75358288	chr6:55987364	COL21A1	chr6:55921389-56258892:-	-0.38	-6.92	7.66E-12	Psychosis (atypical)	
BRCA	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.71	-23.25	4.28E-97	Homocysteine levels	
BRCA	cis	1	rs7537507	chr1:110131105	AMIGO1	chr1:110049447-110052336:-	0.17	3.97	7.57E-5	Major depressive disorder	
BRCA	cis	1	rs7537507	chr1:110131105	SYPL2	chr1:110009100-110024763:+	-0.16	-3.83	0.000136	Major depressive disorder	
BRCA	cis	1	rs7537765	chr1:11887303	CLCN6	chr1:11866207-11907674:+	-0.17	-4.79	1.9E-6	QRS complex (12-leadsum)	
BRCA	cis	1	rs7539932	chr1:46292354	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.84	1.72E-30	Body mass index	
BRCA	cis	1	rs7539932	chr1:46292354	CCDC17	chr1:46085717-46089729:-	0.11	3.45	0.000592	Body mass index	
BRCA	cis	1	rs7539932	chr1:46292354	MUTYH	chr1:45794915-45806142:-	0.12	4.91	1.05E-6	Body mass index	
BRCA	cis	1	rs75399471	chr1:76339092	ACADM	chr1:76190043-76229353:+	-0.23	-3.56	0.000382	Attention function in attention deficit hyperactive disorder	
BRCA	cis	1	rs7540325	chr1:46338217	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.71	7.32E-30	Body mass index	
BRCA	cis	1	rs7540325	chr1:46338217	CCDC17	chr1:46085717-46089729:-	0.11	3.54	0.000424	Body mass index	
BRCA	cis	1	rs7540325	chr1:46338217	MUTYH	chr1:45794915-45806142:-	0.13	5.11	3.87E-7	Body mass index	
BRCA	cis	1	rs75404862	chr10:96441082	C10orf129	chr10:96953957-96988685:+	0.34	5.57	3.27E-8	Blood metabolite levels	
BRCA	cis	1	rs7543089	chr1:107591693	NTNG1	chr1:107682629-108024471:+	0.17	3.76	0.000181	AIDS	
BRCA	cis	1	rs7543089	chr1:107591693	PRMT6	chr1:107599267-107601907:+	0.24	5.02	6.12E-7	AIDS	
BRCA	cis	1	rs7543126	chr1:21406088	HP1BP3	chr1:21069171-21113799:-	0.11	3.48	0.000528	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs7544256	chr1:115824398	AMPD1	chr1:115215722-115238176:-	-0.1	-3.42	0.000654	Migraine	
BRCA	cis	1	rs7545911	chr1:166947681	MAEL	chr1:166958519-166991447:+	-0.15	-3.72	0.000213	Refractive astigmatism	
BRCA	cis	1	rs7546090	chr1:67083981	TCTEX1D1	chr1:67218140-67244729:+	0.12	3.38	0.000747	Menopause (age at onset)	
BRCA	cis	1	rs7546342	chr1:247213292	ZNF670	chr1:247200087-247242069:-	-0.25	-6.86	1.2E-11	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs75470184	chr10:96392186	C10orf129	chr10:96953957-96988685:+	0.27	4.91	1.06E-6	Blood metabolite levels	
BRCA	cis	1	rs75487138	chr11:18461878	LDHC	chr11:18433853-18472792:+	-0.3	-5.28	1.58E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs7549410	chr1:247214167	ZNF670	chr1:247200087-247242069:-	-0.25	-7.02	4.0E-12	Response to taxane treatment (docetaxel)	
BRCA	cis	1	rs7549475	chr1:227774700	SNAP47	chr1:227916240-227968932:+	0.14	4.25	2.31E-5	Height	
BRCA	cis	1	rs7550698	chr1:166951081	MAEL	chr1:166958519-166991447:+	-0.14	-3.55	0.000405	Refractive astigmatism	
BRCA	cis	1	rs7550746	chr1:46351719	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.92	7.39E-31	Body mass index	
BRCA	cis	1	rs7550746	chr1:46351719	CCDC17	chr1:46085717-46089729:-	0.12	3.76	0.000179	Body mass index	
BRCA	cis	1	rs7550746	chr1:46351719	MUTYH	chr1:45794915-45806142:-	0.12	4.72	2.66E-6	Body mass index	
BRCA	cis	1	rs755109	chr9:100696203	C9orf156	chr9:100666772-100684852:-	0.17	4.92	9.9E-7	Quantitative traits	
BRCA	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.39	10.99	1.13E-26	Height	
BRCA	cis	1	rs7551849	chr1:8539463	RERE	chr1:8412466-8877699:-	0.1	3.43	0.000621	Vitiligo	
BRCA	cis	1	rs75535620	chr20:33601498	MMP24	chr20:33814539-33864804:+	-0.23	-4.07	5.07E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs75535620	chr20:33601498	PROCR	chr20:33758727-33765164:+	-0.24	-4.9	1.1E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs75537616	chr20:33592588	MMP24	chr20:33814539-33864804:+	-0.22	-3.88	0.000109	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs75537616	chr20:33592588	PROCR	chr20:33758727-33765164:+	-0.24	-4.91	1.07E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs755495	chr6:33734128	C6orf125	chr6:33662057-33679504:-	-0.11	-3.64	0.000282	Body mass index	
BRCA	cis	1	rs755495	chr6:33734128	LEMD2	chr6:33738991-33756906:-	-0.16	-5.03	5.88E-7	Body mass index	
BRCA	cis	1	rs7555523	chr1:165718979	LMX1A	chr1:165171105-165325475:-	0.19	3.4	0.0007	Glaucoma (high intraocular pressure);Intraocular pressure	
BRCA	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.4	12.17	5.18E-32	Body mass index	
BRCA	cis	1	rs7556436	chr1:46363880	MUTYH	chr1:45794915-45806142:-	-0.1	-4.14	3.82E-5	Body mass index	
BRCA	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.82	2.28E-30	Body mass index	
BRCA	cis	1	rs7556615	chr1:46461369	CCDC17	chr1:46085717-46089729:-	0.11	3.38	0.000741	Body mass index	
BRCA	cis	1	rs7556615	chr1:46461369	MUTYH	chr1:45794915-45806142:-	0.12	4.84	1.5E-6	Body mass index	
BRCA	cis	1	rs7557709	chr2:219167529	GPBAR1	chr2:219125738-219128582:+	-0.1	-3.43	0.000634	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs7557709	chr2:219167529	TMBIM1	chr2:219138917-219157280:-	0.13	3.9	0.000103	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs75582893	chr2:160118126	WDSUB1	chr2:160092305-160143236:-	0.32	3.91	9.83E-5	Sudden cardiac arrest	
BRCA	cis	1	rs7560327	chr2:190772522	ORMDL1	chr2:190634994-190649097:-	0.31	4.58	5.27E-6	Subcutaneous adipose tissue	
BRCA	cis	1	rs7560328	chr2:202164837	ALS2CR12	chr2:202153148-202222101:-	-0.28	-7.57	7.91E-14	Melanoma;Esophageal squamous cell carcinoma	
BRCA	cis	1	rs7560357	chr2:99247820	INPP4A	chr2:99061321-99207495:+	0.13	3.68	0.000246	Bipolar disorder	
BRCA	cis	1	rs7560357	chr2:99247820	UNC50	chr2:99225042-99234975:+	0.29	6.37	2.86E-10	Bipolar disorder	
BRCA	cis	1	rs75615599	chr11:96112059	CCDC82	chr11:96085930-96123083:-	-0.12	-3.38	0.00074	Parkinson's disease	
BRCA	cis	1	rs7561906	chr2:218312731	DIRC3	chr2:218148748-218621316:-	0.19	3.92	9.58E-5	Metabolite levels (MHPG)	
BRCA	cis	1	rs7562072	chr2:218312691	DIRC3	chr2:218148748-218621316:-	0.19	3.92	9.58E-5	Metabolite levels (MHPG)	
BRCA	cis	1	rs7562091	chr2:218312748	DIRC3	chr2:218148748-218621316:-	0.19	3.92	9.58E-5	Metabolite levels (MHPG)	
BRCA	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.25	6.23	6.81E-10	Body mass index	
BRCA	cis	1	rs75635914	chr20:33555815	MMP24	chr20:33814539-33864804:+	-0.21	-3.77	0.00017	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs75635914	chr20:33555815	PROCR	chr20:33758727-33765164:+	-0.25	-5.14	3.29E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs75642445	chr10:96507575	C10orf129	chr10:96953957-96988685:+	0.33	5.5	4.85E-8	Blood metabolite levels	
BRCA	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.27	6.89	9.55E-12	Metabolite levels	
BRCA	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.68	-19.96	1.49E-75	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs756631	chr22:23463183	RTDR1	chr22:23401594-23484241:-	-0.17	-4.46	8.98E-6	Bone mineral density	
BRCA	cis	1	rs7570836	chr2:86141433	POLR1A	chr2:86253453-86333278:-	-0.19	-3.58	0.000355	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs7571716	chr2:233441420	EIF4E2	chr2:233415357-233448349:+	0.18	4.04	5.83E-5	Height	
BRCA	cis	1	rs7571716	chr2:233441420	TIGD1	chr2:233412779-233415226:-	0.15	3.71	0.000215	Height	
BRCA	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.26	6.65	4.77E-11	Metabolite levels	
BRCA	cis	1	rs7573442	chr2:70154037	ANXA4	chr2:69969127-70053594:+	-0.13	-3.82	0.000138	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs75740864	chr11:18470689	LDHC	chr11:18433853-18472792:+	-0.26	-4.68	3.19E-6	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs75754909	chr12:56726349	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.29E-5	Psoriasis vulgaris	
BRCA	cis	1	rs75754909	chr12:56726349	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.000187	Psoriasis vulgaris	
BRCA	cis	1	rs75754909	chr12:56726349	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000365	Psoriasis vulgaris	
BRCA	cis	1	rs75759008	chr7:123418478	HYAL4	chr7:123485223-123517529:+	0.28	4.09	4.62E-5	Platelet count	
BRCA	cis	1	rs7577696	chr2:32278782	NLRC4	chr2:32449518-32490801:-	-0.16	-6.61	6.08E-11	Inflammatory biomarkers	
BRCA	cis	1	rs7577894	chr2:56008904	EFEMP1	chr2:56093103-56150932:-	0.16	4.47	8.86E-6	Amyotrophic lateral sclerosis	
BRCA	cis	1	rs7578199	chr2:242192848	SEPT2	chr2:242254723-242293439:+	0.18	4.45	9.4E-6	Chronic lymphocytic leukemia	
BRCA	cis	1	rs7578456	chr2:202235348	ALS2CR12	chr2:202153148-202222101:-	-0.22	-5.82	7.81E-9	Basal cell carcinoma	
BRCA	cis	1	rs7578456	chr2:202235348	PPIL3	chr2:201735680-201753999:-	-0.14	-3.75	0.000183	Basal cell carcinoma	
BRCA	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.27	-6.68	3.82E-11	Body mass index	
BRCA	cis	1	rs757978	chr2:242371101	SEPT2	chr2:242254723-242293439:+	0.33	6.38	2.64E-10	Chronic lymphocytic leukemia	
BRCA	cis	1	rs75800624	chr18:44633605	HDHD2	chr18:44633782-44676871:-	0.3	5.17	2.85E-7	Sitting height ratio	
BRCA	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.25	5.41	7.84E-8	Breast cancer (estrogen-receptor negative);Breast cancer	
BRCA	cis	1	rs7581224	chr2:84709215	DNAH6	chr2:84743579-85046711:+	0.22	6.31	4.06E-10	Coronary artery calcification	
BRCA	cis	1	rs75817507	chr4:106767623	INTS12	chr4:106603787-106629881:-	-0.28	-3.5	0.000478	Post bronchodilator FEV1	
BRCA	cis	1	rs75824619	chr20:61856471	BIRC7	chr20:61867276-61871853:+	0.45	6.55	9.18E-11	Response to cytadine analogues (cytosine arabinoside)	
BRCA	cis	1	rs75857982	chr2:48164539	MSH6	chr2:48010221-48034084:+	-0.19	-4.59	4.87E-6	QT interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs75866240	chr20:33558839	MMP24	chr20:33814539-33864804:+	-0.21	-3.76	0.000181	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs75866240	chr20:33558839	PROCR	chr20:33758727-33765164:+	-0.25	-5.12	3.7E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7587220	chr2:219160864	GPBAR1	chr2:219125738-219128582:+	0.12	4.18	3.22E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs7587220	chr2:219160864	TMBIM1	chr2:219138917-219157280:-	-0.13	-3.93	9.02E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs7587476	chr2:215653887	BARD1	chr2:215593275-215674428:-	0.12	4.45	9.32E-6	Neuroblastoma	
BRCA	cis	1	rs7588296	chr2:218312698	DIRC3	chr2:218148748-218621316:-	0.19	3.92	9.58E-5	Metabolite levels (MHPG)	
BRCA	cis	1	rs75888794	chr20:33702998	MMP24	chr20:33814539-33864804:+	-0.21	-3.8	0.000152	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs75888794	chr20:33702998	PROCR	chr20:33758727-33765164:+	-0.26	-5.41	7.67E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs758944	chr7:75953297	UPK3B	chr7:76139745-76157197:+	-0.25	-6.41	2.18E-10	Multiple sclerosis	
BRCA	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.6	-11.43	1.27E-28	Plasma clusterin levels	
BRCA	cis	1	rs7590071	chr2:240900947	NDUFA10	chr2:240900158-240964798:-	0.25	6.75	2.48E-11	Odorant perception (isobutyraldehyde)	
BRCA	cis	1	rs7591472	chr2:201889751	CFLAR	chr2:201980816-202029001:+	-0.14	-4.73	2.58E-6	Triptolide cytotoxicity	
BRCA	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.85	-20.06	3.29E-76	Triptolide cytotoxicity	
BRCA	cis	1	rs75921373	chr6:26191843	HIST1H3E	chr6:26224427-26226589:+	0.34	6.79	1.83E-11	Renal underexcretion gout;Gout	
BRCA	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.26	6.69	3.54E-11	Metabolite levels	
BRCA	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.68	-20.21	3.47E-77	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs7597199	chr2:70341575	FAM136A	chr2:70523109-70529220:-	-0.13	-4.34	1.54E-5	Obesity-related traits	
BRCA	cis	1	rs7597469	chr2:203194270	NOP58	chr2:203130515-203168382:+	0.15	3.48	0.000513	Urate levels	
BRCA	cis	1	rs7598283	chr2:70128717	ANXA4	chr2:69969127-70053594:+	-0.14	-4.05	5.56E-5	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.27	6.97	5.55E-12	Metabolite levels	
BRCA	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.22	5.52	4.31E-8	Metabolite levels	
BRCA	cis	1	rs7598759	chr2:232321956	C2orf52	chr2:232373137-232379050:-	-0.25	-6.45	1.65E-10	Noise-induced hearing loss	
BRCA	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.25	-6.13	1.24E-9	Body mass index	
BRCA	cis	1	rs7599132	chr2:26279810	GPR113	chr2:26531041-26569685:-	0.14	3.42	0.000648	Gut microbiome composition (summer)	
BRCA	cis	1	rs7600987	chr2:219915871	GLB1L	chr2:220101505-220110131:-	-0.22	-4.11	4.23E-5	Height	
BRCA	cis	1	rs7601738	chr2:242375813	SEPT2	chr2:242254723-242293439:+	-0.36	-6.99	4.83E-12	Chronic lymphocytic leukemia	
BRCA	cis	1	rs76024966	chr7:75995021	UPK3B	chr7:76139745-76157197:+	-0.24	-6.24	6.44E-10	Multiple sclerosis	
BRCA	cis	1	rs7604393	chr2:241825034	C2orf54	chr2:241825466-241835573:-	0.27	7.46	1.77E-13	Urinary metabolites	
BRCA	cis	1	rs7604798	chr2:27824940	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.01	6.52E-5	Oral cavity cancer	
BRCA	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.69	20.5	4.88E-79	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs76063586	chr10:96642431	C10orf129	chr10:96953957-96988685:+	0.35	5.71	1.45E-8	Blood metabolite levels	
BRCA	cis	1	rs7607014	chr2:73730174	ALMS1P	chr2:73872046-73912692:+	-0.26	-6.82	1.49E-11	Metabolite levels	
BRCA	cis	1	rs76081054	chr2:86285037	LOC90784	chr2:86247339-86250991:-	-0.45	-5.47	5.52E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs7608623	chr2:23948953	LOC375190	chr2:24299728-24397519:+	0.18	5.49	4.89E-8	Obesity-related traits	
BRCA	cis	1	rs7608697	chr2:61204641	AHSA2	chr2:61404553-61414058:+	-0.12	-5.49	4.91E-8	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.31	7.88	8.21E-15	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs76088375	chr4:109393181	SEC24B	chr4:110354971-110461614:+	0.13	3.6	0.000329	Gut microbiome composition (summer)	
BRCA	cis	1	rs7608910	chr2:61204856	AHSA2	chr2:61404553-61414058:+	0.13	6.01	2.61E-9	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.34	-8.82	4.56E-18	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
BRCA	cis	1	rs7609045	chr2:165555207	SLC38A11	chr2:165754812-165812035:-	0.17	5.2	2.36E-7	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
BRCA	cis	1	rs761025	chr20:25426968	FAM182A	chr20:26035250-26067552:+	-0.23	-6.2	7.93E-10	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs761025	chr20:25426968	FAM182B	chr20:25744102-25848786:-	0.22	5.78	9.83E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs76110720	chr10:96641794	C10orf129	chr10:96953957-96988685:+	0.35	5.71	1.45E-8	Blood metabolite levels	
BRCA	cis	1	rs76112204	chr5:115618889	COMMD10	chr5:115420727-115628978:+	0.22	4.32	1.69E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs7611238	chr3:195072918	C3orf21	chr3:194789015-194991895:-	0.19	5.65	2.03E-8	Body mass index	
BRCA	cis	1	rs76112431	chr6:55988182	COL21A1	chr6:55921389-56258892:-	-0.38	-6.92	7.66E-12	Psychosis (atypical)	
BRCA	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.39	12.59	5.21E-34	Height	
BRCA	cis	1	rs7611611	chr3:134307877	CEP63	chr3:134204575-134293852:+	0.14	3.81	0.000146	Height	
BRCA	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.42	14.03	3.52E-41	Height	
BRCA	cis	1	rs7611828	chr3:134250325	CEP63	chr3:134204575-134293852:+	0.14	3.94	8.54E-5	Height	
BRCA	cis	1	rs76129108	chr7:1089159	ZFAND2A	chr7:1192544-1199855:-	-0.34	-6.58	7.49E-11	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs7613491	chr3:49508976	AMT	chr3:49454212-49460012:-	-0.14	-4.59	4.95E-6	Menarche (age at onset)	
BRCA	cis	1	rs7613491	chr3:49508976	CCDC36	chr3:49235861-49295537:+	-0.1	-3.59	0.000349	Menarche (age at onset)	
BRCA	cis	1	rs7613491	chr3:49508976	GMPPB	chr3:49758932-49761384:-	0.13	3.62	0.000307	Menarche (age at onset)	
BRCA	cis	1	rs7613491	chr3:49508976	NCKIPSD	chr3:48711280-48723334:-	-0.15	-3.66	0.000265	Menarche (age at onset)	
BRCA	cis	1	rs7613491	chr3:49508976	P4HTM	chr3:49027341-49044579:+	-0.1	-4.15	3.55E-5	Menarche (age at onset)	
BRCA	cis	1	rs7613491	chr3:49508976	WDR6	chr3:49044637-49053386:+	0.16	4.55	5.92E-6	Menarche (age at onset)	
BRCA	cis	1	rs7613866	chr3:156964032	LEKR1	chr3:156544076-156763918:+	-0.24	-3.51	0.00047	Smoking cessation in chronic obstructive pulmonary disease;Diabetic retinopathy	
BRCA	cis	1	rs7614311	chr3:63813654	PSMD6	chr3:63996231-64009658:-	-0.15	-3.5	0.000493	Lung function (FEV1);Lung function (FVC)	
BRCA	cis	1	rs7614311	chr3:63813654	THOC7	chr3:63819547-63849597:-	-0.13	-3.59	0.000344	Lung function (FEV1);Lung function (FVC)	
BRCA	cis	1	rs7614727	chr3:52295895	SPCS1	chr3:52739857-52742195:+	0.12	3.79	0.00016	Electroencephalogram traits	
BRCA	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.29	-5.88	5.44E-9	Blood pressure (smoking interaction)	
BRCA	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.3	5.98	3.04E-9	Blood pressure (smoking interaction)	
BRCA	cis	1	rs76191812	chr20:33563911	MMP24	chr20:33814539-33864804:+	-0.22	-3.92	9.54E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs76191812	chr20:33563911	PROCR	chr20:33758727-33765164:+	-0.24	-4.87	1.26E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs76192904	chr1:76359995	ACADM	chr1:76190043-76229353:+	-0.2	-3.89	0.000107	Attention function in attention deficit hyperactive disorder	
BRCA	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.4	12.4	4.29E-33	Height	
BRCA	cis	1	rs7619451	chr3:134233238	CEP63	chr3:134204575-134293852:+	0.14	3.46	0.00056	Height	
BRCA	cis	1	rs76194	chr19:18630580	LRRC25	chr19:18501955-18508421:-	-0.13	-6.36	2.98E-10	Breast cancer	
BRCA	cis	1	rs7619789	chr3:49476263	AMT	chr3:49454212-49460012:-	0.14	4.66	3.61E-6	Menarche (age at onset)	
BRCA	cis	1	rs7619789	chr3:49476263	CCDC36	chr3:49235861-49295537:+	0.1	3.78	0.000169	Menarche (age at onset)	
BRCA	cis	1	rs7619789	chr3:49476263	GMPPB	chr3:49758932-49761384:-	-0.13	-3.73	0.000202	Menarche (age at onset)	
BRCA	cis	1	rs7619789	chr3:49476263	NCKIPSD	chr3:48711280-48723334:-	0.15	3.9	0.000103	Menarche (age at onset)	
BRCA	cis	1	rs7619789	chr3:49476263	P4HTM	chr3:49027341-49044579:+	0.09	3.73	0.000198	Menarche (age at onset)	
BRCA	cis	1	rs7619789	chr3:49476263	TREX1	chr3:48501186-48509043:+	-0.11	-3.66	0.000268	Menarche (age at onset)	
BRCA	cis	1	rs7619789	chr3:49476263	WDR6	chr3:49044637-49053386:+	-0.17	-4.94	8.99E-7	Menarche (age at onset)	
BRCA	cis	1	rs76198862	chr6:55988150	COL21A1	chr6:55921389-56258892:-	-0.38	-6.92	7.66E-12	Psychosis (atypical)	
BRCA	cis	1	rs762317	chr3:38497659	XYLB	chr3:38388251-38456467:+	0.18	5.39	8.56E-8	Electrocardiographic conduction measures	
BRCA	cis	1	rs7624377	chr3:190988079	UTS2D	chr3:190984945-191048325:-	-0.22	-6.4	2.39E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs762629	chr3:119280892	CD80	chr3:119243142-119278481:-	0.12	4.23	2.57E-5	Vitiligo	
BRCA	cis	1	rs76265521	chr10:96514016	C10orf129	chr10:96953957-96988685:+	0.33	5.5	4.85E-8	Blood metabolite levels	
BRCA	cis	1	rs7629072	chr3:52305633	NT5DC2	chr3:52558386-52569093:-	-0.09	-3.38	0.000756	Electroencephalogram traits	
BRCA	cis	1	rs7629072	chr3:52305633	SPCS1	chr3:52739857-52742195:+	0.12	3.8	0.000153	Electroencephalogram traits	
BRCA	cis	1	rs76291634	chr19:10836545	LOC147727	chr19:10762539-10764548:-	0.22	3.72	0.000207	LDL cholesterol	
BRCA	cis	1	rs76297018	chr2:86227007	POLR1A	chr2:86253453-86333278:-	-0.28	-4.59	4.95E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs763014	chr16:675680	IFT140	chr16:1560429-1662109:-	-0.09	-3.51	0.000464	Height	
BRCA	cis	1	rs763014	chr16:675680	PIGQ	chr16:617032-634108:+	-0.11	-4.98	7.59E-7	Height	
BRCA	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.3	8.92	1.99E-18	Height	
BRCA	cis	1	rs7630741	chr3:48419723	ATRIP	chr3:48488141-48507708:+	0.1	3.64	0.000291	Longevity	
BRCA	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.28	-10.4	3.33E-24	Longevity	
BRCA	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.4	-13.04	3.4E-36	Height	
BRCA	cis	1	rs7630874	chr3:134293291	CEP63	chr3:134204575-134293852:+	-0.14	-3.68	0.000243	Height	
BRCA	cis	1	rs76329209	chr6:26196430	HIST1H3E	chr6:26224427-26226589:+	0.35	6.74	2.58E-11	Renal underexcretion gout;Gout	
BRCA	cis	1	rs7633752	chr3:191000252	CCDC50	chr3:191046874-191116458:+	0.1	3.5	0.000481	Total ventricular volume (Alzheimer's disease interaction)	
BRCA	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.26	-9.92	3.08E-22	Longevity	
BRCA	cis	1	rs7634816	chr3:46350725	FYCO1	chr3:45959396-46037307:-	-0.11	-3.57	0.000372	Celiac disease	
BRCA	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.25	-9.51	1.22E-20	Longevity	
BRCA	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.27	-10.11	5.4E-23	Longevity	
BRCA	cis	1	rs7636782	chr3:48421387	ATRIP	chr3:48488141-48507708:+	0.1	3.54	0.00042	Longevity	
BRCA	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.24	-9.18	2.26E-19	Longevity	
BRCA	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.42	14	5.28E-41	Height	
BRCA	cis	1	rs7637227	chr3:134244155	CEP63	chr3:134204575-134293852:+	0.14	3.89	0.000108	Height	
BRCA	cis	1	rs7637230	chr3:101663555	LOC152225	chr3:101659703-101716770:+	-0.16	-4.02	6.34E-5	Psoriasis vulgaris;Psoriasis	
BRCA	cis	1	rs76388414	chr7:1100694	ZFAND2A	chr7:1192544-1199855:-	-0.3	-5.87	5.65E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs763919	chr20:44016052	SYS1	chr20:43991701-44004724:+	-0.17	-4.51	7.18E-6	Psoriasis	
BRCA	cis	1	rs763919	chr20:44016052	WFDC10B	chr20:44313291-44333658:-	-0.15	-3.6	0.000334	Psoriasis	
BRCA	cis	1	rs76422498	chr7:49328505	CDC14C	chr7:48964157-48967049:+	0.18	3.41	0.000683	Thiazide-induced adverse metabolic effects in hypertensive patients	
BRCA	cis	1	rs76430365	chr12:56699993	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.29E-5	Psoriasis vulgaris	
BRCA	cis	1	rs76430365	chr12:56699993	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.000187	Psoriasis vulgaris	
BRCA	cis	1	rs76430365	chr12:56699993	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000365	Psoriasis vulgaris	
BRCA	cis	1	rs76435840	chr11:58285981	CNTF	chr11:58390146-58393203:+	0.18	3.85	0.000123	Lymphoma	
BRCA	cis	1	rs7644148	chr3:49545241	AMT	chr3:49454212-49460012:-	-0.13	-4.39	1.25E-5	Menarche (age at onset)	
BRCA	cis	1	rs7644148	chr3:49545241	CCDC36	chr3:49235861-49295537:+	-0.11	-4.06	5.29E-5	Menarche (age at onset)	
BRCA	cis	1	rs7644148	chr3:49545241	GMPPB	chr3:49758932-49761384:-	0.13	3.69	0.000233	Menarche (age at onset)	
BRCA	cis	1	rs7644148	chr3:49545241	NCKIPSD	chr3:48711280-48723334:-	-0.14	-3.54	0.000425	Menarche (age at onset)	
BRCA	cis	1	rs7644148	chr3:49545241	P4HTM	chr3:49027341-49044579:+	-0.09	-3.83	0.000138	Menarche (age at onset)	
BRCA	cis	1	rs7644148	chr3:49545241	WDR6	chr3:49044637-49053386:+	0.14	4.26	2.24E-5	Menarche (age at onset)	
BRCA	cis	1	rs76449411	chr2:17799354	GEN1	chr2:17935162-17966632:+	0.16	3.53	0.00044	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs7644967	chr3:190999675	CCDC50	chr3:191046874-191116458:+	0.09	3.43	0.000616	Total ventricular volume (Alzheimer's disease interaction)	
BRCA	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.39	12.59	5.63E-34	Height	
BRCA	cis	1	rs7645295	chr3:134307734	CEP63	chr3:134204575-134293852:+	0.14	3.85	0.000123	Height	
BRCA	cis	1	rs7645540	chr3:191000322	CCDC50	chr3:191046874-191116458:+	0.1	3.55	0.000405	Total ventricular volume (Alzheimer's disease interaction)	
BRCA	cis	1	rs7645716	chr3:46336781	TDGF1	chr3:46619180-46623950:+	0.16	4.36	1.4E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs76466034	chr12:56719450	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.29E-5	Psoriasis vulgaris	
BRCA	cis	1	rs76466034	chr12:56719450	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.000187	Psoriasis vulgaris	
BRCA	cis	1	rs76466034	chr12:56719450	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000365	Psoriasis vulgaris	
BRCA	cis	1	rs76467433	chr7:142824852	TMEM139	chr7:142982044-142985140:+	-0.22	-3.55	0.000401	Dermatomyositis	
BRCA	cis	1	rs7647973	chr3:49510931	AMT	chr3:49454212-49460012:-	-0.14	-4.59	4.95E-6	Menarche (age at onset)	
BRCA	cis	1	rs7647973	chr3:49510931	CCDC36	chr3:49235861-49295537:+	-0.1	-3.59	0.000349	Menarche (age at onset)	
BRCA	cis	1	rs7647973	chr3:49510931	GMPPB	chr3:49758932-49761384:-	0.13	3.62	0.000307	Menarche (age at onset)	
BRCA	cis	1	rs7647973	chr3:49510931	NCKIPSD	chr3:48711280-48723334:-	-0.15	-3.66	0.000265	Menarche (age at onset)	
BRCA	cis	1	rs7647973	chr3:49510931	P4HTM	chr3:49027341-49044579:+	-0.1	-4.15	3.55E-5	Menarche (age at onset)	
BRCA	cis	1	rs7647973	chr3:49510931	WDR6	chr3:49044637-49053386:+	0.16	4.55	5.92E-6	Menarche (age at onset)	
BRCA	cis	1	rs7648592	chr3:135575079	TMEM22	chr3:136537861-136574732:+	-0.13	-3.45	0.000586	Anticoagulant levels	
BRCA	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.42	13.99	6.23E-41	Height	
BRCA	cis	1	rs7648990	chr3:134244390	CEP63	chr3:134204575-134293852:+	0.14	3.92	9.49E-5	Height	
BRCA	cis	1	rs7648995	chr3:49438803	AMT	chr3:49454212-49460012:-	-0.14	-4.73	2.59E-6	Menarche (age at onset)	
BRCA	cis	1	rs7648995	chr3:49438803	CCDC36	chr3:49235861-49295537:+	-0.1	-3.92	9.6E-5	Menarche (age at onset)	
BRCA	cis	1	rs7648995	chr3:49438803	NCKIPSD	chr3:48711280-48723334:-	-0.15	-3.92	9.61E-5	Menarche (age at onset)	
BRCA	cis	1	rs7648995	chr3:49438803	P4HTM	chr3:49027341-49044579:+	-0.1	-4.28	2.06E-5	Menarche (age at onset)	
BRCA	cis	1	rs7648995	chr3:49438803	WDR6	chr3:49044637-49053386:+	0.13	3.86	0.000122	Menarche (age at onset)	
BRCA	cis	1	rs7649764	chr3:46330862	TDGF1	chr3:46619180-46623950:+	0.13	3.72	0.000212	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs76506978	chr18:51790340	POLI	chr18:51795849-51824602:+	0.15	4.69	3.01E-6	Psoriasis	
BRCA	cis	1	rs76507298	chr20:33623522	MMP24	chr20:33814539-33864804:+	-0.23	-3.97	7.73E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs76507298	chr20:33623522	PROCR	chr20:33758727-33765164:+	-0.24	-4.88	1.21E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.29	-10.89	2.93E-26	Longevity	
BRCA	cis	1	rs7651446	chr3:156406997	LEKR1	chr3:156544076-156763918:+	-0.38	-5.49	5.09E-8	Epithelial ovarian cancer;Ovarian cancer	
BRCA	cis	1	rs7651518	chr3:57801714	ARF4	chr3:57557092-57583215:-	0.15	4.81	1.74E-6	Obesity-related traits	
BRCA	cis	1	rs7651518	chr3:57801714	PDHB	chr3:58413355-58419565:-	0.12	3.52	0.000443	Obesity-related traits	
BRCA	cis	1	rs7651518	chr3:57801714	SLMAP	chr3:57743174-57914894:+	0.1	3.54	0.00041	Obesity-related traits	
BRCA	cis	1	rs76524920	chr2:48136092	MSH6	chr2:48010221-48034084:+	-0.16	-4.14	3.81E-5	QT interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs7653691	chr3:48419689	ATRIP	chr3:48488141-48507708:+	-0.1	-3.46	0.000555	Longevity	
BRCA	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.25	9.58	6.52E-21	Longevity	
BRCA	cis	1	rs76541158	chr10:96383524	C10orf129	chr10:96953957-96988685:+	0.32	5.15	3.12E-7	Blood metabolite levels	
BRCA	cis	1	rs7655122	chr4:39122016	KLHL5	chr4:39046659-39123828:+	-0.15	-4.71	2.77E-6	Uric acid levels	
BRCA	cis	1	rs765516	chr6:117728118	ROS1	chr6:117609530-117747018:-	-0.14	-4.73	2.6E-6	Lung cancer	
BRCA	cis	1	rs765527	chr19:22129555	ZNF257	chr19:22235266-22273901:+	-0.18	-3.83	0.000135	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.41	-11.15	2.2E-27	Plasma amyloid beta peptide concentrations (ABx-40)	
BRCA	cis	1	rs7657678	chr4:17951035	NCAPG	chr4:17812525-17846485:+	0.09	4.05	5.59E-5	Height	
BRCA	cis	1	rs7657926	chr4:39134063	KLHL5	chr4:39046659-39123828:+	-0.14	-4.51	7.36E-6	Uric acid levels	
BRCA	cis	1	rs7657962	chr4:106966715	TBCK	chr4:106967233-107237861:-	0.26	7.83	1.21E-14	Airflow obstruction	
BRCA	cis	1	rs7659195	chr4:18022692	NCAPG	chr4:17812525-17846485:+	0.08	3.53	0.000426	Height	
BRCA	cis	1	rs76594057	chr18:44637272	HDHD2	chr18:44633782-44676871:-	0.3	5.16	3.01E-7	Sitting height ratio	
BRCA	cis	1	rs7659604	chr4:122665514	EXOSC9	chr4:122722472-122738175:+	-0.14	-4.7	3.0E-6	Type 2 diabetes	
BRCA	cis	1	rs76599129	chr11:18471627	LDHC	chr11:18433853-18472792:+	-0.3	-5.29	1.49E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs7659943	chr4:122665560	EXOSC9	chr4:122722472-122738175:+	0.16	5.22	2.12E-7	Type 2 diabetes	
BRCA	cis	1	rs7660078	chr4:122665577	EXOSC9	chr4:122722472-122738175:+	0.14	4.55	6.12E-6	Type 2 diabetes	
BRCA	cis	1	rs7660642	chr4:17956017	NCAPG	chr4:17812525-17846485:+	0.09	4.29	1.97E-5	Height	
BRCA	cis	1	rs7661070	chr4:39724365	LOC401127	chr4:39481875-39483521:+	0.13	3.43	0.000635	Plasma amyloid beta peptide concentrations (ABx-40)	
BRCA	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.41	-11.09	3.97E-27	Plasma amyloid beta peptide concentrations (ABx-40)	
BRCA	cis	1	rs7661129	chr4:17973171	NCAPG	chr4:17812525-17846485:+	0.09	4.4	1.21E-5	Height	
BRCA	cis	1	rs7661148	chr4:17973217	NCAPG	chr4:17812525-17846485:+	0.12	4.67	3.48E-6	Height	
BRCA	cis	1	rs7661702	chr4:104140129	MANBA	chr4:103552644-103682151:-	0.17	4.56	5.67E-6	Testicular germ cell tumor	
BRCA	cis	1	rs7662221	chr4:17966468	NCAPG	chr4:17812525-17846485:+	0.09	4.31	1.81E-5	Height	
BRCA	cis	1	rs7663818	chr4:17936443	NCAPG	chr4:17812525-17846485:+	0.09	4.04	5.84E-5	Height	
BRCA	cis	1	rs7663887	chr4:17902920	NCAPG	chr4:17812525-17846485:+	0.09	4.11	4.28E-5	Height	
BRCA	cis	1	rs7664078	chr4:39118203	KLHL5	chr4:39046659-39123828:+	-0.15	-4.69	3.03E-6	Uric acid levels	
BRCA	cis	1	rs76648234	chr20:33689941	MMP24	chr20:33814539-33864804:+	-0.2	-3.48	0.000516	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs76648234	chr20:33689941	PROCR	chr20:33758727-33765164:+	-0.24	-4.81	1.73E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7664828	chr4:103551376	MANBA	chr4:103552644-103682151:-	0.21	5.39	8.62E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs7665090	chr4:103551603	MANBA	chr4:103552644-103682151:-	-0.2	-5.23	2.01E-7	Primary biliary cirrhosis	
BRCA	cis	1	rs7665659	chr4:103551818	MANBA	chr4:103552644-103682151:-	0.21	5.39	8.62E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs7665727	chr4:277057	ZNF718	chr4:53272-156488:+	0.35	7.26	7.31E-13	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs7665854	chr4:103551909	MANBA	chr4:103552644-103682151:-	0.21	5.39	8.62E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs7667496	chr4:103509455	MANBA	chr4:103552644-103682151:-	0.17	4.13	3.84E-5	Ulcerative colitis	
BRCA	cis	1	rs76683169	chr10:102358397	SEC31B	chr10:102246403-102289636:-	-0.25	-8.11	1.34E-15	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7668417	chr4:18025029	NCAPG	chr4:17812525-17846485:+	0.08	3.53	0.000426	Height	
BRCA	cis	1	rs76688555	chr2:190747415	ORMDL1	chr2:190634994-190649097:-	0.24	4.01	6.61E-5	Subcutaneous adipose tissue	
BRCA	cis	1	rs7668933	chr4:17988141	NCAPG	chr4:17812525-17846485:+	0.1	4.47	8.58E-6	Height	
BRCA	cis	1	rs7670435	chr4:17962260	NCAPG	chr4:17812525-17846485:+	0.09	4.31	1.81E-5	Height	
BRCA	cis	1	rs7671110	chr4:17874089	NCAPG	chr4:17812525-17846485:+	0.1	4.47	8.6E-6	Height	
BRCA	cis	1	rs76722536	chr6:26192946	HIST1H3E	chr6:26224427-26226589:+	0.35	6.57	7.66E-11	Renal underexcretion gout;Gout	
BRCA	cis	1	rs7673299	chr4:39110758	KLHL5	chr4:39046659-39123828:+	-0.16	-4.86	1.33E-6	Uric acid levels	
BRCA	cis	1	rs7673321	chr4:17957688	NCAPG	chr4:17812525-17846485:+	0.1	4.39	1.23E-5	Height	
BRCA	cis	1	rs7673500	chr4:17621383	MED28	chr4:17616273-17629791:+	0.14	3.52	0.000454	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs767391	chr12:62745268	FAM19A2	chr12:62102043-62653925:-	0.18	3.86	0.000119	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs76745316	chr12:56627652	COQ10A	chr12:56660642-56664748:+	-0.29	-3.88	0.000111	Psoriasis vulgaris	
BRCA	cis	1	rs76745316	chr12:56627652	RPS26	chr12:56435686-56438005:+	-0.3	-3.72	0.000213	Psoriasis vulgaris	
BRCA	cis	1	rs76745316	chr12:56627652	SLC39A5	chr12:56623820-56631627:+	-0.28	-4	6.86E-5	Psoriasis vulgaris	
BRCA	cis	1	rs7674560	chr4:263319	ZNF718	chr4:53272-156488:+	0.31	6.85	1.27E-11	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs767471	chr6:26557854	BTN2A3	chr6:26422317-26431927:+	0.16	5.36	1.03E-7	Educational attainment	
BRCA	cis	1	rs767471	chr6:26557854	C6orf41	chr6:26924772-26991752:+	-0.13	-3.95	8.31E-5	Educational attainment	
BRCA	cis	1	rs767471	chr6:26557854	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.51	0.000462	Educational attainment	
BRCA	cis	1	rs76757237	chr7:123424956	HYAL4	chr7:123485223-123517529:+	0.28	4.09	4.62E-5	Platelet count	
BRCA	cis	1	rs7675782	chr4:39121668	KLHL5	chr4:39046659-39123828:+	-0.15	-4.52	6.8E-6	Uric acid levels	
BRCA	cis	1	rs7675806	chr4:17952959	NCAPG	chr4:17812525-17846485:+	0.09	4.08	4.75E-5	Height	
BRCA	cis	1	rs7676008	chr4:39121774	KLHL5	chr4:39046659-39123828:+	-0.15	-4.71	2.77E-6	Uric acid levels	
BRCA	cis	1	rs7677194	chr4:17962684	NCAPG	chr4:17812525-17846485:+	0.11	4.49	8.06E-6	Height	
BRCA	cis	1	rs7677248	chr4:106960497	TBCK	chr4:106967233-107237861:-	-0.25	-7.62	5.65E-14	Airflow obstruction	
BRCA	cis	1	rs7677509	chr4:103550006	MANBA	chr4:103552644-103682151:-	0.21	5.5	4.83E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs76784350	chr2:27764278	KRTCAP3	chr2:27665263-27667163:+	-0.13	-4.02	6.3E-5	Oral cavity cancer	
BRCA	cis	1	rs7678847	chr4:106987426	TBCK	chr4:106967233-107237861:-	0.23	7.23	9.42E-13	Airflow obstruction	
BRCA	cis	1	rs7679608	chr4:76514201	G3BP2	chr4:76567955-76598667:-	-0.13	-4.31	1.8E-5	Magnesium levels	
BRCA	cis	1	rs7679	chr20:44576502	SLC12A5	chr20:44650329-44688789:+	-0.2	-3.81	0.000145	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
BRCA	cis	1	rs7680372	chr4:41039713	SLC30A9	chr4:41992523-42089550:+	0.25	3.98	7.32E-5	Dental caries	
BRCA	cis	1	rs7680372	chr4:41039713	TMEM33	chr4:41937137-41962824:+	0.31	4.72	2.74E-6	Dental caries	
BRCA	cis	1	rs76804143	chr7:1082021	ZFAND2A	chr7:1192544-1199855:-	-0.33	-6.44	1.75E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs7681116	chr4:39134635	KLHL5	chr4:39046659-39123828:+	-0.14	-4.47	8.81E-6	Uric acid levels	
BRCA	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.65	8.99	1.08E-18	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs76812330	chr19:50531860	TBC1D17	chr19:50380829-50392000:+	-0.2	-3.86	0.000118	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs7682206	chr4:68428980	STAP1	chr4:68424446-68473053:+	-0.18	-6.13	1.27E-9	Parkinson's disease	
BRCA	cis	1	rs7682402	chr4:1743343	FAM53A	chr4:1641609-1685854:-	-0.2	-5.24	1.89E-7	Urinary bladder cancer;Bladder cancer	
BRCA	cis	1	rs76828799	chr10:96611177	C10orf129	chr10:96953957-96988685:+	0.35	5.74	1.26E-8	Blood metabolite levels	
BRCA	cis	1	rs7683315	chr4:88773095	SPP1	chr4:88896802-88904562:+	0.18	5.97	3.3E-9	Bone mineral density;Bone mineral density (paediatric, total body less head)	
BRCA	cis	1	rs7684221	chr4:17957354	NCAPG	chr4:17812525-17846485:+	0.09	4.24	2.43E-5	Height	
BRCA	cis	1	rs7684318	chr4:90655003	MMRN1	chr4:90816003-90875778:+	0.13	3.43	0.000617	Parkinson's disease	
BRCA	cis	1	rs7685082	chr4:39118092	KLHL5	chr4:39046659-39123828:+	-0.15	-4.74	2.41E-6	Uric acid levels	
BRCA	cis	1	rs76852223	chr6:159370432	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs7685468	chr4:39118269	KLHL5	chr4:39046659-39123828:+	-0.15	-4.63	4.04E-6	Uric acid levels	
BRCA	cis	1	rs7686082	chr4:17957576	NCAPG	chr4:17812525-17846485:+	0.1	4.52	6.79E-6	Height	
BRCA	cis	1	rs7687557	chr4:39769260	LOC401127	chr4:39481875-39483521:+	0.15	4.22	2.71E-5	Plasma amyloid beta peptide concentrations (ABx-40)	
BRCA	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.39	-10.9	2.76E-26	Plasma amyloid beta peptide concentrations (ABx-40)	
BRCA	cis	1	rs76886731	chr2:102945416	IL18R1	chr2:102927962-103015215:+	0.09	4.22	2.69E-5	Leprosy	
BRCA	cis	1	rs7689714	chr4:122665943	EXOSC9	chr4:122722472-122738175:+	0.14	4.5	7.59E-6	Type 2 diabetes	
BRCA	cis	1	rs7689722	chr4:122665955	EXOSC9	chr4:122722472-122738175:+	0.14	4.5	7.59E-6	Type 2 diabetes	
BRCA	cis	1	rs768994	chr6:159399348	RSPH3	chr6:159398268-159421198:-	0.22	3.95	8.17E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs7690734	chr4:76537889	G3BP2	chr4:76567955-76598667:-	-0.11	-3.91	9.85E-5	Magnesium levels	
BRCA	cis	1	rs7690823	chr4:17957698	NCAPG	chr4:17812525-17846485:+	0.09	4.24	2.43E-5	Height	
BRCA	cis	1	rs7692069	chr4:106959289	TBCK	chr4:106967233-107237861:-	0.25	7.78	1.68E-14	Airflow obstruction	
BRCA	cis	1	rs7692606	chr4:103509681	MANBA	chr4:103552644-103682151:-	0.17	4.24	2.4E-5	Ulcerative colitis	
BRCA	cis	1	rs7692919	chr4:165902781	TRIM61	chr4:165875600-165898818:-	0.25	8.18	8.15E-16	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs7692995	chr4:17936634	NCAPG	chr4:17812525-17846485:+	0.09	4.04	5.84E-5	Height	
BRCA	cis	1	rs7693977	chr4:165903050	TRIM61	chr4:165875600-165898818:-	0.25	8.13	1.16E-15	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs7694190	chr4:104168017	MANBA	chr4:103552644-103682151:-	0.16	4.16	3.4E-5	Testicular germ cell tumor	
BRCA	cis	1	rs7694379	chr4:88186509	HSD17B11	chr4:88257691-88312455:-	0.14	5.22	2.17E-7	Platelet count	
BRCA	cis	1	rs76945967	chr9:107741646	TMEM38B	chr9:108456825-108537444:+	0.25	4.18	3.17E-5	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs7694606	chr4:18028987	NCAPG	chr4:17812525-17846485:+	0.09	4.1	4.52E-5	Height	
BRCA	cis	1	rs7694760	chr4:39128101	KLHL5	chr4:39046659-39123828:+	-0.15	-4.6	4.82E-6	Uric acid levels	
BRCA	cis	1	rs7694806	chr4:18029100	NCAPG	chr4:17812525-17846485:+	0.08	3.68	0.000242	Height	
BRCA	cis	1	rs7695840	chr4:17962379	NCAPG	chr4:17812525-17846485:+	0.09	4.31	1.81E-5	Height	
BRCA	cis	1	rs76961885	chr7:123407020	HYAL4	chr7:123485223-123517529:+	0.23	3.51	0.000473	Platelet count	
BRCA	cis	1	rs76964971	chr2:9763904	YWHAQ	chr2:9724107-9771106:-	0.14	3.7	0.000227	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
BRCA	cis	1	rs7696532	chr4:18029299	NCAPG	chr4:17812525-17846485:+	0.09	4.27	2.13E-5	Height	
BRCA	cis	1	rs7697634	chr4:17966746	NCAPG	chr4:17812525-17846485:+	0.09	4.38	1.33E-5	Height	
BRCA	cis	1	rs7697889	chr4:17617961	MED28	chr4:17616273-17629791:+	0.15	3.9	0.000103	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs7698271	chr4:18019413	NCAPG	chr4:17812525-17846485:+	0.08	3.6	0.000332	Height	
BRCA	cis	1	rs7698644	chr4:18019572	NCAPG	chr4:17812525-17846485:+	0.08	3.6	0.000332	Height	
BRCA	cis	1	rs76994419	chr15:40714150	C15orf23	chr15:40674922-40686488:+	0.4	10.62	4.19E-25	Heschl's gyrus morphology	
BRCA	cis	1	rs76994419	chr15:40714150	C15orf57	chr15:40823540-40857252:-	0.19	3.8	0.000155	Heschl's gyrus morphology	
BRCA	cis	1	rs7699589	chr4:54533996	LNX1	chr4:54326439-54518682:-	0.13	3.58	0.000352	Beard thickness	
BRCA	cis	1	rs7699678	chr4:103550096	MANBA	chr4:103552644-103682151:-	0.21	5.5	4.83E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs77032009	chr12:56679971	COQ10A	chr12:56660642-56664748:+	-0.3	-4.18	3.12E-5	Psoriasis vulgaris	
BRCA	cis	1	rs77032009	chr12:56679971	RPS26	chr12:56435686-56438005:+	-0.29	-3.69	0.000239	Psoriasis vulgaris	
BRCA	cis	1	rs77032009	chr12:56679971	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.9	0.0001	Psoriasis vulgaris	
BRCA	cis	1	rs7705093	chr5:96290647	ERAP1	chr5:96096515-96149837:-	-0.15	-4.95	8.84E-7	Birdshot chorioretinopathy	
BRCA	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.06	51.49	1.58E-291	Birdshot chorioretinopathy	
BRCA	cis	1	rs77097088	chr6:159354815	RSPH3	chr6:159398268-159421198:-	0.21	3.86	0.000121	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs7710900	chr5:82433020	XRCC4	chr5:82373317-82649577:+	-0.12	-3.4	0.000703	Hypertension	
BRCA	cis	1	rs77120931	chr12:56646213	COQ10A	chr12:56660642-56664748:+	-0.29	-4.08	4.91E-5	Psoriasis vulgaris	
BRCA	cis	1	rs77120931	chr12:56646213	RPS26	chr12:56435686-56438005:+	-0.28	-3.62	0.000303	Psoriasis vulgaris	
BRCA	cis	1	rs77120931	chr12:56646213	SLC39A5	chr12:56623820-56631627:+	-0.26	-3.88	0.000112	Psoriasis vulgaris	
BRCA	cis	1	rs77131854	chr12:56664231	COQ10A	chr12:56660642-56664748:+	-0.3	-4.19	3.02E-5	Psoriasis vulgaris	
BRCA	cis	1	rs77131854	chr12:56664231	RPS26	chr12:56435686-56438005:+	-0.31	-3.99	7.01E-5	Psoriasis vulgaris	
BRCA	cis	1	rs77131854	chr12:56664231	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.95	8.2E-5	Psoriasis vulgaris	
BRCA	cis	1	rs7716219	chr5:54955071	PPAP2A	chr5:54720685-54830873:-	0.11	4.13	3.92E-5	Height	
BRCA	cis	1	rs7716600	chr5:44875005	MRPS30	chr5:44809027-44815614:+	-0.15	-3.67	0.000257	Breast cancer	
BRCA	cis	1	rs7716931	chr5:82434675	XRCC4	chr5:82373317-82649577:+	-0.12	-3.54	0.000411	Hypertension	
BRCA	cis	1	rs7717000	chr5:112709742	YTHDC2	chr5:112849410-112930979:+	0.14	4.09	4.71E-5	Cerebral amyloid angiopathy	
BRCA	cis	1	rs77181006	chr2:48137033	MSH6	chr2:48010221-48034084:+	-0.19	-4.42	1.07E-5	QT interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.75	9.72	1.92E-21	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs77187281	chr19:50507667	TBC1D17	chr19:50380829-50392000:+	-0.22	-3.94	8.76E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs7718874	chr5:176358065	MXD3	chr5:176732501-176739292:-	-0.08	-4.03	6.07E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
BRCA	cis	1	rs7719994	chr5:156430076	TIMD4	chr5:156346293-156390266:-	-0.16	-4.29	1.97E-5	Hypertriglyceridemia	
BRCA	cis	1	rs772029	chr10:104072327	PITX3	chr10:103989946-104001231:-	-0.11	-3.45	0.000584	QT interval	
BRCA	cis	1	rs7721416	chr5:82434993	XRCC4	chr5:82373317-82649577:+	-0.12	-3.54	0.000411	Hypertension	
BRCA	cis	1	rs77225875	chr6:159418145	RSPH3	chr6:159398268-159421198:-	0.27	4.72	2.65E-6	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs77245075	chr2:17810302	GEN1	chr2:17935162-17966632:+	0.17	3.54	0.000414	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs7724832	chr5:156381370	TIMD4	chr5:156346293-156390266:-	-0.22	-7.18	1.31E-12	Triglycerides;Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs77257477	chr8:96045399	C8orf38	chr8:95908040-96088396:+	-0.19	-4.31	1.79E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs7726556	chr5:156478780	TIMD4	chr5:156346293-156390266:-	-0.15	-4.08	4.85E-5	Hypertriglyceridemia	
BRCA	cis	1	rs7726839	chr5:618586	SLC9A3	chr5:473334-524549:-	0.2	5.27	1.68E-7	Obesity-related traits	
BRCA	cis	1	rs7727038	chr5:131590257	PDLIM4	chr5:131593351-131609145:+	-0.16	-5.52	4.28E-8	Blood metabolite levels	
BRCA	cis	1	rs7727038	chr5:131590257	SLC22A5	chr5:131705401-131731302:+	-0.13	-4.67	3.35E-6	Blood metabolite levels	
BRCA	cis	1	rs7727544	chr5:131590534	PDLIM4	chr5:131593351-131609145:+	-0.16	-5.52	4.26E-8	Blood metabolite levels	
BRCA	cis	1	rs7727544	chr5:131590534	SLC22A5	chr5:131705401-131731302:+	-0.13	-4.67	3.37E-6	Blood metabolite levels	
BRCA	cis	1	rs7727882	chr5:115614507	COMMD10	chr5:115420727-115628978:+	0.2	4.36	1.46E-5	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs77305932	chr7:1100861	ZFAND2A	chr7:1192544-1199855:-	-0.3	-5.87	5.65E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs7731099	chr5:45038026	MRPS30	chr5:44809027-44815614:+	0.14	3.45	0.000582	Age at first birth	
BRCA	cis	1	rs7731390	chr5:131721749	P4HA2	chr5:131528306-131563556:-	-0.31	-4.54	6.29E-6	IgG glycosylation	
BRCA	cis	1	rs7733331	chr5:32828846	TARS	chr5:33440802-33468194:+	0.11	3.6	0.000331	Height	
BRCA	cis	1	rs77374467	chr6:24475278	ALDH5A1	chr6:24495197-24537434:+	0.24	4.47	8.71E-6	Hematological and biochemical traits	
BRCA	cis	1	rs77374467	chr6:24475278	GPLD1	chr6:24428405-24489850:-	0.42	7.74	2.25E-14	Hematological and biochemical traits	
BRCA	cis	1	rs77374467	chr6:24475278	MRS2	chr6:24403153-24425809:+	0.18	3.45	0.000592	Hematological and biochemical traits	
BRCA	cis	1	rs7740487	chr6:28216486	HIST1H4J	chr6:27791903-27792257:+	-0.19	-3.71	0.000222	Depression	
BRCA	cis	1	rs7740487	chr6:28216486	ZNF323	chr6:28292517-28324048:-	0.2	3.44	0.000594	Depression	
BRCA	cis	1	rs7740487	chr6:28216486	ZNF389	chr6:28129551-28137375:+	-0.19	-3.44	0.000598	Depression	
BRCA	cis	1	rs7740487	chr6:28216486	ZSCAN23	chr6:28393287-28411279:-	0.17	3.54	0.000415	Depression	
BRCA	cis	1	rs7740682	chr6:49488745	CENPQ	chr6:49431096-49460820:+	0.18	6.06	1.92E-9	Brain structure	
BRCA	cis	1	rs77419080	chr10:96546020	C10orf129	chr10:96953957-96988685:+	0.32	5.36	1.03E-7	Blood metabolite levels	
BRCA	cis	1	rs7742626	chr6:136132496	C6orf217	chr6:135818939-136037192:+	0.13	3.64	0.000286	Phosphorus levels	
BRCA	cis	1	rs77437249	chr20:33564738	MMP24	chr20:33814539-33864804:+	-0.21	-3.78	0.000163	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs77437249	chr20:33564738	PROCR	chr20:33758727-33765164:+	-0.24	-4.99	6.96E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs77446828	chr6:159414034	RSPH3	chr6:159398268-159421198:-	0.23	4.07	4.94E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs7744697	chr6:152948986	VIP	chr6:153071933-153080898:+	0.12	4	6.81E-5	Tonometry	
BRCA	cis	1	rs7744715	chr6:152949026	VIP	chr6:153071933-153080898:+	0.12	4	6.81E-5	Tonometry	
BRCA	cis	1	rs77447765	chr12:56690662	COQ10A	chr12:56660642-56664748:+	-0.29	-3.96	7.85E-5	Psoriasis vulgaris	
BRCA	cis	1	rs77447765	chr12:56690662	RPS26	chr12:56435686-56438005:+	-0.3	-3.88	0.000111	Psoriasis vulgaris	
BRCA	cis	1	rs77447765	chr12:56690662	SLC39A5	chr12:56623820-56631627:+	-0.26	-3.75	0.000189	Psoriasis vulgaris	
BRCA	cis	1	rs77452668	chr2:48135517	MSH6	chr2:48010221-48034084:+	-0.19	-4.64	3.86E-6	QT interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs7747003	chr6:153428982	RGS17	chr6:153332041-153452389:-	-0.12	-3.47	0.000538	Prostate cancer	
BRCA	cis	1	rs7747061	chr6:4381445	CDYL	chr6:4706393-4955777:+	-0.19	-3.46	0.000567	Obesity-related traits	
BRCA	cis	1	rs7747061	chr6:4381445	LYRM4	chr6:5108654-5261168:-	-0.17	-3.62	0.000312	Obesity-related traits	
BRCA	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.59	-19.4	4.57E-72	Response to antipsychotic treatment	
BRCA	cis	1	rs7750803	chr6:111800113	KIAA1919	chr6:111580482-111590259:+	-0.32	-4.49	7.88E-6	Psoriasis	
BRCA	cis	1	rs7750918	chr6:49430082	CENPQ	chr6:49431096-49460820:+	-0.24	-7.7	2.98E-14	Folate pathway vitamin levels	
BRCA	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.31	9.69	2.37E-21	Folate pathway vitamin levels	
BRCA	cis	1	rs7752664	chr6:160219035	PNLDC1	chr6:160221301-160241735:+	-0.41	-5.28	1.56E-7	Iron status biomarkers	
BRCA	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	0.32	9.26	1.07E-19	Heschl's gyrus morphology	
BRCA	cis	1	rs77531164	chr15:40673466	IVD	chr15:40697686-40713512:+	-0.16	-3.75	0.000186	Heschl's gyrus morphology	
BRCA	cis	1	rs7755323	chr6:33761159	LEMD2	chr6:33738991-33756906:-	0.14	4.75	2.34E-6	Body mass index	
BRCA	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.56	-17.95	3.91E-63	Response to antipsychotic treatment	
BRCA	cis	1	rs77562891	chr18:51791235	POLI	chr18:51795849-51824602:+	0.14	4.62	4.24E-6	Psoriasis	
BRCA	cis	1	rs77564939	chr5:115564294	COMMD10	chr5:115420727-115628978:+	0.23	4.91	1.07E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs7757014	chr6:49491690	CENPQ	chr6:49431096-49460820:+	-0.21	-7.03	3.6E-12	Brain structure	
BRCA	cis	1	rs7759001	chr6:27341409	ZNF391	chr6:27356524-27369227:+	0.17	4.59	4.91E-6	Glomerular filtration rate (creatinine)	
BRCA	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.32	-10.76	1.05E-25	Homocysteine levels	
BRCA	cis	1	rs7759071	chr6:49433198	MUT	chr6:49398994-49431031:-	0.16	4.8	1.81E-6	Homocysteine levels	
BRCA	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.59	-18.45	3.3E-66	Response to antipsychotic treatment	
BRCA	cis	1	rs77605770	chr6:159370528	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs77619527	chr7:123407736	HYAL4	chr7:123485223-123517529:+	0.29	4.2	2.84E-5	Platelet count	
BRCA	cis	1	rs7762901	chr6:24449639	ALDH5A1	chr6:24495197-24537434:+	-0.15	-3.5	0.000479	Liver enzyme levels	
BRCA	cis	1	rs7764785	chr6:163009967	PACRG	chr6:163148164-163736523:+	0.23	4.37	1.36E-5	Body mass index	
BRCA	cis	1	rs7765586	chr6:152949109	VIP	chr6:153071933-153080898:+	-0.12	-3.84	0.00013	Tonometry	
BRCA	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.58	-19.32	1.53E-71	Response to antipsychotic treatment	
BRCA	cis	1	rs7767550	chr6:43899252	HSP90AB1	chr6:44214849-44221614:+	0.13	3.54	0.000415	Vascular endothelial growth factor levels	
BRCA	cis	1	rs7767550	chr6:43899252	MRPL14	chr6:44081374-44095191:-	0.13	4.31	1.75E-5	Vascular endothelial growth factor levels	
BRCA	cis	1	rs77680330	chr2:160121237	WDSUB1	chr2:160092305-160143236:-	0.33	3.96	7.86E-5	Sudden cardiac arrest	
BRCA	cis	1	rs7769686	chr6:163199467	PACRG	chr6:163148164-163736523:+	0.2	3.47	0.000535	Body mass index	
BRCA	cis	1	rs7769943	chr6:134196327	TCF21	chr6:134210259-134219157:+	0.15	3.96	8.11E-5	Coronary heart disease	
BRCA	cis	1	rs7769954	chr6:134196381	TCF21	chr6:134210259-134219157:+	0.14	3.81	0.000148	Coronary heart disease	
BRCA	cis	1	rs77702926	chr7:1088838	ZFAND2A	chr7:1192544-1199855:-	-0.34	-6.57	7.96E-11	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs77706078	chr5:56268686	MAP3K1	chr5:56110900-56191976:+	-0.25	-4.04	5.72E-5	Breast cancer (early onset)	
BRCA	cis	1	rs7770848	chr6:44769237	AARS2	chr6:44266463-44281063:-	-0.27	-4.69	3.02E-6	Asthma (childhood onset)	
BRCA	cis	1	rs7770848	chr6:44769237	CDC5L	chr6:44355302-44414779:+	-0.28	-4.93	9.43E-7	Asthma (childhood onset)	
BRCA	cis	1	rs7770848	chr6:44769237	HSP90AB1	chr6:44214849-44221614:+	-0.24	-4.2	2.87E-5	Asthma (childhood onset)	
BRCA	cis	1	rs7770848	chr6:44769237	MRPL14	chr6:44081374-44095191:-	-0.24	-5.44	6.51E-8	Asthma (childhood onset)	
BRCA	cis	1	rs7770848	chr6:44769237	SLC29A1	chr6:44187242-44201888:+	-0.26	-3.82	0.000141	Asthma (childhood onset)	
BRCA	cis	1	rs7770848	chr6:44769237	SLC35B2	chr6:44221839-44225283:-	-0.41	-6.22	7.04E-10	Asthma (childhood onset)	
BRCA	cis	1	rs7770848	chr6:44769237	SUPT3H	chr6:44777054-45345670:-	-0.27	-3.88	0.00011	Asthma (childhood onset)	
BRCA	cis	1	rs7770848	chr6:44769237	TMEM63B	chr6:44095376-44123255:+	-0.31	-5.05	5.22E-7	Asthma (childhood onset)	
BRCA	cis	1	rs7770923	chr6:117726980	ROS1	chr6:117609530-117747018:-	-0.14	-4.68	3.25E-6	Lung cancer	
BRCA	cis	1	rs7771211	chr6:117727025	ROS1	chr6:117609530-117747018:-	-0.15	-5.02	6.0E-7	Lung cancer	
BRCA	cis	1	rs7771271	chr6:117727236	ROS1	chr6:117609530-117747018:-	-0.15	-5.02	5.92E-7	Lung cancer	
BRCA	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.56	-17.95	3.91E-63	Response to antipsychotic treatment	
BRCA	cis	1	rs7771437	chr6:117727313	ROS1	chr6:117609530-117747018:-	-0.15	-5.02	5.92E-7	Lung cancer	
BRCA	cis	1	rs7771637	chr6:117727491	ROS1	chr6:117609530-117747018:-	-0.15	-4.87	1.28E-6	Lung cancer	
BRCA	cis	1	rs7772046	chr6:117727485	ROS1	chr6:117609530-117747018:-	-0.15	-4.99	6.96E-7	Lung cancer	
BRCA	cis	1	rs77738210	chr7:123428916	HYAL4	chr7:123485223-123517529:+	0.27	3.95	8.2E-5	Platelet count	
BRCA	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.32	-10.56	7.66E-25	Homocysteine levels	
BRCA	cis	1	rs7774688	chr6:49387292	MUT	chr6:49398994-49431031:-	0.15	4.61	4.58E-6	Homocysteine levels	
BRCA	cis	1	rs77760339	chr7:1083927	ZFAND2A	chr7:1192544-1199855:-	-0.33	-6.45	1.72E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs7776244	chr6:117727949	ROS1	chr6:117609530-117747018:-	-0.15	-5.02	5.92E-7	Lung cancer	
BRCA	cis	1	rs77763497	chr20:3250007	ITPA	chr20:3190056-3204504:+	-0.13	-3.71	0.000221	IFN-related cytopenia	
BRCA	cis	1	rs77768890	chr12:56725121	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.29E-5	Psoriasis vulgaris	
BRCA	cis	1	rs77768890	chr12:56725121	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.000187	Psoriasis vulgaris	
BRCA	cis	1	rs77768890	chr12:56725121	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000365	Psoriasis vulgaris	
BRCA	cis	1	rs7777389	chr7:143744802	ARHGEF35	chr7:143883677-143892736:-	-0.41	-10	1.42E-22	Obesity-related traits	
BRCA	cis	1	rs7777389	chr7:143744802	OR2A7	chr7:143955790-143974852:-	0.21	4.88	1.2E-6	Obesity-related traits	
BRCA	cis	1	rs7778258	chr7:50666378	FIGNL1	chr7:50511834-50518088:-	-0.13	-4.05	5.51E-5	Response to zileuton treatment in asthma (FEV1 change interaction)	
BRCA	cis	1	rs7778911	chr7:65694506	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.61	6.14E-11	Diabetic kidney disease	
BRCA	cis	1	rs7778911	chr7:65694506	CRCP	chr7:65579805-65619551:+	0.2	3.42	0.000654	Diabetic kidney disease	
BRCA	cis	1	rs7778911	chr7:65694506	LOC493754	chr7:65993446-66057363:-	-0.22	-3.7	0.00023	Diabetic kidney disease	
BRCA	cis	1	rs77819408	chr10:96552188	C10orf129	chr10:96953957-96988685:+	0.21	3.83	0.000134	Blood metabolite levels	
BRCA	cis	1	rs7782320	chr7:66177098	CRCP	chr7:65579805-65619551:+	-0.13	-3.46	0.00056	Aortic root size	
BRCA	cis	1	rs7782320	chr7:66177098	TYW1	chr7:66461817-66704496:+	0.15	3.99	7.19E-5	Aortic root size	
BRCA	cis	1	rs77828555	chr9:20124092	PLIN2	chr9:19115760-19127573:-	-0.18	-3.38	0.000747	Asthma (toluene diisocyanate-induced)	
BRCA	cis	1	rs7783924	chr7:66209057	CRCP	chr7:65579805-65619551:+	-0.14	-3.69	0.000239	Aortic root size	
BRCA	cis	1	rs7783924	chr7:66209057	TYW1	chr7:66461817-66704496:+	0.14	3.72	0.000208	Aortic root size	
BRCA	cis	1	rs77849630	chr5:115556900	COMMD10	chr5:115420727-115628978:+	0.25	4.82	1.64E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs7785213	chr7:66138978	TYW1	chr7:66461817-66704496:+	-0.15	-4.06	5.18E-5	Aortic root size	
BRCA	cis	1	rs77853814	chr12:56687572	COQ10A	chr12:56660642-56664748:+	-0.29	-3.95	8.18E-5	Psoriasis vulgaris	
BRCA	cis	1	rs77853814	chr12:56687572	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.00019	Psoriasis vulgaris	
BRCA	cis	1	rs77853814	chr12:56687572	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.61	0.000316	Psoriasis vulgaris	
BRCA	cis	1	rs77856716	chr5:115565660	COMMD10	chr5:115420727-115628978:+	0.24	4.49	8.03E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs778679	chr7:65840911	CCT6P1	chr7:65216092-65228661:+	0.33	6.94	6.97E-12	Diabetic kidney disease	
BRCA	cis	1	rs778679	chr7:65840911	LOC493754	chr7:65993446-66057363:-	0.25	4.17	3.29E-5	Diabetic kidney disease	
BRCA	cis	1	rs778691	chr7:65873092	CCT6P1	chr7:65216092-65228661:+	0.31	6.53	1.02E-10	Diabetic kidney disease	
BRCA	cis	1	rs778691	chr7:65873092	CRCP	chr7:65579805-65619551:+	-0.21	-3.51	0.00046	Diabetic kidney disease	
BRCA	cis	1	rs778691	chr7:65873092	LOC493754	chr7:65993446-66057363:-	0.22	3.7	0.000228	Diabetic kidney disease	
BRCA	cis	1	rs778704	chr7:65863467	CCT6P1	chr7:65216092-65228661:+	0.31	6.53	1.02E-10	Diabetic kidney disease	
BRCA	cis	1	rs778704	chr7:65863467	CRCP	chr7:65579805-65619551:+	-0.21	-3.51	0.00046	Diabetic kidney disease	
BRCA	cis	1	rs778704	chr7:65863467	LOC493754	chr7:65993446-66057363:-	0.22	3.7	0.000228	Diabetic kidney disease	
BRCA	cis	1	rs7787230	chr7:65629099	CCT6P1	chr7:65216092-65228661:+	-0.29	-6.17	9.76E-10	Diabetic kidney disease	
BRCA	cis	1	rs7787230	chr7:65629099	CRCP	chr7:65579805-65619551:+	0.23	3.81	0.000148	Diabetic kidney disease	
BRCA	cis	1	rs7787230	chr7:65629099	LOC493754	chr7:65993446-66057363:-	-0.21	-3.47	0.000546	Diabetic kidney disease	
BRCA	cis	1	rs7787274	chr7:2275993	FTSJ2	chr7:2273928-2281833:-	0.23	5.9	4.88E-9	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
BRCA	cis	1	rs778729	chr7:65824419	CCT6P1	chr7:65216092-65228661:+	0.33	6.96	5.89E-12	Diabetic kidney disease	
BRCA	cis	1	rs778729	chr7:65824419	LOC493754	chr7:65993446-66057363:-	0.25	4.13	3.9E-5	Diabetic kidney disease	
BRCA	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.25	-12.26	2.1E-32	Tuberculosis	
BRCA	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.51	13.25	3.31E-37	Tuberculosis	
BRCA	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.25	-12.07	1.52E-31	Tuberculosis	
BRCA	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.5	13.13	1.27E-36	Tuberculosis	
BRCA	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.26	-12.27	1.74E-32	Tuberculosis	
BRCA	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.5	13.19	6.7E-37	Tuberculosis	
BRCA	cis	1	rs77876414	chr6:159414811	RSPH3	chr6:159398268-159421198:-	0.27	4.8	1.78E-6	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs7788576	chr7:66148302	TYW1	chr7:66461817-66704496:+	-0.15	-3.94	8.8E-5	Aortic root size	
BRCA	cis	1	rs7788766	chr7:117527041	CTTNBP2	chr7:117350708-117513561:-	-0.13	-3.82	0.00014	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs7789184	chr7:66210195	CRCP	chr7:65579805-65619551:+	-0.14	-3.69	0.000239	Aortic root size	
BRCA	cis	1	rs7789184	chr7:66210195	TYW1	chr7:66461817-66704496:+	0.14	3.72	0.000208	Aortic root size	
BRCA	cis	1	rs7789940	chr7:75951230	UPK3B	chr7:76139745-76157197:+	-0.24	-6.08	1.7E-9	Multiple sclerosis	
BRCA	cis	1	rs77902909	chr6:24478715	ALDH5A1	chr6:24495197-24537434:+	0.24	4.45	9.48E-6	Hematological and biochemical traits	
BRCA	cis	1	rs77902909	chr6:24478715	GPLD1	chr6:24428405-24489850:-	0.41	7.62	5.71E-14	Hematological and biochemical traits	
BRCA	cis	1	rs77902909	chr6:24478715	MRS2	chr6:24403153-24425809:+	0.18	3.48	0.000528	Hematological and biochemical traits	
BRCA	cis	1	rs77921213	chr10:96546246	C10orf129	chr10:96953957-96988685:+	0.32	5.36	1.03E-7	Blood metabolite levels	
BRCA	cis	1	rs7792391	chr7:65773429	CCT6P1	chr7:65216092-65228661:+	-0.31	-6.66	4.5E-11	Diabetic kidney disease	
BRCA	cis	1	rs7792391	chr7:65773429	CRCP	chr7:65579805-65619551:+	0.21	3.51	0.000465	Diabetic kidney disease	
BRCA	cis	1	rs7792391	chr7:65773429	LOC493754	chr7:65993446-66057363:-	-0.22	-3.71	0.00022	Diabetic kidney disease	
BRCA	cis	1	rs77931772	chr7:123425913	HYAL4	chr7:123485223-123517529:+	0.26	3.74	0.000196	Platelet count	
BRCA	cis	1	rs7794364	chr7:117508506	CTTNBP2	chr7:117350708-117513561:-	-0.14	-4.19	3.04E-5	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs7794661	chr7:65389730	CCT6P1	chr7:65216092-65228661:+	0.34	7.51	1.2E-13	Diabetic kidney disease	
BRCA	cis	1	rs7794661	chr7:65389730	LOC493754	chr7:65993446-66057363:-	0.2	3.39	0.000737	Diabetic kidney disease	
BRCA	cis	1	rs7794661	chr7:65389730	ZNF117	chr7:64434830-64467121:-	-0.28	-5.13	3.46E-7	Diabetic kidney disease	
BRCA	cis	1	rs7795242	chr7:65390094	CCT6P1	chr7:65216092-65228661:+	0.33	7.26	7.5E-13	Diabetic kidney disease	
BRCA	cis	1	rs7795242	chr7:65390094	LOC493754	chr7:65993446-66057363:-	0.21	3.56	0.000384	Diabetic kidney disease	
BRCA	cis	1	rs7795242	chr7:65390094	ZNF117	chr7:64434830-64467121:-	-0.27	-4.94	9.17E-7	Diabetic kidney disease	
BRCA	cis	1	rs7795627	chr7:117512601	CTTNBP2	chr7:117350708-117513561:-	-0.14	-4.01	6.61E-5	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs77957229	chr6:26185226	HIST1H3E	chr6:26224427-26226589:+	0.32	5.8	8.51E-9	Renal underexcretion gout;Gout	
BRCA	cis	1	rs77961951	chr6:26186075	HIST1H3E	chr6:26224427-26226589:+	0.33	5.94	3.94E-9	Renal underexcretion gout;Gout	
BRCA	cis	1	rs7796616	chr7:117512985	CTTNBP2	chr7:117350708-117513561:-	-0.14	-4.03	6.03E-5	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs77972171	chr7:123418493	HYAL4	chr7:123485223-123517529:+	0.28	3.97	7.71E-5	Platelet count	
BRCA	cis	1	rs7799006	chr7:2278226	FTSJ2	chr7:2273928-2281833:-	0.21	5.53	3.95E-8	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
BRCA	cis	1	rs7800418	chr7:26606005	LOC441204	chr7:26438339-26538594:+	-0.18	-4.82	1.67E-6	Cognitive function	
BRCA	cis	1	rs780092	chr2:27743154	C2orf18	chr2:26987142-27004099:+	-0.18	-3.6	0.000334	Triglycerides;Metabolite levels;Lipid traits	
BRCA	cis	1	rs780094	chr2:27741237	NRBP1	chr2:27650657-27665122:+	0.11	3.54	0.000423	Crohn's disease;Metabolic syndrome;Urate levels;Fasting glucose-related traits (interaction with BMI);Fasting plasma glucose;Urate levels in obese individuals;Hypertriglyceridemia;Urate levels in overweight individuals;Fasting insulin-related traits;Uric acid levels;Height;Calcium levels;Metabolic t	
BRCA	cis	1	rs78012445	chr6:26195080	HIST1H3E	chr6:26224427-26226589:+	0.34	6.71	3.13E-11	Renal underexcretion gout;Gout	
BRCA	cis	1	rs7801539	chr7:117506763	CTTNBP2	chr7:117350708-117513561:-	-0.14	-4.03	6.09E-5	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs7801931	chr7:117506858	CTTNBP2	chr7:117350708-117513561:-	-0.15	-4.3	1.87E-5	Idiopathic osteonecrosis of the femoral head	
BRCA	cis	1	rs7802797	chr7:110911133	IMMP2L	chr7:110303110-111202538:-	0.16	4.34	1.55E-5	Schizophrenia	
BRCA	cis	1	rs78032828	chr2:86309032	LOC90784	chr2:86247339-86250991:-	-0.3	-3.96	8.13E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs78032828	chr2:86309032	ST3GAL5	chr2:86066271-86116157:-	0.31	4.44	9.74E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs7804223	chr7:65664559	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.3	4.26E-10	Diabetic kidney disease	
BRCA	cis	1	rs7804223	chr7:65664559	CRCP	chr7:65579805-65619551:+	0.22	3.76	0.000176	Diabetic kidney disease	
BRCA	cis	1	rs7804223	chr7:65664559	LOC493754	chr7:65993446-66057363:-	-0.22	-3.6	0.000328	Diabetic kidney disease	
BRCA	cis	1	rs78055011	chr20:33618606	MMP24	chr20:33814539-33864804:+	-0.23	-3.97	7.73E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs78055011	chr20:33618606	PROCR	chr20:33758727-33765164:+	-0.24	-4.88	1.21E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs78057537	chr2:160101705	WDSUB1	chr2:160092305-160143236:-	0.33	4.06	5.24E-5	Sudden cardiac arrest	
BRCA	cis	1	rs78075030	chr6:55987294	COL21A1	chr6:55921389-56258892:-	-0.38	-6.92	7.66E-12	Psychosis (atypical)	
BRCA	cis	1	rs78075821	chr1:171724645	VAMP4	chr1:171669298-171711214:-	0.23	6.45	1.65E-10	Hippocampal atrophy	
BRCA	cis	1	rs78087496	chr7:123412837	HYAL4	chr7:123485223-123517529:+	0.29	4.11	4.29E-5	Platelet count	
BRCA	cis	1	rs7810543	chr7:110894778	IMMP2L	chr7:110303110-111202538:-	-0.16	-4.24	2.43E-5	Schizophrenia	
BRCA	cis	1	rs7810970	chr7:2276385	FTSJ2	chr7:2273928-2281833:-	0.22	5.85	6.72E-9	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
BRCA	cis	1	rs781142	chr7:65438778	CCT6P1	chr7:65216092-65228661:+	0.34	7.55	9.3E-14	Diabetic kidney disease	
BRCA	cis	1	rs781142	chr7:65438778	LOC493754	chr7:65993446-66057363:-	0.2	3.4	0.000688	Diabetic kidney disease	
BRCA	cis	1	rs781142	chr7:65438778	ZNF117	chr7:64434830-64467121:-	-0.27	-4.96	8.06E-7	Diabetic kidney disease	
BRCA	cis	1	rs781149	chr7:65481284	CCT6P1	chr7:65216092-65228661:+	0.3	6.64	5.09E-11	Diabetic kidney disease	
BRCA	cis	1	rs781149	chr7:65481284	LOC493754	chr7:65993446-66057363:-	0.2	3.47	0.000551	Diabetic kidney disease	
BRCA	cis	1	rs781150	chr7:65480973	CCT6P1	chr7:65216092-65228661:+	0.34	7.39	3.03E-13	Diabetic kidney disease	
BRCA	cis	1	rs781150	chr7:65480973	LOC493754	chr7:65993446-66057363:-	0.21	3.51	0.000462	Diabetic kidney disease	
BRCA	cis	1	rs781156	chr7:65479141	CCT6P1	chr7:65216092-65228661:+	0.34	7.28	6.53E-13	Diabetic kidney disease	
BRCA	cis	1	rs781156	chr7:65479141	LOC493754	chr7:65993446-66057363:-	0.2	3.44	0.000608	Diabetic kidney disease	
BRCA	cis	1	rs781157	chr7:65478311	CCT6P1	chr7:65216092-65228661:+	0.31	6.73	2.85E-11	Diabetic kidney disease	
BRCA	cis	1	rs781157	chr7:65478311	CRCP	chr7:65579805-65619551:+	-0.2	-3.38	0.000745	Diabetic kidney disease	
BRCA	cis	1	rs781157	chr7:65478311	LOC493754	chr7:65993446-66057363:-	0.2	3.38	0.000748	Diabetic kidney disease	
BRCA	cis	1	rs78121408	chr12:56684798	COQ10A	chr12:56660642-56664748:+	-0.29	-3.96	7.85E-5	Psoriasis vulgaris	
BRCA	cis	1	rs78121408	chr12:56684798	RPS26	chr12:56435686-56438005:+	-0.3	-3.88	0.000111	Psoriasis vulgaris	
BRCA	cis	1	rs78121408	chr12:56684798	SLC39A5	chr12:56623820-56631627:+	-0.26	-3.75	0.000189	Psoriasis vulgaris	
BRCA	cis	1	rs7812644	chr8:65681616	CYP7B1	chr8:65508529-65711348:-	0.12	3.89	0.000108	HIV-1 susceptibility	
BRCA	cis	1	rs78133532	chr18:51794210	POLI	chr18:51795849-51824602:+	0.14	4.4	1.19E-5	Psoriasis	
BRCA	cis	1	rs78149779	chr12:56694817	COQ10A	chr12:56660642-56664748:+	-0.28	-3.94	8.81E-5	Psoriasis vulgaris	
BRCA	cis	1	rs78149779	chr12:56694817	RPS26	chr12:56435686-56438005:+	-0.3	-3.9	0.000101	Psoriasis vulgaris	
BRCA	cis	1	rs78149779	chr12:56694817	SLC39A5	chr12:56623820-56631627:+	-0.26	-3.73	0.000205	Psoriasis vulgaris	
BRCA	cis	1	rs78150064	chr10:96388665	C10orf129	chr10:96953957-96988685:+	0.26	4.72	2.71E-6	Blood metabolite levels	
BRCA	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	0.32	9.27	9.87E-20	Heschl's gyrus morphology	
BRCA	cis	1	rs78153629	chr15:40673465	IVD	chr15:40697686-40713512:+	-0.16	-3.73	0.0002	Heschl's gyrus morphology	
BRCA	cis	1	rs78158942	chr7:1090440	ZFAND2A	chr7:1192544-1199855:-	-0.33	-6.39	2.49E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs7818067	chr8:15535716	TUSC3	chr8:15397730-15621993:+	0.25	5.7	1.55E-8	Pulmonary function decline	
BRCA	cis	1	rs78185558	chr7:1090183	ZFAND2A	chr7:1192544-1199855:-	-0.3	-6.24	6.29E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs7819021	chr8:15535593	TUSC3	chr8:15397730-15621993:+	0.23	5.07	4.79E-7	Pulmonary function decline	
BRCA	cis	1	rs78210154	chr11:96109480	CCDC82	chr11:96085930-96123083:-	-0.12	-3.38	0.00074	Parkinson's disease	
BRCA	cis	1	rs78213404	chr1:171685491	VAMP4	chr1:171669298-171711214:-	0.19	5.4	8.35E-8	Hippocampal atrophy	
BRCA	cis	1	rs7822232	chr8:145145687	KIAA1875	chr8:145162629-145173218:+	-0.23	-5	6.68E-7	Blood metabolite levels	
BRCA	cis	1	rs78233646	chr12:131520170	EP400	chr12:132434508-132565004:+	-0.11	-3.45	0.000588	Longevity	
BRCA	cis	1	rs78233646	chr12:131520170	FZD10	chr12:130647032-130650284:+	0.14	3.53	0.00043	Longevity	
BRCA	cis	1	rs7824557	chr8:11104111	TDH	chr8:11197146-11225961:+	0.16	3.97	7.55E-5	Retinal vascular caliber	
BRCA	cis	1	rs7825175	chr8:32416274	C8orf41	chr8:33330904-33370703:-	-0.16	-3.4	0.000698	Thyroid hormone levels	
BRCA	cis	1	rs782590	chr2:55843413	PNPT1	chr2:55861198-55921011:-	-0.17	-6	2.62E-9	Metabolic syndrome	
BRCA	cis	1	rs782594	chr2:55844445	PNPT1	chr2:55861198-55921011:-	-0.17	-6.02	2.37E-9	Metabolic syndrome	
BRCA	cis	1	rs78261998	chr10:96630716	C10orf129	chr10:96953957-96988685:+	0.35	5.71	1.46E-8	Blood metabolite levels	
BRCA	cis	1	rs7826501	chr8:65676291	CYP7B1	chr8:65508529-65711348:-	0.12	3.79	0.000158	HIV-1 susceptibility	
BRCA	cis	1	rs78267272	chr2:17790782	GEN1	chr2:17935162-17966632:+	0.16	3.48	0.000512	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs78297976	chr2:86144241	POLR1A	chr2:86253453-86333278:-	-0.21	-3.63	0.000292	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs7832570	chr8:96023795	C8orf38	chr8:95908040-96088396:+	-0.15	-3.38	0.000748	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs78343340	chr4:267437	ZNF718	chr4:53272-156488:+	0.34	7.28	6.4E-13	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs783531	chr15:83249119	FAM154B	chr15:82555152-82577265:+	-0.13	-3.86	0.000122	Schizophrenia	
BRCA	cis	1	rs783531	chr15:83249119	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.1	-3.81	0.000145	Schizophrenia	
BRCA	cis	1	rs783540	chr15:83254708	FAM154B	chr15:82555152-82577265:+	0.14	4.25	2.29E-5	Schizophrenia	
BRCA	cis	1	rs783540	chr15:83254708	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.11	4.22	2.71E-5	Schizophrenia	
BRCA	cis	1	rs78362565	chr5:115564293	COMMD10	chr5:115420727-115628978:+	0.22	4.62	4.4E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs78369300	chr7:123413550	HYAL4	chr7:123485223-123517529:+	0.29	4.15	3.54E-5	Platelet count	
BRCA	cis	1	rs78373114	chr10:96643896	C10orf129	chr10:96953957-96988685:+	0.33	5.55	3.59E-8	Blood metabolite levels	
BRCA	cis	1	rs78397134	chr10:96549486	C10orf129	chr10:96953957-96988685:+	0.23	4.12	4.08E-5	Blood metabolite levels	
BRCA	cis	1	rs78420872	chr6:24464429	ALDH5A1	chr6:24495197-24537434:+	0.25	4.59	4.88E-6	Hematological and biochemical traits	
BRCA	cis	1	rs78420872	chr6:24464429	GPLD1	chr6:24428405-24489850:-	0.42	7.7	3.17E-14	Hematological and biochemical traits	
BRCA	cis	1	rs78468492	chr2:86083029	POLR1A	chr2:86253453-86333278:-	-0.2	-3.39	0.000723	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs7847663	chr9:100544868	CORO2A	chr9:100883258-100954956:-	-0.13	-3.51	0.000464	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7847663	chr9:100544868	NCBP1	chr9:100395705-100436027:+	-0.13	-3.91	9.97E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7847663	chr9:100544868	TSTD2	chr9:100362364-100395962:-	-0.11	-4.13	3.87E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7849160	chr9:131874552	SH3GLB2	chr9:131770314-131790579:-	-0.12	-4.67	3.44E-6	Blood metabolite ratios	
BRCA	cis	1	rs7849270	chr9:131874641	GLE1	chr9:131266971-131304579:+	-0.13	-3.45	0.000583	Blood metabolite ratios	
BRCA	cis	1	rs7849270	chr9:131874641	ODF2	chr9:131217466-131263238:+	-0.13	-3.47	0.000537	Blood metabolite ratios	
BRCA	cis	1	rs7849270	chr9:131874641	SH3GLB2	chr9:131770314-131790579:-	-0.12	-4.46	9.16E-6	Blood metabolite ratios	
BRCA	cis	1	rs7849420	chr9:21499624	MTAP	chr9:21802635-22029593:+	0.12	3.38	0.000756	Lipid traits	
BRCA	cis	1	rs78495928	chr12:56635080	COQ10A	chr12:56660642-56664748:+	-0.29	-4.09	4.65E-5	Psoriasis vulgaris	
BRCA	cis	1	rs78495928	chr12:56635080	RPS26	chr12:56435686-56438005:+	-0.29	-3.69	0.000233	Psoriasis vulgaris	
BRCA	cis	1	rs78495928	chr12:56635080	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.9	0.000102	Psoriasis vulgaris	
BRCA	cis	1	rs7850258	chr9:100549013	CORO2A	chr9:100883258-100954956:-	0.13	3.57	0.000376	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7850258	chr9:100549013	NCBP1	chr9:100395705-100436027:+	0.14	4.18	3.2E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7850258	chr9:100549013	TRIM14	chr9:100831569-100881488:-	0.14	3.69	0.000237	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7850258	chr9:100549013	TSTD2	chr9:100362364-100395962:-	0.12	4.18	3.19E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7850258	chr9:100549013	XPA	chr9:100437192-100459691:-	0.11	3.4	0.000703	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7850311	chr9:38060968	TOMM5	chr9:37582646-37592636:-	0.09	3.39	0.000735	Brain structure	
BRCA	cis	1	rs7850311	chr9:38060968	ZCCHC7	chr9:37120469-37358143:+	0.12	3.56	0.000394	Brain structure	
BRCA	cis	1	rs78523927	chr7:1089458	ZFAND2A	chr7:1192544-1199855:-	-0.34	-6.59	6.83E-11	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.79	3.13E-30	Body mass index	
BRCA	cis	1	rs785464	chr1:46523089	MUTYH	chr1:45794915-45806142:-	0.12	4.83	1.6E-6	Body mass index	
BRCA	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.72	6.31E-30	Body mass index	
BRCA	cis	1	rs785471	chr1:46518677	MUTYH	chr1:45794915-45806142:-	0.12	4.6	4.67E-6	Body mass index	
BRCA	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.51	5.52E-29	Body mass index	
BRCA	cis	1	rs785479	chr1:46492144	CCDC17	chr1:46085717-46089729:-	0.12	3.66	0.000265	Body mass index	
BRCA	cis	1	rs785479	chr1:46492144	MUTYH	chr1:45794915-45806142:-	0.12	4.8	1.79E-6	Body mass index	
BRCA	cis	1	rs785481	chr1:46554518	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.76	4.3E-30	Body mass index	
BRCA	cis	1	rs785481	chr1:46554518	MUTYH	chr1:45794915-45806142:-	0.12	4.81	1.71E-6	Body mass index	
BRCA	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.63	1.54E-29	Body mass index	
BRCA	cis	1	rs785485	chr1:46574424	MUTYH	chr1:45794915-45806142:-	0.12	4.79	1.92E-6	Body mass index	
BRCA	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.69	8.18E-30	Body mass index	
BRCA	cis	1	rs785488	chr1:46576095	MUTYH	chr1:45794915-45806142:-	0.12	4.78	2.02E-6	Body mass index	
BRCA	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.69	8.18E-30	Body mass index	
BRCA	cis	1	rs785489	chr1:46576390	MUTYH	chr1:45794915-45806142:-	0.12	4.78	2.02E-6	Body mass index	
BRCA	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.68	9.07E-30	Body mass index	
BRCA	cis	1	rs785491	chr1:46583418	MUTYH	chr1:45794915-45806142:-	0.12	4.78	2.0E-6	Body mass index	
BRCA	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.67	1.06E-29	Body mass index	
BRCA	cis	1	rs785492	chr1:46583607	MUTYH	chr1:45794915-45806142:-	0.12	4.76	2.2E-6	Body mass index	
BRCA	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.69	8.42E-30	Body mass index	
BRCA	cis	1	rs785494	chr1:46586626	MUTYH	chr1:45794915-45806142:-	0.12	4.78	1.99E-6	Body mass index	
BRCA	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.39	-11.51	5.72E-29	Body mass index	
BRCA	cis	1	rs785495	chr1:46587887	MUTYH	chr1:45794915-45806142:-	0.12	4.63	4.09E-6	Body mass index	
BRCA	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.69	9.01E-30	Body mass index	
BRCA	cis	1	rs785503	chr1:46595868	MUTYH	chr1:45794915-45806142:-	0.12	4.78	1.98E-6	Body mass index	
BRCA	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.73	5.46E-30	Body mass index	
BRCA	cis	1	rs785520	chr1:46568836	MUTYH	chr1:45794915-45806142:-	0.12	4.85	1.41E-6	Body mass index	
BRCA	cis	1	rs78552657	chr6:159417840	RSPH3	chr6:159398268-159421198:-	0.26	4.55	6.05E-6	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs78581866	chr1:27247566	GPATCH3	chr1:27216980-27226962:-	0.23	3.83	0.000136	HDL cholesterol;Triglycerides;LDL cholesterol	
BRCA	cis	1	rs78609324	chr10:96603745	C10orf129	chr10:96953957-96988685:+	0.34	5.52	4.15E-8	Blood metabolite levels	
BRCA	cis	1	rs7861658	chr9:100679954	C9orf156	chr9:100666772-100684852:-	-0.17	-4.83	1.59E-6	Quantitative traits	
BRCA	cis	1	rs7864322	chr9:100548934	NCBP1	chr9:100395705-100436027:+	-0.12	-3.62	0.000311	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs7864322	chr9:100548934	TSTD2	chr9:100362364-100395962:-	-0.1	-3.68	0.000245	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs78646493	chr2:86283195	LOC90784	chr2:86247339-86250991:-	-0.45	-5.46	6.05E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs7869487	chr9:117580914	TNFSF15	chr9:117551613-117568408:-	-0.12	-3.38	0.000744	Crohn's disease	
BRCA	cis	1	rs78803505	chr7:65382572	CCT6P1	chr7:65216092-65228661:+	0.33	7.26	7.5E-13	Diabetic kidney disease	
BRCA	cis	1	rs78803505	chr7:65382572	LOC493754	chr7:65993446-66057363:-	0.21	3.56	0.000384	Diabetic kidney disease	
BRCA	cis	1	rs78803505	chr7:65382572	ZNF117	chr7:64434830-64467121:-	-0.27	-4.94	9.17E-7	Diabetic kidney disease	
BRCA	cis	1	rs78896566	chr7:1080182	ZFAND2A	chr7:1192544-1199855:-	-0.33	-6.46	1.61E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs78913826	chr3:101632638	LOC152225	chr3:101659703-101716770:+	-0.16	-3.72	0.000208	Psoriasis vulgaris;Psoriasis	
BRCA	cis	1	rs78919131	chr10:96638446	C10orf129	chr10:96953957-96988685:+	0.35	5.71	1.45E-8	Blood metabolite levels	
BRCA	cis	1	rs789208	chr10:105935096	C10orf79	chr10:105889647-105992120:-	0.14	4.89	1.15E-6	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs78925509	chr5:56267141	MAP3K1	chr5:56110900-56191976:+	-0.25	-4.04	5.8E-5	Breast cancer (early onset)	
BRCA	cis	1	rs7893480	chr10:124734829	PSTK	chr10:124739556-124749906:+	0.13	3.7	0.000227	Migraine without aura	
BRCA	cis	1	rs78945802	chr6:111728346	KIAA1919	chr6:111580482-111590259:+	0.31	4.42	1.08E-5	Psoriasis	
BRCA	cis	1	rs78953187	chr1:93000574	EVI5	chr1:92974255-93257961:-	-0.18	-4.98	7.56E-7	Cholesterol, total	
BRCA	cis	1	rs7896033	chr10:124731507	PSTK	chr10:124739556-124749906:+	0.13	3.49	0.000506	Migraine without aura	
BRCA	cis	1	rs78962927	chr2:48175452	MSH6	chr2:48010221-48034084:+	-0.18	-4.4	1.2E-5	QT interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs7896691	chr10:3155173	PITRM1	chr10:3179116-3215003:-	0.25	4.64	3.85E-6	Disc degeneration (lumbar)	
BRCA	cis	1	rs78974622	chr22:38059925	LGALS2	chr22:37966254-37976024:-	0.08	3.43	0.000636	Fat distribution (HIV)	
BRCA	cis	1	rs78996483	chr6:55934556	COL21A1	chr6:55921389-56258892:-	-0.38	-6.94	6.82E-12	Psychosis (atypical)	
BRCA	cis	1	rs789970	chr10:105977721	C10orf79	chr10:105889647-105992120:-	0.14	4.83	1.58E-6	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs7900134	chr10:124744123	PSTK	chr10:124739556-124749906:+	0.13	3.66	0.000264	Migraine without aura	
BRCA	cis	1	rs7902253	chr10:124739748	PSTK	chr10:124739556-124749906:+	0.13	3.62	0.000306	Migraine without aura	
BRCA	cis	1	rs7902273	chr10:124734824	PSTK	chr10:124739556-124749906:+	0.13	3.7	0.000227	Migraine without aura	
BRCA	cis	1	rs7903456	chr10:88919319	FAM35A	chr10:88854953-88951220:+	-0.15	-4.07	5.0E-5	Renal underexcretion gout;Gout	
BRCA	cis	1	rs79048371	chr20:33731484	MMP24	chr20:33814539-33864804:+	-0.22	-3.82	0.000141	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs79048371	chr20:33731484	PROCR	chr20:33758727-33765164:+	-0.27	-5.33	1.2E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7905163	chr10:91383930	FLJ37201	chr10:91451057-91457685:-	-0.18	-3.98	7.49E-5	Metabolic traits	
BRCA	cis	1	rs7905961	chr10:102297391	SEC31B	chr10:102246403-102289636:-	-0.29	-10.98	1.19E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs7907195	chr10:96515341	C10orf129	chr10:96953957-96988685:+	0.23	4.13	3.95E-5	Blood metabolite levels	
BRCA	cis	1	rs79101914	chr12:56729739	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.3E-5	Psoriasis vulgaris	
BRCA	cis	1	rs79101914	chr12:56729739	RPS26	chr12:56435686-56438005:+	-0.29	-3.74	0.000191	Psoriasis vulgaris	
BRCA	cis	1	rs79101914	chr12:56729739	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000361	Psoriasis vulgaris	
BRCA	cis	1	rs79103432	chr10:96545475	C10orf129	chr10:96953957-96988685:+	0.32	5.36	1.03E-7	Blood metabolite levels	
BRCA	cis	1	rs7910521	chr10:29803661	LOC387647	chr10:29698483-29776785:+	0.14	3.76	0.000177	Platelet thrombus formation	
BRCA	cis	1	rs7910598	chr10:29803549	LOC387647	chr10:29698483-29776785:+	0.14	3.76	0.000177	Platelet thrombus formation	
BRCA	cis	1	rs7910643	chr10:82251769	DYDC1	chr10:82095864-82116511:-	0.16	3.64	0.000288	Post bronchodilator FEV1	
BRCA	cis	1	rs7910668	chr10:15548925	FAM171A1	chr10:15253647-15413058:-	-0.11	-3.79	0.000157	Parkinson's disease	
BRCA	cis	1	rs7910927	chr10:65138910	NRBF2	chr10:64893007-64914785:+	-0.15	-5.56	3.36E-8	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7912093	chr10:17203934	TRDMT1	chr10:17184983-17243681:-	-0.11	-3.48	0.000531	Homocysteine levels	
BRCA	cis	1	rs7913801	chr10:29803731	LOC387647	chr10:29698483-29776785:+	0.14	3.75	0.000185	Platelet thrombus formation	
BRCA	cis	1	rs7917792	chr10:97365627	ENTPD1	chr10:97471536-97637022:+	0.17	5.76	1.12E-8	Blood metabolite levels	
BRCA	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.58	18.95	2.93E-69	Response to antipsychotic treatment	
BRCA	cis	1	rs79187906	chr10:96560695	C10orf129	chr10:96953957-96988685:+	0.26	4.6	4.62E-6	Blood metabolite levels	
BRCA	cis	1	rs79197732	chr20:33562476	MMP24	chr20:33814539-33864804:+	-0.19	-3.49	0.00051	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs79197732	chr20:33562476	PROCR	chr20:33758727-33765164:+	-0.24	-5.05	5.21E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs79199586	chr11:18452146	LDHC	chr11:18433853-18472792:+	-0.33	-5.36	1.01E-7	Amyotrophic lateral sclerosis (sporadic)	
BRCA	cis	1	rs7921096	chr10:124731468	PSTK	chr10:124739556-124749906:+	0.13	3.49	0.000506	Migraine without aura	
BRCA	cis	1	rs7923609	chr10:65133822	NRBF2	chr10:64893007-64914785:+	-0.15	-5.5	4.75E-8	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs7924699	chr11:47893120	MADD	chr11:47290927-47351582:+	-0.12	-3.64	0.000291	Intraocular pressure	
BRCA	cis	1	rs79264785	chr6:26194121	HIST1H3E	chr6:26224427-26226589:+	0.35	6.74	2.58E-11	Renal underexcretion gout;Gout	
BRCA	cis	1	rs7927771	chr11:47781306	MADD	chr11:47290927-47351582:+	0.15	4.51	7.28E-6	Subjective well-being	
BRCA	cis	1	rs7927771	chr11:47781306	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.29	1.98E-5	Subjective well-being	
BRCA	cis	1	rs79327308	chr7:1108141	ZFAND2A	chr7:1192544-1199855:-	-0.31	-6.05	2.01E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs7934085	chr11:28369660	METT5D1	chr11:28129798-28355054:+	-0.14	-4.25	2.3E-5	Bipolar disorder	
BRCA	cis	1	rs79341738	chr20:33702104	MMP24	chr20:33814539-33864804:+	-0.19	-3.5	0.00048	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs79341738	chr20:33702104	PROCR	chr20:33758727-33765164:+	-0.26	-5.46	5.83E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs79357647	chr6:159402432	RSPH3	chr6:159398268-159421198:-	0.24	4.26	2.2E-5	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs79366248	chr4:266659	ZNF718	chr4:53272-156488:+	0.34	7.18	1.27E-12	Immune response to smallpox vaccine (IL-6)	
BRCA	cis	1	rs7937117	chr11:28370038	METT5D1	chr11:28129798-28355054:+	-0.14	-4.25	2.3E-5	Bipolar disorder	
BRCA	cis	1	rs79381550	chr7:123406524	HYAL4	chr7:123485223-123517529:+	0.24	3.53	0.000435	Platelet count	
BRCA	cis	1	rs7938380	chr11:64034866	C11orf20	chr11:64067863-64072238:+	-0.23	-4.6	4.66E-6	Mean platelet volume	
BRCA	cis	1	rs7939107	chr11:64034773	C11orf20	chr11:64067863-64072238:+	-0.23	-4.6	4.66E-6	Mean platelet volume	
BRCA	cis	1	rs79404901	chr5:115449332	COMMD10	chr5:115420727-115628978:+	0.25	4.89	1.17E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs7940554	chr11:118142930	AMICA1	chr11:118064442-118095809:-	0.06	4.1	4.41E-5	Pain	
BRCA	cis	1	rs7940554	chr11:118142930	SCN2B	chr11:118033519-118047337:-	0.1	4.52	6.94E-6	Pain	
BRCA	cis	1	rs7942031	chr11:47868474	MADD	chr11:47290927-47351582:+	-0.14	-4.11	4.21E-5	Intraocular pressure	
BRCA	cis	1	rs79422648	chr7:1080241	ZFAND2A	chr7:1192544-1199855:-	-0.33	-6.46	1.61E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs79429965	chr10:96494912	C10orf129	chr10:96953957-96988685:+	0.33	5.44	6.47E-8	Blood metabolite levels	
BRCA	cis	1	rs79436528	chr12:56686997	COQ10A	chr12:56660642-56664748:+	-0.29	-3.95	8.18E-5	Psoriasis vulgaris	
BRCA	cis	1	rs79436528	chr12:56686997	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.00019	Psoriasis vulgaris	
BRCA	cis	1	rs79436528	chr12:56686997	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.61	0.000316	Psoriasis vulgaris	
BRCA	cis	1	rs79438986	chr20:33702280	PROCR	chr20:33758727-33765164:+	-0.26	-5.21	2.22E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs7944004	chr11:2311152	C11orf21	chr11:2317507-2323143:-	0.11	5.7	1.58E-8	Chronic lymphocytic leukemia	
BRCA	cis	1	rs7944004	chr11:2311152	TSPAN32	chr11:2323243-2339430:+	0.08	3.41	0.000681	Chronic lymphocytic leukemia	
BRCA	cis	1	rs7945367	chr11:28166272	METT5D1	chr11:28129798-28355054:+	-0.12	-3.41	0.000672	Bipolar disorder	
BRCA	cis	1	rs79459889	chr5:56269286	MAP3K1	chr5:56110900-56191976:+	-0.25	-4.23	2.59E-5	Breast cancer (early onset)	
BRCA	cis	1	rs79465461	chr2:160100779	WDSUB1	chr2:160092305-160143236:-	0.34	4.2	2.91E-5	Sudden cardiac arrest	
BRCA	cis	1	rs79466937	chr7:123416273	HYAL4	chr7:123485223-123517529:+	0.28	4.09	4.62E-5	Platelet count	
BRCA	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.3	7.82	1.31E-14	Pancreatic cancer	
BRCA	cis	1	rs79475579	chr11:58295900	CNTF	chr11:58390146-58393203:+	0.17	3.61	0.000319	Lymphoma	
BRCA	cis	1	rs79477087	chr11:22116168	ANO5	chr11:22214722-22304913:+	0.28	5.68	1.77E-8	Parkinson's disease	
BRCA	cis	1	rs7947730	chr11:47786184	MADD	chr11:47290927-47351582:+	0.15	4.51	7.28E-6	Subjective well-being	
BRCA	cis	1	rs7947730	chr11:47786184	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.29	1.98E-5	Subjective well-being	
BRCA	cis	1	rs7948661	chr11:118341649	CD3D	chr11:118209789-118213459:-	0.08	3.56	0.00038	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
BRCA	cis	1	rs7948969	chr11:62907048	B3GAT3	chr11:62382769-62389449:-	-0.12	-3.8	0.000153	Conotruncal heart defects	
BRCA	cis	1	rs7948969	chr11:62907048	BSCL2	chr11:62457747-62477046:-	-0.14	-3.49	0.000494	Conotruncal heart defects	
BRCA	cis	1	rs7948969	chr11:62907048	HNRNPUL2	chr11:62457747-62494821:-	-0.18	-4.08	4.87E-5	Conotruncal heart defects	
BRCA	cis	1	rs7948969	chr11:62907048	INTS5	chr11:62414322-62420774:-	-0.15	-3.44	0.000599	Conotruncal heart defects	
BRCA	cis	1	rs7948969	chr11:62907048	MTA2	chr11:62360675-62369303:-	-0.14	-3.65	0.000275	Conotruncal heart defects	
BRCA	cis	1	rs7948969	chr11:62907048	POLR2G	chr11:62529011-62534185:+	-0.15	-3.93	9.05E-5	Conotruncal heart defects	
BRCA	cis	1	rs7948969	chr11:62907048	TAF6L	chr11:62538875-62554811:+	-0.14	-4.16	3.41E-5	Conotruncal heart defects	
BRCA	cis	1	rs7948969	chr11:62907048	TMEM179B	chr11:62554874-62557871:+	-0.17	-4.29	1.91E-5	Conotruncal heart defects	
BRCA	cis	1	rs7948969	chr11:62907048	TTC9C	chr11:62495584-62506105:+	-0.16	-3.51	0.000469	Conotruncal heart defects	
BRCA	cis	1	rs7948969	chr11:62907048	ZBTB3	chr11:62518437-62521656:-	-0.16	-3.45	0.000581	Conotruncal heart defects	
BRCA	cis	1	rs7949704	chr11:28373543	METT5D1	chr11:28129798-28355054:+	-0.13	-3.53	0.000436	Bipolar disorder	
BRCA	cis	1	rs7950335	chr11:27322503	LGR4	chr11:27387510-27494334:-	-0.14	-3.86	0.00012	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs79512403	chr7:123408499	HYAL4	chr7:123485223-123517529:+	0.29	4.15	3.54E-5	Platelet count	
BRCA	cis	1	rs7953014	chr12:109998097	MMAB	chr12:109991523-110011358:-	-0.12	-3.71	0.000219	HDL cholesterol	
BRCA	cis	1	rs7953014	chr12:109998097	MYO1H	chr12:109826524-109886176:+	0.26	7.9	6.94E-15	HDL cholesterol	
BRCA	cis	1	rs7953249	chr12:121403724	HNF1A	chr12:121416549-121440312:+	0.16	4.55	5.89E-6	N-glycan levels;Chronic obstructive pulmonary disease-related biomarkers	
BRCA	cis	1	rs79533393	chr2:160100219	WDSUB1	chr2:160092305-160143236:-	0.34	4.2	2.91E-5	Sudden cardiac arrest	
BRCA	cis	1	rs7953704	chr12:122625992	LRRC43	chr12:122652266-122688017:+	0.17	4.68	3.18E-6	Urate levels	
BRCA	cis	1	rs79538247	chr7:32467792	LOC441208	chr7:32767562-32794385:+	-0.14	-3.37	0.000771	Metabolite levels (HVA/MHPG ratio)	
BRCA	cis	1	rs7954144	chr12:110015893	MMAB	chr12:109991523-110011358:-	-0.12	-3.77	0.00017	HDL cholesterol	
BRCA	cis	1	rs7954144	chr12:110015893	MYO1H	chr12:109826524-109886176:+	0.27	8.1	1.55E-15	HDL cholesterol	
BRCA	cis	1	rs7955571	chr12:122616759	LRRC43	chr12:122652266-122688017:+	0.16	4.53	6.52E-6	Urate levels	
BRCA	cis	1	rs7955575	chr12:122616766	LRRC43	chr12:122652266-122688017:+	0.16	4.53	6.52E-6	Urate levels	
BRCA	cis	1	rs7958691	chr12:124440743	DNAH10	chr12:124247042-124420265:+	0.26	6.79	1.87E-11	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.72	9.58	6.8E-21	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs79602855	chr19:50525725	TBC1D17	chr19:50380829-50392000:+	-0.23	-4.2	2.9E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs7960884	chr12:31360640	DDX11	chr12:31226779-31257725:+	0.13	3.47	0.000537	Systolic blood pressure response to hydrochlorothiazide in hypertension	
BRCA	cis	1	rs79611756	chr10:96387031	C10orf129	chr10:96953957-96988685:+	0.32	5.17	2.85E-7	Blood metabolite levels	
BRCA	cis	1	rs7963950	chr12:62790448	FAM19A2	chr12:62102043-62653925:-	0.16	3.51	0.000461	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs7964021	chr12:109997645	MMAB	chr12:109991523-110011358:-	-0.12	-3.6	0.000327	HDL cholesterol	
BRCA	cis	1	rs7964021	chr12:109997645	MYO1H	chr12:109826524-109886176:+	0.26	8.04	2.38E-15	HDL cholesterol	
BRCA	cis	1	rs7964148	chr12:122619261	LRRC43	chr12:122652266-122688017:+	0.16	4.51	7.09E-6	Urate levels	
BRCA	cis	1	rs7966755	chr12:82221604	PPFIA2	chr12:81652880-82153109:-	0.14	3.53	0.00043	Resting heart rate	
BRCA	cis	1	rs79678941	chr10:96449450	C10orf129	chr10:96953957-96988685:+	0.36	5.87	5.77E-9	Blood metabolite levels	
BRCA	cis	1	rs7971298	chr12:8703141	CLEC4D	chr12:8666136-8674958:+	0.12	4.39	1.26E-5	Response to radiotherapy in prostate cancer (overall toxicity)	
BRCA	cis	1	rs7971588	chr12:62783051	FAM19A2	chr12:62102043-62653925:-	0.18	3.81	0.000144	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.68	-20.1	1.86E-76	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs79718165	chr12:56644251	COQ10A	chr12:56660642-56664748:+	-0.29	-4.09	4.65E-5	Psoriasis vulgaris	
BRCA	cis	1	rs79718165	chr12:56644251	RPS26	chr12:56435686-56438005:+	-0.29	-3.69	0.000233	Psoriasis vulgaris	
BRCA	cis	1	rs79718165	chr12:56644251	SLC39A5	chr12:56623820-56631627:+	-0.27	-3.9	0.000102	Psoriasis vulgaris	
BRCA	cis	1	rs7973683	chr12:124449223	DNAH10	chr12:124247042-124420265:+	0.26	6.93	7.33E-12	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs7973719	chr12:7334813	PEX5	chr12:7341759-7371167:+	0.24	7	4.53E-12	IgG glycosylation	
BRCA	cis	1	rs79738251	chr2:17786558	GEN1	chr2:17935162-17966632:+	0.16	3.5	0.000482	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs79750959	chr12:56702012	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.29E-5	Psoriasis vulgaris	
BRCA	cis	1	rs79750959	chr12:56702012	RPS26	chr12:56435686-56438005:+	-0.29	-3.75	0.000187	Psoriasis vulgaris	
BRCA	cis	1	rs79750959	chr12:56702012	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000365	Psoriasis vulgaris	
BRCA	cis	1	rs7975863	chr12:82227288	PPFIA2	chr12:81652880-82153109:-	0.13	3.38	0.000754	Resting heart rate	
BRCA	cis	1	rs79760198	chr5:56262639	MAP3K1	chr5:56110900-56191976:+	-0.25	-4.08	4.79E-5	Breast cancer (early onset)	
BRCA	cis	1	rs79765398	chr7:1073764	ZFAND2A	chr7:1192544-1199855:-	-0.33	-6.42	2.08E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs7976608	chr12:62648952	FAM19A2	chr12:62102043-62653925:-	0.17	3.76	0.000178	Pyoderma gangrenosum in inflammatory bowel disease	
BRCA	cis	1	rs79767540	chr2:86112662	POLR1A	chr2:86253453-86333278:-	-0.2	-3.54	0.000421	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
BRCA	cis	1	rs79770253	chr2:17784158	GEN1	chr2:17935162-17966632:+	0.16	3.51	0.000472	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs7977765	chr12:107205390	C12orf23	chr12:107349544-107367811:+	-0.17	-4.37	1.39E-5	Social autistic-like traits	
BRCA	cis	1	rs7977765	chr12:107205390	MTERFD3	chr12:107371069-107380929:-	-0.15	-4.19	3.05E-5	Social autistic-like traits	
BRCA	cis	1	rs7980501	chr12:3912972	PARP11	chr12:3918027-3982608:-	-0.15	-4.27	2.11E-5	Cognitive performance	
BRCA	cis	1	rs7980687	chr12:123822711	CDK2AP1	chr12:123745542-123756687:-	-0.23	-7.05	3.18E-12	Educational attainment;Height;Head circumference (infant)	
BRCA	cis	1	rs79808876	chr11:465763	RNH1	chr11:494512-507273:-	-0.2	-4.85	1.44E-6	Body mass index	
BRCA	cis	1	rs79824801	chr12:56728137	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.3E-5	Psoriasis vulgaris	
BRCA	cis	1	rs79824801	chr12:56728137	RPS26	chr12:56435686-56438005:+	-0.29	-3.74	0.000191	Psoriasis vulgaris	
BRCA	cis	1	rs79824801	chr12:56728137	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000361	Psoriasis vulgaris	
BRCA	cis	1	rs79831012	chr10:102237059	SEC31B	chr10:102246403-102289636:-	-0.28	-10.5	1.3E-24	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs79868973	chr6:26189312	HIST1H3E	chr6:26224427-26226589:+	0.36	7.12	2.05E-12	Renal underexcretion gout;Gout	
BRCA	cis	1	rs798766	chr4:1734239	FAM53A	chr4:1641609-1685854:-	0.21	5.71	1.5E-8	Urinary bladder cancer;Bladder cancer	
BRCA	cis	1	rs798767	chr4:1734281	FAM53A	chr4:1641609-1685854:-	-0.2	-5.3	1.4E-7	Urinary bladder cancer;Bladder cancer	
BRCA	cis	1	rs79889615	chr5:115591292	COMMD10	chr5:115420727-115628978:+	0.25	4.61	4.49E-6	Asthma or chronic obstructive pulmonary disease	
BRCA	cis	1	rs79947009	chr7:123416573	HYAL4	chr7:123485223-123517529:+	0.28	4.09	4.62E-5	Platelet count	
BRCA	cis	1	rs7996093	chr13:99133092	STK24	chr13:99102455-99229396:-	-0.13	-3.56	0.000394	Longevity	
BRCA	cis	1	rs7996629	chr13:99128037	STK24	chr13:99102455-99229396:-	-0.13	-3.56	0.000391	Longevity	
BRCA	cis	1	rs79975794	chr7:123408575	HYAL4	chr7:123485223-123517529:+	0.29	4.15	3.54E-5	Platelet count	
BRCA	cis	1	rs8003061	chr14:81451956	TSHR	chr14:81421869-81612646:+	-0.13	-3.85	0.000124	Graves' disease	
BRCA	cis	1	rs8003506	chr14:75586288	EIF2B2	chr14:75469612-75476292:+	-0.25	-6.93	7.08E-12	Height	
BRCA	cis	1	rs8003506	chr14:75586288	MLH3	chr14:75480467-75518235:-	-0.28	-8.54	4.6E-17	Height	
BRCA	cis	1	rs8005309	chr14:66056508	LOC645431	chr14:65877313-65879335:-	-0.32	-6.51	1.13E-10	Ischemic stroke	
BRCA	cis	1	rs80059054	chr10:96483008	C10orf129	chr10:96953957-96988685:+	0.33	5.44	6.5E-8	Blood metabolite levels	
BRCA	cis	1	rs80063229	chr2:48169673	MSH6	chr2:48010221-48034084:+	-0.2	-4.66	3.6E-6	QT interval in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs8006909	chr14:74944788	PTGR2	chr14:74318534-74352166:+	-0.16	-3.92	9.42E-5	Advanced glycation end-product levels	
BRCA	cis	1	rs8006958	chr14:74944851	PTGR2	chr14:74318534-74352166:+	-0.16	-3.94	8.73E-5	Advanced glycation end-product levels	
BRCA	cis	1	rs80076579	chr4:106991115	TBCK	chr4:106967233-107237861:-	0.23	7.23	9.42E-13	Airflow obstruction	
BRCA	cis	1	rs80085676	chr2:242347907	SEPT2	chr2:242254723-242293439:+	0.37	6.81	1.68E-11	Chronic lymphocytic leukemia	
BRCA	cis	1	rs80089016	chr5:56267444	MAP3K1	chr5:56110900-56191976:+	-0.25	-4.04	5.72E-5	Breast cancer (early onset)	
BRCA	cis	1	rs80094748	chr7:1103958	ZFAND2A	chr7:1192544-1199855:-	-0.3	-5.85	6.67E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
BRCA	cis	1	rs80095925	chr6:26184942	HIST1H3E	chr6:26224427-26226589:+	0.33	5.94	3.94E-9	Renal underexcretion gout;Gout	
BRCA	cis	1	rs80097053	chr5:56269492	MAP3K1	chr5:56110900-56191976:+	-0.25	-4.23	2.59E-5	Breast cancer (early onset)	
BRCA	cis	1	rs8010344	chr14:93086918	NDUFB1	chr14:92582470-92588153:-	0.13	3.57	0.000369	Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.36	-13.13	1.34E-36	IgG glycosylation	
BRCA	cis	1	rs80109502	chr20:33587596	MMP24	chr20:33814539-33864804:+	-0.22	-3.89	0.000105	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs80109502	chr20:33587596	PROCR	chr20:33758727-33765164:+	-0.24	-4.92	9.8E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs80127902	chr7:123428850	HYAL4	chr7:123485223-123517529:+	0.28	3.96	7.9E-5	Platelet count	
BRCA	cis	1	rs8014204	chr14:75322794	RPS6KL1	chr14:75372347-75389958:-	0.21	5.39	8.57E-8	Caffeine consumption	
BRCA	cis	1	rs8014374	chr14:75322914	RPS6KL1	chr14:75372347-75389958:-	-0.2	-5.28	1.56E-7	Caffeine consumption	
BRCA	cis	1	rs8017980	chr14:102961341	ANKRD9	chr14:102973198-102976128:-	0.11	3.45	0.000583	QT interval	
BRCA	cis	1	rs80189444	chr2:206340580	NRP2	chr2:206547224-206662856:+	0.15	3.51	0.000461	AIDS progression	
BRCA	cis	1	rs8018967	chr14:73976934	ACOT1	chr14:74003928-74042357:+	-0.17	-5.57	3.3E-8	Blood metabolite ratios	
BRCA	cis	1	rs8018967	chr14:73976934	HEATR4	chr14:73945193-74025651:-	-0.42	-12.16	6.18E-32	Blood metabolite ratios	
BRCA	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.77	10.05	9.03E-23	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs802070	chr6:49656358	CRISP3	chr6:49695092-49712056:-	0.14	3.63	0.000297	Bone mineral density (hip) and age at menarche	
BRCA	cis	1	rs802072	chr6:49656000	CRISP3	chr6:49695092-49712056:-	0.14	3.7	0.000225	Bone mineral density (hip) and age at menarche	
BRCA	cis	1	rs802075	chr6:49654166	CRISP3	chr6:49695092-49712056:-	0.14	3.93	9.12E-5	Bone mineral density (hip) and age at menarche	
BRCA	cis	1	rs8021692	chr14:104428576	TDRD9	chr14:104394817-104519002:+	0.4	10.23	1.66E-23	Bipolar disorder	
BRCA	cis	1	rs8023482	chr15:40307095	SRP14	chr15:40327891-40331389:-	-0.26	-5.62	2.39E-8	Response to haloperidol in psychosis	
BRCA	cis	1	rs80245547	chr4:106628955	INTS12	chr4:106603787-106629881:-	-0.28	-3.47	0.000547	Post bronchodilator FEV1	
BRCA	cis	1	rs80259160	chr6:26190199	HIST1H3E	chr6:26224427-26226589:+	0.35	6.78	1.93E-11	Renal underexcretion gout;Gout	
BRCA	cis	1	rs80259168	chr10:96543753	C10orf129	chr10:96953957-96988685:+	0.32	5.36	1.03E-7	Blood metabolite levels	
BRCA	cis	1	rs8026166	chr15:100299414	C15orf51	chr15:100330361-100347132:-	-0.18	-4.36	1.41E-5	Major depressive disorder	
BRCA	cis	1	rs8027260	chr15:65955172	DPP8	chr15:65737999-65810035:-	0.09	4.37	1.38E-5	Mean corpuscular hemoglobin	
BRCA	cis	1	rs80277764	chr20:33739456	MMP24	chr20:33814539-33864804:+	-0.26	-4.26	2.26E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs80277764	chr20:33739456	PROCR	chr20:33758727-33765164:+	-0.27	-5.14	3.23E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs80310238	chr5:56267984	MAP3K1	chr5:56110900-56191976:+	-0.26	-4.33	1.66E-5	Breast cancer (early onset)	
BRCA	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.75	9.55	8.55E-21	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs80314222	chr19:50525514	TBC1D17	chr19:50380829-50392000:+	-0.23	-4.12	4.1E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
BRCA	cis	1	rs8031540	chr15:69328606	GLCE	chr15:69452973-69564544:+	0.25	4.1	4.5E-5	Obesity-related traits	
BRCA	cis	1	rs8031540	chr15:69328606	TMEM84	chr15:69365266-69388161:+	0.25	3.91	9.73E-5	Obesity-related traits	
BRCA	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.48	-12.61	4.57E-34	Type 2 diabetes	
BRCA	cis	1	rs80317430	chr12:56727705	COQ10A	chr12:56660642-56664748:+	-0.28	-3.92	9.3E-5	Psoriasis vulgaris	
BRCA	cis	1	rs80317430	chr12:56727705	RPS26	chr12:56435686-56438005:+	-0.29	-3.74	0.000191	Psoriasis vulgaris	
BRCA	cis	1	rs80317430	chr12:56727705	SLC39A5	chr12:56623820-56631627:+	-0.25	-3.58	0.000361	Psoriasis vulgaris	
BRCA	cis	1	rs8031948	chr15:78816057	AGPHD1	chr15:78799906-78829714:+	-0.15	-3.5	0.000482	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs8031948	chr15:78816057	CHRNA5	chr15:78857906-78886458:+	-0.19	-5.83	7.51E-9	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs8032675	chr15:67959464	IQCH	chr15:67547188-67794139:+	0.14	4.92	9.86E-7	Motion sickness	
BRCA	cis	1	rs8034191	chr15:78806023	AGPHD1	chr15:78799906-78829714:+	-0.21	-4.89	1.15E-6	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs8034191	chr15:78806023	CHRNA5	chr15:78857906-78886458:+	-0.18	-5.58	3.02E-8	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs8035635	chr15:51010829	AP4E1	chr15:51200946-51298097:+	-0.11	-4.23	2.56E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs8035635	chr15:51010829	SPPL2A	chr15:50999739-51057910:-	-0.11	-4.2	2.89E-5	Alzheimer's disease (late onset)	
BRCA	cis	1	rs8035675	chr15:67965581	IQCH	chr15:67547188-67794139:+	0.14	5.11	3.87E-7	Motion sickness	
BRCA	cis	1	rs803688	chr15:83216793	FAM154B	chr15:82555152-82577265:+	-0.13	-3.81	0.000146	Schizophrenia	
BRCA	cis	1	rs803688	chr15:83216793	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.1	-3.79	0.000162	Schizophrenia	
BRCA	cis	1	rs8041357	chr15:74869438	STRA6	chr15:74471810-74502046:-	0.29	3.69	0.000233	Bladder cancer	
BRCA	cis	1	rs8042849	chr15:78817929	AGPHD1	chr15:78799906-78829714:+	0.15	3.7	0.000231	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs8042849	chr15:78817929	CHRNA5	chr15:78857906-78886458:+	0.16	5.05	5.29E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs8049173	chr16:11436882	C16orf75	chr16:11343506-11445617:+	0.31	9.19	1.92E-19	Vein graft stenosis in coronary artery bypass grafting	
BRCA	cis	1	rs8049439	chr16:28837515	EIF3C	chr16:28722782-28747052:+;chr16	0.15	4.43	1.03E-5	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
BRCA	cis	1	rs8049439	chr16:28837515	EIF3CL	chr16:28699879-28747052:+;chr16	0.24	6.64	5.09E-11	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
BRCA	cis	1	rs8055427	chr16:11436883	C16orf75	chr16:11343506-11445617:+	0.31	9.19	1.92E-19	Vein graft stenosis in coronary artery bypass grafting	
BRCA	cis	1	rs8065437	chr17:45721653	C17orf57	chr17:45401142-45518675:+	0.29	10.05	9.11E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs8065437	chr17:45721653	TBKBP1	chr17:45772630-45789427:+	-0.15	-4.56	5.74E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
BRCA	cis	1	rs8066156	chr17:30361629	C17orf79	chr17:30178885-30186326:-	-0.16	-4.17	3.27E-5	Height	
BRCA	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.17	-5.94	3.94E-9	Metabolite levels	
BRCA	cis	1	rs807931	chr3:47389317	CCR2	chr3:46395235-46402412:+	0.06	3.43	0.000616	Colorectal cancer	
BRCA	cis	1	rs807931	chr3:47389317	CCRL2	chr3:46448721-46451013:+	-0.08	-3.41	0.000675	Colorectal cancer	
BRCA	cis	1	rs809367	chr10:89741806	ATAD1	chr10:89512875-89577917:-	0.17	4.04	5.67E-5	Parental extreme longevity (95 years and older)	
BRCA	cis	1	rs809367	chr10:89741806	FAM35A	chr10:88854953-88951220:+	0.18	4.21	2.75E-5	Parental extreme longevity (95 years and older)	
BRCA	cis	1	rs809367	chr10:89741806	GLUD1	chr10:88810246-88854623:-	0.16	3.98	7.43E-5	Parental extreme longevity (95 years and older)	
BRCA	cis	1	rs809367	chr10:89741806	LIPK	chr10:90484301-90512511:+	-0.13	-3.38	0.000743	Parental extreme longevity (95 years and older)	
BRCA	cis	1	rs809367	chr10:89741806	MINPP1	chr10:89264223-89313168:+	0.18	3.92	9.28E-5	Parental extreme longevity (95 years and older)	
BRCA	cis	1	rs809367	chr10:89741806	PTEN	chr10:89623195-89728531:+	0.18	4.19	2.96E-5	Parental extreme longevity (95 years and older)	
BRCA	cis	1	rs809775	chr1:46538040	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.81	2.37E-30	Body mass index	
BRCA	cis	1	rs809775	chr1:46538040	MUTYH	chr1:45794915-45806142:-	0.12	4.69	3.09E-6	Body mass index	
BRCA	cis	1	rs8098064	chr18:8209269	ANKRD12	chr18:9136758-9285206:+	0.21	4.11	4.17E-5	Dialysis-related mortality	
BRCA	cis	1	rs8098064	chr18:8209269	NDUFV2	chr18:9102675-9134336:+	0.3	5.19	2.57E-7	Dialysis-related mortality	
BRCA	cis	1	rs8098064	chr18:8209269	RAB12	chr18:8609435-8639379:+	0.28	4.31	1.82E-5	Dialysis-related mortality	
BRCA	cis	1	rs8101881	chr19:33364628	SLC7A9	chr19:33321421-33360683:-	-0.23	-6.95	6.5E-12	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
BRCA	cis	1	rs8103622	chr19:18572834	LRRC25	chr19:18501955-18508421:-	-0.15	-7.19	1.25E-12	Breast cancer	
BRCA	cis	1	rs8105833	chr19:41896145	B3GNT8	chr19:41931265-41934635:-	-0.22	-6.61	6.07E-11	Height	
BRCA	cis	1	rs8105994	chr19:18593553	LRRC25	chr19:18501955-18508421:-	-0.15	-7.61	5.89E-14	Breast cancer	
BRCA	cis	1	rs8105994	chr19:18593553	SSBP4	chr19:18530221-18545371:+	-0.11	-4.23	2.56E-5	Breast cancer	
BRCA	cis	1	rs8107367	chr19:18564705	LRRC25	chr19:18501955-18508421:-	-0.14	-6.95	6.5E-12	Breast cancer	
BRCA	cis	1	rs8109573	chr19:18617151	LRRC25	chr19:18501955-18508421:-	-0.13	-6.55	9.02E-11	Breast cancer	
BRCA	cis	1	rs8111746	chr19:39212859	LGALS4	chr19:39292312-39303740:-	-0.11	-3.53	0.000433	Heart rate	
BRCA	cis	1	rs8111746	chr19:39212859	LGALS7	chr19:39261608-39264157:-	-0.2	-6.29	4.73E-10	Heart rate	
BRCA	cis	1	rs8112837	chr19:10837030	LOC147727	chr19:10762539-10764548:-	0.21	3.55	0.000406	LDL cholesterol	
BRCA	cis	1	rs8113312	chr19:23061182	ZNF492	chr19:22817126-22850472:+	-0.25	-5.57	3.31E-8	Bronchopulmonary dysplasia	
BRCA	cis	1	rs8114671	chr20:33789142	PROCR	chr20:33758727-33765164:+	0.1	3.4	0.000705	Height	
BRCA	cis	1	rs8117100	chr20:33692261	PROCR	chr20:33758727-33765164:+	-0.22	-4.66	3.58E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs8117359	chr20:23645826	CST1	chr20:23728191-23731574:-	0.33	6.5	1.22E-10	Plasma cystastin c levels in acute coronary syndrome	
BRCA	cis	1	rs8117359	chr20:23645826	CST4	chr20:23666277-23669662:-	0.16	3.53	0.000435	Plasma cystastin c levels in acute coronary syndrome	
BRCA	cis	1	rs8118008	chr20:3168166	FASTKD5	chr20:3127167-3140532:-	0.14	3.55	0.000408	Parkinson's disease	
BRCA	cis	1	rs8118008	chr20:3168166	ITPA	chr20:3190056-3204504:+	0.2	6.95	6.14E-12	Parkinson's disease	
BRCA	cis	1	rs8118008	chr20:3168166	ProSAPiP1	chr20:3143273-3154192:-	0.2	5.44	6.46E-8	Parkinson's disease	
BRCA	cis	1	rs8123062	chr20:55069310	C20orf43	chr20:55043647-55093942:+	0.15	3.99	7.19E-5	Refractive astigmatism	
BRCA	cis	1	rs8123289	chr20:3253831	ITPA	chr20:3190056-3204504:+	-0.14	-3.83	0.000133	IFN-related cytopenia	
BRCA	cis	1	rs8123978	chr20:33598789	MMP24	chr20:33814539-33864804:+	-0.23	-3.99	7.13E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs8123978	chr20:33598789	PROCR	chr20:33758727-33765164:+	-0.24	-4.78	1.98E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs8125868	chr20:25324410	FAM182A	chr20:26035250-26067552:+	0.21	5.61	2.51E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs8125868	chr20:25324410	FAM182B	chr20:25744102-25848786:-	-0.23	-5.9	4.86E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs8131214	chr21:30483386	N6AMT1	chr21:30244513-30257693:-	-0.12	-3.4	0.000691	Dental caries	
BRCA	cis	1	rs8131214	chr21:30483386	NCRNA00189	chr21:30565801-30660525:+	0.18	5.46	5.83E-8	Dental caries	
BRCA	cis	1	rs8133949	chr21:43421114	C21orf121	chr21:43442113-43445060:+	0.29	6.79	1.82E-11	Hand grip strength	
BRCA	cis	1	rs8135828	chr22:29929239	NIPSNAP1	chr22:29950800-29977144:-	-0.2	-4.14	3.73E-5	Lipid traits	
BRCA	cis	1	rs8138799	chr22:24556902	SUSD2	chr22:24577444-24585074:+	0.79	12.63	3.56E-34	Amyotrophic lateral sclerosis	
BRCA	cis	1	rs8170	chr19:17389704	ANKLE1	chr19:17392454-17398454:+	0.21	6.09	1.53E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs8170	chr19:17389704	OCEL1	chr19:17337055-17340027:+	0.15	4.76	2.25E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs8170	chr19:17389704	PLVAP	chr19:17462264-17488137:-	-0.09	-3.49	0.000502	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
BRCA	cis	1	rs8181385	chr10:19560960	PLXDC2	chr10:20105372-20569115:+	-0.11	-3.45	0.000589	Bone mineral density (Ward's triangle area)	
BRCA	cis	1	rs8181644	chr12:58173466	B4GALNT1	chr12:58019551-58026985:-	0.12	3.5	0.000489	Multiple sclerosis	
BRCA	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.41	9.96	2.03E-22	Multiple sclerosis	
BRCA	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.36	-10.46	1.88E-24	Multiple sclerosis	
BRCA	cis	1	rs8181644	chr12:58173466	XRCC6BP1	chr12:58335445-58351051:+	-0.19	-5.1	3.96E-7	Multiple sclerosis	
BRCA	cis	1	rs820429	chr3:27549188	NEK10	chr3:27152395-27410912:-	0.12	4.35	1.51E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs820430	chr3:27548900	NEK10	chr3:27152395-27410912:-	-0.13	-4.44	9.8E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.78	19.89	4.15E-75	Type 2 diabetes	
BRCA	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.78	20.53	3.16E-79	Type 2 diabetes	
BRCA	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.78	20.49	6.1E-79	Type 2 diabetes	
BRCA	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.77	19.72	4.87E-74	Type 2 diabetes	
BRCA	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.77	19.71	5.41E-74	Type 2 diabetes	
BRCA	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.77	19.71	5.41E-74	Type 2 diabetes	
BRCA	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.79	21.17	2.71E-83	Type 2 diabetes	
BRCA	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.77	19.65	1.32E-73	Type 2 diabetes	
BRCA	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.78	19.88	4.85E-75	Type 2 diabetes	
BRCA	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.74	-18.68	1.3E-67	Type 2 diabetes	
BRCA	cis	1	rs834575	chr1:100368382	LRRC39	chr1:100614413-100643800:-	0.35	4.19	3.02E-5	Carotid intima media thickness	
BRCA	cis	1	rs842361	chr2:135340840	TMEM163	chr2:135213331-135525334:-	-0.19	-4.98	7.4E-7	Neuroticism	
BRCA	cis	1	rs848490	chr7:77555005	PHTF2	chr7:77428109-77586818:+	0.17	4.94	8.91E-7	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
BRCA	cis	1	rs849142	chr7:28185891	JAZF1	chr7:27870196-28220437:-	-0.1	-3.6	0.000334	Crohn's disease;Type 2 diabetes	
BRCA	cis	1	rs853676	chr6:28299687	ZNF323	chr6:28292517-28324048:-	0.21	3.74	0.000194	Depression	
BRCA	cis	1	rs853676	chr6:28299687	ZSCAN23	chr6:28393287-28411279:-	0.18	3.75	0.000186	Depression	
BRCA	cis	1	rs853678	chr6:28297313	ZNF323	chr6:28292517-28324048:-	0.19	3.45	0.000583	Depression	
BRCA	cis	1	rs853678	chr6:28297313	ZSCAN23	chr6:28393287-28411279:-	0.18	3.68	0.000244	Depression	
BRCA	cis	1	rs853679	chr6:28296863	ZNF323	chr6:28292517-28324048:-	0.19	3.45	0.000583	Depression	
BRCA	cis	1	rs853679	chr6:28296863	ZSCAN23	chr6:28393287-28411279:-	0.18	3.68	0.000244	Depression	
BRCA	cis	1	rs853685	chr6:28288785	ZNF323	chr6:28292517-28324048:-	0.21	3.84	0.00013	Depression	
BRCA	cis	1	rs853685	chr6:28288785	ZSCAN23	chr6:28393287-28411279:-	0.18	3.79	0.000157	Depression	
BRCA	cis	1	rs853694	chr6:28279100	ZNF323	chr6:28292517-28324048:-	0.2	3.57	0.000372	Depression	
BRCA	cis	1	rs853694	chr6:28279100	ZSCAN23	chr6:28393287-28411279:-	0.18	3.74	0.000194	Depression	
BRCA	cis	1	rs854572	chr7:94954696	PON1	chr7:94927671-95025687:-	0.14	3.92	9.28E-5	Paraoxonase activity	
BRCA	cis	1	rs858232	chr7:23241719	NUPL2	chr7:23221446-23240629:+	-0.3	-4.05	5.55E-5	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858237	chr7:23239223	NUPL2	chr7:23221446-23240629:+	-0.27	-3.75	0.000185	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858239	chr7:23286315	GPNMB	chr7:23286316-23314728:+	-0.15	-5.45	6.15E-8	Parkinson's disease	
BRCA	cis	1	rs858240	chr7:23284237	GPNMB	chr7:23286316-23314728:+	-0.15	-5.63	2.28E-8	Parkinson's disease	
BRCA	cis	1	rs858245	chr7:23222727	NUPL2	chr7:23221446-23240629:+	-0.25	-3.43	0.000619	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858251	chr7:23218351	NUPL2	chr7:23221446-23240629:+	-0.28	-3.46	0.000561	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858277	chr7:23252261	NUPL2	chr7:23221446-23240629:+	0.27	3.58	0.000358	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858285	chr7:23249518	NUPL2	chr7:23221446-23240629:+	-0.27	-3.63	0.000296	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858291	chr7:23247361	NUPL2	chr7:23221446-23240629:+	-0.26	-3.66	0.00027	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858292	chr7:23246733	NUPL2	chr7:23221446-23240629:+	-0.27	-3.63	0.000296	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858296	chr7:23245548	NUPL2	chr7:23221446-23240629:+	-0.25	-3.5	0.000481	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858297	chr7:23244961	NUPL2	chr7:23221446-23240629:+	-0.25	-3.5	0.000481	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858301	chr7:23244323	NUPL2	chr7:23221446-23240629:+	-0.25	-3.5	0.000481	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs858302	chr7:23244243	NUPL2	chr7:23221446-23240629:+	-0.25	-3.5	0.000481	Chronic obstructive pulmonary disease	
BRCA	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.32	-10.66	2.81E-25	Homocysteine levels	
BRCA	cis	1	rs8589	chr6:49403282	MUT	chr6:49398994-49431031:-	0.15	4.57	5.49E-6	Homocysteine levels	
BRCA	cis	1	rs859767	chr2:135341200	TMEM163	chr2:135213331-135525334:-	-0.2	-5.11	3.87E-7	Neuroticism	
BRCA	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.77	-20.56	2.1E-79	Type 2 diabetes	
BRCA	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.77	19.73	4.0E-74	Type 2 diabetes	
BRCA	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.76	18.82	2.01E-68	Type 2 diabetes	
BRCA	cis	1	rs864745	chr7:28180556	JAZF1	chr7:27870196-28220437:-	0.1	3.86	0.00012	Crohn's disease;Type 2 diabetes	
BRCA	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.77	19.73	4.0E-74	Type 2 diabetes	
BRCA	cis	1	rs867186	chr20:33764554	PROCR	chr20:33758727-33765164:+	0.24	5.1	4.12E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs867234	chr3:119281636	CD80	chr3:119243142-119278481:-	0.12	4.23	2.57E-5	Vitiligo	
BRCA	cis	1	rs867411	chr12:131621789	FZD10	chr12:130647032-130650284:+	0.13	3.5	0.000483	RR interval (heart rate)	
BRCA	cis	1	rs868105	chr4:8501030	C4orf23	chr4:8440604-8495258:+	0.16	4.17	3.34E-5	Response to antineoplastic agents	
BRCA	cis	1	rs868530	chr5:156430916	TIMD4	chr5:156346293-156390266:-	-0.15	-4.01	6.51E-5	Hypertriglyceridemia	
BRCA	cis	1	rs869518	chr12:63412321	PPM1H	chr12:63037763-63328915:-	-0.15	-3.95	8.17E-5	Obesity-related traits	
BRCA	cis	1	rs870355	chr17:76166196	AFMID	chr17:76183398-76203782:+	0.12	3.54	0.000425	Adenocarcinoma;Lung cancer	
BRCA	cis	1	rs870355	chr17:76166196	SYNGR2	chr17:76164671-76169009:+	0.15	4.73	2.5E-6	Adenocarcinoma;Lung cancer	
BRCA	cis	1	rs870355	chr17:76166196	TMC6	chr17:76108999-76128488:-	0.12	4.36	1.44E-5	Adenocarcinoma;Lung cancer	
BRCA	cis	1	rs871130	chr12:56648777	COQ10A	chr12:56660642-56664748:+	0.29	4.29	1.95E-5	Psoriasis vulgaris	
BRCA	cis	1	rs871130	chr12:56648777	RPS26	chr12:56435686-56438005:+	0.27	3.77	0.000173	Psoriasis vulgaris	
BRCA	cis	1	rs871130	chr12:56648777	SLC39A5	chr12:56623820-56631627:+	0.24	3.82	0.000144	Psoriasis vulgaris	
BRCA	cis	1	rs871546	chr21:43413553	C21orf121	chr21:43442113-43445060:+	0.29	7.13	1.81E-12	Hand grip strength	
BRCA	cis	1	rs872863	chr9:126154354	DENND1A	chr9:126141933-126692417:-	0.25	4.35	1.52E-5	Myopia (pathological)	
BRCA	cis	1	rs872863	chr9:126154354	PDCL	chr9:125580623-125590840:-	0.18	3.46	0.000556	Myopia (pathological)	
BRCA	cis	1	rs872863	chr9:126154354	RABGAP1	chr9:125703112-125867146:+	0.21	4.08	4.92E-5	Myopia (pathological)	
BRCA	cis	1	rs872863	chr9:126154354	ZBTB6	chr9:125670336-125675609:-	0.14	3.4	0.000693	Myopia (pathological)	
BRCA	cis	1	rs873686	chr4:185638876	CASP3	chr4:185548852-185570629:-	-0.14	-4.17	3.27E-5	Kawasaki disease	
BRCA	cis	1	rs873686	chr4:185638876	CCDC111	chr4:185570767-185616112:+	-0.14	-4.03	5.96E-5	Kawasaki disease	
BRCA	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.4	16.08	2.84E-52	Kawasaki disease	
BRCA	cis	1	rs8758	chr10:97366107	ENTPD1	chr10:97471536-97637022:+	0.16	5.63	2.31E-8	Blood metabolite levels	
BRCA	cis	1	rs876402	chr14:75601862	EIF2B2	chr14:75469612-75476292:+	-0.23	-6.42	2.0E-10	Height	
BRCA	cis	1	rs876402	chr14:75601862	MLH3	chr14:75480467-75518235:-	-0.23	-7.08	2.68E-12	Height	
BRCA	cis	1	rs877187	chr6:33706211	IP6K3	chr6:33689443-33714762:-	-0.23	-4.18	3.09E-5	Obesity (extreme)	
BRCA	cis	1	rs877529	chr22:39542292	APOBEC3H	chr22:39493290-39500070:+	-0.12	-5.4	8.12E-8	Multiple myeloma	
BRCA	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.64	-19.01	1.28E-69	Cognitive function	
BRCA	cis	1	rs877710	chr12:109993976	MYO1H	chr12:109826524-109886176:+	0.25	7.55	9.21E-14	HDL cholesterol	
BRCA	cis	1	rs878082	chr19:41897674	B3GNT8	chr19:41931265-41934635:-	-0.22	-6.65	4.59E-11	Height	
BRCA	cis	1	rs878083	chr19:41897688	ATP5SL	chr19:41937224-41945810:-	0.13	3.6	0.000333	Height	
BRCA	cis	1	rs878083	chr19:41897688	B3GNT8	chr19:41931265-41934635:-	-0.23	-7.04	3.34E-12	Height	
BRCA	cis	1	rs879568	chr18:34311659	C18orf10	chr18:34366472-34409158:-	-0.18	-5.29	1.47E-7	QRS duration	
BRCA	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.36	-9.89	3.87E-22	Rheumatoid arthritis	
BRCA	cis	1	rs881375	chr9:123652898	TRAF1	chr9:123664672-123691479:-	0.11	5.04	5.36E-7	Rheumatoid arthritis	
BRCA	cis	1	rs881827	chr21:48019868	C21orf57	chr21:47706267-47717664:+	-0.16	-4.06	5.37E-5	Lymphocyte counts	
BRCA	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.72	-23.67	6.28E-100	Homocysteine levels	
BRCA	cis	1	rs883433	chr19:39206288	LGALS7	chr19:39261608-39264157:-	0.2	6.4	2.38E-10	Heart rate	
BRCA	cis	1	rs883565	chr3:39055317	TTC21A	chr3:39149152-39180394:+	0.13	3.99	7.17E-5	Handedness	
BRCA	cis	1	rs883838	chr9:135815474	C9orf98	chr9:135600965-135754198:-	0.09	3.38	0.00076	Psoriasis	
BRCA	cis	1	rs884613	chr20:25288505	ABHD12	chr20:25275380-25371477:-	-0.12	-3.46	0.000569	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs884613	chr20:25288505	FAM182A	chr20:26035250-26067552:+	0.23	5.98	2.99E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs884613	chr20:25288505	FAM182B	chr20:25744102-25848786:-	-0.22	-5.67	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.56	-17.63	3.09E-61	Response to antipsychotic treatment	
BRCA	cis	1	rs885363	chr1:21325360	HP1BP3	chr1:21069171-21113799:-	0.12	3.61	0.000315	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs885363	chr1:21325360	SH2D5	chr1:21046225-21059330:-	0.13	3.4	0.00069	Superior frontal gyrus grey matter volume	
BRCA	cis	1	rs885389	chr12:131621762	FZD10	chr12:130647032-130650284:+	-0.14	-3.59	0.000343	RR interval (heart rate)	
BRCA	cis	1	rs885654	chr3:119281590	CD80	chr3:119243142-119278481:-	0.13	4.18	3.14E-5	Vitiligo	
BRCA	cis	1	rs885963	chr22:23460939	RTDR1	chr22:23401594-23484241:-	-0.17	-4.42	1.1E-5	Bone mineral density	
BRCA	cis	1	rs885964	chr22:23461003	RTDR1	chr22:23401594-23484241:-	-0.16	-4.43	1.06E-5	Bone mineral density	
BRCA	cis	1	rs885965	chr22:23461425	RTDR1	chr22:23401594-23484241:-	-0.17	-4.5	7.69E-6	Bone mineral density	
BRCA	cis	1	rs886448	chr7:24240165	C7orf30	chr7:23338940-23349182:+	-0.25	-4.24	2.42E-5	Asthma (childhood onset)	
BRCA	cis	1	rs886448	chr7:24240165	CYCS	chr7:25158277-25164955:-	-0.23	-3.91	9.94E-5	Asthma (childhood onset)	
BRCA	cis	1	rs888192	chr12:109995097	MMAB	chr12:109991523-110011358:-	0.12	3.61	0.000323	HDL cholesterol	
BRCA	cis	1	rs888192	chr12:109995097	MYO1H	chr12:109826524-109886176:+	-0.27	-8.06	2.09E-15	HDL cholesterol	
BRCA	cis	1	rs889122	chr19:9995867	FBXL12	chr19:9920945-9938492:-	-0.12	-3.56	0.000384	Menarche (age at onset)	
BRCA	cis	1	rs889122	chr19:9995867	OLFM2	chr19:9964395-10047070:-	-0.15	-4.54	6.4E-6	Menarche (age at onset)	
BRCA	cis	1	rs889312	chr5:56031884	C5orf35	chr5:56205103-56213010:+	0.34	8.65	1.83E-17	Breast cancer (early onset);Breast cancer	
BRCA	cis	1	rs8897	chr3:49460407	AMT	chr3:49454212-49460012:-	0.12	4.35	1.48E-5	Menarche (age at onset)	
BRCA	cis	1	rs8897	chr3:49460407	CCDC36	chr3:49235861-49295537:+	0.1	3.89	0.000108	Menarche (age at onset)	
BRCA	cis	1	rs8897	chr3:49460407	GMPPB	chr3:49758932-49761384:-	-0.12	-3.64	0.000289	Menarche (age at onset)	
BRCA	cis	1	rs8897	chr3:49460407	P4HTM	chr3:49027341-49044579:+	0.1	4.27	2.09E-5	Menarche (age at onset)	
BRCA	cis	1	rs8897	chr3:49460407	TREX1	chr3:48501186-48509043:+	-0.11	-3.55	0.000406	Menarche (age at onset)	
BRCA	cis	1	rs8897	chr3:49460407	WDR6	chr3:49044637-49053386:+	-0.15	-4.51	7.32E-6	Menarche (age at onset)	
BRCA	cis	1	rs891386	chr18:21103971	NPC1	chr18:21108363-21166581:-	0.14	4.41	1.16E-5	Body mass index	
BRCA	cis	1	rs892864	chr5:127835859	FBN2	chr5:127593602-127873916:-	0.24	4.05	5.5E-5	Multiple system atrophy	
BRCA	cis	1	rs892974	chr3:49398514	AMT	chr3:49454212-49460012:-	0.14	4.69	3.06E-6	Menarche (age at onset)	
BRCA	cis	1	rs892974	chr3:49398514	CCDC36	chr3:49235861-49295537:+	0.1	3.5	0.000483	Menarche (age at onset)	
BRCA	cis	1	rs892974	chr3:49398514	NCKIPSD	chr3:48711280-48723334:-	0.16	3.91	0.0001	Menarche (age at onset)	
BRCA	cis	1	rs892974	chr3:49398514	P4HTM	chr3:49027341-49044579:+	0.11	4.55	5.86E-6	Menarche (age at onset)	
BRCA	cis	1	rs892974	chr3:49398514	TREX1	chr3:48501186-48509043:+	-0.12	-3.65	0.000278	Menarche (age at onset)	
BRCA	cis	1	rs892974	chr3:49398514	WDR6	chr3:49044637-49053386:+	-0.14	-3.96	8.04E-5	Menarche (age at onset)	
BRCA	cis	1	rs894157	chr15:90168108	PEX11A	chr15:90226289-90233958:-	-0.21	-3.86	0.00012	Obesity-related traits	
BRCA	cis	1	rs894737	chr12:54418143	FLJ12825	chr12:54452038-54516018:+	0.16	4.14	3.82E-5	Bone mineral density	
BRCA	cis	1	rs894737	chr12:54418143	SMUG1	chr12:54573783-54582757:-	-0.12	-3.69	0.000234	Bone mineral density	
BRCA	cis	1	rs894738	chr12:54417525	FLJ12825	chr12:54452038-54516018:+	0.16	4.15	3.55E-5	Bone mineral density	
BRCA	cis	1	rs894738	chr12:54417525	SMUG1	chr12:54573783-54582757:-	-0.11	-3.55	0.000395	Bone mineral density	
BRCA	cis	1	rs896625	chr16:80647550	CDYL2	chr16:80637678-80838175:-	0.16	5.63	2.29E-8	Breast cancer	
BRCA	cis	1	rs897119	chr2:70160658	ANXA4	chr2:69969127-70053594:+	-0.13	-3.67	0.000256	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs897120	chr2:70160982	ANXA4	chr2:69969127-70053594:+	0.13	3.77	0.000172	Carotid plaque burden (smoking interaction)	
BRCA	cis	1	rs897601	chr1:99516406	LPPR4	chr1:99729900-99775136:+	-0.17	-3.53	0.000434	Obesity-related traits;Myopia (pathological)	
BRCA	cis	1	rs898225	chr3:48413179	ATRIP	chr3:48488141-48507708:+	-0.1	-3.54	0.000413	Longevity	
BRCA	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.25	9.38	3.84E-20	Longevity	
BRCA	cis	1	rs899302	chr11:27309577	LGR4	chr11:27387510-27494334:-	0.14	4.09	4.59E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs899303	chr11:27309681	LGR4	chr11:27387510-27494334:-	0.14	4.09	4.59E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs904061	chr14:52504624	NID2	chr14:52471521-52535946:-	0.08	3.61	0.000324	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs904093	chr4:100263247	ADH1C	chr4:100257651-100273917:-	-0.2	-6.38	2.65E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs904093	chr4:100263247	ADH4	chr4:100044835-100065449:-	-0.11	-3.42	0.000643	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs904094	chr4:100263252	ADH1C	chr4:100257651-100273917:-	-0.2	-6.38	2.65E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs904094	chr4:100263252	ADH4	chr4:100044835-100065449:-	-0.11	-3.42	0.000643	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs904095	chr4:100263383	ADH1C	chr4:100257651-100273917:-	-0.2	-6.32	3.73E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs904096	chr4:100263584	ADH1C	chr4:100257651-100273917:-	-0.2	-6.28	4.79E-10	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs904251	chr6:37451696	C6orf129	chr6:37450699-37467700:-	0.12	4.64	3.83E-6	Cognitive performance	
BRCA	cis	1	rs904251	chr6:37451696	RNF8	chr6:37321748-37362513:+	0.12	3.54	0.00041	Cognitive performance	
BRCA	cis	1	rs905356	chr9:91546375	C9orf47	chr9:91605778-91611055:+	0.13	3.69	0.000238	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs906134	chr7:65444288	CCT6P1	chr7:65216092-65228661:+	0.35	7.68	3.52E-14	Diabetic kidney disease	
BRCA	cis	1	rs906134	chr7:65444288	LOC493754	chr7:65993446-66057363:-	0.21	3.52	0.000454	Diabetic kidney disease	
BRCA	cis	1	rs906134	chr7:65444288	ZNF117	chr7:64434830-64467121:-	-0.27	-4.95	8.8E-7	Diabetic kidney disease	
BRCA	cis	1	rs909349	chr4:103556316	MANBA	chr4:103552644-103682151:-	-0.23	-5.91	4.68E-9	Primary biliary cirrhosis	
BRCA	cis	1	rs910316	chr14:75626042	EIF2B2	chr14:75469612-75476292:+	0.2	5.53	3.98E-8	Height	
BRCA	cis	1	rs910316	chr14:75626042	MLH3	chr14:75480467-75518235:-	0.23	7.11	2.14E-12	Height	
BRCA	cis	1	rs910997	chr20:25267301	FAM182A	chr20:26035250-26067552:+	-0.21	-5.64	2.13E-8	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs910997	chr20:25267301	FAM182B	chr20:25744102-25848786:-	0.23	5.97	3.13E-9	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs910997	chr20:25267301	PYGB	chr20:25228706-25278647:+	-0.13	-3.48	0.000513	Liver enzyme levels (alkaline phosphatase)	
BRCA	cis	1	rs911119	chr20:23612737	CST1	chr20:23728191-23731574:-	-0.18	-3.96	7.91E-5	Chronic kidney disease	
BRCA	cis	1	rs912337	chr13:99141272	STK24	chr13:99102455-99229396:-	0.13	3.48	0.000512	Longevity	
BRCA	cis	1	rs914187	chr21:42619749	BACE2	chr21:42539728-42648523:+	-0.12	-3.61	0.000319	Body mass index	
BRCA	cis	1	rs916583	chr22:23469267	RTDR1	chr22:23401594-23484241:-	-0.17	-4.54	6.14E-6	Bone mineral density	
BRCA	cis	1	rs916584	chr22:23469433	RTDR1	chr22:23401594-23484241:-	-0.16	-4.34	1.59E-5	Bone mineral density	
BRCA	cis	1	rs916585	chr22:23469438	RTDR1	chr22:23401594-23484241:-	-0.17	-4.63	4.05E-6	Bone mineral density	
BRCA	cis	1	rs917063	chr14:71648072	RGS6	chr14:72399156-73033237:+	0.15	3.4	0.000699	Gestational age at birth in labor-initiated deliveries (child effect);Response to zileuton treatment in asthma (FEV1 change interaction)	
BRCA	cis	1	rs917117	chr7:28176305	JAZF1	chr7:27870196-28220437:-	0.15	5.11	3.82E-7	Rheumatoid arthritis	
BRCA	cis	1	rs917665	chr4:17668504	MED28	chr4:17616273-17629791:+	-0.18	-4.91	1.07E-6	Parasitemia in Tripanosoma cruzi seropositivity	
BRCA	cis	1	rs917911	chr12:9905851	CLEC2D	chr12:9822309-9852039:+	0.14	4.66	3.56E-6	Type 1 diabetes	
BRCA	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.34	13.35	1.05E-37	Type 1 diabetes	
BRCA	cis	1	rs917962	chr2:39966594	THUMPD2	chr2:39963200-40006416:-	-0.12	-3.82	0.000142	Personality dimensions	
BRCA	cis	1	rs918814	chr2:23948466	C2orf84	chr2:24397531-24414566:+	-0.13	-3.54	0.000412	Obesity-related traits	
BRCA	cis	1	rs918814	chr2:23948466	LOC375190	chr2:24299728-24397519:+	0.16	4.88	1.22E-6	Obesity-related traits	
BRCA	cis	1	rs919586	chr8:13174671	FAM86B2	chr8:12283126-12293864:-	0.22	4.41	1.15E-5	Obesity-related traits	
BRCA	cis	1	rs919586	chr8:13174671	LONRF1	chr8:12579406-12612992:-	0.28	5.61	2.52E-8	Obesity-related traits	
BRCA	cis	1	rs920573	chr11:59924959	MS4A4A	chr11:60048139-60076444:+	-0.09	-3.68	0.000246	Alzheimer's disease (late onset)	
BRCA	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.68	-19.83	9.88E-75	Spherical equivalent (joint main effects and education interaction)	
BRCA	cis	1	rs921450	chr7:50623260	FIGNL1	chr7:50511834-50518088:-	0.12	4.09	4.57E-5	Malaria	
BRCA	cis	1	rs921451	chr7:50623285	FIGNL1	chr7:50511834-50518088:-	-0.12	-4.29	1.91E-5	Malaria	
BRCA	cis	1	rs922075	chr3:48489398	ATRIP	chr3:48488141-48507708:+	-0.09	-3.38	0.000755	Longevity	
BRCA	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.26	9.78	1.1E-21	Longevity	
BRCA	cis	1	rs923782	chr4:145648032	ABCE1	chr4:146019156-146050675:+	0.1	3.74	0.000197	Height	
BRCA	cis	1	rs9253	chr1:37958813	SNIP1	chr1:38002145-38019903:-	-0.19	-3.81	0.000148	Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs925410	chr2:160912652	LY75	chr2:160625141-160761262:-	-0.13	-4.37	1.34E-5	Idiopathic membranous nephropathy	
BRCA	cis	1	rs925410	chr2:160912652	PLA2R1	chr2:160798012-160919121:-	-0.15	-5.05	5.24E-7	Idiopathic membranous nephropathy	
BRCA	cis	1	rs925488	chr9:100546391	NCBP1	chr9:100395705-100436027:+	-0.12	-3.68	0.000243	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs925488	chr9:100546391	TSTD2	chr9:100362364-100395962:-	-0.1	-3.63	0.000299	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs925489	chr9:100546600	CORO2A	chr9:100883258-100954956:-	-0.12	-3.38	0.000741	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs925489	chr9:100546600	NCBP1	chr9:100395705-100436027:+	-0.13	-3.92	9.48E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs925489	chr9:100546600	TSTD2	chr9:100362364-100395962:-	-0.11	-4.09	4.72E-5	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs925718	chr1:35675764	C1orf216	chr1:36179477-36184790:-	-0.19	-3.42	0.000654	Endometrial cancer	
BRCA	cis	1	rs926391	chr20:37690485	DHX35	chr20:37591000-37668363:+	-0.14	-4.08	4.93E-5	Dialysis-related mortality	
BRCA	cis	1	rs926392	chr20:37690464	DHX35	chr20:37591000-37668363:+	-0.12	-3.52	0.000449	Dialysis-related mortality	
BRCA	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.75	18.57	6.51E-67	Type 2 diabetes	
BRCA	cis	1	rs9288316	chr2:202163483	ALS2CR12	chr2:202153148-202222101:-	0.26	6.67	4.11E-11	Melanoma;Esophageal squamous cell carcinoma	
BRCA	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.43	14.51	1.15E-43	Height	
BRCA	cis	1	rs9289471	chr3:134230811	CEP63	chr3:134204575-134293852:+	0.16	4.36	1.42E-5	Height	
BRCA	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.42	13.97	7.41E-41	Height	
BRCA	cis	1	rs9289475	chr3:134236459	CEP63	chr3:134204575-134293852:+	0.14	3.89	0.000106	Height	
BRCA	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.4	13.42	4.59E-38	Height	
BRCA	cis	1	rs9289476	chr3:134237103	CEP63	chr3:134204575-134293852:+	0.14	3.95	8.33E-5	Height	
BRCA	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.41	13.5	1.94E-38	Height	
BRCA	cis	1	rs9289478	chr3:134268619	CEP63	chr3:134204575-134293852:+	0.14	3.94	8.72E-5	Height	
BRCA	cis	1	rs9291683	chr4:10324160	SLC2A9	chr4:9827850-10041872:-	-0.14	-4.09	4.65E-5	Bone mineral density	
BRCA	cis	1	rs9291683	chr4:10324160	WDR1	chr4:10075964-10118573:-	0.15	3.95	8.48E-5	Bone mineral density	
BRCA	cis	1	rs9292468	chr5:32819073	TARS	chr5:33440802-33468194:+	-0.11	-3.53	0.000436	Height	
BRCA	cis	1	rs9293332	chr5:82437365	XRCC4	chr5:82373317-82649577:+	-0.12	-3.42	0.000656	Hypertension	
BRCA	cis	1	rs9295695	chr6:26528250	BTN2A3	chr6:26422317-26431927:+	-0.17	-5.48	5.19E-8	Educational attainment	
BRCA	cis	1	rs9295695	chr6:26528250	C6orf41	chr6:26924772-26991752:+	0.13	3.81	0.000145	Educational attainment	
BRCA	cis	1	rs9295695	chr6:26528250	ZNF322A	chr6:26634612-26659963:-	0.1	3.46	0.000555	Educational attainment	
BRCA	cis	1	rs9296095	chr6:33542523	BAK1	chr6:33540324-33548070:-	-0.16	-4.53	6.49E-6	Platelet count	
BRCA	cis	1	rs9296404	chr6:42925803	CNPY3	chr6:42896860-42907007:+	0.13	4.54	6.33E-6	Plasma homocysteine levels (post-methionine load test)	
BRCA	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.11	-3.43	0.000618	Plasma homocysteine levels (post-methionine load test)	
BRCA	cis	1	rs9296404	chr6:42925803	KIAA0240	chr6:42749790-42836296:+	0.09	3.45	0.000591	Plasma homocysteine levels (post-methionine load test)	
BRCA	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.64	21.18	2.21E-83	Plasma homocysteine levels (post-methionine load test)	
BRCA	cis	1	rs9296504	chr6:46629505	SLC25A27	chr6:46620679-46645925:+	0.13	4.7	2.91E-6	QRS complex (Sokolow-Lyon)	
BRCA	cis	1	rs9296505	chr6:46629841	CYP39A1	chr6:46517445-46620523:-	0.11	3.71	0.000222	QRS complex (Sokolow-Lyon)	
BRCA	cis	1	rs9296505	chr6:46629841	SLC25A27	chr6:46620679-46645925:+	0.14	5.07	4.79E-7	QRS complex (Sokolow-Lyon)	
BRCA	cis	1	rs9296616	chr6:49414235	CENPQ	chr6:49431096-49460820:+	-0.23	-7.38	3.22E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.32	9.85	5.96E-22	Folate pathway vitamin levels	
BRCA	cis	1	rs9296617	chr6:49428360	CENPQ	chr6:49431096-49460820:+	-0.23	-7.67	3.96E-14	Folate pathway vitamin levels	
BRCA	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.33	10.3	9.06E-24	Folate pathway vitamin levels	
BRCA	cis	1	rs9296832	chr6:56100909	COL21A1	chr6:55921389-56258892:-	0.68	21.15	3.42E-83	Pulse pressure	
BRCA	cis	1	rs9297006	chr6:9854470	C6orf218	chr6:10428018-10435055:-	-0.16	-3.38	0.000755	Adiponectin levels	
BRCA	cis	1	rs9297951	chr8:96041437	C8orf38	chr8:95908040-96088396:+	-0.18	-4.46	9.09E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
BRCA	cis	1	rs9299997	chr11:27336872	LGR4	chr11:27387510-27494334:-	0.15	4.22	2.66E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs930421	chr2:42981239	HAAO	chr2:42994230-43019751:-	0.11	3.8	0.000155	Attention deficit hyperactivity disorder	
BRCA	cis	1	rs9304341	chr18:44670263	KATNAL2	chr18:44497557-44628613:+	0.14	3.94	8.53E-5	Educational attainment	
BRCA	cis	1	rs9304578	chr19:39250337	LGALS4	chr19:39292312-39303740:-	0.11	3.5	0.000486	Heart rate	
BRCA	cis	1	rs9304578	chr19:39250337	LGALS7	chr19:39261608-39264157:-	0.17	5.3	1.4E-7	Heart rate	
BRCA	cis	1	rs9304593	chr19:41942875	B3GNT8	chr19:41931265-41934635:-	0.21	6.28	4.95E-10	Height	
BRCA	cis	1	rs9304742	chr19:53451291	ZNF816A	chr19:53452632-53466114:-	-0.12	-3.65	0.000276	Psoriasis	
BRCA	cis	1	rs9306329	chr22:39072454	DDX17	chr22:38879445-38903665:-	-0.1	-3.43	0.000627	Resting heart rate	
BRCA	cis	1	rs9306329	chr22:39072454	JOSD1	chr22:39081549-39096459:-	-0.13	-4.18	3.12E-5	Resting heart rate	
BRCA	cis	1	rs9306329	chr22:39072454	TOMM22	chr22:39077954-39080763:+	-0.11	-3.63	0.000297	Resting heart rate	
BRCA	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.21	-5.28	1.53E-7	Longevity	
BRCA	cis	1	rs9309331	chr2:61141615	AHSA2	chr2:61404553-61414058:+	-0.13	-5.24	1.96E-7	Inflammatory skin disease	
BRCA	cis	1	rs9309331	chr2:61141615	C2orf74	chr2:61372243-61391964:+	0.29	6.23	6.51E-10	Inflammatory skin disease	
BRCA	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.26	6.73	2.79E-11	Metabolite levels	
BRCA	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.38	7.92	5.85E-15	Crohn's disease	
BRCA	cis	1	rs931080	chr11:27324312	LGR4	chr11:27387510-27494334:-	0.14	4.15	3.57E-5	Bone mineral density (paediatric, skull)	
BRCA	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.27	-9.97	1.96E-22	Longevity	
BRCA	cis	1	rs9311474	chr3:52338852	SPCS1	chr3:52739857-52742195:+	0.14	4.37	1.35E-5	Electroencephalogram traits	
BRCA	cis	1	rs9311676	chr3:58470351	PDHB	chr3:58413355-58419565:-	-0.22	-5.98	3.11E-9	Systemic lupus erythematosus	
BRCA	cis	1	rs9311676	chr3:58470351	PXK	chr3:58318617-58410878:+	-0.13	-4.37	1.34E-5	Systemic lupus erythematosus	
BRCA	cis	1	rs931608	chr19:22614122	ZNF257	chr19:22235266-22273901:+	-0.21	-3.47	0.00055	Dental caries;Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs931617	chr5:178514893	ZNF354C	chr5:178487607-178507689:+	-0.12	-4.11	4.21E-5	Height	
BRCA	cis	1	rs9316337	chr13:21962207	ZDHHC20	chr13:21950510-22033423:-	0.07	3.42	0.000639	Schizophrenia	
BRCA	cis	1	rs9320656	chr6:118894468	C6orf204	chr6:118786239-119031238:-	0.12	3.81	0.000148	Renal cell carcinoma	
BRCA	cis	1	rs9320660	chr6:118956827	C6orf204	chr6:118786239-119031238:-	-0.11	-3.47	0.000534	Renal cell carcinoma	
BRCA	cis	1	rs9325	chr15:58245986	ALDH1A2	chr15:58245628-58571462:-	-0.1	-3.91	9.75E-5	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	
BRCA	cis	1	rs932809	chr10:96488469	HELLS	chr10:96305543-96361855:+	0.12	3.37	0.000769	Migraine	
BRCA	cis	1	rs932833	chr9:131884041	NUP188	chr9:131703724-131769374:+	-0.12	-3.47	0.000542	Blood metabolite ratios	
BRCA	cis	1	rs932833	chr9:131884041	SH3GLB2	chr9:131770314-131790579:-	-0.13	-4.86	1.35E-6	Blood metabolite ratios	
BRCA	cis	1	rs932835	chr9:131887071	SH3GLB2	chr9:131770314-131790579:-	-0.13	-4.72	2.65E-6	Blood metabolite ratios	
BRCA	cis	1	rs9332093	chr10:96696555	C10orf129	chr10:96953957-96988685:+	-0.3	-5.42	7.49E-8	Blood metabolite levels	
BRCA	cis	1	rs9332846	chr11:118377523	CCDC84	chr11:118868852-118886454:+	-0.18	-3.76	0.000179	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
BRCA	cis	1	rs9332846	chr11:118377523	TMEM25	chr11:118401803-118417313:+	-0.18	-3.6	0.000336	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
BRCA	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.43	14.39	4.85E-43	Height	
BRCA	cis	1	rs934093	chr3:134195885	CEP63	chr3:134204575-134293852:+	0.16	4.31	1.82E-5	Height	
BRCA	cis	1	rs9349407	chr6:47453378	GPR111	chr6:47624222-47663805:+	0.14	3.6	0.000335	Alzheimer's disease (late onset)	
BRCA	cis	1	rs9349804	chr6:56098876	COL21A1	chr6:55921389-56258892:-	0.69	21.78	2.58E-87	Pulse pressure	
BRCA	cis	1	rs9355256	chr6:159375477	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs9357010	chr6:26527945	BTN2A3	chr6:26422317-26431927:+	0.16	5.31	1.3E-7	Educational attainment	
BRCA	cis	1	rs9357010	chr6:26527945	C6orf41	chr6:26924772-26991752:+	-0.13	-4.01	6.38E-5	Educational attainment	
BRCA	cis	1	rs9357010	chr6:26527945	LOC100270746	chr6:26987146-26988085:-	-0.12	-3.42	0.000639	Educational attainment	
BRCA	cis	1	rs9357010	chr6:26527945	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.39	0.000721	Educational attainment	
BRCA	cis	1	rs9357037	chr6:27327349	ZNF391	chr6:27356524-27369227:+	0.18	4.95	8.79E-7	Glomerular filtration rate (creatinine)	
BRCA	cis	1	rs9357619	chr6:49490094	CENPQ	chr6:49431096-49460820:+	0.2	6.54	9.74E-11	Brain structure	
BRCA	cis	1	rs9357733	chr6:52292136	EFHC1	chr6:52284994-52387892:+	0.15	4.1	4.42E-5	Atopic march	
BRCA	cis	1	rs936228	chr15:75132164	MPI	chr15:75182410-75190565:+	0.2	5.4	8.17E-8	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
BRCA	cis	1	rs936228	chr15:75132164	ULK3	chr15:75128459-75135552:-	-0.17	-4.93	9.57E-7	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
BRCA	cis	1	rs936229	chr15:75132319	MPI	chr15:75182410-75190565:+	0.2	5.42	7.19E-8	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
BRCA	cis	1	rs936229	chr15:75132319	ULK3	chr15:75128459-75135552:-	-0.17	-4.93	9.53E-7	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
BRCA	cis	1	rs9362426	chr6:88089874	C6orf163	chr6:88057220-88075180:+	0.17	4.16	3.39E-5	Depressive episodes in bipolar disorder	
BRCA	cis	1	rs9362426	chr6:88089874	C6orf164	chr6:88032306-88109459:+	-0.14	-3.54	0.000417	Depressive episodes in bipolar disorder	
BRCA	cis	1	rs9364505	chr6:159375426	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs9365012	chr6:159373408	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs9365013	chr6:159373446	RSPH3	chr6:159398268-159421198:-	0.2	3.71	0.000216	Bladder cancer (smoking interaction)	
BRCA	cis	1	rs936525	chr19:23056189	ZNF492	chr19:22817126-22850472:+	-0.23	-5.2	2.34E-7	Bronchopulmonary dysplasia	
BRCA	cis	1	rs936526	chr19:23055987	ZNF492	chr19:22817126-22850472:+	-0.21	-4.51	7.05E-6	Bronchopulmonary dysplasia	
BRCA	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.32	-10.55	8.14E-25	Homocysteine levels	
BRCA	cis	1	rs9369898	chr6:49382193	MUT	chr6:49398994-49431031:-	0.15	4.6	4.76E-6	Homocysteine levels	
BRCA	cis	1	rs937108	chr7:65428452	CCT6P1	chr7:65216092-65228661:+	0.34	7.53	1.09E-13	Diabetic kidney disease	
BRCA	cis	1	rs937108	chr7:65428452	LOC493754	chr7:65993446-66057363:-	0.2	3.48	0.000517	Diabetic kidney disease	
BRCA	cis	1	rs937108	chr7:65428452	ZNF117	chr7:64434830-64467121:-	-0.27	-4.95	8.75E-7	Diabetic kidney disease	
BRCA	cis	1	rs9371620	chr6:152949230	VIP	chr6:153071933-153080898:+	0.12	3.99	6.94E-5	Tonometry	
BRCA	cis	1	rs9371626	chr6:153008926	SYNE1	chr6:152442823-152958534:-	0.09	3.56	0.000394	Tonometry	
BRCA	cis	1	rs9371626	chr6:153008926	VIP	chr6:153071933-153080898:+	-0.13	-4.22	2.68E-5	Tonometry	
BRCA	cis	1	rs9373571	chr6:101133834	ASCC3	chr6:100956609-101329224:-	0.11	4.26	2.24E-5	Menarche (age at onset)	
BRCA	cis	1	rs9381469	chr6:46630068	CYP39A1	chr6:46517445-46620523:-	-0.11	-3.6	0.000335	QRS complex (Sokolow-Lyon)	
BRCA	cis	1	rs9381469	chr6:46630068	SLC25A27	chr6:46620679-46645925:+	-0.14	-5.07	4.6E-7	QRS complex (Sokolow-Lyon)	
BRCA	cis	1	rs9381469	chr6:46630068	TDRD6	chr6:46655866-46670149:+	0.1	3.38	0.000758	QRS complex (Sokolow-Lyon)	
BRCA	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.28	8.68	1.48E-17	Homocysteine levels	
BRCA	cis	1	rs9381784	chr6:49398115	MUT	chr6:49398994-49431031:-	-0.15	-4.16	3.37E-5	Homocysteine levels	
BRCA	cis	1	rs9383649	chr6:153428102	RGS17	chr6:153332041-153452389:-	-0.12	-3.47	0.000538	Prostate cancer	
BRCA	cis	1	rs9383993	chr6:150299299	ULBP2	chr6:150263136-150270366:+	0.12	3.56	0.000384	Radiation response	
BRCA	cis	1	rs9385012	chr6:117733191	ROS1	chr6:117609530-117747018:-	-0.14	-4.65	3.73E-6	Lung cancer	
BRCA	cis	1	rs938875	chr15:67952922	IQCH	chr15:67547188-67794139:+	0.14	4.93	9.76E-7	Motion sickness	
BRCA	cis	1	rs938875	chr15:67952922	LBXCOR1	chr15:68117941-68126174:+	0.12	3.56	0.000394	Motion sickness	
BRCA	cis	1	rs938878	chr15:67993366	IQCH	chr15:67547188-67794139:+	0.14	4.89	1.17E-6	Motion sickness	
BRCA	cis	1	rs9390502	chr6:101057478	ASCC3	chr6:100956609-101329224:-	0.11	4.24	2.38E-5	Menarche (age at onset)	
BRCA	cis	1	rs9390626	chr6:101163109	ASCC3	chr6:100956609-101329224:-	0.12	4.83	1.55E-6	Menarche (age at onset)	
BRCA	cis	1	rs939338	chr3:183704068	KLHL24	chr3:183353411-183402302:+	0.11	3.51	0.000471	Anterior chamber depth	
BRCA	cis	1	rs9393692	chr6:26276650	BTN3A2	chr6:26365398-26378546:+	0.19	5.94	3.94E-9	Educational attainment	
BRCA	cis	1	rs9393728	chr6:26509330	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.18E-8	Educational attainment	
BRCA	cis	1	rs9393728	chr6:26509330	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.46	0.000559	Educational attainment	
BRCA	cis	1	rs9393729	chr6:26514166	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.38E-8	Educational attainment	
BRCA	cis	1	rs9393729	chr6:26514166	C6orf41	chr6:26924772-26991752:+	-0.12	-3.58	0.000354	Educational attainment	
BRCA	cis	1	rs9393729	chr6:26514166	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.48	0.00052	Educational attainment	
BRCA	cis	1	rs9393731	chr6:26529374	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.59E-8	Educational attainment	
BRCA	cis	1	rs9393731	chr6:26529374	C6orf41	chr6:26924772-26991752:+	-0.12	-3.7	0.000227	Educational attainment	
BRCA	cis	1	rs9393731	chr6:26529374	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.5	0.000486	Educational attainment	
BRCA	cis	1	rs9393732	chr6:26530898	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.58E-8	Educational attainment	
BRCA	cis	1	rs9393732	chr6:26530898	C6orf41	chr6:26924772-26991752:+	-0.12	-3.7	0.000227	Educational attainment	
BRCA	cis	1	rs9393732	chr6:26530898	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.5	0.000489	Educational attainment	
BRCA	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.36	-10.22	1.92E-23	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
BRCA	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.33	-11.19	1.53E-27	Homocysteine levels	
BRCA	cis	1	rs9395493	chr6:49427409	MUT	chr6:49398994-49431031:-	0.14	4.38	1.3E-5	Homocysteine levels	
BRCA	cis	1	rs9398235	chr6:110732116	DDO	chr6:110713384-110736753:-	-0.16	-4.03	5.89E-5	Systemic lupus erythematosus	
BRCA	cis	1	rs940045	chr3:49449638	AMT	chr3:49454212-49460012:-	0.14	4.96	8.17E-7	Menarche (age at onset)	
BRCA	cis	1	rs940045	chr3:49449638	CCDC36	chr3:49235861-49295537:+	0.1	3.85	0.000126	Menarche (age at onset)	
BRCA	cis	1	rs940045	chr3:49449638	NCKIPSD	chr3:48711280-48723334:-	0.17	4.29	1.91E-5	Menarche (age at onset)	
BRCA	cis	1	rs940045	chr3:49449638	P4HTM	chr3:49027341-49044579:+	0.1	4.11	4.26E-5	Menarche (age at onset)	
BRCA	cis	1	rs940045	chr3:49449638	WDR6	chr3:49044637-49053386:+	-0.14	-4.34	1.59E-5	Menarche (age at onset)	
BRCA	cis	1	rs9400467	chr6:111424015	DDO	chr6:110713384-110736753:-	-0.13	-3.54	0.000414	Blood metabolite levels;Amino acid levels	
BRCA	cis	1	rs9400478	chr6:111799644	KIAA1919	chr6:111580482-111590259:+	-0.33	-4.19	3.09E-5	Psoriasis	
BRCA	cis	1	rs9401006	chr6:117732924	ROS1	chr6:117609530-117747018:-	-0.14	-4.49	7.98E-6	Lung cancer	
BRCA	cis	1	rs9410258	chr9:91545917	C9orf47	chr9:91605778-91611055:+	0.13	3.6	0.000328	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs9410260	chr9:91549376	C9orf47	chr9:91605778-91611055:+	0.13	3.69	0.000238	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs9410261	chr9:91551028	C9orf47	chr9:91605778-91611055:+	0.13	3.7	0.000229	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs9410263	chr9:91554638	C9orf47	chr9:91605778-91611055:+	0.13	3.72	0.000209	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs9410264	chr9:91554748	C9orf47	chr9:91605778-91611055:+	0.13	3.72	0.000209	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs9410283	chr9:91565027	C9orf47	chr9:91605778-91611055:+	0.12	3.44	0.000597	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs9410414	chr9:91549857	C9orf47	chr9:91605778-91611055:+	0.13	3.69	0.000238	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs9410415	chr9:91552207	C9orf47	chr9:91605778-91611055:+	0.13	3.75	0.000186	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs9410431	chr9:91564117	C9orf47	chr9:91605778-91611055:+	0.12	3.41	0.000663	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs9410432	chr9:91564233	C9orf47	chr9:91605778-91611055:+	0.12	3.47	0.000548	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs9410436	chr9:91566370	C9orf47	chr9:91605778-91611055:+	-0.14	-3.96	8.05E-5	Response to statins (LDL cholesterol change)	
BRCA	cis	1	rs941898	chr14:100599437	BCL11B	chr14:99635627-99737822:-	-0.11	-3.6	0.000336	White matter hyperintensity burden	
BRCA	cis	1	rs9419788	chr10:96013705	HELLS	chr10:96305543-96361855:+	-0.12	-4.19	2.97E-5	Personality traits in bipolar disorder	
BRCA	cis	1	rs9419897	chr10:102246125	SEC31B	chr10:102246403-102289636:-	-0.29	-10.77	9.32E-26	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs9420782	chr10:102235015	SEC31B	chr10:102246403-102289636:-	-0.28	-10.65	3.06E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs9420785	chr10:102240451	SEC31B	chr10:102246403-102289636:-	-0.28	-10.55	7.89E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs9420797	chr10:102331147	SEC31B	chr10:102246403-102289636:-	-0.28	-10.76	1.07E-25	Palmitoleic acid (16:1n-7) plasma levels	
BRCA	cis	1	rs9420	chr11:57510294	MED19	chr11:57471182-57479673:-	0.16	4.07	5.02E-5	Schizophrenia	
BRCA	cis	1	rs9423239	chr10:124740727	C10orf88	chr10:124690419-124713919:-	0.13	3.66	0.000264	Migraine without aura	
BRCA	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.84	1.71E-30	Body mass index	
BRCA	cis	1	rs9429183	chr1:46524582	MUTYH	chr1:45794915-45806142:-	0.12	4.7	2.98E-6	Body mass index	
BRCA	cis	1	rs943125	chr10:91379546	FLJ37201	chr10:91451057-91457685:-	-0.17	-3.7	0.000226	Metabolic traits	
BRCA	cis	1	rs943461	chr6:33769409	LEMD2	chr6:33738991-33756906:-	0.17	5.24	1.94E-7	Body mass index	
BRCA	cis	1	rs943462	chr6:33769578	LEMD2	chr6:33738991-33756906:-	0.17	5.23	2.06E-7	Body mass index	
BRCA	cis	1	rs943466	chr6:33731787	C6orf125	chr6:33662057-33679504:-	-0.11	-3.82	0.00014	Body mass index	
BRCA	cis	1	rs943466	chr6:33731787	LEMD2	chr6:33738991-33756906:-	-0.15	-4.81	1.69E-6	Body mass index	
BRCA	cis	1	rs9450662	chr6:88088593	C6orf163	chr6:88057220-88075180:+	0.16	4.06	5.26E-5	Depressive episodes in bipolar disorder	
BRCA	cis	1	rs9450662	chr6:88088593	C6orf164	chr6:88032306-88109459:+	-0.13	-3.41	0.000668	Depressive episodes in bipolar disorder	
BRCA	cis	1	rs945961	chr20:33769926	PROCR	chr20:33758727-33765164:+	-0.23	-4.55	5.95E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
BRCA	cis	1	rs9461011	chr6:24440351	ALDH5A1	chr6:24495197-24537434:+	0.15	3.58	0.000362	Liver enzyme levels	
BRCA	cis	1	rs9461011	chr6:24440351	MRS2	chr6:24403153-24425809:+	0.16	4.09	4.73E-5	Liver enzyme levels	
BRCA	cis	1	rs9461259	chr6:26504835	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.58E-8	Educational attainment	
BRCA	cis	1	rs9461259	chr6:26504835	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.42	0.000651	Educational attainment	
BRCA	cis	1	rs9461271	chr6:26554968	BTN2A3	chr6:26422317-26431927:+	0.16	5.34	1.15E-7	Educational attainment	
BRCA	cis	1	rs9461271	chr6:26554968	C6orf41	chr6:26924772-26991752:+	-0.13	-3.87	0.000114	Educational attainment	
BRCA	cis	1	rs9462007	chr6:34715341	UHRF1BP1	chr6:34759794-34853117:+	0.15	4.29	1.95E-5	Pubertal anthropometrics	
BRCA	cis	1	rs9462016	chr6:34739790	UHRF1BP1	chr6:34759794-34853117:+	0.15	4.31	1.8E-5	Pubertal anthropometrics	
BRCA	cis	1	rs9462939	chr6:43899646	HSP90AB1	chr6:44214849-44221614:+	0.13	3.44	0.000611	Vascular endothelial growth factor levels	
BRCA	cis	1	rs9462939	chr6:43899646	MRPL14	chr6:44081374-44095191:-	0.13	4.46	9.27E-6	Vascular endothelial growth factor levels	
BRCA	cis	1	rs9462940	chr6:43900048	MRPL14	chr6:44081374-44095191:-	0.13	4.38	1.28E-5	Vascular endothelial growth factor levels	
BRCA	cis	1	rs9463078	chr6:45181340	SUPT3H	chr6:44777054-45345670:-	-0.16	-4.25	2.37E-5	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
BRCA	cis	1	rs9463473	chr6:49380121	CENPQ	chr6:49431096-49460820:+	-0.23	-7.32	4.95E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.32	9.97	1.98E-22	Folate pathway vitamin levels	
BRCA	cis	1	rs9463474	chr6:49380199	CENPQ	chr6:49431096-49460820:+	-0.23	-7.32	4.95E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.32	9.97	1.98E-22	Folate pathway vitamin levels	
BRCA	cis	1	rs9463475	chr6:49380899	CENPQ	chr6:49431096-49460820:+	0.23	7.36	3.79E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.32	-9.93	2.82E-22	Folate pathway vitamin levels	
BRCA	cis	1	rs9463477	chr6:49386446	CENPQ	chr6:49431096-49460820:+	-0.23	-7.38	3.22E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.32	10.09	6.26E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.32	-10.56	7.66E-25	Homocysteine levels	
BRCA	cis	1	rs9463478	chr6:49386564	MUT	chr6:49398994-49431031:-	0.15	4.61	4.58E-6	Homocysteine levels	
BRCA	cis	1	rs9463479	chr6:49393275	CENPQ	chr6:49431096-49460820:+	-0.23	-7.4	2.82E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.32	10.06	8.19E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs9463480	chr6:49400795	CENPQ	chr6:49431096-49460820:+	-0.22	-7.17	1.38E-12	Folate pathway vitamin levels	
BRCA	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.33	10.3	9.12E-24	Folate pathway vitamin levels	
BRCA	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.4	-11.77	3.64E-30	Body mass index	
BRCA	cis	1	rs946529	chr1:46485548	CCDC17	chr1:46085717-46089729:-	0.11	3.49	0.000494	Body mass index	
BRCA	cis	1	rs946529	chr1:46485548	MUTYH	chr1:45794915-45806142:-	0.13	4.92	9.79E-7	Body mass index	
BRCA	cis	1	rs9467773	chr6:26498426	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.54E-8	Educational attainment	
BRCA	cis	1	rs9467773	chr6:26498426	ZNF322A	chr6:26634612-26659963:-	-0.09	-3.38	0.000762	Educational attainment	
BRCA	cis	1	rs9467774	chr6:26505036	BTN2A3	chr6:26422317-26431927:+	0.16	5.45	6.19E-8	Educational attainment	
BRCA	cis	1	rs9467774	chr6:26505036	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.4	0.000701	Educational attainment	
BRCA	cis	1	rs9467778	chr6:26534743	BTN2A3	chr6:26422317-26431927:+	0.16	5.51	4.58E-8	Educational attainment	
BRCA	cis	1	rs9467778	chr6:26534743	C6orf41	chr6:26924772-26991752:+	-0.12	-3.7	0.000227	Educational attainment	
BRCA	cis	1	rs9467778	chr6:26534743	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.5	0.000489	Educational attainment	
BRCA	cis	1	rs9467779	chr6:26536687	BTN2A3	chr6:26422317-26431927:+	-0.16	-5.42	7.52E-8	Educational attainment	
BRCA	cis	1	rs9467779	chr6:26536687	C6orf41	chr6:26924772-26991752:+	0.12	3.57	0.000372	Educational attainment	
BRCA	cis	1	rs9467779	chr6:26536687	ZNF322A	chr6:26634612-26659963:-	0.09	3.38	0.00075	Educational attainment	
BRCA	cis	1	rs9467782	chr6:26542773	BTN2A3	chr6:26422317-26431927:+	0.16	5.5	4.63E-8	Educational attainment	
BRCA	cis	1	rs9467782	chr6:26542773	C6orf41	chr6:26924772-26991752:+	-0.12	-3.73	0.000198	Educational attainment	
BRCA	cis	1	rs9467782	chr6:26542773	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.66	0.000263	Educational attainment	
BRCA	cis	1	rs9467783	chr6:26542894	BTN2A3	chr6:26422317-26431927:+	0.17	5.55	3.62E-8	Educational attainment	
BRCA	cis	1	rs9467783	chr6:26542894	C6orf41	chr6:26924772-26991752:+	-0.12	-3.69	0.000234	Educational attainment	
BRCA	cis	1	rs9467783	chr6:26542894	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.59	0.000348	Educational attainment	
BRCA	cis	1	rs9467787	chr6:26556769	BTN2A3	chr6:26422317-26431927:+	0.16	5.4	8.09E-8	Educational attainment	
BRCA	cis	1	rs9467787	chr6:26556769	C6orf41	chr6:26924772-26991752:+	-0.13	-3.86	0.000121	Educational attainment	
BRCA	cis	1	rs9467791	chr6:26562486	BTN2A3	chr6:26422317-26431927:+	-0.16	-5.42	7.39E-8	Educational attainment	
BRCA	cis	1	rs9467791	chr6:26562486	C6orf41	chr6:26924772-26991752:+	0.13	4.02	6.22E-5	Educational attainment	
BRCA	cis	1	rs9467796	chr6:26568411	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.27E-8	Educational attainment	
BRCA	cis	1	rs9467796	chr6:26568411	C6orf41	chr6:26924772-26991752:+	-0.13	-3.94	8.81E-5	Educational attainment	
BRCA	cis	1	rs9467796	chr6:26568411	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.73	0.000201	Educational attainment	
BRCA	cis	1	rs9467797	chr6:26568473	BTN2A3	chr6:26422317-26431927:+	0.16	5.42	7.27E-8	Educational attainment	
BRCA	cis	1	rs9467797	chr6:26568473	C6orf41	chr6:26924772-26991752:+	-0.13	-3.94	8.81E-5	Educational attainment	
BRCA	cis	1	rs9467797	chr6:26568473	ZNF322A	chr6:26634612-26659963:-	-0.11	-3.73	0.000201	Educational attainment	
BRCA	cis	1	rs9468186	chr6:27626631	ZNF323	chr6:28292517-28324048:-	0.21	5.06	4.92E-7	Neuroticism	
BRCA	cis	1	rs9468186	chr6:27626631	ZSCAN23	chr6:28393287-28411279:-	0.18	4.87	1.28E-6	Neuroticism	
BRCA	cis	1	rs9469860	chr6:34724815	UHRF1BP1	chr6:34759794-34853117:+	0.15	4.28	2.03E-5	Pubertal anthropometrics	
BRCA	cis	1	rs9469890	chr6:34763982	UHRF1BP1	chr6:34759794-34853117:+	0.15	4.25	2.3E-5	Pubertal anthropometrics	
BRCA	cis	1	rs9473549	chr6:49380020	CENPQ	chr6:49431096-49460820:+	-0.23	-7.44	2.06E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.31	9.55	8.3E-21	Folate pathway vitamin levels	
BRCA	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.3	-10.01	1.3E-22	Homocysteine levels	
BRCA	cis	1	rs9473550	chr6:49385182	MUT	chr6:49398994-49431031:-	0.15	4.43	1.02E-5	Homocysteine levels	
BRCA	cis	1	rs9473552	chr6:49387154	CENPQ	chr6:49431096-49460820:+	-0.23	-7.38	3.22E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.32	10.09	6.26E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs9473553	chr6:49395977	CENPQ	chr6:49431096-49460820:+	-0.23	-7.29	5.82E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.32	10.1	5.73E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs9473555	chr6:49409487	CENPQ	chr6:49431096-49460820:+	-0.22	-7.26	7.51E-13	Folate pathway vitamin levels	
BRCA	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.33	10.19	2.37E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs9473560	chr6:49427918	CENPQ	chr6:49431096-49460820:+	-0.23	-7.67	3.96E-14	Folate pathway vitamin levels	
BRCA	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.33	10.3	9.06E-24	Folate pathway vitamin levels	
BRCA	cis	1	rs9473561	chr6:49428755	CENPQ	chr6:49431096-49460820:+	-0.24	-7.97	4.15E-15	Folate pathway vitamin levels	
BRCA	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.32	10.25	1.42E-23	Folate pathway vitamin levels	
BRCA	cis	1	rs9473563	chr6:49453651	CENPQ	chr6:49431096-49460820:+	-0.24	-7.64	4.91E-14	Folate pathway vitamin levels	
BRCA	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.32	9.61	5.01E-21	Folate pathway vitamin levels	
BRCA	cis	1	rs9473582	chr6:49488908	CENPQ	chr6:49431096-49460820:+	0.18	6.06	1.92E-9	Brain structure	
BRCA	cis	1	rs9475752	chr6:56780741	BEND6	chr6:56819773-56892138:+	-0.28	-8.27	4.07E-16	Menarche (age at onset)	
BRCA	cis	1	rs9475752	chr6:56780741	KIAA1586	chr6:56911384-56920021:+	-0.2	-4.4	1.17E-5	Menarche (age at onset)	
BRCA	cis	1	rs947583	chr6:136133659	C6orf217	chr6:135818939-136037192:+	-0.13	-3.6	0.000334	Phosphorus levels	
BRCA	cis	1	rs9481808	chr6:118784571	C6orf204	chr6:118786239-119031238:-	-0.11	-3.47	0.000543	Renal cell carcinoma	
BRCA	cis	1	rs9481821	chr6:118846022	GOPC	chr6:117639351-117923681:-	0.15	3.57	0.000369	Renal cell carcinoma	
BRCA	cis	1	rs9481825	chr6:118876092	C6orf204	chr6:118786239-119031238:-	-0.12	-3.86	0.00012	Renal cell carcinoma	
BRCA	cis	1	rs9481833	chr6:118919631	C6orf204	chr6:118786239-119031238:-	-0.11	-3.39	0.000721	Renal cell carcinoma	
BRCA	cis	1	rs9482736	chr6:98900621	COQ3	chr6:99817349-99842082:-	-0.24	-3.84	0.000129	Brain imaging in schizophrenia (interaction)	
BRCA	cis	1	rs948562	chr11:58347765	CNTF	chr11:58390146-58393203:+	0.15	3.39	0.000735	Lymphoma	
BRCA	cis	1	rs9489065	chr6:117234711	FAM162B	chr6:117073360-117086886:-	0.14	5.32	1.27E-7	Prostate cancer	
BRCA	cis	1	rs9489066	chr6:117239499	FAM162B	chr6:117073360-117086886:-	-0.09	-3.46	0.000554	Prostate cancer	
BRCA	cis	1	rs9489394	chr6:118758234	C6orf204	chr6:118786239-119031238:-	-0.11	-3.6	0.000334	Renal cell carcinoma	
BRCA	cis	1	rs9489395	chr6:118758884	C6orf204	chr6:118786239-119031238:-	-0.11	-3.6	0.000334	Renal cell carcinoma	
BRCA	cis	1	rs9489399	chr6:118767147	C6orf204	chr6:118786239-119031238:-	-0.11	-3.59	0.000345	Renal cell carcinoma	
BRCA	cis	1	rs9489407	chr6:118792337	C6orf204	chr6:118786239-119031238:-	0.12	3.92	9.57E-5	Renal cell carcinoma	
BRCA	cis	1	rs9489409	chr6:118802721	C6orf204	chr6:118786239-119031238:-	-0.11	-3.53	0.000435	Renal cell carcinoma	
BRCA	cis	1	rs9489433	chr6:118867006	C6orf204	chr6:118786239-119031238:-	-0.11	-3.52	0.000443	Renal cell carcinoma	
BRCA	cis	1	rs9489436	chr6:118873817	C6orf204	chr6:118786239-119031238:-	-0.11	-3.52	0.000449	Renal cell carcinoma	
BRCA	cis	1	rs9489442	chr6:118885950	C6orf204	chr6:118786239-119031238:-	-0.1	-3.39	0.000733	Renal cell carcinoma	
BRCA	cis	1	rs9489447	chr6:118900846	C6orf204	chr6:118786239-119031238:-	-0.11	-3.47	0.000534	Renal cell carcinoma	
BRCA	cis	1	rs9489450	chr6:118904385	C6orf204	chr6:118786239-119031238:-	-0.11	-3.43	0.000622	Renal cell carcinoma	
BRCA	cis	1	rs9489452	chr6:118910868	C6orf204	chr6:118786239-119031238:-	-0.11	-3.46	0.000554	Renal cell carcinoma	
BRCA	cis	1	rs9489457	chr6:118920285	C6orf204	chr6:118786239-119031238:-	-0.11	-3.39	0.000721	Renal cell carcinoma	
BRCA	cis	1	rs9489458	chr6:118920503	C6orf204	chr6:118786239-119031238:-	-0.11	-3.39	0.000721	Renal cell carcinoma	
BRCA	cis	1	rs9489460	chr6:118925754	C6orf204	chr6:118786239-119031238:-	-0.11	-3.42	0.000646	Renal cell carcinoma	
BRCA	cis	1	rs9489467	chr6:118935206	C6orf204	chr6:118786239-119031238:-	-0.11	-3.58	0.000353	Renal cell carcinoma	
BRCA	cis	1	rs9489477	chr6:118946192	C6orf204	chr6:118786239-119031238:-	-0.11	-3.52	0.000443	Renal cell carcinoma	
BRCA	cis	1	rs9491697	chr6:127456122	RSPO3	chr6:127440048-127518910:+	-0.11	-4.35	1.48E-5	Crohn's disease	
BRCA	cis	1	rs9496639	chr6:143768508	ADAT2	chr6:143743970-143771841:-	-0.12	-3.64	0.000285	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
BRCA	cis	1	rs9500256	chr6:58308955	GUSBL2	chr6:58246159-58287724:-	-0.23	-7.25	7.78E-13	Eosinophilic esophagitis (pediatric)	
BRCA	cis	1	rs950880	chr2:102932562	IL18R1	chr2:102927962-103015215:+	0.11	4.77	2.08E-6	Serum protein levels (sST2)	
BRCA	cis	1	rs9527	chr10:104623578	AS3MT	chr10:104613967-104661653:+	-0.24	-5.75	1.15E-8	Arsenic metabolism	
BRCA	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.38	-12.73	1.13E-34	Arsenic metabolism	
BRCA	cis	1	rs9534458	chr13:47237952	ZC3H13	chr13:46529805-46626894:-	-0.15	-5.23	2.03E-7	PR segment	
BRCA	cis	1	rs9545602	chr13:36456503	SOHLH2	chr13:36742347-36871992:-	0.15	3.82	0.000144	Non-alcoholic fatty liver disease	
BRCA	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.59	18.6	4.07E-67	Response to antipsychotic treatment	
BRCA	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.6	-18.65	2.11E-67	Response to antipsychotic treatment	
BRCA	cis	1	rs9557192	chr13:99944165	UBAC2	chr13:99852679-100038751:+	0.16	3.6	0.000334	Inflammatory bowel disease	
BRCA	cis	1	rs955754	chr2:102849081	IL18R1	chr2:102927962-103015215:+	0.09	3.55	0.000406	Serum protein levels (sST2)	
BRCA	cis	1	rs958476	chr11:129321818	FLI1	chr11:128556430-128683161:+	0.05	3.38	0.000759	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	
BRCA	cis	1	rs9584857	chr13:99128572	STK24	chr13:99102455-99229396:-	-0.14	-3.74	0.000191	Longevity	
BRCA	cis	1	rs958550	chr7:65635679	CCT6P1	chr7:65216092-65228661:+	-0.24	-5.21	2.28E-7	Diabetic kidney disease	
BRCA	cis	1	rs958550	chr7:65635679	CRCP	chr7:65579805-65619551:+	0.24	4.19	3.05E-5	Diabetic kidney disease	
BRCA	cis	1	rs9593	chr12:109994870	MMAB	chr12:109991523-110011358:-	-0.12	-3.79	0.000159	HDL cholesterol	
BRCA	cis	1	rs9593	chr12:109994870	MYO1H	chr12:109826524-109886176:+	0.26	7.78	1.76E-14	HDL cholesterol	
BRCA	cis	1	rs9607566	chr22:39075434	DDX17	chr22:38879445-38903665:-	-0.1	-3.43	0.00062	Resting heart rate	
BRCA	cis	1	rs9607566	chr22:39075434	JOSD1	chr22:39081549-39096459:-	-0.13	-4.17	3.35E-5	Resting heart rate	
BRCA	cis	1	rs9607566	chr22:39075434	TOMM22	chr22:39077954-39080763:+	-0.11	-3.61	0.000322	Resting heart rate	
BRCA	cis	1	rs962221	chr1:92970770	EVI5	chr1:92974255-93257961:-	-0.18	-4.83	1.55E-6	Cholesterol, total	
BRCA	cis	1	rs962222	chr1:92970953	EVI5	chr1:92974255-93257961:-	-0.18	-4.83	1.55E-6	Cholesterol, total	
BRCA	cis	1	rs9624447	chr22:24681555	POM121L9P	chr22:24647589-24661490:+	-0.26	-7.18	1.34E-12	Gut microbiome composition (summer)	
BRCA	cis	1	rs963265	chr9:73094535	KLF9	chr9:72999515-73029573:-	-0.11	-3.52	0.000449	Migraine with aura	
BRCA	cis	1	rs9638180	chr7:72998952	MLXIPL	chr7:73007524-73038870:-	0.36	6.86	1.19E-11	Triglycerides	
BRCA	cis	1	rs9638182	chr7:72999105	MLXIPL	chr7:73007524-73038870:-	0.35	6.84	1.31E-11	Triglycerides	
BRCA	cis	1	rs964503	chr4:103349213	SLC39A8	chr4:103172198-103266655:-	0.17	4.33	1.6E-5	Homeostasis model assessment of beta-cell function (interaction)	
BRCA	cis	1	rs9647448	chr4:18005250	NCAPG	chr4:17812525-17846485:+	0.11	4.21	2.74E-5	Height	
BRCA	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.59	-19.49	1.27E-72	Response to antipsychotic treatment	
BRCA	cis	1	rs9649213	chr7:98021211	BAIAP2L1	chr7:97920964-98030427:-	-0.14	-3.76	0.00018	Prostate cancer (gene x gene interaction)	
BRCA	cis	1	rs9652601	chr16:11174365	RSL1D1	chr16:11928055-11945442:-	0.13	3.55	0.000409	Systemic lupus erythematosus	
BRCA	cis	1	rs9653282	chr2:165554658	SLC38A11	chr2:165754812-165812035:-	0.17	5.17	2.78E-7	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
BRCA	cis	1	rs965469	chr20:3381549	ITPA	chr20:3190056-3204504:+	-0.14	-4.08	4.75E-5	IFN-related cytopenia	
BRCA	cis	1	rs965513	chr9:100556109	NCBP1	chr9:100395705-100436027:+	-0.11	-3.47	0.000535	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs965513	chr9:100556109	TSTD2	chr9:100362364-100395962:-	-0.1	-3.57	0.000371	Thyroid cancer (Papillary, radiation-related);Thyroid cancer	
BRCA	cis	1	rs9655613	chr7:151713518	LOC100128822	chr7:152161209-152162628:+	0.16	4.3	1.89E-5	Kidney function decline traits	
BRCA	cis	1	rs9664049	chr10:104000307	C10orf32	chr10:104613967-104624718:+	0.1	3.75	0.000187	QT interval	
BRCA	cis	1	rs9664049	chr10:104000307	PITX3	chr10:103989946-104001231:-	0.12	3.46	0.000555	QT interval	
BRCA	cis	1	rs9665626	chr10:104300638	SFXN2	chr10:104474298-104498946:+	0.21	4.3	1.85E-5	Schizophrenia	
BRCA	cis	1	rs9665626	chr10:104300638	TMEM180	chr10:104221170-104238858:+	-0.19	-3.76	0.000176	Schizophrenia	
BRCA	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.39	10.68	2.39E-25	Erythrocyte sedimentation rate	
BRCA	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.49	-14.08	2.11E-41	Erythrocyte sedimentation rate	
BRCA	cis	1	rs9715911	chr5:156394441	TIMD4	chr5:156346293-156390266:-	-0.35	-11.32	3.84E-28	Triglycerides;Cholesterol, total;LDL cholesterol	
BRCA	cis	1	rs9730839	chr10:72122983	LRRC20	chr10:72058729-72142382:-	0.4	4.75	2.36E-6	Brain connectivity	
BRCA	cis	1	rs974014	chr4:48409363	OCIAD1	chr4:48833015-48863831:+	0.13	4.2	2.88E-5	Crohn's disease;Inflammatory bowel disease	
BRCA	cis	1	rs974495	chr3:49400482	AMT	chr3:49454212-49460012:-	0.14	4.93	9.47E-7	Menarche (age at onset)	
BRCA	cis	1	rs974495	chr3:49400482	CCDC36	chr3:49235861-49295537:+	0.1	3.87	0.000115	Menarche (age at onset)	
BRCA	cis	1	rs974495	chr3:49400482	NCKIPSD	chr3:48711280-48723334:-	0.17	4.26	2.22E-5	Menarche (age at onset)	
BRCA	cis	1	rs974495	chr3:49400482	P4HTM	chr3:49027341-49044579:+	0.1	4.13	3.96E-5	Menarche (age at onset)	
BRCA	cis	1	rs974495	chr3:49400482	WDR6	chr3:49044637-49053386:+	-0.14	-4.36	1.4E-5	Menarche (age at onset)	
BRCA	cis	1	rs976798	chr7:38008174	EPDR1	chr7:37960163-37991539:+	0.22	3.64	0.000282	Myopia (pathological)	
BRCA	cis	1	rs9769882	chr7:65642925	CCT6P1	chr7:65216092-65228661:+	-0.3	-6.38	2.6E-10	Diabetic kidney disease	
BRCA	cis	1	rs9769882	chr7:65642925	CRCP	chr7:65579805-65619551:+	0.21	3.58	0.000354	Diabetic kidney disease	
BRCA	cis	1	rs9769882	chr7:65642925	LOC493754	chr7:65993446-66057363:-	-0.22	-3.78	0.000167	Diabetic kidney disease	
BRCA	cis	1	rs9783239	chr10:96504276	HELLS	chr10:96305543-96361855:+	0.12	3.41	0.000667	Migraine	
BRCA	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.37	9.72	1.88E-21	Forced vital capacity	
BRCA	cis	1	rs9783347	chr11:18384938	GTF2H1	chr11:18343816-18388590:+	0.3	8.14	1.13E-15	Pancreatic cancer	
BRCA	cis	1	rs9783992	chr2:231035589	SP110	chr2:231033645-231084827:-	0.2	3.86	0.000121	Obesity-related traits	
BRCA	cis	1	rs9784019	chr2:231035575	SP110	chr2:231033645-231084827:-	0.2	3.86	0.000121	Obesity-related traits	
BRCA	cis	1	rs9788721	chr15:78802869	AGPHD1	chr15:78799906-78829714:+	0.17	4.12	4.11E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs9788721	chr15:78802869	CHRNA5	chr15:78857906-78886458:+	0.16	5.24	1.92E-7	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
BRCA	cis	1	rs9789748	chr2:17801397	GEN1	chr2:17935162-17966632:+	0.16	3.53	0.00044	Psychosis and Alzheimer's disease	
BRCA	cis	1	rs979233	chr5:42375243	CCDC152	chr5:42756920-42802539:+	-0.12	-3.66	0.000261	Systemic lupus erythematosus	
BRCA	cis	1	rs979233	chr5:42375243	OXCT1	chr5:41730168-41870791:-	-0.14	-3.85	0.000124	Systemic lupus erythematosus	
BRCA	cis	1	rs979971	chr19:39144244	LGALS7	chr19:39261608-39264157:-	-0.16	-4.92	1.01E-6	Heart rate	
BRCA	cis	1	rs979972	chr19:39144167	LGALS7	chr19:39261608-39264157:-	-0.17	-5.31	1.36E-7	Heart rate	
BRCA	cis	1	rs9804992	chr12:988894	RAD52	chr12:1021255-1099219:-	0.33	7.45	1.99E-13	Colorectal cancer	
BRCA	cis	1	rs9806159	chr15:31209654	MTMR15	chr15:31196055-31235307:+	0.14	3.49	0.000512	Hypertriglyceridemia	
BRCA	cis	1	rs9809263	chr3:190989466	UTS2D	chr3:190984945-191048325:-	-0.22	-6.39	2.52E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.42	13.96	8.43E-41	Height	
BRCA	cis	1	rs9809619	chr3:134280948	CEP63	chr3:134204575-134293852:+	0.14	3.88	0.000113	Height	
BRCA	cis	1	rs980972	chr4:100279247	ADH1C	chr4:100257651-100273917:-	-0.21	-6.72	3.03E-11	Oral cavity and pharyngeal cancer	
BRCA	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.27	-10.16	3.17E-23	Longevity	
BRCA	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.27	10	1.4E-22	Longevity	
BRCA	cis	1	rs9812791	chr3:49682311	AMT	chr3:49454212-49460012:-	0.11	3.5	0.00048	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9812791	chr3:49682311	GMPPB	chr3:49758932-49761384:-	-0.12	-3.44	0.000604	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9813756	chr3:46349352	FYCO1	chr3:45959396-46037307:-	-0.11	-3.84	0.000133	Celiac disease	
BRCA	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.43	14.46	2.02E-43	Height	
BRCA	cis	1	rs9813774	chr3:134227100	CEP63	chr3:134204575-134293852:+	0.15	4.2	2.89E-5	Height	
BRCA	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.42	-13.58	7.07E-39	Height	
BRCA	cis	1	rs9814567	chr3:134218557	CEP63	chr3:134204575-134293852:+	-0.15	-3.9	0.0001	Height	
BRCA	cis	1	rs9815103	chr3:48414215	ATRIP	chr3:48488141-48507708:+	0.1	3.61	0.00032	Longevity	
BRCA	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.28	-10.3	8.95E-24	Longevity	
BRCA	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.52	14.36	7.34E-43	Diastolic blood pressure	
BRCA	cis	1	rs9815383	chr3:27538731	NEK10	chr3:27152395-27410912:-	-0.1	-3.7	0.000223	Hypertension;Systolic blood pressure;Diastolic blood pressure	
BRCA	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.26	-10.07	7.85E-23	Longevity	
BRCA	cis	1	rs9818982	chr3:45812514	EXOSC7	chr3:45016750-45054158:+	-0.26	-6.09	1.55E-9	Blood metabolite levels	
BRCA	cis	1	rs9818982	chr3:45812514	LARS2	chr3:45430075-45590328:+	-0.22	-4.75	2.27E-6	Blood metabolite levels	
BRCA	cis	1	rs9818982	chr3:45812514	LIMD1	chr3:45636323-45722754:+	-0.19	-4.67	3.42E-6	Blood metabolite levels	
BRCA	cis	1	rs9818982	chr3:45812514	LZTFL1	chr3:45865446-45957534:-	-0.2	-5.47	5.72E-8	Blood metabolite levels	
BRCA	cis	1	rs9818982	chr3:45812514	SACM1L	chr3:45730754-45786900:+	-0.26	-6.95	6.5E-12	Blood metabolite levels	
BRCA	cis	1	rs9818982	chr3:45812514	ZDHHC3	chr3:44956754-45017674:-	-0.23	-4.87	1.31E-6	Blood metabolite levels	
BRCA	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.41	13.7	1.72E-39	Height	
BRCA	cis	1	rs9819532	chr3:134288644	CEP63	chr3:134204575-134293852:+	0.14	3.79	0.000161	Height	
BRCA	cis	1	rs9822268	chr3:49719729	AMT	chr3:49454212-49460012:-	0.1	3.38	0.000764	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9822268	chr3:49719729	GMPPB	chr3:49758932-49761384:-	-0.13	-3.9	0.000101	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs982256	chr7:110904226	IMMP2L	chr7:110303110-111202538:-	0.14	3.89	0.000105	Schizophrenia	
BRCA	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.52	14.38	5.4E-43	Diastolic blood pressure	
BRCA	cis	1	rs9823546	chr3:49705512	AMT	chr3:49454212-49460012:-	0.11	3.67	0.000259	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9823546	chr3:49705512	GMPPB	chr3:49758932-49761384:-	-0.12	-3.53	0.000425	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.52	14.29	1.55E-42	Diastolic blood pressure	
BRCA	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.27	-10.16	3.17E-23	Longevity	
BRCA	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.43	14.41	3.7E-43	Height	
BRCA	cis	1	rs9826496	chr3:134224437	CEP63	chr3:134204575-134293852:+	0.15	4.17	3.31E-5	Height	
BRCA	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.42	13.92	1.29E-40	Height	
BRCA	cis	1	rs9827987	chr3:134272621	CEP63	chr3:134204575-134293852:+	0.13	3.64	0.000283	Height	
BRCA	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.42	13.99	6.23E-41	Height	
BRCA	cis	1	rs9828815	chr3:134265749	CEP63	chr3:134204575-134293852:+	0.14	3.92	9.49E-5	Height	
BRCA	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.42	13.77	7.75E-40	Height	
BRCA	cis	1	rs9829092	chr3:134229866	CEP63	chr3:134204575-134293852:+	0.16	4.2	2.95E-5	Height	
BRCA	cis	1	rs9832314	chr3:72518040	FOXP1	chr3:71004737-71633140:-	-0.19	-3.38	0.000759	IgG glycosylation	
BRCA	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.43	14.44	2.78E-43	Height	
BRCA	cis	1	rs9832785	chr3:134213070	CEP63	chr3:134204575-134293852:+	0.15	4.04	5.82E-5	Height	
BRCA	cis	1	rs983392	chr11:59923508	MS4A4A	chr11:60048139-60076444:+	-0.09	-3.82	0.000139	Alzheimer's disease (late onset)	
BRCA	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.43	14.38	5.8E-43	Height	
BRCA	cis	1	rs9834755	chr3:134206845	CEP63	chr3:134204575-134293852:+	0.15	4.13	3.91E-5	Height	
BRCA	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.42	13.99	6.23E-41	Height	
BRCA	cis	1	rs9835204	chr3:134261342	CEP63	chr3:134204575-134293852:+	0.14	3.92	9.49E-5	Height	
BRCA	cis	1	rs9835434	chr3:190986962	UTS2D	chr3:190984945-191048325:-	-0.22	-6.42	2.08E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs9835883	chr3:190987251	UTS2D	chr3:190984945-191048325:-	-0.22	-6.47	1.44E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs9836053	chr3:150885877	P2RY12	chr3:151055238-151102544:-	0.16	4.13	3.98E-5	Heschl's gyrus morphology	
BRCA	cis	1	rs9836291	chr3:49697459	AMT	chr3:49454212-49460012:-	0.12	3.99	7.01E-5	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9836291	chr3:49697459	GMPPB	chr3:49758932-49761384:-	-0.12	-3.53	0.000435	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9837038	chr3:156568469	LEKR1	chr3:156544076-156763918:+	-0.21	-5.8	8.63E-9	Multiple sclerosis (severity)	
BRCA	cis	1	rs9838618	chr3:48487353	SHISA5	chr3:48509197-48542228:-	-0.11	-3.43	0.000624	Longevity	
BRCA	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.3	-11.33	3.41E-28	Longevity	
BRCA	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.43	14.03	3.58E-41	Height	
BRCA	cis	1	rs9841212	chr3:134191938	CEP63	chr3:134204575-134293852:+	0.24	6.44	1.85E-10	Height	
BRCA	cis	1	rs9842132	chr3:49427933	AMT	chr3:49454212-49460012:-	-0.14	-4.72	2.67E-6	Menarche (age at onset)	
BRCA	cis	1	rs9842132	chr3:49427933	CCDC36	chr3:49235861-49295537:+	-0.1	-3.92	9.56E-5	Menarche (age at onset)	
BRCA	cis	1	rs9842132	chr3:49427933	NCKIPSD	chr3:48711280-48723334:-	-0.15	-3.91	9.64E-5	Menarche (age at onset)	
BRCA	cis	1	rs9842132	chr3:49427933	P4HTM	chr3:49027341-49044579:+	-0.1	-4.27	2.14E-5	Menarche (age at onset)	
BRCA	cis	1	rs9842132	chr3:49427933	WDR6	chr3:49044637-49053386:+	0.13	3.87	0.000113	Menarche (age at onset)	
BRCA	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.27	-7.32	5.0E-13	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
BRCA	cis	1	rs9846190	chr3:57395037	DNAH12	chr3:57327727-57530071:-	0.14	3.52	0.000456	Prostate cancer (gene x gene interaction)	
BRCA	cis	1	rs9847242	chr3:190989523	UTS2D	chr3:190984945-191048325:-	-0.22	-6.38	2.56E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs9847710	chr3:53062661	ITIH4	chr3:52847007-52866554:-	-0.11	-3.77	0.000169	Ulcerative colitis	
BRCA	cis	1	rs9848323	chr3:101656208	LOC152225	chr3:101659703-101716770:+	0.15	3.65	0.000274	Psoriasis vulgaris;Psoriasis	
BRCA	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.26	-9.94	2.47E-22	Longevity	
BRCA	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.42	13.92	1.29E-40	Height	
BRCA	cis	1	rs9850015	chr3:134269541	CEP63	chr3:134204575-134293852:+	0.13	3.64	0.000283	Height	
BRCA	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.38	12.45	2.44E-33	Height	
BRCA	cis	1	rs9851441	chr3:134315091	CEP63	chr3:134204575-134293852:+	0.14	3.95	8.48E-5	Height	
BRCA	cis	1	rs9852052	chr3:46343534	FYCO1	chr3:45959396-46037307:-	-0.11	-3.85	0.000124	Celiac disease	
BRCA	cis	1	rs9854155	chr3:46294468	TDGF1	chr3:46619180-46623950:+	0.14	3.91	9.99E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.43	14.45	2.3E-43	Height	
BRCA	cis	1	rs9854299	chr3:134206728	CEP63	chr3:134204575-134293852:+	0.16	4.34	1.53E-5	Height	
BRCA	cis	1	rs9854776	chr3:46294851	TDGF1	chr3:46619180-46623950:+	-0.14	-3.97	7.68E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
BRCA	cis	1	rs9856076	chr3:190987344	UTS2D	chr3:190984945-191048325:-	-0.22	-6.48	1.43E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs9856098	chr3:46349905	FYCO1	chr3:45959396-46037307:-	-0.11	-3.57	0.000372	Celiac disease	
BRCA	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.39	12.59	5.21E-34	Height	
BRCA	cis	1	rs9856693	chr3:134306913	CEP63	chr3:134204575-134293852:+	0.14	3.81	0.000146	Height	
BRCA	cis	1	rs9857375	chr3:57397400	DNAH12	chr3:57327727-57530071:-	0.14	3.57	0.000376	Prostate cancer (gene x gene interaction)	
BRCA	cis	1	rs9857697	chr3:190991384	UTS2D	chr3:190984945-191048325:-	-0.22	-6.28	4.79E-10	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs9858213	chr3:49731861	AMT	chr3:49454212-49460012:-	0.11	3.46	0.000557	Educational attainment	
BRCA	cis	1	rs9858213	chr3:49731861	GMPPB	chr3:49758932-49761384:-	-0.13	-3.72	0.000211	Educational attainment	
BRCA	cis	1	rs9858542	chr3:49701983	AMT	chr3:49454212-49460012:-	-0.1	-3.39	0.000727	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9858542	chr3:49701983	GMPPB	chr3:49758932-49761384:-	0.13	3.69	0.000236	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9860055	chr3:49506900	AMT	chr3:49454212-49460012:-	-0.13	-4.39	1.25E-5	Menarche (age at onset)	
BRCA	cis	1	rs9860055	chr3:49506900	CCDC36	chr3:49235861-49295537:+	-0.11	-4.06	5.29E-5	Menarche (age at onset)	
BRCA	cis	1	rs9860055	chr3:49506900	GMPPB	chr3:49758932-49761384:-	0.13	3.69	0.000233	Menarche (age at onset)	
BRCA	cis	1	rs9860055	chr3:49506900	NCKIPSD	chr3:48711280-48723334:-	-0.14	-3.54	0.000425	Menarche (age at onset)	
BRCA	cis	1	rs9860055	chr3:49506900	P4HTM	chr3:49027341-49044579:+	-0.09	-3.83	0.000138	Menarche (age at onset)	
BRCA	cis	1	rs9860055	chr3:49506900	TREX1	chr3:48501186-48509043:+	0.11	3.63	0.0003	Menarche (age at onset)	
BRCA	cis	1	rs9860055	chr3:49506900	WDR6	chr3:49044637-49053386:+	0.14	4.26	2.24E-5	Menarche (age at onset)	
BRCA	cis	1	rs9862534	chr3:49598064	AMT	chr3:49454212-49460012:-	0.11	3.81	0.000148	Menarche (age at onset)	
BRCA	cis	1	rs9862534	chr3:49598064	CCDC36	chr3:49235861-49295537:+	0.1	3.85	0.000126	Menarche (age at onset)	
BRCA	cis	1	rs9862534	chr3:49598064	GMPPB	chr3:49758932-49761384:-	-0.12	-3.56	0.000394	Menarche (age at onset)	
BRCA	cis	1	rs9862534	chr3:49598064	NCKIPSD	chr3:48711280-48723334:-	0.14	3.38	0.00075	Menarche (age at onset)	
BRCA	cis	1	rs9862534	chr3:49598064	P4HTM	chr3:49027341-49044579:+	0.09	3.56	0.000385	Menarche (age at onset)	
BRCA	cis	1	rs9862534	chr3:49598064	WDR6	chr3:49044637-49053386:+	-0.17	-5.04	5.4E-7	Menarche (age at onset)	
BRCA	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.42	13.99	6.23E-41	Height	
BRCA	cis	1	rs9863786	chr3:134247203	CEP63	chr3:134204575-134293852:+	0.14	3.92	9.49E-5	Height	
BRCA	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.4	13.22	4.49E-37	Height	
BRCA	cis	1	rs9864346	chr3:134312352	CEP63	chr3:134204575-134293852:+	0.14	3.74	0.000194	Height	
BRCA	cis	1	rs9864371	chr3:48426766	ATRIP	chr3:48488141-48507708:+	0.1	3.4	0.000687	Longevity	
BRCA	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.28	-10.63	3.68E-25	Longevity	
BRCA	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.38	12.53	1.09E-33	Height	
BRCA	cis	1	rs9864439	chr3:134298671	CEP63	chr3:134204575-134293852:+	0.14	3.87	0.000115	Height	
BRCA	cis	1	rs9865905	chr3:156649594	LEKR1	chr3:156544076-156763918:+	0.18	4.76	2.2E-6	Multiple sclerosis (severity)	
BRCA	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.42	13.99	6.23E-41	Height	
BRCA	cis	1	rs9869981	chr3:134248801	CEP63	chr3:134204575-134293852:+	0.14	3.92	9.49E-5	Height	
BRCA	cis	1	rs9871024	chr3:49554241	AMT	chr3:49454212-49460012:-	-0.13	-4.37	1.37E-5	Menarche (age at onset)	
BRCA	cis	1	rs9871024	chr3:49554241	CCDC36	chr3:49235861-49295537:+	-0.1	-3.88	0.000111	Menarche (age at onset)	
BRCA	cis	1	rs9871024	chr3:49554241	GMPPB	chr3:49758932-49761384:-	0.13	3.8	0.000156	Menarche (age at onset)	
BRCA	cis	1	rs9871024	chr3:49554241	NCKIPSD	chr3:48711280-48723334:-	-0.14	-3.66	0.000268	Menarche (age at onset)	
BRCA	cis	1	rs9871024	chr3:49554241	P4HTM	chr3:49027341-49044579:+	-0.09	-3.97	7.75E-5	Menarche (age at onset)	
BRCA	cis	1	rs9871024	chr3:49554241	WDR6	chr3:49044637-49053386:+	0.14	4.15	3.51E-5	Menarche (age at onset)	
BRCA	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.42	13.77	7.75E-40	Height	
BRCA	cis	1	rs9871305	chr3:134213538	CEP63	chr3:134204575-134293852:+	0.16	4.2	2.95E-5	Height	
BRCA	cis	1	rs9872999	chr3:133457514	TF	chr3:133419211-133497635:+	-0.14	-4.73	2.55E-6	Iron status biomarkers	
BRCA	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.52	14.31	1.35E-42	Diastolic blood pressure	
BRCA	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.52	14.36	7.34E-43	Diastolic blood pressure	
BRCA	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.38	-12.59	5.5E-34	Height	
BRCA	cis	1	rs9876658	chr3:134179453	CEP63	chr3:134204575-134293852:+	-0.16	-4.46	8.98E-6	Height	
BRCA	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.26	-9.97	1.93E-22	Longevity	
BRCA	cis	1	rs9877400	chr3:190991439	UTS2D	chr3:190984945-191048325:-	0.21	6.07	1.76E-9	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs9878833	chr3:190988302	UTS2D	chr3:190984945-191048325:-	-0.21	-6.06	1.84E-9	Age-related hearing impairment (interaction)	
BRCA	cis	1	rs9879311	chr3:10415343	GHRLOS	chr3:10322637-10335132:+	0.13	3.75	0.000188	Schizophrenia	
BRCA	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.29	-10.98	1.2E-26	Longevity	
BRCA	cis	1	rs9882740	chr3:49702484	AMT	chr3:49454212-49460012:-	0.11	3.74	0.000194	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9882740	chr3:49702484	GMPPB	chr3:49758932-49761384:-	-0.12	-3.54	0.000423	Crohn's disease;Ulcerative colitis	
BRCA	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.4	13.43	3.94E-38	Height	
BRCA	cis	1	rs9883753	chr3:134247231	CEP63	chr3:134204575-134293852:+	0.15	3.98	7.5E-5	Height	
BRCA	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.29	-10.87	3.61E-26	Longevity	
BRCA	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.27	-10.1	5.59E-23	Longevity	
BRCA	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.42	14.03	3.79E-41	Height	
BRCA	cis	1	rs9884031	chr3:134256500	CEP63	chr3:134204575-134293852:+	0.14	3.94	8.69E-5	Height	
BRCA	cis	1	rs9890032	chr17:29165934	SUZ12P	chr17:29035714-29097067:+	0.18	5.74	1.2E-8	Height	
BRCA	cis	1	rs9891800	chr17:33895015	SLFN12L	chr17:33801926-33864880:-	0.08	4.8	1.78E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs9898723	chr17:80439907	C17orf62	chr17:80400520-80408694:-	-0.22	-5.64	2.22E-8	Protein quantitative trait loci	
BRCA	cis	1	rs9900378	chr17:33911302	SLFN12L	chr17:33801926-33864880:-	0.09	4.86	1.34E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs9906595	chr17:37101380	CACNB1	chr17:37329709-37353901:-	-0.28	-3.93	9.12E-5	Obesity-related traits	
BRCA	cis	1	rs9909	chr11:47799775	MADD	chr11:47290927-47351582:+	0.15	4.54	6.32E-6	Subjective well-being	
BRCA	cis	1	rs9909	chr11:47799775	MYBPC3	chr11:47352958-47374253:-	-0.14	-4.29	1.91E-5	Subjective well-being	
BRCA	cis	1	rs9913003	chr17:33893904	SLFN12L	chr17:33801926-33864880:-	0.08	4.5	7.62E-6	Response to radiotherapy in cancer (late toxicity)	
BRCA	cis	1	rs9917978	chr4:165885143	TRIM61	chr4:165875600-165898818:-	0.25	7.82	1.26E-14	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs9921222	chr16:375782	DECR2	chr16:451858-462486:+	-0.11	-4.17	3.23E-5	Bone mineral density (spine);Bone mineral density	
BRCA	cis	1	rs9921338	chr16:11416839	C16orf75	chr16:11343506-11445617:+	-0.27	-8.5	6.29E-17	Vein graft stenosis in coronary artery bypass grafting	
BRCA	cis	1	rs9923856	chr16:11210415	DEXI	chr16:11022750-11036257:-	0.13	3.87	0.000116	Adult asthma;Atopic dermatitis	
BRCA	cis	1	rs9924078	chr16:48557918	SIAH1	chr16:48390277-48482309:-	-0.13	-3.48	0.000523	Response to tocilizumab in rheumatoid arthritis	
BRCA	cis	1	rs9930728	chr16:69466275	CHTF8	chr16:69151913-69166484:-	0.19	4.51	7.11E-6	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	COG8	chr16:69362524-69373526:-	0.21	5.17	2.74E-7	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	CYB5B	chr16:69458498-69500167:+	0.23	5.95	3.54E-9	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	DDX19A	chr16:70333072-70407279:+	0.15	4.39	1.26E-5	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	DDX19B	chr16:70328700-70404288:+	0.17	3.98	7.23E-5	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	EXOSC6	chr16:70284134-70285833:-	0.18	4.38	1.32E-5	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	NFAT5	chr16:69598997-69738553:+	0.11	3.44	0.000599	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	NIP7	chr16:69373546-69377007:+	0.16	5.04	5.53E-7	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	NOB1	chr16:69775775-69788829:-	0.13	3.59	0.000345	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	PDF	chr16:69362524-69364498:-	0.15	4.33	1.67E-5	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	PDXDC2	chr16:70010210-70099851:-	0.13	4.08	4.86E-5	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	TERF2	chr16:69389535-69419873:-	0.22	5.49	4.94E-8	Blood pressure (smoking interaction)	
BRCA	cis	1	rs9930728	chr16:69466275	VPS4A	chr16:69345287-69358945:+	0.17	5.57	3.14E-8	Blood pressure (smoking interaction)	
BRCA	cis	1	rs993394	chr6:117117143	FAM162B	chr6:117073360-117086886:-	0.18	6.71	3.24E-11	C-reactive protein levels	
BRCA	cis	1	rs993394	chr6:117117143	FAM26F	chr6:116782556-116784933:+	0.08	3.61	0.000322	C-reactive protein levels	
BRCA	cis	1	rs9938630	chr16:29837108	LOC440356	chr16:29875004-29879374:+	-0.25	-5.63	2.34E-8	Multiple sclerosis	
BRCA	cis	1	rs9943661	chr11:32893777	CCDC73	chr11:32623627-32816187:-	0.22	6.05	2.02E-9	Parkinson's disease (age of onset)	
BRCA	cis	1	rs9943661	chr11:32893777	QSER1	chr11:32914792-33014862:+	0.09	3.79	0.000156	Parkinson's disease (age of onset)	
BRCA	cis	1	rs9945428	chr18:71788676	FBXO15	chr18:71740588-71815100:-	0.17	5.32	1.26E-7	Venous thromboembolism (SNP x SNP interaction)	
BRCA	cis	1	rs995432	chr8:23522851	NKX3-1	chr8:23536207-23540450:-	-0.14	-3.68	0.000241	Prostate cancer (gene x gene interaction);Prostate cancer	
BRCA	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.42	-13.88	2.23E-40	Height	
BRCA	cis	1	rs9968172	chr3:134231251	CEP63	chr3:134204575-134293852:+	-0.17	-4.46	9.01E-6	Height	
BRCA	cis	1	rs9971695	chr12:124413491	DNAH10	chr12:124247042-124420265:+	0.25	6.39	2.53E-10	Waist-to-hip ratio adjusted for body mass index	
BRCA	cis	1	rs997295	chr15:68016343	IQCH	chr15:67547188-67794139:+	0.14	5.08	4.54E-7	Motion sickness	
BRCA	cis	1	rs997295	chr15:68016343	LBXCOR1	chr15:68117941-68126174:+	0.12	3.73	0.000201	Motion sickness	
BRCA	cis	1	rs9984793	chr21:30486471	NCRNA00189	chr21:30565801-30660525:+	0.18	5.29	1.48E-7	Dental caries	
BRCA	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.4	-13.01	4.97E-36	Height	
BRCA	cis	1	rs9985356	chr3:134232920	CEP63	chr3:134204575-134293852:+	-0.15	-4	6.87E-5	Height	
BRCA	cis	1	rs9986131	chr5:82444856	XRCC4	chr5:82373317-82649577:+	-0.12	-3.57	0.000373	Hypertension	
BRCA	cis	1	rs9986382	chr6:26550619	BTN2A3	chr6:26422317-26431927:+	0.16	5.35	1.05E-7	Educational attainment	
BRCA	cis	1	rs9986382	chr6:26550619	C6orf41	chr6:26924772-26991752:+	-0.13	-3.93	9.16E-5	Educational attainment	
BRCA	cis	1	rs9986382	chr6:26550619	ZNF322A	chr6:26634612-26659963:-	-0.1	-3.45	0.000588	Educational attainment	
BRCA	cis	1	rs9986596	chr6:28219661	HIST1H4J	chr6:27791903-27792257:+	-0.19	-3.66	0.000261	Depression	
BRCA	cis	1	rs9986596	chr6:28219661	ZNF187	chr6:28234788-28245978:+	-0.16	-3.78	0.000163	Depression	
BRCA	cis	1	rs9986596	chr6:28219661	ZNF389	chr6:28129551-28137375:+	-0.21	-3.69	0.000238	Depression	
BRCA	cis	1	rs9986596	chr6:28219661	ZSCAN23	chr6:28393287-28411279:-	0.17	3.54	0.000417	Depression	
BRCA	cis	1	rs9986765	chr7:142835239	TMEM139	chr7:142982044-142985140:+	0.22	3.74	0.00019	Dermatomyositis	
BRCA	cis	1	rs9988866	chr11:18392983	GTF2H1	chr11:18343816-18388590:+	0.28	7.6	6.67E-14	Pancreatic cancer	
BRCA	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.4	13.43	3.94E-38	Height	
BRCA	cis	1	rs9989967	chr3:134238964	CEP63	chr3:134204575-134293852:+	0.15	3.98	7.5E-5	Height	
BRCA	cis	1	rs9990333	chr3:195827205	SDHAP2	chr3:195384910-195415733:+	-0.12	-3.37	0.000771	Iron status biomarkers (transferrin saturation);Iron status biomarkers (transferrin levels)	
BRCA	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.4	-13.45	3.39E-38	Height	
BRCA	cis	1	rs9990351	chr3:134239191	CEP63	chr3:134204575-134293852:+	-0.14	-3.87	0.000115	Height	
BRCA	cis	1	rs9990702	chr4:88772316	SPP1	chr4:88896802-88904562:+	-0.18	-5.79	9.23E-9	Bone mineral density;Bone mineral density (paediatric, total body less head)	
BRCA	cis	1	rs9990742	chr4:39121414	KLHL5	chr4:39046659-39123828:+	-0.14	-4.42	1.08E-5	Uric acid levels	
BRCA	cis	1	rs9990755	chr4:39121439	KLHL5	chr4:39046659-39123828:+	-0.15	-4.71	2.77E-6	Uric acid levels	
BRCA	cis	1	rs9991678	chr4:165885039	TRIM61	chr4:165875600-165898818:-	0.25	8.02	2.76E-15	Ovarian cancer in BRCA1 mutation carriers	
BRCA	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.21	-5.35	1.1E-7	Longevity	
BRCA	cis	1	rs9996285	chr4:39132176	KLHL5	chr4:39046659-39123828:+	-0.14	-4.28	2.08E-5	Uric acid levels	
BRCA	cis	1	rs9996834	chr4:103557529	MANBA	chr4:103552644-103682151:-	0.21	5.46	5.91E-8	Primary biliary cirrhosis	
BRCA	cis	1	rs9997089	chr4:39120883	KLHL5	chr4:39046659-39123828:+	-0.15	-4.71	2.77E-6	Uric acid levels	
BRCA	cis	1	rs9998481	chr4:39118835	KLHL5	chr4:39046659-39123828:+	-0.15	-4.75	2.28E-6	Uric acid levels	
BRCA	cis	1	rs9998867	chr4:39119162	KLHL5	chr4:39046659-39123828:+	-0.15	-4.81	1.71E-6	Uric acid levels	
BRCA	cis	1	rs9998898	chr4:88772189	SPP1	chr4:88896802-88904562:+	-0.18	-5.79	9.23E-9	Bone mineral density;Bone mineral density (paediatric, total body less head)	
BRCA	cis	1	rs9998975	chr4:88772233	SPP1	chr4:88896802-88904562:+	-0.18	-5.79	9.23E-9	Bone mineral density;Bone mineral density (paediatric, total body less head)	
BRCA	cis	1	rs9999327	chr4:39111731	KLHL5	chr4:39046659-39123828:+	-0.16	-4.91	1.05E-6	Uric acid levels	
BRCA	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.48	-14.88	1.15E-45	Migraine without aura	
BRCA	trans	1	rs1013841	chr21:40173345	CCNK	chr14:99947739-99977851:+	0.21	5.72	1.39E-8	Non-small cell lung cancer (survival)	
BRCA	trans	1	rs10206271	chr2:134332896	ANKRD20A4	chr9:69381981-69425108:+	-0.29	-6.41	2.12E-10	Alzheimer's disease (survival time)	
BRCA	trans	1	rs10209165	chr2:134333536	ANKRD20A4	chr9:69381981-69425108:+	0.29	6.46	1.63E-10	Alzheimer's disease (survival time)	
BRCA	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.45	13.62	4.81E-39	Educational attainment	
BRCA	trans	1	rs1030136	chr2:190735660	GSK3B	chr3:119540804-119813264:-	0.29	5.77	1.06E-8	Subcutaneous adipose tissue	
BRCA	trans	1	rs1037036	chr17:18764077	PTBP1	chr19:797392-812327:+	-0.18	-5.49	5.12E-8	Educational attainment (years of education)	
BRCA	trans	1	rs10456362	chr6:28221816	BTN3A2	chr6:26365398-26378546:+	0.4	10.12	4.71E-23	Depression	
BRCA	trans	1	rs10456362	chr6:28221816	RNF5P1	chr8:38457695-38458775:-	-0.31	-6.06	1.86E-9	Depression	
BRCA	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.44	13.56	9.39E-39	Educational attainment	
BRCA	trans	1	rs10501335	chr11:55306577	FOLH1B	chr11:89392465-89431885:+	0.51	6.9	9.18E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs10501336	chr11:55315519	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.43	13.24	3.75E-37	Educational attainment	
BRCA	trans	1	rs10742862	chr11:48649316	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.74	1.51E-21	HDL cholesterol	
BRCA	trans	1	rs10748526	chr10:82273079	C2orf43	chr2:20883803-21022827:-	0.25	5.42	7.33E-8	Post bronchodilator FEV1	
BRCA	trans	1	rs10769371	chr11:48531184	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.18	2.7E-23	HDL cholesterol	
BRCA	trans	1	rs10769390	chr11:48618222	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.98	1.73E-22	HDL cholesterol	
BRCA	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.45	13.55	1.04E-38	Educational attainment	
BRCA	trans	1	rs10794671	chr1:121168242	NBPF14	chr1:148003643-148346791:-	0.3	10.22	1.91E-23	Hip geometry	
BRCA	trans	1	rs10838912	chr11:48496477	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.25	1.46E-23	HDL cholesterol	
BRCA	trans	1	rs10838917	chr11:48503127	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.07	7.3E-23	HDL cholesterol	
BRCA	trans	1	rs10838931	chr11:48540973	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.2	2.29E-23	HDL cholesterol	
BRCA	trans	1	rs10838943	chr11:48557442	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.97	1.86E-22	HDL cholesterol	
BRCA	trans	1	rs10838944	chr11:48559571	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.95	2.35E-22	HDL cholesterol	
BRCA	trans	1	rs10838954	chr11:48579323	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.92	3.03E-22	HDL cholesterol	
BRCA	trans	1	rs10838966	chr11:48589723	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.94	2.57E-22	HDL cholesterol	
BRCA	trans	1	rs10838971	chr11:48606624	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.88	4.43E-22	HDL cholesterol	
BRCA	trans	1	rs10838975	chr11:48617615	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.88	4.43E-22	HDL cholesterol	
BRCA	trans	1	rs10839171	chr11:48923034	FOLH1B	chr11:89392465-89431885:+	0.38	10.2	2.2E-23	HDL cholesterol	
BRCA	trans	1	rs10893380	chr11:125311674	ATP5L	chr11:118272104-118280561:+	0.19	5.55	3.54E-8	Schizophrenia	
BRCA	trans	1	rs10893380	chr11:125311674	DDX6	chr11:118618473-118661972:-	0.19	5.43	7.08E-8	Schizophrenia	
BRCA	trans	1	rs10893380	chr11:125311674	RPS25	chr11:118886422-118889057:-	0.18	5.45	6.18E-8	Schizophrenia	
BRCA	trans	1	rs10900224	chr10:46024534	AGAP8	chr10:51224690-51371331:-	0.23	5.9	4.84E-9	HDL cholesterol;Cholesterol, total	
BRCA	trans	1	rs10902112	chr11:244106	WASH7P	chr1:14363-29961:-	-0.13	-6.4	2.3E-10	Menarche (age at onset)	
BRCA	trans	1	rs10902113	chr11:245523	WASH7P	chr1:14363-29961:-	-0.13	-6.4	2.39E-10	Menarche (age at onset)	
BRCA	trans	1	rs10902114	chr11:246234	WASH7P	chr1:14363-29961:-	-0.13	-6.34	3.47E-10	Menarche (age at onset)	
BRCA	trans	1	rs10903159	chr1:121181997	NBPF14	chr1:148003643-148346791:-	0.3	10.3	9.07E-24	Hip geometry	
BRCA	trans	1	rs10903161	chr1:121178741	NBPF14	chr1:148003643-148346791:-	0.28	9.73	1.65E-21	Hip geometry	
BRCA	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.44	13.39	6.94E-38	Educational attainment	
BRCA	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.44	13.39	6.94E-38	Educational attainment	
BRCA	trans	1	rs11039745	chr11:48463811	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.12	4.74E-23	HDL cholesterol	
BRCA	trans	1	rs11039777	chr11:48517049	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.04	1.04E-22	HDL cholesterol	
BRCA	trans	1	rs11039779	chr11:48517895	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.03	1.11E-22	HDL cholesterol	
BRCA	trans	1	rs11039800	chr11:48542579	FOLH1B	chr11:89392465-89431885:+	0.37	10.04	1.04E-22	HDL cholesterol	
BRCA	trans	1	rs11039817	chr11:48561480	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.88	4.27E-22	HDL cholesterol	
BRCA	trans	1	rs11039819	chr11:48562181	FOLH1B	chr11:89392465-89431885:+	-0.35	-9.56	7.56E-21	HDL cholesterol	
BRCA	trans	1	rs11039820	chr11:48562252	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.76	1.24E-21	HDL cholesterol	
BRCA	trans	1	rs11039821	chr11:48562875	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.87	4.77E-22	HDL cholesterol	
BRCA	trans	1	rs11039851	chr11:48600839	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.11	5.02E-23	HDL cholesterol	
BRCA	trans	1	rs11039854	chr11:48607688	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.98	1.73E-22	HDL cholesterol	
BRCA	trans	1	rs11039857	chr11:48610853	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.88	4.43E-22	HDL cholesterol	
BRCA	trans	1	rs11039859	chr11:48611988	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.88	4.43E-22	HDL cholesterol	
BRCA	trans	1	rs11039862	chr11:48618306	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.06	8.24E-23	HDL cholesterol	
BRCA	trans	1	rs11039868	chr11:48622146	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.98	1.73E-22	HDL cholesterol	
BRCA	trans	1	rs11039871	chr11:48626620	FOLH1B	chr11:89392465-89431885:+	0.37	9.95	2.37E-22	HDL cholesterol	
BRCA	trans	1	rs11039890	chr11:48653468	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.96	2.02E-22	HDL cholesterol	
BRCA	trans	1	rs11039904	chr11:48682597	FOLH1B	chr11:89392465-89431885:+	0.4	7.77	1.81E-14	Axial length	
BRCA	trans	1	rs11039978	chr11:48760237	FOLH1B	chr11:89392465-89431885:+	0.4	7.77	1.81E-14	Axial length	
BRCA	trans	1	rs11130213	chr3:49712297	TREX1	chr3:48501186-48509043:+	-0.18	-5.59	2.83E-8	Crohn's disease;Ulcerative colitis	
BRCA	trans	1	rs111693873	chr11:55187836	FOLH1B	chr11:89392465-89431885:+	0.54	6.97	5.69E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs1119153	chr11:55324134	FOLH1B	chr11:89392465-89431885:+	0.59	7.45	1.92E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs11231757	chr11:64106317	TFCP2	chr12:51488608-51566917:-	0.21	5.43	6.87E-8	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
BRCA	trans	1	rs11239544	chr10:46007533	AGAP8	chr10:51224690-51371331:-	0.22	5.56	3.44E-8	Cholesterol, total	
BRCA	trans	1	rs11239545	chr10:46012245	AGAP8	chr10:51224690-51371331:-	-0.23	-5.94	3.79E-9	HDL cholesterol;Cholesterol, total	
BRCA	trans	1	rs11246602	chr11:51512090	FOLH1B	chr11:89392465-89431885:+	0.34	5.9	4.92E-9	HDL cholesterol	
BRCA	trans	1	rs11249350	chr1:121178446	NBPF14	chr1:148003643-148346791:-	0.3	10.35	5.54E-24	Hip geometry	
BRCA	trans	1	rs11249351	chr1:121171942	NBPF14	chr1:148003643-148346791:-	0.28	9.76	1.31E-21	Hip geometry	
BRCA	trans	1	rs112752859	chr11:55158284	FOLH1B	chr11:89392465-89431885:+	0.53	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs1128320	chr11:244167	WASH7P	chr1:14363-29961:-	-0.13	-6.4	2.3E-10	Menarche (age at onset)	
BRCA	trans	1	rs1128322	chr11:244197	WASH7P	chr1:14363-29961:-	0.14	6.72	3.0E-11	Menarche (age at onset)	
BRCA	trans	1	rs113079896	chr11:55196683	FOLH1B	chr11:89392465-89431885:+	0.52	7.01	4.36E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs1131095	chr3:49714225	TREX1	chr3:48501186-48509043:+	-0.18	-5.59	2.83E-8	Crohn's disease;Ulcerative colitis	
BRCA	trans	1	rs113150368	chr11:55135045	FOLH1B	chr11:89392465-89431885:+	0.54	7.05	3.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs113334225	chr11:55134980	FOLH1B	chr11:89392465-89431885:+	0.54	7.05	3.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs113732116	chr11:55242946	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs113745672	chr11:55051738	FOLH1B	chr11:89392465-89431885:+	0.52	7.02	3.98E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs114037190	chr11:55293219	FOLH1B	chr11:89392465-89431885:+	0.54	7.12	2.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs114635668	chr11:54812845	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs115224187	chr11:48757499	FOLH1B	chr11:89392465-89431885:+	0.37	9.88	4.43E-22	HDL cholesterol	
BRCA	trans	1	rs11530232	chr11:48622376	FOLH1B	chr11:89392465-89431885:+	0.39	6.41	2.18E-10	Axial length	
BRCA	trans	1	rs115429994	chr11:48761183	FOLH1B	chr11:89392465-89431885:+	0.4	7.77	1.81E-14	Axial length	
BRCA	trans	1	rs115582955	chr11:54823391	FOLH1B	chr11:89392465-89431885:+	0.51	6.71	3.09E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs116415674	chr11:55055790	FOLH1B	chr11:89392465-89431885:+	0.58	7.44	2.0E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs116475522	chr11:55022636	FOLH1B	chr11:89392465-89431885:+	0.55	7.13	1.89E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs116777062	chr11:54802952	FOLH1B	chr11:89392465-89431885:+	0.48	6.35	3.12E-10	Systemic lupus erythematosus	
BRCA	trans	1	rs1167827	chr7:75163169	TRIM74	chr7:75021265-75040277:+	-0.2	-5.91	4.52E-9	Body mass index	
BRCA	trans	1	rs116849536	chr11:55473875	FOLH1B	chr11:89392465-89431885:+	0.58	7.2	1.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs116858638	chr11:55184859	FOLH1B	chr11:89392465-89431885:+	0.6	7.37	3.41E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs116868501	chr11:55353720	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs116912712	chr11:55123489	FOLH1B	chr11:89392465-89431885:+	0.6	7.42	2.31E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs116966729	chr11:55225831	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs116969778	chr11:55213922	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs116984732	chr11:54901489	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117067781	chr11:55572932	FOLH1B	chr11:89392465-89431885:+	0.56	7.07	2.88E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117110854	chr11:55325763	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs117154767	chr11:55356741	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117189006	chr11:55263160	FOLH1B	chr11:89392465-89431885:+	0.58	7.22	9.81E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs117233182	chr11:55011757	FOLH1B	chr11:89392465-89431885:+	0.61	7.48	1.57E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs117245504	chr11:55175422	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs117292063	chr11:54987085	FOLH1B	chr11:89392465-89431885:+	0.54	6.9	9.02E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117311484	chr11:55224735	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.73E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117352062	chr11:55135019	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs117427130	chr11:55189935	FOLH1B	chr11:89392465-89431885:+	0.6	7.37	3.41E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs117431413	chr11:55147469	FOLH1B	chr11:89392465-89431885:+	0.6	7.44	2.09E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs117438754	chr11:55101588	FOLH1B	chr11:89392465-89431885:+	0.61	7.47	1.7E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs117533468	chr11:55293193	FOLH1B	chr11:89392465-89431885:+	0.59	7.41	2.54E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.44	13.39	6.94E-38	Educational attainment	
BRCA	trans	1	rs117619703	chr11:55187799	FOLH1B	chr11:89392465-89431885:+	0.54	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117696469	chr11:55003433	FOLH1B	chr11:89392465-89431885:+	0.61	7.48	1.57E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs117722297	chr11:54841706	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117788647	chr11:55187201	FOLH1B	chr11:89392465-89431885:+	0.6	7.37	3.41E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs117803056	chr11:55177266	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117808016	chr11:55070074	FOLH1B	chr11:89392465-89431885:+	0.61	7.55	9.05E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs117904544	chr11:55279095	FOLH1B	chr11:89392465-89431885:+	0.54	7.1	2.2E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117961171	chr11:54828312	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117967582	chr11:54979275	FOLH1B	chr11:89392465-89431885:+	0.58	6.94	6.78E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117975165	chr11:54807491	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117987119	chr11:54986601	FOLH1B	chr11:89392465-89431885:+	0.59	7.09	2.39E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs117999297	chr11:55164192	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.55E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs118079991	chr11:55347493	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.01E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs118121544	chr11:55263793	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs118186653	chr11:54846271	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11819779	chr11:55065192	FOLH1B	chr11:89392465-89431885:+	0.51	6.89	9.62E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11819957	chr11:55304262	FOLH1B	chr11:89392465-89431885:+	0.53	7.02	3.94E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11819980	chr11:55304399	FOLH1B	chr11:89392465-89431885:+	0.51	6.81	1.61E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs11820245	chr11:55240895	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs11820246	chr11:55240901	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs11821230	chr11:55064967	FOLH1B	chr11:89392465-89431885:+	0.54	7.12	1.91E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11821647	chr11:54978609	FOLH1B	chr11:89392465-89431885:+	0.54	6.9	9.02E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11821737	chr11:55077765	FOLH1B	chr11:89392465-89431885:+	0.54	7.04	3.35E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11822057	chr11:55242495	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs11823212	chr11:55159844	FOLH1B	chr11:89392465-89431885:+	0.53	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11823346	chr11:55214688	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs11823401	chr11:55274744	FOLH1B	chr11:89392465-89431885:+	0.51	6.81	1.6E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs11824035	chr11:55180676	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11825077	chr11:54838034	FOLH1B	chr11:89392465-89431885:+	0.51	6.71	3.09E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs11825313	chr11:55188887	FOLH1B	chr11:89392465-89431885:+	0.52	6.86	1.19E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs11826609	chr11:55297635	FOLH1B	chr11:89392465-89431885:+	0.54	7.12	2.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11827117	chr11:55315605	FOLH1B	chr11:89392465-89431885:+	0.51	6.93	7.5E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11827274	chr11:54866387	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.6E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11827405	chr11:55186587	FOLH1B	chr11:89392465-89431885:+	0.52	6.85	1.21E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs11828054	chr11:55297562	FOLH1B	chr11:89392465-89431885:+	0.53	6.98	5.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11828245	chr11:55116941	FOLH1B	chr11:89392465-89431885:+	0.58	7.38	3.16E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs11828784	chr11:54866721	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.6E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs11965538	chr6:28239915	BTN3A2	chr6:26365398-26378546:+	-0.43	-10.3	8.93E-24	Depression	
BRCA	trans	1	rs11965538	chr6:28239915	RNF5P1	chr8:38457695-38458775:-	0.35	6.42	2.05E-10	Depression	
BRCA	trans	1	rs12047116	chr1:121185770	NBPF14	chr1:148003643-148346791:-	0.3	10.28	1.03E-23	Hip geometry	
BRCA	trans	1	rs12145080	chr1:121185531	NBPF14	chr1:148003643-148346791:-	-0.29	-9.92	2.92E-22	Hip geometry	
BRCA	trans	1	rs1216215	chr11:55184504	FOLH1B	chr11:89392465-89431885:+	-0.46	-6.65	4.54E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs1216240	chr11:55178067	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.71	3.12E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs12213036	chr6:113143519	DKFZp686A1627	chr13:19620293-19692423:-	0.19	5.67	1.89E-8	Bipolar disorder (body mass index interaction)	
BRCA	trans	1	rs12213872	chr6:124347567	OC90	chr8:133036467-133071627:-	0.2	5.5	4.81E-8	Schizophrenia	
BRCA	trans	1	rs12225599	chr11:48755868	FOLH1B	chr11:89392465-89431885:+	0.4	7.78	1.7E-14	Axial length	
BRCA	trans	1	rs12257549	chr10:46029631	AGAP8	chr10:51224690-51371331:-	0.22	5.69	1.61E-8	HDL cholesterol;Cholesterol, total	
BRCA	trans	1	rs12280020	chr11:48618844	FOLH1B	chr11:89392465-89431885:+	0.37	7.53	1.07E-13	Axial length	
BRCA	trans	1	rs12281162	chr11:48650491	FOLH1B	chr11:89392465-89431885:+	0.36	7.3	5.75E-13	Axial length	
BRCA	trans	1	rs1230338	chr11:55173061	FOLH1B	chr11:89392465-89431885:+	-0.52	-6.9	8.91E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs12361812	chr11:48563104	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.89	4.09E-22	HDL cholesterol	
BRCA	trans	1	rs12365220	chr11:48555957	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.02	1.23E-22	HDL cholesterol	
BRCA	trans	1	rs12366208	chr11:48563128	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.94	2.6E-22	HDL cholesterol	
BRCA	trans	1	rs12419576	chr11:48581644	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.95	2.27E-22	HDL cholesterol	
BRCA	trans	1	rs12420372	chr11:48497603	FOLH1B	chr11:89392465-89431885:+	0.36	9.96	2.02E-22	HDL cholesterol	
BRCA	trans	1	rs12421159	chr11:48624841	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.98	1.73E-22	HDL cholesterol	
BRCA	trans	1	rs12421879	chr11:48689978	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.15	3.47E-23	HDL cholesterol	
BRCA	trans	1	rs12509991	chr4:126996870	POLE3	chr9:116169518-116173029:-	-0.23	-5.56	3.36E-8	Response to Homoharringtonine (cytotoxicity)	
BRCA	trans	1	rs12526680	chr6:26550954	RICH2	chr17:12692829-12894959:+	0.23	5.61	2.6E-8	Educational attainment	
BRCA	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.43	13.23	4.07E-37	Educational attainment	
BRCA	trans	1	rs12570188	chr10:100855702	ACTR1A	chr10:104238987-104262512:-	-0.46	-6.63	5.26E-11	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	BLOC1S2	chr10:102033713-102046439:-	-0.39	-5.6	2.68E-8	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	BTRC	chr10:103113825-103317068:+	-0.31	-5.48	5.33E-8	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	C10orf119	chr10:121588972-121633133:-	-0.34	-5.45	6.37E-8	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	C10orf2	chr10:102747293-102754158:+	-0.38	-6.65	4.79E-11	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	C10orf76	chr10:103605356-103815932:-	-0.46	-5.94	3.79E-9	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	C10orf88	chr10:124690419-124713919:-	-0.41	-5.45	6.25E-8	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	C10orf95	chr10:104209594-104211300:-	-0.45	-5.89	5.14E-9	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	CHUK	chr10:101948125-101989344:-	-0.4	-6.32	3.79E-10	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	CWF19L1	chr10:101992055-102027437:-	-0.5	-6.84	1.31E-11	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	FAM178A	chr10:102672326-102724889:+	-0.36	-6.2	8.05E-10	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	FAM45A	chr10:120863611-120897215:+	-0.44	-5.74	1.22E-8	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	FAM45B	chrX:129628915-129630732:+	-0.35	-5.67	1.8E-8	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	GBF1	chr10:104005259-104142649:+	-0.37	-5.92	4.33E-9	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	GLRX3	chr10:131934663-131982784:+	-0.4	-6.29	4.58E-10	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	HPS6	chr10:103825147-103827792:+	-0.4	-6.22	7.31E-10	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	KIF11	chr10:94352825-94415150:+	-0.2	-5.66	1.91E-8	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	KIF20B	chr10:91461367-91534700:+	-0.28	-6.32	3.83E-10	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	LZTS2	chr10:102756965-102767585:+	-0.33	-6.48	1.43E-10	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	MRPL43	chr10:102737579-102747272:-	-0.34	-6.21	7.35E-10	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	NDUFB8	chr10:102283497-102289636:-	-0.3	-5.96	3.43E-9	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	NOC3L	chr10:96092989-96122683:-	-0.45	-7.73	2.47E-14	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	NOLC1	chr10:103911933-103923627:+	-0.41	-7.28	6.39E-13	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	OBFC1	chr10:105637320-105678045:-	-0.42	-5.87	5.66E-9	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	PCGF6	chr10:105062554-105110891:-	-0.4	-5.78	9.75E-9	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	SMC3	chr10:112327449-112364390:+	-0.28	-5.46	5.92E-8	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	SMNDC1	chr10:112052799-112064707:-	-0.42	-6.46	1.61E-10	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	TAF5	chr10:105127724-105148820:+	-0.38	-6.6	6.26E-11	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	TBC1D12	chr10:96162186-96296089:+	-0.34	-5.82	7.84E-9	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	TCTN3	chr10:97423154-97453900:-	-0.39	-5.54	3.72E-8	Asthma (childhood onset)	
BRCA	trans	1	rs12570188	chr10:100855702	TRUB1	chr10:116697915-116737438:+	-0.34	-5.6	2.66E-8	Asthma (childhood onset)	
BRCA	trans	1	rs12692349	chr2:8114312	S100A7A	chr1:153389000-153395701:+	0.17	5.58	3.02E-8	Response to anti-TNF therapy in rheumatoid arthritis	
BRCA	trans	1	rs12806328	chr11:48647971	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.02	1.25E-22	HDL cholesterol	
BRCA	trans	1	rs12891047	chr14:68243075	DDX28	chr16:68055174-68057959:-	-0.17	-5.48	5.34E-8	Amyotrophic lateral sclerosis (sporadic)	
BRCA	trans	1	rs13027438	chr2:134337990	ANKRD20A4	chr9:69381981-69425108:+	-0.28	-6.14	1.16E-9	Alzheimer's disease (survival time)	
BRCA	trans	1	rs13195401	chr6:26463574	RNF5P1	chr8:38457695-38458775:-	0.65	8.34	2.22E-16	Schizophrenia	
BRCA	trans	1	rs13195401	chr6:26463574	ZFP57	chr6:29640171-29648887:-	0.67	9.17	2.35E-19	Schizophrenia	
BRCA	trans	1	rs13195402	chr6:26463575	RNF5P1	chr8:38457695-38458775:-	0.65	8.34	2.22E-16	Schizophrenia	
BRCA	trans	1	rs13195402	chr6:26463575	ZFP57	chr6:29640171-29648887:-	0.67	9.17	2.35E-19	Schizophrenia	
BRCA	trans	1	rs13200462	chr6:28218199	BTN3A2	chr6:26365398-26378546:+	-0.45	-10.65	3.21E-25	Depression	
BRCA	trans	1	rs13200462	chr6:28218199	RNF5P1	chr8:38457695-38458775:-	0.34	6.13	1.22E-9	Depression	
BRCA	trans	1	rs13200462	chr6:28218199	ZFP57	chr6:29640171-29648887:-	0.29	5.56	3.42E-8	Depression	
BRCA	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.39	-12.1	1.09E-31	Educational attainment	
BRCA	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.44	13.43	4.2E-38	Educational attainment	
BRCA	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.43	13.18	7.22E-37	Educational attainment	
BRCA	trans	1	rs13220495	chr6:26441640	RNF5P1	chr8:38457695-38458775:-	0.64	8.23	5.38E-16	Schizophrenia	
BRCA	trans	1	rs13220495	chr6:26441640	ZFP57	chr6:29640171-29648887:-	0.67	9.08	4.96E-19	Schizophrenia	
BRCA	trans	1	rs13402078	chr2:8113107	S100A7A	chr1:153389000-153395701:+	0.17	5.56	3.36E-8	Response to anti-TNF therapy in rheumatoid arthritis	
BRCA	trans	1	rs1351696	chr11:48382471	FOLH1B	chr11:89392465-89431885:+	-0.38	-7.59	7.14E-14	D-dimer levels	
BRCA	trans	1	rs1362005	chr7:126422818	CLDN7	chr17:7163223-7166512:-	0.19	5.57	3.17E-8	Creutzfeldt-Jakob disease (sporadic)	
BRCA	trans	1	rs1364759	chr11:55216910	FOLH1B	chr11:89392465-89431885:+	-0.47	-6.54	9.52E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs1364762	chr11:55197913	FOLH1B	chr11:89392465-89431885:+	-0.5	-6.6	6.38E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs1419183	chr6:28242794	BTN3A2	chr6:26365398-26378546:+	-0.43	-10.45	2.21E-24	Depression	
BRCA	trans	1	rs1419183	chr6:28242794	RNF5P1	chr8:38457695-38458775:-	0.34	6.37	2.89E-10	Depression	
BRCA	trans	1	rs1425192	chr11:55139994	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs1425195	chr11:55195255	FOLH1B	chr11:89392465-89431885:+	0.43	6.14	1.14E-9	Systemic lupus erythematosus	
BRCA	trans	1	rs1459105	chr11:55317617	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs1459106	chr11:55317814	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs1459111	chr11:55256732	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs1472750	chr10:115235114	C10orf46	chr10:120433634-120514758:-	-0.3	-5.86	6.07E-9	Migraine without aura	
BRCA	trans	1	rs1472750	chr10:115235114	POLL	chr10:103338639-103348012:-	-0.23	-5.55	3.51E-8	Migraine without aura	
BRCA	trans	1	rs1504670	chr11:55321254	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs1504671	chr11:55321156	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.45	13.55	1.04E-38	Educational attainment	
BRCA	trans	1	rs1580922	chr11:55324138	FOLH1B	chr11:89392465-89431885:+	0.59	7.42	2.42E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs1591882	chr1:121183313	NBPF14	chr1:148003643-148346791:-	0.3	10.43	2.49E-24	Hip geometry	
BRCA	trans	1	rs1605364	chr11:48684843	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.08	6.64E-23	HDL cholesterol	
BRCA	trans	1	rs1679709	chr6:28228342	BTN3A2	chr6:26365398-26378546:+	0.45	10.84	4.56E-26	Depression	
BRCA	trans	1	rs1679709	chr6:28228342	RNF5P1	chr8:38457695-38458775:-	-0.34	-6.37	2.79E-10	Depression	
BRCA	trans	1	rs1679709	chr6:28228342	ZFP57	chr6:29640171-29648887:-	-0.28	-5.51	4.61E-8	Depression	
BRCA	trans	1	rs1679732	chr6:28221264	BTN3A2	chr6:26365398-26378546:+	0.45	11.11	3.15E-27	Depression	
BRCA	trans	1	rs1679732	chr6:28221264	RNF5P1	chr8:38457695-38458775:-	-0.33	-6.15	1.12E-9	Depression	
BRCA	trans	1	rs16899788	chr6:167431326	C6orf70	chr6:170151721-170181617:+	0.4	5.53	3.92E-8	Smooth-surface caries	
BRCA	trans	1	rs16899788	chr6:167431326	DYNLT1	chr6:159057506-159065740:-	0.38	5.49	5.13E-8	Smooth-surface caries	
BRCA	trans	1	rs16899788	chr6:167431326	FAM120B	chr6:170615844-170714236:+	0.4	5.76	1.12E-8	Smooth-surface caries	
BRCA	trans	1	rs16899788	chr6:167431326	PDCD2	chr6:170886451-170893748:-	0.45	5.98	3.03E-9	Smooth-surface caries	
BRCA	trans	1	rs16899788	chr6:167431326	PSMB1	chr6:170780107-170862417:-	0.39	6.06	1.87E-9	Smooth-surface caries	
BRCA	trans	1	rs16899788	chr6:167431326	TBP	chr6:170863471-170881946:+	0.49	5.96	3.45E-9	Smooth-surface caries	
BRCA	trans	1	rs16929097	chr9:12521826	CDC37L1	chr9:4679566-4706593:+	0.43	6.04	2.19E-9	Asthma (childhood onset)	
BRCA	trans	1	rs16929097	chr9:12521826	KDM4C	chr9:6716495-7175647:+	0.43	6.42	2.02E-10	Asthma (childhood onset)	
BRCA	trans	1	rs16929097	chr9:12521826	KIAA0020	chr9:2804155-2844130:-	0.33	5.66	1.98E-8	Asthma (childhood onset)	
BRCA	trans	1	rs16929097	chr9:12521826	PPAPDC2	chr9:4662298-4665256:+	0.38	5.45	6.4E-8	Asthma (childhood onset)	
BRCA	trans	1	rs16929097	chr9:12521826	UHRF2	chr9:6413151-6507049:+	0.35	5.56	3.49E-8	Asthma (childhood onset)	
BRCA	trans	1	rs16942155	chr15:60418758	ARIH1	chr15:72766667-72878895:+	0.3	6.02	2.4E-9	Type 2 diabetes	
BRCA	trans	1	rs16942155	chr15:60418758	COMMD4	chr15:75628374-75634268:+	0.22	5.44	6.79E-8	Type 2 diabetes	
BRCA	trans	1	rs16942155	chr15:60418758	PRC1	chr15:91509274-91537804:-	0.19	5.49	5.05E-8	Type 2 diabetes	
BRCA	trans	1	rs16942155	chr15:60418758	SELS	chr15:101811214-101817700:-	0.33	5.53	3.93E-8	Type 2 diabetes	
BRCA	trans	1	rs16942155	chr15:60418758	SLTM	chr15:59171245-59225852:-	0.29	5.63	2.33E-8	Type 2 diabetes	
BRCA	trans	1	rs16958445	chr15:74176557	ANP32A	chr15:69070877-69113261:-	0.47	5.73	1.33E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	BBS4	chr15:72978526-73030816:+	0.36	6.48	1.37E-10	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	BTBD1	chr15:83685183-83736106:-	0.42	5.98	3.07E-9	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	C15orf44	chr15:65871120-65903469:-	0.47	5.65	2.06E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	CLN6	chr15:68499331-68549444:-	0.39	5.9	5.0E-9	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	CLPX	chr15:65442785-65477563:-	0.36	5.59	2.88E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	COMMD4	chr15:75628374-75634268:+	0.32	6.19	8.81E-10	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	COX5A	chr15:75212619-75230495:-	0.37	6.56	8.43E-11	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	FBXO22	chr15:76196200-76226942:+	0.47	6.2	8.24E-10	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	IDH3A	chr15:78441719-78462883:+	0.4	5.72	1.42E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	IREB2	chr15:78730518-78793798:+	0.31	5.66	1.9E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	MESDC2	chr15:81239670-81282205:-	0.45	5.43	7.12E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	MORF4L1	chr15:79165172-79190072:+	0.41	5.47	5.6E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	MRPL46	chr15:89002708-89010633:-	0.46	5.64	2.15E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	PIAS1	chr15:68346572-68480402:+	0.37	6.33	3.57E-10	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	PPCDC	chr15:75315927-75343066:+	0.4	6.02	2.34E-9	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	PTPLAD1	chr15:65822827-65870691:+	0.31	5.53	4.14E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	SCAPER	chr15:76640529-77197744:-	0.36	5.88	5.58E-9	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	SIN3A	chr15:75661722-75748124:-	0.42	7.11	2.15E-12	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	SNUPN	chr15:75890426-75918719:-	0.45	5.81	8.4E-9	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16958445	chr15:74176557	WDR61	chr15:78575580-78591940:-	0.42	5.55	3.54E-8	Exfoliation glaucoma or exfoliation syndrome	
BRCA	trans	1	rs16995986	chr4:86693317	CISD2	chr4:103790135-103809913:+	-0.4	-5.8	8.86E-9	Diisocyanate-induced asthma	
BRCA	trans	1	rs16995986	chr4:86693317	DNAJB14	chr4:100820712-100867879:-	-0.27	-5.74	1.21E-8	Diisocyanate-induced asthma	
BRCA	trans	1	rs16995986	chr4:86693317	SMARCAD1	chr4:95128759-95212441:+	-0.34	-6.28	4.97E-10	Diisocyanate-induced asthma	
BRCA	trans	1	rs16995986	chr4:86693317	UBE2D3	chr4:103715547-103790032:-	-0.42	-5.44	6.69E-8	Diisocyanate-induced asthma	
BRCA	trans	1	rs1700576	chr5:8544182	MRPS18C	chr4:84377118-84389352:+	0.2	5.45	6.28E-8	Verbal declarative memory	
BRCA	trans	1	rs17099531	chr1:77182965	CHST1	chr11:45670427-45687172:-	0.38	5.43	7.14E-8	Amyotrophic lateral sclerosis (sporadic)	
BRCA	trans	1	rs17116334	chr11:113961762	BUD13	chr11:116618888-116643714:-	-0.26	-6.13	1.21E-9	Conduct disorder (interaction)	
BRCA	trans	1	rs17116334	chr11:113961762	RNF214	chr11:117103404-117156402:+	-0.23	-5.48	5.28E-8	Conduct disorder (interaction)	
BRCA	trans	1	rs1728344	chr7:23250044	ETV4	chr17:41605212-41623762:-	-0.42	-5.44	6.6E-8	Chronic obstructive pulmonary disease	
BRCA	trans	1	rs17492508	chr11:55091619	FOLH1B	chr11:89392465-89431885:+	0.56	7.24	8.58E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17492564	chr11:55129798	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17492571	chr11:55129994	FOLH1B	chr11:89392465-89431885:+	0.57	7.34	4.17E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17493401	chr11:55171930	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs17493596	chr11:55200610	FOLH1B	chr11:89392465-89431885:+	0.61	7.5	1.31E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17493710	chr11:55204758	FOLH1B	chr11:89392465-89431885:+	-0.36	-5.42	7.28E-8	Systemic lupus erythematosus	
BRCA	trans	1	rs17494102	chr11:55258196	FOLH1B	chr11:89392465-89431885:+	0.51	6.67	4.11E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs17494249	chr11:55258881	FOLH1B	chr11:89392465-89431885:+	0.51	6.67	4.11E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs17494536	chr11:55261272	FOLH1B	chr11:89392465-89431885:+	0.53	6.96	6.07E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17494990	chr11:55277761	FOLH1B	chr11:89392465-89431885:+	0.55	7.05	3.24E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17495071	chr11:55278447	FOLH1B	chr11:89392465-89431885:+	0.58	7.36	3.73E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17495142	chr11:55282594	FOLH1B	chr11:89392465-89431885:+	0.58	7.36	3.73E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17495303	chr11:55290011	FOLH1B	chr11:89392465-89431885:+	0.59	7.41	2.54E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17496054	chr11:55310280	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17496160	chr11:55314073	FOLH1B	chr11:89392465-89431885:+	0.55	7.12	1.93E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17496444	chr11:55319012	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17496724	chr11:55322099	FOLH1B	chr11:89392465-89431885:+	0.57	7.26	7.4E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17499703	chr11:55492391	FOLH1B	chr11:89392465-89431885:+	0.55	6.93	7.06E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17501535	chr11:55561893	FOLH1B	chr11:89392465-89431885:+	0.54	6.77	2.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs17501618	chr11:55568216	FOLH1B	chr11:89392465-89431885:+	-0.54	-6.89	9.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17578388	chr11:55200433	FOLH1B	chr11:89392465-89431885:+	0.61	7.5	1.31E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17578479	chr11:55203672	FOLH1B	chr11:89392465-89431885:+	0.52	6.99	4.75E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17578535	chr11:55204022	FOLH1B	chr11:89392465-89431885:+	0.52	6.99	4.75E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17579334	chr11:55261146	FOLH1B	chr11:89392465-89431885:+	0.58	7.31	5.17E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17579348	chr11:55261238	FOLH1B	chr11:89392465-89431885:+	0.58	7.22	9.81E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17579755	chr11:55273190	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17579825	chr11:55277617	FOLH1B	chr11:89392465-89431885:+	0.51	6.94	6.96E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17579895	chr11:55278100	FOLH1B	chr11:89392465-89431885:+	-0.6	-7.62	5.46E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs17580294	chr11:55296106	FOLH1B	chr11:89392465-89431885:+	0.54	7.12	2.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17580581	chr11:55303299	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.66E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17580623	chr11:55303486	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.66E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17580694	chr11:55304199	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.58	7.54E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs17580938	chr11:55311980	FOLH1B	chr11:89392465-89431885:+	0.51	6.9	9.18E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17580966	chr11:55312550	FOLH1B	chr11:89392465-89431885:+	-0.42	-5.94	3.76E-9	Systemic lupus erythematosus	
BRCA	trans	1	rs17580994	chr11:55312897	FOLH1B	chr11:89392465-89431885:+	-0.5	-6.82	1.5E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs17581051	chr11:55314303	FOLH1B	chr11:89392465-89431885:+	0.51	6.93	7.5E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17581191	chr11:55316023	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17581261	chr11:55318210	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17581303	chr11:55318698	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17581337	chr11:55319882	FOLH1B	chr11:89392465-89431885:+	0.51	6.93	7.5E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17581532	chr11:55321823	FOLH1B	chr11:89392465-89431885:+	0.53	6.75	2.41E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs17581700	chr11:55322606	FOLH1B	chr11:89392465-89431885:+	0.57	7.26	7.23E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17581742	chr11:55326524	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs17592197	chr11:55531324	FOLH1B	chr11:89392465-89431885:+	0.56	6.84	1.34E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs17592698	chr11:55558804	FOLH1B	chr11:89392465-89431885:+	0.54	6.77	2.18E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs17593355	chr11:55592874	FOLH1B	chr11:89392465-89431885:+	0.56	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs17627822	chr4:64308401	PKP3	chr11:394217-404907:+	0.19	5.47	5.6E-8	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	
BRCA	trans	1	rs1778508	chr6:28229881	BTN3A2	chr6:26365398-26378546:+	0.45	10.84	4.82E-26	Depression	
BRCA	trans	1	rs1778508	chr6:28229881	RNF5P1	chr8:38457695-38458775:-	-0.36	-6.64	4.92E-11	Depression	
BRCA	trans	1	rs1778511	chr6:28229411	BTN3A2	chr6:26365398-26378546:+	0.45	10.73	1.45E-25	Depression	
BRCA	trans	1	rs1778511	chr6:28229411	RNF5P1	chr8:38457695-38458775:-	-0.35	-6.46	1.59E-10	Depression	
BRCA	trans	1	rs1809986	chr11:48987539	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.14	4.05E-23	HDL cholesterol	
BRCA	trans	1	rs1832558	chr1:121177380	NBPF14	chr1:148003643-148346791:-	0.29	9.82	7.54E-22	Hip geometry	
BRCA	trans	1	rs1835629	chr15:86955731	SAMD12	chr8:119201695-119634234:-	0.36	5.45	6.26E-8	Schizophrenia	
BRCA	trans	1	rs1836287	chr11:55066687	FOLH1B	chr11:89392465-89431885:+	0.54	7.12	1.91E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs1841165	chr11:55256084	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs1856572	chr1:121169579	NBPF14	chr1:148003643-148346791:-	0.3	10.3	8.73E-24	Hip geometry	
BRCA	trans	1	rs1867486	chr16:86681155	MVD	chr16:88718348-88729495:-	0.15	5.99	2.87E-9	IgG glycosylation	
BRCA	trans	1	rs1881534	chr11:62085083	FAM21B	chr10:47894023-47949416:+;chr10	-0.34	-5.62	2.46E-8	Chronic obstructive pulmonary disease-related biomarkers	
BRCA	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.43	13.2	5.98E-37	Educational attainment	
BRCA	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.45	13.55	1.04E-38	Educational attainment	
BRCA	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.45	13.55	1.04E-38	Educational attainment	
BRCA	trans	1	rs1936365	chr6:28268452	BTN3A2	chr6:26365398-26378546:+	0.43	10.77	9.8E-26	Depression	
BRCA	trans	1	rs1936365	chr6:28268452	RNF5P1	chr8:38457695-38458775:-	-0.35	-6.68	3.82E-11	Depression	
BRCA	trans	1	rs1958056	chr14:34248312	TMEM184C	chr4:148538539-148556670:+	0.18	5.58	3.1E-8	Schizophrenia	
BRCA	trans	1	rs1974929	chr11:55157381	FOLH1B	chr11:89392465-89431885:+	0.53	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs1979	chr6:26377591	RNF5P1	chr8:38457695-38458775:-	0.5	7.83	1.13E-14	Schizophrenia	
BRCA	trans	1	rs1979	chr6:26377591	ZFP57	chr6:29640171-29648887:-	0.43	7	4.65E-12	Schizophrenia	
BRCA	trans	1	rs1986111	chr1:121204788	NBPF14	chr1:148003643-148346791:-	0.32	10.81	6.13E-26	Hip geometry	
BRCA	trans	1	rs2042591	chr11:55222990	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs2084385	chr3:196553867	LOC646214	chr15:21932514-21940739:-	-0.46	-9.32	6.48E-20	Total ventricular volume (Alzheimer's disease interaction)	
BRCA	trans	1	rs2113914	chr11:55157322	FOLH1B	chr11:89392465-89431885:+	0.53	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs2113916	chr11:55197672	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.8	1.78E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs2125587	chr11:55253578	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs2155029	chr11:55211811	FOLH1B	chr11:89392465-89431885:+	0.51	6.81	1.58E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs2185281	chr1:121179991	NBPF14	chr1:148003643-148346791:-	0.31	10.46	1.98E-24	Hip geometry	
BRCA	trans	1	rs2186595	chr11:55212033	FOLH1B	chr11:89392465-89431885:+	0.51	6.81	1.58E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs2194835	chr11:55237265	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs2204238	chr11:54922520	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.43	13.3	1.81E-37	Educational attainment	
BRCA	trans	1	rs2216993	chr11:55236954	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs2217761	chr11:54928472	FOLH1B	chr11:89392465-89431885:+	0.55	7.18	1.32E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs2220004	chr11:55895745	OSBP	chr11:59341871-59383617:-	0.18	5.63	2.3E-8	Odorant perception (&beta;-damascenone)	
BRCA	trans	1	rs2221559	chr11:48707973	FOLH1B	chr11:89392465-89431885:+	0.38	10.35	5.71E-24	HDL cholesterol	
BRCA	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.45	13.72	1.36E-39	Educational attainment	
BRCA	trans	1	rs2235701	chr1:40883095	AGER	chr6:32148746-32152023:-	0.18	5.52	4.22E-8	Ejection fraction in Tripanosoma cruzi seropositivity	
BRCA	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.43	13.32	1.43E-37	Educational attainment	
BRCA	trans	1	rs2272565	chr11:244414	WASH7P	chr1:14363-29961:-	-0.13	-6.37	2.73E-10	Menarche (age at onset)	
BRCA	trans	1	rs2279167	chr15:86076584	ARHGAP30	chr1:161016733-161039760:-	0.12	5.82	7.9E-9	Response to platinum-based chemotherapy (carboplatin)	
BRCA	trans	1	rs2282745	chr2:102632064	RPRD1B	chr20:36661948-36720764:+	-0.26	-5.53	4.02E-8	Hormone measurements	
BRCA	trans	1	rs2292239	chr12:56482180	RPS26P11	chrX:71264259-71264809:+	0.37	10.32	7.11E-24	Cognitive function	
BRCA	trans	1	rs2305983	chr11:47858755	FOLH1B	chr11:89392465-89431885:+	0.26	6.06	1.9E-9	Intraocular pressure	
BRCA	trans	1	rs2319969	chr1:121207335	NBPF14	chr1:148003643-148346791:-	0.3	9.75	1.42E-21	Hip geometry	
BRCA	trans	1	rs2320937	chr2:134341287	ANKRD20A4	chr9:69381981-69425108:+	0.29	6.16	1.05E-9	Alzheimer's disease (survival time)	
BRCA	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.44	13.39	6.96E-38	Educational attainment	
BRCA	trans	1	rs2463822	chr11:62103420	FAM21B	chr10:47894023-47949416:+;chr10	-0.33	-5.52	4.25E-8	Chronic obstructive pulmonary disease-related biomarkers	
BRCA	trans	1	rs2524005	chr6:29899677	BTN3A2	chr6:26365398-26378546:+	-0.3	-7.82	1.28E-14	Bipolar disorder and schizophrenia	
BRCA	trans	1	rs2524005	chr6:29899677	RNF5P1	chr8:38457695-38458775:-	0.39	8.1	1.55E-15	Bipolar disorder and schizophrenia	
BRCA	trans	1	rs2799077	chr6:28234597	BTN3A2	chr6:26365398-26378546:+	-0.44	-10.59	5.39E-25	Depression	
BRCA	trans	1	rs2799077	chr6:28234597	RNF5P1	chr8:38457695-38458775:-	0.35	6.5	1.27E-10	Depression	
BRCA	trans	1	rs2799079	chr6:28235176	BTN3A2	chr6:26365398-26378546:+	-0.42	-10.43	2.53E-24	Depression	
BRCA	trans	1	rs2799079	chr6:28235176	RNF5P1	chr8:38457695-38458775:-	0.3	5.84	7.09E-9	Depression	
BRCA	trans	1	rs280001	chr15:77003566	CCDC77	chr12:498516-551804:+	-0.21	-5.42	7.37E-8	Recalcitrant atopic dermatitis	
BRCA	trans	1	rs28416696	chr2:54484326	HRC	chr19:49654458-49658681:-	0.2	5.42	7.37E-8	Telomere length	
BRCA	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.44	13.43	3.98E-38	Educational attainment	
BRCA	trans	1	rs2865774	chr4:97950534	MYO1G	chr7:45002260-45018704:-	-0.18	-5.49	5.01E-8	Post bronchodilator FEV1/FVC ratio	
BRCA	trans	1	rs28752322	chr11:54798443	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs2878332	chr11:54900383	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.6E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs28805394	chr11:54813776	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs28809233	chr11:54824518	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs28826070	chr11:54801549	FOLH1B	chr11:89392465-89431885:+	0.51	6.71	3.09E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs28839871	chr11:54800231	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs28846177	chr11:54813850	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs28848478	chr11:54799302	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs28867852	chr11:54795118	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs28871886	chr11:54822390	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs28897249	chr11:54814284	FOLH1B	chr11:89392465-89431885:+	0.51	6.71	3.09E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs2955095	chr3:127977665	RNF150	chr4:141786725-142054616:-	-0.2	-5.53	3.93E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
BRCA	trans	1	rs3019587	chr11:68569642	NDUFV1	chr11:67374323-67380012:+	0.34	6.1	1.48E-9	Obesity-related traits	
BRCA	trans	1	rs313813	chr7:65503500	ZNF117	chr7:64434830-64467121:-	-0.31	-5.48	5.21E-8	Diabetic kidney disease	
BRCA	trans	1	rs34099327	chr11:55305250	FOLH1B	chr11:89392465-89431885:+	0.51	6.9	9.18E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs34505904	chr2:8115159	S100A7A	chr1:153389000-153395701:+	0.17	5.56	3.44E-8	Response to anti-TNF therapy in rheumatoid arthritis	
BRCA	trans	1	rs34636547	chr11:48590103	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.94	2.57E-22	HDL cholesterol	
BRCA	trans	1	rs35195107	chr11:55046715	FOLH1B	chr11:89392465-89431885:+	0.55	7.14	1.71E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs35398717	chr2:8115041	S100A7A	chr1:153389000-153395701:+	0.18	5.61	2.55E-8	Response to anti-TNF therapy in rheumatoid arthritis	
BRCA	trans	1	rs35968796	chr11:55305322	FOLH1B	chr11:89392465-89431885:+	0.51	6.9	9.18E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.43	13.29	2.2E-37	Educational attainment	
BRCA	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.43	13.29	2.2E-37	Educational attainment	
BRCA	trans	1	rs3753242	chr1:2069681	DTD1	chr20:18568556-18744558:+	-0.34	-6	2.71E-9	Response to antipsychotic treatment in schizophrenia (reasoning)	
BRCA	trans	1	rs3816804	chr12:56680745	MAP1B	chr5:71403118-71505396:+	0.3	5.5	4.68E-8	Height	
BRCA	trans	1	rs3949112	chr11:55212093	FOLH1B	chr11:89392465-89431885:+	0.51	6.81	1.58E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs41005	chr2:8111231	S100A7A	chr1:153389000-153395701:+	0.17	5.51	4.56E-8	Response to anti-TNF therapy in rheumatoid arthritis	
BRCA	trans	1	rs41343448	chr8:20271413	CDCA2	chr8:25316513-25365425:+	0.18	5.46	5.92E-8	Preeclampsia	
BRCA	trans	1	rs41343448	chr8:20271413	CNOT7	chr8:17086740-17104387:-	0.3	5.63	2.29E-8	Preeclampsia	
BRCA	trans	1	rs41343448	chr8:20271413	ELP3	chr8:27947749-28048667:+	0.32	5.57	3.31E-8	Preeclampsia	
BRCA	trans	1	rs4272382	chr8:8433488	BNIP3L	chr8:26240523-26270644:+	-0.3	-5.58	3.09E-8	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4272382	chr8:8433488	CCDC25	chr8:27590835-27630170:-	-0.33	-5.6	2.72E-8	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4272382	chr8:8433488	CNOT7	chr8:17086740-17104387:-	-0.41	-7.34	4.13E-13	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4272382	chr8:8433488	INTS9	chr8:28625180-28747698:-	-0.32	-5.63	2.25E-8	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4272382	chr8:8433488	KIAA1967	chr8:22462257-22477981:+	-0.32	-5.58	3.09E-8	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4272382	chr8:8433488	MCPH1	chr8:6264121-6506025:+	-0.35	-5.89	5.19E-9	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4272382	chr8:8433488	MTMR9	chr8:11142000-11185652:+	-0.3	-5.97	3.32E-9	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4272382	chr8:8433488	PPP2R2A	chr8:25230075-26228645:+	-0.32	-5.64	2.23E-8	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4272382	chr8:8433488	REEP4	chr8:21995533-21999448:-	-0.28	-5.67	1.87E-8	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4272382	chr8:8433488	VPS37A	chr8:17104401-17155532:+	-0.32	-5.58	3.0E-8	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4272382	chr8:8433488	XPO7	chr8:21777180-21864095:+	-0.33	-5.94	3.88E-9	Response to cytidine analogues (gemcitabine)	
BRCA	trans	1	rs4316524	chr11:55159965	FOLH1B	chr11:89392465-89431885:+	-0.6	-7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs4341558	chr11:54869378	FOLH1B	chr11:89392465-89431885:+	0.53	6.69	3.56E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs4488212	chr11:55212096	FOLH1B	chr11:89392465-89431885:+	0.51	6.81	1.58E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs4517536	chr11:54900569	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.6E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs4537777	chr11:55241556	FOLH1B	chr11:89392465-89431885:+	0.5	6.56	8.16E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs466983	chr7:65520496	ZNF117	chr7:64434830-64467121:-	-0.31	-5.47	5.5E-8	Diabetic kidney disease	
BRCA	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.44	13.57	8.58E-39	Educational attainment	
BRCA	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.43	13.18	7.22E-37	Educational attainment	
BRCA	trans	1	rs4742269	chr9:6849317	HEPACAM2	chr7:92817900-92855782:-	0.31	5.47	5.51E-8	Radiation response	
BRCA	trans	1	rs4759229	chr12:56474480	RPS26P11	chrX:71264259-71264809:+	-0.36	-9.78	1.13E-21	Cognitive function	
BRCA	trans	1	rs4769671	chr13:29621461	CDC5L	chr6:44355302-44414779:+	0.36	5.49	5.09E-8	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
BRCA	trans	1	rs4844380	chr1:121193620	NBPF14	chr1:148003643-148346791:-	0.32	10.79	7.87E-26	Hip geometry	
BRCA	trans	1	rs4844381	chr1:121184898	NBPF14	chr1:148003643-148346791:-	0.3	10.18	2.76E-23	Hip geometry	
BRCA	trans	1	rs4844607	chr1:121184059	NBPF14	chr1:148003643-148346791:-	-0.3	-10.37	4.66E-24	Hip geometry	
BRCA	trans	1	rs4844616	chr1:121171208	NBPF14	chr1:148003643-148346791:-	0.3	10.38	4.08E-24	Hip geometry	
BRCA	trans	1	rs4853634	chr2:190779231	GSK3B	chr3:119540804-119813264:-	0.29	5.77	1.05E-8	Subcutaneous adipose tissue	
BRCA	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.44	13.26	2.78E-37	Educational attainment	
BRCA	trans	1	rs4881994	chr11:48498139	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.08	6.83E-23	HDL cholesterol	
BRCA	trans	1	rs4882010	chr11:48559173	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.95	2.35E-22	HDL cholesterol	
BRCA	trans	1	rs4882015	chr11:48565573	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.93	2.66E-22	HDL cholesterol	
BRCA	trans	1	rs4882016	chr11:48570125	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.03	1.08E-22	HDL cholesterol	
BRCA	trans	1	rs4882017	chr11:48570182	FOLH1B	chr11:89392465-89431885:+	0.36	9.9	3.6E-22	HDL cholesterol	
BRCA	trans	1	rs4882019	chr11:48598748	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.08	6.84E-23	HDL cholesterol	
BRCA	trans	1	rs4882021	chr11:48615966	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.88	4.43E-22	HDL cholesterol	
BRCA	trans	1	rs4882096	chr11:48534102	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.18	2.7E-23	HDL cholesterol	
BRCA	trans	1	rs4882111	chr11:48558447	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.97	1.9E-22	HDL cholesterol	
BRCA	trans	1	rs4882117	chr11:48565468	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.93	2.66E-22	HDL cholesterol	
BRCA	trans	1	rs4882120	chr11:48573529	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.04	1.04E-22	HDL cholesterol	
BRCA	trans	1	rs4882123	chr11:48575739	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.04	1.04E-22	HDL cholesterol	
BRCA	trans	1	rs4882129	chr11:48588774	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.94	2.57E-22	HDL cholesterol	
BRCA	trans	1	rs4882130	chr11:48588954	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.94	2.57E-22	HDL cholesterol	
BRCA	trans	1	rs4882132	chr11:48593125	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.57	6.85E-21	HDL cholesterol	
BRCA	trans	1	rs4882134	chr11:48598795	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.08	6.84E-23	HDL cholesterol	
BRCA	trans	1	rs4882136	chr11:48615311	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.98	1.73E-22	HDL cholesterol	
BRCA	trans	1	rs488213	chr11:55271407	FOLH1B	chr11:89392465-89431885:+	0.4	5.95	3.69E-9	Systemic lupus erythematosus	
BRCA	trans	1	rs490049	chr13:33564863	AKAP11	chr13:42846289-42897402:+	0.26	5.62	2.43E-8	Diabetic kidney disease	
BRCA	trans	1	rs490049	chr13:33564863	ALG5	chr13:37523910-37573504:-	0.41	5.85	6.47E-9	Diabetic kidney disease	
BRCA	trans	1	rs490049	chr13:33564863	COG6	chr13:40229764-40365802:+	0.35	5.5	4.63E-8	Diabetic kidney disease	
BRCA	trans	1	rs490049	chr13:33564863	EXOSC8	chr13:37574678-37583749:+	0.38	6.22	7.15E-10	Diabetic kidney disease	
BRCA	trans	1	rs490049	chr13:33564863	FAM48A	chr13:37583453-37633850:-	0.37	5.68	1.7E-8	Diabetic kidney disease	
BRCA	trans	1	rs490049	chr13:33564863	KBTBD7	chr13:41765711-41768702:-	0.29	5.74	1.23E-8	Diabetic kidney disease	
BRCA	trans	1	rs490049	chr13:33564863	MRP63	chr13:21750372-21753218:+	0.35	5.92	4.35E-9	Diabetic kidney disease	
BRCA	trans	1	rs490049	chr13:33564863	MRPS31	chr13:41303433-41345347:-	0.39	5.59	2.92E-8	Diabetic kidney disease	
BRCA	trans	1	rs490049	chr13:33564863	SLC25A15	chr13:41363547-41386595:+	0.39	5.49	4.99E-8	Diabetic kidney disease	
BRCA	trans	1	rs490049	chr13:33564863	UFM1	chr13:38923942-38937142:+	0.38	5.57	3.25E-8	Diabetic kidney disease	
BRCA	trans	1	rs492647	chr11:55253629	FOLH1B	chr11:89392465-89431885:+	0.47	6.48	1.42E-10	Systemic lupus erythematosus	
BRCA	trans	1	rs4929903	chr11:48913332	FOLH1B	chr11:89392465-89431885:+	-0.32	-8.59	3.01E-17	HDL cholesterol	
BRCA	trans	1	rs4942487	chr13:46709389	C13orf23	chr13:39584003-39612252:-	-0.25	-5.61	2.54E-8	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	CDC16	chr13:115000362-115038150:+	-0.3	-5.6	2.69E-8	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	COG6	chr13:40229764-40365802:+	-0.28	-6.34	3.3E-10	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	DIS3	chr13:73329542-73356344:-	-0.25	-5.53	3.92E-8	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	ELF1	chr13:41506056-41593508:-	-0.23	-5.89	5.05E-9	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	EXOSC8	chr13:37574678-37583749:+	-0.24	-5.66	1.97E-8	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	FAM48A	chr13:37583453-37633850:-	-0.27	-5.96	3.32E-9	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	FNDC3A	chr13:49550048-49783914:+	-0.2	-5.65	2.02E-8	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	INTS6	chr13:51935702-52027275:-	-0.27	-6.1	1.48E-9	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	KBTBD7	chr13:41765711-41768702:-	-0.21	-6.01	2.48E-9	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	KIAA1704	chr13:45563687-45607742:+	-0.28	-6.1	1.52E-9	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	KPNA3	chr13:50273443-50367057:-	-0.22	-5.66	1.98E-8	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	MED4	chr13:48627462-48669251:-	-0.33	-6.58	7.21E-11	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	MTRF1	chr13:41790517-41837742:-	-0.27	-5.54	3.85E-8	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	NAA16	chr13:41885341-41951166:+	-0.27	-5.95	3.72E-9	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	NEK3	chr13:52706780-52733996:-	-0.32	-6.1	1.45E-9	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	NUFIP1	chr13:45513384-45563613:-	-0.28	-5.51	4.4E-8	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	RBM26	chr13:79894100-79979923:-	-0.24	-5.74	1.23E-8	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	SUCLA2	chr13:48516792-48612125:-	-0.3	-6.31	3.98E-10	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	SUGT1	chr13:53226831-53262433:+	-0.3	-6.27	5.35E-10	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	TDRD3	chr13:60970591-61148012:+	-0.33	-6.48	1.44E-10	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	THSD1P1	chr13:52741847-52865680:-	-0.24	-5.75	1.17E-8	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	UTP14C	chr13:52586550-52607734:+	-0.25	-7.1	2.32E-12	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4942487	chr13:46709389	VPS36	chr13:52986739-53024763:-	-0.31	-6.77	2.11E-11	Non-alcoholic fatty liver disease histology (other)	
BRCA	trans	1	rs4970948	chr1:151291243	PIPSL	chr10:95717897-95721672:-	0.24	7.37	3.34E-13	Gut microbiota (functional units)	
BRCA	trans	1	rs5022636	chr1:151295061	PIPSL	chr10:95717897-95721672:-	0.24	7.42	2.31E-13	Gut microbiota (functional units)	
BRCA	trans	1	rs5025344	chr11:55225024	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs505338	chr11:55320583	FOLH1B	chr11:89392465-89431885:+	-0.5	-6.63	5.2E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs508970	chr11:60906450	MRPS36	chr5:68513573-68525983:+	-0.16	-5.7	1.55E-8	Rheumatoid arthritis	
BRCA	trans	1	rs530679	chr11:55271372	FOLH1B	chr11:89392465-89431885:+	0.48	6.72	2.98E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs531971	chr11:55259583	FOLH1B	chr11:89392465-89431885:+	0.48	6.56	8.47E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs548768	chr11:55269362	FOLH1B	chr11:89392465-89431885:+	0.48	6.67	4.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs554821	chr18:322183	SCNM1	chr1:151138517-151141612:+	-0.14	-5.54	3.89E-8	Obesity-related traits	
BRCA	trans	1	rs55636526	chr11:55341726	FOLH1B	chr11:89392465-89431885:+	0.57	7.25	7.87E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55637752	chr11:54838621	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55647117	chr11:55340896	FOLH1B	chr11:89392465-89431885:+	0.52	7.03	3.75E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55654725	chr11:55331229	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.63E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55657388	chr11:55203117	FOLH1B	chr11:89392465-89431885:+	0.52	6.92	7.89E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55657490	chr11:55195818	FOLH1B	chr11:89392465-89431885:+	0.51	6.89	9.38E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55663900	chr11:54800112	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55667318	chr11:55210291	FOLH1B	chr11:89392465-89431885:+	0.6	7.52	1.13E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55669714	chr11:55362393	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55675343	chr11:55302662	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.66E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55686425	chr11:55297270	FOLH1B	chr11:89392465-89431885:+	0.59	7.41	2.54E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55693437	chr11:54839081	FOLH1B	chr11:89392465-89431885:+	0.51	6.71	3.09E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs55696537	chr11:55264605	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55705038	chr11:55302497	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.66E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55708507	chr11:55341154	FOLH1B	chr11:89392465-89431885:+	0.57	7.27	7.05E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55716293	chr11:55134486	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55720733	chr11:55352466	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55721957	chr11:55080847	FOLH1B	chr11:89392465-89431885:+	0.56	7.24	8.58E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55736192	chr11:55241123	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs55744313	chr11:54872326	FOLH1B	chr11:89392465-89431885:+	0.53	6.69	3.56E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs55770365	chr11:55276880	FOLH1B	chr11:89392465-89431885:+	0.57	7.23	9.07E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55775069	chr11:55197656	FOLH1B	chr11:89392465-89431885:+	0.6	7.55	9.36E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs55791965	chr11:55132659	FOLH1B	chr11:89392465-89431885:+	0.54	7.05	3.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55828496	chr11:55321661	FOLH1B	chr11:89392465-89431885:+	0.57	7.26	7.29E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55833102	chr11:55512176	FOLH1B	chr11:89392465-89431885:+	0.55	6.85	1.23E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs55834832	chr11:48562583	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.87	4.77E-22	HDL cholesterol	
BRCA	trans	1	rs55837706	chr11:55142112	FOLH1B	chr11:89392465-89431885:+	0.6	7.44	2.09E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55853559	chr11:55289338	FOLH1B	chr11:89392465-89431885:+	0.54	7.11	2.17E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55854157	chr11:55192464	FOLH1B	chr11:89392465-89431885:+	0.6	7.32	4.84E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55864866	chr11:55134895	FOLH1B	chr11:89392465-89431885:+	0.54	7.05	3.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55869276	chr11:55316412	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55881253	chr11:55310743	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55884431	chr11:55151822	FOLH1B	chr11:89392465-89431885:+	0.61	7.5	1.34E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55889092	chr11:55192872	FOLH1B	chr11:89392465-89431885:+	0.6	7.32	4.84E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55895944	chr11:55241716	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs55899800	chr11:54810250	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs55900934	chr11:55065607	FOLH1B	chr11:89392465-89431885:+	0.61	7.55	9.05E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs55902215	chr11:55352483	FOLH1B	chr11:89392465-89431885:+	0.56	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55912300	chr11:55297127	FOLH1B	chr11:89392465-89431885:+	0.59	7.41	2.54E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs55917312	chr11:55180056	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs55959477	chr11:55352289	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55967107	chr11:55305619	FOLH1B	chr11:89392465-89431885:+	0.51	6.82	1.48E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs55972122	chr11:55320834	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs55993784	chr11:55195873	FOLH1B	chr11:89392465-89431885:+	0.6	7.55	9.36E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs55999106	chr11:55257965	FOLH1B	chr11:89392465-89431885:+	0.58	7.09	2.45E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56037431	chr11:55296074	FOLH1B	chr11:89392465-89431885:+	0.54	7.12	2.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56045005	chr11:55257798	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56053002	chr11:55085327	FOLH1B	chr11:89392465-89431885:+	0.56	7.24	8.58E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs56055236	chr11:55192754	FOLH1B	chr11:89392465-89431885:+	0.6	7.32	4.84E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs56056425	chr11:55352227	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56058343	chr11:55362428	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56063920	chr11:55326249	FOLH1B	chr11:89392465-89431885:+	0.52	7.01	4.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56063922	chr11:55272853	FOLH1B	chr11:89392465-89431885:+	0.51	6.81	1.6E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs56068831	chr11:55045363	FOLH1B	chr11:89392465-89431885:+	0.57	7.33	4.63E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs56073785	chr11:55302673	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.66E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56078420	chr11:55189969	FOLH1B	chr11:89392465-89431885:+	0.52	6.86	1.19E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs56080803	chr11:54821372	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs56082718	chr11:55296318	FOLH1B	chr11:89392465-89431885:+	0.59	7.41	2.54E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs56098095	chr11:55289413	FOLH1B	chr11:89392465-89431885:+	0.54	7.11	2.17E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56101935	chr11:55096089	FOLH1B	chr11:89392465-89431885:+	0.56	7.24	8.58E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs56118676	chr11:55341735	FOLH1B	chr11:89392465-89431885:+	0.57	7.25	7.87E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs56127747	chr11:55337259	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs56131310	chr11:55156065	FOLH1B	chr11:89392465-89431885:+	0.53	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56147666	chr11:55210551	FOLH1B	chr11:89392465-89431885:+	0.53	7.13	1.81E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56148636	chr11:55195800	FOLH1B	chr11:89392465-89431885:+	0.52	7.01	4.36E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56152577	chr11:55307780	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56160445	chr11:55155815	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs56182407	chr11:55155797	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs56182790	chr11:54799991	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56184662	chr11:55180816	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs56189573	chr11:54810461	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs56190422	chr11:55202643	FOLH1B	chr11:89392465-89431885:+	0.61	7.5	1.31E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs56229188	chr11:55081098	FOLH1B	chr11:89392465-89431885:+	0.54	7.09	2.47E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56234219	chr11:54866274	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56254109	chr11:55305615	FOLH1B	chr11:89392465-89431885:+	0.51	6.82	1.48E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs56266612	chr11:55304962	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56291726	chr11:55210585	FOLH1B	chr11:89392465-89431885:+	0.55	7.25	7.87E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs56299119	chr11:55328348	FOLH1B	chr11:89392465-89431885:+	0.52	7.01	4.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56333107	chr11:55314754	FOLH1B	chr11:89392465-89431885:+	0.51	6.93	7.5E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56381852	chr11:55264455	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56400349	chr11:55435962	FOLH1B	chr11:89392465-89431885:+	0.58	7.1	2.27E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56406459	chr11:55160340	FOLH1B	chr11:89392465-89431885:+	0.53	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs56410859	chr11:55193186	FOLH1B	chr11:89392465-89431885:+	0.6	7.32	4.84E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs5743112	chr2:190708982	GSK3B	chr3:119540804-119813264:-	0.29	5.62	2.43E-8	Subcutaneous adipose tissue	
BRCA	trans	1	rs5743117	chr2:190714245	GSK3B	chr3:119540804-119813264:-	0.29	5.74	1.27E-8	Subcutaneous adipose tissue	
BRCA	trans	1	rs5743208	chr2:190743048	GSK3B	chr3:119540804-119813264:-	-0.27	-5.5	4.68E-8	Subcutaneous adipose tissue	
BRCA	trans	1	rs5743208	chr2:190743048	SNX4	chr3:125165495-125239058:-	-0.33	-5.55	3.58E-8	Subcutaneous adipose tissue	
BRCA	trans	1	rs58865519	chr10:46010891	AGAP8	chr10:51224690-51371331:-	0.22	5.58	3.13E-8	HDL cholesterol;Cholesterol, total	
BRCA	trans	1	rs58893672	chr11:55308305	FOLH1B	chr11:89392465-89431885:+	0.51	6.89	9.69E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894220	chr11:55343454	FOLH1B	chr11:89392465-89431885:+	0.57	7.25	7.87E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61894221	chr11:55343809	FOLH1B	chr11:89392465-89431885:+	0.57	7.25	7.87E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61894222	chr11:55344293	FOLH1B	chr11:89392465-89431885:+	0.57	7.25	7.9E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61894224	chr11:55344825	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.01E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894225	chr11:55344928	FOLH1B	chr11:89392465-89431885:+	0.51	6.8	1.7E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61894241	chr11:55351097	FOLH1B	chr11:89392465-89431885:+	0.56	7.01	4.1E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894242	chr11:55351153	FOLH1B	chr11:89392465-89431885:+	0.56	7.01	4.1E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894243	chr11:55351244	FOLH1B	chr11:89392465-89431885:+	0.56	7.01	4.1E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894244	chr11:55351528	FOLH1B	chr11:89392465-89431885:+	0.56	7.01	4.1E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894245	chr11:55351631	FOLH1B	chr11:89392465-89431885:+	0.51	6.8	1.75E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61894765	chr11:55460012	FOLH1B	chr11:89392465-89431885:+	0.58	7.09	2.48E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894766	chr11:55462473	FOLH1B	chr11:89392465-89431885:+	0.58	7.09	2.48E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894769	chr11:55465984	FOLH1B	chr11:89392465-89431885:+	0.57	6.93	7.35E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894770	chr11:55469059	FOLH1B	chr11:89392465-89431885:+	0.57	6.93	7.35E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894771	chr11:55469143	FOLH1B	chr11:89392465-89431885:+	0.57	6.93	7.35E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894774	chr11:55478092	FOLH1B	chr11:89392465-89431885:+	0.57	7.08	2.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894789	chr11:55486919	FOLH1B	chr11:89392465-89431885:+	0.57	7.14	1.78E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894790	chr11:55488052	FOLH1B	chr11:89392465-89431885:+	0.57	7.14	1.78E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894792	chr11:55498659	FOLH1B	chr11:89392465-89431885:+	0.54	6.64	4.87E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61894793	chr11:55500102	FOLH1B	chr11:89392465-89431885:+	0.54	6.68	3.92E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61894794	chr11:55502938	FOLH1B	chr11:89392465-89431885:+	0.54	6.68	3.92E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61894797	chr11:55514318	FOLH1B	chr11:89392465-89431885:+	0.54	6.67	4.13E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61894847	chr11:55530776	FOLH1B	chr11:89392465-89431885:+	0.56	6.84	1.34E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61894851	chr11:55537356	FOLH1B	chr11:89392465-89431885:+	0.56	6.95	6.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894852	chr11:55537513	FOLH1B	chr11:89392465-89431885:+	0.56	6.95	6.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894853	chr11:55538625	FOLH1B	chr11:89392465-89431885:+	0.56	6.95	6.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894854	chr11:55548453	FOLH1B	chr11:89392465-89431885:+	0.55	6.9	9.01E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894856	chr11:55550232	FOLH1B	chr11:89392465-89431885:+	0.54	6.77	2.07E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61894885	chr11:55031130	FOLH1B	chr11:89392465-89431885:+	0.53	7	4.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61894895	chr11:55037442	FOLH1B	chr11:89392465-89431885:+	0.6	7.45	1.99E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61894909	chr11:55044269	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.27E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61894946	chr11:55046877	FOLH1B	chr11:89392465-89431885:+	0.57	7.35	3.81E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61894947	chr11:55047032	FOLH1B	chr11:89392465-89431885:+	0.57	7.35	3.81E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61894948	chr11:55047047	FOLH1B	chr11:89392465-89431885:+	0.57	7.35	3.81E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61895191	chr11:55352786	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895192	chr11:55354108	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895193	chr11:55354239	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895194	chr11:55354435	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895195	chr11:55354636	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895196	chr11:55355308	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895197	chr11:55355735	FOLH1B	chr11:89392465-89431885:+	0.56	7.03	3.79E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895199	chr11:55356496	FOLH1B	chr11:89392465-89431885:+	0.56	7.02	4.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895200	chr11:55357348	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895201	chr11:55358164	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895202	chr11:55358456	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895203	chr11:55359728	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895204	chr11:55359925	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895206	chr11:55362587	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895207	chr11:55362826	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895804	chr11:54798190	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895808	chr11:54802000	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895817	chr11:54804311	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895825	chr11:54808326	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61895829	chr11:54810489	FOLH1B	chr11:89392465-89431885:+	0.5	6.6	6.39E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61895830	chr11:54810605	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895833	chr11:54812147	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895834	chr11:54812253	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895838	chr11:54819428	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61895839	chr11:54820200	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895859	chr11:54828661	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895863	chr11:54901372	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.6E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61895962	chr11:55050596	FOLH1B	chr11:89392465-89431885:+	0.61	7.55	9.62E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61895965	chr11:55053732	FOLH1B	chr11:89392465-89431885:+	0.61	7.55	9.62E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61895971	chr11:55057172	FOLH1B	chr11:89392465-89431885:+	0.61	7.55	9.62E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61895978	chr11:55059965	FOLH1B	chr11:89392465-89431885:+	0.61	7.55	9.62E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61896026	chr11:55071382	FOLH1B	chr11:89392465-89431885:+	0.54	7.04	3.35E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61896307	chr11:55560426	FOLH1B	chr11:89392465-89431885:+	0.54	6.77	2.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61896308	chr11:55560483	FOLH1B	chr11:89392465-89431885:+	0.54	6.77	2.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61896309	chr11:55563761	FOLH1B	chr11:89392465-89431885:+	0.54	6.77	2.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61896310	chr11:55563846	FOLH1B	chr11:89392465-89431885:+	0.54	6.77	2.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61896311	chr11:55567208	FOLH1B	chr11:89392465-89431885:+	0.55	6.95	6.47E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61896312	chr11:55572698	FOLH1B	chr11:89392465-89431885:+	0.56	7.07	2.88E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61896314	chr11:55573704	FOLH1B	chr11:89392465-89431885:+	0.57	7.12	1.95E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61896315	chr11:55575952	FOLH1B	chr11:89392465-89431885:+	0.57	7.12	1.95E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61896316	chr11:55576553	FOLH1B	chr11:89392465-89431885:+	0.57	7.12	1.95E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61896320	chr11:55580588	FOLH1B	chr11:89392465-89431885:+	0.57	7.12	1.95E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61897266	chr11:54931514	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61897286	chr11:54943203	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61897323	chr11:54955299	FOLH1B	chr11:89392465-89431885:+	0.58	6.94	6.78E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898060	chr11:54830021	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898061	chr11:54830100	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898062	chr11:54830140	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61898066	chr11:54833565	FOLH1B	chr11:89392465-89431885:+	0.49	6.74	2.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61898073	chr11:54840287	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61898074	chr11:54842180	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61898076	chr11:54847536	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61898077	chr11:54849654	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898110	chr11:54858537	FOLH1B	chr11:89392465-89431885:+	0.54	7.04	3.35E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898112	chr11:54859595	FOLH1B	chr11:89392465-89431885:+	0.53	6.69	3.56E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61898116	chr11:54863390	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898130	chr11:54866139	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898135	chr11:54873017	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.6E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898136	chr11:54873052	FOLH1B	chr11:89392465-89431885:+	0.53	6.69	3.56E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61898140	chr11:54875529	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898141	chr11:54875569	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898148	chr11:54880614	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.6E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898149	chr11:54880953	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61898150	chr11:54881308	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.6E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916162	chr11:55114797	FOLH1B	chr11:89392465-89431885:+	0.56	7.17	1.39E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916164	chr11:55115800	FOLH1B	chr11:89392465-89431885:+	0.56	7.17	1.39E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916165	chr11:55116113	FOLH1B	chr11:89392465-89431885:+	0.56	7.17	1.39E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916166	chr11:55116451	FOLH1B	chr11:89392465-89431885:+	0.56	7.17	1.39E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916169	chr11:55121453	FOLH1B	chr11:89392465-89431885:+	0.53	7.05	3.3E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916170	chr11:55121885	FOLH1B	chr11:89392465-89431885:+	0.53	7.05	3.3E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916171	chr11:55122112	FOLH1B	chr11:89392465-89431885:+	0.6	7.42	2.31E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916172	chr11:55122789	FOLH1B	chr11:89392465-89431885:+	0.53	7.05	3.3E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916173	chr11:55123586	FOLH1B	chr11:89392465-89431885:+	0.56	7.24	8.34E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916174	chr11:55123610	FOLH1B	chr11:89392465-89431885:+	0.53	7.05	3.3E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916175	chr11:55124088	FOLH1B	chr11:89392465-89431885:+	0.56	7.24	8.34E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916177	chr11:55125502	FOLH1B	chr11:89392465-89431885:+	0.6	7.42	2.31E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916184	chr11:55135689	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916211	chr11:55138710	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916212	chr11:55142024	FOLH1B	chr11:89392465-89431885:+	0.53	6.95	6.19E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916218	chr11:55148269	FOLH1B	chr11:89392465-89431885:+	0.53	6.96	6.12E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916219	chr11:55148723	FOLH1B	chr11:89392465-89431885:+	0.53	6.96	5.78E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916222	chr11:55152788	FOLH1B	chr11:89392465-89431885:+	0.53	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916223	chr11:55153050	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61916229	chr11:55156124	FOLH1B	chr11:89392465-89431885:+	0.53	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916231	chr11:55156941	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61916282	chr11:55268646	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61916283	chr11:55271200	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61916284	chr11:55271500	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61916285	chr11:55271681	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61916286	chr11:55271699	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916289	chr11:55274279	FOLH1B	chr11:89392465-89431885:+	0.51	6.81	1.6E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61916290	chr11:55274688	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916297	chr11:55279382	FOLH1B	chr11:89392465-89431885:+	0.58	7.36	3.73E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916299	chr11:55281175	FOLH1B	chr11:89392465-89431885:+	0.58	7.36	3.73E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916300	chr11:55281198	FOLH1B	chr11:89392465-89431885:+	0.53	7.07	2.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916301	chr11:55281391	FOLH1B	chr11:89392465-89431885:+	0.53	7.07	2.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916302	chr11:55281667	FOLH1B	chr11:89392465-89431885:+	0.53	7.07	2.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916319	chr11:55282118	FOLH1B	chr11:89392465-89431885:+	0.53	7.07	2.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916320	chr11:55282293	FOLH1B	chr11:89392465-89431885:+	0.58	7.36	3.73E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916321	chr11:55282371	FOLH1B	chr11:89392465-89431885:+	0.58	7.36	3.73E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916322	chr11:55282687	FOLH1B	chr11:89392465-89431885:+	0.58	7.36	3.73E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916349	chr11:55290219	FOLH1B	chr11:89392465-89431885:+	0.54	7.12	2.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916351	chr11:55290727	FOLH1B	chr11:89392465-89431885:+	0.59	7.41	2.54E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916362	chr11:55207383	FOLH1B	chr11:89392465-89431885:+	0.59	7.42	2.44E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916374	chr11:55210942	FOLH1B	chr11:89392465-89431885:+	0.52	6.91	8.5E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916375	chr11:55211015	FOLH1B	chr11:89392465-89431885:+	0.59	7.29	6.03E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916376	chr11:55211925	FOLH1B	chr11:89392465-89431885:+	0.58	7.18	1.27E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916395	chr11:55212505	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61916396	chr11:55212611	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916398	chr11:55216248	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916400	chr11:55218146	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916402	chr11:55219714	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916403	chr11:55221229	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61916404	chr11:55221576	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916405	chr11:55221776	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916407	chr11:55222470	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61916410	chr11:55224869	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61916411	chr11:55224905	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916453	chr11:55233726	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916457	chr11:55234186	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61916458	chr11:55234406	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61916561	chr11:55336203	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916562	chr11:55336207	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916563	chr11:55337027	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916564	chr11:55337782	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916565	chr11:55338095	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916566	chr11:55338435	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916567	chr11:55339242	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61916568	chr11:55340170	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61917375	chr11:55159324	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917376	chr11:55159677	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917377	chr11:55160040	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917378	chr11:55160192	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917395	chr11:55167773	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917397	chr11:55168405	FOLH1B	chr11:89392465-89431885:+	0.64	7.72	2.66E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917398	chr11:55170016	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917404	chr11:55172653	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917431	chr11:55172955	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917432	chr11:55173049	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917433	chr11:55173059	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917438	chr11:55174980	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917439	chr11:55175027	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917451	chr11:55182769	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917452	chr11:55183007	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.82E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917453	chr11:55183429	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.82E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917454	chr11:55183543	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917455	chr11:55183705	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917456	chr11:55183753	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.82E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917457	chr11:55183759	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917458	chr11:55184196	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61917459	chr11:55184664	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.79E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917884	chr11:55294244	FOLH1B	chr11:89392465-89431885:+	0.54	7.12	2.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917891	chr11:55295283	FOLH1B	chr11:89392465-89431885:+	0.59	7.41	2.54E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61917892	chr11:55295969	FOLH1B	chr11:89392465-89431885:+	0.54	7.12	2.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917897	chr11:55298533	FOLH1B	chr11:89392465-89431885:+	0.6	7.45	1.96E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61917926	chr11:55305160	FOLH1B	chr11:89392465-89431885:+	0.51	6.9	9.18E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917927	chr11:55305170	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917936	chr11:55311417	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917939	chr11:55312619	FOLH1B	chr11:89392465-89431885:+	0.51	6.9	9.18E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917940	chr11:55313406	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917941	chr11:55314405	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917958	chr11:55318492	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917959	chr11:55318782	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917963	chr11:55235759	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61917983	chr11:55235812	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917984	chr11:55237729	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917991	chr11:55240980	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917993	chr11:55242015	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917994	chr11:55242085	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917995	chr11:55242459	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917996	chr11:55242556	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917997	chr11:55242726	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917998	chr11:55243250	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61917999	chr11:55243696	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61918001	chr11:55246041	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61918002	chr11:55246517	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.21E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918003	chr11:55247690	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918004	chr11:55248982	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918005	chr11:55249242	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918007	chr11:55249435	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918008	chr11:55249484	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61918160	chr11:55184667	FOLH1B	chr11:89392465-89431885:+	0.61	7.51	1.25E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918207	chr11:55185232	FOLH1B	chr11:89392465-89431885:+	0.52	6.86	1.16E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918208	chr11:55185449	FOLH1B	chr11:89392465-89431885:+	0.52	6.86	1.16E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918210	chr11:55187431	FOLH1B	chr11:89392465-89431885:+	0.52	6.85	1.21E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918212	chr11:55187947	FOLH1B	chr11:89392465-89431885:+	0.6	7.37	3.41E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918213	chr11:55187973	FOLH1B	chr11:89392465-89431885:+	0.6	7.37	3.41E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918214	chr11:55188031	FOLH1B	chr11:89392465-89431885:+	0.52	6.85	1.21E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918217	chr11:55188818	FOLH1B	chr11:89392465-89431885:+	0.6	7.37	3.41E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918218	chr11:55189675	FOLH1B	chr11:89392465-89431885:+	0.52	6.86	1.19E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918219	chr11:55189833	FOLH1B	chr11:89392465-89431885:+	0.52	6.86	1.19E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918221	chr11:55190708	FOLH1B	chr11:89392465-89431885:+	0.52	6.86	1.19E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61918222	chr11:55191116	FOLH1B	chr11:89392465-89431885:+	0.6	7.37	3.41E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918227	chr11:55193679	FOLH1B	chr11:89392465-89431885:+	0.6	7.32	4.84E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918228	chr11:55194403	FOLH1B	chr11:89392465-89431885:+	0.6	7.55	9.36E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs61918233	chr11:55196983	FOLH1B	chr11:89392465-89431885:+	0.52	7.01	4.36E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61918236	chr11:55198427	FOLH1B	chr11:89392465-89431885:+	0.6	7.52	1.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918251	chr11:55199875	FOLH1B	chr11:89392465-89431885:+	0.6	7.49	1.45E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918253	chr11:55201447	FOLH1B	chr11:89392465-89431885:+	0.52	6.9	8.89E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61918254	chr11:55202417	FOLH1B	chr11:89392465-89431885:+	0.61	7.5	1.31E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918258	chr11:55205398	FOLH1B	chr11:89392465-89431885:+	0.53	7.04	3.44E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61918259	chr11:55205578	FOLH1B	chr11:89392465-89431885:+	0.53	7.05	3.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61918369	chr11:55072772	FOLH1B	chr11:89392465-89431885:+	0.61	7.47	1.7E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918380	chr11:55079317	FOLH1B	chr11:89392465-89431885:+	0.61	7.47	1.7E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918383	chr11:55081930	FOLH1B	chr11:89392465-89431885:+	0.61	7.47	1.7E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918384	chr11:55082332	FOLH1B	chr11:89392465-89431885:+	0.61	7.47	1.7E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918385	chr11:55082859	FOLH1B	chr11:89392465-89431885:+	0.61	7.47	1.7E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918386	chr11:55084367	FOLH1B	chr11:89392465-89431885:+	0.54	7.09	2.38E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61918390	chr11:55091147	FOLH1B	chr11:89392465-89431885:+	0.56	7.24	8.58E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61918407	chr11:55107504	FOLH1B	chr11:89392465-89431885:+	0.54	7.08	2.57E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61918410	chr11:55109560	FOLH1B	chr11:89392465-89431885:+	0.54	7.08	2.57E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61919260	chr11:55205628	FOLH1B	chr11:89392465-89431885:+	0.59	7.42	2.44E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919565	chr11:55319985	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61919569	chr11:55322464	FOLH1B	chr11:89392465-89431885:+	0.57	7.26	7.23E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919570	chr11:55322490	FOLH1B	chr11:89392465-89431885:+	0.57	7.26	7.23E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919571	chr11:55322902	FOLH1B	chr11:89392465-89431885:+	0.57	7.26	7.23E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919573	chr11:55323347	FOLH1B	chr11:89392465-89431885:+	0.57	7.26	7.23E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919574	chr11:55324704	FOLH1B	chr11:89392465-89431885:+	0.59	7.42	2.35E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919575	chr11:55324862	FOLH1B	chr11:89392465-89431885:+	0.59	7.42	2.35E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919576	chr11:55324892	FOLH1B	chr11:89392465-89431885:+	0.52	7.01	4.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61919578	chr11:55326379	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919579	chr11:55326454	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919580	chr11:55326458	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919581	chr11:55327662	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919583	chr11:55328053	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919585	chr11:55328400	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919586	chr11:55328550	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919587	chr11:55328906	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919613	chr11:55329105	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919614	chr11:55329211	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919616	chr11:55330088	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919618	chr11:55332687	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919619	chr11:55333285	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919620	chr11:55333439	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919621	chr11:55333613	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919622	chr11:55333895	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919623	chr11:55334105	FOLH1B	chr11:89392465-89431885:+	0.55	7.28	6.62E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919624	chr11:55334179	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919672	chr11:55249834	FOLH1B	chr11:89392465-89431885:+	0.5	6.57	7.86E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61919673	chr11:55250375	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61919674	chr11:55250427	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61919675	chr11:55250549	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61919676	chr11:55254115	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61919677	chr11:55254510	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61919678	chr11:55255320	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61919681	chr11:55258063	FOLH1B	chr11:89392465-89431885:+	0.58	7.09	2.45E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61919682	chr11:55258253	FOLH1B	chr11:89392465-89431885:+	0.51	6.67	4.11E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61919683	chr11:55258709	FOLH1B	chr11:89392465-89431885:+	0.57	7.03	3.66E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61919684	chr11:55259945	FOLH1B	chr11:89392465-89431885:+	0.51	6.67	4.11E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61919686	chr11:55262910	FOLH1B	chr11:89392465-89431885:+	0.58	7.22	9.81E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919688	chr11:55263224	FOLH1B	chr11:89392465-89431885:+	0.58	7.22	9.81E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs61919689	chr11:55263948	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs61919690	chr11:55264851	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs61919691	chr11:55265214	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs621636	chr18:322522	SCNM1	chr1:151138517-151141612:+	0.15	5.59	2.92E-8	Obesity-related traits	
BRCA	trans	1	rs639903	chr11:55252425	FOLH1B	chr11:89392465-89431885:+	0.47	6.47	1.46E-10	Systemic lupus erythematosus	
BRCA	trans	1	rs641862	chr13:110790232	A2LD1	chr13:101182437-101241046:-	0.44	6.35	3.27E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ABHD13	chr13:108870763-108886602:+	0.58	10.63	3.66E-25	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ADPRHL1	chr13:114076260-114107839:-	0.45	6.85	1.28E-11	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	AKAP11	chr13:42846289-42897402:+	0.28	6.86	1.2E-11	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ALG11	chr13:52586550-52591849:+	0.41	6.28	4.78E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ARGLU1	chr13:107195664-107220514:-	0.52	11.68	9.57E-30	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	BIVM	chr13:103451399-103493887:+	0.43	7.07	2.76E-12	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	C13orf1	chr13:50486842-50510625:-	0.39	6.46	1.64E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	C13orf23	chr13:39584003-39612252:-	0.4	7.13	1.81E-12	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	C13orf27	chr13:103418465-103426149:-	0.46	9.32	6.49E-20	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	C13orf34	chr13:73302042-73330328:+	0.42	8.52	5.58E-17	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	C13orf37	chr13:73282495-73301938:-	0.41	6.94	6.85E-12	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	C2orf69	chr2:200775979-200792994:+	-0.29	-5.52	4.31E-8	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	CAB39L	chr13:49882787-50018221:-	0.33	5.67	1.83E-8	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	CDC16	chr13:115000362-115038150:+	0.77	12.03	2.43E-31	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	CKAP2	chr13:53029495-53050763:+	0.3	6.17	9.53E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	CLN5	chr13:77566059-77576651:+	0.39	6.53	1.02E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	COG3	chr13:46039071-46110759:+	0.51	9.07	5.53E-19	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	COG6	chr13:40229764-40365802:+	0.4	7.27	6.77E-13	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	COMMD6	chr13:76099350-76112938:-	0.38	7.99	3.38E-15	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	CUL4A	chr13:113863086-113919391:+	0.73	11.59	2.34E-29	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	DCUN1D2	chr13:114110134-114145023:-	0.58	9.77	1.14E-21	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	DHRS12	chr13:52342131-52378293:-	0.32	6.02	2.45E-9	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	DIS3	chr13:73329542-73356344:-	0.53	9.69	2.48E-21	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	DNAJC3	chr13:96329402-96447241:+	0.53	10.12	4.92E-23	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	DOCK9	chr13:99445741-99738660:-	0.28	5.79	9.29E-9	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	EBPL	chr13:50234811-50265623:-	0.39	7.22	1.01E-12	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	EFHA1	chr13:22066840-22178307:-	0.36	5.98	2.96E-9	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ELF1	chr13:41506056-41593508:-	0.36	7.59	7.09E-14	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ERCC5	chr13:103459496-103528345:+	0.66	10.96	1.42E-26	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ESD	chr13:47345392-47371367:-	0.44	7.51	1.2E-13	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	FAM48A	chr13:37583453-37633850:-	0.38	6.72	2.9E-11	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	FARP1	chr13:98794816-99102016:+	0.36	5.73	1.34E-8	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	FBXL3	chr13:77579390-77601331:-	0.4	8.11	1.36E-15	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	FNDC3A	chr13:49550048-49783914:+	0.33	7.46	1.85E-13	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	GPR180	chr13:95254104-95281944:+	0.35	6.91	8.29E-12	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	GRTP1	chr13:113978506-114018463:-	0.49	8.42	1.22E-16	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	GTF2F2	chr13:45694631-45858237:+	0.48	7.89	7.41E-15	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	GTF3A	chr13:27998681-28009846:+	0.33	6.18	9.09E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	IFT88	chr13:21141208-21265574:+	0.28	5.55	3.66E-8	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	INTS6	chr13:51935702-52027275:-	0.42	7.66	4.27E-14	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	IPO5	chr13:98605929-98676549:+	0.55	10.44	2.27E-24	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ITM2B	chr13:48807274-48836232:+	0.29	6.54	9.35E-11	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	KBTBD7	chr13:41765711-41768702:-	0.32	7.24	8.61E-13	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	KIAA0564	chr13:42140962-42535221:-	0.32	6.39	2.53E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	KIAA1704	chr13:45563687-45607742:+	0.49	8.82	4.62E-18	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	KPNA3	chr13:50273443-50367057:-	0.38	7.86	9.34E-15	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	LAMP1	chr13:113951469-113977741:+	0.55	8.54	4.56E-17	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	LIG4	chr13:108859794-108870716:-	0.41	7.6	6.34E-14	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	MCF2L	chr13:113622757-113752863:+	0.42	7.17	1.37E-12	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	MED4	chr13:48627462-48669251:-	0.57	9.37	4.22E-20	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	MPHOSPH8	chr13:20207880-20246638:+	0.29	5.82	7.92E-9	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	MRP63	chr13:21750372-21753218:+	0.32	6.23	6.8E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	MRPS31	chr13:41303433-41345347:-	0.44	7.09	2.42E-12	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	MTMR6	chr13:25802307-25861704:-	0.4	7.67	3.81E-14	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	MTRF1	chr13:41790517-41837742:-	0.46	7.63	5.1E-14	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	NAA16	chr13:41885341-41951166:+	0.37	6.71	3.2E-11	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	NDFIP2	chr13:80055259-80130205:+	0.57	9.75	1.47E-21	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	NEK3	chr13:52706780-52733996:-	0.4	6.26	5.65E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	NHLRC3	chr13:39612455-39624242:+	0.35	6.54	9.79E-11	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	NUDT15	chr13:48611703-48621282:+	0.47	8.23	5.27E-16	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	NUFIP1	chr13:45513384-45563613:-	0.49	7.91	6.32E-15	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	NUPL1	chr13:25875666-25916560:+	0.4	7.56	8.57E-14	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	PAN3	chr13:28712643-28869469:+	0.34	6.56	8.32E-11	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	PCCA	chr13:100741337-101182686:+	0.48	7.57	8.17E-14	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	PCID2	chr13:113831925-113863029:-	0.77	12.51	1.28E-33	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	PHF11	chr13:50069801-50103116:+	0.39	7.31	5.14E-13	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	PIBF1	chr13:73356230-73590589:+	0.53	9.52	1.11E-20	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	POLR1D	chr13:28194895-28241547:+	0.34	5.74	1.26E-8	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	POMP	chr13:29233241-29253091:+	0.31	6.45	1.64E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	RAP2A	chr13:98086475-98120251:+	0.31	6.83	1.39E-11	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	RBM26	chr13:79894100-79979923:-	0.48	9.37	4.36E-20	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	RCBTB1	chr13:50106082-50159719:-	0.39	7	4.54E-12	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	RNASEH2B	chr13:51483892-51544594:+	0.4	7.22	9.65E-13	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	RNF219	chr13:79188421-79234700:-	0.45	8.08	1.71E-15	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	RNF6	chr13:26706253-26796508:-	0.34	6.23	6.7E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	SAP18	chr13:21714653-21723223:+	0.45	7.72	2.72E-14	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	SETDB2	chr13:50018429-50069138:+	0.33	5.86	6.17E-9	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	SLC25A15	chr13:41363547-41386595:+	0.37	5.93	4.18E-9	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	STK24	chr13:99102455-99229396:-	0.69	11.17	1.87E-27	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	SUCLA2	chr13:48516792-48612125:-	0.53	9.15	2.89E-19	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	SUGT1	chr13:53226831-53262433:+	0.37	6.14	1.19E-9	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	TDRD3	chr13:60970591-61148012:+	0.42	6.59	7.01E-11	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	TFDP1	chr13:114239003-114295786:+	0.62	11.54	4.16E-29	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	TGDS	chr13:95226309-95248511:-	0.62	10.04	1.0E-22	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	THSD1P1	chr13:52741847-52865680:-	0.38	7.45	1.97E-13	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	TM9SF2	chr13:100153728-100215276:+	0.47	9.34	5.53E-20	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	TMCO3	chr13:114145308-114204542:+	0.49	8.22	5.71E-16	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	TMTC4	chr13:101256091-101327103:-	0.47	7.78	1.71E-14	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	TPP2	chr13:103249286-103331521:+	0.6	11.04	6.42E-27	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	TPT1	chr13:45911304-45915297:-	0.33	6.56	8.14E-11	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	TRIM13	chr13:50571143-50592603:+	0.35	5.83	7.48E-9	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	TUBGCP3	chr13:113139328-113242481:-	0.65	12.01	2.87E-31	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	UBAC2	chr13:99852679-100038751:+	0.67	10.64	3.38E-25	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	UCHL3	chr13:76123927-76180066:+	0.4	8.02	2.78E-15	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	UFM1	chr13:38923942-38937142:+	0.44	7.35	4.06E-13	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	UGGT2	chr13:96453838-96705736:-	0.45	7.31	5.2E-13	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	UPF3A	chr13:115047078-115071281:+	0.64	10.78	8.87E-26	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	UTP14C	chr13:52586550-52607734:+	0.39	8.96	1.43E-18	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	VPS36	chr13:52986739-53024763:-	0.44	7.78	1.66E-14	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	WBP4	chr13:41635697-41658137:+	0.44	7.09	2.44E-12	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	XPO4	chr13:21351469-21476913:-	0.29	5.94	3.96E-9	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ZC3H13	chr13:46529805-46626894:-	0.42	8.75	8.13E-18	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ZMYM2	chr13:20532810-20660938:+	0.3	6.16	1.01E-9	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ZMYM5	chr13:20397624-20437776:-	0.36	6.24	6.46E-10	Obesity-related traits	
BRCA	trans	1	rs641862	chr13:110790232	ZNF828	chr13:115079965-115092802:+	0.53	10.09	6.25E-23	Obesity-related traits	
BRCA	trans	1	rs6426833	chr1:20171860	STK17B	chr2:196998308-197041227:-	-0.13	-5.56	3.35E-8	Ulcerative colitis;Inflammatory bowel disease	
BRCA	trans	1	rs6455128	chr6:62697746	GUSBL2	chr6:58246159-58287724:-	-0.22	-5.53	4.04E-8	Protein quantitative trait loci	
BRCA	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.45	13.58	6.97E-39	Educational attainment	
BRCA	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.45	13.6	5.71E-39	Educational attainment	
BRCA	trans	1	rs6485774	chr11:47773226	FOLH1B	chr11:89392465-89431885:+	0.25	5.89	5.17E-9	Intraocular pressure	
BRCA	trans	1	rs6485784	chr11:47832260	FOLH1B	chr11:89392465-89431885:+	0.26	6.07	1.81E-9	Intraocular pressure	
BRCA	trans	1	rs6485788	chr11:47873883	FOLH1B	chr11:89392465-89431885:+	-0.27	-6.24	6.16E-10	Intraocular pressure	
BRCA	trans	1	rs6485872	chr11:48579710	FOLH1B	chr11:89392465-89431885:+	-0.36	-10.04	1.01E-22	HDL cholesterol	
BRCA	trans	1	rs6485875	chr11:48581034	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.95	2.3E-22	HDL cholesterol	
BRCA	trans	1	rs6485882	chr11:48592435	FOLH1B	chr11:89392465-89431885:+	0.35	9.87	4.92E-22	HDL cholesterol	
BRCA	trans	1	rs6485888	chr11:48605339	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.88	4.43E-22	HDL cholesterol	
BRCA	trans	1	rs6485903	chr11:48639004	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.97	1.83E-22	HDL cholesterol	
BRCA	trans	1	rs6485907	chr11:48651695	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.04	1.0E-22	HDL cholesterol	
BRCA	trans	1	rs6485908	chr11:48652198	FOLH1B	chr11:89392465-89431885:+	-0.35	-7.11	2.09E-12	Axial length	
BRCA	trans	1	rs6485911	chr11:48654784	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.86	5.05E-22	HDL cholesterol	
BRCA	trans	1	rs6591439	chr11:55179208	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs6591466	chr11:55213206	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs6598060	chr11:243987	WASH7P	chr1:14363-29961:-	-0.13	-6.49	1.31E-10	Menarche (age at onset)	
BRCA	trans	1	rs6598061	chr11:243853	WASH7P	chr1:14363-29961:-	-0.13	-6.4	2.3E-10	Menarche (age at onset)	
BRCA	trans	1	rs6598062	chr11:243712	WASH7P	chr1:14363-29961:-	-0.13	-6.35	3.09E-10	Menarche (age at onset)	
BRCA	trans	1	rs6598063	chr11:243672	WASH7P	chr1:14363-29961:-	-0.13	-6.35	3.09E-10	Menarche (age at onset)	
BRCA	trans	1	rs6598065	chr11:243211	WASH7P	chr1:14363-29961:-	-0.13	-6.38	2.66E-10	Menarche (age at onset)	
BRCA	trans	1	rs6600669	chr1:121213639	NBPF14	chr1:148003643-148346791:-	0.32	10.71	1.71E-25	Hip geometry	
BRCA	trans	1	rs6600671	chr1:121200490	NBPF14	chr1:148003643-148346791:-	-0.31	-9.99	1.55E-22	Hip geometry	
BRCA	trans	1	rs6736360	chr2:190748749	GSK3B	chr3:119540804-119813264:-	0.29	5.73	1.27E-8	Subcutaneous adipose tissue	
BRCA	trans	1	rs6740641	chr2:54482989	HRC	chr19:49654458-49658681:-	0.2	5.48	5.17E-8	Telomere length	
BRCA	trans	1	rs6768627	chr3:46895376	PIK3R5	chr17:8782234-8869024:-	-0.14	-5.55	3.56E-8	Microalbuminuria	
BRCA	trans	1	rs68141011	chr6:28217797	BTN3A2	chr6:26365398-26378546:+	-0.45	-10.65	3.21E-25	Depression	
BRCA	trans	1	rs68141011	chr6:28217797	RNF5P1	chr8:38457695-38458775:-	0.34	6.13	1.22E-9	Depression	
BRCA	trans	1	rs68141011	chr6:28217797	ZFP57	chr6:29640171-29648887:-	0.29	5.56	3.42E-8	Depression	
BRCA	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.47	14.63	2.63E-44	Migraine without aura	
BRCA	trans	1	rs6901575	chr6:28250984	BTN3A2	chr6:26365398-26378546:+	-0.44	-10.53	1.01E-24	Depression	
BRCA	trans	1	rs6901575	chr6:28250984	RNF5P1	chr8:38457695-38458775:-	0.36	6.75	2.4E-11	Depression	
BRCA	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.43	13.39	6.49E-38	Educational attainment	
BRCA	trans	1	rs6905391	chr6:28262686	BTN3A2	chr6:26365398-26378546:+	-0.44	-10.69	2.13E-25	Depression	
BRCA	trans	1	rs6905391	chr6:28262686	RNF5P1	chr8:38457695-38458775:-	0.35	6.62	5.54E-11	Depression	
BRCA	trans	1	rs6905913	chr6:124346434	OC90	chr8:133036467-133071627:-	-0.19	-5.44	6.73E-8	Schizophrenia	
BRCA	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.44	13.57	8.55E-39	Educational attainment	
BRCA	trans	1	rs6915784	chr6:143984268	SHC2	chr19:416585-460996:-	0.19	5.42	7.33E-8	Obesity-related traits	
BRCA	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.47	-14.59	4.15E-44	Educational attainment	
BRCA	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.45	13.55	1.02E-38	Educational attainment	
BRCA	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.44	13.55	1.05E-38	Educational attainment	
BRCA	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.45	13.55	1.03E-38	Educational attainment	
BRCA	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.43	13.31	1.67E-37	Educational attainment	
BRCA	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.45	13.72	1.36E-39	Educational attainment	
BRCA	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.45	13.55	1.02E-38	Educational attainment	
BRCA	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.43	13.18	7.21E-37	Educational attainment	
BRCA	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.45	13.71	1.67E-39	Educational attainment	
BRCA	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.45	13.71	1.67E-39	Educational attainment	
BRCA	trans	1	rs6951643	chr7:126429517	CLDN7	chr17:7163223-7166512:-	0.19	5.55	3.56E-8	Creutzfeldt-Jakob disease (sporadic)	
BRCA	trans	1	rs6955934	chr7:23251499	ETV4	chr17:41605212-41623762:-	-0.42	-5.44	6.6E-8	Chronic obstructive pulmonary disease	
BRCA	trans	1	rs705696	chr12:56480648	RPS26P11	chrX:71264259-71264809:+	0.35	8.74	9.05E-18	Cognitive function	
BRCA	trans	1	rs7101448	chr11:55133222	FOLH1B	chr11:89392465-89431885:+	0.54	7.05	3.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7102958	chr11:55298631	FOLH1B	chr11:89392465-89431885:+	0.6	7.45	1.96E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7103234	chr11:55141298	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7103342	chr11:55268805	FOLH1B	chr11:89392465-89431885:+	0.5	6.77	2.11E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7106100	chr11:55219382	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7107184	chr11:48577069	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.02	1.19E-22	HDL cholesterol	
BRCA	trans	1	rs7109010	chr11:55137386	FOLH1B	chr11:89392465-89431885:+	0.59	7.28	6.65E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7109287	chr11:55219432	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7111663	chr11:55218922	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7111681	chr11:55218978	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7111837	chr11:55066266	FOLH1B	chr11:89392465-89431885:+	0.57	7.32	4.77E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7112469	chr11:55266600	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7112674	chr11:55342067	FOLH1B	chr11:89392465-89431885:+	0.57	7.25	7.87E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7112787	chr11:55342155	FOLH1B	chr11:89392465-89431885:+	0.52	7.01	4.1E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7114530	chr11:55030994	FOLH1B	chr11:89392465-89431885:+	0.6	7.42	2.32E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7115527	chr11:55268855	FOLH1B	chr11:89392465-89431885:+	-0.42	-5.97	3.19E-9	Systemic lupus erythematosus	
BRCA	trans	1	rs7116208	chr11:55212816	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7117005	chr11:55169003	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.29E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs7118951	chr11:55105307	FOLH1B	chr11:89392465-89431885:+	0.54	7.08	2.57E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7119050	chr11:55064571	FOLH1B	chr11:89392465-89431885:+	0.57	7.32	4.77E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7119347	chr11:55270585	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7121460	chr11:48545232	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.05	9.44E-23	HDL cholesterol	
BRCA	trans	1	rs7121552	chr11:55141150	FOLH1B	chr11:89392465-89431885:+	0.53	6.95	6.19E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7121555	chr11:55268934	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7121804	chr11:55111222	FOLH1B	chr11:89392465-89431885:+	0.54	7.08	2.57E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7121992	chr11:48592582	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.1	5.64E-23	HDL cholesterol	
BRCA	trans	1	rs7122234	chr11:55137715	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7122704	chr11:55150606	FOLH1B	chr11:89392465-89431885:+	0.6	7.36	3.64E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7124611	chr11:55361189	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7124739	chr11:55361272	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7124871	chr11:55541620	FOLH1B	chr11:89392465-89431885:+	0.55	6.9	9.01E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7125205	chr11:55178992	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs7125559	chr11:48984207	FOLH1B	chr11:89392465-89431885:+	0.39	7.62	5.61E-14	Axial length	
BRCA	trans	1	rs7125913	chr11:48984318	FOLH1B	chr11:89392465-89431885:+	0.39	7.61	6.01E-14	Axial length	
BRCA	trans	1	rs7127405	chr11:55132783	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.71	3.24E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7127570	chr11:55247176	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7128029	chr11:244141	WASH7P	chr1:14363-29961:-	-0.13	-6.4	2.3E-10	Menarche (age at onset)	
BRCA	trans	1	rs7128044	chr11:244115	WASH7P	chr1:14363-29961:-	-0.13	-6.4	2.3E-10	Menarche (age at onset)	
BRCA	trans	1	rs7128331	chr11:55361156	FOLH1B	chr11:89392465-89431885:+	0.59	7.2	1.16E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7128574	chr11:55176997	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7128605	chr11:55245605	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7128617	chr11:55245650	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7129386	chr11:48616694	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.88	4.43E-22	HDL cholesterol	
BRCA	trans	1	rs7129556	chr11:77300048	INTS4L1	chr7:64601603-64694599:+	-0.38	-8.62	2.48E-17	Weight loss (gastric bypass surgery)	
BRCA	trans	1	rs7227401	chr18:21938658	ID2B	chr3:62109161-62110392:-	-0.28	-5.46	6.08E-8	Osteoporosis-related phenotypes	
BRCA	trans	1	rs72843784	chr6:26498758	RNF5P1	chr8:38457695-38458775:-	0.7	8.42	1.21E-16	Schizophrenia	
BRCA	trans	1	rs72843784	chr6:26498758	ZFP57	chr6:29640171-29648887:-	0.73	9.41	2.88E-20	Schizophrenia	
BRCA	trans	1	rs73193868	chr21:30600224	ABCA1	chr9:107543285-107690436:-	0.35	5.73	1.29E-8	Response to mTOR inhibitor (everolimus)	
BRCA	trans	1	rs733318	chr2:190724141	GSK3B	chr3:119540804-119813264:-	0.29	5.7	1.53E-8	Subcutaneous adipose tissue	
BRCA	trans	1	rs7395662	chr11:48518893	FOLH1B	chr11:89392465-89431885:+	0.36	9.88	4.16E-22	HDL cholesterol	
BRCA	trans	1	rs74331841	chr11:55322422	FOLH1B	chr11:89392465-89431885:+	0.57	7.26	7.4E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs74625780	chr11:55225873	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs747782	chr11:47940925	FOLH1B	chr11:89392465-89431885:+	0.3	6.93	7.24E-12	Intraocular pressure	
BRCA	trans	1	rs7478900	chr11:48544003	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.13	4.37E-23	HDL cholesterol	
BRCA	trans	1	rs7479134	chr11:48625409	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.98	1.73E-22	HDL cholesterol	
BRCA	trans	1	rs7479498	chr11:48660499	FOLH1B	chr11:89392465-89431885:+	-0.38	-10.29	9.47E-24	HDL cholesterol	
BRCA	trans	1	rs7481308	chr11:48600067	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.1	5.64E-23	HDL cholesterol	
BRCA	trans	1	rs7481880	chr11:48609347	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.98	1.73E-22	HDL cholesterol	
BRCA	trans	1	rs7482176	chr11:48604620	FOLH1B	chr11:89392465-89431885:+	-0.38	-10.17	2.95E-23	HDL cholesterol	
BRCA	trans	1	rs7482528	chr11:48640052	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.93	2.86E-22	HDL cholesterol	
BRCA	trans	1	rs7482591	chr11:245861	WASH7P	chr1:14363-29961:-	-0.13	-6.4	2.39E-10	Menarche (age at onset)	
BRCA	trans	1	rs7483920	chr11:48599969	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.08	6.84E-23	HDL cholesterol	
BRCA	trans	1	rs75226237	chr11:55158788	FOLH1B	chr11:89392465-89431885:+	0.57	7.3	5.52E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs75287308	chr11:54823902	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7532615	chr1:121172840	NBPF14	chr1:148003643-148346791:-	-0.3	-10.34	6.27E-24	Hip geometry	
BRCA	trans	1	rs75519906	chr11:55115611	FOLH1B	chr11:89392465-89431885:+	0.63	7.58	7.32E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs75619483	chr11:55079010	FOLH1B	chr11:89392465-89431885:+	0.56	7.24	8.58E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs75768461	chr11:55292919	FOLH1B	chr11:89392465-89431885:+	0.59	7.41	2.54E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs75830164	chr1:77168761	CHST1	chr11:45670427-45687172:-	0.37	5.45	6.11E-8	Amyotrophic lateral sclerosis (sporadic)	
BRCA	trans	1	rs75847378	chr2:40181517	STK38L	chr12:27397078-27478888:+	0.26	5.5	4.73E-8	Alzheimer's disease	
BRCA	trans	1	rs75881957	chr11:55339712	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7588354	chr2:134332761	ANKRD20A4	chr9:69381981-69425108:+	0.29	6.42	2.0E-10	Alzheimer's disease (survival time)	
BRCA	trans	1	rs76046642	chr11:55225417	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs76097560	chr11:55329853	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs76202438	chr11:54801567	FOLH1B	chr11:89392465-89431885:+	0.55	6.8	1.78E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs76388671	chr11:55329854	FOLH1B	chr11:89392465-89431885:+	0.58	7.41	2.49E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs76426677	chr11:55225921	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs76515019	chr11:54842025	FOLH1B	chr11:89392465-89431885:+	0.52	6.57	7.62E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs76670300	chr11:55344192	FOLH1B	chr11:89392465-89431885:+	0.54	7.2	1.1E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs76688555	chr2:190747415	GSK3B	chr3:119540804-119813264:-	0.28	5.7	1.55E-8	Subcutaneous adipose tissue	
BRCA	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.44	13.64	3.76E-39	Educational attainment	
BRCA	trans	1	rs76906133	chr11:55224695	FOLH1B	chr11:89392465-89431885:+	0.57	7.07	2.86E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs76914796	chr11:55521982	FOLH1B	chr11:89392465-89431885:+	0.54	6.67	4.13E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs77021942	chr11:54800918	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs77053681	chr11:55135053	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs77074588	chr1:77168662	CHST1	chr11:45670427-45687172:-	0.37	5.45	6.11E-8	Amyotrophic lateral sclerosis (sporadic)	
BRCA	trans	1	rs77219956	chr11:55183893	FOLH1B	chr11:89392465-89431885:+	0.62	7.57	8.34E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs77248666	chr11:55294317	FOLH1B	chr11:89392465-89431885:+	0.59	7.41	2.54E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs77298220	chr11:55290368	FOLH1B	chr11:89392465-89431885:+	0.59	7.39	2.86E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs77352583	chr11:55187803	FOLH1B	chr11:89392465-89431885:+	0.54	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7740487	chr6:28216486	BTN3A2	chr6:26365398-26378546:+	-0.45	-10.68	2.39E-25	Depression	
BRCA	trans	1	rs7740487	chr6:28216486	RNF5P1	chr8:38457695-38458775:-	0.34	6.11	1.41E-9	Depression	
BRCA	trans	1	rs7740487	chr6:28216486	ZFP57	chr6:29640171-29648887:-	0.3	5.62	2.4E-8	Depression	
BRCA	trans	1	rs77611127	chr11:55314571	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs77650525	chr11:55322921	FOLH1B	chr11:89392465-89431885:+	0.57	7.26	7.23E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7770848	chr6:44769237	C6orf153	chr6:42989385-42997337:+	-0.31	-5.48	5.21E-8	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	CUL9	chr6:43149922-43192324:+	-0.31	-5.43	7.0E-8	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	MAD2L1BP	chr6:43597279-43608686:+	-0.39	-5.71	1.48E-8	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	MCM3	chr6:52128812-52149582:-	-0.35	-6.86	1.19E-11	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	MRPS10	chr6:42174540-42185633:-	-0.36	-5.88	5.62E-9	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	MRPS18A	chr6:43639042-43655528:-	-0.3	-5.7	1.58E-8	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	POLR1C	chr6:43484791-43497114:+	-0.3	-5.81	8.39E-9	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	PPP2R5D	chr6:42952330-42980078:+	-0.35	-5.64	2.14E-8	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	TJP3	chr19:3708382-3750681:+	0.29	5.68	1.74E-8	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	TOMM6	chr6:41754178-41757634:+	-0.36	-7.33	4.63E-13	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	UBR2	chr6:42532058-42658909:+	-0.26	-5.58	3.13E-8	Asthma (childhood onset)	
BRCA	trans	1	rs7770848	chr6:44769237	XPO5	chr6:43490069-43543812:-	-0.29	-6.42	2.07E-10	Asthma (childhood onset)	
BRCA	trans	1	rs77718339	chr11:55252306	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs77792938	chr11:55312829	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs77797466	chr11:55071093	FOLH1B	chr11:89392465-89431885:+	0.54	7.04	3.35E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs78036162	chr11:54839925	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs78057082	chr11:55079327	FOLH1B	chr11:89392465-89431885:+	0.54	7.09	2.38E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs78253765	chr11:55343347	FOLH1B	chr11:89392465-89431885:+	0.57	7.25	7.87E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs78301054	chr11:55312925	FOLH1B	chr11:89392465-89431885:+	0.51	6.9	9.18E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs78414330	chr11:55252243	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs78502527	chr11:55187580	FOLH1B	chr11:89392465-89431885:+	0.52	6.85	1.21E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs78612916	chr11:55339704	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7867876	chr9:123723534	FAM168A	chr11:73117028-73309228:-	-0.27	-5.72	1.39E-8	Pre-treatment pain in head and neck squamous cell carcinoma	
BRCA	trans	1	rs78785256	chr11:55282643	FOLH1B	chr11:89392465-89431885:+	0.58	7.36	3.73E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs78799386	chr11:55158334	FOLH1B	chr11:89392465-89431885:+	0.53	7	4.64E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs78875307	chr11:55173669	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs7924699	chr11:47893120	FOLH1B	chr11:89392465-89431885:+	0.26	6.01	2.49E-9	Intraocular pressure	
BRCA	trans	1	rs7924882	chr11:55222061	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7925927	chr11:55171160	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs7925955	chr11:48647533	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.01	1.3E-22	HDL cholesterol	
BRCA	trans	1	rs7927370	chr11:55136219	FOLH1B	chr11:89392465-89431885:+	0.6	7.43	2.18E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7927738	chr11:55251545	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs79277988	chr11:55224325	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7928083	chr11:48613148	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.88	4.43E-22	HDL cholesterol	
BRCA	trans	1	rs7929606	chr11:55275236	FOLH1B	chr11:89392465-89431885:+	0.51	6.81	1.6E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7930341	chr11:55269816	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7931450	chr11:55565359	FOLH1B	chr11:89392465-89431885:+	0.55	6.95	6.47E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7931984	chr11:48580835	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.04	1.04E-22	HDL cholesterol	
BRCA	trans	1	rs7933811	chr11:55298265	FOLH1B	chr11:89392465-89431885:+	0.6	7.45	1.96E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7935445	chr11:55288780	FOLH1B	chr11:89392465-89431885:+	0.6	7.4	2.69E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7935599	chr11:55251546	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7935986	chr11:55136562	FOLH1B	chr11:89392465-89431885:+	0.54	7.05	3.11E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7938739	chr11:55206830	FOLH1B	chr11:89392465-89431885:+	0.59	7.42	2.44E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs7938880	chr11:48642154	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.06	8.16E-23	HDL cholesterol	
BRCA	trans	1	rs7940290	chr11:55274849	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7940435	chr11:55274969	FOLH1B	chr11:89392465-89431885:+	0.5	6.77	2.07E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7940928	chr11:55217478	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7941275	chr11:55269686	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7941839	chr11:55270154	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7941860	chr11:55270188	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7942031	chr11:47868474	FOLH1B	chr11:89392465-89431885:+	0.26	6.15	1.09E-9	Intraocular pressure	
BRCA	trans	1	rs7942480	chr11:55257480	FOLH1B	chr11:89392465-89431885:+	0.56	6.93	7.31E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7943036	chr11:55171193	FOLH1B	chr11:89392465-89431885:+	0.53	6.99	4.74E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7943092	chr11:55261104	FOLH1B	chr11:89392465-89431885:+	0.57	6.98	5.05E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7943639	chr11:55079897	FOLH1B	chr11:89392465-89431885:+	0.54	7.09	2.38E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7943676	chr11:55251205	FOLH1B	chr11:89392465-89431885:+	0.5	6.58	7.25E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7944356	chr11:48610154	FOLH1B	chr11:89392465-89431885:+	-0.36	-9.88	4.43E-22	HDL cholesterol	
BRCA	trans	1	rs7944383	chr11:55487252	FOLH1B	chr11:89392465-89431885:+	0.57	7.14	1.78E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7944525	chr11:55487391	FOLH1B	chr11:89392465-89431885:+	0.57	7.14	1.78E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7945192	chr11:48580737	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.04	9.83E-23	HDL cholesterol	
BRCA	trans	1	rs7945896	chr11:55445243	FOLH1B	chr11:89392465-89431885:+	0.58	7.1	2.27E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7946976	chr11:55206920	FOLH1B	chr11:89392465-89431885:+	0.53	7.04	3.44E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7947870	chr11:55444514	FOLH1B	chr11:89392465-89431885:+	0.58	7.1	2.27E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7948486	chr11:48912140	FOLH1B	chr11:89392465-89431885:+	0.37	10.05	9.29E-23	HDL cholesterol	
BRCA	trans	1	rs7948802	chr11:55217012	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7949348	chr11:48493801	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.25	1.46E-23	HDL cholesterol	
BRCA	trans	1	rs7949554	chr11:48581992	FOLH1B	chr11:89392465-89431885:+	-0.37	-9.94	2.57E-22	HDL cholesterol	
BRCA	trans	1	rs7950542	chr11:55292605	FOLH1B	chr11:89392465-89431885:+	0.54	7.12	2.04E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7950685	chr11:55260691	FOLH1B	chr11:89392465-89431885:+	0.57	7.03	3.66E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7950755	chr11:55269990	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs7950848	chr11:55175602	FOLH1B	chr11:89392465-89431885:+	0.62	7.55	9.5E-14	Systemic lupus erythematosus	
BRCA	trans	1	rs7951100	chr11:55590296	FOLH1B	chr11:89392465-89431885:+	0.53	6.93	7.22E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs7952701	chr11:55289006	FOLH1B	chr11:89392465-89431885:+	0.54	7.11	2.17E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs79545406	chr1:77169119	CHST1	chr11:45670427-45687172:-	0.37	5.43	6.97E-8	Amyotrophic lateral sclerosis (sporadic)	
BRCA	trans	1	rs79551837	chr11:54858233	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs79577263	chr11:54840579	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs79633274	chr11:55224396	FOLH1B	chr11:89392465-89431885:+	0.5	6.71	3.15E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs79727833	chr11:55293051	FOLH1B	chr11:89392465-89431885:+	0.59	7.41	2.54E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs79883073	chr11:55184745	FOLH1B	chr11:89392465-89431885:+	0.52	6.86	1.13E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs79923619	chr1:77169047	CHST1	chr11:45670427-45687172:-	0.37	5.45	6.11E-8	Amyotrophic lateral sclerosis (sporadic)	
BRCA	trans	1	rs80123215	chr11:55339466	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs80210585	chr11:55339740	FOLH1B	chr11:89392465-89431885:+	0.58	7.37	3.48E-13	Systemic lupus erythematosus	
BRCA	trans	1	rs8098064	chr18:8209269	MYL12B	chr18:3262111-3278280:+	0.39	6.06	1.84E-9	Dialysis-related mortality	
BRCA	trans	1	rs8114671	chr20:33789142	KTN1	chr14:56046925-56151301:+	-0.16	-5.42	7.29E-8	Height	
BRCA	trans	1	rs8188963	chr11:48685693	FOLH1B	chr11:89392465-89431885:+	0.41	7.87	8.7E-15	Axial length	
BRCA	trans	1	rs840611	chr2:188198446	PLEKHA7	chr11:16800548-17035963:-	0.16	5.43	6.81E-8	Coronary heart disease	
BRCA	trans	1	rs853676	chr6:28299687	BTN3A2	chr6:26365398-26378546:+	-0.43	-10.28	1.07E-23	Depression	
BRCA	trans	1	rs853676	chr6:28299687	RNF5P1	chr8:38457695-38458775:-	0.35	6.49	1.32E-10	Depression	
BRCA	trans	1	rs853678	chr6:28297313	BTN3A2	chr6:26365398-26378546:+	-0.44	-10.66	2.71E-25	Depression	
BRCA	trans	1	rs853678	chr6:28297313	RNF5P1	chr8:38457695-38458775:-	0.36	6.76	2.23E-11	Depression	
BRCA	trans	1	rs853679	chr6:28296863	BTN3A2	chr6:26365398-26378546:+	-0.44	-10.66	2.71E-25	Depression	
BRCA	trans	1	rs853679	chr6:28296863	RNF5P1	chr8:38457695-38458775:-	0.36	6.76	2.23E-11	Depression	
BRCA	trans	1	rs853685	chr6:28288785	BTN3A2	chr6:26365398-26378546:+	-0.43	-10.39	3.87E-24	Depression	
BRCA	trans	1	rs853685	chr6:28288785	RNF5P1	chr8:38457695-38458775:-	0.36	6.72	2.91E-11	Depression	
BRCA	trans	1	rs853694	chr6:28279100	BTN3A2	chr6:26365398-26378546:+	-0.43	-10.28	1.05E-23	Depression	
BRCA	trans	1	rs853694	chr6:28279100	RNF5P1	chr8:38457695-38458775:-	0.36	6.72	2.95E-11	Depression	
BRCA	trans	1	rs858280	chr7:23250874	ETV4	chr17:41605212-41623762:-	-0.42	-5.44	6.6E-8	Chronic obstructive pulmonary disease	
BRCA	trans	1	rs858281	chr7:23250567	ETV4	chr17:41605212-41623762:-	-0.42	-5.44	6.6E-8	Chronic obstructive pulmonary disease	
BRCA	trans	1	rs877636	chr12:56480583	RPS26P11	chrX:71264259-71264809:+	-0.41	-11.37	2.27E-28	Cognitive function	
BRCA	trans	1	rs886448	chr7:24240165	C7orf26	chr7:6629915-6648355:+	-0.43	-6.66	4.4E-11	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	C7orf70	chr7:6369041-6388590:-	-0.46	-6.02	2.35E-9	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	EIF2AK1	chr7:6061880-6098860:-	-0.38	-5.53	4.0E-8	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	EIF3B	chr7:2394474-2420375:+	-0.37	-6.1	1.46E-9	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	FTSJ2	chr7:2273928-2281833:-	-0.46	-6.22	6.97E-10	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	INTS1	chr7:1509913-1544018:-	-0.33	-5.68	1.78E-8	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	MIOS	chr7:7606616-7647103:+	-0.39	-5.68	1.74E-8	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	PHF14	chr7:11013516-11209241:+	-0.52	-6.88	9.97E-12	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	PMS2	chr7:6010556-6048737:-	-0.52	-6.8	1.74E-11	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	PSMG3	chr7:1606970-1609668:-	-0.28	-5.84	6.76E-9	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	RBAK	chr7:5085452-5109119:+	-0.33	-5.53	4.0E-8	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	RNF216	chr7:5659678-5821292:-	-0.45	-6.05	1.96E-9	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	RNF216L	chr7:5013616-5037798:+	-0.45	-5.94	3.83E-9	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	USP42	chr7:6144550-6201194:+	-0.39	-5.73	1.28E-8	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	WIPI2	chr7:5229835-5273485:+	-0.41	-5.87	5.76E-9	Asthma (childhood onset)	
BRCA	trans	1	rs886448	chr7:24240165	ZNF12	chr7:6728064-6746566:-	-0.32	-5.5	4.78E-8	Asthma (childhood onset)	
BRCA	trans	1	rs919586	chr8:13174671	AGPAT5	chr8:6565878-6619019:+	0.32	6.63	5.21E-11	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	ASAH1	chr8:17913925-17942507:-	0.26	6.63	5.38E-11	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	ATP6V1B2	chr8:20054704-20079205:+	0.26	6.3	4.39E-10	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	BIN3	chr8:22477949-22526661:-	0.26	6.95	6.41E-12	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	C8orf58	chr8:22457122-22461660:+	0.22	5.95	3.55E-9	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	CCDC25	chr8:27590835-27630170:-	0.34	6.98	5.04E-12	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	CHMP7	chr8:23101150-23119512:+	0.32	6.53	1.02E-10	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	CNOT7	chr8:17086740-17104387:-	0.39	8.36	1.91E-16	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	ERI1	chr8:8860314-8890849:+	0.32	7.07	2.73E-12	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	ERICH1	chr8:564749-681226:-	0.28	5.75	1.17E-8	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	ESCO2	chr8:27632058-27670141:+	0.19	5.65	2.02E-8	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	EXTL3	chr8:28559153-28611202:+	0.24	5.54	3.81E-8	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	FAM160B2	chr8:21946714-21961890:+	0.23	5.74	1.23E-8	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	FDFT1	chr8:11653082-11696817:+	0.38	7.33	4.63E-13	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	INTS10	chr8:19674918-19709584:+	0.37	8	3.13E-15	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	INTS9	chr8:28625180-28747698:-	0.33	6.85	1.25E-11	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	KIAA1967	chr8:22462257-22477981:+	0.4	8.39	1.49E-16	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	MCPH1	chr8:6264121-6506025:+	0.35	7.2	1.13E-12	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	MTMR9	chr8:11142000-11185652:+	0.23	5.56	3.32E-8	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	NEIL2	chr8:11627172-11644854:+	0.3	5.95	3.71E-9	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	PBK	chr8:27667140-27695572:-	0.2	5.86	6.27E-9	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	PCM1	chr8:17780366-17887455:+	0.3	7.9	6.87E-15	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	POLR3D	chr8:22102619-22108679:+	0.28	6.23	6.76E-10	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	PPP1R3B	chr8:8993774-9009084:-	0.3	6.69	3.68E-11	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	PPP2R2A	chr8:25230075-26228645:+	0.3	6.37	2.76E-10	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	R3HCC1	chr8:23145612-23153791:+	0.21	5.53	4.14E-8	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	REEP4	chr8:21995533-21999448:-	0.28	6.95	6.17E-12	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	SORBS3	chr8:22409251-22433007:+	0.24	6.43	1.91E-10	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	TNFRSF10A	chr8:23048971-23082639:-	0.26	5.77	1.04E-8	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	TNKS	chr8:9413445-9639855:+	0.28	6.95	6.16E-12	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	TRIM35	chr8:27142404-27168834:-	0.26	5.44	6.65E-8	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	VPS37A	chr8:17104401-17155532:+	0.36	7.7	3.11E-14	Obesity-related traits	
BRCA	trans	1	rs919586	chr8:13174671	XPO7	chr8:21777180-21864095:+	0.38	8.3	3.06E-16	Obesity-related traits	
BRCA	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.45	-13.51	1.71E-38	Educational attainment	
BRCA	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.44	13.47	2.68E-38	Educational attainment	
BRCA	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.43	13.24	3.75E-37	Educational attainment	
BRCA	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.44	13.48	2.42E-38	Educational attainment	
BRCA	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.44	13.38	7.03E-38	Educational attainment	
BRCA	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.44	13.39	6.94E-38	Educational attainment	
BRCA	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.43	13.29	2.2E-37	Educational attainment	
BRCA	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.45	13.74	1.11E-39	Educational attainment	
BRCA	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.43	13.31	1.67E-37	Educational attainment	
BRCA	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.43	13.3	1.81E-37	Educational attainment	
BRCA	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.44	13.39	6.94E-38	Educational attainment	
BRCA	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.44	-13.42	4.59E-38	Educational attainment	
BRCA	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.43	13.25	3.48E-37	Educational attainment	
BRCA	trans	1	rs9467783	chr6:26542894	RICH2	chr17:12692829-12894959:+	0.22	5.43	6.96E-8	Educational attainment	
BRCA	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.44	13.31	1.74E-37	Educational attainment	
BRCA	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.45	13.74	1.11E-39	Educational attainment	
BRCA	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.46	-13.89	1.87E-40	Educational attainment	
BRCA	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.45	13.55	1.04E-38	Educational attainment	
BRCA	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.45	13.55	1.04E-38	Educational attainment	
BRCA	trans	1	rs9534458	chr13:47237952	SUCLA2	chr13:48516792-48612125:-	-0.2	-5.72	1.35E-8	PR segment	
BRCA	trans	1	rs958550	chr7:65635679	ZNF117	chr7:64434830-64467121:-	0.31	5.78	9.6E-9	Diabetic kidney disease	
BRCA	trans	1	rs9645642	chr11:48705455	FOLH1B	chr11:89392465-89431885:+	-0.37	-10.03	1.12E-22	HDL cholesterol	
BRCA	trans	1	rs9666022	chr11:54871984	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.6E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs9666078	chr11:54900223	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs9666121	chr11:55272448	FOLH1B	chr11:89392465-89431885:+	0.5	6.78	2.01E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs9666206	chr11:54850932	FOLH1B	chr11:89392465-89431885:+	0.59	7.08	2.7E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs9666260	chr11:55272410	FOLH1B	chr11:89392465-89431885:+	0.57	7.16	1.52E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs9666612	chr11:54876280	FOLH1B	chr11:89392465-89431885:+	0.55	7.15	1.6E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs9666744	chr11:55276602	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.53	1.04E-10	Systemic lupus erythematosus	
BRCA	trans	1	rs9667732	chr11:55272520	FOLH1B	chr11:89392465-89431885:+	0.51	6.81	1.6E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs970548	chr10:46013277	AGAP8	chr10:51224690-51371331:-	0.22	5.69	1.61E-8	HDL cholesterol;Cholesterol, total	
BRCA	trans	1	rs979111	chr11:55171027	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.71	3.12E-11	Systemic lupus erythematosus	
BRCA	trans	1	rs9818982	chr3:45812514	BAP1	chr3:52435027-52444009:-	-0.25	-5.44	6.79E-8	Blood metabolite levels	
BRCA	trans	1	rs9818982	chr3:45812514	DHX30	chr3:47844399-47891685:+	-0.27	-6.51	1.13E-10	Blood metabolite levels	
BRCA	trans	1	rs9818982	chr3:45812514	GNL3	chr3:52719936-52728508:+	-0.29	-6.24	6.41E-10	Blood metabolite levels	
BRCA	trans	1	rs9818982	chr3:45812514	IP6K2	chr3:48725437-48754920:-	-0.23	-5.51	4.6E-8	Blood metabolite levels	
BRCA	trans	1	rs9818982	chr3:45812514	KIAA1143	chr3:44790239-44803173:-	-0.22	-5.56	3.49E-8	Blood metabolite levels	
BRCA	trans	1	rs9818982	chr3:45812514	QRICH1	chr3:49067144-49131504:-	-0.27	-5.65	2.03E-8	Blood metabolite levels	
BRCA	trans	1	rs9818982	chr3:45812514	SEC22C	chr3:42589475-42642572:-	-0.26	-5.73	1.33E-8	Blood metabolite levels	
BRCA	trans	1	rs9818982	chr3:45812514	USP19	chr3:49145484-49158213:-	-0.25	-5.91	4.72E-9	Blood metabolite levels	
BRCA	trans	1	rs982276	chr11:55320099	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs982277	chr11:55320394	FOLH1B	chr11:89392465-89431885:+	0.56	7.15	1.61E-12	Systemic lupus erythematosus	
BRCA	trans	1	rs9823535	chr3:122327950	FADD	chr11:70049269-70053508:+	-0.38	-5.48	5.19E-8	Major depressive disorder	
BRCA	trans	1	rs9823546	chr3:49705512	TREX1	chr3:48501186-48509043:+	-0.18	-5.77	1.03E-8	Crohn's disease;Ulcerative colitis	
BRCA	trans	1	rs9858542	chr3:49701983	TREX1	chr3:48501186-48509043:+	0.18	5.77	1.04E-8	Crohn's disease;Ulcerative colitis	
BRCA	trans	1	rs9882740	chr3:49702484	TREX1	chr3:48501186-48509043:+	-0.18	-5.75	1.15E-8	Crohn's disease;Ulcerative colitis	
BRCA	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.44	13.56	9.29E-39	Educational attainment	
BRCA	trans	1	rs9986596	chr6:28219661	BTN3A2	chr6:26365398-26378546:+	-0.45	-10.7	1.94E-25	Depression	
BRCA	trans	1	rs9986596	chr6:28219661	RNF5P1	chr8:38457695-38458775:-	0.34	6.19	8.73E-10	Depression	
BRCA	trans	1	rs9986596	chr6:28219661	ZFP57	chr6:29640171-29648887:-	0.28	5.5	4.78E-8	Depression	
